data_2jxa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jxa _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 65.4 mtp85 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.598 0.237 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -153.12 138.37 17.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.296 0.57 . . . . 0.0 112.161 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.532 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 86.8 mt-10 -131.16 149.5 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.472 HD21 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -136.26 139.55 42.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -143.9 145.18 32.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.034 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.3 m -71.25 133.66 46.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.457 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 79.7 tt0 -44.27 137.16 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.496 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.22 -6.94 72.4 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.402 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.442 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 15.1 m-85 -116.9 153.78 49.46 Favored Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 118.972 1.386 . . . . 0.0 111.154 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.05 141.8 40.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.124 1.883 . . . . 0.0 112.725 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 16.5 tt -116.33 144.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 86.0 tt0 -129.98 127.71 40.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.261 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.462 HD13 ' SG ' ' A' ' 102' ' ' CYS . 19.9 mt -111.45 144.74 40.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.254 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.519 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 62.7 mtt180 -147.93 126.62 12.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.309 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.458 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.5 m -95.39 144.54 27.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 27.6 Cg_endo -68.55 157.3 62.39 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.481 2.12 . . . . 0.0 112.295 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.43 -134.51 29.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.438 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -104.63 23.05 13.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -77.67 167.67 21.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.85 145.65 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.635 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.488 HG21 ' CD2' ' A' ' 126' ' ' TYR . 97.4 mt -67.91 136.21 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.821 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.591 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.2 ptm -132.5 100.79 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.16 124.77 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.403 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.562 ' OE1' ' OD1' ' A' ' 127' ' ' ASP . 46.9 mt-10 -102.04 -50.61 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.855 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -148.23 146.5 28.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.948 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -165.8 153.83 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.531 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -151.54 154.16 35.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.159 0.504 . . . . 0.0 111.796 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 30.2 t80 -123.57 122.83 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -138.89 6.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 5.3 ttm-85 -155.69 115.52 3.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.057 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.658 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 14.8 p -124.8 7.67 8.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.525 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 15.2 t70 -146.95 155.47 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' O ' ' CE ' ' A' ' 78' ' ' MET . 58.7 p30 -110.16 0.69 18.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.419 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 14.2 mttp -105.75 8.86 33.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.776 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.646 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 46.1 mm -113.72 136.27 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.781 0.324 . . . . 0.0 110.512 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 51.6 m 59.99 63.7 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -47.99 109.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 112.25 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.449 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -128.35 -164.81 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.758 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.687 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -62.85 144.73 96.63 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.173 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.2 Cg_endo -54.78 -37.59 92.08 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.34 2.027 . . . . 0.0 112.52 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -63.86 -34.47 78.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.597 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.687 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.3 mt-30 -86.82 -10.73 52.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.468 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 88.1 mtp -102.21 -5.49 24.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 37.6 mm-40 -63.99 -52.63 58.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -78.84 115.48 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.379 0.609 . . . . 0.0 112.517 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.531 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.2 m -107.17 32.28 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.127 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -139.93 85.51 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.113 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.425 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.6 t -148.11 118.79 7.51 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -125.74 152.85 44.79 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.08 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.0 tp -147.17 83.66 7.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.66 -47.25 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.078 2.519 . . . . 0.0 113.308 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 82.3 m-20 -54.11 -23.76 15.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.802 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.33 56.78 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.098 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.483 ' CE1' ' OG ' ' A' ' 93' ' ' SER . 33.7 t80 -64.03 -42.85 96.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.99 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 14.4 pttm -63.92 -38.35 90.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.106 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.442 HG22 ' HE ' ' A' ' 95' ' ' ARG . 69.1 mt -60.98 -52.22 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.306 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.5 mmm -68.48 -36.24 78.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.068 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.8 m -60.43 -47.29 86.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -66.55 -36.84 83.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.442 ' HE ' HG22 ' A' ' 91' ' ' ILE . 89.5 mtt-85 -76.96 -32.91 57.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.29 -15.29 13.65 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.539 ' CG ' ' O ' ' A' ' 93' ' ' SER . 48.2 m-20 -60.04 134.07 56.7 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.665 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 66.38 13.53 9.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -115.95 147.35 41.25 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.57 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.7 m -72.53 -31.47 65.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.718 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.48 154.65 35.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.462 ' SG ' HD13 ' A' ' 48' ' ' LEU . 27.2 p -155.16 136.94 14.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.747 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 20.6 t -116.93 130.59 71.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 46' ' ' ILE . 42.3 t -143.09 146.87 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.599 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -80.76 118.49 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.01 37.44 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.723 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.74 -130.16 1.46 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.564 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 107' ' ' GLY . 3.5 t 36.64 -154.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -63.27 -9.01 9.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.273 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.15 -13.45 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.558 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.583 ' O ' ' O ' ' A' ' 112' ' ' PRO . 62.1 m-85 -140.58 128.19 12.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.448 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.4 Cg_exo -48.61 -158.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.352 2.034 . . . . 0.0 111.984 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.19 91.85 12.62 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -82.59 -46.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.134 2.556 . . . . 0.0 113.112 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.5 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -131.79 77.97 71.29 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-O 121.112 0.482 . . . . 0.0 111.319 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.49 131.6 34.53 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.748 1.632 . . . . 0.0 111.739 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.49 -6.59 38.88 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.526 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 119' ' ' TYR . 96.7 m -112.49 147.58 36.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.636 0.718 . . . . 0.0 109.336 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.544 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.3 t80 -85.87 98.43 10.77 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.5 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 11.9 mttp -76.51 -163.01 0.29 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 123.078 1.418 . . . . 0.0 113.803 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.658 ' HH ' ' H ' ' A' ' 66' ' ' THR . 5.7 p90 -169.29 171.9 7.61 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.44 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.2 tp -129.26 122.55 29.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.088 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 54.7 tt0 -115.31 128.42 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.372 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.5 t -135.54 123.77 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.48 -0.888 . . . . 0.0 113.141 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.0 129.32 54.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.488 ' CD2' HG21 ' A' ' 56' ' ' ILE . 35.7 p90 -152.21 166.96 30.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.237 0.541 . . . . 0.0 111.873 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.562 ' OD1' ' OE1' ' A' ' 59' ' ' GLU . 3.1 m-20 -126.75 161.74 27.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.241 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.432 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 65.3 m -111.96 122.26 47.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.623 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.5 m -124.86 154.41 70.82 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 122.342 2.028 . . . . 0.0 112.446 178.761 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.432 ' NH2' HD13 ' A' ' 39' ' ' LEU . 68.6 ttt-85 -143.93 140.43 29.69 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.967 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -137.51 140.32 41.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.58 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -142.36 128.75 20.04 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.448 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -129.91 145.65 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.946 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.6 m -67.78 133.84 49.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.907 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.96 136.63 2.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.015 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.74 -2.96 82.98 Favored Glycine 0 N--CA 1.453 -0.198 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.712 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -117.05 150.76 46.58 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.0 0.9 . . . . 0.0 110.706 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.04 140.64 45.92 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.45 2.1 . . . . 0.0 112.714 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 tt -114.05 149.04 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 48.8 tt0 -126.55 127.86 45.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.154 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.449 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 19.3 mt -115.62 138.87 50.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 79.1 mtt180 -146.9 130.75 17.09 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.753 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.9 m -98.15 146.23 31.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.933 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.84 158.68 49.74 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.724 2.283 . . . . 0.0 112.29 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.83 -129.35 26.41 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.805 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -110.27 25.66 11.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.09 167.84 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.158 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.86 145.0 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.126 0.489 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.449 HG21 ' CD2' ' A' ' 126' ' ' TYR . 73.4 mt -67.89 137.61 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.686 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' ' 129' ' ' VAL . 2.7 ptp -132.52 100.87 5.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 t -63.23 126.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.766 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -101.63 -51.22 3.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.114 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -148.96 147.05 28.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -168.84 151.92 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.401 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 84' ' ' TYR . 13.2 t30 -152.39 161.79 42.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.397 0.618 . . . . 0.0 111.856 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 80.6 t80 -126.73 125.0 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -141.08 7.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.531 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.73 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.6 ttm-85 -155.04 114.87 3.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.266 0.555 . . . . 0.0 111.166 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.639 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 69.8 p -119.89 8.87 11.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.066 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.644 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.2 t0 -145.05 -170.11 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.417 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.623 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 2.9 p30 -146.04 -0.51 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.756 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -107.71 8.74 29.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.213 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.543 ' HB ' HH22 ' A' ' 65' ' ' ARG . 35.2 mm -102.74 134.55 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.578 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' ASP . 73.8 m 55.75 24.15 6.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.648 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.58 ' C ' ' O ' ' A' ' 71' ' ' CYS . 15.8 t70 1.43 105.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.7 -166.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.062 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -63.31 146.25 96.34 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.066 179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.5 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -58.4 -37.65 93.93 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.2 1.933 . . . . 0.0 112.571 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.48 -42.71 95.73 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.541 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 28.9 mt-30 -84.12 -6.14 59.36 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.037 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 mmm -112.51 0.43 15.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.195 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 18.0 mt-10 -64.32 -47.85 77.85 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.934 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -78.86 113.71 17.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.446 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.7 m -105.75 35.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.083 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -140.03 87.26 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.894 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.439 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.5 t -151.75 116.43 5.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.403 ' HA ' HD22 ' A' ' 62' ' ' ASN . 86.1 m-85 -125.29 156.13 39.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.942 0.401 . . . . 0.0 111.035 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 tp -145.59 91.1 5.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -48.89 -45.25 29.31 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.433 2.089 . . . . 0.0 111.622 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 65.9 m-20 -54.38 -30.92 53.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.32 -32.54 49.42 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.242 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.592 ' O ' ' OG ' ' A' ' 93' ' ' SER . 59.7 t80 -65.09 -43.98 90.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.4 pttp -66.08 -38.23 87.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.527 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.413 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 84.1 mt -59.88 -53.28 50.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.732 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 91.8 mmm -67.52 -34.73 77.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.518 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.592 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 23.8 m -58.91 -46.7 87.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.186 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.07 -37.62 84.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.757 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.413 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 96.3 mtt-85 -73.98 -33.62 63.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 13.2 m -114.71 -13.72 12.05 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 93' ' ' SER . 88.5 m-20 -61.22 135.91 57.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.009 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 67.83 13.91 9.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.523 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -116.1 146.74 41.98 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.072 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -72.41 -31.67 65.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.716 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 155.26 38.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.681 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.449 ' SG ' ' CD1' ' A' ' 48' ' ' LEU . 5.1 p -156.19 133.96 11.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.724 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.15 126.89 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.0 t -139.35 146.21 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 111.614 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -81.66 119.6 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 38.38 0.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.118 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.35 -124.19 0.89 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.937 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.71 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 31.04 -158.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.717 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.71 ' N ' ' OG ' ' A' ' 108' ' ' SER . 89.6 m-20 -64.4 -9.23 16.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.6 -8.96 58.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.249 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 112' ' ' PRO . 32.3 m-85 -141.05 131.18 13.15 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.075 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.9 Cg_exo -48.76 -163.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.343 2.029 . . . . 0.0 111.767 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.569 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -136.87 89.24 17.49 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.303 -179.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.78 -54.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.992 2.461 . . . . 0.0 113.139 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 4.1 p -127.49 72.87 77.89 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.887 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -58.74 131.85 44.56 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.908 1.739 . . . . 0.0 111.582 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.91 -16.96 32.95 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.803 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 119' ' ' TYR . 43.4 m -102.91 153.5 20.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.064 0.932 . . . . 0.0 108.495 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.73 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 21.2 t80 -86.21 99.31 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.527 0.68 . . . . 0.0 109.506 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 4.8 mtmp? -81.99 -159.27 0.28 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.599 1.19 . . . . 0.0 113.875 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.639 ' HH ' ' H ' ' A' ' 66' ' ' THR . 19.9 p90 -174.9 174.19 2.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.34 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.411 HD11 ' CE1' ' A' ' 111' ' ' PHE . 18.7 tp -131.51 125.06 31.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.425 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 75.3 tt0 -121.18 130.79 53.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.41 123.47 42.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.011 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -109.7 129.71 55.58 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.449 ' CD2' HG21 ' A' ' 56' ' ' ILE . 40.9 p90 -153.56 169.76 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.51 0.671 . . . . 0.0 111.851 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -124.15 160.67 27.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.418 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 93.0 m -113.57 112.25 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.77 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.429 HG12 ' SD ' ' A' ' 57' ' ' MET . 9.1 m -115.1 165.65 13.65 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.635 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo . . . . . 0 C--N 1.311 -1.408 0 C-N-CA 121.669 1.58 . . . . 0.0 111.63 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.557 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 19.9 mtp180 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HE ' ' CG ' ' A' ' 123' ' ' GLU . 74.7 ttt180 -148.28 133.78 18.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.299 0.571 . . . . 0.0 110.984 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -129.57 146.45 51.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.517 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 7.5 tt -141.6 127.88 19.84 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.81 147.47 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.045 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 m -70.05 132.2 45.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.519 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 17.4 tt0 -44.82 140.47 2.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.782 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 92.06 -8.28 77.99 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.818 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 18.7 m-85 -117.2 147.62 40.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 118.353 1.077 . . . . 0.0 109.928 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.95 146.24 76.88 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.342 2.028 . . . . 0.0 113.069 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 tt -120.47 148.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.943 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.659 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 80.8 tt0 -132.63 126.96 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -112.91 143.38 44.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.659 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 97.8 mtt180 -144.78 134.31 23.28 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.518 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.7 m -103.79 143.65 27.08 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.274 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.546 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 49.3 Cg_endo -73.03 154.71 52.78 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 112.346 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.5 51.09 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.827 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -113.77 27.94 9.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -80.28 167.83 19.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.52 150.05 33.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.797 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.476 HG21 ' CD1' ' A' ' 126' ' ' TYR . 53.6 mt -71.05 138.14 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.181 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.0 ptp -131.04 98.01 4.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.0 t -64.54 126.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.914 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -103.54 -46.78 4.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -150.53 147.55 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.447 0.642 . . . . 0.0 111.13 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.64 154.86 10.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.241 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 84' ' ' TYR . 6.1 t30 -150.5 151.41 32.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.06 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -119.88 122.93 42.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.34 -138.39 5.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.881 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 7.1 ttm-85 -155.21 115.4 3.79 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.168 -0.516 . . . . 0.0 109.845 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.817 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 10.9 p -122.39 11.49 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.044 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.682 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 49.9 t0 -146.91 -171.03 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.272 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.682 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 56.1 p30 -144.55 -0.33 0.96 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -103.9 6.3 36.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.209 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 40.1 mm -113.34 137.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m 57.25 70.56 0.64 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.128 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -53.12 122.16 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.387 0.613 . . . . 0.0 112.084 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.97 -163.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 141.07 98.0 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.437 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.9 Cg_endo -56.82 -35.03 97.9 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.344 2.029 . . . . 0.0 112.554 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -63.16 -36.87 85.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.568 HE21 ' CG ' ' A' ' 74' ' ' ASP . 29.4 mt-30 -88.14 12.54 13.39 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.233 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 75.8 mtp -129.0 -2.99 5.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 53.5 mm-40 -63.27 -47.25 83.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.987 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.44 119.29 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.419 . . . . 0.0 111.912 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.3 m -111.37 31.66 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.623 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -136.23 85.84 2.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.3 t -149.15 112.57 5.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.5 ' HA ' HD22 ' A' ' 62' ' ' ASN . 72.8 m-85 -128.19 152.56 47.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.648 0.261 . . . . 0.0 110.945 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.76 86.76 7.72 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -45.98 -48.43 12.7 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.86 2.374 . . . . 0.0 114.904 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 37.6 m-20 -58.54 -21.89 53.83 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.27 61.65 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.565 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' O ' ' OG ' ' A' ' 93' ' ' SER . 54.5 t80 -63.81 -41.83 97.8 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.6 pttm -66.54 -38.5 87.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.573 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 91' ' ' ILE . 88.5 mt -60.74 -50.7 79.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.804 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.475 ' SD ' HG12 ' A' ' 104' ' ' VAL . 98.6 mmm -67.75 -35.63 79.08 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.11 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 16.4 m -61.82 -46.1 90.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.391 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.92 -35.6 81.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.562 0.696 . . . . 0.0 110.424 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HE ' HG22 ' A' ' 104' ' ' VAL . 23.1 mtp85 -74.47 -34.0 63.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.6 m -112.39 -21.46 11.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' SER . 60.4 m-20 -56.25 129.72 41.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 72.05 14.33 5.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.829 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 84.5 mtt180 -117.12 149.22 40.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.585 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.0 m -71.28 -33.42 69.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.501 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.68 155.01 35.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.98 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.5 p -151.44 149.88 29.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.978 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.56 126.66 75.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.529 HG22 ' HE ' ' A' ' 95' ' ' ARG . 44.0 t -137.34 144.03 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.633 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -85.8 122.15 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.373 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -66.81 23.56 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . -179.59 173.09 44.95 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.935 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.606 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.7 t 94.79 -155.55 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -66.32 -11.19 49.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.008 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.97 -18.47 60.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.55 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.527 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.5 m-85 -141.47 131.22 12.76 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.575 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 111' ' ' PHE . 36.1 Cg_exo -50.64 -156.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.404 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.13 95.63 10.52 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.769 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -82.98 -50.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.657 2.238 . . . . 0.0 113.564 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.478 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 11.2 p -133.05 84.8 47.56 Favored Pre-proline 0 N--CA 1.466 0.36 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.098 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.02 136.1 50.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.08 1.853 . . . . 0.0 112.328 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.6 -4.8 47.22 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.361 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 119' ' ' TYR . 67.2 m -114.4 149.3 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.169 0.984 . . . . 0.0 108.655 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.543 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.3 t80 -85.09 98.99 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 18.6 mttt -76.05 -165.61 0.49 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.918 1.342 . . . . 0.0 113.363 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.817 ' HH ' ' H ' ' A' ' 66' ' ' THR . 8.4 p90 -167.83 167.46 12.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.251 -2.25 . . . . 0.0 109.769 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 25.9 tp -127.76 123.33 35.04 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.699 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 3.4 tm-20 -117.61 129.42 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.11 119.65 41.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.699 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 1.7 mp0 -102.69 127.8 49.67 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.557 ' OH ' ' NE ' ' A' ' 36' ' ' ARG . 18.6 p90 -154.77 170.48 21.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.58 0.705 . . . . 0.0 112.517 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -128.13 163.34 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.779 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.432 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 92.6 m -109.46 114.51 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.367 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.64 151.02 47.9 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 N--CA 1.491 1.33 0 C-N-CA 121.587 1.525 . . . . 0.0 112.342 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.53 ' CZ ' ' H ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 37' ' ' ARG . 37.9 ttp-105 -149.93 137.56 20.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.318 0.58 . . . . 0.0 111.024 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 57.4 mp0 -134.51 146.04 49.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -138.1 137.59 37.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.014 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.442 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -141.41 143.74 34.09 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.883 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.0 m -70.54 133.96 47.24 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -42.21 136.54 2.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.876 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.12 74.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.094 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.69 149.88 45.89 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-N 119.118 1.459 . . . . 0.0 112.02 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.83 137.61 64.01 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.124 2.549 . . . . 0.0 113.06 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -120.06 142.36 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.591 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.3 tt0 -130.03 129.25 43.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.611 -0.835 . . . . 0.0 113.224 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.6 mt -109.93 145.75 36.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.591 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 46.4 mtt85 -148.14 132.27 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.591 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.424 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -98.16 144.33 27.87 Favored Pre-proline 0 N--CA 1.455 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 56.9 Cg_endo -71.1 159.31 52.64 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.215 2.61 . . . . 0.0 112.593 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.46 -120.08 12.6 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.782 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -125.73 26.44 6.67 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.747 0.308 . . . . 0.0 110.996 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -77.41 169.97 17.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.509 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.76 143.09 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.559 ' CG2' ' CD2' ' A' ' 126' ' ' TYR . 78.0 mt -69.74 140.36 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.586 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.461 ' SD ' HG13 ' A' ' 129' ' ' VAL . 2.0 ptp -133.84 100.51 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 89' ' ' PHE . 17.4 t -64.89 127.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.445 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.57 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 76.6 mt-10 -104.25 -49.64 3.54 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.794 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.7 m-20 -147.42 145.47 29.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.089 0.471 . . . . 0.0 110.725 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.0 154.74 9.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.967 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -152.08 156.79 40.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.286 0.565 . . . . 0.0 111.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 70.3 t80 -125.62 119.68 28.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 120' ' ' LYS . . . 156.66 -136.74 5.11 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.69 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 9.2 ttm-85 -154.94 118.03 4.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.329 0.585 . . . . 0.0 112.063 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.457 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 19.5 p -124.73 6.07 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.356 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 56.1 t0 -146.7 154.81 41.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.955 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 51.7 p30 -113.05 2.59 15.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -104.6 5.99 34.18 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.944 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.7 mm -115.69 139.65 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.624 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.3 m 53.77 71.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 39.2 p-10 -54.09 128.55 31.19 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 111.599 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.31 -165.87 2.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.282 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.692 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -61.88 142.48 94.97 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.16 -35.35 95.12 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.241 1.961 . . . . 0.0 112.827 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.6 -33.88 75.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.957 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.519 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.3 mt-30 -89.01 6.64 38.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.92 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.4 mtp -125.73 -3.96 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 39.1 mm-40 -61.54 -45.94 92.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.951 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -83.03 113.27 20.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.621 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 21.3 m -104.16 33.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.316 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.621 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.9 mm-40 -138.69 85.6 2.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.43 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 41.5 t -148.53 122.47 9.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.6 m-85 -131.86 154.14 49.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.14 86.43 7.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.334 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -46.88 -45.98 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.029 2.486 . . . . 0.0 113.162 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 75.7 m-20 -53.01 -29.45 29.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.35 -31.41 33.43 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.573 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.562 ' O ' ' OG ' ' A' ' 93' ' ' SER . 50.9 t80 -67.9 -47.89 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 pttp -64.1 -41.91 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.395 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 70.6 mt -59.53 -48.69 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.051 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.546 ' HG2' HH21 ' A' ' 95' ' ' ARG . 46.0 mtp -70.84 -34.85 72.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.77 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.562 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 23.6 m -57.42 -42.97 83.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.831 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.52 -37.85 87.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.546 HH21 ' HG2' ' A' ' 92' ' ' MET . 36.8 mtm180 -76.38 -30.58 57.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 75.5 m -112.6 -21.42 11.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.515 ' CG ' ' O ' ' A' ' 93' ' ' SER . 69.4 m-20 -55.51 135.64 50.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.984 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 64.05 13.54 7.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.669 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -115.97 147.93 40.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.366 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.1 m -71.63 -33.93 69.35 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.795 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.02 159.23 40.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.278 0.561 . . . . 0.0 110.867 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.6 p -155.5 138.85 15.76 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.701 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.19 126.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.482 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 64.6 t -143.64 146.04 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -75.11 117.67 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.57 42.79 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 175.22 -127.25 1.25 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 35.82 -150.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.129 -0.536 . . . . 0.0 111.381 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.45 -9.62 13.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.12 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' HB3' HH12 ' A' ' 95' ' ' ARG . . . -76.85 -17.23 59.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.169 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.2 m-85 -139.7 130.51 14.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.794 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.7 Cg_exo -52.01 -153.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.459 2.106 . . . . 0.0 112.423 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -137.19 93.71 12.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.44 -51.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 123.034 2.489 . . . . 0.0 113.283 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.4 p -131.62 79.54 68.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.391 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -62.91 138.86 70.73 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.53 2.154 . . . . 0.0 112.53 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.55 -2.54 49.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.898 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.462 HG21 ' N ' ' A' ' 119' ' ' TYR . 95.1 m -120.5 148.85 43.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.106 0.453 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.624 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.1 t80 -86.3 96.68 10.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.465 ' CD ' ' CE2' ' A' ' 63' ' ' TYR . 37.0 mttt -68.12 -156.33 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.217 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.504 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.4 p90 -176.38 168.58 2.76 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 112.665 -2.061 . . . . 0.0 109.37 176.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.466 HD22 ' SD ' ' A' ' 92' ' ' MET . 12.9 tp -129.7 122.79 29.64 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.495 ' OE2' ' NE2' ' A' ' 125' ' ' GLN . 78.2 tt0 -117.77 131.2 56.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.797 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.95 119.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.495 ' NE2' ' OE2' ' A' ' 123' ' ' GLU . 5.1 mp0 -105.04 124.55 49.73 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.559 ' CD2' ' CG2' ' A' ' 56' ' ' ILE . 23.8 p90 -154.22 166.97 31.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.715 0.769 . . . . 0.0 112.055 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.438 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 83.5 m-20 -123.31 162.0 23.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.259 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.53 ' H ' ' CZ ' ' A' ' 36' ' ' ARG . 86.4 m -110.38 119.69 40.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.906 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.461 HG13 ' SD ' ' A' ' 57' ' ' MET . 34.1 m -117.59 156.52 49.32 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.481 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.485 1.004 0 C-N-CA 121.598 1.532 . . . . 0.0 111.078 178.58 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' NH2' ' HG3' ' A' ' 51' ' ' PRO . 4.2 mtt-85 . . . . . 0 C--O 1.232 0.18 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 37' ' ' ARG . 13.0 ttt180 -142.28 136.66 29.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.096 0.475 . . . . 0.0 110.387 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -133.65 143.56 48.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.533 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -139.42 136.27 34.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.512 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.84 144.95 32.72 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.447 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.414 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 25.6 m -71.21 133.68 46.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 9.2 tt0 -45.07 140.91 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.486 0.66 . . . . 0.0 112.511 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 94.12 -12.15 69.55 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.71 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.9 m-85 -116.74 155.64 48.75 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 118.405 1.103 . . . . 0.0 110.051 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.55 146.86 31.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.475 2.117 . . . . 0.0 113.948 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 46' ' ' ILE . 11.4 tt -118.57 145.82 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.913 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -126.64 127.81 45.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.884 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.9 mt -112.93 145.11 41.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -150.79 131.84 14.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.77 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -100.03 145.77 30.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.685 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 43.5 Cg_endo -72.35 160.38 47.1 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.462 2.108 . . . . 0.0 113.073 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.15 -130.68 28.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -107.43 24.45 12.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.34 166.55 22.53 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.829 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 m -127.46 143.38 40.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.113 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.413 HG23 ' CD1' ' A' ' 126' ' ' TYR . 95.3 mt -67.08 138.09 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.622 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -130.41 98.38 4.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.22 123.72 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.38 -48.25 4.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.5 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -147.6 145.6 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.254 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.64 151.1 9.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.508 HD22 ' HA ' ' A' ' 84' ' ' TYR . 6.7 t30 -150.4 152.34 34.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.929 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.748 ' HH ' ' HZ3' ' A' ' 120' ' ' LYS . 66.4 t80 -122.65 125.25 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.468 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.89 -136.31 4.99 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.589 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 6.1 ttm180 -156.6 117.98 3.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.006 0.432 . . . . 0.0 111.127 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.576 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 26.2 p -124.69 7.7 8.19 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.73 152.68 40.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.449 ' O ' ' CE ' ' A' ' 78' ' ' MET . 20.9 p-10 -109.68 -0.36 18.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.333 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -106.37 8.74 31.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.116 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.512 HD13 HG23 ' A' ' 70' ' ' ILE . 39.5 mm -114.31 139.81 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.569 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.6 m 57.48 64.75 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -46.93 120.82 3.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.813 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.52 -167.08 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.933 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -63.02 142.51 97.68 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.037 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.58 -36.09 79.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 121.784 1.656 . . . . 0.0 112.762 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -64.59 -33.77 76.7 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.651 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 81.4 mt-30 -84.04 -12.62 54.88 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.828 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.449 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 66.4 mtp -103.95 -2.18 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 52.6 mm-40 -58.96 -53.2 61.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.806 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -80.43 122.52 27.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.01 28.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.058 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -143.73 90.64 2.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -145.79 120.93 10.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.663 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 5.9 m-85 -128.75 153.02 47.79 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.616 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.7 tp -146.08 91.2 5.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.705 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -49.24 -46.27 26.59 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.228 2.619 . . . . 0.0 113.751 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 23.9 m-20 -53.74 -22.31 8.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.03 -33.49 57.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.763 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -64.8 -44.46 89.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.166 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.9 pttt -65.86 -40.07 91.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.983 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.5 HG23 ' NH1' ' A' ' 95' ' ' ARG . 79.5 mt -60.49 -51.39 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.861 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.0 mmm -68.17 -37.0 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.569 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.449 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 60.9 m -60.31 -44.26 95.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.117 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -65.44 -37.94 88.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.295 0.569 . . . . 0.0 110.665 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.534 HH11 ' HG3' ' A' ' 95' ' ' ARG . 51.4 mtt85 -76.26 -33.3 59.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.8 m -111.94 -15.16 13.39 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.449 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 70.2 m-20 -62.72 135.21 57.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.634 -0.827 . . . . 0.0 111.669 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 64.99 11.48 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt-85 -112.71 145.5 40.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 110.595 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.9 m -72.76 -31.28 64.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.479 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.13 155.23 38.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.262 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 29.3 p -153.76 139.7 18.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.882 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.0 t -119.06 131.05 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 105' ' ' VAL . 17.6 t -141.99 152.01 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.425 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.46 ' N ' HG13 ' A' ' 104' ' ' VAL . 2.4 t -88.81 120.79 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.71 38.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.362 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.84 -125.7 0.98 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.175 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 31.36 -158.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.257 0.551 . . . . 0.0 112.022 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.72 -10.52 19.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.627 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.83 59.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.089 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.5 m-85 -142.51 132.72 12.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.366 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.6 Cg_exo -49.95 -159.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -139.01 86.44 15.01 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.474 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.496 ' HD2' ' HZ2' ' A' ' 120' ' ' LYS . 66.8 Cg_endo -79.32 -29.0 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.718 2.279 . . . . 0.0 113.136 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.1 p -155.67 83.84 3.54 Favored Pre-proline 0 C--N 1.332 -0.155 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.688 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.02 140.87 42.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.94 1.76 . . . . 0.0 112.039 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.54 -2.02 46.03 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.372 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' A' ' 77' ' ' GLN . 30.1 m -117.61 147.02 43.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.589 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 8.9 t80 -84.61 98.2 10.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.748 ' HZ3' ' HH ' ' A' ' 63' ' ' TYR . 21.3 mtmt -77.58 -166.78 0.81 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.469 1.128 . . . . 0.0 113.401 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.576 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 40.0 p90 -167.32 168.6 13.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.621 -2.082 . . . . 0.0 110.321 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.3 tp -127.02 124.93 40.52 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.49 ' HG3' HE21 ' A' ' 125' ' ' GLN . 15.3 tp10 -117.22 128.23 54.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.066 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.79 125.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.262 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.49 HE21 ' HG3' ' A' ' 123' ' ' GLU . 2.6 mt-30 -112.83 130.72 55.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 126' ' ' TYR . 27.5 p90 -153.82 173.24 16.15 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.089 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -124.78 158.83 32.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.352 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.406 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.5 m -105.95 119.43 39.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.439 HG12 ' SD ' ' A' ' 57' ' ' MET . 35.8 m -126.49 158.11 68.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.66 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 N--CA 1.493 1.478 0 C-N-CA 122.096 1.864 . . . . 0.0 112.06 179.445 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 49' ' ' ARG . 70.8 mtp180 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -156.09 137.99 14.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.893 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -127.06 149.96 49.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.204 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -138.83 142.21 38.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -144.29 144.96 31.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.356 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 7.6 m -71.55 134.6 46.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 110.436 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 87.2 tt0 -43.24 138.51 2.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.134 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.66 -7.65 77.21 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.816 -1.084 . . . . 0.0 114.298 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.56 153.91 50.55 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 119.068 1.434 . . . . 0.0 110.909 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.84 140.84 47.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.589 2.192 . . . . 0.0 113.748 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.1 tt -116.84 146.36 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -126.2 127.77 46.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.095 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.1 mt -115.88 138.55 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.545 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 18.8 mtp180 -146.5 133.51 20.3 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.283 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -98.66 136.72 20.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.86 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.49 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 55.6 Cg_endo -70.25 158.29 56.78 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.415 2.077 . . . . 0.0 111.458 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.23 -141.41 30.33 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.652 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.0 p -98.63 22.2 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -78.88 165.09 23.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.7 0.286 . . . . 0.0 110.86 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.57 148.69 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.534 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.447 HG12 ' SG ' ' A' ' 50' ' ' CYS . 78.5 mt -71.19 136.06 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.653 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.36 101.8 5.12 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.43 127.04 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.457 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 71.3 mm-40 -103.92 -48.29 3.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.816 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 65.1 m-20 -148.49 145.76 28.07 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.13 154.23 7.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.851 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.461 HD22 ' HA ' ' A' ' 84' ' ' TYR . 6.0 t30 -150.24 151.99 33.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.37 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.626 ' CD2' ' CG ' ' A' ' 111' ' ' PHE . 54.9 t80 -118.4 121.09 39.5 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.6 -135.33 4.54 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.382 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 10.5 ttm-85 -156.55 117.53 3.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 111.362 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.519 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 23.6 p -122.87 9.44 9.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.071 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 15.2 t0 -147.2 -178.22 6.1 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.135 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 54.7 p30 -138.36 -0.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.065 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -102.65 2.83 36.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.844 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.67 137.7 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.019 0.437 . . . . 0.0 110.855 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.4 m 54.63 70.79 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.14 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.0 p30 -52.09 125.95 17.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.923 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.91 -163.61 1.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 142.64 98.21 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.301 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.44 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.7 Cg_endo -54.44 -35.93 86.41 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.952 1.768 . . . . 0.0 112.008 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -63.87 -37.18 86.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.558 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 81.2 mt-30 -83.46 -9.72 58.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.359 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.9 mtp -106.04 -0.92 24.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 76.2 mt-10 -60.47 -53.04 62.33 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.08 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.425 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 48.9 t30 -76.54 117.46 18.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.578 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.0 m -107.71 29.42 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.832 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.8 mm-40 -141.01 85.37 1.98 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.389 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 44.8 t -146.94 124.23 11.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.461 ' HA ' HD22 ' A' ' 62' ' ' ASN . 58.1 m-85 -133.54 159.04 41.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.7 tp -147.73 94.99 4.3 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.18 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.48 -43.83 31.82 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.825 2.35 . . . . 0.0 114.06 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -61.16 -23.68 65.74 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.59 62.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.928 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.57 ' O ' ' OG ' ' A' ' 93' ' ' SER . 17.3 t80 -67.12 -47.73 70.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.069 0.461 . . . . 0.0 112.087 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 pttm -67.23 -41.22 86.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.965 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.561 ' CG2' HH21 ' A' ' 95' ' ' ARG . 69.7 mt -61.39 -47.41 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.795 ' SD ' ' NH1' ' A' ' 95' ' ' ARG . 96.2 mmm -66.97 -36.13 81.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 5.1 m -60.88 -42.11 97.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.93 -36.82 85.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 111.245 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.795 ' NH1' ' SD ' ' A' ' 92' ' ' MET . 20.8 mtm180 -76.17 -33.34 59.34 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 36.2 m -113.66 -14.02 12.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.577 ' CG ' ' O ' ' A' ' 93' ' ' SER . 2.7 m120 -58.58 136.88 57.71 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.807 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 67.04 14.37 9.8 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.017 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -116.49 147.01 42.16 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.306 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.5 m -73.76 -31.93 63.57 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.086 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 153.37 37.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.449 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 12.1 p -156.75 131.33 8.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.4 ' C ' HG23 ' A' ' 104' ' ' VAL . 22.4 t -121.72 125.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.692 ' CG1' ' NH1' ' A' ' 95' ' ' ARG . 91.5 t -141.94 146.4 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.441 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.507 ' N ' HG11 ' A' ' 104' ' ' VAL . 2.5 t -72.5 120.23 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.98 41.76 0.06 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.82 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 108' ' ' SER . . . 179.3 -130.66 1.55 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.353 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 107' ' ' GLY . 5.9 t 31.58 -146.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.019 0.438 . . . . 0.0 110.943 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.05 -10.27 13.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.14 -21.76 53.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.265 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.626 ' CG ' ' CD2' ' A' ' 63' ' ' TYR . 36.1 m-85 -138.26 128.98 15.46 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.494 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.8 Cg_exo -52.18 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.855 1.703 . . . . 0.0 111.645 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -140.06 80.39 20.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.296 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.57 -19.89 18.5 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.572 2.181 . . . . 0.0 113.171 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.629 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.8 p -157.12 80.37 3.45 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.484 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -65.95 139.23 55.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.122 1.881 . . . . 0.0 111.698 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.14 -3.16 47.63 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.576 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 77' ' ' GLN . 90.1 m -120.29 145.62 46.9 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.502 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 15.7 t80 -84.74 96.95 9.41 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.629 ' NZ ' ' O ' ' A' ' 115' ' ' CYS . 20.3 mtmm -71.47 -165.97 0.17 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.576 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 9.0 p90 -168.16 169.27 11.11 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.6 tp -128.02 123.64 35.19 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -116.55 127.41 54.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.137 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.19 121.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.346 -0.941 . . . . 0.0 112.535 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.56 127.72 52.35 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -152.32 168.8 24.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.317 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -126.73 162.62 25.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.424 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 86.1 m -113.61 113.89 25.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 0.0 110.239 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 m -115.19 156.88 44.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo . . . . . 0 C--N 1.312 -1.376 0 C-N-CA 121.594 1.529 . . . . 0.0 110.942 178.407 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 . . . . . 0 C--O 1.233 0.19 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.555 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 40.2 ttt-85 -147.73 141.09 25.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.441 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -130.06 145.61 51.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.554 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.7 tt -139.31 137.93 36.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.501 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.7 144.14 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.873 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.68 130.41 43.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.568 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.495 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 31.0 tt0 -41.39 136.87 1.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.324 0.583 . . . . 0.0 112.183 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.09 76.75 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.084 -0.962 . . . . 0.0 114.179 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -115.48 152.56 47.19 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 118.896 1.348 . . . . 0.0 111.193 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -69.88 139.9 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.02 1.813 . . . . 0.0 112.341 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 tt -115.19 147.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.648 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 40.8 tt0 -126.83 129.17 47.76 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.185 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.6 mt -115.87 138.86 50.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.648 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 91.1 mtt180 -144.09 132.68 22.27 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.931 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.473 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -100.3 138.89 20.32 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.215 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.08 157.83 53.49 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.367 2.045 . . . . 0.0 111.612 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.1 38.28 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.9 p -103.1 25.11 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.333 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.52 164.2 24.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.088 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.64 146.24 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.473 HG12 ' SG ' ' A' ' 50' ' ' CYS . 70.4 mt -69.31 134.63 29.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.162 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.5 ptp -129.39 97.76 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 89' ' ' PHE . 32.7 t -61.7 125.26 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.955 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.509 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 79.7 mm-40 -101.35 -49.84 3.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.745 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.1 m-20 -152.27 150.61 29.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -169.66 156.59 6.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 84' ' ' TYR . 13.5 t30 -151.36 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.528 0.68 . . . . 0.0 111.606 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.495 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 35.9 t80 -123.01 120.33 33.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.69 -140.42 6.91 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.416 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.666 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 5.3 ttm180 -157.55 118.27 3.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 0.0 111.978 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.601 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 72.7 p -125.76 7.42 7.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.401 0.62 . . . . 0.0 109.704 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 54.6 t0 -146.43 154.13 41.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.4 p30 -114.17 3.1 15.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 110.424 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -104.6 4.64 33.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.774 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.4 mm -110.84 137.58 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.6 m 55.95 62.94 2.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -44.61 121.0 2.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . . . -140.41 -166.81 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.355 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.618 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -62.55 133.58 94.81 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.437 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -51.78 -34.78 56.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.181 1.921 . . . . 0.0 113.224 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.8 -37.1 85.37 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.589 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 81.7 mt-30 -80.12 -17.89 51.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.254 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.666 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 7.9 mtm -102.18 1.39 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 55.3 mm-40 -61.97 -47.59 84.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.699 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.55 114.39 19.41 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 66' ' ' THR . 15.6 m -104.34 34.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.944 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.546 HE21 ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -143.95 88.07 1.95 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.944 0.402 . . . . 0.0 111.739 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.469 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.0 t -147.39 122.78 10.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.466 ' HA ' HD22 ' A' ' 62' ' ' ASN . 97.6 m-85 -126.02 153.81 43.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 111.796 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -147.92 85.94 6.33 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.92 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.82 -49.35 16.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.919 2.412 . . . . 0.0 113.061 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.5 m-20 -49.13 -30.35 6.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -32.8 53.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.822 0.344 . . . . 0.0 111.11 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' O ' ' OG ' ' A' ' 93' ' ' SER . 59.3 t80 -65.08 -41.89 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 34.2 pttt -65.86 -40.67 91.88 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.806 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.3 mt -60.27 -48.75 86.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.868 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -70.03 -36.61 75.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.114 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.53 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 19.8 m -58.79 -47.61 84.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.549 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -65.1 -35.93 82.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.05 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.533 HH11 ' CG1' ' A' ' 104' ' ' VAL . 99.5 mtt180 -79.9 -30.57 40.11 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.0 m -112.43 -20.18 11.88 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 89.4 m-20 -58.25 135.87 57.21 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.8 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 64.53 13.06 7.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.851 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 95' ' ' ARG . 75.0 mtp180 -114.02 145.66 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.2 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.4 m -71.79 -30.98 66.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.454 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.44 152.8 31.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 p -151.91 141.76 21.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.48 128.96 75.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.809 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.533 ' CG1' HH11 ' A' ' 95' ' ' ARG . 22.6 t -144.7 147.58 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.229 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -78.71 118.39 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.903 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.94 41.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.8 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 175.54 -123.04 0.9 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.178 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.6 t 31.04 -157.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.911 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.94 -9.58 22.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.851 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.72 -9.39 58.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.524 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.8 m-85 -144.0 133.54 11.61 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.858 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 44.9 Cg_exo -49.62 -161.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.925 1.75 . . . . 0.0 111.334 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -139.29 97.6 8.49 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.042 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.25 -58.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.847 2.364 . . . . 0.0 112.725 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.422 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 8.4 p -126.56 80.37 69.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.177 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -64.71 137.82 55.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.79 1.66 . . . . 0.0 111.942 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.52 -13.75 22.9 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.737 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.491 HG23 ' N ' ' A' ' 119' ' ' TYR . 1.0 OUTLIER -111.09 151.74 27.73 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.258 0.529 . . . . 0.0 109.983 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.587 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.5 t80 -85.63 96.96 9.84 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.474 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 12.6 mttp -76.4 -161.19 0.17 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.729 1.252 . . . . 0.0 113.125 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.601 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 5.6 p90 -168.93 171.17 8.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.955 -1.93 . . . . 0.0 110.732 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 35.9 tp -129.86 123.52 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.555 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 69.9 tt0 -118.65 129.42 55.29 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.46 121.74 48.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.965 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.468 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.9 mp0 -105.37 129.1 53.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -152.69 167.36 29.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.307 0.575 . . . . 0.0 111.896 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 57' ' ' MET . 96.8 m-20 -123.51 159.56 28.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.066 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.6 m -114.47 107.43 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.414 HG13 ' SD ' ' A' ' 57' ' ' MET . 1.9 m -111.08 158.06 36.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo . . . . . 0 C--N 1.312 -1.384 0 C-N-CA 121.962 1.775 . . . . 0.0 111.912 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -149.7 137.33 20.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.41 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -134.86 148.98 50.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.901 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -140.28 144.46 36.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.254 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.411 ' N ' ' CD2' ' A' ' 39' ' ' LEU . . . -145.97 145.33 30.6 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.108 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.7 m -66.2 131.08 45.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.725 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -42.24 132.04 3.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.685 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.5 76.38 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.065 -0.97 . . . . 0.0 113.252 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -118.06 151.09 48.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 118.238 1.019 . . . . 0.0 110.309 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.94 139.7 33.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.616 2.211 . . . . 0.0 113.384 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.7 tt -114.65 140.64 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -117.51 132.3 56.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.689 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.7 mt -114.87 142.22 46.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.401 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -149.8 134.84 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.646 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.457 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.5 m -102.15 142.76 25.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.932 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.73 156.44 63.41 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.846 2.364 . . . . 0.0 112.01 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.08 -127.9 29.58 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.241 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 p -110.59 23.9 13.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.039 -0.58 . . . . 0.0 111.303 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -79.34 169.34 18.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.74 146.88 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.413 0.625 . . . . 0.0 110.598 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.457 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 85.5 mt -68.18 137.19 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.063 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.1 ptm -132.34 100.81 5.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.49 ' CG2' ' OD1' ' A' ' 97' ' ' ASN . 41.1 t -64.54 125.38 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.667 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.94 -48.91 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -153.48 150.35 28.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.444 0.64 . . . . 0.0 110.417 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -170.53 156.18 5.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.473 HD22 ' HA ' ' A' ' 84' ' ' TYR . 8.8 t30 -150.58 154.9 38.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.785 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 33.9 t80 -117.31 117.47 29.62 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.65 -137.71 5.35 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.498 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.685 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -160.61 121.83 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.368 0.604 . . . . 0.0 112.036 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.462 HG21 ' CZ ' ' A' ' 84' ' ' TYR . 8.1 p -124.2 8.9 8.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.54 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.622 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 49.4 t0 -143.6 -170.14 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.834 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.616 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 22.3 p30 -148.17 -0.4 0.59 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.745 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -104.56 7.57 35.2 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 70' ' ' ILE . 38.0 mm -108.51 135.6 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.6 m 55.58 69.95 0.68 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 34.4 p30 -48.39 111.87 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.62 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.29 -162.18 1.18 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.766 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -64.18 141.37 98.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.473 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.6 Cg_endo -55.95 -38.95 93.93 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.393 2.062 . . . . 0.0 112.904 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.81 -34.48 77.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.048 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.766 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 72.3 mt-30 -87.23 -11.96 48.18 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.302 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.477 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.4 mmm -100.59 -3.98 29.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.372 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 21.6 mt-10 -66.9 -47.57 71.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.9 t30 -79.31 119.81 22.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.752 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.4 33.3 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.782 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -141.63 86.9 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.312 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.426 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 51.3 t -149.8 120.85 7.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.886 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.473 ' HA ' HD22 ' A' ' 62' ' ' ASN . 97.3 m-85 -131.24 149.57 52.51 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.913 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 38.1 tp -138.42 90.85 12.88 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.32 -47.76 25.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.657 2.238 . . . . 0.0 113.364 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 69.4 m-20 -54.33 -23.74 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.03 54.44 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.938 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.411 ' O ' ' OG ' ' A' ' 93' ' ' SER . 61.5 t80 -65.05 -43.43 92.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.82 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 15.5 pttm -64.44 -39.99 94.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.293 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.61 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 72.3 mt -58.55 -50.53 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.023 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.442 ' HE3' ' SG ' ' A' ' 96' ' ' CYS . 93.8 mmm -68.43 -35.47 77.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.062 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.481 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 49.4 m -58.1 -48.49 80.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.355 0.597 . . . . 0.0 110.647 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -67.7 -37.51 82.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.61 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 66.8 mtt-85 -76.61 -36.4 57.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.442 ' SG ' ' HE3' ' A' ' 92' ' ' MET . 4.7 m -114.16 -20.74 10.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.49 ' OD1' ' CG2' ' A' ' 58' ' ' VAL . 46.5 m-20 -59.36 139.87 56.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.683 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 23.5 m-20 70.6 15.04 7.18 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.956 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -119.17 149.9 40.96 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.048 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 m -70.48 -32.92 70.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.81 158.77 43.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.848 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 29.9 t -155.15 142.81 19.78 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.317 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.0 129.11 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.133 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 t -145.33 142.59 22.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.272 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.0 t -77.02 119.15 24.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.382 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.05 30.94 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.055 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 177.95 175.99 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.652 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 3.1 t 95.95 -158.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.266 0.555 . . . . 0.0 110.872 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.78 -8.56 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.365 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.01 -11.47 58.81 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.073 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.2 m-85 -140.62 126.43 11.48 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.976 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.602 ' O ' ' O ' ' A' ' 111' ' ' PHE . 51.0 Cg_exo -46.24 -159.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.792 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.45 93.23 12.86 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.264 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.89 -55.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.222 2.615 . . . . 0.0 112.991 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 26.5 p -127.47 90.3 48.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.508 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.37 140.03 47.17 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.897 2.398 . . . . 0.0 111.814 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.05 4.62 56.57 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.735 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 m -127.71 146.53 50.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.565 0.682 . . . . 0.0 109.351 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.685 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 29.3 t80 -86.52 99.14 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.447 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 23.0 mttt -73.35 -156.22 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.436 1.112 . . . . 0.0 113.645 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -175.41 174.94 2.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.753 -2.022 . . . . 0.0 110.105 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.9 tp -131.9 123.52 27.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.265 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.448 ' HG2' HE21 ' A' ' 125' ' ' GLN . 83.7 tt0 -115.18 128.34 56.12 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.14 118.27 40.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.723 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.448 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.3 mt-30 -106.34 129.17 54.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -153.26 171.48 18.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.444 0.64 . . . . 0.0 111.774 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -129.6 160.82 32.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.204 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 86.2 m -110.38 123.79 50.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.74 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.83 157.4 63.19 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.115 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo . . . . . 0 N--CA 1.499 1.795 0 C-N-CA 122.442 2.095 . . . . 0.0 112.316 179.821 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.472 ' NH1' ' HG2' ' A' ' 36' ' ' ARG . 50.7 mtp85 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 60.5 ttp180 -148.85 135.99 20.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.501 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 28.6 mp0 -133.18 148.76 52.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.098 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.48 144.78 38.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -144.3 143.75 31.15 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.428 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.9 m -69.26 132.53 46.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.342 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 37.7 tt0 -44.63 139.95 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.21 -8.08 80.44 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.601 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -113.55 149.96 42.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 118.343 1.072 . . . . 0.0 110.878 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.49 139.58 49.59 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.636 2.224 . . . . 0.0 113.116 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.3 tt -118.42 146.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.706 ' CD ' HH21 ' A' ' 49' ' ' ARG . 88.1 tt0 -129.7 129.94 44.86 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.6 mt -114.17 146.67 40.03 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.706 HH21 ' CD ' ' A' ' 47' ' ' GLU . 84.1 mtt180 -147.17 136.24 22.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.192 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 137.01 19.14 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.156 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.92 158.81 56.44 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.498 2.132 . . . . 0.0 112.061 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.56 -130.62 34.7 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -108.43 26.01 10.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.608 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -79.85 165.19 22.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.916 0.389 . . . . 0.0 110.8 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.74 145.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.054 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.441 ' CG2' ' CD1' ' A' ' 126' ' ' TYR . 84.9 mt -69.37 138.3 22.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.575 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.6 ptp -132.08 99.27 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG11 ' CE1' ' A' ' 89' ' ' PHE . 47.0 t -62.53 123.63 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.512 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.96 -47.73 3.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.738 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -146.27 142.45 28.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -165.57 154.0 11.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.675 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.45 HD22 ' HA ' ' A' ' 84' ' ' TYR . 7.7 t30 -152.26 150.29 29.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 112.054 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.496 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 47.2 t80 -117.21 119.97 36.84 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.27 -138.41 5.86 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 10.6 ttm-85 -158.4 119.16 3.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.4 0.619 . . . . 0.0 111.378 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.563 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 32.3 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.349 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 16.0 t70 -146.99 -170.95 3.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.944 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.541 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.4 p30 -146.92 -2.06 0.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.521 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -102.88 5.15 38.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.86 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.9 mm -106.8 137.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.129 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.8 m 56.89 66.2 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.628 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.6 p-10 -47.98 121.34 4.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.592 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.79 -165.73 2.18 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.714 ' CG ' HE21 ' A' ' 77' ' ' GLN . 0.4 OUTLIER -63.7 140.63 97.84 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.174 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -56.33 -36.91 97.61 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.983 2.455 . . . . 0.0 114.151 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -65.82 -32.71 74.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.487 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.714 HE21 ' CG ' ' A' ' 74' ' ' ASP . 27.7 mt-30 -88.82 10.43 21.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.691 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.4 mtm -132.82 0.9 3.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.398 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.6 mt-10 -63.16 -48.0 80.28 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.721 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -76.17 114.66 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 111.773 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.511 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 35.9 m -107.08 31.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.978 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.511 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.3 mm100 -141.4 87.45 2.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.437 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 15.5 t -148.06 123.51 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.45 ' HA ' HD22 ' A' ' 62' ' ' ASN . 91.7 m-85 -127.86 151.96 48.42 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.55 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.9 tp -146.95 85.73 6.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.092 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -45.89 -44.36 18.58 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.21 2.607 . . . . 0.0 114.665 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 51.1 m-20 -56.02 -24.76 41.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.04 -31.44 51.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' O ' ' OG ' ' A' ' 93' ' ' SER . 82.5 t80 -65.17 -47.36 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 12.6 pttp -64.82 -37.71 88.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.741 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 93.7 mt -61.79 -52.46 60.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.405 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.485 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 31.2 m -63.15 -47.54 82.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.016 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -68.08 -36.67 80.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 73.6 mtt180 -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 82.7 m -110.52 -22.18 11.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 88.6 m-20 -57.54 134.02 55.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.399 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 66.89 9.79 7.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.038 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.621 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 62.4 mtt85 -111.97 146.43 37.85 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.253 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.4 m -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.547 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.21 156.01 34.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.0 p -154.65 142.4 19.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.58 123.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.078 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.08 145.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.33 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.46 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -77.78 118.49 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.28 41.59 0.05 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.646 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.78 -125.5 0.99 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.593 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.766 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 32.5 t 31.06 -155.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 0.0 111.578 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.766 ' H ' ' HG ' ' A' ' 108' ' ' SER . 96.5 m-20 -65.17 -10.51 31.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.712 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.51 59.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.472 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.1 m-85 -142.19 130.27 11.66 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.061 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 48.4 Cg_exo -47.66 -157.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.713 2.276 . . . . 0.0 112.546 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -139.08 91.75 11.22 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.45 -46.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.509 2.139 . . . . 0.0 113.168 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.6 p -140.69 85.21 13.0 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.855 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -58.97 146.9 92.38 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.239 2.626 . . . . 0.0 111.728 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.98 63.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.324 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.0 m -130.98 144.36 51.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.3 t80 -86.54 96.66 10.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 24.1 mtmm -74.27 -168.49 0.66 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.927 1.346 . . . . 0.0 114.005 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.563 ' OH ' ' N ' ' A' ' 66' ' ' THR . 12.7 p90 -167.03 169.07 13.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.146 -2.297 . . . . 0.0 110.68 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.4 125.64 33.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.343 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.569 ' OE2' ' O ' ' A' ' 38' ' ' GLU . 10.6 tp10 -118.48 131.28 56.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.895 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.0 t -135.39 123.07 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.413 HE21 ' HG3' ' A' ' 123' ' ' GLU . 2.3 mt-30 -107.39 126.76 52.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.829 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.441 ' CD1' ' CG2' ' A' ' 56' ' ' ILE . 34.9 p90 -153.78 168.35 26.59 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.743 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 92.6 m-20 -119.89 159.61 24.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.964 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 55.0 m -111.49 111.42 22.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.353 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.443 HG11 ' SD ' ' A' ' 57' ' ' MET . 5.1 m -115.72 156.45 46.29 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 N--CA 1.495 1.595 0 C-N-CA 122.124 1.882 . . . . 0.0 111.981 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.71 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 68.3 mtp85 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.559 ' HE ' ' CG ' ' A' ' 125' ' ' GLN . 40.8 ttm180 -147.08 132.57 18.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.539 0.685 . . . . 0.0 110.972 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -128.13 143.01 51.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.524 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 6.9 tt -139.24 137.97 36.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.795 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.6 142.88 32.21 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.124 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 31.0 m -67.89 138.1 55.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.935 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.639 ' CD ' ' HH ' ' A' ' 63' ' ' TYR . 13.8 tt0 -42.86 139.28 1.72 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.3 0.572 . . . . 0.0 112.512 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.99 -5.55 83.15 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.735 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -115.41 152.79 47.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 118.506 1.153 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.24 143.55 39.8 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 122.512 2.141 . . . . 0.0 113.461 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.02 143.64 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.654 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 88.0 tt0 -126.14 127.99 46.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.423 0.63 . . . . 0.0 111.698 -177.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.3 mt -113.57 140.75 47.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.842 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.71 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 97.4 mtt180 -144.79 131.23 19.76 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.828 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.2 m -100.65 146.63 32.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.27 157.28 37.5 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.343 2.028 . . . . 0.0 112.415 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 54.9 -133.98 47.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.166 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -107.2 25.3 11.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.114 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -78.65 165.98 23.04 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.94 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.45 145.78 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.488 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 50' ' ' CYS . 77.9 mt -68.67 135.7 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.628 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.2 ptm -129.96 100.06 5.32 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.97 124.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.43 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -100.13 -51.2 3.74 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.432 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 40.6 m-80 -150.03 147.51 27.92 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.998 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -163.25 151.47 13.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.858 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -152.41 148.62 27.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.403 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.639 ' HH ' ' CD ' ' A' ' 42' ' ' GLU . 59.4 t80 -117.93 123.62 46.26 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.429 ' HA2' ' CD ' ' A' ' 120' ' ' LYS . . . 158.83 -139.6 6.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -177.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.616 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 5.1 ttm180 -157.11 116.79 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.442 . . . . 0.0 111.51 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.608 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 41.8 p -125.37 8.8 7.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.9 t0 -147.49 158.33 43.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p30 -115.23 3.17 14.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.697 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -105.23 0.58 27.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.735 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.4 mm -113.14 138.46 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.4 m 59.81 61.18 1.98 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -51.96 125.98 16.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.004 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HB1' ' CD2' ' A' ' 119' ' ' TYR . . . -145.44 -164.83 2.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.006 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.673 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -60.87 135.0 92.67 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 3.6 Cg_endo -52.3 -33.38 55.34 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.409 2.073 . . . . 0.0 113.934 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -34.88 79.05 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.673 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 30.0 mt-30 -89.08 12.59 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.498 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 82.9 mtp -129.36 -3.81 4.9 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.082 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.0 mt-10 -59.99 -50.93 71.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.532 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -78.41 113.88 16.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 29.6 m -105.39 32.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.289 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.2 mm100 -141.05 87.95 2.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.5 t -146.54 122.88 10.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -129.97 152.05 49.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.941 0.4 . . . . 0.0 111.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.9 tp -144.63 90.43 6.45 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.968 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -48.78 -47.24 21.72 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.648 2.232 . . . . 0.0 113.743 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.2 m-20 -56.72 -29.13 62.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.38 -32.04 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.832 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.476 ' O ' ' OG ' ' A' ' 93' ' ' SER . 74.0 t80 -64.46 -40.32 95.48 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.488 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 3.4 ptmt -66.54 -40.95 89.34 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.618 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.488 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 77.8 mt -59.88 -50.32 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.104 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.465 ' SD ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.03 -32.72 73.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.366 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 53.4 m -62.48 -47.15 85.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.676 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -67.46 -33.56 75.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 58.1 mtt180 -79.81 -32.11 40.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 63.5 m -113.7 -16.36 12.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.559 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.5 m-20 -60.06 130.9 48.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.595 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 44.4 m-20 68.86 14.66 8.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.858 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt180 -115.05 146.74 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.274 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.2 m -72.2 -32.13 66.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.739 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.16 154.58 32.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.233 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.1 p -153.46 148.59 26.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.908 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.62 126.22 66.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.2 t -142.49 143.13 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.27 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 107' ' ' GLY . 4.5 t -77.23 118.2 23.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -71.6 44.48 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.53 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.59 -124.92 0.93 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.689 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 28.13 -153.34 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 111.183 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.12 -10.15 20.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.077 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.0 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.292 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.3 m-85 -143.51 130.21 10.45 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.396 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.9 Cg_exo -47.74 -158.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.443 2.096 . . . . 0.0 112.479 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -138.81 91.91 11.54 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.68 -38.83 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.518 2.145 . . . . 0.0 113.14 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.05 84.4 11.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.674 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -65.6 139.84 60.07 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.259 2.639 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.5 -1.38 62.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.367 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.3 m -114.07 146.35 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.5 t80 -87.43 97.16 10.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.471 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 24.3 mtmm -74.58 -165.84 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.952 1.358 . . . . 0.0 114.251 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.608 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 12.9 p90 -165.26 165.58 19.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.317 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 25.7 tp -128.12 126.38 41.01 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.2 tt0 -124.82 127.55 47.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.753 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.465 HG21 ' SD ' ' A' ' 92' ' ' MET . 60.4 t -131.83 128.19 59.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.115 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.559 ' CG ' ' HE ' ' A' ' 37' ' ' ARG . 3.1 mp0 -109.83 132.15 54.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.327 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.433 ' CE2' ' HD3' ' A' ' 36' ' ' ARG . 42.4 p90 -156.84 171.71 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -129.58 161.12 31.25 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.791 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.8 m -113.33 124.62 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.677 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.9 157.36 60.38 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.142 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo . . . . . 0 C--N 1.311 -1.4 0 C-N-CA 121.641 1.561 . . . . 0.0 111.272 178.931 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 36' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -146.76 136.22 22.87 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.109 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -130.14 147.35 51.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.557 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.504 HD21 ' N ' ' A' ' 40' ' ' ALA . 7.1 tt -139.61 134.97 32.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.504 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -137.52 147.37 45.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.406 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -67.67 131.52 45.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 61.4 tt0 -42.14 138.47 1.62 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.601 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.52 79.2 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.611 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.55 147.46 40.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 118.52 1.16 . . . . 0.0 110.493 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.08 137.81 45.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.758 2.306 . . . . 0.0 112.605 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -111.23 148.36 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -127.78 127.72 44.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.003 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.5 mt -116.83 144.83 44.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.363 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -149.23 133.65 17.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.22 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.474 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.5 m -99.88 138.74 20.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.162 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -66.94 161.35 42.84 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.65 2.233 . . . . 0.0 113.244 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.7 -136.4 13.65 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 p -97.43 23.51 7.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.821 -0.69 . . . . 0.0 110.407 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -79.39 161.3 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.782 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.8 143.4 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.165 0.507 . . . . 0.0 110.396 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.474 HG12 ' SG ' ' A' ' 50' ' ' CYS . 93.6 mt -68.67 139.97 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.447 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.459 ' N ' HG21 ' A' ' 56' ' ' ILE . 2.0 ptp -135.15 103.25 5.47 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.912 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.4 t -63.88 124.62 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.248 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -102.59 -51.34 3.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.91 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -150.27 145.43 26.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.578 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.36 154.73 7.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.401 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -152.41 153.44 33.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.286 0.565 . . . . 0.0 111.559 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.567 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 50.1 t80 -118.81 124.34 46.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.11 -141.92 8.39 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.529 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 11.1 ttm-85 -151.71 115.56 4.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.313 0.578 . . . . 0.0 110.724 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.478 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 13.5 p -121.07 6.8 10.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.83 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 11.7 t70 -142.9 -169.62 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.698 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 40.9 p-10 -150.55 -2.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 110.41 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -100.44 4.94 44.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.79 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 138.58 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.19 63.21 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -47.66 115.74 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.347 0.594 . . . . 0.0 111.645 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.47 -163.02 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.73 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.637 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.66 140.25 97.98 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.707 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.476 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 Cg_endo -56.81 -31.41 88.45 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 121.942 1.761 . . . . 0.0 111.999 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -64.37 -35.44 80.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.637 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 79.6 mt-30 -87.7 -13.17 43.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.048 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.489 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 4.5 mtm -107.86 -2.17 20.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.95 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 9.2 mt-10 -63.92 -46.52 84.45 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.889 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -78.66 115.11 18.15 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.821 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.457 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 12.0 m -106.48 32.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.338 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.457 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.8 mm-40 -139.68 85.36 2.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.857 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.416 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.8 t -151.05 115.74 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -124.97 157.66 35.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.913 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 tp -148.13 87.83 5.64 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.726 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -46.96 -46.5 18.59 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.735 2.29 . . . . 0.0 114.064 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -53.32 -27.07 21.27 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.66 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.738 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CE1' HG12 ' A' ' 58' ' ' VAL . 45.9 t80 -67.51 -47.19 70.69 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.2 pttt -65.0 -39.61 93.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.585 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.6 mt -59.79 -45.43 94.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.944 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.492 ' HE1' ' SG ' ' A' ' 96' ' ' CYS . 91.4 mmm -69.82 -37.34 76.19 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.249 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.466 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 66.3 m -58.57 -45.12 89.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.24 -38.82 91.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -76.09 -34.01 59.52 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.492 ' SG ' ' HE1' ' A' ' 92' ' ' MET . 4.6 m -113.88 -16.83 12.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -58.99 136.53 57.97 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.52 -0.737 . . . . 0.0 111.839 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 69.96 13.12 7.92 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.944 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -112.42 145.33 40.35 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.5 m -71.21 -30.13 66.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.79 158.53 43.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.431 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 t -155.82 137.03 13.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.764 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -126.23 128.9 71.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.497 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 105' ' ' VAL . 58.7 t -146.34 142.86 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.486 ' N ' HG11 ' A' ' 104' ' ' VAL . 2.4 t -74.85 116.24 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.9 42.46 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.547 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.18 -125.99 1.04 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.95 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 107' ' ' GLY . 44.5 t 28.94 -155.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.459 0.647 . . . . 0.0 112.039 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.496 ' N ' ' OG ' ' A' ' 108' ' ' SER . 71.2 m-20 -62.19 -9.68 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.4 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.0 -11.16 59.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.11 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.9 m-85 -143.45 126.68 9.02 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.795 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.578 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.0 Cg_exo -47.7 -157.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.826 2.35 . . . . 0.0 112.42 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -139.1 88.88 12.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -75.69 -46.51 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.832 2.355 . . . . 0.0 112.838 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -132.31 79.53 65.64 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-O 121.673 0.749 . . . . 0.0 110.589 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -57.5 130.14 37.45 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.846 2.364 . . . . 0.0 111.919 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.16 -9.32 46.15 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.941 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.504 ' CG2' ' O ' ' A' ' 77' ' ' GLN . 90.3 m -106.57 148.41 28.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.997 0.898 . . . . 0.0 108.965 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.495 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 8.2 t80 -88.27 97.85 11.26 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 14.1 mttt -75.78 -154.1 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.912 1.339 . . . . 0.0 113.435 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -173.74 170.01 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.11 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 54.4 tp -131.53 125.03 31.34 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG2' HE21 ' A' ' 125' ' ' GLN . 76.6 tt0 -118.05 127.54 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.039 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.13 123.43 53.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.638 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.508 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.5 mp0 -109.96 131.16 55.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.688 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -152.92 165.94 33.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.165 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.431 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 36.6 m-20 -116.97 161.82 18.76 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.311 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 94.5 m -116.25 115.91 26.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.838 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.4 156.32 67.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.228 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo . . . . . 0 N--CA 1.492 1.439 0 C-N-CA 122.025 1.817 . . . . 0.0 112.159 179.311 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -150.77 133.81 16.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.312 0.577 . . . . 0.0 111.906 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 53.3 mp0 -130.62 149.35 52.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.368 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tt -141.6 139.06 33.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.665 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.95 142.97 36.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.201 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.5 m -71.62 134.6 46.49 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.555 ' CD ' ' HH ' ' A' ' 63' ' ' TYR . 81.8 tt0 -42.95 135.8 2.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.576 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.94 -9.74 63.84 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.099 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.72 150.58 47.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 119.03 1.415 . . . . 0.0 110.741 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -68.23 142.51 55.65 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.072 1.848 . . . . 0.0 111.866 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -118.03 143.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 88.8 tt0 -130.19 129.18 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.505 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.6 mt -110.29 146.03 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.336 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.549 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 72.4 mtt180 -145.41 134.23 22.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.36 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.445 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -102.52 142.9 25.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.77 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 42.6 Cg_endo -69.75 155.11 66.84 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.658 2.238 . . . . 0.0 112.607 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.68 -131.84 35.65 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.199 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -105.18 25.32 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.844 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -79.71 164.18 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.738 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.35 147.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 0.0 110.083 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.48 HG22 ' CD2' ' A' ' 126' ' ' TYR . 86.3 mt -71.66 139.88 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.33 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.9 ptp -132.02 102.17 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 89' ' ' PHE . 63.4 t -63.95 124.58 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.221 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.0 mm-40 -103.03 -51.76 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 7.6 m-20 -148.94 146.78 28.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.136 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -168.76 156.53 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.005 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.506 HD22 ' HA ' ' A' ' 84' ' ' TYR . 8.7 t30 -152.91 150.79 29.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.954 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.555 ' HH ' ' CD ' ' A' ' 42' ' ' GLU . 81.5 t80 -119.38 124.99 47.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -138.46 6.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.67 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -154.6 114.57 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.408 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.498 ' HG1' ' HH ' ' A' ' 121' ' ' TYR . 6.0 p -125.51 6.46 7.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.1 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -148.26 156.95 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' O ' ' CE ' ' A' ' 78' ' ' MET . 55.9 p30 -118.33 5.81 11.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.03 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -103.76 4.62 35.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 mm -113.03 136.94 47.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.49 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m 54.98 72.4 0.48 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.805 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -55.77 124.7 18.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.97 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.22 -164.14 1.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.739 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.708 ' CG ' HE21 ' A' ' 77' ' ' GLN . 2.7 p-10 -59.1 139.48 87.73 Favored Pre-proline 0 C--N 1.333 -0.132 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.399 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -54.67 -37.32 91.31 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.591 2.194 . . . . 0.0 113.672 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -62.51 -34.95 77.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.934 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.708 HE21 ' CG ' ' A' ' 74' ' ' ASP . 31.0 mt-30 -88.23 9.49 22.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.068 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.437 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 77.2 mtp -122.69 -6.24 8.6 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.385 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 90.7 mt-10 -62.63 -49.24 75.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.994 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.34 116.3 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.625 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -107.01 34.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.262 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 92.9 mm-40 -139.84 85.35 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.085 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.421 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 26.5 t -148.97 121.68 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.506 ' HA ' HD22 ' A' ' 62' ' ' ASN . 38.0 m-85 -130.44 153.05 49.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.505 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.4 tp -141.65 94.29 7.44 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 -48.22 22.66 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.556 2.171 . . . . 0.0 113.173 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.5 m-20 -56.77 -24.88 53.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.63 -30.81 44.56 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.733 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CE1' HG13 ' A' ' 58' ' ' VAL . 53.7 t80 -64.91 -42.84 94.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.1 ptpt -64.19 -42.18 96.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.785 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.458 HG21 ' NH2' ' A' ' 95' ' ' ARG . 36.4 mt -60.1 -50.0 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.173 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.9 mmm -66.71 -34.91 78.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.741 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.556 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.4 m -59.84 -45.92 90.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.066 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -65.85 -34.22 77.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.489 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.458 ' NH2' HG21 ' A' ' 91' ' ' ILE . 31.5 mtm180 -80.97 -32.19 34.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 84.2 m -109.6 -19.61 13.14 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 93' ' ' SER . 82.1 m-20 -58.75 133.99 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.249 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 65.02 12.74 8.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.581 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.94 146.23 41.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.0 m -72.22 -31.65 66.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.924 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 157.77 42.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.61 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 7.8 p -154.82 142.15 19.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.641 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.53 131.91 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.491 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.5 t -144.46 140.8 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.644 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -80.54 119.46 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.59 28.55 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.722 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.644 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 176.88 177.11 45.57 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.954 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 4.2 t 92.78 -155.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.996 0.427 . . . . 0.0 110.774 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.619 ' H ' ' HG ' ' A' ' 108' ' ' SER . 92.6 m-20 -62.21 -11.09 12.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.905 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.52 -19.31 53.23 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.296 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.9 m-85 -136.98 129.26 17.06 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.992 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.5 Cg_exo -48.68 -155.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.47 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -138.49 89.48 13.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 0.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.0 -30.67 0.67 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.064 2.51 . . . . 0.0 113.544 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.579 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -149.04 66.46 8.68 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-O 120.93 0.395 . . . . 0.0 111.192 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.22 135.27 69.11 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.122 1.881 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.47 -14.99 42.61 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.766 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 119' ' ' TYR . 20.8 m -107.79 153.52 22.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.146 0.973 . . . . 0.0 109.433 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.517 ' HB3' HH12 ' A' ' 65' ' ' ARG . 7.6 t80 -86.73 97.47 10.61 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.579 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 13.2 mttp -72.4 -164.13 0.14 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.903 -1.498 . . . . 0.0 113.528 -177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.498 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 9.3 p90 -170.44 167.2 8.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.138 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.8 tp -129.2 124.79 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.9 tt0 -119.9 125.08 47.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.26 123.5 60.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.684 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -109.64 128.82 55.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.142 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.48 ' CD2' HG22 ' A' ' 56' ' ' ILE . 39.5 p90 -153.33 174.01 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.377 0.608 . . . . 0.0 111.637 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -127.43 162.62 25.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.225 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.443 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.0 m -112.22 120.22 41.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.47 156.93 74.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.839 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 N--CA 1.493 1.485 0 C-N-CA 122.047 1.831 . . . . 0.0 112.967 -179.434 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.435 ' CZ ' ' HD3' ' A' ' 51' ' ' PRO . 87.0 mtt-85 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' A' ' 37' ' ' ARG . 12.8 ttp180 -148.0 138.93 23.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 111.688 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.612 ' O ' ' OE2' ' A' ' 123' ' ' GLU . 71.4 mm-40 -131.86 146.01 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.608 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -139.72 137.53 35.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.818 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.507 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.99 145.21 37.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.137 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -65.89 132.77 49.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.254 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 37.2 tt0 -43.14 134.78 3.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.397 -0.819 . . . . 0.0 113.13 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 90.3 -1.23 79.34 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.69 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -116.16 146.25 36.78 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 118.219 1.01 . . . . 0.0 110.674 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 136.93 48.62 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.753 2.302 . . . . 0.0 112.141 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 15.5 tt -113.86 151.8 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.16 127.1 44.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.505 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 101' ' ' GLN . 50.2 mt -113.54 142.89 45.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -151.19 134.81 16.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.054 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -101.25 142.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.719 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD3' ' CZ ' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -64.18 157.83 51.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.798 2.332 . . . . 0.0 112.589 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.8 -124.78 7.3 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.299 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.6 p -109.83 22.6 15.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.005 -0.598 . . . . 0.0 111.089 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.59 167.83 20.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.34 145.71 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.348 0.594 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.8 mt -70.27 137.55 23.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.667 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.7 ptp -134.34 100.37 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.29 124.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.451 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 73.2 mm-40 -99.77 -48.58 4.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 19.1 m-80 -153.92 152.59 30.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.91 158.03 8.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.6 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.449 HD22 ' HA ' ' A' ' 84' ' ' TYR . 4.2 t30 -149.98 148.98 29.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 111.606 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.497 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 65.3 t80 -119.47 121.74 40.14 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 155.88 -140.53 7.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.6 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 8.2 ttm180 -149.35 118.47 6.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 111.23 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.574 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 13.6 p -124.4 3.61 8.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.023 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 22.5 t70 -148.45 154.93 40.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.571 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.506 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 43.6 p30 -112.17 5.76 18.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.252 0.548 . . . . 0.0 109.767 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.589 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 29.6 mttt -104.27 7.29 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.8 mm -114.1 135.52 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 110.622 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.4 m 50.1 80.76 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.02 125.67 24.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.321 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.3 -163.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p30 -63.97 138.44 97.4 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.626 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.76 -33.65 71.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.007 1.805 . . . . 0.0 112.24 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -63.69 -36.01 82.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.475 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.552 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 76.7 mt-30 -85.94 -10.18 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.787 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.489 ' CE ' HH12 ' A' ' 65' ' ' ARG . 74.0 mtp -104.01 -2.6 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.905 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.7 mt-10 -64.49 -48.69 74.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -77.25 114.11 15.72 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.811 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.499 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 23.1 m -107.96 29.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.57 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -139.18 82.99 1.92 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.852 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.0 t -147.35 119.51 8.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.449 ' HA ' HD22 ' A' ' 62' ' ' ASN . 78.3 m-85 -129.92 155.14 46.54 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.218 0.532 . . . . 0.0 111.644 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.5 tp -142.76 96.71 6.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.71 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -53.13 -48.04 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.637 2.225 . . . . 0.0 113.146 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.8 m-20 -55.39 -23.81 26.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.79 -35.71 66.58 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.716 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -65.04 -45.49 85.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.731 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.1 -39.81 93.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.033 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.47 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 94.4 mt -59.67 -52.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.838 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.466 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 18.6 mtp -68.17 -34.98 77.31 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.442 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.509 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 60.5 m -56.77 -43.63 81.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.109 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.701 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 86.8 mt-30 -68.04 -35.51 78.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.938 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.719 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 71.6 mtt180 -74.74 -34.08 62.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.833 ' N ' HH21 ' A' ' 99' ' ' ARG . 28.4 m -114.32 -18.56 11.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.528 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 45.0 m-20 -58.55 137.41 57.45 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.563 -0.71 . . . . 0.0 112.349 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 65.62 13.42 8.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.259 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.833 HH21 ' N ' ' A' ' 96' ' ' CYS . 54.7 mtm-85 -114.37 145.81 41.35 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.273 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.1 m -71.82 -32.58 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.646 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -150.11 155.64 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.504 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.404 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.3 p -155.01 150.23 27.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.294 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 59.4 t -127.86 131.79 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.492 HG11 HH11 ' A' ' 95' ' ' ARG . 60.1 t -144.66 140.5 23.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.704 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.33 119.45 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -72.17 41.98 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.31 -122.69 0.81 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.25 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER 31.64 -160.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.526 0.679 . . . . 0.0 111.473 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' OG ' ' A' ' 108' ' ' SER . 99.0 m-20 -65.43 -8.19 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.271 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.403 ' H ' ' HG ' ' A' ' 108' ' ' SER . . . -78.11 -11.44 59.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.592 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 112' ' ' PRO . 41.6 m-85 -142.12 126.03 9.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.235 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 111' ' ' PHE . 28.5 Cg_exo -49.42 -160.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.66 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 116' ' ' PRO . 25.0 t70 -139.2 92.31 10.77 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.565 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.92 -38.34 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.804 2.336 . . . . 0.0 113.445 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.404 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.6 p -136.27 72.66 58.78 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 7.2 Cg_endo -57.1 133.82 60.29 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.711 1.607 . . . . 0.0 110.853 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.24 -12.38 33.79 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.469 HG21 ' N ' ' A' ' 119' ' ' TYR . 97.5 m -117.59 147.18 43.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.473 0.637 . . . . 0.0 109.535 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.6 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 22.8 t80 -86.33 98.64 11.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.577 0.703 . . . . 0.0 109.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.497 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.6 mttm -71.31 -153.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.892 -177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.574 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.5 p90 -176.6 176.69 1.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 112.698 -2.046 . . . . 0.0 110.648 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.463 HD21 ' SD ' ' A' ' 92' ' ' MET . 14.3 tp -134.08 126.12 29.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.905 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.697 ' OE1' ' NE2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -124.64 128.64 49.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 123' ' ' GLU . 88.9 t -131.85 124.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.424 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.697 ' NE2' ' OE1' ' A' ' 123' ' ' GLU . 2.7 mp0 -107.66 129.37 55.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.475 ' C ' ' OD1' ' A' ' 127' ' ' ASP . 36.8 p90 -153.01 168.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 111.724 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.475 ' OD1' ' C ' ' A' ' 126' ' ' TYR . 2.1 m-20 -126.38 162.99 24.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.593 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.8 m -113.45 116.89 30.32 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.583 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.9 m -121.44 157.09 57.22 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.496 1.622 0 C-N-CA 122.103 1.868 . . . . 0.0 112.44 179.573 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 7.4 mmm180 . . . . . 0 CA--C 1.52 -0.176 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -149.88 131.75 15.14 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.381 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -130.84 145.32 51.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.501 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 40' ' ' ALA . 8.7 tt -137.61 137.51 38.57 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -141.6 145.44 35.04 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.159 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.7 m -67.97 131.35 45.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.635 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 6.4 tt0 -43.06 139.04 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.72 -1.86 83.99 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.166 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.4 158.02 37.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 118.034 0.917 . . . . 0.0 109.962 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.02 140.11 14.02 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.885 1.723 . . . . 0.0 111.631 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 20.2 tt -117.59 147.2 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.697 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.5 tt0 -126.52 128.6 47.15 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.101 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 20.4 mt -115.41 141.63 47.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.697 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 89.4 mtt180 -147.82 132.86 18.22 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.183 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.7 m -99.76 138.83 20.46 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.769 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.38 161.07 46.8 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.562 2.175 . . . . 0.0 112.176 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -135.13 38.35 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -107.36 26.65 9.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 110.455 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 53.2 m-20 -80.92 166.81 20.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.063 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 148.6 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.349 0.595 . . . . 0.0 111.629 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.464 HG22 ' CD2' ' A' ' 126' ' ' TYR . 96.1 mt -69.29 134.86 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.937 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -134.83 98.39 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.891 0.853 . . . . 0.0 108.829 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.79 127.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.77 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -102.76 -48.38 4.12 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.767 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -151.73 150.96 30.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.51 . . . . 0.0 110.47 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -168.14 154.76 7.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.074 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.472 HD22 ' HA ' ' A' ' 84' ' ' TYR . 1.7 t30 -149.41 146.32 27.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.4 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.442 ' CE2' ' HD3' ' A' ' 120' ' ' LYS . 63.5 t80 -114.66 122.49 46.63 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.39 -139.78 6.77 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.491 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.706 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -155.42 117.1 4.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.919 179.44 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.637 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 32.9 p -123.6 8.67 8.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.583 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.7 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 50.1 t0 -150.2 158.42 44.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 44.2 p30 -115.41 5.81 14.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.688 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -106.39 6.14 30.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.528 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 29.2 mm -114.2 139.36 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.523 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 57.21 61.66 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 6.4 p-10 -46.31 118.57 1.99 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.041 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . . . -136.16 -162.65 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.303 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -64.08 145.21 98.09 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.366 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -50.69 -38.28 55.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.54 2.16 . . . . 0.0 112.353 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -64.95 -35.66 81.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.677 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.565 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 80.7 mt-30 -83.65 -7.62 59.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 75.1 mmm -113.61 40.65 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.682 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -101.74 -59.87 1.63 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.062 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 17.8 t30 -78.24 119.52 21.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.507 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.545 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 27.1 m -110.16 27.5 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.894 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.3 mm-40 -141.94 82.84 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.622 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.4 t -146.54 118.98 8.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.472 ' HA ' HD22 ' A' ' 62' ' ' ASN . 44.4 m-85 -123.41 156.56 35.23 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.151 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.2 tp -142.13 83.98 11.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.27 -46.41 11.59 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 123.361 2.707 . . . . 0.0 114.127 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -54.56 -25.49 26.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.2 -32.27 47.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.282 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.596 ' O ' ' OG ' ' A' ' 93' ' ' SER . 7.7 t80 -65.63 -46.38 79.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.025 0.44 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.7 pttp -67.55 -40.39 84.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.244 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.505 ' CG2' ' NH1' ' A' ' 95' ' ' ARG . 79.9 mt -58.16 -49.17 82.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.553 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 4.2 mtp -70.36 -32.44 70.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.176 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.596 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.7 m -60.24 -44.89 94.86 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.4 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -64.49 -37.41 87.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 0.0 111.496 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.505 ' NH1' ' CG2' ' A' ' 91' ' ' ILE . 60.0 mtt85 -77.04 -32.85 57.25 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 22.9 m -112.81 -13.48 13.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.55 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.6 m120 -62.23 130.57 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.354 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 67.88 14.88 9.51 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.18 145.92 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.772 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.04 -31.8 68.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.51 154.94 40.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.208 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.432 ' SG ' ' CD1' ' A' ' 48' ' ' LEU . 9.6 p -154.63 136.59 14.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.103 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 22.8 t -122.29 129.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.886 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.2 t -144.1 146.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 0.0 111.805 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.3 t -77.81 117.86 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.16 38.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.709 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.14 -125.23 0.96 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.914 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.59 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 1.7 t 27.99 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.967 0.413 . . . . 0.0 110.619 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.59 ' H ' ' HG ' ' A' ' 108' ' ' SER . 88.9 m-20 -64.12 -10.43 22.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.856 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.64 60.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.052 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.614 ' O ' ' O ' ' A' ' 112' ' ' PRO . 83.1 m-85 -141.77 129.03 11.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.237 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 111' ' ' PHE . 50.7 Cg_exo -45.55 -158.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 123.061 2.507 . . . . 0.0 112.694 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -139.13 91.46 11.31 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.8 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.54 -50.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.125 2.55 . . . . 0.0 113.288 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.431 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -135.27 81.62 43.37 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.991 0.424 . . . . 0.0 111.473 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.11 143.65 94.96 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.598 2.199 . . . . 0.0 111.73 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.91 -5.53 56.49 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 120.634 -0.794 . . . . 0.0 113.168 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 119' ' ' TYR . 99.3 m -115.06 147.84 39.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.706 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 11.2 t80 -87.02 97.78 10.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.442 ' HD3' ' CE2' ' A' ' 63' ' ' TYR . 19.7 mttt -73.51 -163.74 0.17 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 122.848 1.309 . . . . 0.0 113.241 -177.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.637 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 6.4 p90 -165.42 165.14 19.45 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.388 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.516 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 35.8 tp -126.14 122.24 35.13 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.672 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 2.6 tm-20 -113.62 126.91 55.79 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.564 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.553 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 58.6 t -133.2 120.6 40.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.979 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.672 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 5.3 mt-30 -107.37 128.27 54.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.082 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.464 ' CD2' HG22 ' A' ' 56' ' ' ILE . 33.9 p90 -153.56 171.6 18.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.74 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 40.2 m-20 -128.5 164.27 23.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.231 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.57 120.52 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.373 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 20.1 m -116.97 150.83 46.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.385 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 C--N 1.312 -1.374 0 C-N-CA 121.875 1.717 . . . . 0.0 112.265 179.421 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.472 ' NH1' ' HG2' ' A' ' 36' ' ' ARG . 40.0 mtp85 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -148.07 137.28 22.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -134.81 146.08 48.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.712 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.9 tt -140.77 143.3 34.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.696 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.4 145.56 29.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.727 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.1 m -70.73 136.19 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.37 0.605 . . . . 0.0 111.122 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 7.6 tt0 -44.92 139.0 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.215 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.33 -11.99 66.82 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.702 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -118.29 153.35 51.59 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 118.395 1.098 . . . . 0.0 110.313 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.19 145.37 43.78 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.275 1.984 . . . . 0.0 113.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -114.88 149.57 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -127.14 128.78 46.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.205 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 101' ' ' GLN . 31.6 mt -115.61 139.39 50.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.401 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -144.9 135.15 24.12 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.246 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -100.52 140.17 21.2 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.12 155.95 66.47 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 121.908 1.739 . . . . 0.0 111.505 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.03 -137.09 37.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 121.689 0.605 . . . . 0.0 112.625 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -100.92 22.19 12.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.446 -0.877 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -79.02 166.75 21.99 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.681 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.75 148.04 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.43 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 85.8 mt -71.25 137.84 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.109 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -135.1 101.64 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.27 125.43 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.348 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.577 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 97.5 mt-10 -100.04 -49.57 4.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.3 m-20 -150.19 149.4 30.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.618 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -167.12 152.49 7.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.712 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.506 HD22 ' HA ' ' A' ' 84' ' ' TYR . 3.6 t30 -149.32 149.15 30.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.191 0.519 . . . . 0.0 111.182 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.491 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 26.3 t80 -119.3 122.89 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -137.26 5.5 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 1.8 ttm180 -155.1 116.37 4.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.112 0.482 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.485 HG23 ' HH ' ' A' ' 121' ' ' TYR . 7.2 p -122.74 6.7 9.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 14.1 t70 -149.81 157.74 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.716 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 5.6 p-10 -113.58 5.44 16.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.189 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.489 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 31.1 mtmt -102.61 0.16 32.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.616 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 mm -113.09 138.54 42.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 48.2 m 60.87 59.18 2.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.2 0.524 . . . . 0.0 109.651 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -43.72 97.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.981 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB1' ' CD2' ' A' ' 119' ' ' TYR . . . -115.39 -174.22 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -55.78 141.01 66.98 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.896 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.7 Cg_endo -50.52 -38.77 54.94 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.149 1.9 . . . . 0.0 111.745 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.99 -35.26 80.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.15 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.674 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 79.8 mt-30 -85.41 -4.9 59.3 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.703 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 5.0 mmm -108.1 -5.15 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.201 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 68.6 mt-10 -62.54 -48.4 79.67 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.204 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -79.97 115.88 19.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 m -108.65 29.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.158 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.433 HE21 ' HA ' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -139.52 82.96 1.91 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.836 -179.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -146.12 123.67 11.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.506 ' HA ' HD22 ' A' ' 62' ' ' ASN . 21.3 m-85 -132.85 157.3 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.173 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 tp -145.86 83.69 8.61 Favored Pre-proline 0 N--CA 1.462 0.159 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.36 -44.32 20.55 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 123.078 2.519 . . . . 0.0 113.674 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.3 m-20 -59.07 -25.21 63.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.29 -33.39 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.012 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.493 ' O ' ' OG ' ' A' ' 93' ' ' SER . 12.2 t80 -64.23 -40.23 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.807 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -66.12 -38.25 87.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.052 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HG3' ' A' ' 95' ' ' ARG . 90.4 mt -57.93 -53.66 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.867 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.3 mmm -66.62 -34.25 77.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.023 0.439 . . . . 0.0 110.571 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.561 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.4 m -59.54 -48.61 80.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.69 -37.23 82.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 53.9 mtp85 -72.8 -34.44 66.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.413 -178.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.2 m -113.44 -15.26 12.64 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.561 ' CG ' ' O ' ' A' ' 93' ' ' SER . 74.4 m-20 -58.65 132.25 53.28 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.127 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 68.47 13.37 8.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.764 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -111.4 143.05 42.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.324 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.3 m -70.42 -32.94 70.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.541 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -149.79 150.03 31.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.863 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 12.3 p -153.41 138.62 17.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.924 0.393 . . . . 0.0 111.052 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.1 t -116.75 131.31 69.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.661 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 105' ' ' VAL . 39.7 t -139.39 149.51 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.506 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.3 t -87.13 117.68 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.59 36.02 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.209 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.44 -125.4 0.92 Allowed Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 30.77 -157.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.792 0.329 . . . . 0.0 111.214 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.92 -9.26 3.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.523 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.78 60.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.674 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 112' ' ' PRO . 53.3 m-85 -141.48 132.75 13.41 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.887 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 111' ' ' PHE . 33.1 Cg_exo -49.58 -157.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.937 2.425 . . . . 0.0 112.584 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.22 87.99 22.12 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.633 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.23 -43.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.288 2.659 . . . . 0.0 113.544 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.458 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -135.72 85.54 30.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.151 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.87 136.49 27.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.263 1.975 . . . . 0.0 111.746 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.57 -1.34 36.75 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.271 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.458 HG22 ' N ' ' A' ' 119' ' ' TYR . 35.2 m -122.18 146.71 46.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.22 0.51 . . . . 0.0 109.92 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.573 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 17.7 t80 -85.94 98.88 11.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.458 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 14.6 mttt -73.9 -161.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.76 1.267 . . . . 0.0 113.669 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HH ' HG23 ' A' ' 66' ' ' THR . 12.0 p90 -169.9 168.62 8.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.281 176.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.417 HD23 ' CZ ' ' A' ' 111' ' ' PHE . 21.9 tp -130.8 126.69 36.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.501 ' HG2' HE21 ' A' ' 125' ' ' GLN . 76.5 tt0 -119.84 128.9 54.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.4 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.5 t -130.27 121.3 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.111 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.501 HE21 ' HG2' ' A' ' 123' ' ' GLU . 3.6 mt-30 -107.96 125.91 52.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -151.9 165.69 33.79 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.133 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.3 OUTLIER -120.59 159.03 26.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.997 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.7 m -110.25 118.13 35.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 m -116.17 152.38 47.76 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.377 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.303 -1.85 0 C-N-CA 121.812 1.675 . . . . 0.0 110.668 179.225 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.502 HH11 ' HG3' ' A' ' 36' ' ' ARG . 57.1 mtt85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.653 0.263 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.645 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 2.2 ttt-85 -150.8 141.01 22.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.377 0.608 . . . . 0.0 112.1 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.603 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 35.5 mt-10 -132.44 145.09 50.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.342 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 6.3 tt -138.65 139.07 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.97 145.38 39.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.234 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.6 m -70.1 137.45 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.484 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -43.09 132.78 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.279 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.04 75.52 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.959 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.84 154.29 49.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 118.878 1.339 . . . . 0.0 110.751 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.8 142.79 44.18 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.699 2.266 . . . . 0.0 113.359 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.7 tt -115.97 149.9 18.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.603 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 81.0 tt0 -132.36 126.04 32.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.246 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.454 HD11 ' SG ' ' A' ' 96' ' ' CYS . 24.2 mt -113.58 143.68 44.15 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.593 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 64.7 mtt180 -149.67 132.02 15.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.397 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.442 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -99.9 140.27 21.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.966 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.1 Cg_endo -66.41 163.83 30.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.658 2.238 . . . . 0.0 112.915 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.28 -121.55 14.66 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.478 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 p -122.98 26.01 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 0.0 110.066 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.7 169.75 17.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.232 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.88 143.96 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.084 0.469 . . . . 0.0 110.696 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.442 HG12 ' SG ' ' A' ' 50' ' ' CYS . 69.3 mt -68.4 138.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.143 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.7 ptm -132.43 103.14 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.82 125.67 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.345 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -100.46 -50.18 3.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.625 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -150.57 148.35 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.402 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.85 155.74 10.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 84' ' ' TYR . 10.1 t30 -152.54 151.5 30.76 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.187 0.518 . . . . 0.0 112.188 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 33.6 t80 -121.48 122.86 40.68 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.56 -141.17 7.85 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -176.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.702 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.2 ttm-85 -151.36 114.77 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.666 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.537 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 11.8 p -120.48 6.13 10.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.865 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 41.2 t0 -144.75 -170.82 3.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.613 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.541 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 35.0 p30 -146.24 -2.74 0.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.968 0.413 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -103.91 9.38 36.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.122 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.33 136.33 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.8 m 54.28 70.9 0.56 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -51.53 118.82 3.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.721 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . . . -138.78 -163.28 1.44 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.246 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.719 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -61.93 136.79 95.22 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.302 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.525 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.8 Cg_endo -57.1 -34.31 97.47 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.787 1.658 . . . . 0.0 112.251 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -61.62 -35.98 79.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.417 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.719 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 82.1 mt-30 -82.13 -18.56 42.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.655 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 3.7 mtm -98.8 0.38 44.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.845 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 73.9 mt-10 -64.49 -51.32 63.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.264 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -79.32 110.98 15.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.064 0.459 . . . . 0.0 111.37 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.44 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 11.0 m -103.68 33.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.38 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 22.7 mm100 -138.43 83.97 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.258 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.8 t -147.95 121.86 9.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HH ' ' HB ' ' A' ' 66' ' ' THR . 97.1 m-85 -130.17 156.6 44.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.921 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.19 86.49 8.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.468 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.49 -46.8 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.904 2.403 . . . . 0.0 113.68 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.0 m-20 -54.11 -30.22 47.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.891 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.81 -31.2 37.55 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.574 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -64.12 -41.38 97.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.539 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 1.3 pttp -67.87 -39.73 83.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.078 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.539 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 52.8 mt -60.23 -49.85 82.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.0 mmm -69.94 -39.04 76.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.656 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 50.3 m -60.43 -44.45 95.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.572 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 77.4 mt-30 -64.79 -37.21 86.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.803 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.491 ' C ' ' NH1' ' A' ' 99' ' ' ARG . 67.6 mtt180 -78.69 -31.36 46.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.454 ' SG ' HD11 ' A' ' 48' ' ' LEU . 51.6 m -111.27 -13.41 13.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.7 m-20 -64.45 131.11 46.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 67.26 13.79 9.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.605 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.491 ' NH1' ' C ' ' A' ' 95' ' ' ARG . 61.4 mtt85 -113.38 146.07 40.08 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.295 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -70.22 -31.5 68.95 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.92 157.78 42.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.171 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.423 ' SG ' HD11 ' A' ' 48' ' ' LEU . 29.8 p -155.48 138.5 15.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.477 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 61.5 t -123.75 130.03 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.7 146.97 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 112.078 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.8 t -79.69 119.49 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.84 39.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.82 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.6 -142.62 5.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.249 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.3 t 47.12 -151.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 111.542 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.69 -9.5 20.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.961 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.24 -14.48 60.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.434 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.652 ' O ' ' O ' ' A' ' 112' ' ' PRO . 95.5 m-85 -143.87 128.51 9.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.821 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 111' ' ' PHE . 53.4 Cg_exo -45.79 -157.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.662 2.241 . . . . 0.0 112.019 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -137.84 92.58 12.71 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.148 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.52 -42.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.3 2.667 . . . . 0.0 113.397 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.453 ' SG ' ' HE3' ' A' ' 120' ' ' LYS . 1.3 p -136.86 74.83 50.31 Favored Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.256 0.551 . . . . 0.0 112.404 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.75 135.13 47.08 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.114 1.876 . . . . 0.0 110.703 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.85 -6.87 52.31 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' A' ' 77' ' ' GLN . 99.3 m -114.35 147.09 39.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.702 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.2 t80 -86.46 96.34 10.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HD2' ' CZ ' ' A' ' 63' ' ' TYR . 36.1 mttp -72.07 -156.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.497 1.142 . . . . 0.0 112.846 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.537 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 10.1 p90 -175.41 172.68 2.63 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.356 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 21.5 tp -130.97 122.69 27.33 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.645 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 45.1 tt0 -119.09 130.5 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.4 t -134.5 124.39 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 119.639 -0.824 . . . . 0.0 112.325 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.17 131.38 55.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.301 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -154.74 173.69 16.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.632 0.73 . . . . 0.0 112.374 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -131.71 162.61 30.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.965 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.43 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 83.4 m -111.27 117.61 33.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.679 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.8 m -119.57 156.22 53.68 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.78 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo . . . . . 0 N--CA 1.492 1.434 0 C-N-CA 122.226 1.951 . . . . 0.0 111.785 179.153 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 126' ' ' TYR . 42.7 mmm-85 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.616 HH21 ' CD ' ' A' ' 123' ' ' GLU . 70.4 ttt-85 -144.95 132.57 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.464 0.65 . . . . 0.0 111.46 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -133.63 144.32 49.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.409 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.415 HD13 ' NH2' ' A' ' 37' ' ' ARG . 7.0 tt -143.39 132.94 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.794 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.96 150.98 45.15 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.725 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.36 132.44 47.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.591 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 11.1 tt0 -42.43 141.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.458 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 88.65 -4.6 85.07 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.215 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -117.32 153.19 49.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 118.463 1.131 . . . . 0.0 110.857 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -68.11 137.65 41.34 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 tt -119.89 138.02 51.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.1 tt0 -122.37 131.97 54.15 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.311 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.453 HD22 ' CE1' ' A' ' 126' ' ' TYR . 8.9 mt -108.75 144.93 35.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.269 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.538 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 30.5 mtt85 -149.24 132.12 16.11 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.706 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.512 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -100.8 147.14 33.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.25 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.59 159.01 28.67 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.37 2.047 . . . . 0.0 111.96 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.43 -137.42 38.36 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 121.321 0.4 . . . . 0.0 112.668 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.2 p -102.64 24.14 10.96 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.674 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.65 166.06 22.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.9 142.76 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.849 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.512 HG12 ' SG ' ' A' ' 50' ' ' CYS . 88.3 mt -67.67 138.73 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.077 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.41 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.8 ptp -135.59 100.88 4.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.406 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.91 124.61 15.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.399 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.586 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.48 -51.38 3.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.419 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.586 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 28.4 m-20 -148.28 145.75 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.92 155.04 9.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.761 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 84' ' ' TYR . 10.5 t30 -153.78 154.58 34.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.241 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.591 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 85.4 t80 -120.07 122.64 41.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.19 7.62 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.04 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.758 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 13.7 ttm180 -156.89 116.23 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 p -124.53 8.73 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 57.9 t0 -147.35 157.6 43.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.506 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.587 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p-10 -114.18 0.2 14.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -102.22 6.57 40.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.25 135.29 50.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 110.16 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 60.63 61.27 1.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.228 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.626 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.6 p30 -41.3 104.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.583 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 119' ' ' TYR . . . -124.28 -164.69 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.96 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.47 145.09 98.58 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.694 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -55.3 -37.96 94.12 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.239 1.959 . . . . 0.0 112.714 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.51 -32.88 74.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.784 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.682 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 82.2 mt-30 -85.71 -11.39 53.81 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.797 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.758 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 3.1 mmt -100.74 -4.89 27.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.647 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -61.06 -56.2 23.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -79.42 118.02 20.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.433 0.635 . . . . 0.0 112.65 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.605 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.9 m -109.24 28.9 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.676 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.605 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.7 mm-40 -141.71 87.13 2.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.5 t -145.51 120.22 9.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.447 ' HA ' HD22 ' A' ' 62' ' ' ASN . 93.6 m-85 -127.93 155.72 43.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 112.007 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.1 tp -148.34 91.89 4.67 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.166 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.54 -46.6 28.74 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.151 1.9 . . . . 0.0 112.868 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 74.5 m-20 -50.05 -31.29 12.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.38 -31.98 36.43 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.597 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.433 ' O ' ' OG ' ' A' ' 93' ' ' SER . 79.7 t80 -64.48 -47.88 77.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.584 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 2.0 ptpp? -64.02 -41.56 97.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.474 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 98.0 mt -59.97 -48.9 86.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.865 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.592 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 63.1 mtp -69.87 -32.47 70.84 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.292 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.434 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 19.8 m -59.93 -45.89 91.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.627 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.61 -38.97 88.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.45 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -73.84 -37.29 64.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.4 m -113.54 -22.34 10.36 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 50.9 m-20 -55.3 140.55 38.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 69.95 12.94 7.93 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.157 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 99' ' ' ARG . 51.0 mtt85 -113.22 145.27 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.329 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.5 m -71.64 -28.83 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.58 155.31 42.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.547 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.81 143.97 26.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.113 0.483 . . . . 0.0 111.066 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.07 125.87 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.623 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -143.06 144.24 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.693 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.636 ' C ' ' H ' ' A' ' 107' ' ' GLY . 8.3 t -79.45 121.6 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.385 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -67.06 26.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.641 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . -178.94 172.13 44.31 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.028 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 4.3 t 97.26 -156.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 110.217 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.62 -10.71 38.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.176 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.35 -21.47 58.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.9 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.8 m-85 -138.27 125.95 13.72 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.744 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.3 Cg_exo -46.29 -155.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.764 2.31 . . . . 0.0 112.688 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -138.02 92.07 12.76 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.18 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -73.95 -54.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.531 2.154 . . . . 0.0 112.988 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.73 89.33 17.97 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.986 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.11 141.58 94.28 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.609 2.206 . . . . 0.0 111.64 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.92 4.99 57.63 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.749 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.1 m -126.48 146.55 50.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.658 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 9.4 t80 -87.93 97.66 11.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 4.9 mtmp? -79.61 -158.96 0.18 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.644 1.212 . . . . 0.0 113.679 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.408 ' H ' ' HB3' ' A' ' 120' ' ' LYS . 9.8 p90 -172.44 175.56 3.53 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.543 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.5 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 19.5 tp -132.17 124.17 28.5 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.477 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.616 ' CD ' HH21 ' A' ' 37' ' ' ARG . 78.6 tt0 -117.77 130.44 56.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.592 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 97.2 t -134.4 123.4 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.013 -1.075 . . . . 0.0 113.113 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.477 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -110.98 128.32 55.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.071 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.536 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 37.3 p90 -152.29 168.71 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 111.842 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 57' ' ' MET . 86.2 m-20 -119.35 160.35 22.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.5 m -112.51 128.07 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.53 155.45 80.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.69 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo . . . . . 0 N--CA 1.491 1.365 0 C-N-CA 122.182 1.921 . . . . 0.0 112.12 178.89 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.85 0.357 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -149.56 132.54 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.372 0.606 . . . . 0.0 111.158 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.0 mp0 -129.17 146.79 51.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.615 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.404 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -142.24 139.64 32.02 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.985 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -140.94 146.53 37.49 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.265 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.5 m -68.28 129.92 41.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.201 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 77.0 tt0 -45.41 142.53 2.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.99 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.412 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 93.11 -12.96 68.8 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.554 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.5 m-85 -115.74 149.97 44.03 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 118.256 1.028 . . . . 0.0 110.084 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.73 143.46 61.84 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.551 2.167 . . . . 0.0 113.439 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.3 tt -115.67 149.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.624 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.4 tt0 -129.2 128.97 44.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.494 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.4 mt -115.36 143.62 45.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.919 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.624 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 74.3 mtt180 -150.01 129.55 13.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.073 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.8 m -97.55 145.4 29.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.9 Cg_endo -69.04 158.91 56.07 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.609 2.206 . . . . 0.0 112.654 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.28 -130.74 25.08 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.328 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -107.33 22.29 16.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.819 -0.69 . . . . 0.0 111.232 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.12 168.96 19.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.447 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.89 147.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.232 0.539 . . . . 0.0 110.271 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.453 HG12 ' SG ' ' A' ' 50' ' ' CYS . 79.5 mt -68.96 136.09 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.553 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 ptp -130.18 99.54 5.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.416 HG13 ' CE1' ' A' ' 89' ' ' PHE . 61.2 t -64.07 125.93 21.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.724 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.49 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 78.2 mm-40 -101.07 -51.43 3.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.742 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 25.3 m-20 -149.67 148.64 29.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.224 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.84 152.42 11.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.983 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.471 HD22 ' HA ' ' A' ' 84' ' ' TYR . 9.8 t30 -150.4 149.34 29.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.222 0.534 . . . . 0.0 111.706 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.47 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 81.9 t80 -118.53 122.52 42.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 0.0 108.839 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 157.26 -140.69 7.29 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.35 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.512 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 10.2 ttm180 -153.5 115.44 4.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.172 0.51 . . . . 0.0 110.603 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.442 HG23 ' CZ ' ' A' ' 84' ' ' TYR . 10.7 p -121.59 7.38 10.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.356 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -150.01 157.18 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.886 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 44.2 p30 -113.74 4.29 15.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.706 0.289 . . . . 0.0 110.39 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 91.9 mttt -104.47 7.22 35.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.626 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.6 mm -113.87 138.17 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.883 0.373 . . . . 0.0 110.722 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.3 m 54.18 70.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.0 p30 -47.82 120.3 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 111.739 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -137.89 -165.14 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.011 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.605 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 1.9 p-10 -67.97 143.54 96.35 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.23 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -51.43 -36.31 58.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.264 1.976 . . . . 0.0 112.062 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -65.99 -41.36 91.19 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.482 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 31.7 mt-30 -86.96 -2.32 58.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.343 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.1 mtp -110.02 -6.76 15.06 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.777 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.23 -45.43 84.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.124 -0.63 . . . . 0.0 112.129 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.439 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 54.9 t30 -76.81 116.25 17.31 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.918 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.553 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 32.2 m -109.27 30.83 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -141.38 86.56 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 54.0 t -145.75 120.01 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.471 ' HA ' HD22 ' A' ' 62' ' ' ASN . 72.1 m-85 -132.43 154.69 49.6 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.124 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.1 tp -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.7 -48.6 13.67 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.275 2.65 . . . . 0.0 113.54 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 94.7 m-20 -58.25 -20.95 46.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.726 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.17 -36.05 60.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.729 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.518 ' O ' ' OG ' ' A' ' 93' ' ' SER . 51.7 t80 -64.33 -40.39 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.075 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 7.9 pttp -64.3 -40.68 96.43 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.367 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 91' ' ' ILE . 96.7 mt -60.32 -47.9 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.637 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.8 mmm -69.32 -38.83 78.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.529 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 3.7 m -60.82 -43.4 98.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.784 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -66.45 -37.68 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 111.607 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -75.52 -33.14 60.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.4 m -113.15 -16.22 12.62 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.545 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.2 m-20 -59.51 137.23 58.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.98 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 65.64 14.72 9.68 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.934 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -119.46 149.47 41.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.47 -32.91 68.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.353 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.2 156.92 38.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.2 p -154.8 150.52 27.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.238 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.53 128.99 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.474 HG11 ' N ' ' A' ' 105' ' ' VAL . 44.9 t -143.61 143.7 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.949 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.474 ' N ' HG11 ' A' ' 104' ' ' VAL . 2.4 t -79.07 118.46 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -72.56 43.75 0.11 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.54 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.87 -127.37 1.11 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.493 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' GLY . 47.2 t 29.43 -153.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.406 . . . . 0.0 110.982 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 108' ' ' SER . 14.0 m-20 -64.79 -9.86 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.3 -13.16 59.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.739 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.0 m-85 -139.34 126.45 12.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.5 Cg_exo -51.14 -155.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.443 2.095 . . . . 0.0 111.581 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -136.58 89.44 18.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.639 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.421 ' HD2' ' HZ2' ' A' ' 120' ' ' LYS . 79.1 Cg_endo -78.6 -26.62 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.426 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 22.2 p -158.53 97.13 1.78 Allowed Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.402 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.27 138.84 22.9 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.714 2.276 . . . . 0.0 113.058 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.37 57.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.765 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 119' ' ' TYR . 53.3 m -118.37 145.78 44.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.512 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 7.9 t80 -88.15 98.69 11.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HD2' ' CZ ' ' A' ' 63' ' ' TYR . 27.1 mttt -72.76 -156.57 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.679 1.228 . . . . 0.0 113.309 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.3 p90 -174.86 172.54 2.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.138 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 54.9 tp -130.56 122.52 27.69 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.438 ' HG2' HE21 ' A' ' 125' ' ' GLN . 74.4 tt0 -117.38 128.76 55.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.9 t -134.49 122.54 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.762 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.438 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.0 mt-30 -111.24 129.81 55.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.43 173.88 16.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.137 0.494 . . . . 0.0 111.953 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -127.67 163.46 24.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.534 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.439 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.6 m -114.07 108.99 17.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.453 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.5 m -113.6 167.52 9.26 Favored Pre-proline 0 N--CA 1.465 0.311 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo . . . . . 0 N--CA 1.489 1.236 0 C-N-CA 122.217 1.944 . . . . 0.0 112.407 -179.574 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.657 ' HE ' ' HH ' ' A' ' 126' ' ' TYR . 78.3 mtp85 . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' NH2' ' HG2' ' A' ' 125' ' ' GLN . 42.4 ttm105 -147.36 136.39 22.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.497 0.665 . . . . 0.0 111.472 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -128.69 142.71 50.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.025 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 tt -139.76 135.32 32.97 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.97 148.22 35.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.417 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 m -69.89 134.36 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.744 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 22.5 tt0 -42.68 137.69 2.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.81 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.45 -4.69 80.22 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.53 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.47 150.53 46.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 118.585 1.193 . . . . 0.0 109.997 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.37 142.04 36.38 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -118.37 147.12 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -127.11 129.84 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.346 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.432 HD13 ' SG ' ' A' ' 96' ' ' CYS . 19.6 mt -115.04 142.47 46.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -148.45 135.34 20.0 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.473 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.493 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.23 140.42 21.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.746 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.3 Cg_endo -70.39 159.41 53.04 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.477 2.118 . . . . 0.0 111.948 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.78 -138.67 33.65 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.002 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -100.56 24.79 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.117 -0.541 . . . . 0.0 111.211 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.04 164.33 24.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.301 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 m -124.97 140.88 46.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.651 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.503 HG22 ' CD2' ' A' ' 126' ' ' TYR . 67.3 mt -67.22 138.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.535 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.8 ptp -133.99 98.52 4.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.694 0.759 . . . . 0.0 109.171 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.75 125.73 20.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.988 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.48 -46.49 4.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -150.21 147.66 27.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.952 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -168.39 151.86 5.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.914 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -149.3 151.48 34.24 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.744 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.55 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 80.8 t80 -118.12 122.78 43.95 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.88 -138.71 6.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.388 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.551 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 14.7 ttm-85 -157.86 117.63 3.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 111.329 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.484 ' CG2' ' CZ ' ' A' ' 84' ' ' TYR . 5.0 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.631 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.508 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.1 t0 -147.72 -171.74 3.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.226 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 37.3 p30 -146.17 -0.47 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -103.94 7.13 36.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.479 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mm -118.31 139.63 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.0 m 59.51 58.56 2.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.5 p-10 -44.52 121.48 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.19 -170.11 3.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.034 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.3 p30 -61.91 138.23 95.55 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.688 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.486 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.8 Cg_endo -49.86 -33.34 32.87 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.51 2.14 . . . . 0.0 113.322 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -63.55 -37.05 85.84 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.415 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 26.0 mt-30 -89.47 8.76 29.32 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.387 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.45 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 78.7 mtp -124.91 -1.97 7.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 69.5 mt-10 -61.61 -53.2 59.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.293 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.0 t30 -76.97 117.07 18.2 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.428 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.533 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 23.8 m -108.87 27.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.566 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 93.5 mm-40 -138.34 85.81 2.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.037 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 48.6 t -147.04 119.02 8.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CZ ' ' CG2' ' A' ' 66' ' ' THR . 83.1 m-85 -129.77 155.34 46.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.56 . . . . 0.0 111.625 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.1 tp -147.66 90.64 5.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.999 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.58 -44.26 31.04 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 113.348 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.0 m-20 -55.19 -27.4 45.65 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.62 -33.43 33.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.368 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.53 -42.81 91.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.095 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.8 pttt -64.36 -41.83 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.653 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.527 HG21 ' HE ' ' A' ' 95' ' ' ARG . 97.6 mt -59.67 -49.53 83.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.048 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.8 mmm -68.11 -35.4 78.08 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.767 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.477 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 66.3 m -59.58 -45.62 91.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -66.29 -35.12 79.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.584 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.527 ' HE ' HG21 ' A' ' 91' ' ' ILE . 94.2 mtt-85 -79.96 -32.85 39.92 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 48' ' ' LEU . 58.0 m -111.98 -15.87 13.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.477 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -60.62 134.32 56.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 65.03 12.62 8.06 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.649 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.09 145.6 40.62 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.329 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.4 m -70.27 -31.11 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.292 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.1 158.46 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.399 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' A' ' 48' ' ' LEU . 31.3 p -156.17 143.68 19.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.428 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.5 t -122.24 127.6 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 105' ' ' VAL . 19.2 t -142.39 146.28 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.479 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.599 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -85.52 120.83 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.829 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.42 28.83 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.438 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . -179.96 179.08 48.81 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.469 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.3 t 88.86 -158.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.57 -10.65 19.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.88 58.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.82 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 39.5 m-85 -140.87 131.12 13.32 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.006 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.1 Cg_exo -49.72 -162.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.869 2.379 . . . . 0.0 112.964 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -138.16 91.6 12.85 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.452 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.48 ' HD2' ' HZ2' ' A' ' 120' ' ' LYS . 83.7 Cg_endo -86.56 -44.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 123.355 2.703 . . . . 0.0 113.391 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.488 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.8 p -134.99 79.4 51.27 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.9 140.5 79.88 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.024 1.816 . . . . 0.0 111.963 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.52 -2.15 58.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.293 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.419 ' CG2' ' HD2' ' A' ' 65' ' ' ARG . 51.8 m -114.76 147.71 39.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.626 0.713 . . . . 0.0 109.085 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.551 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.6 t80 -86.97 96.99 10.46 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.488 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 18.4 mtmt -76.74 -164.16 0.4 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.079 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 9.0 p90 -166.24 169.26 14.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.653 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.2 tp -130.85 125.32 33.32 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 69.7 tt0 -118.74 129.06 55.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.101 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.5 t -131.93 122.98 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.619 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 2.4 mt-30 -110.34 128.98 55.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.657 ' HH ' ' HE ' ' A' ' 36' ' ' ARG . 37.5 p90 -151.23 163.54 38.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.324 0.583 . . . . 0.0 111.656 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 57' ' ' MET . 95.4 m-20 -115.83 158.09 23.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.317 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 96.5 m -109.69 125.6 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.34 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.31 149.7 74.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 N--CA 1.492 1.41 0 C-N-CA 122.338 2.025 . . . . 0.0 111.918 179.638 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.716 HH12 ' H ' ' A' ' 128' ' ' CYS . 82.6 mtt85 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -141.58 137.29 31.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.204 0.526 . . . . 0.0 110.851 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 44.2 mp0 -134.92 141.99 46.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -140.48 134.16 30.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.744 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.67 144.72 44.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.024 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.9 m -71.99 131.1 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.462 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 34.5 tt0 -42.95 135.96 2.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.628 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.48 -9.8 66.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.126 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.7 155.72 50.36 Favored Pre-proline 0 CA--C 1.52 -0.206 0 CA-C-N 118.963 1.382 . . . . 0.0 110.675 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.89 143.54 33.27 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.235 1.957 . . . . 0.0 113.387 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 18.3 tt -116.12 145.93 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 86.6 tt0 -130.79 129.83 42.93 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.989 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' CB ' ' CD1' ' A' ' 56' ' ' ILE . 23.9 mt -113.79 145.72 41.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.268 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 98.4 mtt180 -150.25 136.15 18.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.167 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.433 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -104.66 138.25 19.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.119 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 12.0 Cg_endo -63.82 155.51 63.34 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.567 2.178 . . . . 0.0 112.705 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.04 -132.14 32.94 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.613 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.4 p -103.62 26.55 8.38 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -80.75 162.39 24.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.881 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -131.12 146.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.093 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.433 HG12 ' SG ' ' A' ' 50' ' ' CYS . 63.1 mt -67.04 138.11 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 111.518 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.619 ' O ' ' CG ' ' A' ' 57' ' ' MET . 10.4 ptm -130.45 98.07 4.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.437 HG11 ' CE1' ' A' ' 89' ' ' PHE . 61.0 t -65.63 125.77 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.967 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.69 -45.59 5.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -151.8 150.35 30.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.106 0.479 . . . . 0.0 110.664 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -169.08 152.16 5.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.848 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 1.2 t30 -150.39 151.8 33.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.968 0.413 . . . . 0.0 111.617 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.545 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 47.7 t80 -120.26 126.16 49.9 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.74 -137.7 5.79 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.677 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 15.7 ttm-85 -156.25 118.18 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.723 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.43 ' HB ' ' HH ' ' A' ' 84' ' ' TYR . 4.2 p -123.88 11.57 9.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.232 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.578 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.8 t0 -144.94 -170.5 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.752 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.517 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 46.5 p30 -146.49 -4.12 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.172 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -103.43 5.98 37.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.434 HD13 HG23 ' A' ' 70' ' ' ILE . 32.4 mm -108.98 139.65 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.818 0.342 . . . . 0.0 110.552 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' ASP . 26.7 m 64.66 24.79 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.754 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.57 ' C ' ' O ' ' A' ' 71' ' ' CYS . 14.3 p30 -3.28 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.545 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.63 -167.66 1.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.704 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -62.17 145.58 93.42 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.251 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -58.99 -38.47 87.77 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.776 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -63.92 -39.62 94.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.897 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.704 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.9 mt-30 -84.83 -10.32 57.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.677 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 48.7 mmm -109.96 -2.96 16.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mt-10 -66.46 -44.36 82.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.562 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -78.26 121.27 24.19 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 67' ' ' ASP . 22.9 m -112.75 31.2 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.835 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -140.52 86.31 2.06 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.3 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.8 t -150.34 117.46 5.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.43 ' HH ' ' HB ' ' A' ' 66' ' ' THR . 73.0 m-85 -127.46 157.57 39.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.908 0.385 . . . . 0.0 111.233 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.6 tp -147.03 87.21 6.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.417 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -44.04 -46.04 11.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.504 2.136 . . . . 0.0 114.081 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.7 m-20 -54.93 -26.84 38.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.94 -33.05 35.67 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.994 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' HG11 ' A' ' 58' ' ' VAL . 57.1 t80 -66.24 -44.94 82.31 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 3.0 pttt -65.08 -40.32 94.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.42 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.459 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.3 mt -59.87 -49.31 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.531 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 74.4 mtp -72.83 -35.13 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.491 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.471 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 69.4 m -58.48 -42.69 88.12 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -66.28 -35.47 80.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 110.753 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 92.9 mtt-85 -79.14 -31.89 44.2 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 57.4 m -112.68 -20.87 11.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.471 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 69.7 m-20 -60.58 134.45 57.09 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.904 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 66.04 13.8 9.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.693 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -116.68 147.98 41.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.207 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.9 m -72.05 -32.0 66.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.451 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.21 156.28 36.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.743 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.401 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.6 p -155.47 146.74 22.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 58.2 t -126.35 132.57 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.81 139.45 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.654 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.7 t -76.48 118.76 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.99 28.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.004 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.654 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 178.2 -177.29 48.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.4 t 91.4 -162.77 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.836 0.35 . . . . 0.0 110.286 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.18 -9.24 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.24 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.44 56.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.302 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.584 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.0 m-85 -135.64 125.88 16.68 Favored Pre-proline 0 N--CA 1.455 -0.222 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.777 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 111' ' ' PHE . 27.2 Cg_exo -49.18 -158.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.518 2.145 . . . . 0.0 111.565 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -138.41 93.26 11.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -86.98 -12.82 4.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 123.185 2.59 . . . . 0.0 112.648 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.44 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -168.6 92.42 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.5 133.67 14.63 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.876 2.384 . . . . 0.0 112.828 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.03 11.52 36.79 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.887 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 47.3 m -127.91 145.63 50.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.473 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 6.5 t80 -83.55 98.27 9.48 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.517 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 6.1 mtmp? -77.25 -167.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.69 1.234 . . . . 0.0 113.683 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.451 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.5 p90 -168.11 173.85 7.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.232 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 26.4 tp -128.73 119.34 24.42 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.093 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -114.35 132.27 56.26 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.531 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 95.1 t -131.24 149.32 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.441 ' N ' HG13 ' A' ' 124' ' ' VAL . 1.9 mt-30 -136.16 127.83 28.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 126' ' ' TYR . 20.8 p90 -158.73 174.33 15.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.812 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.37 158.17 36.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.696 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.716 ' H ' HH12 ' A' ' 36' ' ' ARG . 62.3 m -106.35 123.9 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.146 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 57' ' ' MET . 4.9 m -130.54 157.4 77.65 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.502 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo . . . . . 0 N--CA 1.496 1.66 0 C-N-CA 122.361 2.04 . . . . 0.0 113.084 -179.848 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 62.5 mtp85 . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 33.0 ttp-105 -142.75 137.13 29.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.865 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.2 mp0 -137.59 144.14 41.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.528 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -139.21 139.22 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.801 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -141.09 142.51 34.13 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.597 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 16.6 m -71.08 135.48 47.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 84.2 tt0 -44.97 137.51 4.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.12 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.285 177.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.36 149.63 46.3 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 118.994 1.397 . . . . 0.0 110.319 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.18 146.12 68.88 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.346 2.031 . . . . 0.0 113.597 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' ' 104' ' ' VAL . 15.2 tt -115.39 144.51 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.669 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 51.2 tt0 -121.35 128.0 51.82 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.463 -178.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.453 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 43.8 mt -117.79 140.32 49.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.669 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 89.5 mtt-85 -148.92 136.32 20.24 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.47 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.6 m -103.18 138.13 19.46 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.392 179.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -66.54 156.01 67.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.473 2.115 . . . . 0.0 112.26 -179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.49 -134.67 38.11 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -103.41 25.1 10.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.503 . . . . 0.0 110.544 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.97 163.09 25.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.019 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.64 144.04 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.412 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.474 HG23 ' CD1' ' A' ' 126' ' ' TYR . 88.3 mt -68.31 137.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.114 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.4 ptm -130.9 99.04 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 t -61.46 123.37 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.585 -177.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.574 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.6 mm-40 -98.66 -50.63 4.18 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.6 m-20 -153.74 153.74 32.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.123 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.6 157.51 8.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.099 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -150.43 153.58 36.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.148 0.499 . . . . 0.0 111.992 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 32.1 t80 -123.35 121.09 34.93 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.59 -139.26 6.28 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.938 -177.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 6.6 ttm180 -155.5 116.72 3.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.141 0.496 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.425 HG21 ' CE2' ' A' ' 84' ' ' TYR . 5.2 p -124.22 10.21 8.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.973 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 37.4 t0 -145.87 -175.2 4.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.451 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 33.1 p30 -141.89 3.01 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.414 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -107.61 6.12 27.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.216 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.445 HG21 HD11 ' A' ' 70' ' ' ILE . 31.2 mm -117.81 137.85 50.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.5 m 54.47 74.91 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.767 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -53.62 125.42 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.408 0.623 . . . . 0.0 112.026 -178.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.473 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -138.88 -177.52 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.213 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -59.32 147.6 75.39 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.281 0.562 . . . . 0.0 110.066 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.4 Cg_endo -53.83 -38.52 85.63 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.114 1.876 . . . . 0.0 111.457 -178.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -61.44 -33.0 72.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.583 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 72.1 mt-30 -91.15 -6.2 53.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.438 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 73' ' ' ALA . 75.1 mtp -109.12 -9.1 15.06 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 40.9 mt-10 -63.89 -48.23 77.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.087 -178.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -81.21 116.83 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.536 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 20.9 m -106.66 33.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.554 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 90.6 mm-40 -141.76 86.72 2.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.2 t -145.4 118.22 8.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.425 ' CE2' HG21 ' A' ' 66' ' ' THR . 94.3 m-85 -129.08 154.82 46.31 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.579 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.8 tp -147.16 89.2 5.62 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.26 -46.98 13.22 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 123.555 2.837 . . . . 0.0 115.094 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.5 m-20 -60.86 -14.03 19.4 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.87 -36.34 59.0 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.358 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.404 ' O ' ' OG ' ' A' ' 93' ' ' SER . 43.1 t80 -64.56 -43.52 93.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.307 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.03 -42.18 99.71 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.723 -178.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.562 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 44.2 mt -60.27 -50.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.69 0.281 . . . . 0.0 111.305 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 83.6 mmm -66.98 -35.26 79.56 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.617 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.465 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 69.9 m -60.63 -48.59 81.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.74 -38.85 87.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.051 0.453 . . . . 0.0 111.355 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.562 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 83.9 mtt-85 -74.21 -34.23 63.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 56.4 m -112.62 -16.31 12.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -60.57 138.56 58.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.929 -0.709 . . . . 0.0 112.495 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 62.03 13.4 5.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.979 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -116.23 146.66 42.17 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.453 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -73.52 -28.0 61.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.825 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.475 HE21 ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -153.03 153.59 33.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.135 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 31.1 p -154.02 141.99 20.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.619 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.63 128.77 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.355 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 46' ' ' ILE . 45.3 t -139.42 141.36 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.082 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.658 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -80.8 119.76 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -64.89 28.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.982 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.658 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 176.58 -175.97 47.72 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 90.01 -159.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.524 . . . . 0.0 110.61 179.407 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -62.49 -9.5 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.751 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.61 -18.37 51.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.553 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -140.88 129.92 12.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.434 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.553 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.8 Cg_exo -49.99 -153.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.267 1.978 . . . . 0.0 112.46 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -140.88 91.02 9.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.275 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.439 ' HD2' ' HZ2' ' A' ' 120' ' ' LYS . 73.3 Cg_endo -81.58 -28.61 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.656 2.237 . . . . 0.0 113.031 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.441 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.8 p -146.11 77.22 12.04 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.07 131.97 49.16 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.244 1.962 . . . . 0.0 111.585 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.63 3.64 58.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.771 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 119' ' ' TYR . 93.2 m -116.95 145.95 43.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.19 0.995 . . . . 0.0 109.519 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.519 ' HB3' HH12 ' A' ' 65' ' ' ARG . 11.5 t80 -88.22 96.85 10.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.491 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 26.2 mttt -76.32 -161.8 0.2 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.488 -177.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.501 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 14.2 p90 -170.69 172.42 5.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.69 176.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.5 tp -129.59 124.44 33.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -116.86 128.9 55.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.941 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.0 t -132.17 120.57 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 119.463 -0.895 . . . . 0.0 113.096 -178.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -106.97 123.99 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.542 ' C ' ' OD1' ' A' ' 127' ' ' ASP . 17.5 p90 -154.08 174.88 14.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.555 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.627 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.4 OUTLIER -127.7 159.98 33.07 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.597 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.432 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 83.7 m -108.93 115.04 29.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.43 HG12 ' SD ' ' A' ' 57' ' ' MET . 25.1 m -115.73 155.49 47.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo . . . . . 0 C--N 1.31 -1.465 0 C-N-CA 121.911 1.741 . . . . 0.0 112.224 -179.929 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.457 ' HD3' ' HH ' ' A' ' 126' ' ' TYR . 77.1 mtt-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.785 0.326 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.73 137.1 23.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.333 0.587 . . . . 0.0 111.69 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.3 mp0 -135.25 146.16 48.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.785 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.407 179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.63 148.61 44.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.176 0.513 . . . . 0.0 111.116 -179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.8 m -70.56 133.31 46.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.918 -178.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 5.8 tt0 -44.96 139.12 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.471 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -9.89 73.9 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.924 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -117.45 150.46 46.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 118.415 1.107 . . . . 0.0 110.555 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 138.56 55.82 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.584 2.19 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 tt -113.62 145.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -124.42 128.77 49.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.234 -178.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.418 HD11 ' SG ' ' A' ' 102' ' ' CYS . 50.3 mt -113.99 142.4 46.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.707 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -152.23 137.03 17.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.5 -178.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.82 149.74 36.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.916 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.4 Cg_endo -72.38 159.36 49.54 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.691 2.261 . . . . 0.0 112.757 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.87 -118.04 6.73 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.264 178.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -125.85 24.12 7.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -75.54 171.2 14.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.98 149.09 29.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.495 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.443 HG12 ' SG ' ' A' ' 50' ' ' CYS . 66.1 mt -73.45 138.87 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.623 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.7 ptm -133.29 100.24 4.78 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.12 124.12 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.853 -178.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 84.0 mt-10 -102.62 -45.71 4.96 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.5 m-20 -150.64 148.74 28.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.0 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.41 152.41 7.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.946 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.429 HD22 ' HA ' ' A' ' 84' ' ' TYR . 5.3 t30 -149.76 150.19 31.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.149 0.5 . . . . 0.0 111.509 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.575 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 57.4 t80 -120.74 122.39 40.3 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.48 -137.35 5.43 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.76 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 11.1 ttm-85 -154.69 119.47 4.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.959 0.409 . . . . 0.0 111.473 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.582 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 10.5 p -123.4 7.53 9.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.807 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 61.9 t0 -148.76 154.87 40.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.901 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p-10 -112.18 3.56 17.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 110.521 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -109.2 9.39 26.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.323 -178.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 mm -112.76 137.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.4 m 54.73 73.03 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.397 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.12 120.12 6.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.787 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.87 -164.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.577 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -64.32 138.2 97.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 7.2 Cg_endo -54.24 -31.99 68.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.968 1.779 . . . . 0.0 111.929 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -62.36 -41.89 98.97 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.577 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 29.0 mt-30 -92.45 -2.98 55.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.889 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.76 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 51.4 mmm -115.29 -4.1 12.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.111 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mm-40 -69.49 -38.85 77.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.063 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -76.07 124.13 26.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.599 -178.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.73 29.47 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -139.34 85.65 2.07 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.411 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.431 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.4 t -147.66 124.5 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.429 ' HA ' HD22 ' A' ' 62' ' ' ASN . 94.0 m-85 -134.2 155.63 49.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.276 0.56 . . . . 0.0 111.752 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.0 tp -147.17 95.5 4.39 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.962 179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.17 -47.6 26.61 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.582 2.188 . . . . 0.0 113.568 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 90.0 m-20 -54.38 -21.6 10.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.837 -178.09 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.4 65.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.431 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -65.06 -40.95 95.44 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.4 pttp -65.13 -38.2 89.89 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.58 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 64.4 mt -61.3 -51.57 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.5 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.466 ' SD ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.41 -34.5 76.11 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.864 -178.867 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.5 m -61.02 -47.42 86.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.5 -35.97 80.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.58 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 94.9 mtt-85 -77.35 -35.02 55.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -177.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.415 ' SG ' HD11 ' A' ' 48' ' ' LEU . 57.5 m -112.67 -15.69 12.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -177.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.6 m-20 -60.59 139.28 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.03 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 65.45 12.82 8.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.631 178.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -117.32 147.75 42.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.278 0.561 . . . . 0.0 110.915 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 m -72.78 -31.78 65.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.927 179.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.75 155.92 38.11 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.168 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 48' ' ' LEU . 30.2 p -155.01 144.8 21.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.846 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.4 125.12 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.161 178.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 105' ' ' VAL . 29.9 t -140.35 142.55 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.867 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -70.81 119.94 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.161 179.066 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -66.73 39.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.879 -178.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.32 -121.82 0.78 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.007 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 29.52 -155.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.439 0.637 . . . . 0.0 111.137 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -64.82 -11.55 38.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.49 60.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.859 -178.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 68.1 m-85 -144.52 129.46 9.33 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.012 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 49.2 Cg_exo -46.65 -159.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.558 2.172 . . . . 0.0 112.943 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -138.81 90.35 12.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.594 ' HD2' ' HZ3' ' A' ' 120' ' ' LYS . 55.8 Cg_endo -80.67 -53.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.152 2.568 . . . . 0.0 113.18 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -125.35 76.85 68.62 Favored Pre-proline 0 C--O 1.238 0.476 0 CA-C-O 121.181 0.515 . . . . 0.0 111.598 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.07 131.98 34.81 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.705 1.604 . . . . 0.0 111.469 179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.05 -11.27 34.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.227 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 119' ' ' TYR . 79.6 m -110.05 149.2 30.35 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.4 t80 -85.19 97.8 10.11 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.594 ' HZ3' ' HD2' ' A' ' 114' ' ' PRO . 16.8 mtmt -72.09 -169.8 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 123.131 1.443 . . . . 0.0 114.572 -177.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.582 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.6 p90 -164.21 165.91 21.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 112.014 -2.357 . . . . 0.0 110.317 176.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.1 tp -126.8 123.05 36.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.614 ' OE2' ' NE2' ' A' ' 125' ' ' GLN . 43.2 tt0 -120.4 126.72 51.16 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.561 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.466 HG22 ' SD ' ' A' ' 92' ' ' MET . 37.3 t -133.07 126.78 53.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.474 -178.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.614 ' NE2' ' OE2' ' A' ' 123' ' ' GLU . 3.1 mp0 -114.09 131.49 56.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.457 ' HH ' ' HD3' ' A' ' 36' ' ' ARG . 27.9 p90 -153.84 169.18 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 112.007 -178.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -122.72 162.03 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.76 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.446 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.4 m -109.26 131.96 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.23 161.71 59.51 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.593 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 N--CA 1.493 1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 112.828 -179.097 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.558 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 65.4 mtt85 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.498 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 39.2 ttp180 -147.03 139.7 24.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.336 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.687 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.8 mp0 -133.11 142.37 48.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.236 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -141.44 137.42 32.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.479 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -143.99 149.08 36.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.691 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.7 m -68.53 131.64 45.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 48.5 tt0 -45.9 142.65 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.431 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.0 -6.9 82.87 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.761 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.94 140.64 27.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.832 0.816 . . . . 0.0 110.016 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.14 141.48 88.57 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.514 2.142 . . . . 0.0 113.606 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.406 HG22 HD13 ' A' ' 46' ' ' ILE . 13.0 tt -120.01 145.09 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.63 130.37 52.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.149 0.499 . . . . 0.0 112.18 -178.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 16.5 mt -113.21 143.41 44.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -150.05 135.16 17.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.066 -178.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.8 m -101.81 148.71 35.68 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.723 179.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 60.4 Cg_endo -73.91 157.95 46.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.134 2.556 . . . . 0.0 112.34 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.92 -128.07 32.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 p -113.85 24.53 12.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -77.65 168.26 20.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.296 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 m -126.79 147.74 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.486 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.504 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 92.4 mt -72.55 140.02 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.395 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.453 ' SD ' HG12 ' A' ' 129' ' ' VAL . 1.5 ptp -131.87 102.0 5.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.452 HG11 ' HG ' ' A' ' 93' ' ' SER . 99.9 t -63.93 123.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.093 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.3 mm-40 -102.17 -50.49 3.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 46.4 m-20 -146.86 144.18 29.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.447 -179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.22 148.26 6.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.847 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 4.8 t30 -150.92 156.81 41.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.366 0.603 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.547 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 49.4 t80 -120.27 122.13 40.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.09 -143.47 9.26 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.999 -177.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.692 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.6 ttm-85 -150.63 115.79 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.383 0.611 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.541 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 19.7 p -123.52 3.45 9.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.355 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.684 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 53.7 t0 -145.04 153.24 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.224 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 38.6 p30 -112.55 0.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -102.48 1.82 35.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.401 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mm -110.44 138.8 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.391 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m 56.34 70.25 0.66 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.997 -179.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -54.26 121.04 7.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HB1' ' CD2' ' A' ' 119' ' ' TYR . . . -140.82 -163.05 1.46 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.028 179.403 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.02 143.91 97.4 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.27 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.0 Cg_endo -56.74 -38.69 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.515 2.144 . . . . 0.0 113.498 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -63.77 -29.95 71.1 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.183 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.7 mt-30 -88.33 -12.86 42.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.052 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.413 ' HE3' ' O ' ' A' ' 68' ' ' ASP . 73.0 mtp -102.97 -5.4 23.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 57.3 mm-40 -65.23 -47.33 77.18 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.453 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -78.61 111.74 15.0 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.888 -178.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.614 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.3 m -103.34 31.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.614 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 96.7 mm-40 -142.89 86.95 1.95 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.554 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.4 t -149.45 119.74 7.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.47 ' CZ ' HG22 ' A' ' 66' ' ' THR . 51.2 m-85 -129.47 147.39 51.28 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.266 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.3 tp -138.31 91.97 12.34 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -50.26 -45.87 31.58 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.768 2.312 . . . . 0.0 113.319 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -53.64 -30.6 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.246 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.93 54.03 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.188 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.595 ' O ' ' OG ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -65.5 -44.32 87.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.241 178.624 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.23 -41.19 97.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 -179.311 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.489 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 60.7 mt -60.69 -48.91 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.02 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.29 -36.19 81.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.918 0.389 . . . . 0.0 110.499 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.595 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 15.8 m -59.88 -45.43 92.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -65.93 -35.87 81.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.518 0.675 . . . . 0.0 110.883 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HE ' HG21 ' A' ' 91' ' ' ILE . 95.1 mtt-85 -76.08 -34.25 59.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 33.0 m -112.42 -13.73 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' SER . 83.0 m-20 -60.77 134.59 57.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.273 0.559 . . . . 0.0 112.208 -179.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 66.37 12.73 8.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.679 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -115.8 147.72 40.67 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.281 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.9 m -74.02 -30.91 62.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.03 153.19 33.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.4 ' SG ' ' CD1' ' A' ' 48' ' ' LEU . 20.3 p -154.68 139.63 17.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.4 124.58 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.9 t -138.74 151.83 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 112.123 -178.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.4 t -84.5 116.57 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.184 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -67.22 40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.059 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 178.3 -131.03 1.67 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.753 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.579 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 1.6 t 32.75 -150.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.036 -0.582 . . . . 0.0 112.227 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.579 ' H ' ' HG ' ' A' ' 108' ' ' SER . 94.0 m-20 -64.46 -11.74 36.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.698 -178.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.83 -12.33 59.77 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.613 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.0 m-85 -142.2 124.73 9.19 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.445 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -46.23 -159.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.079 2.519 . . . . 0.0 113.547 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -137.05 85.82 21.74 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.34 -34.33 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.966 2.444 . . . . 0.0 112.775 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.73 89.99 6.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.88 139.04 42.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.812 2.341 . . . . 0.0 112.75 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.04 15.66 47.59 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.49 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.454 HG21 ' N ' ' A' ' 119' ' ' TYR . 91.3 m -128.93 144.65 51.24 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.692 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 11.5 t80 -89.03 97.24 11.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.164 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.547 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 16.3 mttt -74.0 -153.77 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.765 1.269 . . . . 0.0 113.034 -177.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.541 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 12.4 p90 -175.6 171.6 2.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.275 -2.239 . . . . 0.0 109.085 176.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 18.1 tp -127.49 120.38 28.18 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.5 ' HG2' HE21 ' A' ' 125' ' ' GLN . 80.8 tt0 -113.11 125.65 54.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.1 t -135.75 124.79 39.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.202 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.5 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.9 mp0 -113.68 130.62 56.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.069 179.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 126' ' ' TYR . 37.8 p90 -154.47 173.36 16.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 111.454 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.437 ' HA ' HH11 ' A' ' 36' ' ' ARG . 88.3 m-20 -127.51 161.72 28.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.558 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.5 m -109.49 117.54 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.262 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.453 HG12 ' SD ' ' A' ' 57' ' ' MET . 3.0 m -124.07 158.19 61.35 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.921 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 N--CA 1.496 1.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.164 -179.723 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 66.0 mtp85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.576 ' NH2' ' OE2' ' A' ' 123' ' ' GLU . 74.6 ttt180 -147.77 131.81 17.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.686 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.613 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 46.4 mt-10 -132.54 145.62 51.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.045 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.12 141.94 34.14 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.49 146.23 36.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.468 -178.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.34 130.0 41.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.973 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 5.9 tt0 -40.39 136.13 1.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.126 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.45 83.7 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.111 -0.949 . . . . 0.0 114.173 177.123 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -117.8 148.18 42.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 118.994 1.397 . . . . 0.0 111.074 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.03 137.68 63.41 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.518 2.145 . . . . 0.0 113.32 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.4 143.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.71 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 44.7 tt0 -131.24 127.18 37.31 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.554 -178.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.1 mt -108.7 144.58 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.71 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 93.3 mtt-85 -149.15 127.22 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.274 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -95.78 141.57 23.35 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.704 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -66.6 158.7 54.47 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.031 1.821 . . . . 0.0 112.245 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.66 -134.28 34.75 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.427 0.459 . . . . 0.0 112.946 178.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.4 p -104.81 22.62 14.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.94 -0.63 . . . . 0.0 110.913 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -75.91 166.62 23.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.743 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 m -126.98 144.87 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.521 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.404 HG23 ' CD2' ' A' ' 126' ' ' TYR . 86.0 mt -70.23 136.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.143 0.497 . . . . 0.0 112.088 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.7 ptp -130.43 98.9 4.82 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.417 HG13 ' CE1' ' A' ' 89' ' ' PHE . 53.4 t -62.99 123.61 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.79 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.404 ' C ' ' CG ' ' A' ' 60' ' ' ASN . 73.4 mm-40 -99.49 -45.12 5.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' CG ' ' C ' ' A' ' 59' ' ' GLU . 2.8 m-80 -154.12 148.14 25.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.304 -179.085 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.26 152.87 11.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.885 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -149.32 153.65 37.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.428 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 61.6 t80 -125.84 125.69 43.27 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.06 -137.96 5.88 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -177.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.599 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -155.02 114.97 3.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 111.055 179.299 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.778 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 13.9 p -119.26 9.49 11.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.661 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 44.7 t0 -143.49 -167.12 2.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.612 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.661 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 53.9 p30 -151.83 -5.89 0.24 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 38.1 mttm -97.36 11.04 38.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.472 HG22 HD13 ' A' ' 70' ' ' ILE . 39.9 mm -115.03 138.56 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.939 0.4 . . . . 0.0 110.312 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m 56.92 70.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.117 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.6 p-10 -51.39 117.33 2.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.584 0.707 . . . . 0.0 111.315 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.94 -163.84 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.676 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 3.4 p30 -60.71 132.71 91.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 119.164 -1.014 . . . . 0.0 108.667 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.41 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -57.0 -27.14 72.08 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.452 2.101 . . . . 0.0 113.968 -178.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -63.88 -30.02 71.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.032 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.676 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.0 mt-30 -88.59 -5.72 57.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.516 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.599 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 6.0 mtm -110.84 -1.48 16.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.264 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 49.9 mt-10 -60.97 -52.32 65.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.963 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.98 107.76 11.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.051 -0.406 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.6 m -101.4 31.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.33 0.586 . . . . 0.0 110.662 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -139.26 85.9 2.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.5 t -149.32 115.39 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -124.25 156.01 37.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.727 0.299 . . . . 0.0 111.221 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 tp -142.69 82.02 12.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -44.91 -45.42 13.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.245 2.63 . . . . 0.0 114.256 -177.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 86.6 m-20 -57.1 -25.29 58.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.885 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.36 -34.77 49.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.576 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.527 ' O ' ' OG ' ' A' ' 93' ' ' SER . 26.7 t80 -64.1 -40.37 96.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.8 pttm -67.17 -39.25 86.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.835 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.564 ' CG2' ' NH1' ' A' ' 95' ' ' ARG . 69.9 mt -60.19 -52.45 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.561 ' SD ' ' CD2' ' A' ' 122' ' ' LEU . 62.1 mtp -69.68 -32.56 71.25 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.527 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 62.5 m -59.97 -43.37 95.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.592 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 90.4 mt-30 -66.59 -36.23 82.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.353 0.596 . . . . 0.0 110.014 178.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.564 ' NH1' ' CG2' ' A' ' 91' ' ' ILE . 52.9 mtt85 -77.45 -34.08 54.54 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 59.4 m -110.89 -16.19 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.477 ' CG ' ' O ' ' A' ' 93' ' ' SER . 77.0 m-20 -61.44 133.39 55.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.804 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 66.52 13.31 9.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.592 ' NH2' ' O ' ' A' ' 94' ' ' GLN . 42.9 mtt85 -113.89 147.03 39.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.944 178.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -71.04 -31.32 67.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.623 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 156.59 35.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.102 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.3 p -153.6 142.34 21.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.29 126.25 70.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.328 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.71 146.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.855 -178.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.45 120.26 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.268 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -71.76 43.5 0.09 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.165 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.1 -126.72 1.03 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 29.36 -154.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.239 0.543 . . . . 0.0 112.209 179.588 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -64.43 -10.56 25.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.642 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.05 59.9 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.807 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 112' ' ' PRO . 64.4 m-85 -142.69 126.76 9.68 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.684 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.546 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.4 Cg_exo -50.1 -156.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.323 2.015 . . . . 0.0 112.436 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.459 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 20.9 t0 -139.35 93.21 10.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.411 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.49 -38.55 0.98 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.714 2.276 . . . . 0.0 113.328 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -140.25 79.08 22.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.057 0.456 . . . . 0.0 110.995 -179.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 17.2 Cg_exo -56.18 133.4 57.83 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.187 1.924 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.46 -10.9 56.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.888 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.414 ' CG2' ' O ' ' A' ' 77' ' ' GLN . 62.9 m -105.95 147.54 28.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.616 0.708 . . . . 0.0 109.104 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.593 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 t80 -84.37 97.61 9.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.491 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 22.5 mtmm -73.54 -171.65 1.05 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.457 1.599 . . . . 0.0 115.083 -177.056 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.778 ' HH ' ' H ' ' A' ' 66' ' ' THR . 10.6 p90 -164.47 167.73 19.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 111.58 -2.555 . . . . 0.0 110.579 177.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.561 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 25.9 tp -129.33 122.56 29.78 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.576 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 83.5 tt0 -115.33 132.93 56.46 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.774 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.541 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 41.5 t -133.33 144.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.82 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.493 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -133.26 130.44 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.081 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.404 ' CD2' HG23 ' A' ' 56' ' ' ILE . 27.9 p90 -156.09 171.62 19.82 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.138 -178.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 57' ' ' MET . 87.8 m-20 -125.5 162.22 25.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.775 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 92.4 m -108.93 125.52 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.7 m -130.34 157.58 76.9 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.674 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.492 1.41 0 C-N-CA 122.025 1.816 . . . . 0.0 111.979 178.796 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.525 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 3.3 mtm-85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.407 ' HE ' ' CG ' ' A' ' 125' ' ' GLN . 41.0 ttm180 -146.69 135.84 22.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -132.04 143.6 50.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.672 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 tt -139.16 141.09 38.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.91 142.73 34.4 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.266 -179.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.423 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 65.7 m -66.84 134.45 52.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.994 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 5.4 tt0 -44.04 134.86 4.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -4.91 79.67 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.326 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 12.1 m-85 -118.1 150.08 46.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 118.189 0.995 . . . . 0.0 110.798 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 24.4 Cg_endo -65.94 141.76 65.95 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.879 2.386 . . . . 0.0 113.722 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.0 tt -117.3 145.53 22.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.135 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -127.5 129.29 47.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.317 -178.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.454 HD13 ' SG ' ' A' ' 102' ' ' CYS . 40.4 mt -112.44 141.81 45.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.538 178.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -149.43 132.85 16.6 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.577 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.45 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.8 m -102.68 142.98 25.68 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.901 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.17 161.59 44.15 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.6 2.2 . . . . 0.0 112.844 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.03 -128.1 33.34 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.6 p -112.88 25.84 11.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.45 166.82 22.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.5 m -127.62 143.99 38.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.472 HG23 ' CD2' ' A' ' 126' ' ' TYR . 92.0 mt -69.48 139.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.234 -178.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 ptp -132.85 103.12 5.93 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.442 HG13 ' HG ' ' A' ' 93' ' ' SER . 97.5 t -64.67 125.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.25 -178.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 96.0 mt-10 -102.94 -51.0 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -149.05 145.1 27.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.202 0.525 . . . . 0.0 110.549 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.85 156.22 10.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.716 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -152.59 154.95 36.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.177 0.513 . . . . 0.0 111.618 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 76.9 t80 -122.39 122.48 39.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.445 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 120' ' ' LYS . . . 157.11 -142.45 8.68 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -177.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -151.6 119.15 6.05 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.17 0.51 . . . . 0.0 111.722 179.11 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.501 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 26.6 p -128.09 5.49 5.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.557 179.134 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.745 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 61.8 t0 -144.39 151.63 39.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.399 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.658 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 40.7 p30 -112.66 3.5 16.65 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.471 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -103.1 8.52 38.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.737 -178.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 70' ' ' ILE . 45.2 mm -112.31 135.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m 55.69 72.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.611 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 57.8 p30 -49.65 106.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.529 0.68 . . . . 0.0 112.19 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.56 -166.78 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.152 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.626 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.18 141.6 97.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 5.9 Cg_endo -54.99 -33.82 84.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 121.895 1.73 . . . . 0.0 112.509 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -63.51 -40.26 96.57 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.463 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 25.5 mt-30 -90.37 -6.68 54.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.974 0.416 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.461 ' HE1' ' NH2' ' A' ' 65' ' ' ARG . 80.2 mmm -106.66 -5.23 18.76 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.758 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.583 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 1.9 mm-40 -66.98 -46.58 74.18 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.7 t30 -78.25 122.99 26.43 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.838 -178.26 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.24 32.59 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.1 85.5 2.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.496 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.2 t -151.27 121.22 7.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.9 m-85 -131.75 156.59 45.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.964 0.411 . . . . 0.0 111.939 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.401 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 27.8 tp -147.93 87.66 5.76 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.567 178.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -48.03 -46.6 21.64 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.621 2.214 . . . . 0.0 113.361 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.5 m-20 -55.15 -23.92 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.124 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 85' ' ' LEU . . . -55.59 -33.08 63.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.615 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.541 ' O ' ' OG ' ' A' ' 93' ' ' SER . 4.7 t80 -65.18 -40.75 94.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.598 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 10.1 pttp -64.87 -40.6 95.39 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.39 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 60.6 mt -59.94 -50.52 79.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.703 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.0 mmm -67.16 -33.99 76.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.541 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 28.1 m -60.02 -45.09 93.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.283 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.71 -36.78 83.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.179 0.514 . . . . 0.0 111.01 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.44 ' CZ ' HG12 ' A' ' 104' ' ' VAL . 16.9 mtp180 -74.09 -35.4 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.2 m -112.99 -12.88 13.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.502 ' CG ' ' O ' ' A' ' 93' ' ' SER . 68.2 m-20 -60.02 133.76 56.4 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.55 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 67.31 13.83 9.5 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 178.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -113.85 145.16 41.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.802 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.7 m -69.13 -31.26 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 155.4 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.267 179.326 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -153.86 130.8 10.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.25 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 97.3 t -114.25 132.4 63.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.875 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.44 HG12 ' CZ ' ' A' ' 95' ' ' ARG . 43.5 t -144.03 149.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -83.62 117.52 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.08 37.48 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.62 -178.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.94 -127.73 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.554 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.525 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 12.4 t 31.69 -153.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.525 ' H ' ' HG ' ' A' ' 108' ' ' SER . 94.9 m-20 -63.46 -9.08 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.101 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.36 60.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.922 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -141.57 126.36 10.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.8 Cg_exo -49.96 -154.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.602 2.201 . . . . 0.0 112.162 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -137.72 87.39 17.25 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -84.7 -20.89 3.57 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.313 2.675 . . . . 0.0 114.092 -179.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.487 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -153.49 73.47 6.71 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 121.109 0.48 . . . . 0.0 110.858 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.26 135.42 50.33 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.084 1.856 . . . . 0.0 112.048 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.76 -12.0 53.35 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.586 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -111.25 149.79 30.52 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.187 0.994 . . . . 0.0 108.835 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.2 t80 -82.2 98.5 8.76 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.257 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.504 ' CD ' ' CE2' ' A' ' 63' ' ' TYR . 20.7 mttt -70.89 -160.74 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.652 1.215 . . . . 0.0 112.98 -178.418 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.514 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -176.5 171.73 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.052 176.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 20.3 tp -130.11 123.83 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 57.6 tt0 -117.89 125.07 49.8 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.9 t -131.01 124.73 56.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.938 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.407 ' CG ' ' HE ' ' A' ' 37' ' ' ARG . 1.6 mt-30 -109.48 131.41 55.09 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.472 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.8 p90 -151.46 171.93 16.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.357 -178.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.455 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 48.9 m-20 -127.08 160.9 29.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.898 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.525 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 84.2 m -112.6 120.94 43.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.744 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 30.7 m -121.16 149.18 50.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.902 179.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 121.83 1.686 . . . . 0.0 112.163 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.441 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.649 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 16.1 mt -55.81 -36.24 43.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.919 -0.141 . . . . 0.0 111.183 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 5.1 Cg_endo -82.76 -157.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.858 2.372 . . . . 0.0 111.963 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -79.52 -7.62 58.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 110.722 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.46 19.82 64.97 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.8 OUTLIER -166.4 129.77 2.0 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.414 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 34' ' ' LEU . 6.0 mtt 47.96 117.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.244 0.545 . . . . 0.0 111.164 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 65.4 mtp85 -93.45 153.06 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.736 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -153.12 138.37 17.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.296 0.57 . . . . 0.0 112.161 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.532 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 86.8 mt-10 -131.16 149.5 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.472 HD21 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -136.26 139.55 42.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -143.9 145.18 32.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.034 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.3 m -71.25 133.66 46.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.457 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.585 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 79.7 tt0 -44.27 137.16 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.496 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.22 -6.94 72.4 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.402 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.442 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 15.1 m-85 -116.9 153.78 49.46 Favored Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 118.972 1.386 . . . . 0.0 111.154 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.05 141.8 40.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.124 1.883 . . . . 0.0 112.725 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 16.5 tt -116.33 144.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 86.0 tt0 -129.98 127.71 40.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.261 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 HD13 ' SG ' ' A' ' 102' ' ' CYS . 19.9 mt -111.45 144.74 40.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.254 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.519 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 62.7 mtt180 -147.93 126.62 12.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.309 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.458 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.5 m -95.39 144.54 27.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 27.6 Cg_endo -68.55 157.3 62.39 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.481 2.12 . . . . 0.0 112.295 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.43 -134.51 29.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.438 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -104.63 23.05 13.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -77.67 167.67 21.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.85 145.65 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.635 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.488 HG21 ' CD2' ' A' ' 126' ' ' TYR . 97.4 mt -67.91 136.21 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.821 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.591 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.2 ptm -132.5 100.79 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.16 124.77 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.403 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.562 ' OE1' ' OD1' ' A' ' 127' ' ' ASP . 46.9 mt-10 -102.04 -50.61 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.855 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -148.23 146.5 28.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.948 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -165.8 153.83 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.531 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -151.54 154.16 35.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.159 0.504 . . . . 0.0 111.796 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 30.2 t80 -123.57 122.83 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -138.89 6.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 5.3 ttm-85 -155.69 115.52 3.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.057 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.658 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 14.8 p -124.8 7.67 8.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.525 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 15.2 t70 -146.95 155.47 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' O ' ' CE ' ' A' ' 78' ' ' MET . 58.7 p30 -110.16 0.69 18.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.419 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 14.2 mttp -105.75 8.86 33.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.776 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.646 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 46.1 mm -113.72 136.27 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.781 0.324 . . . . 0.0 110.512 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 51.6 m 59.99 63.7 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -47.99 109.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 112.25 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -128.35 -164.81 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.758 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.687 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -62.85 144.73 96.63 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.173 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.2 Cg_endo -54.78 -37.59 92.08 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.34 2.027 . . . . 0.0 112.52 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -63.86 -34.47 78.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.597 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.687 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.3 mt-30 -86.82 -10.73 52.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.468 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 88.1 mtp -102.21 -5.49 24.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 37.6 mm-40 -63.99 -52.63 58.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -78.84 115.48 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.379 0.609 . . . . 0.0 112.517 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.531 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.2 m -107.17 32.28 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.127 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -139.93 85.51 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.113 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.425 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.6 t -148.11 118.79 7.51 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -125.74 152.85 44.79 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.08 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.0 tp -147.17 83.66 7.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.66 -47.25 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.078 2.519 . . . . 0.0 113.308 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 82.3 m-20 -54.11 -23.76 15.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.802 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.33 56.78 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.098 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.483 ' CE1' ' OG ' ' A' ' 93' ' ' SER . 33.7 t80 -64.03 -42.85 96.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.99 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 14.4 pttm -63.92 -38.35 90.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.106 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.442 HG22 ' HE ' ' A' ' 95' ' ' ARG . 69.1 mt -60.98 -52.22 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.306 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.5 mmm -68.48 -36.24 78.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.068 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.8 m -60.43 -47.29 86.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -66.55 -36.84 83.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.442 ' HE ' HG22 ' A' ' 91' ' ' ILE . 89.5 mtt-85 -76.96 -32.91 57.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.29 -15.29 13.65 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.539 ' CG ' ' O ' ' A' ' 93' ' ' SER . 48.2 m-20 -60.04 134.07 56.7 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.665 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 66.38 13.53 9.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -115.95 147.35 41.25 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.57 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.7 m -72.53 -31.47 65.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.718 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.48 154.65 35.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.462 ' SG ' HD13 ' A' ' 48' ' ' LEU . 27.2 p -155.16 136.94 14.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.747 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 20.6 t -116.93 130.59 71.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 46' ' ' ILE . 42.3 t -143.09 146.87 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.599 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -80.76 118.49 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.01 37.44 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.723 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.74 -130.16 1.46 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.564 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 107' ' ' GLY . 3.5 t 36.64 -154.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -63.27 -9.01 9.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.273 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.15 -13.45 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.558 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.583 ' O ' ' O ' ' A' ' 112' ' ' PRO . 62.1 m-85 -140.58 128.19 12.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.448 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.4 Cg_exo -48.61 -158.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.352 2.034 . . . . 0.0 111.984 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.19 91.85 12.62 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -82.59 -46.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.134 2.556 . . . . 0.0 113.112 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.5 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -131.79 77.97 71.29 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-O 121.112 0.482 . . . . 0.0 111.319 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.49 131.6 34.53 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.748 1.632 . . . . 0.0 111.739 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.49 -6.59 38.88 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.526 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.596 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 96.7 m -112.49 147.58 36.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.636 0.718 . . . . 0.0 109.336 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.544 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.3 t80 -85.87 98.43 10.77 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.806 ' HZ2' ' HO3' ' A' ' 136' ' ' RAM . 11.9 mttp -76.51 -163.01 0.29 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 123.078 1.418 . . . . 0.0 113.803 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.658 ' HH ' ' H ' ' A' ' 66' ' ' THR . 5.7 p90 -169.29 171.9 7.61 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.44 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.2 tp -129.26 122.55 29.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.088 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 54.7 tt0 -115.31 128.42 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.372 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.5 t -135.54 123.77 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.48 -0.888 . . . . 0.0 113.141 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.0 129.32 54.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.488 ' CD2' HG21 ' A' ' 56' ' ' ILE . 35.7 p90 -152.21 166.96 30.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.237 0.541 . . . . 0.0 111.873 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.562 ' OD1' ' OE1' ' A' ' 59' ' ' GLU . 3.1 m-20 -126.75 161.74 27.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.241 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.432 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 65.3 m -111.96 122.26 47.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.623 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.5 m -124.86 154.41 70.82 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.63 149.05 60.86 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.342 2.028 . . . . 0.0 112.446 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -76.47 2.08 14.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.888 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.703 ' CD ' ' N ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -144.56 -163.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.577 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 134' ' ' GLU . 7.6 p -86.68 132.2 32.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.07 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 133' ' ' VAL . 21.3 tp10 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.324 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.806 ' HO3' ' HZ2' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -130.28 142.06 44.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.844 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -68.88 148.83 71.56 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.389 2.059 . . . . 0.0 111.601 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -78.93 -5.54 53.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.238 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.93 38.82 94.57 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -155.36 55.89 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.04 0.448 . . . . 0.0 110.295 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' LEU . 5.4 mtt 57.91 150.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.993 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -90.45 147.95 23.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.432 ' NH2' HD13 ' A' ' 39' ' ' LEU . 68.6 ttt-85 -143.93 140.43 29.69 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.967 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -137.51 140.32 41.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.58 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -142.36 128.75 20.04 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.448 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -129.91 145.65 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.946 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.6 m -67.78 133.84 49.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.907 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.673 ' CD ' ' HO4' ' A' ' 136' ' ' RAM . 0.0 OUTLIER -42.96 136.63 2.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.015 -178.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.74 -2.96 82.98 Favored Glycine 0 N--CA 1.453 -0.198 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.712 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -117.05 150.76 46.58 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.0 0.9 . . . . 0.0 110.706 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.04 140.64 45.92 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.45 2.1 . . . . 0.0 112.714 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 tt -114.05 149.04 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 48.8 tt0 -126.55 127.86 45.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.154 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.449 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 19.3 mt -115.62 138.87 50.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 79.1 mtt180 -146.9 130.75 17.09 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.753 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.9 m -98.15 146.23 31.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.933 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.84 158.68 49.74 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.724 2.283 . . . . 0.0 112.29 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.83 -129.35 26.41 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.805 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -110.27 25.66 11.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.09 167.84 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.158 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.86 145.0 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.126 0.489 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.449 HG21 ' CD2' ' A' ' 126' ' ' TYR . 73.4 mt -67.89 137.61 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.686 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' ' 129' ' ' VAL . 2.7 ptp -132.52 100.87 5.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 t -63.23 126.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.766 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -101.63 -51.22 3.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.114 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -148.96 147.05 28.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -168.84 151.92 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.401 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 84' ' ' TYR . 13.2 t30 -152.39 161.79 42.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.397 0.618 . . . . 0.0 111.856 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 80.6 t80 -126.73 125.0 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -141.08 7.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.531 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.73 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.6 ttm-85 -155.04 114.87 3.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.266 0.555 . . . . 0.0 111.166 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.639 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 69.8 p -119.89 8.87 11.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.066 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.644 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.2 t0 -145.05 -170.11 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.417 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.623 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 2.9 p30 -146.04 -0.51 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.756 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -107.71 8.74 29.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.213 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.543 ' HB ' HH22 ' A' ' 65' ' ' ARG . 35.2 mm -102.74 134.55 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.578 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' ASP . 73.8 m 55.75 24.15 6.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.648 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.58 ' C ' ' O ' ' A' ' 71' ' ' CYS . 15.8 t70 1.43 105.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.7 -166.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.062 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -63.31 146.25 96.34 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.066 179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.5 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -58.4 -37.65 93.93 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.2 1.933 . . . . 0.0 112.571 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.48 -42.71 95.73 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.541 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 28.9 mt-30 -84.12 -6.14 59.36 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.037 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 mmm -112.51 0.43 15.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.195 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 18.0 mt-10 -64.32 -47.85 77.85 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.934 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -78.86 113.71 17.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.446 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.7 m -105.75 35.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.083 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -140.03 87.26 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.894 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.439 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.5 t -151.75 116.43 5.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.403 ' HA ' HD22 ' A' ' 62' ' ' ASN . 86.1 m-85 -125.29 156.13 39.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.942 0.401 . . . . 0.0 111.035 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 tp -145.59 91.1 5.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -48.89 -45.25 29.31 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.433 2.089 . . . . 0.0 111.622 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 65.9 m-20 -54.38 -30.92 53.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.32 -32.54 49.42 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.242 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.592 ' O ' ' OG ' ' A' ' 93' ' ' SER . 59.7 t80 -65.09 -43.98 90.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.4 pttp -66.08 -38.23 87.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.527 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.413 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 84.1 mt -59.88 -53.28 50.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.732 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 91.8 mmm -67.52 -34.73 77.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.518 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.592 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 23.8 m -58.91 -46.7 87.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.186 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.07 -37.62 84.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.757 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.413 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 96.3 mtt-85 -73.98 -33.62 63.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 13.2 m -114.71 -13.72 12.05 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 93' ' ' SER . 88.5 m-20 -61.22 135.91 57.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.009 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 67.83 13.91 9.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.523 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -116.1 146.74 41.98 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.072 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -72.41 -31.67 65.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.716 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 155.26 38.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.681 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.449 ' SG ' ' CD1' ' A' ' 48' ' ' LEU . 5.1 p -156.19 133.96 11.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.724 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.15 126.89 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.0 t -139.35 146.21 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 111.614 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -81.66 119.6 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 38.38 0.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.118 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.35 -124.19 0.89 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.937 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.71 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 31.04 -158.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.717 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.71 ' N ' ' OG ' ' A' ' 108' ' ' SER . 89.6 m-20 -64.4 -9.23 16.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.6 -8.96 58.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.249 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 112' ' ' PRO . 32.3 m-85 -141.05 131.18 13.15 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.075 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.9 Cg_exo -48.76 -163.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.343 2.029 . . . . 0.0 111.767 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.569 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -136.87 89.24 17.49 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.303 -179.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.78 -54.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.992 2.461 . . . . 0.0 113.139 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 4.1 p -127.49 72.87 77.89 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.887 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HA ' ' HO2' ' A' ' 136' ' ' RAM . 7.8 Cg_endo -58.74 131.85 44.56 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.908 1.739 . . . . 0.0 111.582 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.473 ' N ' ' O2 ' ' A' ' 136' ' ' RAM . . . 108.91 -16.96 32.95 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.803 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 119' ' ' TYR . 43.4 m -102.91 153.5 20.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.064 0.932 . . . . 0.0 108.495 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.73 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 21.2 t80 -86.21 99.31 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.527 0.68 . . . . 0.0 109.506 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.702 ' HZ2' ' HO4' ' A' ' 136' ' ' RAM . 4.8 mtmp? -81.99 -159.27 0.28 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.599 1.19 . . . . 0.0 113.875 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.639 ' HH ' ' H ' ' A' ' 66' ' ' THR . 19.9 p90 -174.9 174.19 2.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.34 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.411 HD11 ' CE1' ' A' ' 111' ' ' PHE . 18.7 tp -131.51 125.06 31.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.425 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 75.3 tt0 -121.18 130.79 53.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.41 123.47 42.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.011 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -109.7 129.71 55.58 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.449 ' CD2' HG21 ' A' ' 56' ' ' ILE . 40.9 p90 -153.56 169.76 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.51 0.671 . . . . 0.0 111.851 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -124.15 160.67 27.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.418 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 93.0 m -113.57 112.25 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.77 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.429 HG12 ' SD ' ' A' ' 57' ' ' MET . 9.1 m -115.1 165.65 13.65 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.635 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -65.61 148.53 87.32 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.669 1.58 . . . . 0.0 111.63 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.413 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 35.2 t80 -72.24 -96.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.138 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 25.4 tttt -90.29 -74.13 0.5 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.567 ' O ' ' O ' ' A' ' 134' ' ' GLU . 92.7 t -143.71 136.36 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.851 0.358 . . . . 0.0 110.932 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 133' ' ' VAL . 82.9 tt0 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.701 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.702 ' HO4' ' HZ2' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 mp -70.42 145.46 93.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.3 134.74 65.83 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.385 2.057 . . . . 0.0 111.184 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -74.71 -54.05 8.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.574 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.01 23.71 76.92 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 35' ' ' MET . 1.1 tt -161.5 124.11 3.06 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.688 0.28 . . . . 0.0 110.49 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.484 ' N ' HD23 ' A' ' 34' ' ' LEU . 2.6 mtt 58.06 153.9 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.296 0.57 . . . . 0.0 111.124 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.557 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 19.9 mtp180 -90.82 146.39 23.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.213 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HE ' ' CG ' ' A' ' 123' ' ' GLU . 74.7 ttt180 -148.28 133.78 18.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.299 0.571 . . . . 0.0 110.984 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -129.57 146.45 51.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.517 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 7.5 tt -141.6 127.88 19.84 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.81 147.47 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.045 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 m -70.05 132.2 45.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.519 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.598 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 17.4 tt0 -44.82 140.47 2.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.782 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 92.06 -8.28 77.99 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.818 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 18.7 m-85 -117.2 147.62 40.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 118.353 1.077 . . . . 0.0 109.928 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.95 146.24 76.88 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.342 2.028 . . . . 0.0 113.069 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 tt -120.47 148.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.943 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.659 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 80.8 tt0 -132.63 126.96 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -112.91 143.38 44.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.659 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 97.8 mtt180 -144.78 134.31 23.28 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.518 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.7 m -103.79 143.65 27.08 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.274 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.546 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 49.3 Cg_endo -73.03 154.71 52.78 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 112.346 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.5 51.09 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.827 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -113.77 27.94 9.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -80.28 167.83 19.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.52 150.05 33.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.797 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.476 HG21 ' CD1' ' A' ' 126' ' ' TYR . 53.6 mt -71.05 138.14 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.181 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.0 ptp -131.04 98.01 4.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.0 t -64.54 126.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.914 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -103.54 -46.78 4.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -150.53 147.55 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.447 0.642 . . . . 0.0 111.13 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.64 154.86 10.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.241 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 84' ' ' TYR . 6.1 t30 -150.5 151.41 32.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.06 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -119.88 122.93 42.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.34 -138.39 5.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.881 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 7.1 ttm-85 -155.21 115.4 3.79 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.168 -0.516 . . . . 0.0 109.845 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.817 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 10.9 p -122.39 11.49 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.044 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.682 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 49.9 t0 -146.91 -171.03 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.272 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.682 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 56.1 p30 -144.55 -0.33 0.96 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -103.9 6.3 36.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.209 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 40.1 mm -113.34 137.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m 57.25 70.56 0.64 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.128 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -53.12 122.16 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.387 0.613 . . . . 0.0 112.084 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.97 -163.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 141.07 98.0 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.437 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.9 Cg_endo -56.82 -35.03 97.9 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.344 2.029 . . . . 0.0 112.554 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -63.16 -36.87 85.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.568 HE21 ' CG ' ' A' ' 74' ' ' ASP . 29.4 mt-30 -88.14 12.54 13.39 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.233 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 75.8 mtp -129.0 -2.99 5.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 53.5 mm-40 -63.27 -47.25 83.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.987 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.44 119.29 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.419 . . . . 0.0 111.912 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.3 m -111.37 31.66 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.623 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -136.23 85.84 2.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.3 t -149.15 112.57 5.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.5 ' HA ' HD22 ' A' ' 62' ' ' ASN . 72.8 m-85 -128.19 152.56 47.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.648 0.261 . . . . 0.0 110.945 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.76 86.76 7.72 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -45.98 -48.43 12.7 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.86 2.374 . . . . 0.0 114.904 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 37.6 m-20 -58.54 -21.89 53.83 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.27 61.65 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.565 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' O ' ' OG ' ' A' ' 93' ' ' SER . 54.5 t80 -63.81 -41.83 97.8 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.6 pttm -66.54 -38.5 87.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.573 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 91' ' ' ILE . 88.5 mt -60.74 -50.7 79.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.804 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.475 ' SD ' HG12 ' A' ' 104' ' ' VAL . 98.6 mmm -67.75 -35.63 79.08 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.11 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 16.4 m -61.82 -46.1 90.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.391 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.92 -35.6 81.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.562 0.696 . . . . 0.0 110.424 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HE ' HG22 ' A' ' 104' ' ' VAL . 23.1 mtp85 -74.47 -34.0 63.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.6 m -112.39 -21.46 11.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' SER . 60.4 m-20 -56.25 129.72 41.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 72.05 14.33 5.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.829 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 84.5 mtt180 -117.12 149.22 40.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.585 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.0 m -71.28 -33.42 69.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.501 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.68 155.01 35.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.98 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.5 p -151.44 149.88 29.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.978 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.56 126.66 75.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.529 HG22 ' HE ' ' A' ' 95' ' ' ARG . 44.0 t -137.34 144.03 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.633 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -85.8 122.15 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.373 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -66.81 23.56 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . -179.59 173.09 44.95 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.935 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.606 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.7 t 94.79 -155.55 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -66.32 -11.19 49.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.008 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.97 -18.47 60.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.55 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.527 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.5 m-85 -141.47 131.22 12.76 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.575 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 111' ' ' PHE . 36.1 Cg_exo -50.64 -156.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.404 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.13 95.63 10.52 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.769 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -82.98 -50.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.657 2.238 . . . . 0.0 113.564 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.478 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 11.2 p -133.05 84.8 47.56 Favored Pre-proline 0 N--CA 1.466 0.36 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.098 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.02 136.1 50.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.08 1.853 . . . . 0.0 112.328 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.6 -4.8 47.22 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.361 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 119' ' ' TYR . 67.2 m -114.4 149.3 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.169 0.984 . . . . 0.0 108.655 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.543 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.3 t80 -85.09 98.99 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 18.6 mttt -76.05 -165.61 0.49 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.918 1.342 . . . . 0.0 113.363 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.817 ' HH ' ' H ' ' A' ' 66' ' ' THR . 8.4 p90 -167.83 167.46 12.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.251 -2.25 . . . . 0.0 109.769 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 25.9 tp -127.76 123.33 35.04 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.699 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 3.4 tm-20 -117.61 129.42 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.11 119.65 41.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.699 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 1.7 mp0 -102.69 127.8 49.67 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.557 ' OH ' ' NE ' ' A' ' 36' ' ' ARG . 18.6 p90 -154.77 170.48 21.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.58 0.705 . . . . 0.0 112.517 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -128.13 163.34 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.779 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.432 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 92.6 m -109.46 114.51 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.367 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.64 151.02 47.9 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.66 141.91 83.18 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.587 1.525 . . . . 0.0 112.342 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -79.26 136.98 37.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.803 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -92.36 129.12 38.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.455 ' O ' ' OXT' ' A' ' 134' ' ' GLU . 86.8 t -97.45 134.59 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.455 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 73.1 tt0 . . . . . 0 C--O 1.218 -0.59 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.523 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.598 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -125.01 57.8 16.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.726 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.67 143.1 12.99 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.278 2.652 . . . . 0.0 112.342 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -82.11 -6.03 58.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.634 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.65 21.17 76.26 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -154.03 98.4 2.16 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.823 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.582 ' O ' ' O ' ' A' ' 34' ' ' LEU . 9.7 mtt 50.26 134.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.863 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.53 ' CZ ' ' H ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -93.16 144.33 25.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.833 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 37' ' ' ARG . 37.9 ttp-105 -149.93 137.56 20.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.318 0.58 . . . . 0.0 111.024 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 57.4 mp0 -134.51 146.04 49.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -138.1 137.59 37.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.014 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.442 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -141.41 143.74 34.09 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.883 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.0 m -70.54 133.96 47.24 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 84.8 tt0 -42.21 136.54 2.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.876 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.12 74.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.094 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.69 149.88 45.89 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-N 119.118 1.459 . . . . 0.0 112.02 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.83 137.61 64.01 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.124 2.549 . . . . 0.0 113.06 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -120.06 142.36 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.591 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.3 tt0 -130.03 129.25 43.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.611 -0.835 . . . . 0.0 113.224 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.6 mt -109.93 145.75 36.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.591 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 46.4 mtt85 -148.14 132.27 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.591 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.424 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -98.16 144.33 27.87 Favored Pre-proline 0 N--CA 1.455 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 56.9 Cg_endo -71.1 159.31 52.64 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.215 2.61 . . . . 0.0 112.593 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.46 -120.08 12.6 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.782 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -125.73 26.44 6.67 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.747 0.308 . . . . 0.0 110.996 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -77.41 169.97 17.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.509 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.76 143.09 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.559 ' CG2' ' CD2' ' A' ' 126' ' ' TYR . 78.0 mt -69.74 140.36 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.586 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.461 ' SD ' HG13 ' A' ' 129' ' ' VAL . 2.0 ptp -133.84 100.51 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 89' ' ' PHE . 17.4 t -64.89 127.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.445 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.57 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 76.6 mt-10 -104.25 -49.64 3.54 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.794 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.7 m-20 -147.42 145.47 29.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.089 0.471 . . . . 0.0 110.725 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.0 154.74 9.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.967 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -152.08 156.79 40.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.286 0.565 . . . . 0.0 111.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 70.3 t80 -125.62 119.68 28.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 120' ' ' LYS . . . 156.66 -136.74 5.11 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.69 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 9.2 ttm-85 -154.94 118.03 4.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.329 0.585 . . . . 0.0 112.063 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.457 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 19.5 p -124.73 6.07 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.356 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 56.1 t0 -146.7 154.81 41.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.955 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 51.7 p30 -113.05 2.59 15.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -104.6 5.99 34.18 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.944 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.7 mm -115.69 139.65 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.624 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.3 m 53.77 71.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 39.2 p-10 -54.09 128.55 31.19 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 111.599 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.31 -165.87 2.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.282 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.692 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -61.88 142.48 94.97 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.16 -35.35 95.12 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.241 1.961 . . . . 0.0 112.827 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.6 -33.88 75.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.957 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.519 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.3 mt-30 -89.01 6.64 38.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.92 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.4 mtp -125.73 -3.96 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 39.1 mm-40 -61.54 -45.94 92.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.951 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -83.03 113.27 20.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.621 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 21.3 m -104.16 33.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.316 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.621 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.9 mm-40 -138.69 85.6 2.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.43 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 41.5 t -148.53 122.47 9.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.6 m-85 -131.86 154.14 49.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.14 86.43 7.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.334 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -46.88 -45.98 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.029 2.486 . . . . 0.0 113.162 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 75.7 m-20 -53.01 -29.45 29.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.35 -31.41 33.43 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.573 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.562 ' O ' ' OG ' ' A' ' 93' ' ' SER . 50.9 t80 -67.9 -47.89 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 pttp -64.1 -41.91 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.395 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 70.6 mt -59.53 -48.69 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.051 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.546 ' HG2' HH21 ' A' ' 95' ' ' ARG . 46.0 mtp -70.84 -34.85 72.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.77 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.562 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 23.6 m -57.42 -42.97 83.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.831 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.52 -37.85 87.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.546 HH21 ' HG2' ' A' ' 92' ' ' MET . 36.8 mtm180 -76.38 -30.58 57.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 75.5 m -112.6 -21.42 11.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.515 ' CG ' ' O ' ' A' ' 93' ' ' SER . 69.4 m-20 -55.51 135.64 50.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.984 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 64.05 13.54 7.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.669 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -115.97 147.93 40.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.366 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.1 m -71.63 -33.93 69.35 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.795 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.02 159.23 40.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.278 0.561 . . . . 0.0 110.867 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.6 p -155.5 138.85 15.76 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.701 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.19 126.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.482 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 64.6 t -143.64 146.04 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -75.11 117.67 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.57 42.79 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 175.22 -127.25 1.25 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 35.82 -150.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.129 -0.536 . . . . 0.0 111.381 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.45 -9.62 13.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.12 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' HB3' HH12 ' A' ' 95' ' ' ARG . . . -76.85 -17.23 59.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.169 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.2 m-85 -139.7 130.51 14.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.794 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.7 Cg_exo -52.01 -153.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.459 2.106 . . . . 0.0 112.423 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -137.19 93.71 12.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.44 -51.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 123.034 2.489 . . . . 0.0 113.283 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.4 p -131.62 79.54 68.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.391 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -62.91 138.86 70.73 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.53 2.154 . . . . 0.0 112.53 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.55 -2.54 49.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.898 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.462 HG21 ' N ' ' A' ' 119' ' ' TYR . 95.1 m -120.5 148.85 43.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.106 0.453 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.624 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.1 t80 -86.3 96.68 10.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.511 ' HZ3' ' HO3' ' A' ' 136' ' ' RAM . 37.0 mttt -68.12 -156.33 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.217 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.504 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.4 p90 -176.38 168.58 2.76 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 112.665 -2.061 . . . . 0.0 109.37 176.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.466 HD22 ' SD ' ' A' ' 92' ' ' MET . 12.9 tp -129.7 122.79 29.64 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.495 ' OE2' ' NE2' ' A' ' 125' ' ' GLN . 78.2 tt0 -117.77 131.2 56.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.797 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.95 119.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.495 ' NE2' ' OE2' ' A' ' 123' ' ' GLU . 5.1 mp0 -105.04 124.55 49.73 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.559 ' CD2' ' CG2' ' A' ' 56' ' ' ILE . 23.8 p90 -154.22 166.97 31.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.715 0.769 . . . . 0.0 112.055 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.438 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 83.5 m-20 -123.31 162.0 23.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.259 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.53 ' H ' ' CZ ' ' A' ' 36' ' ' ARG . 86.4 m -110.38 119.69 40.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.906 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.461 HG13 ' SD ' ' A' ' 57' ' ' MET . 34.1 m -117.59 156.52 49.32 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.481 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -64.86 144.12 82.06 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 121.598 1.532 . . . . 0.0 111.078 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.587 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 39.3 t80 -78.71 -175.14 4.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.981 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.587 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 57.3 mttm -93.17 144.25 25.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.248 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.2 p -144.7 138.95 23.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.393 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.97 -1.014 . . . . 0.0 111.026 178.584 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . 0.44 ' H83' HD21 ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.511 ' HO3' ' HZ3' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.8 mm? -67.25 -45.56 50.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.629 0.252 . . . . 0.0 111.033 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 55.6 Cg_endo -78.84 59.46 7.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.573 2.182 . . . . 0.0 112.385 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 70.9 t80 -78.45 0.31 26.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.965 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.12 31.04 62.11 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -163.71 118.5 1.58 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.427 ' O ' ' O ' ' A' ' 34' ' ' LEU . 25.0 mtt 52.97 108.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.595 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' NH2' ' HG3' ' A' ' 51' ' ' PRO . 4.2 mtt-85 -88.88 154.34 20.33 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 37' ' ' ARG . 13.0 ttt180 -142.28 136.66 29.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.096 0.475 . . . . 0.0 110.387 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -133.65 143.56 48.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.533 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -139.42 136.27 34.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.512 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.84 144.95 32.72 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.447 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.414 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 25.6 m -71.21 133.68 46.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 9.2 tt0 -45.07 140.91 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.486 0.66 . . . . 0.0 112.511 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 94.12 -12.15 69.55 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.71 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.9 m-85 -116.74 155.64 48.75 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 118.405 1.103 . . . . 0.0 110.051 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.55 146.86 31.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.475 2.117 . . . . 0.0 113.948 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 46' ' ' ILE . 11.4 tt -118.57 145.82 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.913 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -126.64 127.81 45.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.884 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.9 mt -112.93 145.11 41.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -150.79 131.84 14.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.77 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -100.03 145.77 30.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.685 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 43.5 Cg_endo -72.35 160.38 47.1 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.462 2.108 . . . . 0.0 113.073 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.15 -130.68 28.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -107.43 24.45 12.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.34 166.55 22.53 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.829 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 m -127.46 143.38 40.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.113 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.413 HG23 ' CD1' ' A' ' 126' ' ' TYR . 95.3 mt -67.08 138.09 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.622 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -130.41 98.38 4.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.22 123.72 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.38 -48.25 4.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.5 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -147.6 145.6 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.254 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.64 151.1 9.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.508 HD22 ' HA ' ' A' ' 84' ' ' TYR . 6.7 t30 -150.4 152.34 34.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.929 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.748 ' HH ' ' HZ3' ' A' ' 120' ' ' LYS . 66.4 t80 -122.65 125.25 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.468 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.89 -136.31 4.99 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.589 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 6.1 ttm180 -156.6 117.98 3.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.006 0.432 . . . . 0.0 111.127 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.576 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 26.2 p -124.69 7.7 8.19 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.73 152.68 40.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.449 ' O ' ' CE ' ' A' ' 78' ' ' MET . 20.9 p-10 -109.68 -0.36 18.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.333 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -106.37 8.74 31.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.116 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.512 HD13 HG23 ' A' ' 70' ' ' ILE . 39.5 mm -114.31 139.81 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.569 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.6 m 57.48 64.75 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -46.93 120.82 3.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.813 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.52 -167.08 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.933 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -63.02 142.51 97.68 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.037 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.58 -36.09 79.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 121.784 1.656 . . . . 0.0 112.762 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -64.59 -33.77 76.7 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.651 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 81.4 mt-30 -84.04 -12.62 54.88 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.828 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.449 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 66.4 mtp -103.95 -2.18 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 52.6 mm-40 -58.96 -53.2 61.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.806 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -80.43 122.52 27.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.01 28.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.058 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -143.73 90.64 2.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -145.79 120.93 10.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.663 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 5.9 m-85 -128.75 153.02 47.79 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.616 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.7 tp -146.08 91.2 5.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.705 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -49.24 -46.27 26.59 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.228 2.619 . . . . 0.0 113.751 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 23.9 m-20 -53.74 -22.31 8.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.03 -33.49 57.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.763 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -64.8 -44.46 89.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.166 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.9 pttt -65.86 -40.07 91.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.983 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.5 HG23 ' NH1' ' A' ' 95' ' ' ARG . 79.5 mt -60.49 -51.39 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.861 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.0 mmm -68.17 -37.0 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.569 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.449 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 60.9 m -60.31 -44.26 95.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.117 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -65.44 -37.94 88.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.295 0.569 . . . . 0.0 110.665 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.534 HH11 ' HG3' ' A' ' 95' ' ' ARG . 51.4 mtt85 -76.26 -33.3 59.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.8 m -111.94 -15.16 13.39 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.449 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 70.2 m-20 -62.72 135.21 57.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.634 -0.827 . . . . 0.0 111.669 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 64.99 11.48 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt-85 -112.71 145.5 40.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 110.595 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.9 m -72.76 -31.28 64.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.479 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.13 155.23 38.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.262 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 29.3 p -153.76 139.7 18.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.882 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.0 t -119.06 131.05 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 105' ' ' VAL . 17.6 t -141.99 152.01 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.425 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.46 ' N ' HG13 ' A' ' 104' ' ' VAL . 2.4 t -88.81 120.79 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.71 38.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.362 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.84 -125.7 0.98 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.175 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 31.36 -158.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.257 0.551 . . . . 0.0 112.022 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.72 -10.52 19.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.627 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.83 59.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.089 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.5 m-85 -142.51 132.72 12.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.366 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.6 Cg_exo -49.95 -159.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -139.01 86.44 15.01 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.474 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.496 ' HD2' ' HZ2' ' A' ' 120' ' ' LYS . 66.8 Cg_endo -79.32 -29.0 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.718 2.279 . . . . 0.0 113.136 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.1 p -155.67 83.84 3.54 Favored Pre-proline 0 C--N 1.332 -0.155 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.688 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.444 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 18.4 Cg_endo -70.02 140.87 42.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.94 1.76 . . . . 0.0 112.039 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.54 -2.02 46.03 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.372 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.589 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 30.1 m -117.61 147.02 43.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.589 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 8.9 t80 -84.61 98.2 10.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.748 ' HZ3' ' HH ' ' A' ' 63' ' ' TYR . 21.3 mtmt -77.58 -166.78 0.81 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.469 1.128 . . . . 0.0 113.401 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.576 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 40.0 p90 -167.32 168.6 13.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.621 -2.082 . . . . 0.0 110.321 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.3 tp -127.02 124.93 40.52 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.49 ' HG3' HE21 ' A' ' 125' ' ' GLN . 15.3 tp10 -117.22 128.23 54.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.066 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.79 125.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.262 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.49 HE21 ' HG3' ' A' ' 123' ' ' GLU . 2.6 mt-30 -112.83 130.72 55.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 126' ' ' TYR . 27.5 p90 -153.82 173.24 16.15 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.089 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -124.78 158.83 32.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.352 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.406 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.5 m -105.95 119.43 39.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.439 HG12 ' SD ' ' A' ' 57' ' ' MET . 35.8 m -126.49 158.11 68.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.66 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.32 145.22 88.62 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.096 1.864 . . . . 0.0 112.06 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -72.7 -12.81 61.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.903 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -97.3 135.43 39.23 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.449 ' O ' ' OXT' ' A' ' 134' ' ' GLU . 81.3 t -141.84 117.4 5.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.987 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 71.1 tt0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.544 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . 0.464 ' O3 ' ' O7 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.589 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.7 74.25 78.31 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.244 0.545 . . . . 0.0 110.334 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.37 152.31 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.287 2.658 . . . . 0.0 112.472 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.486 ' C ' ' H ' ' A' ' 34' ' ' LEU . 2.1 m-85 -78.19 4.87 11.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.28 -33.76 0.95 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.695 ' N ' ' CD1' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -159.22 107.54 1.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.741 0.781 . . . . 0.0 111.567 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' LEU . 8.2 mtp 53.95 150.78 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.737 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 49' ' ' ARG . 70.8 mtp180 -96.56 146.09 25.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -156.09 137.99 14.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.893 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -127.06 149.96 49.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.204 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -138.83 142.21 38.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.455 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -144.29 144.96 31.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.356 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 7.6 m -71.55 134.6 46.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 110.436 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.616 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 87.2 tt0 -43.24 138.51 2.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.134 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.66 -7.65 77.21 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.816 -1.084 . . . . 0.0 114.298 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.56 153.91 50.55 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 119.068 1.434 . . . . 0.0 110.909 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.84 140.84 47.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.589 2.192 . . . . 0.0 113.748 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.1 tt -116.84 146.36 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -126.2 127.77 46.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.095 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.1 mt -115.88 138.55 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.545 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 18.8 mtp180 -146.5 133.51 20.3 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.283 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -98.66 136.72 20.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.86 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.49 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 55.6 Cg_endo -70.25 158.29 56.78 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.415 2.077 . . . . 0.0 111.458 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.23 -141.41 30.33 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.652 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.0 p -98.63 22.2 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -78.88 165.09 23.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.7 0.286 . . . . 0.0 110.86 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.57 148.69 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.534 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.447 HG12 ' SG ' ' A' ' 50' ' ' CYS . 78.5 mt -71.19 136.06 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.653 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.36 101.8 5.12 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.43 127.04 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.457 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 71.3 mm-40 -103.92 -48.29 3.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.816 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 65.1 m-20 -148.49 145.76 28.07 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.13 154.23 7.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.851 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.461 HD22 ' HA ' ' A' ' 84' ' ' TYR . 6.0 t30 -150.24 151.99 33.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.37 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.626 ' CD2' ' CG ' ' A' ' 111' ' ' PHE . 54.9 t80 -118.4 121.09 39.5 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.6 -135.33 4.54 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.382 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 10.5 ttm-85 -156.55 117.53 3.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 111.362 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.519 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 23.6 p -122.87 9.44 9.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.071 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 15.2 t0 -147.2 -178.22 6.1 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.135 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 54.7 p30 -138.36 -0.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.065 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -102.65 2.83 36.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.844 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.67 137.7 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.019 0.437 . . . . 0.0 110.855 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.4 m 54.63 70.79 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.14 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.0 p30 -52.09 125.95 17.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.923 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.91 -163.61 1.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 142.64 98.21 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.301 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.44 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.7 Cg_endo -54.44 -35.93 86.41 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.952 1.768 . . . . 0.0 112.008 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -63.87 -37.18 86.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.558 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 81.2 mt-30 -83.46 -9.72 58.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.359 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.9 mtp -106.04 -0.92 24.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 76.2 mt-10 -60.47 -53.04 62.33 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.08 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.425 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 48.9 t30 -76.54 117.46 18.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.578 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.0 m -107.71 29.42 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.832 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.8 mm-40 -141.01 85.37 1.98 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.389 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 44.8 t -146.94 124.23 11.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.461 ' HA ' HD22 ' A' ' 62' ' ' ASN . 58.1 m-85 -133.54 159.04 41.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.7 tp -147.73 94.99 4.3 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.18 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.48 -43.83 31.82 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.825 2.35 . . . . 0.0 114.06 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -61.16 -23.68 65.74 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.59 62.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.928 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.57 ' O ' ' OG ' ' A' ' 93' ' ' SER . 17.3 t80 -67.12 -47.73 70.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.069 0.461 . . . . 0.0 112.087 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 pttm -67.23 -41.22 86.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.965 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.561 ' CG2' HH21 ' A' ' 95' ' ' ARG . 69.7 mt -61.39 -47.41 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.795 ' SD ' ' NH1' ' A' ' 95' ' ' ARG . 96.2 mmm -66.97 -36.13 81.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 5.1 m -60.88 -42.11 97.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.93 -36.82 85.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 111.245 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.795 ' NH1' ' SD ' ' A' ' 92' ' ' MET . 20.8 mtm180 -76.17 -33.34 59.34 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 36.2 m -113.66 -14.02 12.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.577 ' CG ' ' O ' ' A' ' 93' ' ' SER . 2.7 m120 -58.58 136.88 57.71 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.807 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 67.04 14.37 9.8 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.017 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -116.49 147.01 42.16 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.306 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.5 m -73.76 -31.93 63.57 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.086 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 153.37 37.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.449 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 12.1 p -156.75 131.33 8.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.4 ' C ' HG23 ' A' ' 104' ' ' VAL . 22.4 t -121.72 125.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.692 ' CG1' ' NH1' ' A' ' 95' ' ' ARG . 91.5 t -141.94 146.4 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.441 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.507 ' N ' HG11 ' A' ' 104' ' ' VAL . 2.5 t -72.5 120.23 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.98 41.76 0.06 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.82 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 108' ' ' SER . . . 179.3 -130.66 1.55 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.353 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 107' ' ' GLY . 5.9 t 31.58 -146.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.019 0.438 . . . . 0.0 110.943 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.05 -10.27 13.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.14 -21.76 53.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.265 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.626 ' CG ' ' CD2' ' A' ' 63' ' ' TYR . 36.1 m-85 -138.26 128.98 15.46 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.494 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.8 Cg_exo -52.18 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.855 1.703 . . . . 0.0 111.645 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -140.06 80.39 20.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.296 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.57 -19.89 18.5 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.572 2.181 . . . . 0.0 113.171 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.629 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.8 p -157.12 80.37 3.45 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.484 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -65.95 139.23 55.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.122 1.881 . . . . 0.0 111.698 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.14 -3.16 47.63 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.576 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.486 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 90.1 m -120.29 145.62 46.9 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.502 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 15.7 t80 -84.74 96.95 9.41 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.629 ' NZ ' ' O ' ' A' ' 115' ' ' CYS . 20.3 mtmm -71.47 -165.97 0.17 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.576 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 9.0 p90 -168.16 169.27 11.11 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.6 tp -128.02 123.64 35.19 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -116.55 127.41 54.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.137 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.19 121.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.346 -0.941 . . . . 0.0 112.535 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.56 127.72 52.35 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -152.32 168.8 24.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.317 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -126.73 162.62 25.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.424 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 86.1 m -113.61 113.89 25.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 0.0 110.239 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 m -115.19 156.88 44.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -60.12 147.25 93.95 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 121.594 1.529 . . . . 0.0 110.942 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.579 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 28.2 t80 -72.76 -143.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.331 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.579 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 41.1 tttp -90.82 -81.71 0.3 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.739 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.75 144.97 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.398 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.433 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.616 ' O3 ' ' OE2' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mt -125.0 73.15 65.17 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -68.2 140.51 49.36 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.236 1.957 . . . . 0.0 111.924 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 79.3 t80 -78.68 0.02 28.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 109.917 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.9 22.87 73.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.4 OUTLIER -162.98 121.29 2.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.075 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.557 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 55.02 136.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 110.793 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -97.6 150.54 21.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.758 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.555 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 40.2 ttt-85 -147.73 141.09 25.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.441 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -130.06 145.61 51.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.554 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.7 tt -139.31 137.93 36.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.501 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.7 144.14 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.873 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.68 130.41 43.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.568 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.495 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 31.0 tt0 -41.39 136.87 1.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.324 0.583 . . . . 0.0 112.183 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.09 76.75 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.084 -0.962 . . . . 0.0 114.179 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -115.48 152.56 47.19 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 118.896 1.348 . . . . 0.0 111.193 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -69.88 139.9 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.02 1.813 . . . . 0.0 112.341 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 tt -115.19 147.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.648 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 40.8 tt0 -126.83 129.17 47.76 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.185 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.6 mt -115.87 138.86 50.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.648 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 91.1 mtt180 -144.09 132.68 22.27 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.931 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.473 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -100.3 138.89 20.32 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.215 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.08 157.83 53.49 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.367 2.045 . . . . 0.0 111.612 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.1 38.28 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.9 p -103.1 25.11 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.333 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.52 164.2 24.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.088 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.405 HG13 ' CD1' ' A' ' 131' ' ' TYR . 29.8 m -125.64 146.24 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.473 HG12 ' SG ' ' A' ' 50' ' ' CYS . 70.4 mt -69.31 134.63 29.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.162 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.5 ptp -129.39 97.76 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 89' ' ' PHE . 32.7 t -61.7 125.26 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.955 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 79.7 mm-40 -101.35 -49.84 3.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.745 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.1 m-20 -152.27 150.61 29.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -169.66 156.59 6.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 84' ' ' TYR . 13.5 t30 -151.36 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.528 0.68 . . . . 0.0 111.606 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 35.9 t80 -123.01 120.33 33.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.69 -140.42 6.91 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.416 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.666 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 5.3 ttm180 -157.55 118.27 3.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 0.0 111.978 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.601 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 72.7 p -125.76 7.42 7.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.401 0.62 . . . . 0.0 109.704 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 54.6 t0 -146.43 154.13 41.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.4 p30 -114.17 3.1 15.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 110.424 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -104.6 4.64 33.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.774 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.4 mm -110.84 137.58 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.6 m 55.95 62.94 2.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -44.61 121.0 2.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . . . -140.41 -166.81 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.355 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.618 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -62.55 133.58 94.81 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.437 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -51.78 -34.78 56.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.181 1.921 . . . . 0.0 113.224 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.8 -37.1 85.37 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.589 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 81.7 mt-30 -80.12 -17.89 51.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.254 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.666 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 7.9 mtm -102.18 1.39 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 55.3 mm-40 -61.97 -47.59 84.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.699 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.55 114.39 19.41 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 66' ' ' THR . 15.6 m -104.34 34.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.944 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.546 HE21 ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -143.95 88.07 1.95 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.944 0.402 . . . . 0.0 111.739 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.469 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.0 t -147.39 122.78 10.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.466 ' HA ' HD22 ' A' ' 62' ' ' ASN . 97.6 m-85 -126.02 153.81 43.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 111.796 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -147.92 85.94 6.33 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.92 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.82 -49.35 16.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.919 2.412 . . . . 0.0 113.061 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.5 m-20 -49.13 -30.35 6.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -32.8 53.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.822 0.344 . . . . 0.0 111.11 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' O ' ' OG ' ' A' ' 93' ' ' SER . 59.3 t80 -65.08 -41.89 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 34.2 pttt -65.86 -40.67 91.88 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.806 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.3 mt -60.27 -48.75 86.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.868 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -70.03 -36.61 75.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.114 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.53 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 19.8 m -58.79 -47.61 84.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.549 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -65.1 -35.93 82.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.05 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.533 HH11 ' CG1' ' A' ' 104' ' ' VAL . 99.5 mtt180 -79.9 -30.57 40.11 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.0 m -112.43 -20.18 11.88 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 89.4 m-20 -58.25 135.87 57.21 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.8 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 64.53 13.06 7.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.851 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 95' ' ' ARG . 75.0 mtp180 -114.02 145.66 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.2 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.4 m -71.79 -30.98 66.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.454 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.44 152.8 31.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 p -151.91 141.76 21.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.48 128.96 75.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.809 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.533 ' CG1' HH11 ' A' ' 95' ' ' ARG . 22.6 t -144.7 147.58 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.229 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -78.71 118.39 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.903 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.94 41.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.8 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 175.54 -123.04 0.9 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.178 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.6 t 31.04 -157.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.911 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.94 -9.58 22.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.851 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.72 -9.39 58.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.524 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.8 m-85 -144.0 133.54 11.61 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.858 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 44.9 Cg_exo -49.62 -161.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.925 1.75 . . . . 0.0 111.334 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -139.29 97.6 8.49 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.042 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.25 -58.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.847 2.364 . . . . 0.0 112.725 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.422 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 8.4 p -126.56 80.37 69.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.177 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.438 ' HA ' ' HO2' ' A' ' 136' ' ' RAM . 24.9 Cg_endo -64.71 137.82 55.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.79 1.66 . . . . 0.0 111.942 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.76 ' H ' ' HO2' ' A' ' 136' ' ' RAM . . . 113.52 -13.75 22.9 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.737 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.577 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 1.0 OUTLIER -111.09 151.74 27.73 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.258 0.529 . . . . 0.0 109.983 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.587 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.5 t80 -85.63 96.96 9.84 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.494 ' NZ ' ' HO3' ' A' ' 136' ' ' RAM . 12.6 mttp -76.4 -161.19 0.17 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.729 1.252 . . . . 0.0 113.125 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.601 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 5.6 p90 -168.93 171.17 8.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.955 -1.93 . . . . 0.0 110.732 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 35.9 tp -129.86 123.52 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.555 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 69.9 tt0 -118.65 129.42 55.29 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.46 121.74 48.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.965 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.468 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.9 mp0 -105.37 129.1 53.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -152.69 167.36 29.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.307 0.575 . . . . 0.0 111.896 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 57' ' ' MET . 96.8 m-20 -123.51 159.56 28.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.066 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.6 m -114.47 107.43 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.414 HG13 ' SD ' ' A' ' 57' ' ' MET . 1.9 m -111.08 158.06 36.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -54.81 143.92 68.65 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.962 1.775 . . . . 0.0 111.912 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.499 ' CD2' ' CG ' ' A' ' 132' ' ' LYS . 10.6 t80 -78.19 -77.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.022 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.499 ' CG ' ' CD2' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -142.28 101.77 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.362 178.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.19 136.16 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.837 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.099 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.76 ' HO2' ' H ' ' A' ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.5 mt -67.05 150.85 97.69 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.03 0.443 . . . . 0.0 110.911 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 33' ' ' GLY . 19.3 Cg_endo -63.32 173.13 4.48 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.822 2.348 . . . . 0.0 112.069 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 57.7 t80 -73.01 6.59 2.56 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.681 -0.408 . . . . 0.0 109.947 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . 62.19 -1.47 1.41 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.892 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' MET . 5.9 tt -158.37 98.29 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.039 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.626 ' SD ' ' OD1' ' A' ' 127' ' ' ASP . 2.4 ttp 47.59 165.45 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.472 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 -91.17 137.92 31.99 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -149.7 137.33 20.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.41 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -134.86 148.98 50.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.901 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -140.28 144.46 36.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.254 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.411 ' N ' ' CD2' ' A' ' 39' ' ' LEU . . . -145.97 145.33 30.6 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.108 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.7 m -66.2 131.08 45.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.725 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 15.8 tt0 -42.24 132.04 3.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.685 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.5 76.38 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.065 -0.97 . . . . 0.0 113.252 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -118.06 151.09 48.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 118.238 1.019 . . . . 0.0 110.309 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.94 139.7 33.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.616 2.211 . . . . 0.0 113.384 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.7 tt -114.65 140.64 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -117.51 132.3 56.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.689 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.7 mt -114.87 142.22 46.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.401 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -149.8 134.84 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.646 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.457 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.5 m -102.15 142.76 25.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.932 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.73 156.44 63.41 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.846 2.364 . . . . 0.0 112.01 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.08 -127.9 29.58 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.241 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 p -110.59 23.9 13.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.039 -0.58 . . . . 0.0 111.303 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -79.34 169.34 18.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.74 146.88 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.413 0.625 . . . . 0.0 110.598 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.457 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 85.5 mt -68.18 137.19 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.063 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.1 ptm -132.34 100.81 5.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.49 ' CG2' ' OD1' ' A' ' 97' ' ' ASN . 41.1 t -64.54 125.38 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.667 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.94 -48.91 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -153.48 150.35 28.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.444 0.64 . . . . 0.0 110.417 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -170.53 156.18 5.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.473 HD22 ' HA ' ' A' ' 84' ' ' TYR . 8.8 t30 -150.58 154.9 38.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.785 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 33.9 t80 -117.31 117.47 29.62 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.65 -137.71 5.35 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.498 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.685 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -160.61 121.83 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.368 0.604 . . . . 0.0 112.036 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.462 HG21 ' CZ ' ' A' ' 84' ' ' TYR . 8.1 p -124.2 8.9 8.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.54 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.622 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 49.4 t0 -143.6 -170.14 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.834 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.616 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 22.3 p30 -148.17 -0.4 0.59 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.745 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -104.56 7.57 35.2 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 70' ' ' ILE . 38.0 mm -108.51 135.6 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.6 m 55.58 69.95 0.68 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 34.4 p30 -48.39 111.87 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.62 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.29 -162.18 1.18 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.766 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -64.18 141.37 98.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.473 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.6 Cg_endo -55.95 -38.95 93.93 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.393 2.062 . . . . 0.0 112.904 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.81 -34.48 77.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.048 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.766 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 72.3 mt-30 -87.23 -11.96 48.18 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.302 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.477 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.4 mmm -100.59 -3.98 29.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.372 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 21.6 mt-10 -66.9 -47.57 71.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.9 t30 -79.31 119.81 22.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.752 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.4 33.3 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.782 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -141.63 86.9 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.312 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.426 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 51.3 t -149.8 120.85 7.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.886 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.473 ' HA ' HD22 ' A' ' 62' ' ' ASN . 97.3 m-85 -131.24 149.57 52.51 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.913 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 38.1 tp -138.42 90.85 12.88 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.32 -47.76 25.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.657 2.238 . . . . 0.0 113.364 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 69.4 m-20 -54.33 -23.74 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.03 54.44 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.938 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.411 ' O ' ' OG ' ' A' ' 93' ' ' SER . 61.5 t80 -65.05 -43.43 92.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.82 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 15.5 pttm -64.44 -39.99 94.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.293 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.61 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 72.3 mt -58.55 -50.53 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.023 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.442 ' HE3' ' SG ' ' A' ' 96' ' ' CYS . 93.8 mmm -68.43 -35.47 77.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.062 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.481 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 49.4 m -58.1 -48.49 80.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.355 0.597 . . . . 0.0 110.647 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -67.7 -37.51 82.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.61 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 66.8 mtt-85 -76.61 -36.4 57.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.442 ' SG ' ' HE3' ' A' ' 92' ' ' MET . 4.7 m -114.16 -20.74 10.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.49 ' OD1' ' CG2' ' A' ' 58' ' ' VAL . 46.5 m-20 -59.36 139.87 56.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.683 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 23.5 m-20 70.6 15.04 7.18 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.956 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -119.17 149.9 40.96 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.048 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 m -70.48 -32.92 70.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.81 158.77 43.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.848 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 29.9 t -155.15 142.81 19.78 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.317 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.0 129.11 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.133 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 t -145.33 142.59 22.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.272 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.0 t -77.02 119.15 24.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.382 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.05 30.94 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.055 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 177.95 175.99 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.652 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 3.1 t 95.95 -158.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.266 0.555 . . . . 0.0 110.872 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.78 -8.56 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.365 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.01 -11.47 58.81 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.073 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.2 m-85 -140.62 126.43 11.48 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.976 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.602 ' O ' ' O ' ' A' ' 111' ' ' PHE . 51.0 Cg_exo -46.24 -159.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.792 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.45 93.23 12.86 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.264 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.89 -55.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.222 2.615 . . . . 0.0 112.991 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 26.5 p -127.47 90.3 48.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.508 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.37 140.03 47.17 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.897 2.398 . . . . 0.0 111.814 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.05 4.62 56.57 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.735 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.416 ' N ' ' H61' ' A' ' 136' ' ' RAM . 30.4 m -127.71 146.53 50.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.565 0.682 . . . . 0.0 109.351 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.685 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 29.3 t80 -86.52 99.14 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.543 ' HZ3' ' HO3' ' A' ' 136' ' ' RAM . 23.0 mttt -73.35 -156.22 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.436 1.112 . . . . 0.0 113.645 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -175.41 174.94 2.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.753 -2.022 . . . . 0.0 110.105 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.9 tp -131.9 123.52 27.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.265 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.448 ' HG2' HE21 ' A' ' 125' ' ' GLN . 83.7 tt0 -115.18 128.34 56.12 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.14 118.27 40.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.723 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.448 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.3 mt-30 -106.34 129.17 54.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -153.26 171.48 18.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.444 0.64 . . . . 0.0 111.774 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.626 ' OD1' ' SD ' ' A' ' 35' ' ' MET . 0.5 OUTLIER -129.6 160.82 32.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.204 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 86.2 m -110.38 123.79 50.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.74 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.83 157.4 63.19 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.115 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.35 149.65 88.49 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.442 2.095 . . . . 0.0 112.316 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -79.27 -5.05 53.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.686 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -136.02 102.61 5.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.719 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.74 132.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.071 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.988 179.266 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.543 ' HO3' ' HZ3' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 29' ' ' GLY . 1.8 mm? 29.22 87.44 0.1 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.409 . . . . 0.0 110.872 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.34 150.67 19.63 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.001 2.467 . . . . 0.0 111.878 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -82.6 -1.42 50.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.408 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.89 42.06 39.22 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.523 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.72 39.61 0.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.095 0.474 . . . . 0.0 110.912 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.3 ttm 64.43 143.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.089 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.472 ' NH1' ' HG2' ' A' ' 36' ' ' ARG . 50.7 mtp85 -92.63 147.38 22.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 60.5 ttp180 -148.85 135.99 20.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.501 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 28.6 mp0 -133.18 148.76 52.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.098 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.48 144.78 38.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -144.3 143.75 31.15 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.428 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.9 m -69.26 132.53 46.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.342 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.601 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 37.7 tt0 -44.63 139.95 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.21 -8.08 80.44 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.601 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -113.55 149.96 42.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 118.343 1.072 . . . . 0.0 110.878 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.49 139.58 49.59 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.636 2.224 . . . . 0.0 113.116 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.3 tt -118.42 146.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.706 ' CD ' HH21 ' A' ' 49' ' ' ARG . 88.1 tt0 -129.7 129.94 44.86 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.6 mt -114.17 146.67 40.03 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.706 HH21 ' CD ' ' A' ' 47' ' ' GLU . 84.1 mtt180 -147.17 136.24 22.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.192 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 137.01 19.14 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.156 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.92 158.81 56.44 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.498 2.132 . . . . 0.0 112.061 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.56 -130.62 34.7 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -108.43 26.01 10.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.608 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -79.85 165.19 22.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.916 0.389 . . . . 0.0 110.8 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.74 145.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.054 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.441 ' CG2' ' CD1' ' A' ' 126' ' ' TYR . 84.9 mt -69.37 138.3 22.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.575 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.6 ptp -132.08 99.27 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.438 HG11 ' CE1' ' A' ' 89' ' ' PHE . 47.0 t -62.53 123.63 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.512 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.96 -47.73 3.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.738 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -146.27 142.45 28.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -165.57 154.0 11.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.675 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.45 HD22 ' HA ' ' A' ' 84' ' ' TYR . 7.7 t30 -152.26 150.29 29.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 112.054 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.496 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 47.2 t80 -117.21 119.97 36.84 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.27 -138.41 5.86 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 10.6 ttm-85 -158.4 119.16 3.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.4 0.619 . . . . 0.0 111.378 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.563 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 32.3 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.349 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 16.0 t70 -146.99 -170.95 3.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.944 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.541 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.4 p30 -146.92 -2.06 0.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.521 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -102.88 5.15 38.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.86 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.9 mm -106.8 137.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.129 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.8 m 56.89 66.2 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.628 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.6 p-10 -47.98 121.34 4.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.592 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.79 -165.73 2.18 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.714 ' CG ' HE21 ' A' ' 77' ' ' GLN . 0.4 OUTLIER -63.7 140.63 97.84 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.174 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -56.33 -36.91 97.61 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.983 2.455 . . . . 0.0 114.151 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -65.82 -32.71 74.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.487 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.714 HE21 ' CG ' ' A' ' 74' ' ' ASP . 27.7 mt-30 -88.82 10.43 21.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.691 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.4 mtm -132.82 0.9 3.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.398 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.6 mt-10 -63.16 -48.0 80.28 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.721 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -76.17 114.66 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 111.773 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.511 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 35.9 m -107.08 31.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.978 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.511 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.3 mm100 -141.4 87.45 2.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.437 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 15.5 t -148.06 123.51 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.45 ' HA ' HD22 ' A' ' 62' ' ' ASN . 91.7 m-85 -127.86 151.96 48.42 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.55 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.9 tp -146.95 85.73 6.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.092 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -45.89 -44.36 18.58 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.21 2.607 . . . . 0.0 114.665 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 51.1 m-20 -56.02 -24.76 41.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.04 -31.44 51.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' O ' ' OG ' ' A' ' 93' ' ' SER . 82.5 t80 -65.17 -47.36 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 12.6 pttp -64.82 -37.71 88.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.741 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 93.7 mt -61.79 -52.46 60.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.405 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.485 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 31.2 m -63.15 -47.54 82.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.016 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -68.08 -36.67 80.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 73.6 mtt180 -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 82.7 m -110.52 -22.18 11.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 88.6 m-20 -57.54 134.02 55.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.399 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 66.89 9.79 7.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.038 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.621 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 62.4 mtt85 -111.97 146.43 37.85 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.253 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.4 m -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.547 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.21 156.01 34.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.0 p -154.65 142.4 19.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.58 123.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.078 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.08 145.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.33 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.46 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -77.78 118.49 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.28 41.59 0.05 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.646 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.78 -125.5 0.99 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.593 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.766 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 32.5 t 31.06 -155.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 0.0 111.578 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.766 ' H ' ' HG ' ' A' ' 108' ' ' SER . 96.5 m-20 -65.17 -10.51 31.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.712 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.51 59.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.472 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.1 m-85 -142.19 130.27 11.66 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.061 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 48.4 Cg_exo -47.66 -157.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.713 2.276 . . . . 0.0 112.546 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -139.08 91.75 11.22 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.45 -46.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.509 2.139 . . . . 0.0 113.168 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.6 p -140.69 85.21 13.0 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.855 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -58.97 146.9 92.38 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.239 2.626 . . . . 0.0 111.728 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.98 63.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.324 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.646 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 91.0 m -130.98 144.36 51.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.3 t80 -86.54 96.66 10.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.867 ' HZ3' ' HO4' ' A' ' 136' ' ' RAM . 24.1 mtmm -74.27 -168.49 0.66 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.927 1.346 . . . . 0.0 114.005 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.563 ' OH ' ' N ' ' A' ' 66' ' ' THR . 12.7 p90 -167.03 169.07 13.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.146 -2.297 . . . . 0.0 110.68 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.4 125.64 33.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.343 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.569 ' OE2' ' O ' ' A' ' 38' ' ' GLU . 10.6 tp10 -118.48 131.28 56.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.895 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.0 t -135.39 123.07 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.413 HE21 ' HG3' ' A' ' 123' ' ' GLU . 2.3 mt-30 -107.39 126.76 52.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.829 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.441 ' CD1' ' CG2' ' A' ' 56' ' ' ILE . 34.9 p90 -153.78 168.35 26.59 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.743 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 92.6 m-20 -119.89 159.61 24.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.964 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 55.0 m -111.49 111.42 22.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.353 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.443 HG11 ' SD ' ' A' ' 57' ' ' MET . 5.1 m -115.72 156.45 46.29 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -55.13 148.43 49.07 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.124 1.882 . . . . 0.0 111.981 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -74.68 -96.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -91.7 131.12 37.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.896 0.379 . . . . 0.0 110.645 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 134' ' ' GLU . 14.0 p -88.32 138.97 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.979 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 133' ' ' VAL . 81.7 tt0 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.003 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.867 ' HO4' ' HZ3' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.596 ' O ' ' O ' ' A' ' 31' ' ' PRO . 9.7 mp 54.81 60.66 9.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 110.047 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 30' ' ' LEU . 81.9 Cg_exo -38.69 -118.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.718 2.945 . . . . 0.0 112.571 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.591 ' C ' ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -77.31 -6.73 54.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.313 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.35 -29.5 0.26 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.134 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.591 ' H ' ' C ' ' A' ' 32' ' ' PHE . 18.9 tp -162.18 110.33 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.036 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 34' ' ' LEU . 83.4 mtp 58.48 151.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.365 0.602 . . . . 0.0 111.608 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.71 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 68.3 mtp85 -90.25 142.74 27.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.148 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.559 ' HE ' ' CG ' ' A' ' 125' ' ' GLN . 40.8 ttm180 -147.08 132.57 18.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.539 0.685 . . . . 0.0 110.972 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -128.13 143.01 51.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.524 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 6.9 tt -139.24 137.97 36.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.795 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.6 142.88 32.21 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.124 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.419 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 31.0 m -67.89 138.1 55.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.935 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.639 ' CD ' ' HH ' ' A' ' 63' ' ' TYR . 13.8 tt0 -42.86 139.28 1.72 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.3 0.572 . . . . 0.0 112.512 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.99 -5.55 83.15 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.735 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -115.41 152.79 47.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 118.506 1.153 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.24 143.55 39.8 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 122.512 2.141 . . . . 0.0 113.461 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.02 143.64 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.654 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 88.0 tt0 -126.14 127.99 46.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.423 0.63 . . . . 0.0 111.698 -177.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.3 mt -113.57 140.75 47.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.842 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.71 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 97.4 mtt180 -144.79 131.23 19.76 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.828 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.2 m -100.65 146.63 32.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.27 157.28 37.5 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.343 2.028 . . . . 0.0 112.415 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 54.9 -133.98 47.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.166 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -107.2 25.3 11.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.114 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -78.65 165.98 23.04 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.94 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.45 145.78 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.488 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 50' ' ' CYS . 77.9 mt -68.67 135.7 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.628 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.2 ptm -129.96 100.06 5.32 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.97 124.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.43 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -100.13 -51.2 3.74 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.432 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 40.6 m-80 -150.03 147.51 27.92 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.998 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -163.25 151.47 13.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.858 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -152.41 148.62 27.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.403 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.639 ' HH ' ' CD ' ' A' ' 42' ' ' GLU . 59.4 t80 -117.93 123.62 46.26 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.429 ' HA2' ' CD ' ' A' ' 120' ' ' LYS . . . 158.83 -139.6 6.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -177.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.616 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 5.1 ttm180 -157.11 116.79 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.442 . . . . 0.0 111.51 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.608 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 41.8 p -125.37 8.8 7.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.9 t0 -147.49 158.33 43.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p30 -115.23 3.17 14.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.697 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -105.23 0.58 27.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.735 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.4 mm -113.14 138.46 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.4 m 59.81 61.18 1.98 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -51.96 125.98 16.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.004 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HB1' ' CD2' ' A' ' 119' ' ' TYR . . . -145.44 -164.83 2.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.006 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.673 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -60.87 135.0 92.67 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 3.6 Cg_endo -52.3 -33.38 55.34 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.409 2.073 . . . . 0.0 113.934 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -34.88 79.05 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.673 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 30.0 mt-30 -89.08 12.59 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.498 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 82.9 mtp -129.36 -3.81 4.9 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.082 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.0 mt-10 -59.99 -50.93 71.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.532 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -78.41 113.88 16.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 29.6 m -105.39 32.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.289 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.2 mm100 -141.05 87.95 2.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.5 t -146.54 122.88 10.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -129.97 152.05 49.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.941 0.4 . . . . 0.0 111.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.9 tp -144.63 90.43 6.45 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.968 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -48.78 -47.24 21.72 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.648 2.232 . . . . 0.0 113.743 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.2 m-20 -56.72 -29.13 62.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.38 -32.04 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.832 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.476 ' O ' ' OG ' ' A' ' 93' ' ' SER . 74.0 t80 -64.46 -40.32 95.48 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.488 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 3.4 ptmt -66.54 -40.95 89.34 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.618 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.488 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 77.8 mt -59.88 -50.32 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.104 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.465 ' SD ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.03 -32.72 73.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.366 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 53.4 m -62.48 -47.15 85.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.676 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -67.46 -33.56 75.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 58.1 mtt180 -79.81 -32.11 40.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 63.5 m -113.7 -16.36 12.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.559 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.5 m-20 -60.06 130.9 48.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.595 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 44.4 m-20 68.86 14.66 8.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.858 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt180 -115.05 146.74 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.274 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.2 m -72.2 -32.13 66.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.739 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.16 154.58 32.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.233 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.1 p -153.46 148.59 26.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.908 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.62 126.22 66.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.2 t -142.49 143.13 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.27 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 107' ' ' GLY . 4.5 t -77.23 118.2 23.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -71.6 44.48 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.53 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.59 -124.92 0.93 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.689 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 28.13 -153.34 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 111.183 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.12 -10.15 20.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.077 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.0 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.292 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.3 m-85 -143.51 130.21 10.45 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.396 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.9 Cg_exo -47.74 -158.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.443 2.096 . . . . 0.0 112.479 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -138.81 91.91 11.54 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.68 -38.83 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.518 2.145 . . . . 0.0 113.14 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.05 84.4 11.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.674 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -65.6 139.84 60.07 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.259 2.639 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.787 ' H ' ' HO2' ' A' ' 136' ' ' RAM . . . 96.5 -1.38 62.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.367 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.576 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 22.3 m -114.07 146.35 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.5 t80 -87.43 97.16 10.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.471 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 24.3 mtmm -74.58 -165.84 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.952 1.358 . . . . 0.0 114.251 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.608 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 12.9 p90 -165.26 165.58 19.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.317 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 25.7 tp -128.12 126.38 41.01 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.2 tt0 -124.82 127.55 47.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.753 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.465 HG21 ' SD ' ' A' ' 92' ' ' MET . 60.4 t -131.83 128.19 59.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.115 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.559 ' CG ' ' HE ' ' A' ' 37' ' ' ARG . 3.1 mp0 -109.83 132.15 54.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.327 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.433 ' CE2' ' HD3' ' A' ' 36' ' ' ARG . 42.4 p90 -156.84 171.71 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -129.58 161.12 31.25 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.791 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.8 m -113.33 124.62 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.677 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.9 157.36 60.38 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.142 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -54.93 140.93 79.17 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.641 1.561 . . . . 0.0 111.272 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -83.37 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.241 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -103.32 132.07 49.87 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.109 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.5 p -93.73 133.24 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.847 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.794 -179.739 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . 0.434 ' O3 ' ' O7 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.787 ' HO2' ' H ' ' A' ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.5 mt -112.35 109.89 53.63 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.357 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.96 -13.35 1.76 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.297 1.998 . . . . 0.0 112.085 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -153.55 -49.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.726 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.67 21.89 73.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 35' ' ' MET . 23.3 tp -160.82 119.33 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.717 0.294 . . . . 0.0 110.465 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 34' ' ' LEU . 16.7 mtt 49.91 109.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.714 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -89.95 151.86 21.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -146.76 136.22 22.87 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.109 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -130.14 147.35 51.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.557 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.504 HD21 ' N ' ' A' ' 40' ' ' ALA . 7.1 tt -139.61 134.97 32.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.504 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -137.52 147.37 45.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.406 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -67.67 131.52 45.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 61.4 tt0 -42.14 138.47 1.62 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.601 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.52 79.2 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.611 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.55 147.46 40.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 118.52 1.16 . . . . 0.0 110.493 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.08 137.81 45.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.758 2.306 . . . . 0.0 112.605 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -111.23 148.36 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -127.78 127.72 44.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.003 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.5 mt -116.83 144.83 44.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.363 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -149.23 133.65 17.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.22 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.474 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.5 m -99.88 138.74 20.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.162 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -66.94 161.35 42.84 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.65 2.233 . . . . 0.0 113.244 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.7 -136.4 13.65 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 p -97.43 23.51 7.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.821 -0.69 . . . . 0.0 110.407 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -79.39 161.3 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.782 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.8 143.4 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.165 0.507 . . . . 0.0 110.396 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.474 HG12 ' SG ' ' A' ' 50' ' ' CYS . 93.6 mt -68.67 139.97 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.447 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.459 ' N ' HG21 ' A' ' 56' ' ' ILE . 2.0 ptp -135.15 103.25 5.47 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.912 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.4 t -63.88 124.62 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.248 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -102.59 -51.34 3.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.91 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -150.27 145.43 26.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.578 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.36 154.73 7.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.401 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -152.41 153.44 33.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.286 0.565 . . . . 0.0 111.559 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.567 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 50.1 t80 -118.81 124.34 46.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.11 -141.92 8.39 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.529 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 11.1 ttm-85 -151.71 115.56 4.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.313 0.578 . . . . 0.0 110.724 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.478 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 13.5 p -121.07 6.8 10.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.83 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 11.7 t70 -142.9 -169.62 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.698 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 40.9 p-10 -150.55 -2.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 110.41 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -100.44 4.94 44.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.79 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 138.58 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.19 63.21 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -47.66 115.74 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.347 0.594 . . . . 0.0 111.645 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.47 -163.02 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.73 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.637 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.66 140.25 97.98 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.707 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.476 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 Cg_endo -56.81 -31.41 88.45 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 121.942 1.761 . . . . 0.0 111.999 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -64.37 -35.44 80.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.637 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 79.6 mt-30 -87.7 -13.17 43.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.048 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.489 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 4.5 mtm -107.86 -2.17 20.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.95 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 9.2 mt-10 -63.92 -46.52 84.45 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.889 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -78.66 115.11 18.15 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.821 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.457 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 12.0 m -106.48 32.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.338 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.457 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.8 mm-40 -139.68 85.36 2.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.857 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.416 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.8 t -151.05 115.74 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -124.97 157.66 35.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.913 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 tp -148.13 87.83 5.64 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.726 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -46.96 -46.5 18.59 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.735 2.29 . . . . 0.0 114.064 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -53.32 -27.07 21.27 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.66 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.738 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CE1' HG12 ' A' ' 58' ' ' VAL . 45.9 t80 -67.51 -47.19 70.69 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.2 pttt -65.0 -39.61 93.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.585 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.6 mt -59.79 -45.43 94.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.944 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.492 ' HE1' ' SG ' ' A' ' 96' ' ' CYS . 91.4 mmm -69.82 -37.34 76.19 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.249 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.466 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 66.3 m -58.57 -45.12 89.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.24 -38.82 91.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -76.09 -34.01 59.52 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.492 ' SG ' ' HE1' ' A' ' 92' ' ' MET . 4.6 m -113.88 -16.83 12.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -58.99 136.53 57.97 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.52 -0.737 . . . . 0.0 111.839 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 69.96 13.12 7.92 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.944 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -112.42 145.33 40.35 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.5 m -71.21 -30.13 66.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.79 158.53 43.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.431 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 t -155.82 137.03 13.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.764 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -126.23 128.9 71.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.497 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 105' ' ' VAL . 58.7 t -146.34 142.86 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.486 ' N ' HG11 ' A' ' 104' ' ' VAL . 2.4 t -74.85 116.24 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.9 42.46 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.547 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.18 -125.99 1.04 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.95 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 107' ' ' GLY . 44.5 t 28.94 -155.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.459 0.647 . . . . 0.0 112.039 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.496 ' N ' ' OG ' ' A' ' 108' ' ' SER . 71.2 m-20 -62.19 -9.68 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.4 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.0 -11.16 59.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.11 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.9 m-85 -143.45 126.68 9.02 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.795 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.578 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.0 Cg_exo -47.7 -157.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.826 2.35 . . . . 0.0 112.42 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -139.1 88.88 12.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -75.69 -46.51 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.832 2.355 . . . . 0.0 112.838 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -132.31 79.53 65.64 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-O 121.673 0.749 . . . . 0.0 110.589 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -57.5 130.14 37.45 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.846 2.364 . . . . 0.0 111.919 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.16 -9.32 46.15 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.941 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.507 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 90.3 m -106.57 148.41 28.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.997 0.898 . . . . 0.0 108.965 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.495 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 8.2 t80 -88.27 97.85 11.26 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 14.1 mttt -75.78 -154.1 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.912 1.339 . . . . 0.0 113.435 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -173.74 170.01 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.11 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 54.4 tp -131.53 125.03 31.34 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG2' HE21 ' A' ' 125' ' ' GLN . 76.6 tt0 -118.05 127.54 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.039 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.13 123.43 53.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.638 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.508 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.5 mp0 -109.96 131.16 55.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.688 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -152.92 165.94 33.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.165 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.431 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 36.6 m-20 -116.97 161.82 18.76 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.311 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 94.5 m -116.25 115.91 26.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.838 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.4 156.32 67.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.228 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -54.86 148.27 47.24 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.025 1.817 . . . . 0.0 112.159 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -73.3 -77.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.585 ' H ' ' CD ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -96.3 138.96 33.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.016 0.436 . . . . 0.0 111.395 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.4 m -148.51 115.73 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.226 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.512 -179.422 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.518 ' O3 ' ' NZ ' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 tt -130.46 88.18 48.02 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.824 0.345 . . . . 0.0 110.545 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -52.99 149.91 25.2 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.684 2.256 . . . . 0.0 112.573 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -82.38 -2.5 53.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.368 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.89 19.96 79.75 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.7 OUTLIER -159.62 49.4 0.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 0.0 110.326 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.418 ' HG2' ' N ' ' A' ' 36' ' ' ARG . 43.0 ttm 57.68 161.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.115 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.418 ' N ' ' HG2' ' A' ' 35' ' ' MET . 3.6 mtt-85 -90.72 144.56 25.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -150.77 133.81 16.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.312 0.577 . . . . 0.0 111.906 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 53.3 mp0 -130.62 149.35 52.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.368 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tt -141.6 139.06 33.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.665 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.95 142.97 36.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.201 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.5 m -71.62 134.6 46.49 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.555 ' CD ' ' HH ' ' A' ' 63' ' ' TYR . 81.8 tt0 -42.95 135.8 2.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.576 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.94 -9.74 63.84 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.099 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.72 150.58 47.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 119.03 1.415 . . . . 0.0 110.741 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -68.23 142.51 55.65 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.072 1.848 . . . . 0.0 111.866 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -118.03 143.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 88.8 tt0 -130.19 129.18 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.505 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.6 mt -110.29 146.03 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.336 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.549 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 72.4 mtt180 -145.41 134.23 22.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.36 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.445 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -102.52 142.9 25.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.77 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 42.6 Cg_endo -69.75 155.11 66.84 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.658 2.238 . . . . 0.0 112.607 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.68 -131.84 35.65 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.199 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -105.18 25.32 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.844 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -79.71 164.18 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.738 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.35 147.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 0.0 110.083 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.48 HG22 ' CD2' ' A' ' 126' ' ' TYR . 86.3 mt -71.66 139.88 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.33 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.9 ptp -132.02 102.17 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 89' ' ' PHE . 63.4 t -63.95 124.58 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.221 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.0 mm-40 -103.03 -51.76 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 7.6 m-20 -148.94 146.78 28.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.136 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -168.76 156.53 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.005 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.506 HD22 ' HA ' ' A' ' 84' ' ' TYR . 8.7 t30 -152.91 150.79 29.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.954 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.555 ' HH ' ' CD ' ' A' ' 42' ' ' GLU . 81.5 t80 -119.38 124.99 47.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -138.46 6.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.67 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -154.6 114.57 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.408 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.498 ' HG1' ' HH ' ' A' ' 121' ' ' TYR . 6.0 p -125.51 6.46 7.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.1 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -148.26 156.95 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' O ' ' CE ' ' A' ' 78' ' ' MET . 55.9 p30 -118.33 5.81 11.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.03 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -103.76 4.62 35.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 mm -113.03 136.94 47.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.49 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m 54.98 72.4 0.48 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.805 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -55.77 124.7 18.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.97 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.22 -164.14 1.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.739 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.708 ' CG ' HE21 ' A' ' 77' ' ' GLN . 2.7 p-10 -59.1 139.48 87.73 Favored Pre-proline 0 C--N 1.333 -0.132 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.399 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -54.67 -37.32 91.31 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.591 2.194 . . . . 0.0 113.672 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -62.51 -34.95 77.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.934 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.708 HE21 ' CG ' ' A' ' 74' ' ' ASP . 31.0 mt-30 -88.23 9.49 22.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.068 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.437 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 77.2 mtp -122.69 -6.24 8.6 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.385 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 90.7 mt-10 -62.63 -49.24 75.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.994 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.34 116.3 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.625 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -107.01 34.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.262 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 92.9 mm-40 -139.84 85.35 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.085 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.421 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 26.5 t -148.97 121.68 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.506 ' HA ' HD22 ' A' ' 62' ' ' ASN . 38.0 m-85 -130.44 153.05 49.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.505 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.4 tp -141.65 94.29 7.44 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 -48.22 22.66 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.556 2.171 . . . . 0.0 113.173 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.5 m-20 -56.77 -24.88 53.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.63 -30.81 44.56 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.733 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CE1' HG13 ' A' ' 58' ' ' VAL . 53.7 t80 -64.91 -42.84 94.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.1 ptpt -64.19 -42.18 96.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.785 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.458 HG21 ' NH2' ' A' ' 95' ' ' ARG . 36.4 mt -60.1 -50.0 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.173 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.9 mmm -66.71 -34.91 78.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.741 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.556 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.4 m -59.84 -45.92 90.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.066 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -65.85 -34.22 77.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.489 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' NH2' HG21 ' A' ' 91' ' ' ILE . 31.5 mtm180 -80.97 -32.19 34.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 84.2 m -109.6 -19.61 13.14 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 93' ' ' SER . 82.1 m-20 -58.75 133.99 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.249 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 65.02 12.74 8.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.581 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.94 146.23 41.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.0 m -72.22 -31.65 66.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.924 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 157.77 42.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.61 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 7.8 p -154.82 142.15 19.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.641 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.53 131.91 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.491 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.5 t -144.46 140.8 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.644 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -80.54 119.46 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.59 28.55 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.722 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.644 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 176.88 177.11 45.57 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.954 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 4.2 t 92.78 -155.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.996 0.427 . . . . 0.0 110.774 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.619 ' H ' ' HG ' ' A' ' 108' ' ' SER . 92.6 m-20 -62.21 -11.09 12.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.905 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.52 -19.31 53.23 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.296 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.9 m-85 -136.98 129.26 17.06 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.992 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.5 Cg_exo -48.68 -155.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.47 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -138.49 89.48 13.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 0.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.0 -30.67 0.67 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.064 2.51 . . . . 0.0 113.544 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.579 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -149.04 66.46 8.68 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-O 120.93 0.395 . . . . 0.0 111.192 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HA ' ' HO2' ' A' ' 136' ' ' RAM . 10.6 Cg_endo -56.22 135.27 69.11 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.122 1.881 . . . . 0.0 111.302 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' N ' ' O2 ' ' A' ' 136' ' ' RAM . . . 106.47 -14.99 42.61 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.766 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.572 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 20.8 m -107.79 153.52 22.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.146 0.973 . . . . 0.0 109.433 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.517 ' HB3' HH12 ' A' ' 65' ' ' ARG . 7.6 t80 -86.73 97.47 10.61 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.579 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 13.2 mttp -72.4 -164.13 0.14 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.903 -1.498 . . . . 0.0 113.528 -177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.498 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 9.3 p90 -170.44 167.2 8.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.138 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.8 tp -129.2 124.79 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.9 tt0 -119.9 125.08 47.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.26 123.5 60.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.684 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -109.64 128.82 55.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.142 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.48 ' CD2' HG22 ' A' ' 56' ' ' ILE . 39.5 p90 -153.33 174.01 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.377 0.608 . . . . 0.0 111.637 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -127.43 162.62 25.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.225 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.443 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.0 m -112.22 120.22 41.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.47 156.93 74.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.839 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -56.52 141.68 90.26 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.047 1.831 . . . . 0.0 112.967 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -74.8 -45.47 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.177 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -97.1 -177.31 3.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.793 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.575 ' O ' ' OXT' ' A' ' 134' ' ' GLU . 4.0 p -88.93 142.58 12.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.575 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 72.1 mm-40 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.577 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.572 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.586 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -53.68 -44.68 98.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.699 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 26.8 Cg_exo -57.34 148.67 69.83 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.885 2.39 . . . . 0.0 113.293 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -83.2 -4.44 58.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.373 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.41 34.82 31.19 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.87 44.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.632 0.253 . . . . 0.0 110.606 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.595 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 26.6 ttm 61.52 166.26 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.464 ' H ' ' HG2' ' A' ' 35' ' ' MET . 87.0 mtt-85 -96.45 138.55 33.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.224 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' A' ' 37' ' ' ARG . 12.8 ttp180 -148.0 138.93 23.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 111.688 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.612 ' O ' ' OE2' ' A' ' 123' ' ' GLU . 71.4 mm-40 -131.86 146.01 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.608 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -139.72 137.53 35.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.818 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.507 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.99 145.21 37.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.137 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -65.89 132.77 49.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.254 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 37.2 tt0 -43.14 134.78 3.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.397 -0.819 . . . . 0.0 113.13 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 90.3 -1.23 79.34 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.69 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -116.16 146.25 36.78 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 118.219 1.01 . . . . 0.0 110.674 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 136.93 48.62 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.753 2.302 . . . . 0.0 112.141 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 15.5 tt -113.86 151.8 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.16 127.1 44.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.505 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 101' ' ' GLN . 50.2 mt -113.54 142.89 45.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -151.19 134.81 16.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.054 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -101.25 142.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.719 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD3' ' CZ ' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -64.18 157.83 51.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.798 2.332 . . . . 0.0 112.589 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.8 -124.78 7.3 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.299 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.6 p -109.83 22.6 15.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.005 -0.598 . . . . 0.0 111.089 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.59 167.83 20.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.34 145.71 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.348 0.594 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.8 mt -70.27 137.55 23.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.667 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.7 ptp -134.34 100.37 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.29 124.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.451 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 73.2 mm-40 -99.77 -48.58 4.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 19.1 m-80 -153.92 152.59 30.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.91 158.03 8.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.6 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.449 HD22 ' HA ' ' A' ' 84' ' ' TYR . 4.2 t30 -149.98 148.98 29.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 111.606 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.497 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 65.3 t80 -119.47 121.74 40.14 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 155.88 -140.53 7.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.6 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 8.2 ttm180 -149.35 118.47 6.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 111.23 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.574 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 13.6 p -124.4 3.61 8.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.023 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 22.5 t70 -148.45 154.93 40.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.571 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.506 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 43.6 p30 -112.17 5.76 18.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.252 0.548 . . . . 0.0 109.767 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.589 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 29.6 mttt -104.27 7.29 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.8 mm -114.1 135.52 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 110.622 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.4 m 50.1 80.76 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.02 125.67 24.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.321 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.3 -163.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p30 -63.97 138.44 97.4 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.626 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.76 -33.65 71.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.007 1.805 . . . . 0.0 112.24 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -63.69 -36.01 82.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.475 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.552 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 76.7 mt-30 -85.94 -10.18 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.787 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.489 ' CE ' HH12 ' A' ' 65' ' ' ARG . 74.0 mtp -104.01 -2.6 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.905 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.7 mt-10 -64.49 -48.69 74.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -77.25 114.11 15.72 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.811 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.499 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 23.1 m -107.96 29.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.57 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -139.18 82.99 1.92 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.852 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.0 t -147.35 119.51 8.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.449 ' HA ' HD22 ' A' ' 62' ' ' ASN . 78.3 m-85 -129.92 155.14 46.54 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.218 0.532 . . . . 0.0 111.644 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.5 tp -142.76 96.71 6.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.71 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -53.13 -48.04 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.637 2.225 . . . . 0.0 113.146 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.8 m-20 -55.39 -23.81 26.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.79 -35.71 66.58 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.716 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -65.04 -45.49 85.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.731 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.1 -39.81 93.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.033 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.47 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 94.4 mt -59.67 -52.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.838 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.466 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 18.6 mtp -68.17 -34.98 77.31 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.442 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.509 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 60.5 m -56.77 -43.63 81.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.109 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.701 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 86.8 mt-30 -68.04 -35.51 78.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.938 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.719 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 71.6 mtt180 -74.74 -34.08 62.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.833 ' N ' HH21 ' A' ' 99' ' ' ARG . 28.4 m -114.32 -18.56 11.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.528 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 45.0 m-20 -58.55 137.41 57.45 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.563 -0.71 . . . . 0.0 112.349 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 65.62 13.42 8.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.259 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.833 HH21 ' N ' ' A' ' 96' ' ' CYS . 54.7 mtm-85 -114.37 145.81 41.35 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.273 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.1 m -71.82 -32.58 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.646 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -150.11 155.64 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.504 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.404 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.3 p -155.01 150.23 27.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.294 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 59.4 t -127.86 131.79 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.492 HG11 HH11 ' A' ' 95' ' ' ARG . 60.1 t -144.66 140.5 23.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.704 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.33 119.45 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -72.17 41.98 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.31 -122.69 0.81 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.25 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER 31.64 -160.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.526 0.679 . . . . 0.0 111.473 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' OG ' ' A' ' 108' ' ' SER . 99.0 m-20 -65.43 -8.19 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.271 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.403 ' H ' ' HG ' ' A' ' 108' ' ' SER . . . -78.11 -11.44 59.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.592 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 112' ' ' PRO . 41.6 m-85 -142.12 126.03 9.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.235 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 111' ' ' PHE . 28.5 Cg_exo -49.42 -160.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.66 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 116' ' ' PRO . 25.0 t70 -139.2 92.31 10.77 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.565 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.92 -38.34 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.804 2.336 . . . . 0.0 113.445 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.404 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.6 p -136.27 72.66 58.78 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 7.2 Cg_endo -57.1 133.82 60.29 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.711 1.607 . . . . 0.0 110.853 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.24 -12.38 33.79 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.469 HG21 ' N ' ' A' ' 119' ' ' TYR . 97.5 m -117.59 147.18 43.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.473 0.637 . . . . 0.0 109.535 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.6 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 22.8 t80 -86.33 98.64 11.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.577 0.703 . . . . 0.0 109.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.497 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.6 mttm -71.31 -153.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.892 -177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.574 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.5 p90 -176.6 176.69 1.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 112.698 -2.046 . . . . 0.0 110.648 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.463 HD21 ' SD ' ' A' ' 92' ' ' MET . 14.3 tp -134.08 126.12 29.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.905 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.697 ' OE1' ' NE2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -124.64 128.64 49.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 123' ' ' GLU . 88.9 t -131.85 124.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.424 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.697 ' NE2' ' OE1' ' A' ' 123' ' ' GLU . 2.7 mp0 -107.66 129.37 55.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.475 ' C ' ' OD1' ' A' ' 127' ' ' ASP . 36.8 p90 -153.01 168.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 111.724 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.595 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 2.1 m-20 -126.38 162.99 24.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.593 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.8 m -113.45 116.89 30.32 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.583 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.9 m -121.44 157.09 57.22 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.59 146.83 62.35 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.103 1.868 . . . . 0.0 112.44 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 24.9 t80 -75.55 1.04 15.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.602 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -143.11 -166.27 2.27 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.307 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.516 ' O ' ' O ' ' A' ' 134' ' ' GLU . 10.3 m -89.63 140.91 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.039 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 133' ' ' VAL . 96.8 mt-10 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.407 ' O3 ' ' OE2' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -85.13 149.17 52.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -50.01 117.38 3.04 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.267 1.978 . . . . 0.0 111.615 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -80.15 -4.14 51.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.131 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.08 29.2 60.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -159.61 80.51 0.73 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.573 ' O ' ' O ' ' A' ' 34' ' ' LEU . 41.4 ttm 52.56 152.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.576 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 7.4 mmm180 -89.18 136.06 33.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -149.88 131.75 15.14 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.381 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -130.84 145.32 51.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.501 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 40' ' ' ALA . 8.7 tt -137.61 137.51 38.57 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -141.6 145.44 35.04 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.159 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.7 m -67.97 131.35 45.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.635 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.662 ' CD ' ' HO4' ' A' ' 136' ' ' RAM . 6.4 tt0 -43.06 139.04 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.72 -1.86 83.99 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.166 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.4 158.02 37.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 118.034 0.917 . . . . 0.0 109.962 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.02 140.11 14.02 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.885 1.723 . . . . 0.0 111.631 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 20.2 tt -117.59 147.2 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.697 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.5 tt0 -126.52 128.6 47.15 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.101 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 20.4 mt -115.41 141.63 47.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.697 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 89.4 mtt180 -147.82 132.86 18.22 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.183 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.7 m -99.76 138.83 20.46 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.769 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.38 161.07 46.8 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.562 2.175 . . . . 0.0 112.176 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -135.13 38.35 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -107.36 26.65 9.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 110.455 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 53.2 m-20 -80.92 166.81 20.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.063 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 148.6 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.349 0.595 . . . . 0.0 111.629 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.464 HG22 ' CD2' ' A' ' 126' ' ' TYR . 96.1 mt -69.29 134.86 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.937 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -134.83 98.39 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.891 0.853 . . . . 0.0 108.829 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.79 127.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.77 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -102.76 -48.38 4.12 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.767 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -151.73 150.96 30.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.51 . . . . 0.0 110.47 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -168.14 154.76 7.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.074 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.472 HD22 ' HA ' ' A' ' 84' ' ' TYR . 1.7 t30 -149.41 146.32 27.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.4 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.442 ' CE2' ' HD3' ' A' ' 120' ' ' LYS . 63.5 t80 -114.66 122.49 46.63 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.39 -139.78 6.77 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.491 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.706 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -155.42 117.1 4.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.919 179.44 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.637 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 32.9 p -123.6 8.67 8.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.583 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.7 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 50.1 t0 -150.2 158.42 44.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 44.2 p30 -115.41 5.81 14.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.688 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -106.39 6.14 30.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.528 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 29.2 mm -114.2 139.36 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.523 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 57.21 61.66 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 6.4 p-10 -46.31 118.57 1.99 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.041 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . . . -136.16 -162.65 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.303 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -64.08 145.21 98.09 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.366 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -50.69 -38.28 55.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.54 2.16 . . . . 0.0 112.353 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -64.95 -35.66 81.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.677 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.565 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 80.7 mt-30 -83.65 -7.62 59.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 75.1 mmm -113.61 40.65 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.682 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -101.74 -59.87 1.63 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.062 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 17.8 t30 -78.24 119.52 21.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.507 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.545 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 27.1 m -110.16 27.5 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.894 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.3 mm-40 -141.94 82.84 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.622 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.4 t -146.54 118.98 8.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.472 ' HA ' HD22 ' A' ' 62' ' ' ASN . 44.4 m-85 -123.41 156.56 35.23 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.151 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.2 tp -142.13 83.98 11.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.27 -46.41 11.59 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 123.361 2.707 . . . . 0.0 114.127 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -54.56 -25.49 26.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.2 -32.27 47.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.282 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' O ' ' OG ' ' A' ' 93' ' ' SER . 7.7 t80 -65.63 -46.38 79.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.025 0.44 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.7 pttp -67.55 -40.39 84.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.244 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.505 ' CG2' ' NH1' ' A' ' 95' ' ' ARG . 79.9 mt -58.16 -49.17 82.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.553 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 4.2 mtp -70.36 -32.44 70.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.176 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.596 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.7 m -60.24 -44.89 94.86 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.4 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -64.49 -37.41 87.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 0.0 111.496 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' NH1' ' CG2' ' A' ' 91' ' ' ILE . 60.0 mtt85 -77.04 -32.85 57.25 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 22.9 m -112.81 -13.48 13.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.55 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.6 m120 -62.23 130.57 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.354 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 67.88 14.88 9.51 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.18 145.92 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.772 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.04 -31.8 68.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.51 154.94 40.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.208 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.432 ' SG ' ' CD1' ' A' ' 48' ' ' LEU . 9.6 p -154.63 136.59 14.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.103 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 22.8 t -122.29 129.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.886 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.2 t -144.1 146.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 0.0 111.805 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.3 t -77.81 117.86 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.16 38.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.709 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.14 -125.23 0.96 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.914 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.59 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 1.7 t 27.99 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.967 0.413 . . . . 0.0 110.619 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.59 ' H ' ' HG ' ' A' ' 108' ' ' SER . 88.9 m-20 -64.12 -10.43 22.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.856 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.64 60.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.052 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.614 ' O ' ' O ' ' A' ' 112' ' ' PRO . 83.1 m-85 -141.77 129.03 11.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.237 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 111' ' ' PHE . 50.7 Cg_exo -45.55 -158.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 123.061 2.507 . . . . 0.0 112.694 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -139.13 91.46 11.31 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.8 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.54 -50.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.125 2.55 . . . . 0.0 113.288 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.431 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -135.27 81.62 43.37 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.991 0.424 . . . . 0.0 111.473 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.11 143.65 94.96 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.598 2.199 . . . . 0.0 111.73 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.91 -5.53 56.49 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 120.634 -0.794 . . . . 0.0 113.168 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.588 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 99.3 m -115.06 147.84 39.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.706 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 11.2 t80 -87.02 97.78 10.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.488 ' NZ ' ' HO3' ' A' ' 136' ' ' RAM . 19.7 mttt -73.51 -163.74 0.17 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 122.848 1.309 . . . . 0.0 113.241 -177.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.637 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 6.4 p90 -165.42 165.14 19.45 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.388 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.516 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 35.8 tp -126.14 122.24 35.13 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.672 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 2.6 tm-20 -113.62 126.91 55.79 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.564 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.553 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 58.6 t -133.2 120.6 40.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.979 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.672 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 5.3 mt-30 -107.37 128.27 54.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.082 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.464 ' CD2' HG22 ' A' ' 56' ' ' ILE . 33.9 p90 -153.56 171.6 18.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.74 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 40.2 m-20 -128.5 164.27 23.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.231 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.57 120.52 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.373 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 20.1 m -116.97 150.83 46.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.385 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -57.14 143.47 93.07 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.875 1.717 . . . . 0.0 112.265 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -79.32 145.45 33.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -104.38 108.84 20.44 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.719 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.1 t -93.7 133.2 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.997 0.427 . . . . 0.0 110.89 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.831 179.261 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.662 ' HO4' ' CD ' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 32' ' ' PHE . 0.8 OUTLIER 55.32 67.98 2.77 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.368 . . . . 0.0 110.152 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HB2' ' CE2' ' A' ' 32' ' ' PHE . 19.7 Cg_exo -59.15 8.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.917 2.411 . . . . 0.0 112.181 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.589 ' H ' ' C ' ' A' ' 30' ' ' LEU . 6.8 m-85 -149.71 -67.42 0.21 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.559 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.67 35.58 54.97 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.486 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -161.27 127.46 3.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.899 0.38 . . . . 0.0 110.562 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.2 ttm 72.77 144.69 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.404 0.621 . . . . 0.0 111.355 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.472 ' NH1' ' HG2' ' A' ' 36' ' ' ARG . 40.0 mtp85 -91.34 146.97 23.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.557 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -148.07 137.28 22.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -134.81 146.08 48.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.712 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.9 tt -140.77 143.3 34.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.696 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.4 145.56 29.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.727 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.1 m -70.73 136.19 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.37 0.605 . . . . 0.0 111.122 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 7.6 tt0 -44.92 139.0 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.215 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.33 -11.99 66.82 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.702 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -118.29 153.35 51.59 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 118.395 1.098 . . . . 0.0 110.313 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.19 145.37 43.78 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.275 1.984 . . . . 0.0 113.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -114.88 149.57 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -127.14 128.78 46.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.205 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 101' ' ' GLN . 31.6 mt -115.61 139.39 50.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.401 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -144.9 135.15 24.12 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.246 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -100.52 140.17 21.2 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.12 155.95 66.47 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 121.908 1.739 . . . . 0.0 111.505 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.03 -137.09 37.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 121.689 0.605 . . . . 0.0 112.625 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -100.92 22.19 12.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.446 -0.877 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -79.02 166.75 21.99 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.681 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.75 148.04 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.43 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 85.8 mt -71.25 137.84 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.109 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -135.1 101.64 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.27 125.43 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.348 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 97.5 mt-10 -100.04 -49.57 4.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.3 m-20 -150.19 149.4 30.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.618 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -167.12 152.49 7.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.712 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.506 HD22 ' HA ' ' A' ' 84' ' ' TYR . 3.6 t30 -149.32 149.15 30.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.191 0.519 . . . . 0.0 111.182 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.491 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 26.3 t80 -119.3 122.89 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -137.26 5.5 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 1.8 ttm180 -155.1 116.37 4.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.112 0.482 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.485 HG23 ' HH ' ' A' ' 121' ' ' TYR . 7.2 p -122.74 6.7 9.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 14.1 t70 -149.81 157.74 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.716 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 5.6 p-10 -113.58 5.44 16.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.189 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.489 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 31.1 mtmt -102.61 0.16 32.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.616 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 mm -113.09 138.54 42.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 48.2 m 60.87 59.18 2.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.2 0.524 . . . . 0.0 109.651 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -43.72 97.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.981 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB1' ' CD2' ' A' ' 119' ' ' TYR . . . -115.39 -174.22 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -55.78 141.01 66.98 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.896 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.7 Cg_endo -50.52 -38.77 54.94 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.149 1.9 . . . . 0.0 111.745 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.99 -35.26 80.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.15 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.674 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 79.8 mt-30 -85.41 -4.9 59.3 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.703 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 5.0 mmm -108.1 -5.15 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.201 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 68.6 mt-10 -62.54 -48.4 79.67 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.204 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -79.97 115.88 19.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 m -108.65 29.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.158 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.433 HE21 ' HA ' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -139.52 82.96 1.91 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.836 -179.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -146.12 123.67 11.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.506 ' HA ' HD22 ' A' ' 62' ' ' ASN . 21.3 m-85 -132.85 157.3 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.173 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 tp -145.86 83.69 8.61 Favored Pre-proline 0 N--CA 1.462 0.159 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.36 -44.32 20.55 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 123.078 2.519 . . . . 0.0 113.674 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.3 m-20 -59.07 -25.21 63.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.29 -33.39 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.012 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.493 ' O ' ' OG ' ' A' ' 93' ' ' SER . 12.2 t80 -64.23 -40.23 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.807 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -66.12 -38.25 87.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.052 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HG3' ' A' ' 95' ' ' ARG . 90.4 mt -57.93 -53.66 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.867 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.3 mmm -66.62 -34.25 77.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.023 0.439 . . . . 0.0 110.571 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.561 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.4 m -59.54 -48.61 80.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.69 -37.23 82.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 53.9 mtp85 -72.8 -34.44 66.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.413 -178.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.2 m -113.44 -15.26 12.64 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.561 ' CG ' ' O ' ' A' ' 93' ' ' SER . 74.4 m-20 -58.65 132.25 53.28 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.127 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 68.47 13.37 8.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.764 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -111.4 143.05 42.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.324 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.3 m -70.42 -32.94 70.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.541 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -149.79 150.03 31.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.863 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.414 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 12.3 p -153.41 138.62 17.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.924 0.393 . . . . 0.0 111.052 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.1 t -116.75 131.31 69.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.661 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 105' ' ' VAL . 39.7 t -139.39 149.51 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.506 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.3 t -87.13 117.68 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.59 36.02 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.209 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.44 -125.4 0.92 Allowed Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 30.77 -157.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.792 0.329 . . . . 0.0 111.214 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.92 -9.26 3.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.523 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.78 60.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.674 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 112' ' ' PRO . 53.3 m-85 -141.48 132.75 13.41 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.887 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 111' ' ' PHE . 33.1 Cg_exo -49.58 -157.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.937 2.425 . . . . 0.0 112.584 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.22 87.99 22.12 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.633 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.23 -43.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.288 2.659 . . . . 0.0 113.544 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.458 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -135.72 85.54 30.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.151 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' HA ' ' HO2' ' A' ' 136' ' ' RAM . 39.6 Cg_endo -71.87 136.49 27.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.263 1.975 . . . . 0.0 111.746 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.57 -1.34 36.75 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.271 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.496 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 35.2 m -122.18 146.71 46.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.22 0.51 . . . . 0.0 109.92 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.573 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 17.7 t80 -85.94 98.88 11.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.492 ' HZ3' ' HO3' ' A' ' 136' ' ' RAM . 14.6 mttt -73.9 -161.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.76 1.267 . . . . 0.0 113.669 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HH ' HG23 ' A' ' 66' ' ' THR . 12.0 p90 -169.9 168.62 8.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.281 176.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.417 HD23 ' CZ ' ' A' ' 111' ' ' PHE . 21.9 tp -130.8 126.69 36.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.501 ' HG2' HE21 ' A' ' 125' ' ' GLN . 76.5 tt0 -119.84 128.9 54.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.4 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.5 t -130.27 121.3 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.111 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.501 HE21 ' HG2' ' A' ' 123' ' ' GLU . 3.6 mt-30 -107.96 125.91 52.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -151.9 165.69 33.79 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.133 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.3 OUTLIER -120.59 159.03 26.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.997 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.7 m -110.25 118.13 35.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 m -116.17 152.38 47.76 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.377 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.69 147.97 67.97 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.812 1.675 . . . . 0.0 110.668 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.47 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 48.3 t80 -73.85 -5.05 38.63 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.38 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -97.84 131.85 43.97 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.345 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 p -88.04 136.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.215 -179.688 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . 0.617 ' HO6' ' HO4' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.496 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 63.1 62.73 1.73 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.641 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -69.83 128.09 15.46 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.194 1.93 . . . . 0.0 111.839 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.23 -10.56 57.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.936 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.44 9.54 83.35 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -164.69 113.99 1.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.511 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.2 mtt 57.75 132.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.482 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.502 HH11 ' HG3' ' A' ' 36' ' ' ARG . 57.1 mtt85 -99.87 154.8 18.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.851 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.645 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 2.2 ttt-85 -150.8 141.01 22.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.377 0.608 . . . . 0.0 112.1 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.603 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 35.5 mt-10 -132.44 145.09 50.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.342 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 6.3 tt -138.65 139.07 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.97 145.38 39.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.234 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.6 m -70.1 137.45 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.484 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 38.1 tt0 -43.09 132.78 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.279 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.04 75.52 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.959 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.84 154.29 49.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 118.878 1.339 . . . . 0.0 110.751 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.8 142.79 44.18 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.699 2.266 . . . . 0.0 113.359 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.7 tt -115.97 149.9 18.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.603 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 81.0 tt0 -132.36 126.04 32.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.246 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.454 HD11 ' SG ' ' A' ' 96' ' ' CYS . 24.2 mt -113.58 143.68 44.15 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.593 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 64.7 mtt180 -149.67 132.02 15.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.397 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.442 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -99.9 140.27 21.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.966 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.1 Cg_endo -66.41 163.83 30.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.658 2.238 . . . . 0.0 112.915 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.28 -121.55 14.66 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.478 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 p -122.98 26.01 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 0.0 110.066 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.7 169.75 17.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.232 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.88 143.96 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.084 0.469 . . . . 0.0 110.696 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.442 HG12 ' SG ' ' A' ' 50' ' ' CYS . 69.3 mt -68.4 138.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.143 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.7 ptm -132.43 103.14 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.82 125.67 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.345 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -100.46 -50.18 3.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.625 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -150.57 148.35 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.402 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.85 155.74 10.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 84' ' ' TYR . 10.1 t30 -152.54 151.5 30.76 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.187 0.518 . . . . 0.0 112.188 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 33.6 t80 -121.48 122.86 40.68 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.56 -141.17 7.85 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -176.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.702 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.2 ttm-85 -151.36 114.77 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.666 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.537 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 11.8 p -120.48 6.13 10.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.865 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 41.2 t0 -144.75 -170.82 3.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.613 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.541 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 35.0 p30 -146.24 -2.74 0.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.968 0.413 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -103.91 9.38 36.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.122 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.33 136.33 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.8 m 54.28 70.9 0.56 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -51.53 118.82 3.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.721 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . . . -138.78 -163.28 1.44 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.246 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.719 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -61.93 136.79 95.22 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.302 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.525 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.8 Cg_endo -57.1 -34.31 97.47 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.787 1.658 . . . . 0.0 112.251 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -61.62 -35.98 79.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.417 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.719 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 82.1 mt-30 -82.13 -18.56 42.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.655 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 3.7 mtm -98.8 0.38 44.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.845 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 73.9 mt-10 -64.49 -51.32 63.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.264 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -79.32 110.98 15.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.064 0.459 . . . . 0.0 111.37 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.44 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 11.0 m -103.68 33.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.38 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 22.7 mm100 -138.43 83.97 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.258 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.8 t -147.95 121.86 9.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HH ' ' HB ' ' A' ' 66' ' ' THR . 97.1 m-85 -130.17 156.6 44.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.921 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.19 86.49 8.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.468 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.49 -46.8 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.904 2.403 . . . . 0.0 113.68 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.0 m-20 -54.11 -30.22 47.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.891 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.81 -31.2 37.55 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.574 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -64.12 -41.38 97.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.539 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 1.3 pttp -67.87 -39.73 83.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.078 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.539 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 52.8 mt -60.23 -49.85 82.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.0 mmm -69.94 -39.04 76.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.656 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 50.3 m -60.43 -44.45 95.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.572 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 77.4 mt-30 -64.79 -37.21 86.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.803 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.491 ' C ' ' NH1' ' A' ' 99' ' ' ARG . 67.6 mtt180 -78.69 -31.36 46.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.454 ' SG ' HD11 ' A' ' 48' ' ' LEU . 51.6 m -111.27 -13.41 13.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.7 m-20 -64.45 131.11 46.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 67.26 13.79 9.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.605 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.491 ' NH1' ' C ' ' A' ' 95' ' ' ARG . 61.4 mtt85 -113.38 146.07 40.08 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.295 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -70.22 -31.5 68.95 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.92 157.78 42.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.171 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.423 ' SG ' HD11 ' A' ' 48' ' ' LEU . 29.8 p -155.48 138.5 15.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.477 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 61.5 t -123.75 130.03 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.7 146.97 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 112.078 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.8 t -79.69 119.49 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.84 39.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.82 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.6 -142.62 5.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.249 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.3 t 47.12 -151.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 111.542 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.69 -9.5 20.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.961 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.24 -14.48 60.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.434 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.652 ' O ' ' O ' ' A' ' 112' ' ' PRO . 95.5 m-85 -143.87 128.51 9.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.821 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 111' ' ' PHE . 53.4 Cg_exo -45.79 -157.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.662 2.241 . . . . 0.0 112.019 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -137.84 92.58 12.71 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.148 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.52 -42.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.3 2.667 . . . . 0.0 113.397 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.453 ' SG ' ' HE3' ' A' ' 120' ' ' LYS . 1.3 p -136.86 74.83 50.31 Favored Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.256 0.551 . . . . 0.0 112.404 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.75 135.13 47.08 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.114 1.876 . . . . 0.0 110.703 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.85 -6.87 52.31 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.487 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 99.3 m -114.35 147.09 39.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.702 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.2 t80 -86.46 96.34 10.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.501 ' NZ ' ' O3 ' ' A' ' 136' ' ' RAM . 36.1 mttp -72.07 -156.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.497 1.142 . . . . 0.0 112.846 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.537 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 10.1 p90 -175.41 172.68 2.63 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.356 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 21.5 tp -130.97 122.69 27.33 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.645 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 45.1 tt0 -119.09 130.5 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.4 t -134.5 124.39 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 119.639 -0.824 . . . . 0.0 112.325 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.17 131.38 55.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.301 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -154.74 173.69 16.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.632 0.73 . . . . 0.0 112.374 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -131.71 162.61 30.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.965 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.43 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 83.4 m -111.27 117.61 33.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.679 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.8 m -119.57 156.22 53.68 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.78 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -55.74 149.84 47.94 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.226 1.951 . . . . 0.0 111.785 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -72.87 -10.36 59.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.215 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.6 mmtm -101.7 131.01 48.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.5 p -97.47 138.74 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.016 0.436 . . . . 0.0 111.772 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.644 179.142 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.565 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.4 OUTLIER 56.1 101.82 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.912 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' O ' ' O ' ' A' ' 30' ' ' LEU . 40.0 Cg_exo -53.08 -131.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.408 2.072 . . . . 0.0 111.645 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -77.95 -17.82 56.76 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.1 14.89 81.44 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 35' ' ' MET . 17.0 tp -161.45 117.2 2.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.628 0.251 . . . . 0.0 110.394 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.508 ' O ' ' O ' ' A' ' 34' ' ' LEU . 3.2 mtt 57.07 128.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.95 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 126' ' ' TYR . 42.7 mmm-85 -90.0 138.65 31.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.222 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.616 HH21 ' CD ' ' A' ' 123' ' ' GLU . 70.4 ttt-85 -144.95 132.57 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.464 0.65 . . . . 0.0 111.46 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -133.63 144.32 49.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.409 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.415 HD13 ' NH2' ' A' ' 37' ' ' ARG . 7.0 tt -143.39 132.94 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.794 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.96 150.98 45.15 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.725 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.36 132.44 47.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.591 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 11.1 tt0 -42.43 141.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.458 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 88.65 -4.6 85.07 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.215 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -117.32 153.19 49.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 118.463 1.131 . . . . 0.0 110.857 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -68.11 137.65 41.34 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 tt -119.89 138.02 51.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.1 tt0 -122.37 131.97 54.15 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.311 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.453 HD22 ' CE1' ' A' ' 126' ' ' TYR . 8.9 mt -108.75 144.93 35.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.269 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.538 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 30.5 mtt85 -149.24 132.12 16.11 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.706 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.512 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -100.8 147.14 33.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.25 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.59 159.01 28.67 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.37 2.047 . . . . 0.0 111.96 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.43 -137.42 38.36 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 121.321 0.4 . . . . 0.0 112.668 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.2 p -102.64 24.14 10.96 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.674 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.65 166.06 22.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.9 142.76 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.849 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.512 HG12 ' SG ' ' A' ' 50' ' ' CYS . 88.3 mt -67.67 138.73 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.077 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.41 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.8 ptp -135.59 100.88 4.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.406 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.91 124.61 15.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.399 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.586 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.48 -51.38 3.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.419 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.586 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 28.4 m-20 -148.28 145.75 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.92 155.04 9.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.761 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 84' ' ' TYR . 10.5 t30 -153.78 154.58 34.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.241 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.591 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 85.4 t80 -120.07 122.64 41.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.19 7.62 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.04 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.758 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 13.7 ttm180 -156.89 116.23 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 p -124.53 8.73 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 57.9 t0 -147.35 157.6 43.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.506 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.587 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p-10 -114.18 0.2 14.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -102.22 6.57 40.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.25 135.29 50.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 110.16 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 60.63 61.27 1.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.228 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.626 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.6 p30 -41.3 104.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.583 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 119' ' ' TYR . . . -124.28 -164.69 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.96 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.47 145.09 98.58 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.694 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -55.3 -37.96 94.12 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.239 1.959 . . . . 0.0 112.714 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.51 -32.88 74.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.784 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.682 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 82.2 mt-30 -85.71 -11.39 53.81 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.797 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.758 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 3.1 mmt -100.74 -4.89 27.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.647 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -61.06 -56.2 23.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -79.42 118.02 20.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.433 0.635 . . . . 0.0 112.65 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.605 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.9 m -109.24 28.9 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.676 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.605 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.7 mm-40 -141.71 87.13 2.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.5 t -145.51 120.22 9.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.447 ' HA ' HD22 ' A' ' 62' ' ' ASN . 93.6 m-85 -127.93 155.72 43.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 112.007 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.1 tp -148.34 91.89 4.67 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.166 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.54 -46.6 28.74 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.151 1.9 . . . . 0.0 112.868 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 74.5 m-20 -50.05 -31.29 12.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.38 -31.98 36.43 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.597 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.433 ' O ' ' OG ' ' A' ' 93' ' ' SER . 79.7 t80 -64.48 -47.88 77.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.584 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 2.0 ptpp? -64.02 -41.56 97.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.474 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 98.0 mt -59.97 -48.9 86.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.865 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.592 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 63.1 mtp -69.87 -32.47 70.84 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.292 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.434 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 19.8 m -59.93 -45.89 91.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.627 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.61 -38.97 88.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.45 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -73.84 -37.29 64.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.4 m -113.54 -22.34 10.36 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 50.9 m-20 -55.3 140.55 38.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 69.95 12.94 7.93 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.157 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 99' ' ' ARG . 51.0 mtt85 -113.22 145.27 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.329 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.5 m -71.64 -28.83 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.58 155.31 42.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.547 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.81 143.97 26.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.113 0.483 . . . . 0.0 111.066 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.07 125.87 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.623 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -143.06 144.24 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.693 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.636 ' C ' ' H ' ' A' ' 107' ' ' GLY . 8.3 t -79.45 121.6 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.385 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -67.06 26.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.641 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . -178.94 172.13 44.31 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.028 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 4.3 t 97.26 -156.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 110.217 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.62 -10.71 38.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.176 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.35 -21.47 58.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.9 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.8 m-85 -138.27 125.95 13.72 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.744 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.3 Cg_exo -46.29 -155.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.764 2.31 . . . . 0.0 112.688 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -138.02 92.07 12.76 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.18 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -73.95 -54.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.531 2.154 . . . . 0.0 112.988 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.73 89.33 17.97 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.986 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.11 141.58 94.28 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.609 2.206 . . . . 0.0 111.64 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.92 4.99 57.63 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.749 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.579 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 58.1 m -126.48 146.55 50.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.658 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 9.4 t80 -87.93 97.66 11.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HZ2' ' HO3' ' A' ' 136' ' ' RAM . 4.9 mtmp? -79.61 -158.96 0.18 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.644 1.212 . . . . 0.0 113.679 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.408 ' H ' ' HB3' ' A' ' 120' ' ' LYS . 9.8 p90 -172.44 175.56 3.53 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.543 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.5 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 19.5 tp -132.17 124.17 28.5 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.477 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.616 ' CD ' HH21 ' A' ' 37' ' ' ARG . 78.6 tt0 -117.77 130.44 56.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.592 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 97.2 t -134.4 123.4 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.013 -1.075 . . . . 0.0 113.113 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.477 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -110.98 128.32 55.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.071 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.536 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 37.3 p90 -152.29 168.71 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 111.842 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 57' ' ' MET . 86.2 m-20 -119.35 160.35 22.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.5 m -112.51 128.07 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.53 155.45 80.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.69 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -55.63 148.06 56.31 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.182 1.921 . . . . 0.0 112.12 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 28.0 t80 -72.53 -136.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.672 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.604 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 7.2 tptt -92.86 -71.0 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.5 t -90.97 129.22 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.221 -0.396 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.455 -179.35 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.769 ' HO3' ' HZ2' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 157.61 86.25 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' A' ' 33' ' ' GLY . 10.1 Cg_endo -54.61 136.16 69.51 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.176 1.917 . . . . 0.0 110.968 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 64.0 t80 -74.66 13.25 0.65 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . 74.33 36.02 51.13 Favored Glycine 0 C--N 1.33 0.246 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tp -157.93 -29.55 0.08 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.05 -0.575 . . . . 0.0 109.793 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.8 ttm 62.83 155.51 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.285 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -93.41 149.0 21.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.155 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -149.56 132.54 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.372 0.606 . . . . 0.0 111.158 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.0 mp0 -129.17 146.79 51.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.615 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.404 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -142.24 139.64 32.02 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.985 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -140.94 146.53 37.49 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.265 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.5 m -68.28 129.92 41.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.201 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 77.0 tt0 -45.41 142.53 2.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.99 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.412 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 93.11 -12.96 68.8 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.554 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.5 m-85 -115.74 149.97 44.03 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 118.256 1.028 . . . . 0.0 110.084 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.73 143.46 61.84 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.551 2.167 . . . . 0.0 113.439 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.3 tt -115.67 149.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.624 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.4 tt0 -129.2 128.97 44.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.494 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.4 mt -115.36 143.62 45.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.919 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.624 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 74.3 mtt180 -150.01 129.55 13.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.073 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.8 m -97.55 145.4 29.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.9 Cg_endo -69.04 158.91 56.07 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.609 2.206 . . . . 0.0 112.654 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.28 -130.74 25.08 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.328 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -107.33 22.29 16.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.819 -0.69 . . . . 0.0 111.232 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.12 168.96 19.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.447 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.89 147.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.232 0.539 . . . . 0.0 110.271 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.453 HG12 ' SG ' ' A' ' 50' ' ' CYS . 79.5 mt -68.96 136.09 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.553 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 ptp -130.18 99.54 5.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 HG13 ' CE1' ' A' ' 89' ' ' PHE . 61.2 t -64.07 125.93 21.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.724 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.49 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 78.2 mm-40 -101.07 -51.43 3.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.742 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 25.3 m-20 -149.67 148.64 29.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.224 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.84 152.42 11.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.983 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.471 HD22 ' HA ' ' A' ' 84' ' ' TYR . 9.8 t30 -150.4 149.34 29.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.222 0.534 . . . . 0.0 111.706 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.47 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 81.9 t80 -118.53 122.52 42.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 0.0 108.839 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 157.26 -140.69 7.29 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.35 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.512 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 10.2 ttm180 -153.5 115.44 4.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.172 0.51 . . . . 0.0 110.603 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.442 HG23 ' CZ ' ' A' ' 84' ' ' TYR . 10.7 p -121.59 7.38 10.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.356 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -150.01 157.18 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.886 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 44.2 p30 -113.74 4.29 15.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.706 0.289 . . . . 0.0 110.39 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.423 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 91.9 mttt -104.47 7.22 35.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.626 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.6 mm -113.87 138.17 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.883 0.373 . . . . 0.0 110.722 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.3 m 54.18 70.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.0 p30 -47.82 120.3 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 111.739 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -137.89 -165.14 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.011 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.605 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 1.9 p-10 -67.97 143.54 96.35 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.23 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -51.43 -36.31 58.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.264 1.976 . . . . 0.0 112.062 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -65.99 -41.36 91.19 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.482 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 31.7 mt-30 -86.96 -2.32 58.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.343 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.1 mtp -110.02 -6.76 15.06 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.777 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.23 -45.43 84.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.124 -0.63 . . . . 0.0 112.129 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.439 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 54.9 t30 -76.81 116.25 17.31 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.918 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.553 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 32.2 m -109.27 30.83 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -141.38 86.56 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 54.0 t -145.75 120.01 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.471 ' HA ' HD22 ' A' ' 62' ' ' ASN . 72.1 m-85 -132.43 154.69 49.6 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.124 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.1 tp -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.7 -48.6 13.67 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.275 2.65 . . . . 0.0 113.54 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 94.7 m-20 -58.25 -20.95 46.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.726 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.17 -36.05 60.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.729 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.518 ' O ' ' OG ' ' A' ' 93' ' ' SER . 51.7 t80 -64.33 -40.39 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.075 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 7.9 pttp -64.3 -40.68 96.43 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.367 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 91' ' ' ILE . 96.7 mt -60.32 -47.9 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.637 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.8 mmm -69.32 -38.83 78.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.529 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 3.7 m -60.82 -43.4 98.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.784 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -66.45 -37.68 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 111.607 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -75.52 -33.14 60.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.4 m -113.15 -16.22 12.62 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.545 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.2 m-20 -59.51 137.23 58.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.98 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 65.64 14.72 9.68 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.934 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -119.46 149.47 41.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.47 -32.91 68.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.353 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.2 156.92 38.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.2 p -154.8 150.52 27.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.238 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.53 128.99 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.474 HG11 ' N ' ' A' ' 105' ' ' VAL . 44.9 t -143.61 143.7 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.949 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.474 ' N ' HG11 ' A' ' 104' ' ' VAL . 2.4 t -79.07 118.46 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -72.56 43.75 0.11 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.54 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.87 -127.37 1.11 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.493 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' GLY . 47.2 t 29.43 -153.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.406 . . . . 0.0 110.982 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 108' ' ' SER . 14.0 m-20 -64.79 -9.86 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.3 -13.16 59.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.739 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.0 m-85 -139.34 126.45 12.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.5 Cg_exo -51.14 -155.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.443 2.095 . . . . 0.0 111.581 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -136.58 89.44 18.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.639 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.421 ' HD2' ' HZ2' ' A' ' 120' ' ' LYS . 79.1 Cg_endo -78.6 -26.62 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.426 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 22.2 p -158.53 97.13 1.78 Allowed Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.402 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.27 138.84 22.9 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.714 2.276 . . . . 0.0 113.058 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.37 57.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.765 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 119' ' ' TYR . 53.3 m -118.37 145.78 44.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.512 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 7.9 t80 -88.15 98.69 11.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.811 ' HZ3' ' HO3' ' A' ' 136' ' ' RAM . 27.1 mttt -72.76 -156.57 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.679 1.228 . . . . 0.0 113.309 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.3 p90 -174.86 172.54 2.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.138 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 54.9 tp -130.56 122.52 27.69 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.438 ' HG2' HE21 ' A' ' 125' ' ' GLN . 74.4 tt0 -117.38 128.76 55.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.9 t -134.49 122.54 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.762 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.438 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.0 mt-30 -111.24 129.81 55.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.43 173.88 16.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.137 0.494 . . . . 0.0 111.953 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -127.67 163.46 24.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.534 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.439 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.6 m -114.07 108.99 17.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.453 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.5 m -113.6 167.52 9.26 Favored Pre-proline 0 N--CA 1.465 0.311 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 132' ' ' LYS . 19.6 Cg_exo -63.1 145.06 93.67 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.217 1.944 . . . . 0.0 112.407 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -75.51 4.81 6.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.5 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 133' ' ' VAL . 4.6 tmtt? -90.98 121.06 32.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.955 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.449 ' N ' ' HD3' ' A' ' 132' ' ' LYS . 9.2 p -88.38 140.75 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.964 0.412 . . . . 0.0 111.569 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.948 179.903 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.811 ' HO3' ' HZ3' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' H1 ' ' H ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' H ' ' H1 ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -117.14 166.81 12.11 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.666 0.27 . . . . 0.0 110.363 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -55.59 140.03 83.27 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.652 2.235 . . . . 0.0 113.005 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -78.85 0.49 26.97 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.87 43.17 35.65 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.486 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.545 ' O ' ' O ' ' A' ' 35' ' ' MET . 23.6 tp -158.56 -18.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.007 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 34' ' ' LEU . 14.1 mtp 54.62 144.76 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.952 0.406 . . . . 0.0 110.859 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.657 ' HE ' ' HH ' ' A' ' 126' ' ' TYR . 78.3 mtp85 -91.37 146.2 24.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' NH2' ' HG2' ' A' ' 125' ' ' GLN . 42.4 ttm105 -147.36 136.39 22.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.497 0.665 . . . . 0.0 111.472 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -128.69 142.71 50.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.025 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 tt -139.76 135.32 32.97 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.97 148.22 35.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.417 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 m -69.89 134.36 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.744 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.55 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 22.5 tt0 -42.68 137.69 2.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.81 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.45 -4.69 80.22 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.53 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.47 150.53 46.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 118.585 1.193 . . . . 0.0 109.997 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.37 142.04 36.38 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -118.37 147.12 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -127.11 129.84 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.346 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.432 HD13 ' SG ' ' A' ' 96' ' ' CYS . 19.6 mt -115.04 142.47 46.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -148.45 135.34 20.0 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.473 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.493 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.23 140.42 21.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.746 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.3 Cg_endo -70.39 159.41 53.04 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.477 2.118 . . . . 0.0 111.948 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.78 -138.67 33.65 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.002 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -100.56 24.79 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.117 -0.541 . . . . 0.0 111.211 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.04 164.33 24.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.301 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 m -124.97 140.88 46.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.651 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.503 HG22 ' CD2' ' A' ' 126' ' ' TYR . 67.3 mt -67.22 138.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.535 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.8 ptp -133.99 98.52 4.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.694 0.759 . . . . 0.0 109.171 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.75 125.73 20.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.988 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.48 -46.49 4.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -150.21 147.66 27.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.952 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -168.39 151.86 5.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.914 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -149.3 151.48 34.24 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.744 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.55 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 80.8 t80 -118.12 122.78 43.95 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.88 -138.71 6.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.388 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.551 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 14.7 ttm-85 -157.86 117.63 3.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 111.329 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.484 ' CG2' ' CZ ' ' A' ' 84' ' ' TYR . 5.0 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.631 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.508 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.1 t0 -147.72 -171.74 3.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.226 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 37.3 p30 -146.17 -0.47 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -103.94 7.13 36.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.479 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mm -118.31 139.63 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.0 m 59.51 58.56 2.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.5 p-10 -44.52 121.48 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.19 -170.11 3.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.034 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.3 p30 -61.91 138.23 95.55 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.688 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.486 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.8 Cg_endo -49.86 -33.34 32.87 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.51 2.14 . . . . 0.0 113.322 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -63.55 -37.05 85.84 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.415 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 26.0 mt-30 -89.47 8.76 29.32 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.387 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.45 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 78.7 mtp -124.91 -1.97 7.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 69.5 mt-10 -61.61 -53.2 59.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.293 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.0 t30 -76.97 117.07 18.2 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.428 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.533 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 23.8 m -108.87 27.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.566 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 93.5 mm-40 -138.34 85.81 2.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.037 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 48.6 t -147.04 119.02 8.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CZ ' ' CG2' ' A' ' 66' ' ' THR . 83.1 m-85 -129.77 155.34 46.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.56 . . . . 0.0 111.625 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.1 tp -147.66 90.64 5.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.999 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.58 -44.26 31.04 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 113.348 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.0 m-20 -55.19 -27.4 45.65 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.62 -33.43 33.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.368 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.53 -42.81 91.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.095 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.8 pttt -64.36 -41.83 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.653 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.527 HG21 ' HE ' ' A' ' 95' ' ' ARG . 97.6 mt -59.67 -49.53 83.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.048 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.8 mmm -68.11 -35.4 78.08 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.767 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.477 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 66.3 m -59.58 -45.62 91.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -66.29 -35.12 79.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.584 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.527 ' HE ' HG21 ' A' ' 91' ' ' ILE . 94.2 mtt-85 -79.96 -32.85 39.92 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 48' ' ' LEU . 58.0 m -111.98 -15.87 13.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.477 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -60.62 134.32 56.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 65.03 12.62 8.06 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.649 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.09 145.6 40.62 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.329 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.4 m -70.27 -31.11 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.292 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.1 158.46 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.399 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' A' ' 48' ' ' LEU . 31.3 p -156.17 143.68 19.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.428 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.5 t -122.24 127.6 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 105' ' ' VAL . 19.2 t -142.39 146.28 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.479 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.599 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -85.52 120.83 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.829 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.42 28.83 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.438 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . -179.96 179.08 48.81 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.469 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.3 t 88.86 -158.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.57 -10.65 19.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.88 58.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.82 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 39.5 m-85 -140.87 131.12 13.32 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.006 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.1 Cg_exo -49.72 -162.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.869 2.379 . . . . 0.0 112.964 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -138.16 91.6 12.85 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.452 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.48 ' HD2' ' HZ2' ' A' ' 120' ' ' LYS . 83.7 Cg_endo -86.56 -44.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 123.355 2.703 . . . . 0.0 113.391 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.488 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.8 p -134.99 79.4 51.27 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.9 140.5 79.88 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.024 1.816 . . . . 0.0 111.963 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.456 ' H ' ' HO2' ' A' ' 136' ' ' RAM . . . 98.52 -2.15 58.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.293 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.619 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 51.8 m -114.76 147.71 39.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.626 0.713 . . . . 0.0 109.085 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.551 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.6 t80 -86.97 96.99 10.46 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.488 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 18.4 mtmt -76.74 -164.16 0.4 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.079 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 9.0 p90 -166.24 169.26 14.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.653 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.2 tp -130.85 125.32 33.32 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 69.7 tt0 -118.74 129.06 55.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.101 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.5 t -131.93 122.98 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.619 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 2.4 mt-30 -110.34 128.98 55.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.657 ' HH ' ' HE ' ' A' ' 36' ' ' ARG . 37.5 p90 -151.23 163.54 38.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.324 0.583 . . . . 0.0 111.656 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 57' ' ' MET . 95.4 m-20 -115.83 158.09 23.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.317 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 96.5 m -109.69 125.6 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.34 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.31 149.7 74.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.45 146.18 43.04 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.338 2.025 . . . . 0.0 111.918 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.04 37.05 0.36 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.32 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -99.26 109.45 22.1 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.838 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.2 t -97.64 129.99 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.891 -179.788 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . 0.596 ' O3 ' ' O7 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.619 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' C ' ' O ' ' A' ' 29' ' ' GLY . 8.2 mt 32.01 60.03 1.3 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 110.426 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.0 144.29 99.43 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 C-N-CA 122.774 2.316 . . . . 0.0 113.169 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -80.78 -34.66 34.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.998 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.49 1.2 89.34 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' MET . 27.5 tp -159.05 113.55 2.43 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.784 0.326 . . . . 0.0 111.297 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 34' ' ' LEU . 93.3 mtp 52.49 141.42 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.532 0.682 . . . . 0.0 111.846 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.716 HH12 ' H ' ' A' ' 128' ' ' CYS . 82.6 mtt85 -90.25 150.13 22.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.803 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -141.58 137.29 31.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.204 0.526 . . . . 0.0 110.851 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 44.2 mp0 -134.92 141.99 46.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -140.48 134.16 30.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.744 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.67 144.72 44.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.024 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.9 m -71.99 131.1 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.462 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.592 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 34.5 tt0 -42.95 135.96 2.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.628 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.48 -9.8 66.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.126 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.7 155.72 50.36 Favored Pre-proline 0 CA--C 1.52 -0.206 0 CA-C-N 118.963 1.382 . . . . 0.0 110.675 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.89 143.54 33.27 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.235 1.957 . . . . 0.0 113.387 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 18.3 tt -116.12 145.93 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 86.6 tt0 -130.79 129.83 42.93 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.989 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' CB ' ' CD1' ' A' ' 56' ' ' ILE . 23.9 mt -113.79 145.72 41.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.268 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 98.4 mtt180 -150.25 136.15 18.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.167 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.433 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -104.66 138.25 19.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.119 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 12.0 Cg_endo -63.82 155.51 63.34 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.567 2.178 . . . . 0.0 112.705 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.04 -132.14 32.94 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.613 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.4 p -103.62 26.55 8.38 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -80.75 162.39 24.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.881 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -131.12 146.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.093 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.433 HG12 ' SG ' ' A' ' 50' ' ' CYS . 63.1 mt -67.04 138.11 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 111.518 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.619 ' O ' ' CG ' ' A' ' 57' ' ' MET . 10.4 ptm -130.45 98.07 4.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.437 HG11 ' CE1' ' A' ' 89' ' ' PHE . 61.0 t -65.63 125.77 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.967 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.69 -45.59 5.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -151.8 150.35 30.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.106 0.479 . . . . 0.0 110.664 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -169.08 152.16 5.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.848 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 1.2 t30 -150.39 151.8 33.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.968 0.413 . . . . 0.0 111.617 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.545 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 47.7 t80 -120.26 126.16 49.9 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.74 -137.7 5.79 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.677 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 15.7 ttm-85 -156.25 118.18 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.723 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.43 ' HB ' ' HH ' ' A' ' 84' ' ' TYR . 4.2 p -123.88 11.57 9.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.232 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.578 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.8 t0 -144.94 -170.5 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.752 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.517 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 46.5 p30 -146.49 -4.12 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.172 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -103.43 5.98 37.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.434 HD13 HG23 ' A' ' 70' ' ' ILE . 32.4 mm -108.98 139.65 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.818 0.342 . . . . 0.0 110.552 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' ASP . 26.7 m 64.66 24.79 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.754 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.57 ' C ' ' O ' ' A' ' 71' ' ' CYS . 14.3 p30 -3.28 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.545 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.63 -167.66 1.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.704 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -62.17 145.58 93.42 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.251 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -58.99 -38.47 87.77 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.776 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -63.92 -39.62 94.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.897 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.704 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.9 mt-30 -84.83 -10.32 57.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.677 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 48.7 mmm -109.96 -2.96 16.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mt-10 -66.46 -44.36 82.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.562 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -78.26 121.27 24.19 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 67' ' ' ASP . 22.9 m -112.75 31.2 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.835 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -140.52 86.31 2.06 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.3 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.8 t -150.34 117.46 5.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.43 ' HH ' ' HB ' ' A' ' 66' ' ' THR . 73.0 m-85 -127.46 157.57 39.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.908 0.385 . . . . 0.0 111.233 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.6 tp -147.03 87.21 6.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.417 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -44.04 -46.04 11.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.504 2.136 . . . . 0.0 114.081 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.7 m-20 -54.93 -26.84 38.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.94 -33.05 35.67 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.994 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' HG11 ' A' ' 58' ' ' VAL . 57.1 t80 -66.24 -44.94 82.31 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 3.0 pttt -65.08 -40.32 94.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.42 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.459 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.3 mt -59.87 -49.31 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.531 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 74.4 mtp -72.83 -35.13 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.491 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.471 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 69.4 m -58.48 -42.69 88.12 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -66.28 -35.47 80.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 110.753 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 92.9 mtt-85 -79.14 -31.89 44.2 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 57.4 m -112.68 -20.87 11.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.471 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 69.7 m-20 -60.58 134.45 57.09 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.904 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 66.04 13.8 9.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.693 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -116.68 147.98 41.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.207 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.9 m -72.05 -32.0 66.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.451 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.21 156.28 36.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.743 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.401 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.6 p -155.47 146.74 22.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 58.2 t -126.35 132.57 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.81 139.45 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.654 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.7 t -76.48 118.76 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.99 28.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.004 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.654 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 178.2 -177.29 48.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.4 t 91.4 -162.77 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.836 0.35 . . . . 0.0 110.286 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.18 -9.24 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.24 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.44 56.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.302 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.584 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.0 m-85 -135.64 125.88 16.68 Favored Pre-proline 0 N--CA 1.455 -0.222 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.777 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 111' ' ' PHE . 27.2 Cg_exo -49.18 -158.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.518 2.145 . . . . 0.0 111.565 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -138.41 93.26 11.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -86.98 -12.82 4.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 123.185 2.59 . . . . 0.0 112.648 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.44 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -168.6 92.42 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.5 133.67 14.63 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.876 2.384 . . . . 0.0 112.828 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.03 11.52 36.79 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.887 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.581 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 47.3 m -127.91 145.63 50.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.473 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 6.5 t80 -83.55 98.27 9.48 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.517 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 6.1 mtmp? -77.25 -167.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.69 1.234 . . . . 0.0 113.683 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.451 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.5 p90 -168.11 173.85 7.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.232 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 26.4 tp -128.73 119.34 24.42 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.093 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -114.35 132.27 56.26 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.531 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 95.1 t -131.24 149.32 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.441 ' N ' HG13 ' A' ' 124' ' ' VAL . 1.9 mt-30 -136.16 127.83 28.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 126' ' ' TYR . 20.8 p90 -158.73 174.33 15.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.812 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.37 158.17 36.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.696 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.716 ' H ' HH12 ' A' ' 36' ' ' ARG . 62.3 m -106.35 123.9 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.146 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 57' ' ' MET . 4.9 m -130.54 157.4 77.65 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.502 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.18 144.1 95.88 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.361 2.04 . . . . 0.0 113.084 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -76.96 -4.04 41.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.979 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -137.71 127.03 24.7 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.671 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.5 m -94.7 132.55 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.224 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.477 179.261 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . 0.505 ' HO3' ' C7 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.592 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.78 58.26 8.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.128 0.489 . . . . 0.0 110.416 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.3 130.14 24.62 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.853 2.369 . . . . 0.0 111.734 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -81.46 -4.75 56.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.945 0.402 . . . . 0.0 110.352 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.91 29.7 50.49 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.776 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' CD1' ' C ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -160.47 113.72 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.072 0.463 . . . . 0.0 110.472 179.294 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.437 ' N ' HD11 ' A' ' 34' ' ' LEU . 28.1 mtt 58.96 125.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.432 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 62.5 mtp85 -88.76 150.82 22.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.497 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 33.0 ttp-105 -142.75 137.13 29.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.865 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.2 mp0 -137.59 144.14 41.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.528 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -139.21 139.22 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.801 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -141.09 142.51 34.13 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.597 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 16.6 m -71.08 135.48 47.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.57 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 84.2 tt0 -44.97 137.51 4.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.12 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.285 177.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.36 149.63 46.3 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 118.994 1.397 . . . . 0.0 110.319 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.18 146.12 68.88 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.346 2.031 . . . . 0.0 113.597 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' ' 104' ' ' VAL . 15.2 tt -115.39 144.51 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.669 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 51.2 tt0 -121.35 128.0 51.82 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.463 -178.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 43.8 mt -117.79 140.32 49.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.669 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 89.5 mtt-85 -148.92 136.32 20.24 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.47 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.6 m -103.18 138.13 19.46 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.392 179.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -66.54 156.01 67.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.473 2.115 . . . . 0.0 112.26 -179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.49 -134.67 38.11 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -103.41 25.1 10.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.503 . . . . 0.0 110.544 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.97 163.09 25.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.019 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.64 144.04 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.412 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.474 HG23 ' CD1' ' A' ' 126' ' ' TYR . 88.3 mt -68.31 137.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.114 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.4 ptm -130.9 99.04 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 t -61.46 123.37 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.585 -177.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.574 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.6 mm-40 -98.66 -50.63 4.18 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.6 m-20 -153.74 153.74 32.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.123 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.6 157.51 8.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.099 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -150.43 153.58 36.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.148 0.499 . . . . 0.0 111.992 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 32.1 t80 -123.35 121.09 34.93 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.59 -139.26 6.28 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.938 -177.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 6.6 ttm180 -155.5 116.72 3.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.141 0.496 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.425 HG21 ' CE2' ' A' ' 84' ' ' TYR . 5.2 p -124.22 10.21 8.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.973 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 37.4 t0 -145.87 -175.2 4.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.451 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 33.1 p30 -141.89 3.01 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.414 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -107.61 6.12 27.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.216 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.445 HG21 HD11 ' A' ' 70' ' ' ILE . 31.2 mm -117.81 137.85 50.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.5 m 54.47 74.91 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.767 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -53.62 125.42 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.408 0.623 . . . . 0.0 112.026 -178.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -138.88 -177.52 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.213 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -59.32 147.6 75.39 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.281 0.562 . . . . 0.0 110.066 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.4 Cg_endo -53.83 -38.52 85.63 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.114 1.876 . . . . 0.0 111.457 -178.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -61.44 -33.0 72.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.583 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 72.1 mt-30 -91.15 -6.2 53.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.438 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 73' ' ' ALA . 75.1 mtp -109.12 -9.1 15.06 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 40.9 mt-10 -63.89 -48.23 77.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.087 -178.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -81.21 116.83 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.536 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 20.9 m -106.66 33.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.554 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 90.6 mm-40 -141.76 86.72 2.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.2 t -145.4 118.22 8.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.425 ' CE2' HG21 ' A' ' 66' ' ' THR . 94.3 m-85 -129.08 154.82 46.31 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.579 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.8 tp -147.16 89.2 5.62 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.26 -46.98 13.22 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 123.555 2.837 . . . . 0.0 115.094 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.5 m-20 -60.86 -14.03 19.4 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.87 -36.34 59.0 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.358 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.404 ' O ' ' OG ' ' A' ' 93' ' ' SER . 43.1 t80 -64.56 -43.52 93.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.307 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.03 -42.18 99.71 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.723 -178.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.562 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 44.2 mt -60.27 -50.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.69 0.281 . . . . 0.0 111.305 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 83.6 mmm -66.98 -35.26 79.56 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.617 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.465 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 69.9 m -60.63 -48.59 81.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.74 -38.85 87.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.051 0.453 . . . . 0.0 111.355 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.562 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 83.9 mtt-85 -74.21 -34.23 63.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 56.4 m -112.62 -16.31 12.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -60.57 138.56 58.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.929 -0.709 . . . . 0.0 112.495 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 62.03 13.4 5.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.979 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -116.23 146.66 42.17 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.453 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -73.52 -28.0 61.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.825 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.475 HE21 ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -153.03 153.59 33.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.135 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 31.1 p -154.02 141.99 20.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.619 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.63 128.77 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.355 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 46' ' ' ILE . 45.3 t -139.42 141.36 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.082 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.658 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -80.8 119.76 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -64.89 28.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.982 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.658 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 176.58 -175.97 47.72 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 90.01 -159.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.524 . . . . 0.0 110.61 179.407 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -62.49 -9.5 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.751 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.61 -18.37 51.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.553 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -140.88 129.92 12.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.434 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.553 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.8 Cg_exo -49.99 -153.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.267 1.978 . . . . 0.0 112.46 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -140.88 91.02 9.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.275 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.439 ' HD2' ' HZ2' ' A' ' 120' ' ' LYS . 73.3 Cg_endo -81.58 -28.61 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.656 2.237 . . . . 0.0 113.031 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.441 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.8 p -146.11 77.22 12.04 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.07 131.97 49.16 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.244 1.962 . . . . 0.0 111.585 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.63 3.64 58.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.771 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.589 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 93.2 m -116.95 145.95 43.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.19 0.995 . . . . 0.0 109.519 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.519 ' HB3' HH12 ' A' ' 65' ' ' ARG . 11.5 t80 -88.22 96.85 10.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.491 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 26.2 mttt -76.32 -161.8 0.2 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.488 -177.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.501 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 14.2 p90 -170.69 172.42 5.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.69 176.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.5 tp -129.59 124.44 33.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -116.86 128.9 55.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.941 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.0 t -132.17 120.57 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 119.463 -0.895 . . . . 0.0 113.096 -178.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -106.97 123.99 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.542 ' C ' ' OD1' ' A' ' 127' ' ' ASP . 17.5 p90 -154.08 174.88 14.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.555 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.627 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.4 OUTLIER -127.7 159.98 33.07 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.597 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.432 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 83.7 m -108.93 115.04 29.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.43 HG12 ' SD ' ' A' ' 57' ' ' MET . 25.1 m -115.73 155.49 47.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.47 142.95 98.38 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.911 1.741 . . . . 0.0 112.224 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.457 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 24.4 t80 -79.39 -118.46 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.207 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.457 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 67.6 mttm -147.01 88.42 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.58 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.0 m -150.27 118.87 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.973 0.416 . . . . 0.0 110.818 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.81 179.931 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.589 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 71.11 39.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.013 0.435 . . . . 0.0 109.96 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -47.28 158.51 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.795 2.33 . . . . 0.0 112.237 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.56 7.43 6.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.937 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.46 43.86 7.19 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.85 101.58 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.483 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 2.7 mtm 61.78 134.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.152 0.501 . . . . 0.0 111.276 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.457 ' HD3' ' HH ' ' A' ' 126' ' ' TYR . 77.1 mtt-85 -91.58 147.39 23.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.951 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.73 137.1 23.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.333 0.587 . . . . 0.0 111.69 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.3 mp0 -135.25 146.16 48.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.785 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.407 179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.63 148.61 44.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.176 0.513 . . . . 0.0 111.116 -179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.8 m -70.56 133.31 46.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.918 -178.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.587 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 5.8 tt0 -44.96 139.12 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.471 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -9.89 73.9 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.924 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -117.45 150.46 46.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 118.415 1.107 . . . . 0.0 110.555 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 138.56 55.82 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.584 2.19 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 tt -113.62 145.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -124.42 128.77 49.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.234 -178.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 HD11 ' SG ' ' A' ' 102' ' ' CYS . 50.3 mt -113.99 142.4 46.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.707 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -152.23 137.03 17.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.5 -178.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.82 149.74 36.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.916 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.4 Cg_endo -72.38 159.36 49.54 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.691 2.261 . . . . 0.0 112.757 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.87 -118.04 6.73 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.264 178.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -125.85 24.12 7.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -75.54 171.2 14.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.98 149.09 29.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.495 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.443 HG12 ' SG ' ' A' ' 50' ' ' CYS . 66.1 mt -73.45 138.87 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.623 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.7 ptm -133.29 100.24 4.78 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.12 124.12 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.853 -178.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 84.0 mt-10 -102.62 -45.71 4.96 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.5 m-20 -150.64 148.74 28.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.0 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.41 152.41 7.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.946 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.429 HD22 ' HA ' ' A' ' 84' ' ' TYR . 5.3 t30 -149.76 150.19 31.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.149 0.5 . . . . 0.0 111.509 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.575 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 57.4 t80 -120.74 122.39 40.3 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.48 -137.35 5.43 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.76 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 11.1 ttm-85 -154.69 119.47 4.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.959 0.409 . . . . 0.0 111.473 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.582 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 10.5 p -123.4 7.53 9.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.807 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 61.9 t0 -148.76 154.87 40.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.901 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p-10 -112.18 3.56 17.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 110.521 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -109.2 9.39 26.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.323 -178.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 mm -112.76 137.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.4 m 54.73 73.03 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.397 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.12 120.12 6.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.787 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.87 -164.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.577 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -64.32 138.2 97.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 7.2 Cg_endo -54.24 -31.99 68.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.968 1.779 . . . . 0.0 111.929 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -62.36 -41.89 98.97 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.577 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 29.0 mt-30 -92.45 -2.98 55.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.889 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.76 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 51.4 mmm -115.29 -4.1 12.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.111 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mm-40 -69.49 -38.85 77.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.063 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -76.07 124.13 26.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.599 -178.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.73 29.47 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -139.34 85.65 2.07 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.411 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.431 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.4 t -147.66 124.5 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.429 ' HA ' HD22 ' A' ' 62' ' ' ASN . 94.0 m-85 -134.2 155.63 49.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.276 0.56 . . . . 0.0 111.752 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.0 tp -147.17 95.5 4.39 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.962 179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.17 -47.6 26.61 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.582 2.188 . . . . 0.0 113.568 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 90.0 m-20 -54.38 -21.6 10.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.837 -178.09 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.4 65.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.431 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -65.06 -40.95 95.44 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.4 pttp -65.13 -38.2 89.89 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 64.4 mt -61.3 -51.57 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.5 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.466 ' SD ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.41 -34.5 76.11 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.864 -178.867 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.5 m -61.02 -47.42 86.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.5 -35.97 80.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.58 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 94.9 mtt-85 -77.35 -35.02 55.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -177.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.415 ' SG ' HD11 ' A' ' 48' ' ' LEU . 57.5 m -112.67 -15.69 12.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -177.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.6 m-20 -60.59 139.28 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.03 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 65.45 12.82 8.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.631 178.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -117.32 147.75 42.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.278 0.561 . . . . 0.0 110.915 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 m -72.78 -31.78 65.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.927 179.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.75 155.92 38.11 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.168 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 48' ' ' LEU . 30.2 p -155.01 144.8 21.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.846 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.4 125.12 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.161 178.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 105' ' ' VAL . 29.9 t -140.35 142.55 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.867 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -70.81 119.94 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.161 179.066 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -66.73 39.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.879 -178.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.32 -121.82 0.78 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.007 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 29.52 -155.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.439 0.637 . . . . 0.0 111.137 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -64.82 -11.55 38.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.49 60.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.859 -178.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 68.1 m-85 -144.52 129.46 9.33 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.012 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 49.2 Cg_exo -46.65 -159.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.558 2.172 . . . . 0.0 112.943 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -138.81 90.35 12.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.594 ' HD2' ' HZ3' ' A' ' 120' ' ' LYS . 55.8 Cg_endo -80.67 -53.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.152 2.568 . . . . 0.0 113.18 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -125.35 76.85 68.62 Favored Pre-proline 0 C--O 1.238 0.476 0 CA-C-O 121.181 0.515 . . . . 0.0 111.598 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 14.1 Cg_endo -63.07 131.98 34.81 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.705 1.604 . . . . 0.0 111.469 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.05 -11.27 34.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.227 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.54 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 79.6 m -110.05 149.2 30.35 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.4 t80 -85.19 97.8 10.11 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.594 ' HZ3' ' HD2' ' A' ' 114' ' ' PRO . 16.8 mtmt -72.09 -169.8 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 123.131 1.443 . . . . 0.0 114.572 -177.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.582 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.6 p90 -164.21 165.91 21.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 112.014 -2.357 . . . . 0.0 110.317 176.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.1 tp -126.8 123.05 36.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.614 ' OE2' ' NE2' ' A' ' 125' ' ' GLN . 43.2 tt0 -120.4 126.72 51.16 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.561 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.466 HG22 ' SD ' ' A' ' 92' ' ' MET . 37.3 t -133.07 126.78 53.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.474 -178.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.614 ' NE2' ' OE2' ' A' ' 123' ' ' GLU . 3.1 mp0 -114.09 131.49 56.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.457 ' HH ' ' HD3' ' A' ' 36' ' ' ARG . 27.9 p90 -153.84 169.18 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 112.007 -178.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.483 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 82.7 m-20 -122.72 162.03 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.76 179.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.446 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.4 m -109.26 131.96 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.23 161.71 59.51 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.593 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -63.15 143.22 89.61 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 112.828 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -79.77 124.22 28.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.334 179.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -106.95 136.44 46.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 134' ' ' GLU . 23.4 t -89.29 138.57 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 133' ' ' VAL . 76.6 tt0 . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.767 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.587 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp 50.07 90.46 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.709 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -55.84 145.33 73.25 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 121.96 1.773 . . . . 0.0 111.113 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' C ' ' H ' ' A' ' 34' ' ' LEU . 32.3 t80 -148.17 7.79 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.12 -7.88 1.55 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.253 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -157.79 103.9 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 111.032 179.954 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 34' ' ' LEU . 8.1 mtt 58.06 138.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.141 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.558 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 65.4 mtt85 -88.55 145.0 25.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 39.2 ttp180 -147.03 139.7 24.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.336 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.687 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.8 mp0 -133.11 142.37 48.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.236 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -141.44 137.42 32.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.479 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -143.99 149.08 36.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.691 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.7 m -68.53 131.64 45.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' CD ' ' HO4' ' A' ' 136' ' ' RAM . 48.5 tt0 -45.9 142.65 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.431 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.0 -6.9 82.87 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.761 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.94 140.64 27.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.832 0.816 . . . . 0.0 110.016 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.14 141.48 88.57 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.514 2.142 . . . . 0.0 113.606 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.406 HG22 HD13 ' A' ' 46' ' ' ILE . 13.0 tt -120.01 145.09 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.63 130.37 52.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.149 0.499 . . . . 0.0 112.18 -178.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 16.5 mt -113.21 143.41 44.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -150.05 135.16 17.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.066 -178.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.8 m -101.81 148.71 35.68 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.723 179.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 60.4 Cg_endo -73.91 157.95 46.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.134 2.556 . . . . 0.0 112.34 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.92 -128.07 32.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 p -113.85 24.53 12.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -77.65 168.26 20.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.296 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 m -126.79 147.74 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.486 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.504 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 92.4 mt -72.55 140.02 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.395 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.453 ' SD ' HG12 ' A' ' 129' ' ' VAL . 1.5 ptp -131.87 102.0 5.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.452 HG11 ' HG ' ' A' ' 93' ' ' SER . 99.9 t -63.93 123.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.093 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.3 mm-40 -102.17 -50.49 3.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 46.4 m-20 -146.86 144.18 29.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.447 -179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.22 148.26 6.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.847 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 4.8 t30 -150.92 156.81 41.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.366 0.603 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.547 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 49.4 t80 -120.27 122.13 40.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.09 -143.47 9.26 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.999 -177.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.692 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.6 ttm-85 -150.63 115.79 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.383 0.611 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.541 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 19.7 p -123.52 3.45 9.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.355 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.684 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 53.7 t0 -145.04 153.24 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.224 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 38.6 p30 -112.55 0.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -102.48 1.82 35.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.401 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mm -110.44 138.8 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.391 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m 56.34 70.25 0.66 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.997 -179.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -54.26 121.04 7.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HB1' ' CD2' ' A' ' 119' ' ' TYR . . . -140.82 -163.05 1.46 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.028 179.403 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.02 143.91 97.4 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.27 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.0 Cg_endo -56.74 -38.69 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.515 2.144 . . . . 0.0 113.498 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -63.77 -29.95 71.1 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.183 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.7 mt-30 -88.33 -12.86 42.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.052 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.413 ' HE3' ' O ' ' A' ' 68' ' ' ASP . 73.0 mtp -102.97 -5.4 23.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 57.3 mm-40 -65.23 -47.33 77.18 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.453 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -78.61 111.74 15.0 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.888 -178.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.614 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.3 m -103.34 31.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.614 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 96.7 mm-40 -142.89 86.95 1.95 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.554 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.4 t -149.45 119.74 7.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.47 ' CZ ' HG22 ' A' ' 66' ' ' THR . 51.2 m-85 -129.47 147.39 51.28 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.266 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.3 tp -138.31 91.97 12.34 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -50.26 -45.87 31.58 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.768 2.312 . . . . 0.0 113.319 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -53.64 -30.6 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.246 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.93 54.03 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.188 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.595 ' O ' ' OG ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -65.5 -44.32 87.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.241 178.624 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.23 -41.19 97.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 -179.311 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.489 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 60.7 mt -60.69 -48.91 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.02 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.29 -36.19 81.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.918 0.389 . . . . 0.0 110.499 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.595 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 15.8 m -59.88 -45.43 92.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -65.93 -35.87 81.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.518 0.675 . . . . 0.0 110.883 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HE ' HG21 ' A' ' 91' ' ' ILE . 95.1 mtt-85 -76.08 -34.25 59.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 33.0 m -112.42 -13.73 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' SER . 83.0 m-20 -60.77 134.59 57.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.273 0.559 . . . . 0.0 112.208 -179.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 66.37 12.73 8.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.679 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -115.8 147.72 40.67 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.281 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.9 m -74.02 -30.91 62.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.03 153.19 33.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.4 ' SG ' ' CD1' ' A' ' 48' ' ' LEU . 20.3 p -154.68 139.63 17.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.4 124.58 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.9 t -138.74 151.83 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 112.123 -178.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.4 t -84.5 116.57 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.184 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -67.22 40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.059 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 178.3 -131.03 1.67 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.753 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.579 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 1.6 t 32.75 -150.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.036 -0.582 . . . . 0.0 112.227 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.579 ' H ' ' HG ' ' A' ' 108' ' ' SER . 94.0 m-20 -64.46 -11.74 36.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.698 -178.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.83 -12.33 59.77 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.613 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.0 m-85 -142.2 124.73 9.19 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.445 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -46.23 -159.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.079 2.519 . . . . 0.0 113.547 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -137.05 85.82 21.74 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.34 -34.33 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.966 2.444 . . . . 0.0 112.775 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.73 89.99 6.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.88 139.04 42.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.812 2.341 . . . . 0.0 112.75 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.04 15.66 47.59 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.49 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.454 HG21 ' N ' ' A' ' 119' ' ' TYR . 91.3 m -128.93 144.65 51.24 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.692 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 11.5 t80 -89.03 97.24 11.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.164 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.547 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 16.3 mttt -74.0 -153.77 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.765 1.269 . . . . 0.0 113.034 -177.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.541 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 12.4 p90 -175.6 171.6 2.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.275 -2.239 . . . . 0.0 109.085 176.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 18.1 tp -127.49 120.38 28.18 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.5 ' HG2' HE21 ' A' ' 125' ' ' GLN . 80.8 tt0 -113.11 125.65 54.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.1 t -135.75 124.79 39.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.202 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.5 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.9 mp0 -113.68 130.62 56.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.069 179.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 126' ' ' TYR . 37.8 p90 -154.47 173.36 16.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 111.454 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.437 ' HA ' HH11 ' A' ' 36' ' ' ARG . 88.3 m-20 -127.51 161.72 28.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.558 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.5 m -109.49 117.54 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.262 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.453 HG12 ' SD ' ' A' ' 57' ' ' MET . 3.0 m -124.07 158.19 61.35 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.921 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.87 145.51 90.5 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.164 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -75.76 -30.61 59.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.341 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.502 ' HG2' ' H ' ' A' ' 133' ' ' VAL . 25.9 tttm -95.19 -144.4 0.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.389 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.502 ' H ' ' HG2' ' A' ' 132' ' ' LYS . 1.3 m -147.09 124.24 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.382 . . . . 0.0 111.019 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.861 179.28 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.512 ' HO4' ' CD ' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.73 64.55 69.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.22 0.533 . . . . 0.0 111.77 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.83 146.27 91.59 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.636 2.224 . . . . 0.0 111.213 178.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -78.95 -14.5 59.18 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.2 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.12 24.93 56.61 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.691 178.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.616 ' O ' ' O ' ' A' ' 35' ' ' MET . 1.4 tt -161.02 77.66 0.58 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.485 0.643 . . . . 0.0 111.089 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.616 ' O ' ' O ' ' A' ' 34' ' ' LEU . 4.3 mtt 52.74 146.59 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.513 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 66.0 mtp85 -89.88 145.39 25.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.576 ' NH2' ' OE2' ' A' ' 123' ' ' GLU . 74.6 ttt180 -147.77 131.81 17.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.686 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.613 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 46.4 mt-10 -132.54 145.62 51.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.045 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.12 141.94 34.14 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.49 146.23 36.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.468 -178.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.34 130.0 41.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.973 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.555 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 5.9 tt0 -40.39 136.13 1.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.126 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.45 83.7 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.111 -0.949 . . . . 0.0 114.173 177.123 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -117.8 148.18 42.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 118.994 1.397 . . . . 0.0 111.074 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.03 137.68 63.41 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.518 2.145 . . . . 0.0 113.32 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.4 143.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.71 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 44.7 tt0 -131.24 127.18 37.31 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.554 -178.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.1 mt -108.7 144.58 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.71 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 93.3 mtt-85 -149.15 127.22 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.274 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -95.78 141.57 23.35 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.704 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -66.6 158.7 54.47 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.031 1.821 . . . . 0.0 112.245 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.66 -134.28 34.75 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.427 0.459 . . . . 0.0 112.946 178.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.4 p -104.81 22.62 14.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.94 -0.63 . . . . 0.0 110.913 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -75.91 166.62 23.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.743 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 m -126.98 144.87 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.521 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.404 HG23 ' CD2' ' A' ' 126' ' ' TYR . 86.0 mt -70.23 136.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.143 0.497 . . . . 0.0 112.088 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.7 ptp -130.43 98.9 4.82 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.417 HG13 ' CE1' ' A' ' 89' ' ' PHE . 53.4 t -62.99 123.61 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.79 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.404 ' C ' ' CG ' ' A' ' 60' ' ' ASN . 73.4 mm-40 -99.49 -45.12 5.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' CG ' ' C ' ' A' ' 59' ' ' GLU . 2.8 m-80 -154.12 148.14 25.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.304 -179.085 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.26 152.87 11.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.885 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -149.32 153.65 37.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.428 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 61.6 t80 -125.84 125.69 43.27 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.06 -137.96 5.88 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -177.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.599 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -155.02 114.97 3.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 111.055 179.299 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.778 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 13.9 p -119.26 9.49 11.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.661 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 44.7 t0 -143.49 -167.12 2.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.612 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.661 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 53.9 p30 -151.83 -5.89 0.24 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 38.1 mttm -97.36 11.04 38.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.472 HG22 HD13 ' A' ' 70' ' ' ILE . 39.9 mm -115.03 138.56 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.939 0.4 . . . . 0.0 110.312 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m 56.92 70.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.117 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.6 p-10 -51.39 117.33 2.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.584 0.707 . . . . 0.0 111.315 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.94 -163.84 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.676 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 3.4 p30 -60.71 132.71 91.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 119.164 -1.014 . . . . 0.0 108.667 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.41 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -57.0 -27.14 72.08 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.452 2.101 . . . . 0.0 113.968 -178.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -63.88 -30.02 71.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.032 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.676 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.0 mt-30 -88.59 -5.72 57.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.516 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.599 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 6.0 mtm -110.84 -1.48 16.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.264 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 49.9 mt-10 -60.97 -52.32 65.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.963 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.98 107.76 11.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.051 -0.406 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.6 m -101.4 31.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.33 0.586 . . . . 0.0 110.662 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -139.26 85.9 2.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.5 t -149.32 115.39 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -124.25 156.01 37.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.727 0.299 . . . . 0.0 111.221 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 tp -142.69 82.02 12.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -44.91 -45.42 13.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.245 2.63 . . . . 0.0 114.256 -177.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 86.6 m-20 -57.1 -25.29 58.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.885 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.36 -34.77 49.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.576 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.527 ' O ' ' OG ' ' A' ' 93' ' ' SER . 26.7 t80 -64.1 -40.37 96.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.8 pttm -67.17 -39.25 86.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.835 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.564 ' CG2' ' NH1' ' A' ' 95' ' ' ARG . 69.9 mt -60.19 -52.45 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.561 ' SD ' ' CD2' ' A' ' 122' ' ' LEU . 62.1 mtp -69.68 -32.56 71.25 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.527 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 62.5 m -59.97 -43.37 95.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.592 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 90.4 mt-30 -66.59 -36.23 82.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.353 0.596 . . . . 0.0 110.014 178.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.564 ' NH1' ' CG2' ' A' ' 91' ' ' ILE . 52.9 mtt85 -77.45 -34.08 54.54 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 59.4 m -110.89 -16.19 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.477 ' CG ' ' O ' ' A' ' 93' ' ' SER . 77.0 m-20 -61.44 133.39 55.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.804 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 66.52 13.31 9.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.592 ' NH2' ' O ' ' A' ' 94' ' ' GLN . 42.9 mtt85 -113.89 147.03 39.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.944 178.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -71.04 -31.32 67.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.623 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 156.59 35.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.102 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.3 p -153.6 142.34 21.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.29 126.25 70.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.328 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.71 146.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.855 -178.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.45 120.26 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.268 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -71.76 43.5 0.09 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.165 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.1 -126.72 1.03 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 29.36 -154.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.239 0.543 . . . . 0.0 112.209 179.588 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -64.43 -10.56 25.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.642 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.05 59.9 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.807 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 112' ' ' PRO . 64.4 m-85 -142.69 126.76 9.68 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.684 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.546 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.4 Cg_exo -50.1 -156.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.323 2.015 . . . . 0.0 112.436 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 20.9 t0 -139.35 93.21 10.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.411 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.49 -38.55 0.98 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.714 2.276 . . . . 0.0 113.328 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -140.25 79.08 22.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.057 0.456 . . . . 0.0 110.995 -179.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 17.2 Cg_exo -56.18 133.4 57.83 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.187 1.924 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.46 -10.9 56.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.888 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.419 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 62.9 m -105.95 147.54 28.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.616 0.708 . . . . 0.0 109.104 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.593 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 t80 -84.37 97.61 9.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.491 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 22.5 mtmm -73.54 -171.65 1.05 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.457 1.599 . . . . 0.0 115.083 -177.056 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.778 ' HH ' ' H ' ' A' ' 66' ' ' THR . 10.6 p90 -164.47 167.73 19.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 111.58 -2.555 . . . . 0.0 110.579 177.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.561 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 25.9 tp -129.33 122.56 29.78 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.576 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 83.5 tt0 -115.33 132.93 56.46 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.774 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.541 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 41.5 t -133.33 144.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.82 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.493 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -133.26 130.44 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.081 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.404 ' CD2' HG23 ' A' ' 56' ' ' ILE . 27.9 p90 -156.09 171.62 19.82 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.138 -178.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 57' ' ' MET . 87.8 m-20 -125.5 162.22 25.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.775 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 92.4 m -108.93 125.52 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.7 m -130.34 157.58 76.9 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.674 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -59.59 148.93 85.29 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.025 1.816 . . . . 0.0 111.979 178.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -74.8 1.61 12.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -95.63 135.35 37.42 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.634 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.18 126.6 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.655 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.497 -179.632 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.555 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.2 mp 64.99 65.93 0.93 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 111.546 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.86 -95.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.345 2.03 . . . . 0.0 111.877 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 55.5 t80 -80.17 -6.0 57.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.798 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.23 19.02 70.32 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 35' ' ' MET . 10.6 tp -161.33 63.45 0.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER 49.23 173.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.485 -179.614 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.525 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 3.3 mtm-85 -93.09 142.72 26.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.168 179.122 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' HE ' ' CG ' ' A' ' 125' ' ' GLN . 41.0 ttm180 -146.69 135.84 22.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -132.04 143.6 50.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.672 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 tt -139.16 141.09 38.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.91 142.73 34.4 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.266 -179.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.423 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 65.7 m -66.84 134.45 52.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.994 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 5.4 tt0 -44.04 134.86 4.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -4.91 79.67 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.326 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 12.1 m-85 -118.1 150.08 46.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 118.189 0.995 . . . . 0.0 110.798 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 24.4 Cg_endo -65.94 141.76 65.95 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.879 2.386 . . . . 0.0 113.722 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.0 tt -117.3 145.53 22.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.135 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -127.5 129.29 47.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.317 -178.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.454 HD13 ' SG ' ' A' ' 102' ' ' CYS . 40.4 mt -112.44 141.81 45.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.538 178.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -149.43 132.85 16.6 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.577 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.45 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.8 m -102.68 142.98 25.68 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.901 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.17 161.59 44.15 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.6 2.2 . . . . 0.0 112.844 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.03 -128.1 33.34 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.6 p -112.88 25.84 11.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.45 166.82 22.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.5 m -127.62 143.99 38.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 HG23 ' CD2' ' A' ' 126' ' ' TYR . 92.0 mt -69.48 139.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.234 -178.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 ptp -132.85 103.12 5.93 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.442 HG13 ' HG ' ' A' ' 93' ' ' SER . 97.5 t -64.67 125.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.25 -178.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 96.0 mt-10 -102.94 -51.0 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -149.05 145.1 27.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.202 0.525 . . . . 0.0 110.549 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.85 156.22 10.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.716 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -152.59 154.95 36.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.177 0.513 . . . . 0.0 111.618 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 76.9 t80 -122.39 122.48 39.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.445 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 120' ' ' LYS . . . 157.11 -142.45 8.68 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -177.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -151.6 119.15 6.05 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.17 0.51 . . . . 0.0 111.722 179.11 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.501 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 26.6 p -128.09 5.49 5.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.557 179.134 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.745 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 61.8 t0 -144.39 151.63 39.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.399 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.658 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 40.7 p30 -112.66 3.5 16.65 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.471 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -103.1 8.52 38.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.737 -178.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 70' ' ' ILE . 45.2 mm -112.31 135.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m 55.69 72.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.611 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 57.8 p30 -49.65 106.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.529 0.68 . . . . 0.0 112.19 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.56 -166.78 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.152 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.626 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.18 141.6 97.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 5.9 Cg_endo -54.99 -33.82 84.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 121.895 1.73 . . . . 0.0 112.509 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -63.51 -40.26 96.57 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.463 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 25.5 mt-30 -90.37 -6.68 54.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.974 0.416 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.461 ' HE1' ' NH2' ' A' ' 65' ' ' ARG . 80.2 mmm -106.66 -5.23 18.76 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.758 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.583 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 1.9 mm-40 -66.98 -46.58 74.18 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.7 t30 -78.25 122.99 26.43 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.838 -178.26 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.24 32.59 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.1 85.5 2.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.496 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.2 t -151.27 121.22 7.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.9 m-85 -131.75 156.59 45.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.964 0.411 . . . . 0.0 111.939 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.401 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 27.8 tp -147.93 87.66 5.76 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.567 178.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -48.03 -46.6 21.64 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.621 2.214 . . . . 0.0 113.361 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.5 m-20 -55.15 -23.92 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.124 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 85' ' ' LEU . . . -55.59 -33.08 63.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.615 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.541 ' O ' ' OG ' ' A' ' 93' ' ' SER . 4.7 t80 -65.18 -40.75 94.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.598 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 10.1 pttp -64.87 -40.6 95.39 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.39 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 60.6 mt -59.94 -50.52 79.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.703 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.0 mmm -67.16 -33.99 76.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.541 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 28.1 m -60.02 -45.09 93.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.283 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.71 -36.78 83.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.179 0.514 . . . . 0.0 111.01 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.44 ' CZ ' HG12 ' A' ' 104' ' ' VAL . 16.9 mtp180 -74.09 -35.4 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.2 m -112.99 -12.88 13.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.502 ' CG ' ' O ' ' A' ' 93' ' ' SER . 68.2 m-20 -60.02 133.76 56.4 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.55 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 67.31 13.83 9.5 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 178.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -113.85 145.16 41.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.802 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.7 m -69.13 -31.26 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 155.4 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.267 179.326 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -153.86 130.8 10.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.25 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 97.3 t -114.25 132.4 63.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.875 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG12 ' CZ ' ' A' ' 95' ' ' ARG . 43.5 t -144.03 149.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -83.62 117.52 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.08 37.48 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.62 -178.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.94 -127.73 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.554 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.525 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 12.4 t 31.69 -153.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.525 ' H ' ' HG ' ' A' ' 108' ' ' SER . 94.9 m-20 -63.46 -9.08 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.101 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.36 60.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.922 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -141.57 126.36 10.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.8 Cg_exo -49.96 -154.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.602 2.201 . . . . 0.0 112.162 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -137.72 87.39 17.25 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -84.7 -20.89 3.57 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.313 2.675 . . . . 0.0 114.092 -179.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.487 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -153.49 73.47 6.71 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 121.109 0.48 . . . . 0.0 110.858 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.26 135.42 50.33 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.084 1.856 . . . . 0.0 112.048 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.495 ' H ' ' HO2' ' A' ' 136' ' ' RAM . . . 103.76 -12.0 53.35 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.586 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -111.25 149.79 30.52 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.187 0.994 . . . . 0.0 108.835 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.2 t80 -82.2 98.5 8.76 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.257 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.504 ' CD ' ' CE2' ' A' ' 63' ' ' TYR . 20.7 mttt -70.89 -160.74 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.652 1.215 . . . . 0.0 112.98 -178.418 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.514 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -176.5 171.73 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.052 176.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 20.3 tp -130.11 123.83 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 57.6 tt0 -117.89 125.07 49.8 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.9 t -131.01 124.73 56.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.938 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.407 ' CG ' ' HE ' ' A' ' 37' ' ' ARG . 1.6 mt-30 -109.48 131.41 55.09 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.472 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.8 p90 -151.46 171.93 16.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.357 -178.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.455 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 48.9 m-20 -127.08 160.9 29.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.898 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.525 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 84.2 m -112.6 120.94 43.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.744 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 30.7 m -121.16 149.18 50.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.902 179.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -54.57 143.45 68.09 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.83 1.686 . . . . 0.0 112.163 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -81.85 -12.88 58.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.63 179.433 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -98.21 135.82 39.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.505 ' O ' ' OXT' ' A' ' 134' ' ' GLU . 13.1 p -152.12 120.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.333 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.505 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 62.5 tt0 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.46 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' RAM . . . . . 0.495 ' HO2' ' H ' ' A' ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.456 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 65.4 mtp85 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.598 0.237 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -153.12 138.37 17.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.296 0.57 . . . . 0.0 112.161 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.765 ' CD ' HD23 ' A' ' 48' ' ' LEU . 86.8 mt-10 -131.16 149.5 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -136.26 139.55 42.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.873 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.9 145.18 32.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.034 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.3 m -71.25 133.66 46.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.457 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 79.7 tt0 -44.27 137.16 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.496 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.22 -6.94 72.4 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.402 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.442 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 15.1 m-85 -116.9 153.78 49.46 Favored Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 118.972 1.386 . . . . 0.0 111.154 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.05 141.8 40.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.124 1.883 . . . . 0.0 112.725 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 16.5 tt -116.33 144.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 86.0 tt0 -129.98 127.71 40.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.261 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.892 HD12 ' SG ' ' A' ' 102' ' ' CYS . 19.9 mt -111.45 144.74 40.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.254 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.519 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 62.7 mtt180 -147.93 126.62 12.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.309 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -95.39 144.54 27.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 27.6 Cg_endo -68.55 157.3 62.39 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.481 2.12 . . . . 0.0 112.295 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.43 -134.51 29.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.438 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -104.63 23.05 13.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -77.67 167.67 21.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.85 145.65 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.635 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.655 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.4 mt -67.91 136.21 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.821 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.591 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.2 ptm -132.5 100.79 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.539 HG12 ' HE1' ' A' ' 89' ' ' PHE . 25.4 t -64.16 124.77 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.403 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.562 ' OE1' ' OD1' ' A' ' 127' ' ' ASP . 46.9 mt-10 -102.04 -50.61 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.855 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -148.23 146.5 28.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.948 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.646 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.8 153.83 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.531 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.766 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.2 t30 -151.54 154.16 35.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.159 0.504 . . . . 0.0 111.796 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 30.2 t80 -123.57 122.83 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -138.89 6.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 5.3 ttm-85 -155.69 115.52 3.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.057 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.545 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 14.8 p -124.8 7.67 8.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.525 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -146.95 155.47 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.523 ' O ' ' HE2' ' A' ' 78' ' ' MET . 58.7 p30 -110.16 0.69 18.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 14.2 mttp -105.75 8.86 33.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.776 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.646 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 46.1 mm -113.72 136.27 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.781 0.324 . . . . 0.0 110.512 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 51.6 m 59.99 63.7 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -47.99 109.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 112.25 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -128.35 -164.81 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.758 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.687 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -62.85 144.73 96.63 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.173 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.2 Cg_endo -54.78 -37.59 92.08 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.34 2.027 . . . . 0.0 112.52 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -63.86 -34.47 78.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.597 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.687 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.3 mt-30 -86.82 -10.73 52.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.523 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 88.1 mtp -102.21 -5.49 24.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 37.6 mm-40 -63.99 -52.63 58.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -78.84 115.48 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.379 0.609 . . . . 0.0 112.517 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.2 m -107.17 32.28 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.127 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -139.93 85.51 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.113 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.443 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.6 t -148.11 118.79 7.51 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.426 ' HA ' HD21 ' A' ' 62' ' ' ASN . 55.9 m-85 -125.74 152.85 44.79 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.08 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 85' ' ' LEU . 35.0 tp -147.17 83.66 7.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.66 -47.25 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.078 2.519 . . . . 0.0 113.308 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 82.3 m-20 -54.11 -23.76 15.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.802 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.33 56.78 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.098 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' HE1' HG12 ' A' ' 58' ' ' VAL . 33.7 t80 -64.03 -42.85 96.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.99 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 14.4 pttm -63.92 -38.35 90.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.106 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.452 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 69.1 mt -60.98 -52.22 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.306 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.5 mmm -68.48 -36.24 78.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.068 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.8 m -60.43 -47.29 86.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -66.55 -36.84 83.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.452 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 89.5 mtt-85 -76.96 -32.91 57.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.616 ' SG ' HD12 ' A' ' 48' ' ' LEU . 61.6 m -111.29 -15.29 13.65 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.539 ' CG ' ' O ' ' A' ' 93' ' ' SER . 48.2 m-20 -60.04 134.07 56.7 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.665 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 66.38 13.53 9.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -115.95 147.35 41.25 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.57 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.7 m -72.53 -31.47 65.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.718 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.48 154.65 35.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.892 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.2 p -155.16 136.94 14.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.747 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 47' ' ' GLU . 20.6 t -116.93 130.59 71.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 46' ' ' ILE . 42.3 t -143.09 146.87 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.599 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -80.76 118.49 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.01 37.44 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.723 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.74 -130.16 1.46 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.564 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 107' ' ' GLY . 3.5 t 36.64 -154.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -63.27 -9.01 9.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.273 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.15 -13.45 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.558 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.583 ' O ' ' O ' ' A' ' 112' ' ' PRO . 62.1 m-85 -140.58 128.19 12.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.448 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.4 Cg_exo -48.61 -158.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.352 2.034 . . . . 0.0 111.984 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.19 91.85 12.62 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -82.59 -46.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.134 2.556 . . . . 0.0 113.112 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.5 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -131.79 77.97 71.29 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-O 121.112 0.482 . . . . 0.0 111.319 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.49 131.6 34.53 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.748 1.632 . . . . 0.0 111.739 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.49 -6.59 38.88 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.526 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 77' ' ' GLN . 96.7 m -112.49 147.58 36.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.636 0.718 . . . . 0.0 109.336 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.544 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.3 t80 -85.87 98.43 10.77 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.5 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 11.9 mttp -76.51 -163.01 0.29 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 123.078 1.418 . . . . 0.0 113.803 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.545 ' OH ' ' N ' ' A' ' 66' ' ' THR . 5.7 p90 -169.29 171.9 7.61 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.44 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 62' ' ' ASN . 55.2 tp -129.26 122.55 29.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.088 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 54.7 tt0 -115.31 128.42 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.372 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.646 HG22 ' HB1' ' A' ' 61' ' ' ALA . 44.5 t -135.54 123.77 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.48 -0.888 . . . . 0.0 113.141 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.0 129.32 54.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.655 ' CD2' HG23 ' A' ' 56' ' ' ILE . 35.7 p90 -152.21 166.96 30.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.237 0.541 . . . . 0.0 111.873 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.562 ' OD1' ' OE1' ' A' ' 59' ' ' GLU . 3.1 m-20 -126.75 161.74 27.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.241 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.456 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 65.3 m -111.96 122.26 47.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.623 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.5 m -124.86 154.41 70.82 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 122.342 2.028 . . . . 0.0 112.446 178.761 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.425 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 68.6 ttt-85 -143.93 140.43 29.69 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.967 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG3' HD23 ' A' ' 48' ' ' LEU . 71.7 mm-40 -137.51 140.32 41.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.58 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -142.36 128.75 20.04 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.555 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -129.91 145.65 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.946 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.6 m -67.78 133.84 49.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.907 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.96 136.63 2.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.015 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.74 -2.96 82.98 Favored Glycine 0 N--CA 1.453 -0.198 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.712 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -117.05 150.76 46.58 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.0 0.9 . . . . 0.0 110.706 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.04 140.64 45.92 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.45 2.1 . . . . 0.0 112.714 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 104' ' ' VAL . 14.4 tt -114.05 149.04 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 48.8 tt0 -126.55 127.86 45.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.154 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 102' ' ' CYS . 19.3 mt -115.62 138.87 50.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 79.1 mtt180 -146.9 130.75 17.09 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.753 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.9 m -98.15 146.23 31.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.933 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 128' ' ' CYS . 51.8 Cg_endo -72.84 158.68 49.74 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.724 2.283 . . . . 0.0 112.29 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.83 -129.35 26.41 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.805 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -110.27 25.66 11.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.09 167.84 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.158 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.86 145.0 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.126 0.489 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.952 HG23 ' CD2' ' A' ' 126' ' ' TYR . 73.4 mt -67.89 137.61 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.686 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.7 ptp -132.52 100.87 5.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 t -63.23 126.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.766 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -101.63 -51.22 3.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.114 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -148.96 147.05 28.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.625 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.84 151.92 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.401 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 122' ' ' LEU . 13.2 t30 -152.39 161.79 42.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.397 0.618 . . . . 0.0 111.856 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.488 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 80.6 t80 -126.73 125.0 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -141.08 7.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.531 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.73 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.6 ttm-85 -155.04 114.87 3.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.266 0.555 . . . . 0.0 111.166 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 69.8 p -119.89 8.87 11.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.066 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.644 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.2 t0 -145.05 -170.11 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.417 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.584 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 2.9 p30 -146.04 -0.51 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.756 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -107.71 8.74 29.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.213 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.574 ' HB ' HH22 ' A' ' 65' ' ' ARG . 35.2 mm -102.74 134.55 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.578 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' ASP . 73.8 m 55.75 24.15 6.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.648 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.58 ' C ' ' O ' ' A' ' 71' ' ' CYS . 15.8 t70 1.43 105.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB3' ' CG ' ' A' ' 78' ' ' MET . . . -121.7 -166.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.062 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -63.31 146.25 96.34 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.066 179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.541 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -58.4 -37.65 93.93 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.2 1.933 . . . . 0.0 112.571 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.48 -42.71 95.73 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.413 ' O ' HG23 ' A' ' 118' ' ' THR . 46.7 mt-30 -84.12 -6.14 59.36 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.037 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.466 ' CG ' ' HB3' ' A' ' 73' ' ' ALA . 54.7 mmm -112.51 0.43 15.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.195 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 18.0 mt-10 -64.32 -47.85 77.85 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.934 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -78.86 113.71 17.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.446 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 67' ' ' ASP . 7.7 m -105.75 35.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.083 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -140.03 87.26 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.894 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.47 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.5 t -151.75 116.43 5.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.428 ' HA ' HD21 ' A' ' 62' ' ' ASN . 86.1 m-85 -125.29 156.13 39.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.942 0.401 . . . . 0.0 111.035 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.584 HD21 ' HG2' ' A' ' 112' ' ' PRO . 27.0 tp -145.59 91.1 5.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -48.89 -45.25 29.31 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.433 2.089 . . . . 0.0 111.622 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 65.9 m-20 -54.38 -30.92 53.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.447 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.32 -32.54 49.42 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.242 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -65.09 -43.98 90.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.4 pttp -66.08 -38.23 87.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.527 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.452 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 84.1 mt -59.88 -53.28 50.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.732 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 91.8 mmm -67.52 -34.73 77.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.518 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.464 ' HB3' HD21 ' A' ' 97' ' ' ASN . 23.8 m -58.91 -46.7 87.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.186 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.07 -37.62 84.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.757 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.452 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 96.3 mtt-85 -73.98 -33.62 63.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.2 m -114.71 -13.72 12.05 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.464 HD21 ' HB3' ' A' ' 93' ' ' SER . 88.5 m-20 -61.22 135.91 57.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.009 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 67.83 13.91 9.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.523 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -116.1 146.74 41.98 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.072 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -72.41 -31.67 65.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.716 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -151.27 155.26 38.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.681 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.1 p -156.19 133.96 11.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.724 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.15 126.89 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 46' ' ' ILE . 45.0 t -139.35 146.21 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 111.614 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.66 119.6 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 38.38 0.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.118 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.35 -124.19 0.89 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.937 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.71 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 31.04 -158.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.717 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.71 ' N ' ' OG ' ' A' ' 108' ' ' SER . 89.6 m-20 -64.4 -9.23 16.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.6 -8.96 58.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.249 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 112' ' ' PRO . 32.3 m-85 -141.05 131.18 13.15 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.075 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.584 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.9 Cg_exo -48.76 -163.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.343 2.029 . . . . 0.0 111.767 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.569 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -136.87 89.24 17.49 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.303 -179.343 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.78 -54.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.992 2.461 . . . . 0.0 113.139 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 4.1 p -127.49 72.87 77.89 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.887 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -58.74 131.85 44.56 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.908 1.739 . . . . 0.0 111.582 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.91 -16.96 32.95 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.803 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' GLN . 43.4 m -102.91 153.5 20.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.064 0.932 . . . . 0.0 108.495 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.73 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 21.2 t80 -86.21 99.31 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.527 0.68 . . . . 0.0 109.506 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.488 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 4.8 mtmp? -81.99 -159.27 0.28 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.599 1.19 . . . . 0.0 113.875 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 19.9 p90 -174.9 174.19 2.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.34 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 62' ' ' ASN . 18.7 tp -131.51 125.06 31.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.425 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 75.3 tt0 -121.18 130.79 53.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.625 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.8 t -134.41 123.47 42.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.011 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.7 129.71 55.58 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.952 ' CD2' HG23 ' A' ' 56' ' ' ILE . 40.9 p90 -153.56 169.76 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.51 0.671 . . . . 0.0 111.851 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -124.15 160.67 27.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.418 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.409 ' CB ' ' HD2' ' A' ' 51' ' ' PRO . 93.0 m -113.57 112.25 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.77 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.1 165.65 13.65 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.635 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo . . . . . 0 C--N 1.311 -1.408 0 C-N-CA 121.669 1.58 . . . . 0.0 111.63 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.571 ' NH1' ' HD3' ' A' ' 51' ' ' PRO . 19.9 mtp180 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.497 ' HE ' ' CG ' ' A' ' 123' ' ' GLU . 74.7 ttt180 -148.28 133.78 18.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.299 0.571 . . . . 0.0 110.984 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -129.57 146.45 51.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.517 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 121' ' ' TYR . 7.5 tt -141.6 127.88 19.84 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -130.81 147.47 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.045 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 m -70.05 132.2 45.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.519 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 17.4 tt0 -44.82 140.47 2.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.782 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 92.06 -8.28 77.99 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.818 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 18.7 m-85 -117.2 147.62 40.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 118.353 1.077 . . . . 0.0 109.928 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.95 146.24 76.88 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.342 2.028 . . . . 0.0 113.069 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 104' ' ' VAL . 20.9 tt -120.47 148.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.943 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.659 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 80.8 tt0 -132.63 126.96 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -112.91 143.38 44.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.659 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 97.8 mtt180 -144.78 134.31 23.28 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.518 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.486 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.7 m -103.79 143.65 27.08 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.274 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.571 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 49.3 Cg_endo -73.03 154.71 52.78 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 112.346 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.5 51.09 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.827 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -113.77 27.94 9.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -80.28 167.83 19.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.52 150.05 33.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.797 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.011 HG23 ' CD1' ' A' ' 126' ' ' TYR . 53.6 mt -71.05 138.14 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.181 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.438 ' HG3' ' H ' ' A' ' 127' ' ' ASP . 3.0 ptp -131.04 98.01 4.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.584 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.0 t -64.54 126.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.914 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -103.54 -46.78 4.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.46 ' HB2' ' NE2' ' A' ' 125' ' ' GLN . 14.3 m-80 -150.53 147.55 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.447 0.642 . . . . 0.0 111.13 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.64 154.86 10.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.241 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.542 HD21 ' HA ' ' A' ' 84' ' ' TYR . 6.1 t30 -150.5 151.41 32.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.06 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.416 ' CE2' ' HD3' ' A' ' 120' ' ' LYS . 47.5 t80 -119.88 122.93 42.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.34 -138.39 5.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.881 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 7.1 ttm-85 -155.21 115.4 3.79 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.168 -0.516 . . . . 0.0 109.845 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 p -122.39 11.49 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.044 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.635 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 49.9 t0 -146.91 -171.03 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.272 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.635 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 56.1 p30 -144.55 -0.33 0.96 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -103.9 6.3 36.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.209 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 40.1 mm -113.34 137.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m 57.25 70.56 0.64 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.128 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -53.12 122.16 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.387 0.613 . . . . 0.0 112.084 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -139.97 -163.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 141.07 98.0 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.9 Cg_endo -56.82 -35.03 97.9 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.344 2.029 . . . . 0.0 112.554 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -63.16 -36.87 85.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -88.14 12.54 13.39 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.233 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 75.8 mtp -129.0 -2.99 5.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 53.5 mm-40 -63.27 -47.25 83.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.987 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.44 119.29 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.419 . . . . 0.0 111.912 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 81' ' ' VAL . 5.3 m -111.37 31.66 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.623 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -136.23 85.84 2.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.48 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.3 t -149.15 112.57 5.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.542 ' HA ' HD21 ' A' ' 62' ' ' ASN . 72.8 m-85 -128.19 152.56 47.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.648 0.261 . . . . 0.0 110.945 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.76 86.76 7.72 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -45.98 -48.43 12.7 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.86 2.374 . . . . 0.0 114.904 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 37.6 m-20 -58.54 -21.89 53.83 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.27 61.65 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.565 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CE1' HG12 ' A' ' 58' ' ' VAL . 54.5 t80 -63.81 -41.83 97.8 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.6 pttm -66.54 -38.5 87.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.573 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.406 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 88.5 mt -60.74 -50.7 79.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.804 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.5 ' SD ' HG11 ' A' ' 104' ' ' VAL . 98.6 mmm -67.75 -35.63 79.08 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.11 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 16.4 m -61.82 -46.1 90.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.391 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.92 -35.6 81.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.562 0.696 . . . . 0.0 110.424 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' A' ' 104' ' ' VAL . 23.1 mtp85 -74.47 -34.0 63.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.6 m -112.39 -21.46 11.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' SER . 60.4 m-20 -56.25 129.72 41.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 72.05 14.33 5.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.829 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 84.5 mtt180 -117.12 149.22 40.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.585 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.0 m -71.28 -33.42 69.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.501 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -153.68 155.01 35.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.98 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.5 p -151.44 149.88 29.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.978 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.56 126.66 75.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 46' ' ' ILE . 44.0 t -137.34 144.03 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -85.8 122.15 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.373 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -66.81 23.56 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . -179.59 173.09 44.95 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.935 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.606 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.7 t 94.79 -155.55 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -66.32 -11.19 49.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.008 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.97 -18.47 60.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.55 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.527 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.5 m-85 -141.47 131.22 12.76 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.575 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 111' ' ' PHE . 36.1 Cg_exo -50.64 -156.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.404 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.13 95.63 10.52 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.769 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -82.98 -50.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.657 2.238 . . . . 0.0 113.564 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.478 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 11.2 p -133.05 84.8 47.56 Favored Pre-proline 0 N--CA 1.466 0.36 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.098 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.02 136.1 50.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.08 1.853 . . . . 0.0 112.328 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.6 -4.8 47.22 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.361 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.2 m -114.4 149.3 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.169 0.984 . . . . 0.0 108.655 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.564 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 7.3 t80 -85.09 98.99 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 18.6 mttt -76.05 -165.61 0.49 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.918 1.342 . . . . 0.0 113.363 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' HB2' HD21 ' A' ' 39' ' ' LEU . 8.4 p90 -167.83 167.46 12.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.251 -2.25 . . . . 0.0 109.769 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 25.9 tp -127.76 123.33 35.04 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.549 ' CD ' ' OE1' ' A' ' 125' ' ' GLN . 3.4 tm-20 -117.61 129.42 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.11 119.65 41.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.549 ' OE1' ' CD ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -102.69 127.8 49.67 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.011 ' CD1' HG23 ' A' ' 56' ' ' ILE . 18.6 p90 -154.77 170.48 21.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.58 0.705 . . . . 0.0 112.517 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.438 ' H ' ' HG3' ' A' ' 57' ' ' MET . 97.6 m-20 -128.13 163.34 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.779 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.458 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 92.6 m -109.46 114.51 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.367 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.64 151.02 47.9 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 N--CA 1.491 1.33 0 C-N-CA 121.587 1.525 . . . . 0.0 112.342 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.529 ' CZ ' ' H ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.467 HH11 ' HD3' ' A' ' 37' ' ' ARG . 37.9 ttp-105 -149.93 137.56 20.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.318 0.58 . . . . 0.0 111.024 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 57.4 mp0 -134.51 146.04 49.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -138.1 137.59 37.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.014 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.672 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.41 143.74 34.09 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.883 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.0 m -70.54 133.96 47.24 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -42.21 136.54 2.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.876 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.12 74.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.094 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.69 149.88 45.89 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-N 119.118 1.459 . . . . 0.0 112.02 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.83 137.61 64.01 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.124 2.549 . . . . 0.0 113.06 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -120.06 142.36 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.631 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.3 tt0 -130.03 129.25 43.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.611 -0.835 . . . . 0.0 113.224 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.456 HD12 ' SG ' ' A' ' 96' ' ' CYS . 30.6 mt -109.93 145.75 36.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.631 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 46.4 mtt85 -148.14 132.27 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.591 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.424 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -98.16 144.33 27.87 Favored Pre-proline 0 N--CA 1.455 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 56.9 Cg_endo -71.1 159.31 52.64 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.215 2.61 . . . . 0.0 112.593 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.46 -120.08 12.6 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.782 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -125.73 26.44 6.67 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.747 0.308 . . . . 0.0 110.996 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -77.41 169.97 17.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.509 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.76 143.09 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.116 HG23 ' CD2' ' A' ' 126' ' ' TYR . 78.0 mt -69.74 140.36 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.586 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.421 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.0 ptp -133.84 100.51 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.637 HG12 ' HE1' ' A' ' 89' ' ' PHE . 17.4 t -64.89 127.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.445 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.57 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 76.6 mt-10 -104.25 -49.64 3.54 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.794 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.7 m-20 -147.42 145.47 29.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.089 0.471 . . . . 0.0 110.725 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.0 154.74 9.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.967 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -152.08 156.79 40.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.286 0.565 . . . . 0.0 111.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 70.3 t80 -125.62 119.68 28.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 120' ' ' LYS . . . 156.66 -136.74 5.11 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.69 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 9.2 ttm-85 -154.94 118.03 4.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.329 0.585 . . . . 0.0 112.063 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 p -124.73 6.07 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.356 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 56.1 t0 -146.7 154.81 41.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.955 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 51.7 p30 -113.05 2.59 15.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.458 ' O ' HD13 ' A' ' 70' ' ' ILE . 18.5 mttt -104.6 5.99 34.18 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.944 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 69' ' ' LYS . 27.7 mm -115.69 139.65 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.624 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.3 m 53.77 71.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 39.2 p-10 -54.09 128.55 31.19 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 111.599 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -144.31 -165.87 2.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.282 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.692 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -61.88 142.48 94.97 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.249 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.16 -35.35 95.12 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.241 1.961 . . . . 0.0 112.827 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.6 -33.88 75.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.957 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.573 ' O ' HG23 ' A' ' 118' ' ' THR . 75.3 mt-30 -89.01 6.64 38.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.92 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.4 mtp -125.73 -3.96 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 39.1 mm-40 -61.54 -45.94 92.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.951 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -83.03 113.27 20.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.478 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 21.3 m -104.16 33.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.316 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.478 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 30.8 mm100 -138.69 85.6 2.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 41.5 t -148.53 122.47 9.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.6 m-85 -131.86 154.14 49.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.14 86.43 7.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.334 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -46.88 -45.98 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.029 2.486 . . . . 0.0 113.162 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 75.7 m-20 -53.01 -29.45 29.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.35 -31.41 33.43 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.573 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.637 ' HE1' HG12 ' A' ' 58' ' ' VAL . 50.9 t80 -67.9 -47.89 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 pttp -64.1 -41.91 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.395 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 70.6 mt -59.53 -48.69 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.051 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.939 ' SD ' HD21 ' A' ' 122' ' ' LEU . 46.0 mtp -70.84 -34.85 72.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.77 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.515 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 23.6 m -57.42 -42.97 83.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.831 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.52 -37.85 87.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.598 HH21 ' HG2' ' A' ' 92' ' ' MET . 36.8 mtm180 -76.38 -30.58 57.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.456 ' SG ' HD12 ' A' ' 48' ' ' LEU . 75.5 m -112.6 -21.42 11.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.515 ' CG ' ' O ' ' A' ' 93' ' ' SER . 69.4 m-20 -55.51 135.64 50.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.984 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 64.05 13.54 7.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.669 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -115.97 147.93 40.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.366 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.1 m -71.63 -33.93 69.35 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.795 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.02 159.23 40.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.278 0.561 . . . . 0.0 110.867 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.6 p -155.5 138.85 15.76 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.701 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' A' ' 47' ' ' GLU . 21.8 t -120.19 126.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 64.6 t -143.64 146.04 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -75.11 117.67 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.57 42.79 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 175.22 -127.25 1.25 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 35.82 -150.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.129 -0.536 . . . . 0.0 111.381 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.45 -9.62 13.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.12 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.487 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -76.85 -17.23 59.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.169 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.2 m-85 -139.7 130.51 14.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.794 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.7 Cg_exo -52.01 -153.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.459 2.106 . . . . 0.0 112.423 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -137.19 93.71 12.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.44 -51.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 123.034 2.489 . . . . 0.0 113.283 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.403 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.4 p -131.62 79.54 68.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.391 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -62.91 138.86 70.73 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.53 2.154 . . . . 0.0 112.53 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.55 -2.54 49.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.898 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 77' ' ' GLN . 95.1 m -120.5 148.85 43.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.106 0.453 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.615 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.1 t80 -86.3 96.68 10.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.465 ' CD ' ' CE2' ' A' ' 63' ' ' TYR . 37.0 mttt -68.12 -156.33 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.217 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.4 p90 -176.38 168.58 2.76 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 112.665 -2.061 . . . . 0.0 109.37 176.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.939 HD21 ' SD ' ' A' ' 92' ' ' MET . 12.9 tp -129.7 122.79 29.64 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.495 ' OE2' ' NE2' ' A' ' 125' ' ' GLN . 78.2 tt0 -117.77 131.2 56.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.797 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.95 119.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.495 ' NE2' ' OE2' ' A' ' 123' ' ' GLU . 5.1 mp0 -105.04 124.55 49.73 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.116 ' CD2' HG23 ' A' ' 56' ' ' ILE . 23.8 p90 -154.22 166.97 31.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.715 0.769 . . . . 0.0 112.055 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.459 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 83.5 m-20 -123.31 162.0 23.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.259 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.529 ' H ' ' CZ ' ' A' ' 36' ' ' ARG . 86.4 m -110.38 119.69 40.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.906 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.1 m -117.59 156.52 49.32 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.481 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.485 1.004 0 C-N-CA 121.598 1.532 . . . . 0.0 111.078 178.58 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.486 ' NH2' ' HG3' ' A' ' 51' ' ' PRO . 4.2 mtt-85 . . . . . 0 C--O 1.232 0.18 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 37' ' ' ARG . 13.0 ttt180 -142.28 136.66 29.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.096 0.475 . . . . 0.0 110.387 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' HG2' HD23 ' A' ' 48' ' ' LEU . 58.2 mp0 -133.65 143.56 48.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.533 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -139.42 136.27 34.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.512 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.736 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.84 144.95 32.72 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.447 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 25.6 m -71.21 133.68 46.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 9.2 tt0 -45.07 140.91 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.486 0.66 . . . . 0.0 112.511 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 94.12 -12.15 69.55 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.71 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.9 m-85 -116.74 155.64 48.75 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 118.405 1.103 . . . . 0.0 110.051 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.55 146.86 31.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.475 2.117 . . . . 0.0 113.948 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 104' ' ' VAL . 11.4 tt -118.57 145.82 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.913 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -126.64 127.81 45.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.884 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.679 HD12 ' SG ' ' A' ' 102' ' ' CYS . 44.9 mt -112.93 145.11 41.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -150.79 131.84 14.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.77 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -100.03 145.77 30.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.685 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.486 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 43.5 Cg_endo -72.35 160.38 47.1 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.462 2.108 . . . . 0.0 113.073 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.15 -130.68 28.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -107.43 24.45 12.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.34 166.55 22.53 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.829 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 m -127.46 143.38 40.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.113 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.827 HG23 ' CD1' ' A' ' 126' ' ' TYR . 95.3 mt -67.08 138.09 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.622 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -130.41 98.38 4.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.22 123.72 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.38 -48.25 4.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.5 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -147.6 145.6 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.254 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.665 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.64 151.1 9.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -150.4 152.34 34.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.929 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.503 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 66.4 t80 -122.65 125.25 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.468 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.89 -136.31 4.99 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.589 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 6.1 ttm180 -156.6 117.98 3.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.006 0.432 . . . . 0.0 111.127 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.553 ' HG1' ' HH ' ' A' ' 121' ' ' TYR . 26.2 p -124.69 7.7 8.19 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.73 152.68 40.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.517 ' O ' ' HE1' ' A' ' 78' ' ' MET . 20.9 p-10 -109.68 -0.36 18.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.333 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -106.37 8.74 31.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.116 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.5 mm -114.31 139.81 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.569 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.6 m 57.48 64.75 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -46.93 120.82 3.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.813 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -139.52 -167.08 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.933 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -63.02 142.51 97.68 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.037 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.58 -36.09 79.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 121.784 1.656 . . . . 0.0 112.762 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -64.59 -33.77 76.7 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.681 ' O ' HG23 ' A' ' 118' ' ' THR . 81.4 mt-30 -84.04 -12.62 54.88 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.828 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.517 ' HE1' ' O ' ' A' ' 68' ' ' ASP . 66.4 mtp -103.95 -2.18 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 52.6 mm-40 -58.96 -53.2 61.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.806 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -80.43 122.52 27.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.01 28.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.058 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -143.73 90.64 2.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -145.79 120.93 10.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.663 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 5.9 m-85 -128.75 153.02 47.79 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.616 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.747 HD21 ' HG2' ' A' ' 112' ' ' PRO . 13.7 tp -146.08 91.2 5.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.705 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -49.24 -46.27 26.59 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.228 2.619 . . . . 0.0 113.751 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 23.9 m-20 -53.74 -22.31 8.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.03 -33.49 57.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.763 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -64.8 -44.46 89.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.166 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.9 pttt -65.86 -40.07 91.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.983 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.527 HG23 ' NH1' ' A' ' 95' ' ' ARG . 79.5 mt -60.49 -51.39 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.861 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.445 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 93.0 mmm -68.17 -37.0 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.569 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.45 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 60.9 m -60.31 -44.26 95.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.117 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -65.44 -37.94 88.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.295 0.569 . . . . 0.0 110.665 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.553 HH11 ' HG3' ' A' ' 95' ' ' ARG . 51.4 mtt85 -76.26 -33.3 59.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.8 m -111.94 -15.16 13.39 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 70.2 m-20 -62.72 135.21 57.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.634 -0.827 . . . . 0.0 111.669 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 64.99 11.48 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt-85 -112.71 145.5 40.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 110.595 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.9 m -72.76 -31.28 64.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.479 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.13 155.23 38.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.262 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.679 ' SG ' HD12 ' A' ' 48' ' ' LEU . 29.3 p -153.76 139.7 18.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.882 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.0 t -119.06 131.05 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 46' ' ' ILE . 17.6 t -141.99 152.01 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.425 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.81 120.79 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.71 38.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.362 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.84 -125.7 0.98 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.175 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 31.36 -158.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.257 0.551 . . . . 0.0 112.022 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.72 -10.52 19.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.627 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.83 59.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.089 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.5 m-85 -142.51 132.72 12.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.366 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.747 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.6 Cg_exo -49.95 -159.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -139.01 86.44 15.01 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.474 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.544 ' HD2' ' HZ3' ' A' ' 120' ' ' LYS . 66.8 Cg_endo -79.32 -29.0 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.718 2.279 . . . . 0.0 113.136 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.1 p -155.67 83.84 3.54 Favored Pre-proline 0 C--N 1.332 -0.155 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.688 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.02 140.87 42.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.94 1.76 . . . . 0.0 112.039 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.54 -2.02 46.03 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.372 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.1 m -117.61 147.02 43.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 8.9 t80 -84.61 98.2 10.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.544 ' HZ3' ' HD2' ' A' ' 114' ' ' PRO . 21.3 mtmt -77.58 -166.78 0.81 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.469 1.128 . . . . 0.0 113.401 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.553 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 40.0 p90 -167.32 168.6 13.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.621 -2.082 . . . . 0.0 110.321 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.3 tp -127.02 124.93 40.52 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' CD ' ' HE ' ' A' ' 37' ' ' ARG . 15.3 tp10 -117.22 128.23 54.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.066 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.665 HG22 ' HB1' ' A' ' 61' ' ' ALA . 41.5 t -135.79 125.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.262 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.83 130.72 55.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.827 ' CD1' HG23 ' A' ' 56' ' ' ILE . 27.5 p90 -153.82 173.24 16.15 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.089 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -124.78 158.83 32.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.352 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.5 m -105.95 119.43 39.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.49 158.11 68.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.66 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 N--CA 1.493 1.478 0 C-N-CA 122.096 1.864 . . . . 0.0 112.06 179.445 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 49' ' ' ARG . 70.8 mtp180 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -156.09 137.99 14.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.893 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -127.06 149.96 49.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.204 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -138.83 142.21 38.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.836 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -144.29 144.96 31.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.356 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 7.6 m -71.55 134.6 46.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 110.436 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 87.2 tt0 -43.24 138.51 2.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.134 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.66 -7.65 77.21 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.816 -1.084 . . . . 0.0 114.298 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.56 153.91 50.55 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 119.068 1.434 . . . . 0.0 110.909 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.84 140.84 47.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.589 2.192 . . . . 0.0 113.748 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 14.1 tt -116.84 146.36 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.604 ' HG3' HG22 ' A' ' 103' ' ' VAL . 78.7 tt0 -126.2 127.77 46.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.095 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.668 HD12 ' SG ' ' A' ' 102' ' ' CYS . 50.1 mt -115.88 138.55 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.545 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 18.8 mtp180 -146.5 133.51 20.3 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.283 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -98.66 136.72 20.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.86 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.522 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 55.6 Cg_endo -70.25 158.29 56.78 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.415 2.077 . . . . 0.0 111.458 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.23 -141.41 30.33 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.652 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.0 p -98.63 22.2 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -78.88 165.09 23.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.7 0.286 . . . . 0.0 110.86 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.57 148.69 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.534 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.795 HG23 ' CD2' ' A' ' 126' ' ' TYR . 78.5 mt -71.19 136.06 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.653 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.36 101.8 5.12 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.43 127.04 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.457 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 71.3 mm-40 -103.92 -48.29 3.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.816 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 65.1 m-20 -148.49 145.76 28.07 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.13 154.23 7.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.851 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.509 HD21 ' HA ' ' A' ' 84' ' ' TYR . 6.0 t30 -150.24 151.99 33.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.37 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.626 ' CD2' ' CG ' ' A' ' 111' ' ' PHE . 54.9 t80 -118.4 121.09 39.5 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.6 -135.33 4.54 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.382 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.525 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 10.5 ttm-85 -156.55 117.53 3.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 111.362 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.475 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 23.6 p -122.87 9.44 9.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.071 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 15.2 t0 -147.2 -178.22 6.1 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.135 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 69' ' ' LYS . 54.7 p30 -138.36 -0.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.065 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 20.4 mttp -102.65 2.83 36.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.844 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.67 137.7 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.019 0.437 . . . . 0.0 110.855 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.4 m 54.63 70.79 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.14 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.0 p30 -52.09 125.95 17.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.923 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -143.91 -163.61 1.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 142.64 98.21 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.301 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.7 Cg_endo -54.44 -35.93 86.41 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.952 1.768 . . . . 0.0 112.008 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -63.87 -37.18 86.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 118' ' ' THR . 81.2 mt-30 -83.46 -9.72 58.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.359 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.9 mtp -106.04 -0.92 24.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 76.2 mt-10 -60.47 -53.04 62.33 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.08 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 48.9 t30 -76.54 117.46 18.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.578 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.0 m -107.71 29.42 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.832 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.8 mm-40 -141.01 85.37 1.98 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.389 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.428 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 44.8 t -146.94 124.23 11.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.509 ' HA ' HD21 ' A' ' 62' ' ' ASN . 58.1 m-85 -133.54 159.04 41.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' A' ' 112' ' ' PRO . 12.7 tp -147.73 94.99 4.3 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.18 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.48 -43.83 31.82 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.825 2.35 . . . . 0.0 114.06 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 65.4 m-20 -61.16 -23.68 65.74 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.59 62.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.928 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.569 ' O ' ' OG ' ' A' ' 93' ' ' SER . 17.3 t80 -67.12 -47.73 70.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.069 0.461 . . . . 0.0 112.087 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 pttm -67.23 -41.22 86.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.965 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.61 HG22 HH21 ' A' ' 95' ' ' ARG . 69.7 mt -61.39 -47.41 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.795 ' SD ' ' NH1' ' A' ' 95' ' ' ARG . 96.2 mmm -66.97 -36.13 81.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.7 ' HB3' HD22 ' A' ' 97' ' ' ASN . 5.1 m -60.88 -42.11 97.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.93 -36.82 85.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 111.245 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 1.124 ' NH1' HG11 ' A' ' 104' ' ' VAL . 20.8 mtm180 -76.17 -33.34 59.34 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.418 ' SG ' HD12 ' A' ' 48' ' ' LEU . 36.2 m -113.66 -14.02 12.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.7 HD22 ' HB3' ' A' ' 93' ' ' SER . 44.6 m-20 -58.58 136.88 57.71 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.807 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 67.04 14.37 9.8 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.017 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -116.49 147.01 42.16 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.306 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.5 m -73.76 -31.93 63.57 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.086 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.28 153.37 37.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.449 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.1 p -156.75 131.33 8.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.604 HG22 ' HG3' ' A' ' 47' ' ' GLU . 22.4 t -121.72 125.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.124 HG11 ' NH1' ' A' ' 95' ' ' ARG . 91.5 t -141.94 146.4 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.441 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.5 120.23 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.98 41.76 0.06 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.82 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 108' ' ' SER . . . 179.3 -130.66 1.55 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.353 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 107' ' ' GLY . 5.9 t 31.58 -146.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.019 0.438 . . . . 0.0 110.943 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.05 -10.27 13.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.14 -21.76 53.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.265 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.626 ' CG ' ' CD2' ' A' ' 63' ' ' TYR . 36.1 m-85 -138.26 128.98 15.46 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.494 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.8 Cg_exo -52.18 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.855 1.703 . . . . 0.0 111.645 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -140.06 80.39 20.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.296 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.57 -19.89 18.5 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.572 2.181 . . . . 0.0 113.171 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.629 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.8 p -157.12 80.37 3.45 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.484 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -65.95 139.23 55.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.122 1.881 . . . . 0.0 111.698 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.14 -3.16 47.63 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.576 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.1 m -120.29 145.62 46.9 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.641 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 15.7 t80 -84.74 96.95 9.41 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.629 ' NZ ' ' O ' ' A' ' 115' ' ' CYS . 20.3 mtmm -71.47 -165.97 0.17 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.576 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.635 ' HB2' HD21 ' A' ' 39' ' ' LEU . 9.0 p90 -168.16 169.27 11.11 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 62' ' ' ASN . 40.6 tp -128.02 123.64 35.19 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -116.55 127.41 54.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.137 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.19 121.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.346 -0.941 . . . . 0.0 112.535 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.56 127.72 52.35 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.795 ' CD2' HG23 ' A' ' 56' ' ' ILE . 36.0 p90 -152.32 168.8 24.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.317 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -126.73 162.62 25.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.424 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 86.1 m -113.61 113.89 25.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 0.0 110.239 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 m -115.19 156.88 44.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo . . . . . 0 C--N 1.312 -1.376 0 C-N-CA 121.594 1.529 . . . . 0.0 110.942 178.407 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 . . . . . 0 C--O 1.233 0.19 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.555 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 40.2 ttt-85 -147.73 141.09 25.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.441 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -130.06 145.61 51.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.554 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.7 tt -139.31 137.93 36.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.585 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.7 144.14 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.873 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.68 130.41 43.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.568 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.495 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 31.0 tt0 -41.39 136.87 1.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.324 0.583 . . . . 0.0 112.183 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.09 76.75 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.084 -0.962 . . . . 0.0 114.179 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -115.48 152.56 47.19 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 118.896 1.348 . . . . 0.0 111.193 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 19.1 Cg_endo -69.88 139.9 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.02 1.813 . . . . 0.0 112.341 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 tt -115.19 147.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.657 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 40.8 tt0 -126.83 129.17 47.76 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.185 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.655 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.6 mt -115.87 138.86 50.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.657 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 91.1 mtt180 -144.09 132.68 22.27 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.931 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -100.3 138.89 20.32 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.215 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.08 157.83 53.49 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.367 2.045 . . . . 0.0 111.612 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.1 38.28 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.9 p -103.1 25.11 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.333 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.52 164.2 24.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.088 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.64 146.24 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.752 HG23 ' CD2' ' A' ' 126' ' ' TYR . 70.4 mt -69.31 134.63 29.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.162 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.5 ptp -129.39 97.76 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.623 HG12 ' HE1' ' A' ' 89' ' ' PHE . 32.7 t -61.7 125.26 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.955 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.509 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 79.7 mm-40 -101.35 -49.84 3.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.745 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.1 m-20 -152.27 150.61 29.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -169.66 156.59 6.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.647 ' O ' HD12 ' A' ' 122' ' ' LEU . 13.5 t30 -151.36 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.528 0.68 . . . . 0.0 111.606 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.649 ' HB3' HD23 ' A' ' 85' ' ' LEU . 35.9 t80 -123.01 120.33 33.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.69 -140.42 6.91 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.416 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.666 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 5.3 ttm180 -157.55 118.27 3.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 0.0 111.978 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.548 ' HG1' ' HH ' ' A' ' 121' ' ' TYR . 72.7 p -125.76 7.42 7.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.401 0.62 . . . . 0.0 109.704 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 54.6 t0 -146.43 154.13 41.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.4 p30 -114.17 3.1 15.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 110.424 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 87.1 mttt -104.6 4.64 33.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.774 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.4 mm -110.84 137.58 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.6 m 55.95 62.94 2.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -44.61 121.0 2.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -140.41 -166.81 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.355 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.618 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -62.55 133.58 94.81 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.437 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -51.78 -34.78 56.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.181 1.921 . . . . 0.0 113.224 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.8 -37.1 85.37 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.589 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 81.7 mt-30 -80.12 -17.89 51.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.254 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.666 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 7.9 mtm -102.18 1.39 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 55.3 mm-40 -61.97 -47.59 84.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.699 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.55 114.39 19.41 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 66' ' ' THR . 15.6 m -104.34 34.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.944 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -143.95 88.07 1.95 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.944 0.402 . . . . 0.0 111.739 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.475 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.0 t -147.39 122.78 10.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.52 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.6 m-85 -126.02 153.81 43.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 111.796 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' A' ' 63' ' ' TYR . 46.3 tp -147.92 85.94 6.33 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.92 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.82 -49.35 16.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.919 2.412 . . . . 0.0 113.061 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.5 m-20 -49.13 -30.35 6.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -32.8 53.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.822 0.344 . . . . 0.0 111.11 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.623 ' HE1' HG12 ' A' ' 58' ' ' VAL . 59.3 t80 -65.08 -41.89 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 34.2 pttt -65.86 -40.67 91.88 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.806 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.3 mt -60.27 -48.75 86.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.868 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -70.03 -36.61 75.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.114 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.486 ' HB3' HD21 ' A' ' 97' ' ' ASN . 19.8 m -58.79 -47.61 84.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.549 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -65.1 -35.93 82.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.05 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.631 HH12 ' HB1' ' A' ' 110' ' ' ALA . 99.5 mtt180 -79.9 -30.57 40.11 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.0 m -112.43 -20.18 11.88 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.486 HD21 ' HB3' ' A' ' 93' ' ' SER . 89.4 m-20 -58.25 135.87 57.21 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.8 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 64.53 13.06 7.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.851 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 95' ' ' ARG . 75.0 mtp180 -114.02 145.66 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.2 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.4 m -71.79 -30.98 66.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.454 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.44 152.8 31.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.655 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.6 p -151.91 141.76 21.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.48 128.96 75.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.809 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.553 ' CG1' HH11 ' A' ' 95' ' ' ARG . 22.6 t -144.7 147.58 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.229 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -78.71 118.39 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.903 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.94 41.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.8 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 175.54 -123.04 0.9 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.178 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.6 t 31.04 -157.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.911 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.94 -9.58 22.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.851 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.631 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -75.72 -9.39 58.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.524 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.8 m-85 -144.0 133.54 11.61 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.858 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 44.9 Cg_exo -49.62 -161.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.925 1.75 . . . . 0.0 111.334 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -139.29 97.6 8.49 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.042 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.25 -58.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.847 2.364 . . . . 0.0 112.725 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.422 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 8.4 p -126.56 80.37 69.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.177 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -64.71 137.82 55.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.79 1.66 . . . . 0.0 111.942 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.52 -13.75 22.9 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.737 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -111.09 151.74 27.73 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.258 0.529 . . . . 0.0 109.983 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.587 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.5 t80 -85.63 96.96 9.84 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.474 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 12.6 mttp -76.4 -161.19 0.17 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.729 1.252 . . . . 0.0 113.125 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 5.6 p90 -168.93 171.17 8.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.955 -1.93 . . . . 0.0 110.732 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 62' ' ' ASN . 35.9 tp -129.86 123.52 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.555 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 69.9 tt0 -118.65 129.42 55.29 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.421 HG22 ' HB1' ' A' ' 61' ' ' ALA . 43.2 t -131.46 121.74 48.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.965 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.37 129.1 53.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.752 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.9 p90 -152.69 167.36 29.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.307 0.575 . . . . 0.0 111.896 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.441 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 96.8 m-20 -123.51 159.56 28.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.066 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.6 m -114.47 107.43 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -111.08 158.06 36.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo . . . . . 0 C--N 1.312 -1.384 0 C-N-CA 121.962 1.775 . . . . 0.0 111.912 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -149.7 137.33 20.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.41 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.448 ' HB3' HD11 ' A' ' 46' ' ' ILE . 57.9 mm-40 -134.86 148.98 50.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.901 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -140.28 144.46 36.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.254 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.908 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -145.97 145.33 30.6 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.108 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.7 m -66.2 131.08 45.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.725 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -42.24 132.04 3.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.685 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.5 76.38 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.065 -0.97 . . . . 0.0 113.252 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -118.06 151.09 48.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 118.238 1.019 . . . . 0.0 110.309 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.94 139.7 33.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.616 2.211 . . . . 0.0 113.384 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 38' ' ' GLU . 20.7 tt -114.65 140.64 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -117.51 132.3 56.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.689 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' GLN . 10.7 mt -114.87 142.22 46.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.401 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -149.8 134.84 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.646 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.457 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.5 m -102.15 142.76 25.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.932 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 44.3 Cg_endo -69.73 156.44 63.41 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.846 2.364 . . . . 0.0 112.01 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.08 -127.9 29.58 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.241 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 p -110.59 23.9 13.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.039 -0.58 . . . . 0.0 111.303 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -79.34 169.34 18.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.74 146.88 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.413 0.625 . . . . 0.0 110.598 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.671 HG23 ' CD1' ' A' ' 126' ' ' TYR . 85.5 mt -68.18 137.19 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.063 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.1 ptm -132.34 100.81 5.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.641 HG23 ' OD1' ' A' ' 97' ' ' ASN . 41.1 t -64.54 125.38 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.667 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.94 -48.91 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -153.48 150.35 28.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.444 0.64 . . . . 0.0 110.417 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -170.53 156.18 5.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.595 ' O ' HD12 ' A' ' 122' ' ' LEU . 8.8 t30 -150.58 154.9 38.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.785 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 33.9 t80 -117.31 117.47 29.62 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.65 -137.71 5.35 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.498 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.685 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -160.61 121.83 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.368 0.604 . . . . 0.0 112.036 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 HG21 ' CE1' ' A' ' 84' ' ' TYR . 8.1 p -124.2 8.9 8.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.54 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.622 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 49.4 t0 -143.6 -170.14 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.834 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.574 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 22.3 p30 -148.17 -0.4 0.59 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.745 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -104.56 7.57 35.2 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.0 mm -108.51 135.6 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.6 m 55.58 69.95 0.68 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 34.4 p30 -48.39 111.87 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.62 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.29 -162.18 1.18 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.766 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -64.18 141.37 98.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.473 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.6 Cg_endo -55.95 -38.95 93.93 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.393 2.062 . . . . 0.0 112.904 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.81 -34.48 77.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.048 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.766 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 72.3 mt-30 -87.23 -11.96 48.18 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.302 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.477 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.4 mmm -100.59 -3.98 29.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.372 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 21.6 mt-10 -66.9 -47.57 71.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.9 t30 -79.31 119.81 22.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.752 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.4 33.3 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.782 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -141.63 86.9 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.312 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 51.3 t -149.8 120.85 7.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.886 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.559 ' CE1' HG21 ' A' ' 66' ' ' THR . 97.3 m-85 -131.24 149.57 52.51 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.913 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' A' ' 63' ' ' TYR . 38.1 tp -138.42 90.85 12.88 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.32 -47.76 25.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.657 2.238 . . . . 0.0 113.364 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 69.4 m-20 -54.33 -23.74 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.03 54.44 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.938 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 58' ' ' VAL . 61.5 t80 -65.05 -43.43 92.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.82 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 15.5 pttm -64.44 -39.99 94.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.293 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.642 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 72.3 mt -58.55 -50.53 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.023 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.412 ' HE3' ' SG ' ' A' ' 96' ' ' CYS . 93.8 mmm -68.43 -35.47 77.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.062 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.479 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.4 m -58.1 -48.49 80.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.355 0.597 . . . . 0.0 110.647 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -67.7 -37.51 82.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.642 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 66.8 mtt-85 -76.61 -36.4 57.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.412 ' SG ' ' HE3' ' A' ' 92' ' ' MET . 4.7 m -114.16 -20.74 10.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.641 ' OD1' HG23 ' A' ' 58' ' ' VAL . 46.5 m-20 -59.36 139.87 56.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.683 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 23.5 m-20 70.6 15.04 7.18 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.956 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -119.17 149.9 40.96 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.048 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 m -70.48 -32.92 70.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -144.81 158.77 43.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.848 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 29.9 t -155.15 142.81 19.78 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.317 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.0 129.11 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.133 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 t -145.33 142.59 22.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.272 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.0 t -77.02 119.15 24.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.382 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.05 30.94 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.055 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 177.95 175.99 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.652 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 3.1 t 95.95 -158.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.266 0.555 . . . . 0.0 110.872 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.78 -8.56 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.365 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.499 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -82.01 -11.47 58.81 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.073 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.2 m-85 -140.62 126.43 11.48 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.976 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.602 ' O ' ' O ' ' A' ' 111' ' ' PHE . 51.0 Cg_exo -46.24 -159.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.792 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.45 93.23 12.86 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.264 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.89 -55.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.222 2.615 . . . . 0.0 112.991 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.473 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 26.5 p -127.47 90.3 48.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.508 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.37 140.03 47.17 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.897 2.398 . . . . 0.0 111.814 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.05 4.62 56.57 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.735 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.4 m -127.71 146.53 50.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.565 0.682 . . . . 0.0 109.351 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.685 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 29.3 t80 -86.52 99.14 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.473 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 23.0 mttt -73.35 -156.22 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.436 1.112 . . . . 0.0 113.645 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -175.41 174.94 2.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.753 -2.022 . . . . 0.0 110.105 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 62' ' ' ASN . 16.9 tp -131.9 123.52 27.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.265 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.7 tt0 -115.18 128.34 56.12 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.14 118.27 40.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.723 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.34 129.17 54.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.671 ' CD1' HG23 ' A' ' 56' ' ' ILE . 40.3 p90 -153.26 171.48 18.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.444 0.64 . . . . 0.0 111.774 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -129.6 160.82 32.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.204 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 86.2 m -110.38 123.79 50.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.74 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.83 157.4 63.19 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.115 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo . . . . . 0 N--CA 1.499 1.795 0 C-N-CA 122.442 2.095 . . . . 0.0 112.316 179.821 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 36' ' ' ARG . 50.7 mtp85 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 60.5 ttp180 -148.85 135.99 20.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.501 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 28.6 mp0 -133.18 148.76 52.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.098 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.48 144.78 38.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.943 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -144.3 143.75 31.15 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.428 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.9 m -69.26 132.53 46.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.342 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.496 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 37.7 tt0 -44.63 139.95 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.21 -8.08 80.44 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.601 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -113.55 149.96 42.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 118.343 1.072 . . . . 0.0 110.878 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.49 139.58 49.59 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.636 2.224 . . . . 0.0 113.116 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 9.3 tt -118.42 146.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.725 ' CD ' HH21 ' A' ' 49' ' ' ARG . 88.1 tt0 -129.7 129.94 44.86 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.483 HD12 ' SG ' ' A' ' 96' ' ' CYS . 29.6 mt -114.17 146.67 40.03 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.725 HH21 ' CD ' ' A' ' 47' ' ' GLU . 84.1 mtt180 -147.17 136.24 22.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.192 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 137.01 19.14 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.156 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.92 158.81 56.44 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.498 2.132 . . . . 0.0 112.061 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.56 -130.62 34.7 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -108.43 26.01 10.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.608 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -79.85 165.19 22.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.916 0.389 . . . . 0.0 110.8 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 129' ' ' VAL . 31.0 m -127.74 145.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.054 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.002 HG23 ' CD1' ' A' ' 126' ' ' TYR . 84.9 mt -69.37 138.3 22.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.575 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.6 ptp -132.08 99.27 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG12 ' CE1' ' A' ' 89' ' ' PHE . 47.0 t -62.53 123.63 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.512 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.96 -47.73 3.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.738 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -146.27 142.45 28.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.547 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.57 154.0 11.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.675 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.787 ' O ' HD12 ' A' ' 122' ' ' LEU . 7.7 t30 -152.26 150.29 29.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 112.054 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.615 ' HB3' HD23 ' A' ' 85' ' ' LEU . 47.2 t80 -117.21 119.97 36.84 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.27 -138.41 5.86 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 10.6 ttm-85 -158.4 119.16 3.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.4 0.619 . . . . 0.0 111.378 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.563 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 32.3 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.349 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 16.0 t70 -146.99 -170.95 3.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.944 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 51.4 p30 -146.92 -2.06 0.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.521 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -102.88 5.15 38.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.86 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.9 mm -106.8 137.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.129 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.8 m 56.89 66.2 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.628 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.6 p-10 -47.98 121.34 4.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.592 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -143.79 -165.73 2.18 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.631 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -63.7 140.63 97.84 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.174 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.532 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -56.33 -36.91 97.61 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.983 2.455 . . . . 0.0 114.151 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -65.82 -32.71 74.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.487 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.527 ' OE1' ' OD2' ' A' ' 74' ' ' ASP . 50.4 mt-30 -88.82 10.43 21.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.691 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.4 mtm -132.82 0.9 3.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.398 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.6 mt-10 -63.16 -48.0 80.28 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.721 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -76.17 114.66 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 111.773 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.577 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 35.9 m -107.08 31.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.978 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 13.9 mm-40 -141.4 87.45 2.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 15.5 t -148.06 123.51 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.502 ' HA ' HD21 ' A' ' 62' ' ' ASN . 91.7 m-85 -127.86 151.96 48.42 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.55 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 63' ' ' TYR . 57.9 tp -146.95 85.73 6.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.092 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -45.89 -44.36 18.58 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.21 2.607 . . . . 0.0 114.665 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 51.1 m-20 -56.02 -24.76 41.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.04 -31.44 51.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' O ' ' OG ' ' A' ' 93' ' ' SER . 82.5 t80 -65.17 -47.36 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 12.6 pttp -64.82 -37.71 88.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.741 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 93.7 mt -61.79 -52.46 60.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.405 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.485 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 31.2 m -63.15 -47.54 82.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.016 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -68.08 -36.67 80.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 73.6 mtt180 -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 48' ' ' LEU . 82.7 m -110.52 -22.18 11.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 88.6 m-20 -57.54 134.02 55.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.399 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 66.89 9.79 7.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.038 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.621 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 62.4 mtt85 -111.97 146.43 37.85 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.253 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.4 m -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.547 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.21 156.01 34.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -154.65 142.4 19.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 59.6 t -123.58 123.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.078 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.572 HG13 ' NH1' ' A' ' 95' ' ' ARG . 45.2 t -138.08 145.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.33 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -77.78 118.49 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.28 41.59 0.05 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.646 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.78 -125.5 0.99 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.593 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 107' ' ' GLY . 32.5 t 31.06 -155.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 0.0 111.578 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.466 ' N ' ' OG ' ' A' ' 108' ' ' SER . 96.5 m-20 -65.17 -10.51 31.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.712 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.51 59.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.472 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.1 m-85 -142.19 130.27 11.66 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.061 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 48.4 Cg_exo -47.66 -157.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.713 2.276 . . . . 0.0 112.546 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -139.08 91.75 11.22 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.45 -46.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.509 2.139 . . . . 0.0 113.168 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.6 p -140.69 85.21 13.0 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.855 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -58.97 146.9 92.38 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.239 2.626 . . . . 0.0 111.728 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.98 63.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.324 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.0 m -130.98 144.36 51.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.3 t80 -86.54 96.66 10.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.458 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 24.1 mtmm -74.27 -168.49 0.66 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.927 1.346 . . . . 0.0 114.005 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.781 ' HB2' HD21 ' A' ' 39' ' ' LEU . 12.7 p90 -167.03 169.07 13.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.146 -2.297 . . . . 0.0 110.68 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 62' ' ' ASN . 58.9 tp -131.4 125.64 33.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.343 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.617 ' OE1' HD12 ' A' ' 39' ' ' LEU . 10.6 tp10 -118.48 131.28 56.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.895 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.547 HG22 ' HB1' ' A' ' 61' ' ' ALA . 44.0 t -135.39 123.07 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.39 126.76 52.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.829 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.002 ' CD1' HG23 ' A' ' 56' ' ' ILE . 34.9 p90 -153.78 168.35 26.59 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.743 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 92.6 m-20 -119.89 159.61 24.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.964 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 55.0 m -111.49 111.42 22.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.353 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 55' ' ' VAL . 5.1 m -115.72 156.45 46.29 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 N--CA 1.495 1.595 0 C-N-CA 122.124 1.882 . . . . 0.0 111.981 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.71 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 68.3 mtp85 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.593 ' HE ' ' CG ' ' A' ' 125' ' ' GLN . 40.8 ttm180 -147.08 132.57 18.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.539 0.685 . . . . 0.0 110.972 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.499 ' HG3' HD23 ' A' ' 48' ' ' LEU . 67.9 mm-40 -128.13 143.01 51.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.524 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.9 tt -139.24 137.97 36.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.795 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.673 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.6 142.88 32.21 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.124 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 31.0 m -67.89 138.1 55.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.935 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 13.8 tt0 -42.86 139.28 1.72 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.3 0.572 . . . . 0.0 112.512 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.99 -5.55 83.15 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.735 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -115.41 152.79 47.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 118.506 1.153 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.24 143.55 39.8 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 122.512 2.141 . . . . 0.0 113.461 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.02 143.64 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.654 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 88.0 tt0 -126.14 127.99 46.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.423 0.63 . . . . 0.0 111.698 -177.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.8 HD12 ' SG ' ' A' ' 102' ' ' CYS . 23.3 mt -113.57 140.75 47.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.71 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 97.4 mtt180 -144.79 131.23 19.76 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.828 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.2 m -100.65 146.63 32.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.27 157.28 37.5 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.343 2.028 . . . . 0.0 112.415 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 54.9 -133.98 47.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.166 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -107.2 25.3 11.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.114 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -78.65 165.98 23.04 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.94 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.45 145.78 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.488 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.847 HG23 ' CD2' ' A' ' 126' ' ' TYR . 77.9 mt -68.67 135.7 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.628 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.2 ptm -129.96 100.06 5.32 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.97 124.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.43 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -100.13 -51.2 3.74 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.441 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 40.6 m-80 -150.03 147.51 27.92 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.998 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.787 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -163.25 151.47 13.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.858 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.567 ' O ' HD12 ' A' ' 122' ' ' LEU . 4.5 t-20 -152.41 148.62 27.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.403 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 59.4 t80 -117.93 123.62 46.26 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.443 ' HA2' ' CD ' ' A' ' 120' ' ' LYS . . . 158.83 -139.6 6.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.616 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 5.1 ttm180 -157.11 116.79 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.442 . . . . 0.0 111.51 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.458 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 41.8 p -125.37 8.8 7.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.9 t0 -147.49 158.33 43.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p30 -115.23 3.17 14.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.697 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 16.8 mtpt -105.23 0.58 27.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.735 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.4 mm -113.14 138.46 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.4 m 59.81 61.18 1.98 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -51.96 125.98 16.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.004 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.44 -164.83 2.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.006 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -60.87 135.0 92.67 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 3.6 Cg_endo -52.3 -33.38 55.34 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.409 2.073 . . . . 0.0 113.934 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -34.88 79.05 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.616 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 41.0 mt-30 -89.08 12.59 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.524 ' HE1' ' O ' ' A' ' 68' ' ' ASP . 82.9 mtp -129.36 -3.81 4.9 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.082 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.0 mt-10 -59.99 -50.93 71.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.532 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -78.41 113.88 16.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 29.6 m -105.39 32.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.289 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.2 mm100 -141.05 87.95 2.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 31.5 t -146.54 122.88 10.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -129.97 152.05 49.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.941 0.4 . . . . 0.0 111.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.708 HD21 ' HG2' ' A' ' 112' ' ' PRO . 32.9 tp -144.63 90.43 6.45 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.968 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -48.78 -47.24 21.72 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.648 2.232 . . . . 0.0 113.743 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.2 m-20 -56.72 -29.13 62.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.38 -32.04 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.832 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 60' ' ' ASN . 74.0 t80 -64.46 -40.32 95.48 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 3.4 ptmt -66.54 -40.95 89.34 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.618 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.493 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 77.8 mt -59.88 -50.32 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.104 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.929 ' SD ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.03 -32.72 73.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.366 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 53.4 m -62.48 -47.15 85.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.676 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -67.46 -33.56 75.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 58.1 mtt180 -79.81 -32.11 40.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 48' ' ' LEU . 63.5 m -113.7 -16.36 12.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.559 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.5 m-20 -60.06 130.9 48.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.595 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 68.86 14.66 8.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.858 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt180 -115.05 146.74 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.274 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.2 m -72.2 -32.13 66.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.739 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -155.16 154.58 32.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.233 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.8 ' SG ' HD12 ' A' ' 48' ' ' LEU . 19.1 p -153.46 148.59 26.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.908 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.62 126.22 66.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.2 t -142.49 143.13 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.27 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 t -77.23 118.2 23.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -71.6 44.48 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.53 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.59 -124.92 0.93 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.689 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 28.13 -153.34 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 111.183 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.12 -10.15 20.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.077 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.0 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.292 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.3 m-85 -143.51 130.21 10.45 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.396 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.708 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.9 Cg_exo -47.74 -158.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.443 2.096 . . . . 0.0 112.479 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -138.81 91.91 11.54 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.68 -38.83 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.518 2.145 . . . . 0.0 113.14 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.05 84.4 11.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.674 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -65.6 139.84 60.07 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.259 2.639 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.5 -1.38 62.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.367 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.3 m -114.07 146.35 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.5 t80 -87.43 97.16 10.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 24.3 mtmm -74.58 -165.84 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.952 1.358 . . . . 0.0 114.251 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HB2' HD21 ' A' ' 39' ' ' LEU . 12.9 p90 -165.26 165.58 19.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.317 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.631 HD21 ' SD ' ' A' ' 92' ' ' MET . 25.7 tp -128.12 126.38 41.01 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.2 tt0 -124.82 127.55 47.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.753 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.929 HG21 ' SD ' ' A' ' 92' ' ' MET . 60.4 t -131.83 128.19 59.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.115 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.593 ' CG ' ' HE ' ' A' ' 37' ' ' ARG . 3.1 mp0 -109.83 132.15 54.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.327 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.847 ' CD2' HG23 ' A' ' 56' ' ' ILE . 42.4 p90 -156.84 171.71 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 57' ' ' MET . 73.2 m-20 -129.58 161.12 31.25 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.791 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.8 m -113.33 124.62 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.677 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.9 157.36 60.38 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.142 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo . . . . . 0 C--N 1.311 -1.4 0 C-N-CA 121.641 1.561 . . . . 0.0 111.272 178.931 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HD2' HH11 ' A' ' 36' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -146.76 136.22 22.87 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.109 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' CB ' HD11 ' A' ' 46' ' ' ILE . 68.1 mm-40 -130.14 147.35 51.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.557 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.1 tt -139.61 134.97 32.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.63 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.52 147.37 45.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.406 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -67.67 131.52 45.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 61.4 tt0 -42.14 138.47 1.62 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.601 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.52 79.2 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.611 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.55 147.46 40.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 118.52 1.16 . . . . 0.0 110.493 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.08 137.81 45.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.758 2.306 . . . . 0.0 112.605 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.483 HD11 ' CB ' ' A' ' 38' ' ' GLU . 17.5 tt -111.23 148.36 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -127.78 127.72 44.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.003 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.5 mt -116.83 144.83 44.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.363 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -149.23 133.65 17.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.22 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.5 m -99.88 138.74 20.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.162 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -66.94 161.35 42.84 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.65 2.233 . . . . 0.0 113.244 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.7 -136.4 13.65 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 p -97.43 23.51 7.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.821 -0.69 . . . . 0.0 110.407 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -79.39 161.3 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.782 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.8 143.4 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.165 0.507 . . . . 0.0 110.396 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.84 HG23 ' CD2' ' A' ' 126' ' ' TYR . 93.6 mt -68.67 139.97 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.447 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 2.0 ptp -135.15 103.25 5.47 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.912 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.615 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.4 t -63.88 124.62 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.248 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -102.59 -51.34 3.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.91 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -150.27 145.43 26.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.578 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.36 154.73 7.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.401 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.671 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.4 t30 -152.41 153.44 33.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.286 0.565 . . . . 0.0 111.559 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.567 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 50.1 t80 -118.81 124.34 46.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.11 -141.92 8.39 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.529 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.531 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 11.1 ttm-85 -151.71 115.56 4.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.313 0.578 . . . . 0.0 110.724 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.479 HG21 ' CE2' ' A' ' 84' ' ' TYR . 13.5 p -121.07 6.8 10.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.83 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 11.7 t70 -142.9 -169.62 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.698 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.496 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 40.9 p-10 -150.55 -2.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 110.41 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -100.44 4.94 44.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.79 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 138.58 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.19 63.21 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -47.66 115.74 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.347 0.594 . . . . 0.0 111.645 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.47 -163.02 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.73 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.637 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.66 140.25 97.98 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.707 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 Cg_endo -56.81 -31.41 88.45 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 121.942 1.761 . . . . 0.0 111.999 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -64.37 -35.44 80.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.811 ' O ' HG23 ' A' ' 118' ' ' THR . 79.6 mt-30 -87.7 -13.17 43.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.048 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.489 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 4.5 mtm -107.86 -2.17 20.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.95 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 9.2 mt-10 -63.92 -46.52 84.45 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.889 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -78.66 115.11 18.15 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.821 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 m -106.48 32.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.338 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -139.68 85.36 2.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.857 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.8 t -151.05 115.74 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.479 ' CE2' HG21 ' A' ' 66' ' ' THR . 68.7 m-85 -124.97 157.66 35.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.913 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 63' ' ' TYR . 62.1 tp -148.13 87.83 5.64 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.726 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -46.96 -46.5 18.59 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.735 2.29 . . . . 0.0 114.064 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -53.32 -27.07 21.27 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.66 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.738 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.615 ' CE1' HG12 ' A' ' 58' ' ' VAL . 45.9 t80 -67.51 -47.19 70.69 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.2 pttt -65.0 -39.61 93.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.585 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.6 mt -59.79 -45.43 94.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.944 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 91.4 mmm -69.82 -37.34 76.19 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.249 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.467 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 66.3 m -58.57 -45.12 89.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.24 -38.82 91.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.409 HH11 HG13 ' A' ' 104' ' ' VAL . 61.5 mtt180 -76.09 -34.01 59.52 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.6 m -113.88 -16.83 12.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.467 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -58.99 136.53 57.97 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.52 -0.737 . . . . 0.0 111.839 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 69.96 13.12 7.92 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.944 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -112.42 145.33 40.35 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.5 m -71.21 -30.13 66.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -143.79 158.53 43.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.431 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 t -155.82 137.03 13.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.764 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -126.23 128.9 71.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.497 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 46' ' ' ILE . 58.7 t -146.34 142.86 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -74.85 116.24 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.9 42.46 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.547 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.18 -125.99 1.04 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.95 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 107' ' ' GLY . 44.5 t 28.94 -155.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.459 0.647 . . . . 0.0 112.039 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.542 ' N ' ' OG ' ' A' ' 108' ' ' SER . 71.2 m-20 -62.19 -9.68 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.4 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.0 -11.16 59.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.11 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.9 m-85 -143.45 126.68 9.02 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.795 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.578 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.0 Cg_exo -47.7 -157.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.826 2.35 . . . . 0.0 112.42 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -139.1 88.88 12.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -75.69 -46.51 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.832 2.355 . . . . 0.0 112.838 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -132.31 79.53 65.64 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-O 121.673 0.749 . . . . 0.0 110.589 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -57.5 130.14 37.45 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.846 2.364 . . . . 0.0 111.919 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.16 -9.32 46.15 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.941 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.3 m -106.57 148.41 28.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.997 0.898 . . . . 0.0 108.965 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.518 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 8.2 t80 -88.27 97.85 11.26 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 14.1 mttt -75.78 -154.1 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.912 1.339 . . . . 0.0 113.435 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.531 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -173.74 170.01 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.11 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.4 tp -131.53 125.03 31.34 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -118.05 127.54 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.039 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.462 HG22 ' HB1' ' A' ' 61' ' ' ALA . 59.5 t -131.13 123.43 53.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.638 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.96 131.16 55.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.688 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.84 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.0 p90 -152.92 165.94 33.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.165 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.442 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 36.6 m-20 -116.97 161.82 18.76 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.311 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.407 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 94.5 m -116.25 115.91 26.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.838 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.4 156.32 67.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.228 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo . . . . . 0 N--CA 1.492 1.439 0 C-N-CA 122.025 1.817 . . . . 0.0 112.159 179.311 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HD2' ' OE2' ' A' ' 123' ' ' GLU . 50.6 ttp85 -150.77 133.81 16.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.312 0.577 . . . . 0.0 111.906 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 53.3 mp0 -130.62 149.35 52.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.368 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.738 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -141.6 139.06 33.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.665 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.738 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.95 142.97 36.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.201 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.5 m -71.62 134.6 46.49 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -42.95 135.8 2.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.576 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.94 -9.74 63.84 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.099 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.72 150.58 47.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 119.03 1.415 . . . . 0.0 110.741 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 20.9 Cg_endo -68.23 142.51 55.65 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.072 1.848 . . . . 0.0 111.866 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.9 tt -118.03 143.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 88.8 tt0 -130.19 129.18 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.505 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD12 ' SG ' ' A' ' 96' ' ' CYS . 13.6 mt -110.29 146.03 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.336 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.549 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 72.4 mtt180 -145.41 134.23 22.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.36 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.462 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -102.52 142.9 25.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.77 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 42.6 Cg_endo -69.75 155.11 66.84 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.658 2.238 . . . . 0.0 112.607 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.68 -131.84 35.65 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.199 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -105.18 25.32 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.844 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -79.71 164.18 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.738 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.35 147.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 0.0 110.083 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.957 HG23 ' CD2' ' A' ' 126' ' ' TYR . 86.3 mt -71.66 139.88 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.33 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.465 ' HG3' ' H ' ' A' ' 127' ' ' ASP . 2.9 ptp -132.02 102.17 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.536 HG12 ' CE1' ' A' ' 89' ' ' PHE . 63.4 t -63.95 124.58 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.221 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.0 mm-40 -103.03 -51.76 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 7.6 m-20 -148.94 146.78 28.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.136 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.76 156.53 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.005 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.574 HD21 ' HA ' ' A' ' 84' ' ' TYR . 8.7 t30 -152.91 150.79 29.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.954 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -119.38 124.99 47.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -138.46 6.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.67 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -154.6 114.57 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.408 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.485 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 6.0 p -125.51 6.46 7.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.1 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -148.26 156.95 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' O ' ' CE ' ' A' ' 78' ' ' MET . 55.9 p30 -118.33 5.81 11.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.03 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -103.76 4.62 35.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 mm -113.03 136.94 47.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.49 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m 54.98 72.4 0.48 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.805 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -55.77 124.7 18.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.97 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -141.22 -164.14 1.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.739 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 2.7 p-10 -59.1 139.48 87.73 Favored Pre-proline 0 C--N 1.333 -0.132 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.399 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -54.67 -37.32 91.31 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.591 2.194 . . . . 0.0 113.672 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -62.51 -34.95 77.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.934 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.67 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 47.3 mt-30 -88.23 9.49 22.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.068 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . 77.2 mtp -122.69 -6.24 8.6 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.385 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 90.7 mt-10 -62.63 -49.24 75.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.994 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.34 116.3 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.625 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -107.01 34.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.262 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 92.9 mm-40 -139.84 85.35 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.085 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.476 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 26.5 t -148.97 121.68 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.574 ' HA ' HD21 ' A' ' 62' ' ' ASN . 38.0 m-85 -130.44 153.05 49.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.505 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 88' ' ' ALA . 44.4 tp -141.65 94.29 7.44 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 -48.22 22.66 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.556 2.171 . . . . 0.0 113.173 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.5 m-20 -56.77 -24.88 53.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.503 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.63 -30.81 44.56 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.733 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.536 ' CE1' HG12 ' A' ' 58' ' ' VAL . 53.7 t80 -64.91 -42.84 94.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.1 ptpt -64.19 -42.18 96.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.785 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.711 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 36.4 mt -60.1 -50.0 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.173 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.441 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 95.9 mmm -66.71 -34.91 78.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.741 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.556 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.4 m -59.84 -45.92 90.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.066 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -65.85 -34.22 77.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.489 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.711 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 31.5 mtm180 -80.97 -32.19 34.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.766 ' SG ' HD12 ' A' ' 48' ' ' LEU . 84.2 m -109.6 -19.61 13.14 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 93' ' ' SER . 82.1 m-20 -58.75 133.99 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.249 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 65.02 12.74 8.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.581 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.94 146.23 41.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.0 m -72.22 -31.65 66.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.924 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 157.77 42.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.61 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.721 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.8 p -154.82 142.15 19.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.641 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 47.1 t -116.53 131.91 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.491 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.521 HG11 ' NH2' ' A' ' 95' ' ' ARG . 90.5 t -144.46 140.8 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.607 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -80.54 119.46 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.59 28.55 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.722 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 176.88 177.11 45.57 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.954 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 4.2 t 92.78 -155.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.996 0.427 . . . . 0.0 110.774 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -62.21 -11.09 12.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.905 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.5 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -78.52 -19.31 53.23 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.296 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.9 m-85 -136.98 129.26 17.06 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.992 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.5 Cg_exo -48.68 -155.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.47 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -138.49 89.48 13.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 0.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.0 -30.67 0.67 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.064 2.51 . . . . 0.0 113.544 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.579 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -149.04 66.46 8.68 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-O 120.93 0.395 . . . . 0.0 111.192 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.22 135.27 69.11 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.122 1.881 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.47 -14.99 42.61 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.766 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.493 HG22 ' HD2' ' A' ' 65' ' ' ARG . 20.8 m -107.79 153.52 22.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.146 0.973 . . . . 0.0 109.433 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.559 ' HB3' HH12 ' A' ' 65' ' ' ARG . 7.6 t80 -86.73 97.47 10.61 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.579 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 13.2 mttp -72.4 -164.13 0.14 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.903 -1.498 . . . . 0.0 113.528 -177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.613 ' HB2' HD21 ' A' ' 39' ' ' LEU . 9.3 p90 -170.44 167.2 8.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.138 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.8 tp -129.2 124.79 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.9 tt0 -119.9 125.08 47.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.9 t -128.26 123.5 60.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.684 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -109.64 128.82 55.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.142 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.957 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.5 p90 -153.33 174.01 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.377 0.608 . . . . 0.0 111.637 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.465 ' H ' ' HG3' ' A' ' 57' ' ' MET . 21.9 m-20 -127.43 162.62 25.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.225 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.474 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.0 m -112.22 120.22 41.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.47 156.93 74.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.839 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 N--CA 1.493 1.485 0 C-N-CA 122.047 1.831 . . . . 0.0 112.967 -179.434 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' CZ ' ' HD3' ' A' ' 51' ' ' PRO . 87.0 mtt-85 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.419 ' HD2' HH11 ' A' ' 37' ' ' ARG . 12.8 ttp180 -148.0 138.93 23.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 111.688 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.612 ' O ' ' OE2' ' A' ' 123' ' ' GLU . 71.4 mm-40 -131.86 146.01 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.608 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.722 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -139.72 137.53 35.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.818 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.99 145.21 37.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.137 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -65.89 132.77 49.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.254 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 37.2 tt0 -43.14 134.78 3.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.397 -0.819 . . . . 0.0 113.13 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 90.3 -1.23 79.34 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.69 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -116.16 146.25 36.78 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 118.219 1.01 . . . . 0.0 110.674 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 136.93 48.62 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.753 2.302 . . . . 0.0 112.141 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 15.5 tt -113.86 151.8 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.16 127.1 44.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.505 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.793 HD12 ' SG ' ' A' ' 102' ' ' CYS . 50.2 mt -113.54 142.89 45.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -151.19 134.81 16.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.054 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -101.25 142.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.719 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -64.18 157.83 51.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.798 2.332 . . . . 0.0 112.589 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.8 -124.78 7.3 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.299 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.6 p -109.83 22.6 15.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.005 -0.598 . . . . 0.0 111.089 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.59 167.83 20.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.34 145.71 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.348 0.594 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.745 HG23 ' CD2' ' A' ' 126' ' ' TYR . 81.8 mt -70.27 137.55 23.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.667 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 127' ' ' ASP . 2.7 ptp -134.34 100.37 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.29 124.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.451 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 73.2 mm-40 -99.77 -48.58 4.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 19.1 m-80 -153.92 152.59 30.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' A' ' 124' ' ' VAL . . . -168.91 158.03 8.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.6 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.497 HD21 ' HA ' ' A' ' 84' ' ' TYR . 4.2 t30 -149.98 148.98 29.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 111.606 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.512 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 65.3 t80 -119.47 121.74 40.14 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 155.88 -140.53 7.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.6 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 8.2 ttm180 -149.35 118.47 6.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 111.23 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.574 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 13.6 p -124.4 3.61 8.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.023 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 22.5 t70 -148.45 154.93 40.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.571 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.519 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 43.6 p30 -112.17 5.76 18.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.252 0.548 . . . . 0.0 109.767 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.589 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 29.6 mttt -104.27 7.29 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.8 mm -114.1 135.52 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 110.622 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.4 m 50.1 80.76 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.02 125.67 24.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.321 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.3 -163.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p30 -63.97 138.44 97.4 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.626 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.76 -33.65 71.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.007 1.805 . . . . 0.0 112.24 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -63.69 -36.01 82.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.475 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.809 ' O ' HG23 ' A' ' 118' ' ' THR . 76.7 mt-30 -85.94 -10.18 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.787 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.505 ' CE ' HH12 ' A' ' 65' ' ' ARG . 74.0 mtp -104.01 -2.6 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.905 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.7 mt-10 -64.49 -48.69 74.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -77.25 114.11 15.72 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.811 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.1 m -107.96 29.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.57 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -139.18 82.99 1.92 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.852 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.421 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 23.0 t -147.35 119.51 8.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.497 ' HA ' HD21 ' A' ' 62' ' ' ASN . 78.3 m-85 -129.92 155.14 46.54 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.218 0.532 . . . . 0.0 111.644 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 88' ' ' ALA . 25.5 tp -142.76 96.71 6.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.71 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -53.13 -48.04 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.637 2.225 . . . . 0.0 113.146 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.8 m-20 -55.39 -23.81 26.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.517 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.79 -35.71 66.58 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.716 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -65.04 -45.49 85.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.731 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.1 -39.81 93.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.033 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.49 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 94.4 mt -59.67 -52.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.838 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.918 ' SD ' HD21 ' A' ' 122' ' ' LEU . 18.6 mtp -68.17 -34.98 77.31 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.442 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.509 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 60.5 m -56.77 -43.63 81.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.109 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.701 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 86.8 mt-30 -68.04 -35.51 78.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.938 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.708 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 71.6 mtt180 -74.74 -34.08 62.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.856 ' N ' HH21 ' A' ' 99' ' ' ARG . 28.4 m -114.32 -18.56 11.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.528 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 45.0 m-20 -58.55 137.41 57.45 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.563 -0.71 . . . . 0.0 112.349 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 65.62 13.42 8.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.259 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.856 HH21 ' N ' ' A' ' 96' ' ' CYS . 54.7 mtm-85 -114.37 145.81 41.35 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.273 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.1 m -71.82 -32.58 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.646 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.11 155.64 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.504 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.793 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.3 p -155.01 150.23 27.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.294 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 59.4 t -127.86 131.79 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.404 HG13 ' NH1' ' A' ' 95' ' ' ARG . 60.1 t -144.66 140.5 23.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.704 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.33 119.45 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -72.17 41.98 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.31 -122.69 0.81 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.25 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER 31.64 -160.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.526 0.679 . . . . 0.0 111.473 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' OG ' ' A' ' 108' ' ' SER . 99.0 m-20 -65.43 -8.19 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.271 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.11 -11.44 59.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.592 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 112' ' ' PRO . 41.6 m-85 -142.12 126.03 9.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.235 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 111' ' ' PHE . 28.5 Cg_exo -49.42 -160.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.66 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -139.2 92.31 10.77 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.565 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.92 -38.34 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.804 2.336 . . . . 0.0 113.445 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.404 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.6 p -136.27 72.66 58.78 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -57.1 133.82 60.29 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.711 1.607 . . . . 0.0 110.853 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.24 -12.38 33.79 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 77' ' ' GLN . 97.5 m -117.59 147.18 43.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.473 0.637 . . . . 0.0 109.535 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.6 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 22.8 t80 -86.33 98.64 11.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.577 0.703 . . . . 0.0 109.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.6 mttm -71.31 -153.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.892 -177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.574 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.5 p90 -176.6 176.69 1.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 112.698 -2.046 . . . . 0.0 110.648 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.918 HD21 ' SD ' ' A' ' 92' ' ' MET . 14.3 tp -134.08 126.12 29.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.905 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.697 ' OE1' ' NE2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -124.64 128.64 49.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.656 HG21 ' SD ' ' A' ' 92' ' ' MET . 88.9 t -131.85 124.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.424 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.697 ' NE2' ' OE1' ' A' ' 123' ' ' GLU . 2.7 mp0 -107.66 129.37 55.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.745 ' CD2' HG23 ' A' ' 56' ' ' ILE . 36.8 p90 -153.01 168.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 111.724 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.475 ' OD1' ' C ' ' A' ' 126' ' ' TYR . 2.1 m-20 -126.38 162.99 24.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.593 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.8 m -113.45 116.89 30.32 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.583 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.9 m -121.44 157.09 57.22 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.496 1.622 0 C-N-CA 122.103 1.868 . . . . 0.0 112.44 179.573 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 7.4 mmm180 . . . . . 0 CA--C 1.52 -0.176 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -149.88 131.75 15.14 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.381 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -130.84 145.32 51.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.501 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 8.7 tt -137.61 137.51 38.57 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.6 145.44 35.04 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.159 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.7 m -67.97 131.35 45.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.635 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 6.4 tt0 -43.06 139.04 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.72 -1.86 83.99 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.166 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.4 158.02 37.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 118.034 0.917 . . . . 0.0 109.962 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.02 140.11 14.02 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.885 1.723 . . . . 0.0 111.631 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 20.2 tt -117.59 147.2 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.708 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.5 tt0 -126.52 128.6 47.15 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.101 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 102' ' ' CYS . 20.4 mt -115.41 141.63 47.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.708 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 89.4 mtt180 -147.82 132.86 18.22 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.183 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.7 m -99.76 138.83 20.46 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.769 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.38 161.07 46.8 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.562 2.175 . . . . 0.0 112.176 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -135.13 38.35 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -107.36 26.65 9.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 110.455 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 53.2 m-20 -80.92 166.81 20.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.063 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 148.6 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.349 0.595 . . . . 0.0 111.629 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.528 HG23 ' CD2' ' A' ' 126' ' ' TYR . 96.1 mt -69.29 134.86 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.937 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -134.83 98.39 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.891 0.853 . . . . 0.0 108.829 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.79 127.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.77 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -102.76 -48.38 4.12 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.767 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -151.73 150.96 30.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.51 . . . . 0.0 110.47 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.14 154.76 7.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.074 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.511 HD21 ' HA ' ' A' ' 84' ' ' TYR . 1.7 t30 -149.41 146.32 27.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.4 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' ' HD3' ' A' ' 120' ' ' LYS . 63.5 t80 -114.66 122.49 46.63 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.39 -139.78 6.77 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.491 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.706 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -155.42 117.1 4.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.919 179.44 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 32.9 p -123.6 8.67 8.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.583 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.7 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 50.1 t0 -150.2 158.42 44.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 44.2 p30 -115.41 5.81 14.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.688 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -106.39 6.14 30.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.528 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 29.2 mm -114.2 139.36 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.523 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 57.21 61.66 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 6.4 p-10 -46.31 118.57 1.99 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.041 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -136.16 -162.65 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.303 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -64.08 145.21 98.09 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.366 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -50.69 -38.28 55.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.54 2.16 . . . . 0.0 112.353 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -64.95 -35.66 81.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.677 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.565 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 80.7 mt-30 -83.65 -7.62 59.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 75.1 mmm -113.61 40.65 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.682 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -101.74 -59.87 1.63 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.062 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 23.7 t-20 -78.24 119.52 21.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.507 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.545 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 27.1 m -110.16 27.5 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.894 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.3 mm-40 -141.94 82.84 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.622 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.4 t -146.54 118.98 8.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.511 ' HA ' HD21 ' A' ' 62' ' ' ASN . 44.4 m-85 -123.41 156.56 35.23 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.151 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.446 HD23 ' HB3' ' A' ' 63' ' ' TYR . 28.2 tp -142.13 83.98 11.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.27 -46.41 11.59 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 123.361 2.707 . . . . 0.0 114.127 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 98.9 m-20 -54.56 -25.49 26.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.2 -32.27 47.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.282 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.596 ' O ' ' OG ' ' A' ' 93' ' ' SER . 7.7 t80 -65.63 -46.38 79.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.025 0.44 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.7 pttp -67.55 -40.39 84.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.244 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.632 HG23 ' NH1' ' A' ' 95' ' ' ARG . 79.9 mt -58.16 -49.17 82.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . 1.045 ' SD ' HD21 ' A' ' 122' ' ' LEU . 4.2 mtp -70.36 -32.44 70.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.176 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.596 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.7 m -60.24 -44.89 94.86 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.4 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -64.49 -37.41 87.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 0.0 111.496 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.632 ' NH1' HG23 ' A' ' 91' ' ' ILE . 60.0 mtt85 -77.04 -32.85 57.25 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.556 ' SG ' HD12 ' A' ' 48' ' ' LEU . 22.9 m -112.81 -13.48 13.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.55 ' CG ' ' O ' ' A' ' 93' ' ' SER . 21.0 m-20 -62.23 130.57 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.354 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 67.88 14.88 9.51 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.18 145.92 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.772 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.04 -31.8 68.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.51 154.94 40.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.208 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 48' ' ' LEU . 9.6 p -154.63 136.59 14.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.103 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 22.8 t -122.29 129.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.886 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.2 t -144.1 146.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 0.0 111.805 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.452 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.3 t -77.81 117.86 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.16 38.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.709 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.14 -125.23 0.96 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.914 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.7 t 27.99 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.967 0.413 . . . . 0.0 110.619 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.12 -10.43 22.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.856 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.64 60.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.052 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.614 ' O ' ' O ' ' A' ' 112' ' ' PRO . 83.1 m-85 -141.77 129.03 11.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.237 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 111' ' ' PHE . 50.7 Cg_exo -45.55 -158.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 123.061 2.507 . . . . 0.0 112.694 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -139.13 91.46 11.31 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.8 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.54 -50.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.125 2.55 . . . . 0.0 113.288 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.457 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -135.27 81.62 43.37 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.991 0.424 . . . . 0.0 111.473 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.11 143.65 94.96 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.598 2.199 . . . . 0.0 111.73 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.91 -5.53 56.49 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 120.634 -0.794 . . . . 0.0 113.168 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 77' ' ' GLN . 99.3 m -115.06 147.84 39.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.706 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 11.2 t80 -87.02 97.78 10.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.465 ' HD3' ' CE2' ' A' ' 63' ' ' TYR . 19.7 mttt -73.51 -163.74 0.17 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 122.848 1.309 . . . . 0.0 113.241 -177.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.425 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 6.4 p90 -165.42 165.14 19.45 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.388 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.045 HD21 ' SD ' ' A' ' 92' ' ' MET . 35.8 tp -126.14 122.24 35.13 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.518 ' CD ' ' OE1' ' A' ' 125' ' ' GLN . 2.6 tm-20 -113.62 126.91 55.79 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.564 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.87 HG21 ' SD ' ' A' ' 92' ' ' MET . 58.6 t -133.2 120.6 40.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.979 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.518 ' OE1' ' CD ' ' A' ' 123' ' ' GLU . 2.8 mt-30 -107.37 128.27 54.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.082 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.528 ' CD2' HG23 ' A' ' 56' ' ' ILE . 33.9 p90 -153.56 171.6 18.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.74 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 40.2 m-20 -128.5 164.27 23.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.231 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.57 120.52 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.373 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 20.1 m -116.97 150.83 46.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.385 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 C--N 1.312 -1.374 0 C-N-CA 121.875 1.717 . . . . 0.0 112.265 179.421 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.47 ' NH1' ' HG2' ' A' ' 36' ' ' ARG . 40.0 mtp85 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -148.07 137.28 22.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -134.81 146.08 48.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.712 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.79 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -140.77 143.3 34.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.696 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.79 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -147.4 145.56 29.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.727 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.1 m -70.73 136.19 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.37 0.605 . . . . 0.0 111.122 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 7.6 tt0 -44.92 139.0 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.215 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.33 -11.99 66.82 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.702 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -118.29 153.35 51.59 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 118.395 1.098 . . . . 0.0 110.313 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.19 145.37 43.78 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.275 1.984 . . . . 0.0 113.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -114.88 149.57 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -127.14 128.78 46.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.205 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD12 ' SG ' ' A' ' 102' ' ' CYS . 31.6 mt -115.61 139.39 50.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.401 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -144.9 135.15 24.12 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.246 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -100.52 140.17 21.2 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.12 155.95 66.47 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 121.908 1.739 . . . . 0.0 111.505 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.03 -137.09 37.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 121.689 0.605 . . . . 0.0 112.625 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -100.92 22.19 12.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.446 -0.877 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -79.02 166.75 21.99 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.681 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.75 148.04 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' CD2' ' A' ' 126' ' ' TYR . 85.8 mt -71.25 137.84 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.109 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -135.1 101.64 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.27 125.43 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.348 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.577 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 97.5 mt-10 -100.04 -49.57 4.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.3 m-20 -150.19 149.4 30.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.618 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.448 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.12 152.49 7.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.712 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.591 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.6 t30 -149.32 149.15 30.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.191 0.519 . . . . 0.0 111.182 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.491 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 26.3 t80 -119.3 122.89 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -137.26 5.5 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 1.8 ttm180 -155.1 116.37 4.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.112 0.482 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.2 p -122.74 6.7 9.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 14.1 t70 -149.81 157.74 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.716 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 5.6 p-10 -113.58 5.44 16.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.189 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.489 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 31.1 mtmt -102.61 0.16 32.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.616 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 mm -113.09 138.54 42.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 48.2 m 60.87 59.18 2.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.2 0.524 . . . . 0.0 109.651 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -43.72 97.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.981 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -115.39 -174.22 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -55.78 141.01 66.98 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.896 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.7 Cg_endo -50.52 -38.77 54.94 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.149 1.9 . . . . 0.0 111.745 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.99 -35.26 80.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.15 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.674 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 79.8 mt-30 -85.41 -4.9 59.3 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.703 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 5.0 mmm -108.1 -5.15 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.201 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 68.6 mt-10 -62.54 -48.4 79.67 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.204 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -79.97 115.88 19.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 66' ' ' THR . 32.8 m -108.65 29.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.158 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -139.52 82.96 1.91 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.836 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -146.12 123.67 11.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.57 ' HA ' HD21 ' A' ' 62' ' ' ASN . 21.3 m-85 -132.85 157.3 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.173 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.551 HD21 ' HG2' ' A' ' 112' ' ' PRO . 28.7 tp -145.86 83.69 8.61 Favored Pre-proline 0 N--CA 1.462 0.159 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.36 -44.32 20.55 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 123.078 2.519 . . . . 0.0 113.674 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.3 m-20 -59.07 -25.21 63.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 91' ' ' ILE . . . -51.29 -33.39 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.012 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.411 ' O ' ' OG ' ' A' ' 93' ' ' SER . 12.2 t80 -64.23 -40.23 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.807 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -66.12 -38.25 87.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.052 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 88' ' ' ALA . 90.4 mt -57.93 -53.66 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.867 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.418 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 95.3 mmm -66.62 -34.25 77.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.023 0.439 . . . . 0.0 110.571 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.561 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.4 m -59.54 -48.61 80.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -67.69 -37.23 82.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.596 ' HE ' HG22 ' A' ' 104' ' ' VAL . 53.9 mtp85 -72.8 -34.44 66.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.413 -178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.524 ' SG ' HD12 ' A' ' 48' ' ' LEU . 26.2 m -113.44 -15.26 12.64 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.561 ' CG ' ' O ' ' A' ' 93' ' ' SER . 74.4 m-20 -58.65 132.25 53.28 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.127 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 68.47 13.37 8.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.764 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -111.4 143.05 42.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.324 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.3 m -70.42 -32.94 70.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.541 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -149.79 150.03 31.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.863 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.3 p -153.41 138.62 17.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.924 0.393 . . . . 0.0 111.052 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.1 t -116.75 131.31 69.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.661 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.596 HG22 ' HE ' ' A' ' 95' ' ' ARG . 39.7 t -139.39 149.51 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.506 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.495 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.3 t -87.13 117.68 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.59 36.02 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.209 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.44 -125.4 0.92 Allowed Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 30.77 -157.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.792 0.329 . . . . 0.0 111.214 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.92 -9.26 3.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.523 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.78 60.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.674 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 112' ' ' PRO . 53.3 m-85 -141.48 132.75 13.41 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.887 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.551 ' HG2' HD21 ' A' ' 85' ' ' LEU . 33.1 Cg_exo -49.58 -157.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.937 2.425 . . . . 0.0 112.584 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.22 87.99 22.12 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.633 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.23 -43.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.288 2.659 . . . . 0.0 113.544 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.483 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -135.72 85.54 30.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.151 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.87 136.49 27.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.263 1.975 . . . . 0.0 111.746 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.57 -1.34 36.75 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.271 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 77' ' ' GLN . 35.2 m -122.18 146.71 46.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.22 0.51 . . . . 0.0 109.92 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 17.7 t80 -85.94 98.88 11.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 14.6 mttt -73.9 -161.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.76 1.267 . . . . 0.0 113.669 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.0 p90 -169.9 168.62 8.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.281 176.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 62' ' ' ASN . 21.9 tp -130.8 126.69 36.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 76.5 tt0 -119.84 128.9 54.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.4 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.448 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.5 t -130.27 121.3 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.111 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -107.96 125.91 52.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.805 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.6 p90 -151.9 165.69 33.79 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.133 -177.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.3 OUTLIER -120.59 159.03 26.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.997 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.7 m -110.25 118.13 35.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 m -116.17 152.38 47.76 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.377 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.303 -1.85 0 C-N-CA 121.812 1.675 . . . . 0.0 110.668 179.225 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.515 HH11 ' HG3' ' A' ' 36' ' ' ARG . 57.1 mtt85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.653 0.263 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.645 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 2.2 ttt-85 -150.8 141.01 22.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.377 0.608 . . . . 0.0 112.1 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.603 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 35.5 mt-10 -132.44 145.09 50.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.342 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -138.65 139.07 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.904 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.97 145.38 39.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.234 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.6 m -70.1 137.45 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.484 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -43.09 132.78 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.279 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.04 75.52 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.959 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.84 154.29 49.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 118.878 1.339 . . . . 0.0 110.751 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.8 142.79 44.18 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.699 2.266 . . . . 0.0 113.359 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.7 tt -115.97 149.9 18.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.603 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 81.0 tt0 -132.36 126.04 32.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.246 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.609 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.2 mt -113.58 143.68 44.15 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.593 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 64.7 mtt180 -149.67 132.02 15.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.397 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -99.9 140.27 21.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.966 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.1 Cg_endo -66.41 163.83 30.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.658 2.238 . . . . 0.0 112.915 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.28 -121.55 14.66 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.478 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 p -122.98 26.01 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 0.0 110.066 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.7 169.75 17.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.232 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.88 143.96 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.084 0.469 . . . . 0.0 110.696 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.746 HG23 ' CD2' ' A' ' 126' ' ' TYR . 69.3 mt -68.4 138.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.143 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.7 ptm -132.43 103.14 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.82 125.67 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.345 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -100.46 -50.18 3.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.625 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -150.57 148.35 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.402 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.608 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.85 155.74 10.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.498 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.1 t30 -152.54 151.5 30.76 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.187 0.518 . . . . 0.0 112.188 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.509 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 33.6 t80 -121.48 122.86 40.68 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.56 -141.17 7.85 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -176.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.702 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.2 ttm-85 -151.36 114.77 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.666 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.533 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 11.8 p -120.48 6.13 10.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.865 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 41.2 t0 -144.75 -170.82 3.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.613 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' O ' ' CE ' ' A' ' 78' ' ' MET . 35.0 p30 -146.24 -2.74 0.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.968 0.413 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.403 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 52.7 mtpt -103.91 9.38 36.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.122 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.33 136.33 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.8 m 54.28 70.9 0.56 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -51.53 118.82 3.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.721 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.78 -163.28 1.44 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.246 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.719 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -61.93 136.79 95.22 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.302 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.8 Cg_endo -57.1 -34.31 97.47 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.787 1.658 . . . . 0.0 112.251 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -61.62 -35.98 79.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.417 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.88 ' O ' HG23 ' A' ' 118' ' ' THR . 82.1 mt-30 -82.13 -18.56 42.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.655 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 3.7 mtm -98.8 0.38 44.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.845 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 73.9 mt-10 -64.49 -51.32 63.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.264 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -79.32 110.98 15.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.064 0.459 . . . . 0.0 111.37 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.44 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 11.0 m -103.68 33.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.38 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 22.7 mm100 -138.43 83.97 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.258 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.419 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 41.8 t -147.95 121.86 9.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.498 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.1 m-85 -130.17 156.6 44.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.921 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.552 HD21 ' HD2' ' A' ' 112' ' ' PRO . 21.6 tp -144.19 86.49 8.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.468 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.49 -46.8 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.904 2.403 . . . . 0.0 113.68 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.0 m-20 -54.11 -30.22 47.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.891 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.81 -31.2 37.55 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.574 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -64.12 -41.38 97.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.562 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 1.3 pttp -67.87 -39.73 83.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.078 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.562 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 52.8 mt -60.23 -49.85 82.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.418 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 95.0 mmm -69.94 -39.04 76.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.656 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 50.3 m -60.43 -44.45 95.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.572 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 77.4 mt-30 -64.79 -37.21 86.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.803 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.491 ' C ' ' NH1' ' A' ' 99' ' ' ARG . 67.6 mtt180 -78.69 -31.36 46.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 48' ' ' LEU . 51.6 m -111.27 -13.41 13.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.7 m-20 -64.45 131.11 46.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 67.26 13.79 9.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.605 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.491 ' NH1' ' C ' ' A' ' 95' ' ' ARG . 61.4 mtt85 -113.38 146.07 40.08 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.295 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -70.22 -31.5 68.95 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -151.92 157.78 42.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.171 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.609 ' SG ' HD12 ' A' ' 48' ' ' LEU . 29.8 p -155.48 138.5 15.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.477 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 61.5 t -123.75 130.03 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.7 146.97 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 112.078 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.8 t -79.69 119.49 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.84 39.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.82 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.6 -142.62 5.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.249 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.3 t 47.12 -151.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 111.542 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.69 -9.5 20.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.961 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.487 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -76.24 -14.48 60.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.434 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.652 ' O ' ' O ' ' A' ' 112' ' ' PRO . 95.5 m-85 -143.87 128.51 9.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.821 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 111' ' ' PHE . 53.4 Cg_exo -45.79 -157.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.662 2.241 . . . . 0.0 112.019 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -137.84 92.58 12.71 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.148 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.52 -42.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.3 2.667 . . . . 0.0 113.397 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.473 ' SG ' ' HE3' ' A' ' 120' ' ' LYS . 1.3 p -136.86 74.83 50.31 Favored Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.256 0.551 . . . . 0.0 112.404 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.75 135.13 47.08 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.114 1.876 . . . . 0.0 110.703 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.85 -6.87 52.31 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 77' ' ' GLN . 99.3 m -114.35 147.09 39.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.702 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.2 t80 -86.46 96.34 10.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.509 ' HD2' ' CZ ' ' A' ' 63' ' ' TYR . 36.1 mttp -72.07 -156.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.497 1.142 . . . . 0.0 112.846 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.632 ' HB2' HD21 ' A' ' 39' ' ' LEU . 10.1 p90 -175.41 172.68 2.63 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.356 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 21.5 tp -130.97 122.69 27.33 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.645 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 45.1 tt0 -119.09 130.5 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.608 HG22 ' HB1' ' A' ' 61' ' ' ALA . 65.4 t -134.5 124.39 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 119.639 -0.824 . . . . 0.0 112.325 -178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.17 131.38 55.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.301 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.746 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.0 p90 -154.74 173.69 16.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.632 0.73 . . . . 0.0 112.374 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -131.71 162.61 30.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.965 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 83.4 m -111.27 117.61 33.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.679 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.8 m -119.57 156.22 53.68 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.78 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo . . . . . 0 N--CA 1.492 1.434 0 C-N-CA 122.226 1.951 . . . . 0.0 111.785 179.153 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 126' ' ' TYR . 42.7 mmm-85 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.632 HH21 ' CD ' ' A' ' 123' ' ' GLU . 70.4 ttt-85 -144.95 132.57 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.464 0.65 . . . . 0.0 111.46 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -133.63 144.32 49.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.409 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.0 tt -143.39 132.94 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.794 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.703 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.96 150.98 45.15 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.725 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.36 132.44 47.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.591 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 11.1 tt0 -42.43 141.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.458 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 88.65 -4.6 85.07 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.215 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -117.32 153.19 49.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 118.463 1.131 . . . . 0.0 110.857 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -68.11 137.65 41.34 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 tt -119.89 138.02 51.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.59 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.1 tt0 -122.37 131.97 54.15 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.311 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' A' ' 126' ' ' TYR . 8.9 mt -108.75 144.93 35.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.269 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.59 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 30.5 mtt85 -149.24 132.12 16.11 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.706 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -100.8 147.14 33.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.25 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.59 159.01 28.67 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.37 2.047 . . . . 0.0 111.96 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.43 -137.42 38.36 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 121.321 0.4 . . . . 0.0 112.668 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.2 p -102.64 24.14 10.96 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.674 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.65 166.06 22.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.9 142.76 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.849 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.875 HG23 ' CD2' ' A' ' 126' ' ' TYR . 88.3 mt -67.67 138.73 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.077 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.41 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.8 ptp -135.59 100.88 4.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.406 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.91 124.61 15.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.399 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.586 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.48 -51.38 3.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.419 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.586 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 28.4 m-20 -148.28 145.75 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.67 ' CB ' HG22 ' A' ' 124' ' ' VAL . . . -166.92 155.04 9.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.761 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' HD12 ' A' ' 122' ' ' LEU . 10.5 t30 -153.78 154.58 34.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.241 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.591 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 85.4 t80 -120.07 122.64 41.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.19 7.62 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.04 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.758 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 13.7 ttm180 -156.89 116.23 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.419 HG21 ' CE2' ' A' ' 84' ' ' TYR . 7.6 p -124.53 8.73 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 57.9 t0 -147.35 157.6 43.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.506 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.587 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p-10 -114.18 0.2 14.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -102.22 6.57 40.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.25 135.29 50.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 110.16 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 60.63 61.27 1.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.228 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.626 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.6 p30 -41.3 104.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.583 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -124.28 -164.69 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.96 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.47 145.09 98.58 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.694 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.8 Cg_endo -55.3 -37.96 94.12 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.239 1.959 . . . . 0.0 112.714 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.51 -32.88 74.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.784 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.682 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 82.2 mt-30 -85.71 -11.39 53.81 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.797 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.758 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 3.1 mmt -100.74 -4.89 27.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.647 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 83.8 mt-10 -61.06 -56.2 23.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -79.42 118.02 20.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.433 0.635 . . . . 0.0 112.65 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.455 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 33.9 m -109.24 28.9 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.676 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.455 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 29.9 mm100 -141.71 87.13 2.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.5 t -145.51 120.22 9.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.477 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.6 m-85 -127.93 155.72 43.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 112.007 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.528 HD21 ' HG2' ' A' ' 112' ' ' PRO . 13.1 tp -148.34 91.89 4.67 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.166 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.54 -46.6 28.74 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.151 1.9 . . . . 0.0 112.868 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 74.5 m-20 -50.05 -31.29 12.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.38 -31.98 36.43 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.597 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -64.48 -47.88 77.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.584 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 2.0 ptpp? -64.02 -41.56 97.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.502 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 98.0 mt -59.97 -48.9 86.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.865 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . 1.038 ' SD ' HD21 ' A' ' 122' ' ' LEU . 63.1 mtp -69.87 -32.47 70.84 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.292 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.431 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 19.8 m -59.93 -45.89 91.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.627 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.61 -38.97 88.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.45 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -73.84 -37.29 64.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.4 m -113.54 -22.34 10.36 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 50.9 m-20 -55.3 140.55 38.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 69.95 12.94 7.93 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.157 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 99' ' ' ARG . 51.0 mtt85 -113.22 145.27 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.329 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.5 m -71.64 -28.83 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.58 155.31 42.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.547 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.81 143.97 26.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.113 0.483 . . . . 0.0 111.066 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.07 125.87 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.623 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -143.06 144.24 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.693 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.608 ' C ' ' H ' ' A' ' 107' ' ' GLY . 8.3 t -79.45 121.6 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.385 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -67.06 26.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.641 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . -178.94 172.13 44.31 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.028 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 4.3 t 97.26 -156.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 110.217 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.62 -10.71 38.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.176 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.35 -21.47 58.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.9 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.8 m-85 -138.27 125.95 13.72 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.744 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.3 Cg_exo -46.29 -155.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.764 2.31 . . . . 0.0 112.688 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -138.02 92.07 12.76 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.18 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -73.95 -54.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.531 2.154 . . . . 0.0 112.988 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.73 89.33 17.97 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.986 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.11 141.58 94.28 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.609 2.206 . . . . 0.0 111.64 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.92 4.99 57.63 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.749 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 77' ' ' GLN . 58.1 m -126.48 146.55 50.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.658 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 9.4 t80 -87.93 97.66 11.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 4.9 mtmp? -79.61 -158.96 0.18 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.644 1.212 . . . . 0.0 113.679 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.442 ' H ' ' HB3' ' A' ' 120' ' ' LYS . 9.8 p90 -172.44 175.56 3.53 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.543 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.038 HD21 ' SD ' ' A' ' 92' ' ' MET . 19.5 tp -132.17 124.17 28.5 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.477 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.632 ' CD ' HH21 ' A' ' 37' ' ' ARG . 78.6 tt0 -117.77 130.44 56.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.736 HG21 ' SD ' ' A' ' 92' ' ' MET . 97.2 t -134.4 123.4 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.013 -1.075 . . . . 0.0 113.113 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -110.98 128.32 55.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.071 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.875 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.3 p90 -152.29 168.71 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 111.842 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 57' ' ' MET . 86.2 m-20 -119.35 160.35 22.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.5 m -112.51 128.07 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.53 155.45 80.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.69 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo . . . . . 0 N--CA 1.491 1.365 0 C-N-CA 122.182 1.921 . . . . 0.0 112.12 178.89 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.85 0.357 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -149.56 132.54 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.372 0.606 . . . . 0.0 111.158 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.0 mp0 -129.17 146.79 51.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.615 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -142.24 139.64 32.02 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.985 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.836 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.94 146.53 37.49 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.265 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.5 m -68.28 129.92 41.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.201 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 77.0 tt0 -45.41 142.53 2.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.99 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.412 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 93.11 -12.96 68.8 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.554 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.5 m-85 -115.74 149.97 44.03 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 118.256 1.028 . . . . 0.0 110.084 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.73 143.46 61.84 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.551 2.167 . . . . 0.0 113.439 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.3 tt -115.67 149.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.664 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.4 tt0 -129.2 128.97 44.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.494 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.558 HD12 ' SG ' ' A' ' 102' ' ' CYS . 38.4 mt -115.36 143.62 45.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.919 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 74.3 mtt180 -150.01 129.55 13.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.073 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.8 m -97.55 145.4 29.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.9 Cg_endo -69.04 158.91 56.07 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.609 2.206 . . . . 0.0 112.654 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.28 -130.74 25.08 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.328 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -107.33 22.29 16.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.819 -0.69 . . . . 0.0 111.232 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.12 168.96 19.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.447 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.89 147.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.232 0.539 . . . . 0.0 110.271 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.675 HG23 ' CD1' ' A' ' 126' ' ' TYR . 79.5 mt -68.96 136.09 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.553 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.433 ' CE ' HG11 ' A' ' 129' ' ' VAL . 3.4 ptp -130.18 99.54 5.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 176.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.619 HG12 ' CE1' ' A' ' 89' ' ' PHE . 61.2 t -64.07 125.93 21.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.724 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.49 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 78.2 mm-40 -101.07 -51.43 3.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.742 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 25.3 m-20 -149.67 148.64 29.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.224 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.84 152.42 11.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.983 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' HD12 ' A' ' 122' ' ' LEU . 9.8 t30 -150.4 149.34 29.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.222 0.534 . . . . 0.0 111.706 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.496 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 81.9 t80 -118.53 122.52 42.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 0.0 108.839 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 157.26 -140.69 7.29 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.35 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.527 HH12 ' HB3' ' A' ' 119' ' ' TYR . 10.2 ttm180 -153.5 115.44 4.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.172 0.51 . . . . 0.0 110.603 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 p -121.59 7.38 10.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.356 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -150.01 157.18 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.886 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 44.2 p30 -113.74 4.29 15.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.706 0.289 . . . . 0.0 110.39 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 91.9 mttt -104.47 7.22 35.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.626 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.6 mm -113.87 138.17 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.883 0.373 . . . . 0.0 110.722 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.3 m 54.18 70.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.0 p30 -47.82 120.3 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 111.739 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -137.89 -165.14 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.011 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.605 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 1.9 p-10 -67.97 143.54 96.35 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.23 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -51.43 -36.31 58.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.264 1.976 . . . . 0.0 112.062 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.412 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 6.5 m-85 -65.99 -41.36 91.19 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.482 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 31.7 mt-30 -86.96 -2.32 58.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.343 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.1 mtp -110.02 -6.76 15.06 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.777 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.23 -45.43 84.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.124 -0.63 . . . . 0.0 112.129 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 54.9 t30 -76.81 116.25 17.31 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.918 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -109.27 30.83 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -141.38 86.56 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.404 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 54.0 t -145.75 120.01 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.512 ' HA ' HD21 ' A' ' 62' ' ' ASN . 72.1 m-85 -132.43 154.69 49.6 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.124 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.6 HD21 ' HG2' ' A' ' 112' ' ' PRO . 65.1 tp -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.7 -48.6 13.67 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.275 2.65 . . . . 0.0 113.54 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 94.7 m-20 -58.25 -20.95 46.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.726 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.17 -36.05 60.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.729 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.619 ' CE1' HG12 ' A' ' 58' ' ' VAL . 51.7 t80 -64.33 -40.39 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.075 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 7.9 pttp -64.3 -40.68 96.43 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.367 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.426 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.7 mt -60.32 -47.9 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.637 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.8 mmm -69.32 -38.83 78.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.529 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 3.7 m -60.82 -43.4 98.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.784 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -66.45 -37.68 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 111.607 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HE ' HG23 ' A' ' 91' ' ' ILE . 90.4 mtt-85 -75.52 -33.14 60.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.4 m -113.15 -16.22 12.62 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.545 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.2 m-20 -59.51 137.23 58.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.98 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 65.64 14.72 9.68 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.934 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -119.46 149.47 41.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.47 -32.91 68.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.353 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -154.2 156.92 38.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.2 p -154.8 150.52 27.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.238 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.53 128.99 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 46' ' ' ILE . 44.9 t -143.61 143.7 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.949 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.07 118.46 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -72.56 43.75 0.11 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.54 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.87 -127.37 1.11 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.493 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' GLY . 47.2 t 29.43 -153.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.406 . . . . 0.0 110.982 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.515 ' N ' ' OG ' ' A' ' 108' ' ' SER . 14.0 m-20 -64.79 -9.86 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.3 -13.16 59.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.739 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.0 m-85 -139.34 126.45 12.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.6 ' HG2' HD21 ' A' ' 85' ' ' LEU . 22.5 Cg_exo -51.14 -155.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.443 2.095 . . . . 0.0 111.581 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -136.58 89.44 18.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.639 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.6 -26.62 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 22.2 p -158.53 97.13 1.78 Allowed Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.402 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.27 138.84 22.9 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.714 2.276 . . . . 0.0 113.058 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.37 57.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.765 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.3 m -118.37 145.78 44.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.527 ' HB3' HH12 ' A' ' 65' ' ' ARG . 7.9 t80 -88.15 98.69 11.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.496 ' HD2' ' CZ ' ' A' ' 63' ' ' TYR . 27.1 mttt -72.76 -156.57 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.679 1.228 . . . . 0.0 113.309 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.582 ' HB2' HD21 ' A' ' 39' ' ' LEU . 5.3 p90 -174.86 172.54 2.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.138 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.9 tp -130.56 122.52 27.69 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -117.38 128.76 55.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.638 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.9 t -134.49 122.54 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.762 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.24 129.81 55.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.675 ' CD1' HG23 ' A' ' 56' ' ' ILE . 41.3 p90 -155.43 173.88 16.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.137 0.494 . . . . 0.0 111.953 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 57' ' ' MET . 29.9 m-20 -127.67 163.46 24.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.534 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.469 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.6 m -114.07 108.99 17.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.453 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.433 HG11 ' CE ' ' A' ' 57' ' ' MET . 1.5 m -113.6 167.52 9.26 Favored Pre-proline 0 N--CA 1.465 0.311 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo . . . . . 0 N--CA 1.489 1.236 0 C-N-CA 122.217 1.944 . . . . 0.0 112.407 -179.574 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' NH2' ' HG2' ' A' ' 125' ' ' GLN . 42.4 ttm105 -147.36 136.39 22.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.497 0.665 . . . . 0.0 111.472 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.63 ' HG3' HD23 ' A' ' 48' ' ' LEU . 68.4 mm-40 -128.69 142.71 50.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.025 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -139.76 135.32 32.97 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.629 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.97 148.22 35.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.417 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 m -69.89 134.36 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.744 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 22.5 tt0 -42.68 137.69 2.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.81 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.45 -4.69 80.22 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.53 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.47 150.53 46.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 118.585 1.193 . . . . 0.0 109.997 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.37 142.04 36.38 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 38' ' ' GLU . 17.5 tt -118.37 147.12 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -127.11 129.84 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.346 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.757 HD12 ' SG ' ' A' ' 96' ' ' CYS . 19.6 mt -115.04 142.47 46.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -148.45 135.34 20.0 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.473 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.521 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.23 140.42 21.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.746 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.3 Cg_endo -70.39 159.41 53.04 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.477 2.118 . . . . 0.0 111.948 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.78 -138.67 33.65 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.002 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -100.56 24.79 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.117 -0.541 . . . . 0.0 111.211 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.04 164.33 24.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.301 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 m -124.97 140.88 46.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.651 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.039 HG23 ' CD2' ' A' ' 126' ' ' TYR . 67.3 mt -67.22 138.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.535 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.8 ptp -133.99 98.52 4.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.694 0.759 . . . . 0.0 109.171 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.75 125.73 20.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.988 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.48 -46.49 4.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -150.21 147.66 27.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.952 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.39 151.86 5.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.914 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 122' ' ' LEU . 2.5 t30 -149.3 151.48 34.24 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.744 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.55 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 80.8 t80 -118.12 122.78 43.95 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.88 -138.71 6.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.388 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.551 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 14.7 ttm-85 -157.86 117.63 3.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 111.329 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.484 ' CG2' ' CZ ' ' A' ' 84' ' ' TYR . 5.0 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.631 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.508 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.1 t0 -147.72 -171.74 3.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.226 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 37.3 p30 -146.17 -0.47 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 2.8 mtmp? -103.94 7.13 36.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.479 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mm -118.31 139.63 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.0 m 59.51 58.56 2.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.5 p-10 -44.52 121.48 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.19 -170.11 3.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.034 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.3 p30 -61.91 138.23 95.55 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.688 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.8 Cg_endo -49.86 -33.34 32.87 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.51 2.14 . . . . 0.0 113.322 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -63.55 -37.05 85.84 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.413 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 26.0 mt-30 -89.47 8.76 29.32 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.387 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.45 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 78.7 mtp -124.91 -1.97 7.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 69.5 mt-10 -61.61 -53.2 59.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.293 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.0 t30 -76.97 117.07 18.2 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.428 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 67' ' ' ASP . 23.8 m -108.87 27.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.566 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -138.34 85.81 2.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.037 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 48.6 t -147.04 119.02 8.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CZ ' ' CG2' ' A' ' 66' ' ' THR . 83.1 m-85 -129.77 155.34 46.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.56 . . . . 0.0 111.625 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.725 HD21 ' HG2' ' A' ' 112' ' ' PRO . 26.1 tp -147.66 90.64 5.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.999 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.58 -44.26 31.04 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 113.348 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.0 m-20 -55.19 -27.4 45.65 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.62 -33.43 33.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.368 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.53 -42.81 91.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.095 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.8 pttt -64.36 -41.83 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.653 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.525 HG23 ' HE ' ' A' ' 95' ' ' ARG . 97.6 mt -59.67 -49.53 83.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.048 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.432 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 96.8 mmm -68.11 -35.4 78.08 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.767 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.477 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 66.3 m -59.58 -45.62 91.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -66.29 -35.12 79.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.584 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.525 ' HE ' HG23 ' A' ' 91' ' ' ILE . 94.2 mtt-85 -79.96 -32.85 39.92 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 48' ' ' LEU . 58.0 m -111.98 -15.87 13.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.477 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -60.62 134.32 56.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 65.03 12.62 8.06 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.649 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.09 145.6 40.62 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.329 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.4 m -70.27 -31.11 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.292 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.1 158.46 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.399 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.725 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.3 p -156.17 143.68 19.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.428 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.5 t -122.24 127.6 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.39 146.28 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.479 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -85.52 120.83 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.829 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.42 28.83 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.438 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.593 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . -179.96 179.08 48.81 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.469 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.3 t 88.86 -158.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.57 -10.65 19.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.88 58.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.82 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 39.5 m-85 -140.87 131.12 13.32 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.006 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.725 ' HG2' HD21 ' A' ' 85' ' ' LEU . 32.1 Cg_exo -49.72 -162.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.869 2.379 . . . . 0.0 112.964 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -138.16 91.6 12.85 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.452 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.56 -44.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 123.355 2.703 . . . . 0.0 113.391 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.485 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.8 p -134.99 79.4 51.27 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.9 140.5 79.88 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.024 1.816 . . . . 0.0 111.963 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.52 -2.15 58.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.293 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.432 ' CG2' ' HD2' ' A' ' 65' ' ' ARG . 51.8 m -114.76 147.71 39.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.626 0.713 . . . . 0.0 109.085 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.551 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.6 t80 -86.97 96.99 10.46 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 18.4 mtmt -76.74 -164.16 0.4 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.079 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.455 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 9.0 p90 -166.24 169.26 14.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.653 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 62' ' ' ASN . 18.2 tp -130.85 125.32 33.32 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 69.7 tt0 -118.74 129.06 55.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.101 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.62 HG22 ' HB1' ' A' ' 61' ' ' ALA . 80.5 t -131.93 122.98 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.619 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.465 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -110.34 128.98 55.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.039 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.5 p90 -151.23 163.54 38.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.324 0.583 . . . . 0.0 111.656 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 57' ' ' MET . 95.4 m-20 -115.83 158.09 23.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.317 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.446 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 96.5 m -109.69 125.6 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.34 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.31 149.7 74.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 N--CA 1.492 1.41 0 C-N-CA 122.338 2.025 . . . . 0.0 111.918 179.638 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.785 HH12 ' H ' ' A' ' 128' ' ' CYS . 82.6 mtt85 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -141.58 137.29 31.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.204 0.526 . . . . 0.0 110.851 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 44.2 mp0 -134.92 141.99 46.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -140.48 134.16 30.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.744 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.668 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.67 144.72 44.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.024 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.9 m -71.99 131.1 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.462 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 34.5 tt0 -42.95 135.96 2.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.628 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.48 -9.8 66.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.126 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.7 155.72 50.36 Favored Pre-proline 0 CA--C 1.52 -0.206 0 CA-C-N 118.963 1.382 . . . . 0.0 110.675 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.89 143.54 33.27 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.235 1.957 . . . . 0.0 113.387 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 104' ' ' VAL . 18.3 tt -116.12 145.93 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 86.6 tt0 -130.79 129.83 42.93 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.989 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.632 HD12 ' SG ' ' A' ' 102' ' ' CYS . 23.9 mt -113.79 145.72 41.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.268 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 98.4 mtt180 -150.25 136.15 18.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.167 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.451 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -104.66 138.25 19.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.119 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 12.0 Cg_endo -63.82 155.51 63.34 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.567 2.178 . . . . 0.0 112.705 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.04 -132.14 32.94 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.613 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.4 p -103.62 26.55 8.38 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -80.75 162.39 24.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.881 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -131.12 146.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.093 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.837 HG23 ' CD1' ' A' ' 126' ' ' TYR . 63.1 mt -67.04 138.11 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 111.518 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.619 ' O ' ' CG ' ' A' ' 57' ' ' MET . 10.4 ptm -130.45 98.07 4.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.567 HG12 ' HE1' ' A' ' 89' ' ' PHE . 61.0 t -65.63 125.77 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.967 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.69 -45.59 5.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -151.8 150.35 30.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.106 0.479 . . . . 0.0 110.664 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.489 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -169.08 152.16 5.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.848 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 1.2 t30 -150.39 151.8 33.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.968 0.413 . . . . 0.0 111.617 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.545 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 47.7 t80 -120.26 126.16 49.9 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.74 -137.7 5.79 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.677 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 15.7 ttm-85 -156.25 118.18 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.723 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.427 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 4.2 p -123.88 11.57 9.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.232 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.578 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.8 t0 -144.94 -170.5 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.752 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 46.5 p30 -146.49 -4.12 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.172 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -103.43 5.98 37.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 71' ' ' CYS . 32.4 mm -108.98 139.65 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.818 0.342 . . . . 0.0 110.552 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' ASP . 26.7 m 64.66 24.79 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.754 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.57 ' C ' ' O ' ' A' ' 71' ' ' CYS . 14.3 p30 -3.28 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.545 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -113.63 -167.66 1.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.704 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -62.17 145.58 93.42 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.251 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -58.99 -38.47 87.77 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.776 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -63.92 -39.62 94.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.897 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.704 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.9 mt-30 -84.83 -10.32 57.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.677 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 48.7 mmm -109.96 -2.96 16.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mt-10 -66.46 -44.36 82.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.562 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -78.26 121.27 24.19 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 67' ' ' ASP . 22.9 m -112.75 31.2 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.835 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -140.52 86.31 2.06 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.3 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.8 t -150.34 117.46 5.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 66' ' ' THR . 73.0 m-85 -127.46 157.57 39.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.908 0.385 . . . . 0.0 111.233 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 112' ' ' PRO . 40.6 tp -147.03 87.21 6.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.417 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -44.04 -46.04 11.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.504 2.136 . . . . 0.0 114.081 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.7 m-20 -54.93 -26.84 38.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.94 -33.05 35.67 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.994 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.567 ' HE1' HG12 ' A' ' 58' ' ' VAL . 57.1 t80 -66.24 -44.94 82.31 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 3.0 pttt -65.08 -40.32 94.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.42 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.465 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 83.3 mt -59.87 -49.31 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.761 ' SD ' HD21 ' A' ' 122' ' ' LEU . 74.4 mtp -72.83 -35.13 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.491 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.473 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 69.4 m -58.48 -42.69 88.12 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -66.28 -35.47 80.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 110.753 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 92.9 mtt-85 -79.14 -31.89 44.2 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 48' ' ' LEU . 57.4 m -112.68 -20.87 11.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 69.7 m-20 -60.58 134.45 57.09 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.904 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 66.04 13.8 9.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.693 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -116.68 147.98 41.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.207 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.9 m -72.05 -32.0 66.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.451 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -154.21 156.28 36.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.743 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.632 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.6 p -155.47 146.74 22.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 58.2 t -126.35 132.57 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.523 ' O ' HG22 ' A' ' 46' ' ' ILE . 42.9 t -143.81 139.45 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.611 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.7 t -76.48 118.76 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.99 28.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.004 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 178.2 -177.29 48.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.4 t 91.4 -162.77 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.836 0.35 . . . . 0.0 110.286 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.18 -9.24 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.24 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.44 56.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.302 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.584 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.0 m-85 -135.64 125.88 16.68 Favored Pre-proline 0 N--CA 1.455 -0.222 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.777 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 111' ' ' PHE . 27.2 Cg_exo -49.18 -158.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.518 2.145 . . . . 0.0 111.565 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -138.41 93.26 11.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -86.98 -12.82 4.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 123.185 2.59 . . . . 0.0 112.648 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.428 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -168.6 92.42 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.5 133.67 14.63 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.876 2.384 . . . . 0.0 112.828 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.03 11.52 36.79 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.887 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 77' ' ' GLN . 47.3 m -127.91 145.63 50.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 6.5 t80 -83.55 98.27 9.48 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 6.1 mtmp? -77.25 -167.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.69 1.234 . . . . 0.0 113.683 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.486 ' HB2' HD21 ' A' ' 39' ' ' LEU . 6.5 p90 -168.11 173.85 7.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.232 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.761 HD21 ' SD ' ' A' ' 92' ' ' MET . 26.4 tp -128.73 119.34 24.42 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.093 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -114.35 132.27 56.26 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.729 HG21 ' CE ' ' A' ' 92' ' ' MET . 95.1 t -131.24 149.32 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.16 127.83 28.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.837 ' CD1' HG23 ' A' ' 56' ' ' ILE . 20.8 p90 -158.73 174.33 15.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.812 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.37 158.17 36.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.696 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.785 ' H ' HH12 ' A' ' 36' ' ' ARG . 62.3 m -106.35 123.9 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.146 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 55' ' ' VAL . 4.9 m -130.54 157.4 77.65 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.502 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo . . . . . 0 N--CA 1.496 1.66 0 C-N-CA 122.361 2.04 . . . . 0.0 113.084 -179.848 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 62.5 mtp85 . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 33.0 ttp-105 -142.75 137.13 29.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.865 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.2 mp0 -137.59 144.14 41.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.528 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.775 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -139.21 139.22 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.801 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.775 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.09 142.51 34.13 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.597 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.4 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 16.6 m -71.08 135.48 47.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 84.2 tt0 -44.97 137.51 4.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.12 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.285 177.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.36 149.63 46.3 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 118.994 1.397 . . . . 0.0 110.319 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.18 146.12 68.88 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.346 2.031 . . . . 0.0 113.597 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 104' ' ' VAL . 15.2 tt -115.39 144.51 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.669 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 51.2 tt0 -121.35 128.0 51.82 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.463 -178.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.824 HD12 ' SG ' ' A' ' 102' ' ' CYS . 43.8 mt -117.79 140.32 49.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.669 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 89.5 mtt-85 -148.92 136.32 20.24 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.47 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.6 m -103.18 138.13 19.46 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.392 179.002 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 24.1 Cg_endo -66.54 156.01 67.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.473 2.115 . . . . 0.0 112.26 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.49 -134.67 38.11 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -103.41 25.1 10.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.503 . . . . 0.0 110.544 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.97 163.09 25.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.019 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.64 144.04 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.412 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.005 HG23 ' CD1' ' A' ' 126' ' ' TYR . 88.3 mt -68.31 137.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.114 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.4 ptm -130.9 99.04 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 t -61.46 123.37 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.585 -177.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.574 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.6 mm-40 -98.66 -50.63 4.18 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.6 m-20 -153.74 153.74 32.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.123 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.48 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.6 157.51 8.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.099 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.779 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.7 t30 -150.43 153.58 36.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.148 0.499 . . . . 0.0 111.992 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.518 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 32.1 t80 -123.35 121.09 34.93 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.59 -139.26 6.28 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.938 -177.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 6.6 ttm180 -155.5 116.72 3.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.141 0.496 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 p -124.22 10.21 8.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.973 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 37.4 t0 -145.87 -175.2 4.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.451 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 33.1 p30 -141.89 3.01 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.414 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 3.2 mtmp? -107.61 6.12 27.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.216 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.2 mm -117.81 137.85 50.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.5 m 54.47 74.91 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.767 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -53.62 125.42 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.408 0.623 . . . . 0.0 112.026 -178.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.88 -177.52 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.213 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -59.32 147.6 75.39 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.281 0.562 . . . . 0.0 110.066 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.4 Cg_endo -53.83 -38.52 85.63 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.114 1.876 . . . . 0.0 111.457 -178.385 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -61.44 -33.0 72.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.583 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 72.1 mt-30 -91.15 -6.2 53.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.438 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 73' ' ' ALA . 75.1 mtp -109.12 -9.1 15.06 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 40.9 mt-10 -63.89 -48.23 77.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.087 -178.344 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -81.21 116.83 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.536 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 20.9 m -106.66 33.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.554 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 90.6 mm-40 -141.76 86.72 2.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.2 t -145.4 118.22 8.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.411 ' HA ' HD21 ' A' ' 62' ' ' ASN . 94.3 m-85 -129.08 154.82 46.31 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.579 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.436 HD21 ' HD2' ' A' ' 112' ' ' PRO . 26.8 tp -147.16 89.2 5.62 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.26 -46.98 13.22 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 123.555 2.837 . . . . 0.0 115.094 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.5 m-20 -60.86 -14.03 19.4 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 62' ' ' ASN . . . -52.87 -36.34 59.0 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.358 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -64.56 -43.52 93.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.307 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.03 -42.18 99.71 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.723 -178.508 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.604 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 44.2 mt -60.27 -50.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.69 0.281 . . . . 0.0 111.305 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.456 ' SD ' HD21 ' A' ' 122' ' ' LEU . 83.6 mmm -66.98 -35.26 79.56 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.617 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.482 ' HB3' HD21 ' A' ' 97' ' ' ASN . 69.9 m -60.63 -48.59 81.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -66.74 -38.85 87.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.051 0.453 . . . . 0.0 111.355 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.604 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 83.9 mtt-85 -74.21 -34.23 63.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.588 ' SG ' HD12 ' A' ' 48' ' ' LEU . 56.4 m -112.62 -16.31 12.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -60.57 138.56 58.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.929 -0.709 . . . . 0.0 112.495 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 62.03 13.4 5.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.979 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -116.23 146.66 42.17 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.453 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -73.52 -28.0 61.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.825 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -153.03 153.59 33.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.824 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.1 p -154.02 141.99 20.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.619 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.63 128.77 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.355 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 46' ' ' ILE . 45.3 t -139.42 141.36 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.082 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.615 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -80.8 119.76 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -64.89 28.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.982 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 176.58 -175.97 47.72 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 90.01 -159.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.524 . . . . 0.0 110.61 179.407 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -62.49 -9.5 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.751 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.409 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -79.61 -18.37 51.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.553 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -140.88 129.92 12.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.434 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.553 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.8 Cg_exo -49.99 -153.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.267 1.978 . . . . 0.0 112.46 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -140.88 91.02 9.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.275 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 73.3 Cg_endo -81.58 -28.61 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.656 2.237 . . . . 0.0 113.031 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.446 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.8 p -146.11 77.22 12.04 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.07 131.97 49.16 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.244 1.962 . . . . 0.0 111.585 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.63 3.64 58.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.771 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 77' ' ' GLN . 93.2 m -116.95 145.95 43.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.19 0.995 . . . . 0.0 109.519 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.707 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 11.5 t80 -88.22 96.85 10.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.518 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 26.2 mttt -76.32 -161.8 0.2 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.488 -177.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 14.2 p90 -170.69 172.42 5.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.69 176.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 62' ' ' ASN . 61.5 tp -129.59 124.44 33.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.041 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -116.86 128.9 55.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.941 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.48 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.0 t -132.17 120.57 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 119.463 -0.895 . . . . 0.0 113.096 -178.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -106.97 123.99 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.005 ' CD1' HG23 ' A' ' 56' ' ' ILE . 17.5 p90 -154.08 174.88 14.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.555 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.627 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.4 OUTLIER -127.7 159.98 33.07 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.597 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.432 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 83.7 m -108.93 115.04 29.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.1 m -115.73 155.49 47.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo . . . . . 0 C--N 1.31 -1.465 0 C-N-CA 121.911 1.741 . . . . 0.0 112.224 -179.929 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.785 0.326 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.73 137.1 23.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.333 0.587 . . . . 0.0 111.69 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.3 mp0 -135.25 146.16 48.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.785 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.407 179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.662 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.63 148.61 44.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.176 0.513 . . . . 0.0 111.116 -179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.8 m -70.56 133.31 46.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.918 -178.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 5.8 tt0 -44.96 139.12 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.471 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -9.89 73.9 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.924 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -117.45 150.46 46.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 118.415 1.107 . . . . 0.0 110.555 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 138.56 55.82 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.584 2.19 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 tt -113.62 145.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -124.42 128.77 49.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.234 -178.061 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.514 HD12 ' SG ' ' A' ' 96' ' ' CYS . 50.3 mt -113.99 142.4 46.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.707 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -152.23 137.03 17.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.5 -178.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.82 149.74 36.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.916 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.4 Cg_endo -72.38 159.36 49.54 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.691 2.261 . . . . 0.0 112.757 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.87 -118.04 6.73 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.264 178.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -125.85 24.12 7.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -75.54 171.2 14.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.98 149.09 29.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.495 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.964 HG23 ' CD1' ' A' ' 126' ' ' TYR . 66.1 mt -73.45 138.87 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.623 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.7 ptm -133.29 100.24 4.78 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.524 HG12 ' HE1' ' A' ' 89' ' ' PHE . 59.7 t -63.12 124.12 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.853 -178.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 84.0 mt-10 -102.62 -45.71 4.96 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.5 m-20 -150.64 148.74 28.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.0 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.621 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.41 152.41 7.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.946 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.428 ' O ' HD12 ' A' ' 122' ' ' LEU . 9.0 t-20 -149.76 150.19 31.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.149 0.5 . . . . 0.0 111.509 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.575 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 57.4 t80 -120.74 122.39 40.3 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.48 -137.35 5.43 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.76 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 11.1 ttm-85 -154.69 119.47 4.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.959 0.409 . . . . 0.0 111.473 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.582 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 10.5 p -123.4 7.53 9.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.807 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 61.9 t0 -148.76 154.87 40.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.901 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p-10 -112.18 3.56 17.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 110.521 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -109.2 9.39 26.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.323 -178.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 mm -112.76 137.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.4 m 54.73 73.03 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.397 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.12 120.12 6.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.787 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -136.87 -164.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.151 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -64.32 138.2 97.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 7.2 Cg_endo -54.24 -31.99 68.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.968 1.779 . . . . 0.0 111.929 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -62.36 -41.89 98.97 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 118' ' ' THR . 36.7 mt-30 -92.45 -2.98 55.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.889 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.76 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 51.4 mmm -115.29 -4.1 12.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.111 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mm-40 -69.49 -38.85 77.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.063 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -76.07 124.13 26.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.599 -178.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.73 29.47 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -139.34 85.65 2.07 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.411 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.462 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.4 t -147.66 124.5 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -134.2 155.63 49.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.276 0.56 . . . . 0.0 111.752 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 112' ' ' PRO . 52.0 tp -147.17 95.5 4.39 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.962 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.17 -47.6 26.61 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.582 2.188 . . . . 0.0 113.568 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 90.0 m-20 -54.38 -21.6 10.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.837 -178.09 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.4 65.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.431 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' HE1' HG12 ' A' ' 58' ' ' VAL . 59.1 t80 -65.06 -40.95 95.44 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.4 pttp -65.13 -38.2 89.89 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 64.4 mt -61.3 -51.57 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.5 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.867 ' SD ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.41 -34.5 76.11 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.864 -178.867 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.5 m -61.02 -47.42 86.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.5 -35.97 80.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.622 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 94.9 mtt-85 -77.35 -35.02 55.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -177.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 48' ' ' LEU . 57.5 m -112.67 -15.69 12.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -177.14 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.6 m-20 -60.59 139.28 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.03 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 65.45 12.82 8.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.631 178.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -117.32 147.75 42.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.278 0.561 . . . . 0.0 110.915 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 m -72.78 -31.78 65.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.927 179.319 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -152.75 155.92 38.11 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.168 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 48' ' ' LEU . 30.2 p -155.01 144.8 21.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.846 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.4 125.12 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.161 178.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 t -140.35 142.55 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.867 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 107' ' ' GLY . 2.6 t -70.81 119.94 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.161 179.066 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -66.73 39.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.879 -178.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.32 -121.82 0.78 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.007 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 29.52 -155.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.439 0.637 . . . . 0.0 111.137 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -64.82 -11.55 38.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.49 60.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.859 -178.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 68.1 m-85 -144.52 129.46 9.33 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.012 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 49.2 Cg_exo -46.65 -159.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.558 2.172 . . . . 0.0 112.943 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -138.81 90.35 12.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.67 -53.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.152 2.568 . . . . 0.0 113.18 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -125.35 76.85 68.62 Favored Pre-proline 0 C--O 1.238 0.476 0 CA-C-O 121.181 0.515 . . . . 0.0 111.598 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.07 131.98 34.81 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.705 1.604 . . . . 0.0 111.469 179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.05 -11.27 34.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.227 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 77' ' ' GLN . 79.6 m -110.05 149.2 30.35 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.4 t80 -85.19 97.8 10.11 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.509 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 16.8 mtmt -72.09 -169.8 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 123.131 1.443 . . . . 0.0 114.572 -177.352 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.582 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.6 p90 -164.21 165.91 21.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 112.014 -2.357 . . . . 0.0 110.317 176.379 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.732 HD21 ' SD ' ' A' ' 92' ' ' MET . 43.1 tp -126.8 123.05 36.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.464 ' OE2' ' OE1' ' A' ' 125' ' ' GLN . 43.2 tt0 -120.4 126.72 51.16 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.561 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.867 HG21 ' SD ' ' A' ' 92' ' ' MET . 37.3 t -133.07 126.78 53.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.474 -178.514 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.464 ' OE1' ' OE2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -114.09 131.49 56.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.987 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.964 ' CD1' HG23 ' A' ' 56' ' ' ILE . 27.9 p90 -153.84 169.18 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 112.007 -178.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -122.72 162.03 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.76 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.477 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.4 m -109.26 131.96 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.23 161.71 59.51 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.593 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 N--CA 1.493 1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 112.828 -179.097 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.562 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 65.4 mtt85 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.498 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 39.2 ttp180 -147.03 139.7 24.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.336 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.687 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.8 mp0 -133.11 142.37 48.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.236 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -141.44 137.42 32.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.706 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.99 149.08 36.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.691 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.7 m -68.53 131.64 45.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 48.5 tt0 -45.9 142.65 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.431 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.0 -6.9 82.87 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.761 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.94 140.64 27.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.832 0.816 . . . . 0.0 110.016 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.14 141.48 88.57 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.514 2.142 . . . . 0.0 113.606 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 38' ' ' GLU . 13.0 tt -120.01 145.09 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.63 130.37 52.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.149 0.499 . . . . 0.0 112.18 -178.091 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.914 HD12 ' SG ' ' A' ' 102' ' ' CYS . 16.5 mt -113.21 143.41 44.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -150.05 135.16 17.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.066 -178.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.8 m -101.81 148.71 35.68 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.723 179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 60.4 Cg_endo -73.91 157.95 46.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.134 2.556 . . . . 0.0 112.34 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.92 -128.07 32.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 p -113.85 24.53 12.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -77.65 168.26 20.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.296 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 m -126.79 147.74 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.486 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.917 HG23 ' CD1' ' A' ' 126' ' ' TYR . 92.4 mt -72.55 140.02 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.395 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptp -131.87 102.0 5.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 93' ' ' SER . 99.9 t -63.93 123.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.093 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.3 mm-40 -102.17 -50.49 3.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' HB2' ' NE2' ' A' ' 125' ' ' GLN . 46.4 m-20 -146.86 144.18 29.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.447 -179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.743 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.22 148.26 6.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.847 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 4.8 t30 -150.92 156.81 41.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.366 0.603 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.547 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 49.4 t80 -120.27 122.13 40.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.09 -143.47 9.26 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.999 -177.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.687 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.6 ttm-85 -150.63 115.79 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.383 0.611 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 84' ' ' TYR . 19.7 p -123.52 3.45 9.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.355 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.684 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 53.7 t0 -145.04 153.24 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.224 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 38.6 p30 -112.55 0.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 43.3 mttm -102.48 1.82 35.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.401 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mm -110.44 138.8 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.391 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m 56.34 70.25 0.66 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.997 -179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -54.26 121.04 7.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.82 -163.05 1.46 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.028 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.02 143.91 97.4 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.27 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.0 Cg_endo -56.74 -38.69 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.515 2.144 . . . . 0.0 113.498 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -63.77 -29.95 71.1 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.183 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.7 mt-30 -88.33 -12.86 42.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.052 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 73.0 mtp -102.97 -5.4 23.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 57.3 mm-40 -65.23 -47.33 77.18 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.453 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 45.3 t30 -78.61 111.74 15.0 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.888 -178.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.464 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 33.3 m -103.34 31.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.464 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 25.6 mm100 -142.89 86.95 1.95 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.554 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.4 t -149.45 119.74 7.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.081 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.511 ' CE2' HG21 ' A' ' 66' ' ' THR . 51.2 m-85 -129.47 147.39 51.28 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.266 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.504 HD21 ' HG2' ' A' ' 112' ' ' PRO . 31.3 tp -138.31 91.97 12.34 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -50.26 -45.87 31.58 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.768 2.312 . . . . 0.0 113.319 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.6 m-20 -53.64 -30.6 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.246 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.93 54.03 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.188 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.509 ' O ' ' OG ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -65.5 -44.32 87.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.241 178.624 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.23 -41.19 97.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 -179.311 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.522 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 60.7 mt -60.69 -48.91 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.02 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.29 -36.19 81.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.918 0.389 . . . . 0.0 110.499 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 15.8 m -59.88 -45.43 92.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -65.93 -35.87 81.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.518 0.675 . . . . 0.0 110.883 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.492 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 95.1 mtt-85 -76.08 -34.25 59.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.504 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.624 ' SG ' HD12 ' A' ' 48' ' ' LEU . 33.0 m -112.42 -13.73 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' SER . 83.0 m-20 -60.77 134.59 57.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.273 0.559 . . . . 0.0 112.208 -179.278 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 66.37 12.73 8.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.679 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -115.8 147.72 40.67 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.281 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.9 m -74.02 -30.91 62.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -152.03 153.19 33.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.914 ' SG ' HD12 ' A' ' 48' ' ' LEU . 20.3 p -154.68 139.63 17.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.4 124.58 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 105' ' ' VAL . 57.9 t -138.74 151.83 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 112.123 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.4 t -84.5 116.57 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.184 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -67.22 40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.059 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 178.3 -131.03 1.67 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.753 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t 32.75 -150.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.036 -0.582 . . . . 0.0 112.227 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.46 -11.74 36.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.698 -178.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.83 -12.33 59.77 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.613 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.0 m-85 -142.2 124.73 9.19 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.445 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -46.23 -159.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.079 2.519 . . . . 0.0 113.547 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -137.05 85.82 21.74 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.34 -34.33 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.966 2.444 . . . . 0.0 112.775 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.415 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.0 p -145.73 89.99 6.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.88 139.04 42.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.812 2.341 . . . . 0.0 112.75 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.04 15.66 47.59 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.49 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.3 m -128.93 144.65 51.24 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.687 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 11.5 t80 -89.03 97.24 11.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.164 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.547 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 16.3 mttt -74.0 -153.77 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.765 1.269 . . . . 0.0 113.034 -177.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.4 p90 -175.6 171.6 2.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.275 -2.239 . . . . 0.0 109.085 176.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 18.1 tp -127.49 120.38 28.18 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 80.8 tt0 -113.11 125.65 54.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.743 HG22 ' HB1' ' A' ' 61' ' ' ALA . 74.1 t -135.75 124.79 39.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.202 -178.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.526 ' NE2' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -113.68 130.62 56.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.069 179.026 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.917 ' CD1' HG23 ' A' ' 56' ' ' ILE . 37.8 p90 -154.47 173.36 16.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 111.454 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.458 ' HA ' HH11 ' A' ' 36' ' ' ARG . 88.3 m-20 -127.51 161.72 28.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.562 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.5 m -109.49 117.54 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.262 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.07 158.19 61.35 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.921 -179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 N--CA 1.496 1.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.164 -179.723 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 66.0 mtp85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.576 ' NH2' ' OE2' ' A' ' 123' ' ' GLU . 74.6 ttt180 -147.77 131.81 17.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.686 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.613 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 46.4 mt-10 -132.54 145.62 51.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.045 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.1 tt -141.12 141.94 34.14 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.843 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.49 146.23 36.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.468 -178.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.34 130.0 41.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.973 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -40.39 136.13 1.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.45 83.7 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.111 -0.949 . . . . 0.0 114.173 177.123 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -117.8 148.18 42.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 118.994 1.397 . . . . 0.0 111.074 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.03 137.68 63.41 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.518 2.145 . . . . 0.0 113.32 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.4 143.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.71 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 44.7 tt0 -131.24 127.18 37.31 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.554 -178.554 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 102' ' ' CYS . 16.1 mt -108.7 144.58 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.164 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.71 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 93.3 mtt-85 -149.15 127.22 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.274 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -95.78 141.57 23.35 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.704 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 15.3 Cg_endo -66.6 158.7 54.47 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.031 1.821 . . . . 0.0 112.245 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.66 -134.28 34.75 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.427 0.459 . . . . 0.0 112.946 178.176 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.4 p -104.81 22.62 14.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.94 -0.63 . . . . 0.0 110.913 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -75.91 166.62 23.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.743 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 m -126.98 144.87 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.521 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.837 HG23 ' CD2' ' A' ' 126' ' ' TYR . 86.0 mt -70.23 136.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.143 0.497 . . . . 0.0 112.088 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.7 ptp -130.43 98.9 4.82 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.632 HG12 ' CE1' ' A' ' 89' ' ' PHE . 53.4 t -62.99 123.61 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.79 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.404 ' C ' ' CG ' ' A' ' 60' ' ' ASN . 73.4 mm-40 -99.49 -45.12 5.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' CG ' ' C ' ' A' ' 59' ' ' GLU . 2.8 m-80 -154.12 148.14 25.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.304 -179.085 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.26 152.87 11.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.885 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.739 ' O ' HD12 ' A' ' 122' ' ' LEU . 11.2 t30 -149.32 153.65 37.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.428 -179.114 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.492 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 61.6 t80 -125.84 125.69 43.27 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.06 -137.96 5.88 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -177.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.599 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -155.02 114.97 3.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 111.055 179.299 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.454 HG21 ' CE2' ' A' ' 84' ' ' TYR . 13.9 p -119.26 9.49 11.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.626 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 44.7 t0 -143.49 -167.12 2.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.612 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.626 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 53.9 p30 -151.83 -5.89 0.24 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 38.1 mttm -97.36 11.04 38.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.9 mm -115.03 138.56 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.939 0.4 . . . . 0.0 110.312 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m 56.92 70.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.117 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.6 p-10 -51.39 117.33 2.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.584 0.707 . . . . 0.0 111.315 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.94 -163.84 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.555 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.676 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 3.4 p30 -60.71 132.71 91.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 119.164 -1.014 . . . . 0.0 108.667 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -57.0 -27.14 72.08 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.452 2.101 . . . . 0.0 113.968 -178.383 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -63.88 -30.02 71.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.032 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.676 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.0 mt-30 -88.59 -5.72 57.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.516 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.599 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 6.0 mtm -110.84 -1.48 16.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.264 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 49.9 mt-10 -60.97 -52.32 65.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.963 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.98 107.76 11.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.051 -0.406 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 67' ' ' ASP . 19.6 m -101.4 31.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.33 0.586 . . . . 0.0 110.662 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -139.26 85.9 2.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.415 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 43.5 t -149.32 115.39 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.454 ' CE2' HG21 ' A' ' 66' ' ' THR . 91.1 m-85 -124.25 156.01 37.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.727 0.299 . . . . 0.0 111.221 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 112' ' ' PRO . 55.1 tp -142.69 82.02 12.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -44.91 -45.42 13.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.245 2.63 . . . . 0.0 114.256 -177.494 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 86.6 m-20 -57.1 -25.29 58.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.885 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.36 -34.77 49.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.576 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.632 ' CE1' HG12 ' A' ' 58' ' ' VAL . 26.7 t80 -64.1 -40.37 96.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.8 pttm -67.17 -39.25 86.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.835 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.669 HG23 ' NH1' ' A' ' 95' ' ' ARG . 69.9 mt -60.19 -52.45 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' MET . . . . . 1.063 ' SD ' HD21 ' A' ' 122' ' ' LEU . 62.1 mtp -69.68 -32.56 71.25 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.478 ' HB3' HD21 ' A' ' 97' ' ' ASN . 62.5 m -59.97 -43.37 95.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.592 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 90.4 mt-30 -66.59 -36.23 82.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.353 0.596 . . . . 0.0 110.014 178.393 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.669 ' NH1' HG23 ' A' ' 91' ' ' ILE . 52.9 mtt85 -77.45 -34.08 54.54 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.607 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.4 m -110.89 -16.19 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.478 HD21 ' HB3' ' A' ' 93' ' ' SER . 77.0 m-20 -61.44 133.39 55.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.804 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 66.52 13.31 9.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.255 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.592 ' NH2' ' O ' ' A' ' 94' ' ' GLN . 42.9 mtt85 -113.89 147.03 39.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.944 178.181 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -71.04 -31.32 67.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.623 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 156.59 35.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.102 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.3 p -153.6 142.34 21.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.29 126.25 70.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.328 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.71 146.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.855 -178.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.45 120.26 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.268 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.76 43.5 0.09 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.165 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.1 -126.72 1.03 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 29.36 -154.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.239 0.543 . . . . 0.0 112.209 179.588 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -64.43 -10.56 25.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.642 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.05 59.9 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.807 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 112' ' ' PRO . 64.4 m-85 -142.69 126.76 9.68 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.684 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.567 ' HG2' HD21 ' A' ' 85' ' ' LEU . 23.4 Cg_exo -50.1 -156.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.323 2.015 . . . . 0.0 112.436 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.459 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 20.9 t0 -139.35 93.21 10.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.411 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.49 -38.55 0.98 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.714 2.276 . . . . 0.0 113.328 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -140.25 79.08 22.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.057 0.456 . . . . 0.0 110.995 -179.349 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 17.2 Cg_exo -56.18 133.4 57.83 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.187 1.924 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.46 -10.9 56.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.888 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 77' ' ' GLN . 62.9 m -105.95 147.54 28.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.616 0.708 . . . . 0.0 109.104 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.593 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 t80 -84.37 97.61 9.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.492 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 22.5 mtmm -73.54 -171.65 1.05 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.457 1.599 . . . . 0.0 115.083 -177.056 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.6 p90 -164.47 167.73 19.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 111.58 -2.555 . . . . 0.0 110.579 177.1 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.063 HD21 ' SD ' ' A' ' 92' ' ' MET . 25.9 tp -129.33 122.56 29.78 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.049 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.576 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 83.5 tt0 -115.33 132.93 56.46 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.774 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.687 HG21 ' SD ' ' A' ' 92' ' ' MET . 41.5 t -133.33 144.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.82 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.26 130.44 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.837 ' CD2' HG23 ' A' ' 56' ' ' ILE . 27.9 p90 -156.09 171.62 19.82 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.138 -178.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 57' ' ' MET . 87.8 m-20 -125.5 162.22 25.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.775 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 92.4 m -108.93 125.52 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.7 m -130.34 157.58 76.9 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.674 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.492 1.41 0 C-N-CA 122.025 1.816 . . . . 0.0 111.979 178.796 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.525 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 3.3 mtm-85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' HE ' ' HG2' ' A' ' 125' ' ' GLN . 41.0 ttm180 -146.69 135.84 22.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' HD23 ' A' ' 48' ' ' LEU . 78.5 mm-40 -132.04 143.6 50.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.672 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.2 tt -139.16 141.09 38.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.774 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.91 142.73 34.4 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.266 -179.175 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.448 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 65.7 m -66.84 134.45 52.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.994 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 5.4 tt0 -44.04 134.86 4.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.118 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -4.91 79.67 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.326 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 12.1 m-85 -118.1 150.08 46.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 118.189 0.995 . . . . 0.0 110.798 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 24.4 Cg_endo -65.94 141.76 65.95 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.879 2.386 . . . . 0.0 113.722 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.0 tt -117.3 145.53 22.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.135 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.445 ' HG3' HG22 ' A' ' 103' ' ' VAL . 80.2 tt0 -127.5 129.29 47.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.317 -178.159 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.764 HD12 ' SG ' ' A' ' 102' ' ' CYS . 40.4 mt -112.44 141.81 45.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.538 178.284 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -149.43 132.85 16.6 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.577 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.8 m -102.68 142.98 25.68 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.901 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.17 161.59 44.15 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.6 2.2 . . . . 0.0 112.844 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.03 -128.1 33.34 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.6 p -112.88 25.84 11.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.45 166.82 22.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.5 m -127.62 143.99 38.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.936 HG23 ' CD2' ' A' ' 126' ' ' TYR . 92.0 mt -69.48 139.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.234 -178.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 127' ' ' ASP . 4.0 ptp -132.85 103.12 5.93 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.67 125.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.25 -178.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 96.0 mt-10 -102.94 -51.0 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -149.05 145.1 27.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.202 0.525 . . . . 0.0 110.549 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.494 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.85 156.22 10.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.716 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.449 ' O ' HD12 ' A' ' 122' ' ' LEU . 6.4 t30 -152.59 154.95 36.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.177 0.513 . . . . 0.0 111.618 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 76.9 t80 -122.39 122.48 39.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.445 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.11 -142.45 8.68 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -177.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -151.6 119.15 6.05 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.17 0.51 . . . . 0.0 111.722 179.11 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.413 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 26.6 p -128.09 5.49 5.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.557 179.134 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.745 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 61.8 t0 -144.39 151.63 39.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.399 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.658 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 40.7 p30 -112.66 3.5 16.65 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.471 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 15.7 mttt -103.1 8.52 38.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.737 -178.518 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.2 mm -112.31 135.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 -179.089 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m 55.69 72.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.611 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 57.8 p30 -49.65 106.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.529 0.68 . . . . 0.0 112.19 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.56 -166.78 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.152 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.626 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.18 141.6 97.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 5.9 Cg_endo -54.99 -33.82 84.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 121.895 1.73 . . . . 0.0 112.509 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -63.51 -40.26 96.57 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -90.37 -6.68 54.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.974 0.416 . . . . 0.0 110.577 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.445 ' HE3' ' NH2' ' A' ' 65' ' ' ARG . 80.2 mmm -106.66 -5.23 18.76 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.758 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.583 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 1.9 mm-40 -66.98 -46.58 74.18 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.225 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.7 t30 -78.25 122.99 26.43 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.838 -178.26 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.24 32.59 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.1 85.5 2.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.496 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.402 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 2.2 t -151.27 121.22 7.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.9 m-85 -131.75 156.59 45.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.964 0.411 . . . . 0.0 111.939 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' A' ' 88' ' ' ALA . 27.8 tp -147.93 87.66 5.76 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.567 178.297 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -48.03 -46.6 21.64 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.621 2.214 . . . . 0.0 113.361 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.5 m-20 -55.15 -23.92 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.124 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.432 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.59 -33.08 63.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.615 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' O ' ' OG ' ' A' ' 93' ' ' SER . 4.7 t80 -65.18 -40.75 94.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.598 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 10.1 pttp -64.87 -40.6 95.39 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.39 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 60.6 mt -59.94 -50.52 79.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.703 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.419 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 96.0 mmm -67.16 -33.99 76.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.502 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 28.1 m -60.02 -45.09 93.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.283 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.71 -36.78 83.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.179 0.514 . . . . 0.0 111.01 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.822 ' CZ ' HG13 ' A' ' 104' ' ' VAL . 16.9 mtp180 -74.09 -35.4 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.455 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.584 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.2 m -112.99 -12.88 13.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.151 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.502 ' CG ' ' O ' ' A' ' 93' ' ' SER . 68.2 m-20 -60.02 133.76 56.4 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.55 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 67.31 13.83 9.5 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 178.257 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -113.85 145.16 41.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.802 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.7 m -69.13 -31.26 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.257 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 155.4 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.267 179.326 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.764 ' SG ' HD12 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -153.86 130.8 10.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.25 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.445 HG22 ' HG3' ' A' ' 47' ' ' GLU . 97.3 t -114.25 132.4 63.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.875 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.822 HG13 ' CZ ' ' A' ' 95' ' ' ARG . 43.5 t -144.03 149.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -83.62 117.52 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.08 37.48 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.62 -178.652 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.94 -127.73 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.554 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 107' ' ' GLY . 12.4 t 31.69 -153.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.46 -9.08 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.101 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.36 60.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.922 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -141.57 126.36 10.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.8 Cg_exo -49.96 -154.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.602 2.201 . . . . 0.0 112.162 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -137.72 87.39 17.25 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -84.7 -20.89 3.57 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.313 2.675 . . . . 0.0 114.092 -179.337 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.508 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -153.49 73.47 6.71 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 121.109 0.48 . . . . 0.0 110.858 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.26 135.42 50.33 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.084 1.856 . . . . 0.0 112.048 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.76 -12.0 53.35 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.586 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -111.25 149.79 30.52 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.187 0.994 . . . . 0.0 108.835 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.2 t80 -82.2 98.5 8.76 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.257 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.508 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 20.7 mttt -70.89 -160.74 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.652 1.215 . . . . 0.0 112.98 -178.418 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -176.5 171.73 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.052 176.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 111' ' ' PHE . 20.3 tp -130.11 123.83 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.666 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 57.6 tt0 -117.89 125.07 49.8 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.494 HG22 ' HB1' ' A' ' 61' ' ' ALA . 29.9 t -131.01 124.73 56.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.938 -178.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.46 ' HG2' ' HE ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -109.48 131.41 55.09 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.936 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.8 p90 -151.46 171.93 16.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.357 -178.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.455 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 48.9 m-20 -127.08 160.9 29.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.898 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.525 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 84.2 m -112.6 120.94 43.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.744 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 30.7 m -121.16 149.18 50.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.902 179.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 121.83 1.686 . . . . 0.0 112.163 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.441 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.649 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 16.1 mt -55.81 -36.24 43.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.919 -0.141 . . . . 0.0 111.183 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 5.1 Cg_endo -82.76 -157.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.858 2.372 . . . . 0.0 111.963 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' O ' HD23 ' A' ' 34' ' ' LEU . 63.0 m-85 -79.52 -7.62 58.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 110.722 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.46 19.82 64.97 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.8 OUTLIER -166.4 129.77 2.0 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.414 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 34' ' ' LEU . 6.0 mtt 47.96 117.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.244 0.545 . . . . 0.0 111.164 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.456 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 65.4 mtp85 -93.45 153.06 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.736 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -153.12 138.37 17.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.296 0.57 . . . . 0.0 112.161 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.765 ' CD ' HD23 ' A' ' 48' ' ' LEU . 86.8 mt-10 -131.16 149.5 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -136.26 139.55 42.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.873 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.9 145.18 32.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.034 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.3 m -71.25 133.66 46.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.457 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.573 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 79.7 tt0 -44.27 137.16 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.496 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.22 -6.94 72.4 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.402 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.442 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 15.1 m-85 -116.9 153.78 49.46 Favored Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 118.972 1.386 . . . . 0.0 111.154 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.05 141.8 40.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.124 1.883 . . . . 0.0 112.725 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 16.5 tt -116.33 144.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 86.0 tt0 -129.98 127.71 40.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.261 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.892 HD12 ' SG ' ' A' ' 102' ' ' CYS . 19.9 mt -111.45 144.74 40.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.254 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.519 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 62.7 mtt180 -147.93 126.62 12.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.309 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -95.39 144.54 27.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 27.6 Cg_endo -68.55 157.3 62.39 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.481 2.12 . . . . 0.0 112.295 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.43 -134.51 29.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.438 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -104.63 23.05 13.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -77.67 167.67 21.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.85 145.65 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.635 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.655 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.4 mt -67.91 136.21 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.821 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.591 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.2 ptm -132.5 100.79 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.539 HG12 ' HE1' ' A' ' 89' ' ' PHE . 25.4 t -64.16 124.77 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.403 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.562 ' OE1' ' OD1' ' A' ' 127' ' ' ASP . 46.9 mt-10 -102.04 -50.61 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.855 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -148.23 146.5 28.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.948 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.646 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.8 153.83 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.531 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.766 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.2 t30 -151.54 154.16 35.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.159 0.504 . . . . 0.0 111.796 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 30.2 t80 -123.57 122.83 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -138.89 6.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 5.3 ttm-85 -155.69 115.52 3.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.057 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.545 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 14.8 p -124.8 7.67 8.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.525 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -146.95 155.47 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.523 ' O ' ' HE2' ' A' ' 78' ' ' MET . 58.7 p30 -110.16 0.69 18.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 14.2 mttp -105.75 8.86 33.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.776 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.646 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 46.1 mm -113.72 136.27 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.781 0.324 . . . . 0.0 110.512 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 51.6 m 59.99 63.7 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -47.99 109.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 112.25 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -128.35 -164.81 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.758 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.687 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -62.85 144.73 96.63 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.173 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.2 Cg_endo -54.78 -37.59 92.08 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.34 2.027 . . . . 0.0 112.52 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -63.86 -34.47 78.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.597 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.687 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.3 mt-30 -86.82 -10.73 52.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.523 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 88.1 mtp -102.21 -5.49 24.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 37.6 mm-40 -63.99 -52.63 58.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -78.84 115.48 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.379 0.609 . . . . 0.0 112.517 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.2 m -107.17 32.28 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.127 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -139.93 85.51 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.113 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.443 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.6 t -148.11 118.79 7.51 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.426 ' HA ' HD21 ' A' ' 62' ' ' ASN . 55.9 m-85 -125.74 152.85 44.79 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.08 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 85' ' ' LEU . 35.0 tp -147.17 83.66 7.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.66 -47.25 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.078 2.519 . . . . 0.0 113.308 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 82.3 m-20 -54.11 -23.76 15.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.802 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.33 56.78 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.098 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' HE1' HG12 ' A' ' 58' ' ' VAL . 33.7 t80 -64.03 -42.85 96.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.99 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 14.4 pttm -63.92 -38.35 90.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.106 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 69.1 mt -60.98 -52.22 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.306 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.5 mmm -68.48 -36.24 78.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.068 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.8 m -60.43 -47.29 86.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -66.55 -36.84 83.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.452 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 89.5 mtt-85 -76.96 -32.91 57.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.616 ' SG ' HD12 ' A' ' 48' ' ' LEU . 61.6 m -111.29 -15.29 13.65 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.539 ' CG ' ' O ' ' A' ' 93' ' ' SER . 48.2 m-20 -60.04 134.07 56.7 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.665 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 66.38 13.53 9.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -115.95 147.35 41.25 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.57 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.7 m -72.53 -31.47 65.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.718 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.48 154.65 35.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.892 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.2 p -155.16 136.94 14.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.747 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 47' ' ' GLU . 20.6 t -116.93 130.59 71.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 46' ' ' ILE . 42.3 t -143.09 146.87 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.599 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -80.76 118.49 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.01 37.44 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.723 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.74 -130.16 1.46 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.564 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 107' ' ' GLY . 3.5 t 36.64 -154.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -63.27 -9.01 9.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.273 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.15 -13.45 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.558 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.583 ' O ' ' O ' ' A' ' 112' ' ' PRO . 62.1 m-85 -140.58 128.19 12.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.448 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.4 Cg_exo -48.61 -158.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.352 2.034 . . . . 0.0 111.984 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.19 91.85 12.62 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -82.59 -46.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.134 2.556 . . . . 0.0 113.112 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.5 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -131.79 77.97 71.29 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-O 121.112 0.482 . . . . 0.0 111.319 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.404 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 9.9 Cg_endo -62.49 131.6 34.53 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.748 1.632 . . . . 0.0 111.739 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.49 -6.59 38.88 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.526 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.586 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 96.7 m -112.49 147.58 36.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.636 0.718 . . . . 0.0 109.336 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.544 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.3 t80 -85.87 98.43 10.77 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.524 ' NZ ' ' O3 ' ' A' ' 136' ' ' RAM . 11.9 mttp -76.51 -163.01 0.29 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 123.078 1.418 . . . . 0.0 113.803 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.545 ' OH ' ' N ' ' A' ' 66' ' ' THR . 5.7 p90 -169.29 171.9 7.61 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.44 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 62' ' ' ASN . 55.2 tp -129.26 122.55 29.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.088 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 54.7 tt0 -115.31 128.42 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.372 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.646 HG22 ' HB1' ' A' ' 61' ' ' ALA . 44.5 t -135.54 123.77 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.48 -0.888 . . . . 0.0 113.141 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.0 129.32 54.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.655 ' CD2' HG23 ' A' ' 56' ' ' ILE . 35.7 p90 -152.21 166.96 30.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.237 0.541 . . . . 0.0 111.873 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.562 ' OD1' ' OE1' ' A' ' 59' ' ' GLU . 3.1 m-20 -126.75 161.74 27.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.241 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.456 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 65.3 m -111.96 122.26 47.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.623 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.5 m -124.86 154.41 70.82 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.63 149.05 60.86 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.342 2.028 . . . . 0.0 112.446 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -76.47 2.08 14.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.888 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.703 ' CD ' ' N ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -144.56 -163.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.577 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 134' ' ' GLU . 7.6 p -86.68 132.2 32.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.07 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 133' ' ' VAL . 21.3 tp10 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.324 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.425 ' H82' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.586 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.718 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -130.28 142.06 44.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.844 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -68.88 148.83 71.56 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.389 2.059 . . . . 0.0 111.601 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -78.93 -5.54 53.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.238 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.93 38.82 94.57 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -155.36 55.89 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.04 0.448 . . . . 0.0 110.295 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' LEU . 5.4 mtt 57.91 150.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.993 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -90.45 147.95 23.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 68.6 ttt-85 -143.93 140.43 29.69 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.967 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG3' HD23 ' A' ' 48' ' ' LEU . 71.7 mm-40 -137.51 140.32 41.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.58 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -142.36 128.75 20.04 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.555 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -129.91 145.65 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.946 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.6 m -67.78 133.84 49.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.907 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.593 ' OE2' ' O4 ' ' A' ' 136' ' ' RAM . 0.0 OUTLIER -42.96 136.63 2.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.015 -178.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.74 -2.96 82.98 Favored Glycine 0 N--CA 1.453 -0.198 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.712 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -117.05 150.76 46.58 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.0 0.9 . . . . 0.0 110.706 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.04 140.64 45.92 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.45 2.1 . . . . 0.0 112.714 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 104' ' ' VAL . 14.4 tt -114.05 149.04 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 48.8 tt0 -126.55 127.86 45.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.154 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 102' ' ' CYS . 19.3 mt -115.62 138.87 50.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 79.1 mtt180 -146.9 130.75 17.09 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.753 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.9 m -98.15 146.23 31.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.933 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 128' ' ' CYS . 51.8 Cg_endo -72.84 158.68 49.74 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.724 2.283 . . . . 0.0 112.29 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.83 -129.35 26.41 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.805 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -110.27 25.66 11.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.09 167.84 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.158 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.86 145.0 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.126 0.489 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.952 HG23 ' CD2' ' A' ' 126' ' ' TYR . 73.4 mt -67.89 137.61 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.686 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.7 ptp -132.52 100.87 5.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 t -63.23 126.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.766 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -101.63 -51.22 3.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.114 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -148.96 147.05 28.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.625 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.84 151.92 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.401 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 122' ' ' LEU . 13.2 t30 -152.39 161.79 42.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.397 0.618 . . . . 0.0 111.856 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.488 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 80.6 t80 -126.73 125.0 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -141.08 7.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.531 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.73 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.6 ttm-85 -155.04 114.87 3.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.266 0.555 . . . . 0.0 111.166 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 69.8 p -119.89 8.87 11.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.066 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.644 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.2 t0 -145.05 -170.11 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.417 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.584 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 2.9 p30 -146.04 -0.51 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.756 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -107.71 8.74 29.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.213 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.574 ' HB ' HH22 ' A' ' 65' ' ' ARG . 35.2 mm -102.74 134.55 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.578 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' ASP . 73.8 m 55.75 24.15 6.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.648 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.58 ' C ' ' O ' ' A' ' 71' ' ' CYS . 15.8 t70 1.43 105.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB3' ' CG ' ' A' ' 78' ' ' MET . . . -121.7 -166.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.062 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -63.31 146.25 96.34 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.066 179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.541 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -58.4 -37.65 93.93 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.2 1.933 . . . . 0.0 112.571 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.48 -42.71 95.73 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.688 ' OE1' ' H61' ' A' ' 136' ' ' RAM . 28.9 mt-30 -84.12 -6.14 59.36 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.037 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.466 ' CG ' ' HB3' ' A' ' 73' ' ' ALA . 54.7 mmm -112.51 0.43 15.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.195 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 18.0 mt-10 -64.32 -47.85 77.85 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.934 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -78.86 113.71 17.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.446 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 67' ' ' ASP . 7.7 m -105.75 35.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.083 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -140.03 87.26 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.894 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.47 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.5 t -151.75 116.43 5.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.428 ' HA ' HD21 ' A' ' 62' ' ' ASN . 86.1 m-85 -125.29 156.13 39.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.942 0.401 . . . . 0.0 111.035 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.584 HD21 ' HG2' ' A' ' 112' ' ' PRO . 27.0 tp -145.59 91.1 5.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -48.89 -45.25 29.31 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.433 2.089 . . . . 0.0 111.622 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 65.9 m-20 -54.38 -30.92 53.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.447 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.32 -32.54 49.42 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.242 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -65.09 -43.98 90.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.4 pttp -66.08 -38.23 87.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.527 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 84.1 mt -59.88 -53.28 50.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.732 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 91.8 mmm -67.52 -34.73 77.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.518 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.464 ' HB3' HD21 ' A' ' 97' ' ' ASN . 23.8 m -58.91 -46.7 87.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.186 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.07 -37.62 84.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.757 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.452 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 96.3 mtt-85 -73.98 -33.62 63.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.2 m -114.71 -13.72 12.05 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.464 HD21 ' HB3' ' A' ' 93' ' ' SER . 88.5 m-20 -61.22 135.91 57.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.009 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 67.83 13.91 9.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.523 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -116.1 146.74 41.98 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.072 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -72.41 -31.67 65.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.716 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -151.27 155.26 38.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.681 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.1 p -156.19 133.96 11.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.724 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.15 126.89 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 46' ' ' ILE . 45.0 t -139.35 146.21 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 111.614 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.66 119.6 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 38.38 0.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.118 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.35 -124.19 0.89 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.937 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.71 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 31.04 -158.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.717 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.71 ' N ' ' OG ' ' A' ' 108' ' ' SER . 89.6 m-20 -64.4 -9.23 16.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.6 -8.96 58.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.249 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 112' ' ' PRO . 32.3 m-85 -141.05 131.18 13.15 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.075 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.584 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.9 Cg_exo -48.76 -163.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.343 2.029 . . . . 0.0 111.767 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.569 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -136.87 89.24 17.49 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.303 -179.343 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.78 -54.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.992 2.461 . . . . 0.0 113.139 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 4.1 p -127.49 72.87 77.89 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.887 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -58.74 131.85 44.56 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.908 1.739 . . . . 0.0 111.582 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.473 ' N ' ' O2 ' ' A' ' 136' ' ' RAM . . . 108.91 -16.96 32.95 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.803 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' GLN . 43.4 m -102.91 153.5 20.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.064 0.932 . . . . 0.0 108.495 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.73 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 21.2 t80 -86.21 99.31 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.527 0.68 . . . . 0.0 109.506 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.488 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 4.8 mtmp? -81.99 -159.27 0.28 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.599 1.19 . . . . 0.0 113.875 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 19.9 p90 -174.9 174.19 2.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.34 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 62' ' ' ASN . 18.7 tp -131.51 125.06 31.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.425 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 75.3 tt0 -121.18 130.79 53.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.625 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.8 t -134.41 123.47 42.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.011 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.7 129.71 55.58 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.952 ' CD2' HG23 ' A' ' 56' ' ' ILE . 40.9 p90 -153.56 169.76 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.51 0.671 . . . . 0.0 111.851 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.408 ' OD1' ' HG2' ' A' ' 35' ' ' MET . 74.8 m-20 -124.15 160.67 27.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.418 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.409 ' CB ' ' HD2' ' A' ' 51' ' ' PRO . 93.0 m -113.57 112.25 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.77 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.1 165.65 13.65 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.635 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -65.61 148.53 87.32 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.669 1.58 . . . . 0.0 111.63 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.413 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 35.2 t80 -72.24 -96.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.138 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 25.4 tttt -90.29 -74.13 0.5 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.567 ' O ' ' O ' ' A' ' 134' ' ' GLU . 92.7 t -143.71 136.36 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.851 0.358 . . . . 0.0 110.932 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 133' ' ' VAL . 82.9 tt0 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.701 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.688 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 mp -70.42 145.46 93.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.3 134.74 65.83 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.385 2.057 . . . . 0.0 111.184 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -74.71 -54.05 8.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.574 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.01 23.71 76.92 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.671 HD23 ' N ' ' A' ' 35' ' ' MET . 1.1 tt -161.5 124.11 3.06 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.688 0.28 . . . . 0.0 110.49 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.671 ' N ' HD23 ' A' ' 34' ' ' LEU . 2.6 mtt 58.06 153.9 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.296 0.57 . . . . 0.0 111.124 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.571 ' NH1' ' HD3' ' A' ' 51' ' ' PRO . 19.9 mtp180 -90.82 146.39 23.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.213 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.497 ' HE ' ' CG ' ' A' ' 123' ' ' GLU . 74.7 ttt180 -148.28 133.78 18.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.299 0.571 . . . . 0.0 110.984 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -129.57 146.45 51.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.517 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 121' ' ' TYR . 7.5 tt -141.6 127.88 19.84 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -130.81 147.47 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.045 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 m -70.05 132.2 45.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.519 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.598 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 17.4 tt0 -44.82 140.47 2.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.782 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 92.06 -8.28 77.99 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.818 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 18.7 m-85 -117.2 147.62 40.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 118.353 1.077 . . . . 0.0 109.928 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.95 146.24 76.88 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.342 2.028 . . . . 0.0 113.069 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 104' ' ' VAL . 20.9 tt -120.47 148.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.943 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.659 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 80.8 tt0 -132.63 126.96 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -112.91 143.38 44.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.659 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 97.8 mtt180 -144.78 134.31 23.28 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.518 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.486 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.7 m -103.79 143.65 27.08 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.274 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.571 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 49.3 Cg_endo -73.03 154.71 52.78 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 112.346 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.5 51.09 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.827 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -113.77 27.94 9.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -80.28 167.83 19.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.52 150.05 33.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.797 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.011 HG23 ' CD1' ' A' ' 126' ' ' TYR . 53.6 mt -71.05 138.14 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.181 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.438 ' HG3' ' H ' ' A' ' 127' ' ' ASP . 3.0 ptp -131.04 98.01 4.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.584 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.0 t -64.54 126.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.914 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -103.54 -46.78 4.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.46 ' HB2' ' NE2' ' A' ' 125' ' ' GLN . 14.3 m-80 -150.53 147.55 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.447 0.642 . . . . 0.0 111.13 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.64 154.86 10.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.241 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.542 HD21 ' HA ' ' A' ' 84' ' ' TYR . 6.1 t30 -150.5 151.41 32.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.06 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.416 ' CE2' ' HD3' ' A' ' 120' ' ' LYS . 47.5 t80 -119.88 122.93 42.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.34 -138.39 5.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.881 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 7.1 ttm-85 -155.21 115.4 3.79 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.168 -0.516 . . . . 0.0 109.845 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 p -122.39 11.49 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.044 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.635 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 49.9 t0 -146.91 -171.03 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.272 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.635 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 56.1 p30 -144.55 -0.33 0.96 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -103.9 6.3 36.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.209 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 40.1 mm -113.34 137.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m 57.25 70.56 0.64 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.128 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -53.12 122.16 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.387 0.613 . . . . 0.0 112.084 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -139.97 -163.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 141.07 98.0 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.9 Cg_endo -56.82 -35.03 97.9 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.344 2.029 . . . . 0.0 112.554 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -63.16 -36.87 85.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.638 ' OE1' ' H61' ' A' ' 136' ' ' RAM . 29.4 mt-30 -88.14 12.54 13.39 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.233 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 75.8 mtp -129.0 -2.99 5.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 53.5 mm-40 -63.27 -47.25 83.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.987 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.44 119.29 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.419 . . . . 0.0 111.912 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 81' ' ' VAL . 5.3 m -111.37 31.66 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.623 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -136.23 85.84 2.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.48 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.3 t -149.15 112.57 5.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.542 ' HA ' HD21 ' A' ' 62' ' ' ASN . 72.8 m-85 -128.19 152.56 47.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.648 0.261 . . . . 0.0 110.945 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.76 86.76 7.72 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -45.98 -48.43 12.7 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.86 2.374 . . . . 0.0 114.904 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 37.6 m-20 -58.54 -21.89 53.83 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.27 61.65 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.565 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CE1' HG12 ' A' ' 58' ' ' VAL . 54.5 t80 -63.81 -41.83 97.8 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.6 pttm -66.54 -38.5 87.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.573 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.406 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 88.5 mt -60.74 -50.7 79.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.804 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.5 ' SD ' HG11 ' A' ' 104' ' ' VAL . 98.6 mmm -67.75 -35.63 79.08 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.11 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 16.4 m -61.82 -46.1 90.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.391 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.92 -35.6 81.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.562 0.696 . . . . 0.0 110.424 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' A' ' 104' ' ' VAL . 23.1 mtp85 -74.47 -34.0 63.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.6 m -112.39 -21.46 11.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' SER . 60.4 m-20 -56.25 129.72 41.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 72.05 14.33 5.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.829 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 84.5 mtt180 -117.12 149.22 40.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.585 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.0 m -71.28 -33.42 69.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.501 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -153.68 155.01 35.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.98 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.5 p -151.44 149.88 29.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.978 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.56 126.66 75.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 46' ' ' ILE . 44.0 t -137.34 144.03 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -85.8 122.15 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.373 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -66.81 23.56 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . -179.59 173.09 44.95 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.935 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.606 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.7 t 94.79 -155.55 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -66.32 -11.19 49.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.008 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.97 -18.47 60.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.55 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.527 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.5 m-85 -141.47 131.22 12.76 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.575 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 111' ' ' PHE . 36.1 Cg_exo -50.64 -156.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.404 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.13 95.63 10.52 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.769 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -82.98 -50.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.657 2.238 . . . . 0.0 113.564 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.478 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 11.2 p -133.05 84.8 47.56 Favored Pre-proline 0 N--CA 1.466 0.36 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.098 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.431 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 27.1 Cg_endo -64.02 136.1 50.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.08 1.853 . . . . 0.0 112.328 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.6 -4.8 47.22 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.361 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.403 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 67.2 m -114.4 149.3 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.169 0.984 . . . . 0.0 108.655 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.564 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 7.3 t80 -85.09 98.99 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 18.6 mttt -76.05 -165.61 0.49 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.918 1.342 . . . . 0.0 113.363 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' HB2' HD21 ' A' ' 39' ' ' LEU . 8.4 p90 -167.83 167.46 12.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.251 -2.25 . . . . 0.0 109.769 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 25.9 tp -127.76 123.33 35.04 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.549 ' CD ' ' OE1' ' A' ' 125' ' ' GLN . 3.4 tm-20 -117.61 129.42 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.11 119.65 41.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.549 ' OE1' ' CD ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -102.69 127.8 49.67 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.011 ' CD1' HG23 ' A' ' 56' ' ' ILE . 18.6 p90 -154.77 170.48 21.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.58 0.705 . . . . 0.0 112.517 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.438 ' H ' ' HG3' ' A' ' 57' ' ' MET . 97.6 m-20 -128.13 163.34 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.779 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.458 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 92.6 m -109.46 114.51 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.367 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.64 151.02 47.9 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.66 141.91 83.18 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.587 1.525 . . . . 0.0 112.342 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -79.26 136.98 37.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.803 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -92.36 129.12 38.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.455 ' O ' ' OXT' ' A' ' 134' ' ' GLU . 86.8 t -97.45 134.59 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.455 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 73.1 tt0 . . . . . 0 C--O 1.218 -0.59 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.523 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.638 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -125.01 57.8 16.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.726 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.67 143.1 12.99 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.278 2.652 . . . . 0.0 112.342 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -82.11 -6.03 58.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.634 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.65 21.17 76.26 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -154.03 98.4 2.16 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.823 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.582 ' O ' ' O ' ' A' ' 34' ' ' LEU . 9.7 mtt 50.26 134.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.863 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.529 ' CZ ' ' H ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -93.16 144.33 25.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.833 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.467 HH11 ' HD3' ' A' ' 37' ' ' ARG . 37.9 ttp-105 -149.93 137.56 20.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.318 0.58 . . . . 0.0 111.024 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 57.4 mp0 -134.51 146.04 49.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -138.1 137.59 37.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.014 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.672 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.41 143.74 34.09 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.883 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.0 m -70.54 133.96 47.24 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 84.8 tt0 -42.21 136.54 2.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.876 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.12 74.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.094 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.69 149.88 45.89 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-N 119.118 1.459 . . . . 0.0 112.02 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.83 137.61 64.01 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.124 2.549 . . . . 0.0 113.06 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -120.06 142.36 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.631 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.3 tt0 -130.03 129.25 43.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.611 -0.835 . . . . 0.0 113.224 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.456 HD12 ' SG ' ' A' ' 96' ' ' CYS . 30.6 mt -109.93 145.75 36.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.631 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 46.4 mtt85 -148.14 132.27 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.591 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.424 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -98.16 144.33 27.87 Favored Pre-proline 0 N--CA 1.455 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 56.9 Cg_endo -71.1 159.31 52.64 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.215 2.61 . . . . 0.0 112.593 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.46 -120.08 12.6 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.782 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -125.73 26.44 6.67 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.747 0.308 . . . . 0.0 110.996 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -77.41 169.97 17.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.509 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.76 143.09 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.116 HG23 ' CD2' ' A' ' 126' ' ' TYR . 78.0 mt -69.74 140.36 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.586 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.421 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.0 ptp -133.84 100.51 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.637 HG12 ' HE1' ' A' ' 89' ' ' PHE . 17.4 t -64.89 127.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.445 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.57 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 76.6 mt-10 -104.25 -49.64 3.54 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.794 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.7 m-20 -147.42 145.47 29.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.089 0.471 . . . . 0.0 110.725 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.0 154.74 9.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.967 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -152.08 156.79 40.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.286 0.565 . . . . 0.0 111.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 70.3 t80 -125.62 119.68 28.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 120' ' ' LYS . . . 156.66 -136.74 5.11 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.69 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 9.2 ttm-85 -154.94 118.03 4.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.329 0.585 . . . . 0.0 112.063 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 p -124.73 6.07 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.356 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 56.1 t0 -146.7 154.81 41.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.955 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 51.7 p30 -113.05 2.59 15.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.458 ' O ' HD13 ' A' ' 70' ' ' ILE . 18.5 mttt -104.6 5.99 34.18 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.944 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 69' ' ' LYS . 27.7 mm -115.69 139.65 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.624 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.3 m 53.77 71.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 39.2 p-10 -54.09 128.55 31.19 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 111.599 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -144.31 -165.87 2.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.282 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.692 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -61.88 142.48 94.97 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.249 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.16 -35.35 95.12 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.241 1.961 . . . . 0.0 112.827 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.6 -33.88 75.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.957 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.573 ' O ' HG23 ' A' ' 118' ' ' THR . 75.3 mt-30 -89.01 6.64 38.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.92 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.4 mtp -125.73 -3.96 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 39.1 mm-40 -61.54 -45.94 92.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.951 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -83.03 113.27 20.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.478 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 21.3 m -104.16 33.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.316 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.478 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 30.8 mm100 -138.69 85.6 2.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 41.5 t -148.53 122.47 9.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.6 m-85 -131.86 154.14 49.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.14 86.43 7.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.334 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -46.88 -45.98 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.029 2.486 . . . . 0.0 113.162 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 75.7 m-20 -53.01 -29.45 29.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.35 -31.41 33.43 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.573 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.637 ' HE1' HG12 ' A' ' 58' ' ' VAL . 50.9 t80 -67.9 -47.89 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 pttp -64.1 -41.91 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.395 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 70.6 mt -59.53 -48.69 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.051 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.939 ' SD ' HD21 ' A' ' 122' ' ' LEU . 46.0 mtp -70.84 -34.85 72.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.77 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.515 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 23.6 m -57.42 -42.97 83.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.831 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.52 -37.85 87.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.598 HH21 ' HG2' ' A' ' 92' ' ' MET . 36.8 mtm180 -76.38 -30.58 57.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.456 ' SG ' HD12 ' A' ' 48' ' ' LEU . 75.5 m -112.6 -21.42 11.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.515 ' CG ' ' O ' ' A' ' 93' ' ' SER . 69.4 m-20 -55.51 135.64 50.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.984 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 64.05 13.54 7.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.669 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -115.97 147.93 40.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.366 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.1 m -71.63 -33.93 69.35 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.795 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.02 159.23 40.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.278 0.561 . . . . 0.0 110.867 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.6 p -155.5 138.85 15.76 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.701 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' A' ' 47' ' ' GLU . 21.8 t -120.19 126.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 64.6 t -143.64 146.04 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -75.11 117.67 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.57 42.79 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 175.22 -127.25 1.25 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 35.82 -150.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.129 -0.536 . . . . 0.0 111.381 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.45 -9.62 13.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.12 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.487 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -76.85 -17.23 59.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.169 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.2 m-85 -139.7 130.51 14.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.794 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.7 Cg_exo -52.01 -153.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.459 2.106 . . . . 0.0 112.423 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -137.19 93.71 12.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.44 -51.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 123.034 2.489 . . . . 0.0 113.283 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.403 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.4 p -131.62 79.54 68.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.391 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -62.91 138.86 70.73 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.53 2.154 . . . . 0.0 112.53 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.55 -2.54 49.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.898 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 77' ' ' GLN . 95.1 m -120.5 148.85 43.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.106 0.453 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.615 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.1 t80 -86.3 96.68 10.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.465 ' CD ' ' CE2' ' A' ' 63' ' ' TYR . 37.0 mttt -68.12 -156.33 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.217 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.4 p90 -176.38 168.58 2.76 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 112.665 -2.061 . . . . 0.0 109.37 176.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.939 HD21 ' SD ' ' A' ' 92' ' ' MET . 12.9 tp -129.7 122.79 29.64 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.495 ' OE2' ' NE2' ' A' ' 125' ' ' GLN . 78.2 tt0 -117.77 131.2 56.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.797 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.95 119.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.495 ' NE2' ' OE2' ' A' ' 123' ' ' GLU . 5.1 mp0 -105.04 124.55 49.73 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.116 ' CD2' HG23 ' A' ' 56' ' ' ILE . 23.8 p90 -154.22 166.97 31.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.715 0.769 . . . . 0.0 112.055 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.459 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 83.5 m-20 -123.31 162.0 23.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.259 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.529 ' H ' ' CZ ' ' A' ' 36' ' ' ARG . 86.4 m -110.38 119.69 40.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.906 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.1 m -117.59 156.52 49.32 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.481 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -64.86 144.12 82.06 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 121.598 1.532 . . . . 0.0 111.078 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.587 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 39.3 t80 -78.71 -175.14 4.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.981 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.587 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 57.3 mttm -93.17 144.25 25.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.248 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 134' ' ' GLU . 13.2 p -144.7 138.95 23.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.393 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 133' ' ' VAL . 66.9 mm-40 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.97 -1.014 . . . . 0.0 111.026 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.402 ' H82' ' HB2' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.451 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.8 mm? -67.25 -45.56 50.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.629 0.252 . . . . 0.0 111.033 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 55.6 Cg_endo -78.84 59.46 7.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.573 2.182 . . . . 0.0 112.385 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 70.9 t80 -78.45 0.31 26.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.965 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.12 31.04 62.11 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -163.71 118.5 1.58 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.469 ' N ' HD13 ' A' ' 34' ' ' LEU . 25.0 mtt 52.97 108.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.595 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.486 ' NH2' ' HG3' ' A' ' 51' ' ' PRO . 4.2 mtt-85 -88.88 154.34 20.33 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 37' ' ' ARG . 13.0 ttt180 -142.28 136.66 29.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.096 0.475 . . . . 0.0 110.387 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' HG2' HD23 ' A' ' 48' ' ' LEU . 58.2 mp0 -133.65 143.56 48.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.533 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -139.42 136.27 34.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.512 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.736 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.84 144.95 32.72 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.447 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 25.6 m -71.21 133.68 46.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 9.2 tt0 -45.07 140.91 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.486 0.66 . . . . 0.0 112.511 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 94.12 -12.15 69.55 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.71 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.9 m-85 -116.74 155.64 48.75 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 118.405 1.103 . . . . 0.0 110.051 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.55 146.86 31.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.475 2.117 . . . . 0.0 113.948 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 104' ' ' VAL . 11.4 tt -118.57 145.82 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.913 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -126.64 127.81 45.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.884 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.679 HD12 ' SG ' ' A' ' 102' ' ' CYS . 44.9 mt -112.93 145.11 41.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -150.79 131.84 14.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.77 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -100.03 145.77 30.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.685 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.486 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 43.5 Cg_endo -72.35 160.38 47.1 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.462 2.108 . . . . 0.0 113.073 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.15 -130.68 28.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -107.43 24.45 12.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.34 166.55 22.53 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.829 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.575 HG11 ' HD1' ' A' ' 131' ' ' TYR . 25.8 m -127.46 143.38 40.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.113 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.827 HG23 ' CD1' ' A' ' 126' ' ' TYR . 95.3 mt -67.08 138.09 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.622 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -130.41 98.38 4.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.22 123.72 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.38 -48.25 4.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.5 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -147.6 145.6 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.254 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.665 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.64 151.1 9.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -150.4 152.34 34.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.929 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.503 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 66.4 t80 -122.65 125.25 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.468 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.89 -136.31 4.99 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.589 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 6.1 ttm180 -156.6 117.98 3.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.006 0.432 . . . . 0.0 111.127 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.553 ' HG1' ' HH ' ' A' ' 121' ' ' TYR . 26.2 p -124.69 7.7 8.19 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.73 152.68 40.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.517 ' O ' ' HE1' ' A' ' 78' ' ' MET . 20.9 p-10 -109.68 -0.36 18.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.333 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -106.37 8.74 31.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.116 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.5 mm -114.31 139.81 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.569 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.6 m 57.48 64.75 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -46.93 120.82 3.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.813 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -139.52 -167.08 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.933 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -63.02 142.51 97.68 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.037 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.58 -36.09 79.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 121.784 1.656 . . . . 0.0 112.762 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -64.59 -33.77 76.7 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.681 ' O ' HG23 ' A' ' 118' ' ' THR . 81.4 mt-30 -84.04 -12.62 54.88 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.828 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.517 ' HE1' ' O ' ' A' ' 68' ' ' ASP . 66.4 mtp -103.95 -2.18 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 52.6 mm-40 -58.96 -53.2 61.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.806 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -80.43 122.52 27.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.01 28.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.058 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -143.73 90.64 2.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -145.79 120.93 10.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.663 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 5.9 m-85 -128.75 153.02 47.79 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.616 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.747 HD21 ' HG2' ' A' ' 112' ' ' PRO . 13.7 tp -146.08 91.2 5.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.705 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -49.24 -46.27 26.59 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.228 2.619 . . . . 0.0 113.751 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 23.9 m-20 -53.74 -22.31 8.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.03 -33.49 57.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.763 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -64.8 -44.46 89.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.166 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.9 pttt -65.86 -40.07 91.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.983 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.527 HG23 ' NH1' ' A' ' 95' ' ' ARG . 79.5 mt -60.49 -51.39 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.861 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.445 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 93.0 mmm -68.17 -37.0 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.569 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.45 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 60.9 m -60.31 -44.26 95.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.117 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -65.44 -37.94 88.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.295 0.569 . . . . 0.0 110.665 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.553 HH11 ' HG3' ' A' ' 95' ' ' ARG . 51.4 mtt85 -76.26 -33.3 59.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.8 m -111.94 -15.16 13.39 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 70.2 m-20 -62.72 135.21 57.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.634 -0.827 . . . . 0.0 111.669 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 64.99 11.48 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt-85 -112.71 145.5 40.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 110.595 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.9 m -72.76 -31.28 64.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.479 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.13 155.23 38.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.262 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.679 ' SG ' HD12 ' A' ' 48' ' ' LEU . 29.3 p -153.76 139.7 18.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.882 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.0 t -119.06 131.05 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 46' ' ' ILE . 17.6 t -141.99 152.01 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.425 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.81 120.79 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.71 38.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.362 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.84 -125.7 0.98 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.175 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 31.36 -158.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.257 0.551 . . . . 0.0 112.022 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.72 -10.52 19.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.627 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.83 59.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.089 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.5 m-85 -142.51 132.72 12.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.366 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.747 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.6 Cg_exo -49.95 -159.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -139.01 86.44 15.01 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.474 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.544 ' HD2' ' HZ3' ' A' ' 120' ' ' LYS . 66.8 Cg_endo -79.32 -29.0 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.718 2.279 . . . . 0.0 113.136 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.1 p -155.67 83.84 3.54 Favored Pre-proline 0 C--N 1.332 -0.155 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.688 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 18.4 Cg_endo -70.02 140.87 42.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.94 1.76 . . . . 0.0 112.039 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.432 ' N ' ' O2 ' ' A' ' 136' ' ' RAM . . . 103.54 -2.02 46.03 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.372 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.1 m -117.61 147.02 43.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 8.9 t80 -84.61 98.2 10.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.544 ' HZ3' ' HD2' ' A' ' 114' ' ' PRO . 21.3 mtmt -77.58 -166.78 0.81 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.469 1.128 . . . . 0.0 113.401 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.553 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 40.0 p90 -167.32 168.6 13.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.621 -2.082 . . . . 0.0 110.321 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.3 tp -127.02 124.93 40.52 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' CD ' ' HE ' ' A' ' 37' ' ' ARG . 15.3 tp10 -117.22 128.23 54.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.066 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.665 HG22 ' HB1' ' A' ' 61' ' ' ALA . 41.5 t -135.79 125.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.262 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.83 130.72 55.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.827 ' CD1' HG23 ' A' ' 56' ' ' ILE . 27.5 p90 -153.82 173.24 16.15 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.089 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -124.78 158.83 32.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.352 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.5 m -105.95 119.43 39.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.49 158.11 68.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.66 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.32 145.22 88.62 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.096 1.864 . . . . 0.0 112.06 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.575 ' HD1' HG11 ' A' ' 55' ' ' VAL . 79.7 t80 -72.7 -12.81 61.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.903 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -97.3 135.43 39.23 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.449 ' O ' ' OXT' ' A' ' 134' ' ' GLU . 81.3 t -141.84 117.4 5.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.987 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 71.1 tt0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.544 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.444 ' O7 ' ' O3 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.564 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.458 ' O ' HD22 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -127.7 74.25 78.31 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.244 0.545 . . . . 0.0 110.334 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.37 152.31 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.287 2.658 . . . . 0.0 112.472 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' C ' ' H ' ' A' ' 34' ' ' LEU . 2.1 m-85 -78.19 4.87 11.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.28 -33.76 0.95 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.049 HD22 ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -159.22 107.54 1.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.741 0.781 . . . . 0.0 111.567 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' LEU . 8.2 mtp 53.95 150.78 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.737 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 49' ' ' ARG . 70.8 mtp180 -96.56 146.09 25.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -156.09 137.99 14.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.893 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -127.06 149.96 49.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.204 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -138.83 142.21 38.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.836 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -144.29 144.96 31.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.356 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 7.6 m -71.55 134.6 46.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 110.436 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.615 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 87.2 tt0 -43.24 138.51 2.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.134 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.66 -7.65 77.21 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.816 -1.084 . . . . 0.0 114.298 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.56 153.91 50.55 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 119.068 1.434 . . . . 0.0 110.909 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.84 140.84 47.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.589 2.192 . . . . 0.0 113.748 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 14.1 tt -116.84 146.36 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.604 ' HG3' HG22 ' A' ' 103' ' ' VAL . 78.7 tt0 -126.2 127.77 46.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.095 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.668 HD12 ' SG ' ' A' ' 102' ' ' CYS . 50.1 mt -115.88 138.55 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.545 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 18.8 mtp180 -146.5 133.51 20.3 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.283 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -98.66 136.72 20.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.86 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.522 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 55.6 Cg_endo -70.25 158.29 56.78 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.415 2.077 . . . . 0.0 111.458 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.23 -141.41 30.33 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.652 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.0 p -98.63 22.2 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -78.88 165.09 23.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.7 0.286 . . . . 0.0 110.86 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.57 148.69 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.534 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.795 HG23 ' CD2' ' A' ' 126' ' ' TYR . 78.5 mt -71.19 136.06 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.653 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.36 101.8 5.12 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.43 127.04 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.457 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 71.3 mm-40 -103.92 -48.29 3.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.816 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 65.1 m-20 -148.49 145.76 28.07 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.13 154.23 7.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.851 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.509 HD21 ' HA ' ' A' ' 84' ' ' TYR . 6.0 t30 -150.24 151.99 33.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.37 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.626 ' CD2' ' CG ' ' A' ' 111' ' ' PHE . 54.9 t80 -118.4 121.09 39.5 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.6 -135.33 4.54 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.382 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.525 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 10.5 ttm-85 -156.55 117.53 3.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 111.362 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.475 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 23.6 p -122.87 9.44 9.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.071 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 15.2 t0 -147.2 -178.22 6.1 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.135 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 69' ' ' LYS . 54.7 p30 -138.36 -0.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.065 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 20.4 mttp -102.65 2.83 36.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.844 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.67 137.7 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.019 0.437 . . . . 0.0 110.855 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.4 m 54.63 70.79 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.14 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.0 p30 -52.09 125.95 17.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.923 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -143.91 -163.61 1.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 142.64 98.21 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.301 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.7 Cg_endo -54.44 -35.93 86.41 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.952 1.768 . . . . 0.0 112.008 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -63.87 -37.18 86.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 118' ' ' THR . 81.2 mt-30 -83.46 -9.72 58.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.359 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.9 mtp -106.04 -0.92 24.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 76.2 mt-10 -60.47 -53.04 62.33 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.08 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 48.9 t30 -76.54 117.46 18.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.578 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.0 m -107.71 29.42 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.832 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.8 mm-40 -141.01 85.37 1.98 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.389 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.428 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 44.8 t -146.94 124.23 11.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.509 ' HA ' HD21 ' A' ' 62' ' ' ASN . 58.1 m-85 -133.54 159.04 41.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' A' ' 112' ' ' PRO . 12.7 tp -147.73 94.99 4.3 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.18 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.48 -43.83 31.82 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.825 2.35 . . . . 0.0 114.06 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 65.4 m-20 -61.16 -23.68 65.74 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.59 62.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.928 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.569 ' O ' ' OG ' ' A' ' 93' ' ' SER . 17.3 t80 -67.12 -47.73 70.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.069 0.461 . . . . 0.0 112.087 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 pttm -67.23 -41.22 86.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.965 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.61 HG22 HH21 ' A' ' 95' ' ' ARG . 69.7 mt -61.39 -47.41 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.795 ' SD ' ' NH1' ' A' ' 95' ' ' ARG . 96.2 mmm -66.97 -36.13 81.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.7 ' HB3' HD22 ' A' ' 97' ' ' ASN . 5.1 m -60.88 -42.11 97.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.93 -36.82 85.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 111.245 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 1.124 ' NH1' HG11 ' A' ' 104' ' ' VAL . 20.8 mtm180 -76.17 -33.34 59.34 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.418 ' SG ' HD12 ' A' ' 48' ' ' LEU . 36.2 m -113.66 -14.02 12.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.7 HD22 ' HB3' ' A' ' 93' ' ' SER . 44.6 m-20 -58.58 136.88 57.71 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.807 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 67.04 14.37 9.8 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.017 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -116.49 147.01 42.16 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.306 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.5 m -73.76 -31.93 63.57 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.086 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.28 153.37 37.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.449 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.1 p -156.75 131.33 8.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.604 HG22 ' HG3' ' A' ' 47' ' ' GLU . 22.4 t -121.72 125.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.124 HG11 ' NH1' ' A' ' 95' ' ' ARG . 91.5 t -141.94 146.4 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.441 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.5 120.23 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.98 41.76 0.06 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.82 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 108' ' ' SER . . . 179.3 -130.66 1.55 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.353 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 107' ' ' GLY . 5.9 t 31.58 -146.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.019 0.438 . . . . 0.0 110.943 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.05 -10.27 13.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.14 -21.76 53.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.265 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.626 ' CG ' ' CD2' ' A' ' 63' ' ' TYR . 36.1 m-85 -138.26 128.98 15.46 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.494 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.8 Cg_exo -52.18 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.855 1.703 . . . . 0.0 111.645 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -140.06 80.39 20.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.296 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.57 -19.89 18.5 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.572 2.181 . . . . 0.0 113.171 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.629 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.8 p -157.12 80.37 3.45 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.484 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -65.95 139.23 55.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.122 1.881 . . . . 0.0 111.698 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.14 -3.16 47.63 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.576 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.1 m -120.29 145.62 46.9 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.641 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 15.7 t80 -84.74 96.95 9.41 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.629 ' NZ ' ' O ' ' A' ' 115' ' ' CYS . 20.3 mtmm -71.47 -165.97 0.17 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.576 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.635 ' HB2' HD21 ' A' ' 39' ' ' LEU . 9.0 p90 -168.16 169.27 11.11 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 62' ' ' ASN . 40.6 tp -128.02 123.64 35.19 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -116.55 127.41 54.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.137 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.19 121.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.346 -0.941 . . . . 0.0 112.535 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.56 127.72 52.35 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.795 ' CD2' HG23 ' A' ' 56' ' ' ILE . 36.0 p90 -152.32 168.8 24.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.317 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -126.73 162.62 25.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.424 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 86.1 m -113.61 113.89 25.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 0.0 110.239 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 m -115.19 156.88 44.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -60.12 147.25 93.95 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 121.594 1.529 . . . . 0.0 110.942 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.579 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 28.2 t80 -72.76 -143.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.331 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.579 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 41.1 tttp -90.82 -81.71 0.3 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.739 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.75 144.97 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.398 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.433 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.559 ' H83' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.615 ' O3 ' ' OE2' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mt -125.0 73.15 65.17 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -68.2 140.51 49.36 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.236 1.957 . . . . 0.0 111.924 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 79.3 t80 -78.68 0.02 28.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 109.917 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.9 22.87 73.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.4 OUTLIER -162.98 121.29 2.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.075 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.557 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 55.02 136.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 110.793 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -97.6 150.54 21.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.758 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.555 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 40.2 ttt-85 -147.73 141.09 25.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.441 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -130.06 145.61 51.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.554 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.7 tt -139.31 137.93 36.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.7 144.14 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.873 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.68 130.41 43.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.568 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.495 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 31.0 tt0 -41.39 136.87 1.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.324 0.583 . . . . 0.0 112.183 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.09 76.75 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.084 -0.962 . . . . 0.0 114.179 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -115.48 152.56 47.19 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 118.896 1.348 . . . . 0.0 111.193 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 19.1 Cg_endo -69.88 139.9 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.02 1.813 . . . . 0.0 112.341 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 tt -115.19 147.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.657 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 40.8 tt0 -126.83 129.17 47.76 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.185 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.655 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.6 mt -115.87 138.86 50.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.657 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 91.1 mtt180 -144.09 132.68 22.27 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.931 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -100.3 138.89 20.32 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.215 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.08 157.83 53.49 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.367 2.045 . . . . 0.0 111.612 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.1 38.28 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.9 p -103.1 25.11 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.333 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.52 164.2 24.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.088 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.691 HG11 ' CD1' ' A' ' 131' ' ' TYR . 29.8 m -125.64 146.24 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.752 HG23 ' CD2' ' A' ' 126' ' ' TYR . 70.4 mt -69.31 134.63 29.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.162 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.5 ptp -129.39 97.76 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.623 HG12 ' HE1' ' A' ' 89' ' ' PHE . 32.7 t -61.7 125.26 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.955 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 79.7 mm-40 -101.35 -49.84 3.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.745 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.1 m-20 -152.27 150.61 29.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -169.66 156.59 6.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.647 ' O ' HD12 ' A' ' 122' ' ' LEU . 13.5 t30 -151.36 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.528 0.68 . . . . 0.0 111.606 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.649 ' HB3' HD23 ' A' ' 85' ' ' LEU . 35.9 t80 -123.01 120.33 33.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.69 -140.42 6.91 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.416 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.666 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 5.3 ttm180 -157.55 118.27 3.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 0.0 111.978 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.548 ' HG1' ' HH ' ' A' ' 121' ' ' TYR . 72.7 p -125.76 7.42 7.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.401 0.62 . . . . 0.0 109.704 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 54.6 t0 -146.43 154.13 41.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.4 p30 -114.17 3.1 15.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 110.424 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 87.1 mttt -104.6 4.64 33.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.774 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.4 mm -110.84 137.58 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.6 m 55.95 62.94 2.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -44.61 121.0 2.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -140.41 -166.81 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.355 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.618 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -62.55 133.58 94.81 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.437 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -51.78 -34.78 56.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.181 1.921 . . . . 0.0 113.224 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.8 -37.1 85.37 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.589 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 81.7 mt-30 -80.12 -17.89 51.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.254 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.666 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 7.9 mtm -102.18 1.39 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 55.3 mm-40 -61.97 -47.59 84.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.699 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.55 114.39 19.41 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 66' ' ' THR . 15.6 m -104.34 34.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.944 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -143.95 88.07 1.95 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.944 0.402 . . . . 0.0 111.739 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.475 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.0 t -147.39 122.78 10.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.52 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.6 m-85 -126.02 153.81 43.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 111.796 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' A' ' 63' ' ' TYR . 46.3 tp -147.92 85.94 6.33 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.92 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.82 -49.35 16.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.919 2.412 . . . . 0.0 113.061 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.5 m-20 -49.13 -30.35 6.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -32.8 53.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.822 0.344 . . . . 0.0 111.11 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.623 ' HE1' HG12 ' A' ' 58' ' ' VAL . 59.3 t80 -65.08 -41.89 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 34.2 pttt -65.86 -40.67 91.88 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.806 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.3 mt -60.27 -48.75 86.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.868 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -70.03 -36.61 75.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.114 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.486 ' HB3' HD21 ' A' ' 97' ' ' ASN . 19.8 m -58.79 -47.61 84.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.549 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -65.1 -35.93 82.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.05 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.631 HH12 ' HB1' ' A' ' 110' ' ' ALA . 99.5 mtt180 -79.9 -30.57 40.11 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.0 m -112.43 -20.18 11.88 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.486 HD21 ' HB3' ' A' ' 93' ' ' SER . 89.4 m-20 -58.25 135.87 57.21 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.8 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 64.53 13.06 7.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.851 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 95' ' ' ARG . 75.0 mtp180 -114.02 145.66 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.2 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.4 m -71.79 -30.98 66.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.454 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.44 152.8 31.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.655 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.6 p -151.91 141.76 21.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.48 128.96 75.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.809 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.553 ' CG1' HH11 ' A' ' 95' ' ' ARG . 22.6 t -144.7 147.58 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.229 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -78.71 118.39 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.903 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.94 41.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.8 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 175.54 -123.04 0.9 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.178 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.6 t 31.04 -157.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.911 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.94 -9.58 22.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.851 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.631 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -75.72 -9.39 58.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.524 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.8 m-85 -144.0 133.54 11.61 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.858 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 44.9 Cg_exo -49.62 -161.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.925 1.75 . . . . 0.0 111.334 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -139.29 97.6 8.49 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.042 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.25 -58.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.847 2.364 . . . . 0.0 112.725 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.422 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 8.4 p -126.56 80.37 69.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.177 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 24.9 Cg_endo -64.71 137.82 55.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.79 1.66 . . . . 0.0 111.942 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.506 ' N ' ' O2 ' ' A' ' 136' ' ' RAM . . . 113.52 -13.75 22.9 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.737 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.538 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 1.0 OUTLIER -111.09 151.74 27.73 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.258 0.529 . . . . 0.0 109.983 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.587 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.5 t80 -85.63 96.96 9.84 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.474 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 12.6 mttp -76.4 -161.19 0.17 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.729 1.252 . . . . 0.0 113.125 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 5.6 p90 -168.93 171.17 8.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.955 -1.93 . . . . 0.0 110.732 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 62' ' ' ASN . 35.9 tp -129.86 123.52 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.555 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 69.9 tt0 -118.65 129.42 55.29 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.421 HG22 ' HB1' ' A' ' 61' ' ' ALA . 43.2 t -131.46 121.74 48.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.965 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.37 129.1 53.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.752 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.9 p90 -152.69 167.36 29.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.307 0.575 . . . . 0.0 111.896 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.441 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 96.8 m-20 -123.51 159.56 28.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.066 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.6 m -114.47 107.43 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -111.08 158.06 36.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -54.81 143.92 68.65 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.962 1.775 . . . . 0.0 111.912 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.691 ' CD1' HG11 ' A' ' 55' ' ' VAL . 10.6 t80 -78.19 -77.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.022 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.499 ' CG ' ' CD2' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -142.28 101.77 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.362 178.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.19 136.16 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.837 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.099 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.538 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD23 ' HD2' ' A' ' 31' ' ' PRO . 10.5 mt -67.05 150.85 97.69 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.03 0.443 . . . . 0.0 110.911 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' HD23 ' A' ' 30' ' ' LEU . 19.3 Cg_endo -63.32 173.13 4.48 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.822 2.348 . . . . 0.0 112.069 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 57.7 t80 -73.01 6.59 2.56 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.681 -0.408 . . . . 0.0 109.947 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . 62.19 -1.47 1.41 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.892 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.612 HD23 ' C ' ' A' ' 34' ' ' LEU . 5.9 tt -158.37 98.29 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.039 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.626 ' SD ' ' OD1' ' A' ' 127' ' ' ASP . 2.4 ttp 47.59 165.45 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.472 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 -91.17 137.92 31.99 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -149.7 137.33 20.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.41 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.448 ' HB3' HD11 ' A' ' 46' ' ' ILE . 57.9 mm-40 -134.86 148.98 50.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.901 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -140.28 144.46 36.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.254 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.908 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -145.97 145.33 30.6 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.108 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.7 m -66.2 131.08 45.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.725 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -42.24 132.04 3.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.685 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.5 76.38 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.065 -0.97 . . . . 0.0 113.252 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -118.06 151.09 48.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 118.238 1.019 . . . . 0.0 110.309 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.94 139.7 33.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.616 2.211 . . . . 0.0 113.384 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 38' ' ' GLU . 20.7 tt -114.65 140.64 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -117.51 132.3 56.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.689 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' GLN . 10.7 mt -114.87 142.22 46.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.401 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -149.8 134.84 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.646 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.457 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.5 m -102.15 142.76 25.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.932 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 44.3 Cg_endo -69.73 156.44 63.41 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.846 2.364 . . . . 0.0 112.01 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.08 -127.9 29.58 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.241 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 p -110.59 23.9 13.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.039 -0.58 . . . . 0.0 111.303 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -79.34 169.34 18.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.74 146.88 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.413 0.625 . . . . 0.0 110.598 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.671 HG23 ' CD1' ' A' ' 126' ' ' TYR . 85.5 mt -68.18 137.19 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.063 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.1 ptm -132.34 100.81 5.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.641 HG23 ' OD1' ' A' ' 97' ' ' ASN . 41.1 t -64.54 125.38 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.667 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.94 -48.91 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -153.48 150.35 28.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.444 0.64 . . . . 0.0 110.417 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -170.53 156.18 5.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.595 ' O ' HD12 ' A' ' 122' ' ' LEU . 8.8 t30 -150.58 154.9 38.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.785 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 33.9 t80 -117.31 117.47 29.62 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.65 -137.71 5.35 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.498 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.685 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -160.61 121.83 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.368 0.604 . . . . 0.0 112.036 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 HG21 ' CE1' ' A' ' 84' ' ' TYR . 8.1 p -124.2 8.9 8.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.54 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.622 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 49.4 t0 -143.6 -170.14 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.834 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.574 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 22.3 p30 -148.17 -0.4 0.59 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.745 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -104.56 7.57 35.2 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.0 mm -108.51 135.6 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.6 m 55.58 69.95 0.68 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 34.4 p30 -48.39 111.87 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.62 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.29 -162.18 1.18 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.766 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -64.18 141.37 98.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.473 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.6 Cg_endo -55.95 -38.95 93.93 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.393 2.062 . . . . 0.0 112.904 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.81 -34.48 77.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.048 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.766 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 72.3 mt-30 -87.23 -11.96 48.18 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.302 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.477 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.4 mmm -100.59 -3.98 29.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.372 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 21.6 mt-10 -66.9 -47.57 71.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.9 t30 -79.31 119.81 22.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.752 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.4 33.3 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.782 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -141.63 86.9 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.312 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 51.3 t -149.8 120.85 7.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.886 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.559 ' CE1' HG21 ' A' ' 66' ' ' THR . 97.3 m-85 -131.24 149.57 52.51 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.913 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' A' ' 63' ' ' TYR . 38.1 tp -138.42 90.85 12.88 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.32 -47.76 25.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.657 2.238 . . . . 0.0 113.364 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 69.4 m-20 -54.33 -23.74 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.03 54.44 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.938 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 58' ' ' VAL . 61.5 t80 -65.05 -43.43 92.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.82 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 15.5 pttm -64.44 -39.99 94.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.293 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.642 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 72.3 mt -58.55 -50.53 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.023 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.412 ' HE3' ' SG ' ' A' ' 96' ' ' CYS . 93.8 mmm -68.43 -35.47 77.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.062 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.479 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.4 m -58.1 -48.49 80.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.355 0.597 . . . . 0.0 110.647 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -67.7 -37.51 82.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.642 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 66.8 mtt-85 -76.61 -36.4 57.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.412 ' SG ' ' HE3' ' A' ' 92' ' ' MET . 4.7 m -114.16 -20.74 10.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.641 ' OD1' HG23 ' A' ' 58' ' ' VAL . 46.5 m-20 -59.36 139.87 56.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.683 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 23.5 m-20 70.6 15.04 7.18 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.956 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -119.17 149.9 40.96 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.048 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 m -70.48 -32.92 70.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -144.81 158.77 43.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.848 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 29.9 t -155.15 142.81 19.78 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.317 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.0 129.11 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.133 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 t -145.33 142.59 22.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.272 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.0 t -77.02 119.15 24.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.382 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.05 30.94 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.055 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 177.95 175.99 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.652 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 3.1 t 95.95 -158.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.266 0.555 . . . . 0.0 110.872 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.78 -8.56 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.365 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.499 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -82.01 -11.47 58.81 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.073 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.2 m-85 -140.62 126.43 11.48 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.976 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.602 ' O ' ' O ' ' A' ' 111' ' ' PHE . 51.0 Cg_exo -46.24 -159.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.792 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.45 93.23 12.86 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.264 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.89 -55.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.222 2.615 . . . . 0.0 112.991 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.473 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 26.5 p -127.47 90.3 48.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.508 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.37 140.03 47.17 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.897 2.398 . . . . 0.0 111.814 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.05 4.62 56.57 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.735 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.4 m -127.71 146.53 50.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.565 0.682 . . . . 0.0 109.351 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.685 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 29.3 t80 -86.52 99.14 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.473 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 23.0 mttt -73.35 -156.22 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.436 1.112 . . . . 0.0 113.645 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -175.41 174.94 2.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.753 -2.022 . . . . 0.0 110.105 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 62' ' ' ASN . 16.9 tp -131.9 123.52 27.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.265 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.7 tt0 -115.18 128.34 56.12 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.14 118.27 40.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.723 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.34 129.17 54.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.671 ' CD1' HG23 ' A' ' 56' ' ' ILE . 40.3 p90 -153.26 171.48 18.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.444 0.64 . . . . 0.0 111.774 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.626 ' OD1' ' SD ' ' A' ' 35' ' ' MET . 0.5 OUTLIER -129.6 160.82 32.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.204 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 86.2 m -110.38 123.79 50.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.74 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.83 157.4 63.19 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.115 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.35 149.65 88.49 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.442 2.095 . . . . 0.0 112.316 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -79.27 -5.05 53.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.686 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -136.02 102.61 5.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.719 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.74 132.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.071 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.988 179.266 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.473 ' H63' ' N ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 29' ' ' GLY . 1.8 mm? 29.22 87.44 0.1 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.409 . . . . 0.0 110.872 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.34 150.67 19.63 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.001 2.467 . . . . 0.0 111.878 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -82.6 -1.42 50.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.408 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.89 42.06 39.22 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.523 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.72 39.61 0.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.095 0.474 . . . . 0.0 110.912 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.3 ttm 64.43 143.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.089 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 36' ' ' ARG . 50.7 mtp85 -92.63 147.38 22.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 60.5 ttp180 -148.85 135.99 20.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.501 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 28.6 mp0 -133.18 148.76 52.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.098 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.48 144.78 38.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.943 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -144.3 143.75 31.15 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.428 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.9 m -69.26 132.53 46.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.342 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.61 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 37.7 tt0 -44.63 139.95 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.21 -8.08 80.44 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.601 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -113.55 149.96 42.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 118.343 1.072 . . . . 0.0 110.878 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.49 139.58 49.59 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.636 2.224 . . . . 0.0 113.116 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 9.3 tt -118.42 146.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.725 ' CD ' HH21 ' A' ' 49' ' ' ARG . 88.1 tt0 -129.7 129.94 44.86 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.483 HD12 ' SG ' ' A' ' 96' ' ' CYS . 29.6 mt -114.17 146.67 40.03 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.725 HH21 ' CD ' ' A' ' 47' ' ' GLU . 84.1 mtt180 -147.17 136.24 22.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.192 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 137.01 19.14 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.156 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.92 158.81 56.44 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.498 2.132 . . . . 0.0 112.061 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.56 -130.62 34.7 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -108.43 26.01 10.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.608 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -79.85 165.19 22.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.916 0.389 . . . . 0.0 110.8 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 129' ' ' VAL . 31.0 m -127.74 145.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.054 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.002 HG23 ' CD1' ' A' ' 126' ' ' TYR . 84.9 mt -69.37 138.3 22.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.575 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.6 ptp -132.08 99.27 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG12 ' CE1' ' A' ' 89' ' ' PHE . 47.0 t -62.53 123.63 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.512 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.96 -47.73 3.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.738 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -146.27 142.45 28.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.547 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.57 154.0 11.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.675 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.787 ' O ' HD12 ' A' ' 122' ' ' LEU . 7.7 t30 -152.26 150.29 29.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 112.054 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.615 ' HB3' HD23 ' A' ' 85' ' ' LEU . 47.2 t80 -117.21 119.97 36.84 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.27 -138.41 5.86 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 10.6 ttm-85 -158.4 119.16 3.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.4 0.619 . . . . 0.0 111.378 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.563 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 32.3 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.349 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 16.0 t70 -146.99 -170.95 3.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.944 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 51.4 p30 -146.92 -2.06 0.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.521 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -102.88 5.15 38.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.86 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.9 mm -106.8 137.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.129 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.8 m 56.89 66.2 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.628 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.6 p-10 -47.98 121.34 4.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.592 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -143.79 -165.73 2.18 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.631 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -63.7 140.63 97.84 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.174 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.532 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -56.33 -36.91 97.61 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.983 2.455 . . . . 0.0 114.151 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -65.82 -32.71 74.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.487 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.803 ' NE2' ' H61' ' A' ' 136' ' ' RAM . 50.4 mt-30 -88.82 10.43 21.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.691 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.4 mtm -132.82 0.9 3.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.398 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.6 mt-10 -63.16 -48.0 80.28 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.721 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -76.17 114.66 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 111.773 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.577 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 35.9 m -107.08 31.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.978 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 13.9 mm-40 -141.4 87.45 2.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 15.5 t -148.06 123.51 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.502 ' HA ' HD21 ' A' ' 62' ' ' ASN . 91.7 m-85 -127.86 151.96 48.42 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.55 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 63' ' ' TYR . 57.9 tp -146.95 85.73 6.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.092 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -45.89 -44.36 18.58 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.21 2.607 . . . . 0.0 114.665 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 51.1 m-20 -56.02 -24.76 41.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.04 -31.44 51.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' O ' ' OG ' ' A' ' 93' ' ' SER . 82.5 t80 -65.17 -47.36 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 12.6 pttp -64.82 -37.71 88.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.741 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 93.7 mt -61.79 -52.46 60.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.405 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.485 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 31.2 m -63.15 -47.54 82.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.016 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -68.08 -36.67 80.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 73.6 mtt180 -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 48' ' ' LEU . 82.7 m -110.52 -22.18 11.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 88.6 m-20 -57.54 134.02 55.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.399 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 66.89 9.79 7.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.038 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.621 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 62.4 mtt85 -111.97 146.43 37.85 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.253 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.4 m -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.547 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.21 156.01 34.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -154.65 142.4 19.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 59.6 t -123.58 123.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.078 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.572 HG13 ' NH1' ' A' ' 95' ' ' ARG . 45.2 t -138.08 145.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.33 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -77.78 118.49 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.28 41.59 0.05 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.646 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.78 -125.5 0.99 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.593 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 107' ' ' GLY . 32.5 t 31.06 -155.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 0.0 111.578 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.466 ' N ' ' OG ' ' A' ' 108' ' ' SER . 96.5 m-20 -65.17 -10.51 31.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.712 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.51 59.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.472 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.1 m-85 -142.19 130.27 11.66 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.061 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 48.4 Cg_exo -47.66 -157.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.713 2.276 . . . . 0.0 112.546 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -139.08 91.75 11.22 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.45 -46.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.509 2.139 . . . . 0.0 113.168 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.6 p -140.69 85.21 13.0 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.855 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -58.97 146.9 92.38 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.239 2.626 . . . . 0.0 111.728 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.98 63.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.324 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.638 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 91.0 m -130.98 144.36 51.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.3 t80 -86.54 96.66 10.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.458 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 24.1 mtmm -74.27 -168.49 0.66 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.927 1.346 . . . . 0.0 114.005 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.781 ' HB2' HD21 ' A' ' 39' ' ' LEU . 12.7 p90 -167.03 169.07 13.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.146 -2.297 . . . . 0.0 110.68 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 62' ' ' ASN . 58.9 tp -131.4 125.64 33.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.343 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.617 ' OE1' HD12 ' A' ' 39' ' ' LEU . 10.6 tp10 -118.48 131.28 56.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.895 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.547 HG22 ' HB1' ' A' ' 61' ' ' ALA . 44.0 t -135.39 123.07 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.39 126.76 52.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.829 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.002 ' CD1' HG23 ' A' ' 56' ' ' ILE . 34.9 p90 -153.78 168.35 26.59 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.743 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 92.6 m-20 -119.89 159.61 24.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.964 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 55.0 m -111.49 111.42 22.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.353 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 55' ' ' VAL . 5.1 m -115.72 156.45 46.29 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -55.13 148.43 49.07 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.124 1.882 . . . . 0.0 111.981 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -74.68 -96.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -91.7 131.12 37.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.896 0.379 . . . . 0.0 110.645 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 134' ' ' GLU . 14.0 p -88.32 138.97 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.979 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 133' ' ' VAL . 81.7 tt0 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.003 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.445 ' H82' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.803 ' H61' ' NE2' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.596 ' O ' ' O ' ' A' ' 31' ' ' PRO . 9.7 mp 54.81 60.66 9.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 110.047 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 30' ' ' LEU . 81.9 Cg_exo -38.69 -118.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.718 2.945 . . . . 0.0 112.571 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.542 ' C ' ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -77.31 -6.73 54.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.313 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.35 -29.5 0.26 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.134 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 32' ' ' PHE . 18.9 tp -162.18 110.33 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.036 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 34' ' ' LEU . 83.4 mtp 58.48 151.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.365 0.602 . . . . 0.0 111.608 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.71 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 68.3 mtp85 -90.25 142.74 27.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.148 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.593 ' HE ' ' CG ' ' A' ' 125' ' ' GLN . 40.8 ttm180 -147.08 132.57 18.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.539 0.685 . . . . 0.0 110.972 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.499 ' HG3' HD23 ' A' ' 48' ' ' LEU . 67.9 mm-40 -128.13 143.01 51.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.524 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.9 tt -139.24 137.97 36.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.795 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.673 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.6 142.88 32.21 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.124 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 31.0 m -67.89 138.1 55.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.935 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 13.8 tt0 -42.86 139.28 1.72 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.3 0.572 . . . . 0.0 112.512 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.99 -5.55 83.15 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.735 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -115.41 152.79 47.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 118.506 1.153 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.24 143.55 39.8 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 122.512 2.141 . . . . 0.0 113.461 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.02 143.64 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.654 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 88.0 tt0 -126.14 127.99 46.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.423 0.63 . . . . 0.0 111.698 -177.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.8 HD12 ' SG ' ' A' ' 102' ' ' CYS . 23.3 mt -113.57 140.75 47.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.71 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 97.4 mtt180 -144.79 131.23 19.76 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.828 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.2 m -100.65 146.63 32.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.27 157.28 37.5 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.343 2.028 . . . . 0.0 112.415 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 54.9 -133.98 47.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.166 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -107.2 25.3 11.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.114 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -78.65 165.98 23.04 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.94 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.45 145.78 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.488 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.847 HG23 ' CD2' ' A' ' 126' ' ' TYR . 77.9 mt -68.67 135.7 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.628 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.2 ptm -129.96 100.06 5.32 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.97 124.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.43 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -100.13 -51.2 3.74 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.441 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 40.6 m-80 -150.03 147.51 27.92 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.998 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.787 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -163.25 151.47 13.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.858 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.567 ' O ' HD12 ' A' ' 122' ' ' LEU . 4.5 t-20 -152.41 148.62 27.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.403 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 59.4 t80 -117.93 123.62 46.26 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.443 ' HA2' ' CD ' ' A' ' 120' ' ' LYS . . . 158.83 -139.6 6.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.616 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 5.1 ttm180 -157.11 116.79 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.442 . . . . 0.0 111.51 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.458 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 41.8 p -125.37 8.8 7.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.9 t0 -147.49 158.33 43.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p30 -115.23 3.17 14.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.697 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 16.8 mtpt -105.23 0.58 27.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.735 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.4 mm -113.14 138.46 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.4 m 59.81 61.18 1.98 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -51.96 125.98 16.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.004 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.44 -164.83 2.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.006 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.673 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -60.87 135.0 92.67 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 3.6 Cg_endo -52.3 -33.38 55.34 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.409 2.073 . . . . 0.0 113.934 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -34.88 79.05 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.673 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 30.0 mt-30 -89.08 12.59 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.524 ' HE1' ' O ' ' A' ' 68' ' ' ASP . 82.9 mtp -129.36 -3.81 4.9 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.082 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.0 mt-10 -59.99 -50.93 71.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.532 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -78.41 113.88 16.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 29.6 m -105.39 32.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.289 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.2 mm100 -141.05 87.95 2.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 31.5 t -146.54 122.88 10.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -129.97 152.05 49.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.941 0.4 . . . . 0.0 111.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.708 HD21 ' HG2' ' A' ' 112' ' ' PRO . 32.9 tp -144.63 90.43 6.45 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.968 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -48.78 -47.24 21.72 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.648 2.232 . . . . 0.0 113.743 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.2 m-20 -56.72 -29.13 62.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.38 -32.04 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.832 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 60' ' ' ASN . 74.0 t80 -64.46 -40.32 95.48 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 3.4 ptmt -66.54 -40.95 89.34 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.618 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.493 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 77.8 mt -59.88 -50.32 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.104 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.929 ' SD ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.03 -32.72 73.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.366 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 53.4 m -62.48 -47.15 85.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.676 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -67.46 -33.56 75.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 58.1 mtt180 -79.81 -32.11 40.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 48' ' ' LEU . 63.5 m -113.7 -16.36 12.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.559 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.5 m-20 -60.06 130.9 48.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.595 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 68.86 14.66 8.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.858 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt180 -115.05 146.74 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.274 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.2 m -72.2 -32.13 66.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.739 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -155.16 154.58 32.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.233 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.8 ' SG ' HD12 ' A' ' 48' ' ' LEU . 19.1 p -153.46 148.59 26.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.908 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.62 126.22 66.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.2 t -142.49 143.13 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.27 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 t -77.23 118.2 23.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -71.6 44.48 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.53 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.59 -124.92 0.93 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.689 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 28.13 -153.34 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 111.183 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.12 -10.15 20.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.077 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.0 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.292 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.3 m-85 -143.51 130.21 10.45 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.396 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.708 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.9 Cg_exo -47.74 -158.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.443 2.096 . . . . 0.0 112.479 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -138.81 91.91 11.54 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.68 -38.83 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.518 2.145 . . . . 0.0 113.14 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.05 84.4 11.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.674 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -65.6 139.84 60.07 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.259 2.639 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.5 -1.38 62.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.367 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.576 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 22.3 m -114.07 146.35 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.5 t80 -87.43 97.16 10.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 24.3 mtmm -74.58 -165.84 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.952 1.358 . . . . 0.0 114.251 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HB2' HD21 ' A' ' 39' ' ' LEU . 12.9 p90 -165.26 165.58 19.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.317 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.631 HD21 ' SD ' ' A' ' 92' ' ' MET . 25.7 tp -128.12 126.38 41.01 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.2 tt0 -124.82 127.55 47.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.753 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.929 HG21 ' SD ' ' A' ' 92' ' ' MET . 60.4 t -131.83 128.19 59.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.115 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.593 ' CG ' ' HE ' ' A' ' 37' ' ' ARG . 3.1 mp0 -109.83 132.15 54.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.327 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.847 ' CD2' HG23 ' A' ' 56' ' ' ILE . 42.4 p90 -156.84 171.71 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 57' ' ' MET . 73.2 m-20 -129.58 161.12 31.25 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.791 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.8 m -113.33 124.62 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.677 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.9 157.36 60.38 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.142 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -54.93 140.93 79.17 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.641 1.561 . . . . 0.0 111.272 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -83.37 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.241 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -103.32 132.07 49.87 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.109 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.5 p -93.73 133.24 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.847 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.794 -179.739 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.576 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.5 mt -112.35 109.89 53.63 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.357 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.96 -13.35 1.76 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.297 1.998 . . . . 0.0 112.085 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -153.55 -49.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.726 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.67 21.89 73.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 35' ' ' MET . 23.3 tp -160.82 119.33 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.717 0.294 . . . . 0.0 110.465 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 34' ' ' LEU . 16.7 mtt 49.91 109.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.714 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HD2' HH11 ' A' ' 36' ' ' ARG . 0.2 OUTLIER -89.95 151.86 21.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -146.76 136.22 22.87 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.109 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' CB ' HD11 ' A' ' 46' ' ' ILE . 68.1 mm-40 -130.14 147.35 51.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.557 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.1 tt -139.61 134.97 32.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.63 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.52 147.37 45.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.406 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -67.67 131.52 45.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 61.4 tt0 -42.14 138.47 1.62 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.601 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.52 79.2 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.611 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.55 147.46 40.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 118.52 1.16 . . . . 0.0 110.493 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.08 137.81 45.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.758 2.306 . . . . 0.0 112.605 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.483 HD11 ' CB ' ' A' ' 38' ' ' GLU . 17.5 tt -111.23 148.36 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -127.78 127.72 44.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.003 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.5 mt -116.83 144.83 44.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.363 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -149.23 133.65 17.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.22 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.5 m -99.88 138.74 20.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.162 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -66.94 161.35 42.84 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.65 2.233 . . . . 0.0 113.244 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.7 -136.4 13.65 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 p -97.43 23.51 7.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.821 -0.69 . . . . 0.0 110.407 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -79.39 161.3 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.782 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.8 143.4 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.165 0.507 . . . . 0.0 110.396 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.84 HG23 ' CD2' ' A' ' 126' ' ' TYR . 93.6 mt -68.67 139.97 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.447 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 2.0 ptp -135.15 103.25 5.47 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.912 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.615 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.4 t -63.88 124.62 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.248 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -102.59 -51.34 3.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.91 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -150.27 145.43 26.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.578 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.36 154.73 7.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.401 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.671 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.4 t30 -152.41 153.44 33.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.286 0.565 . . . . 0.0 111.559 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.567 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 50.1 t80 -118.81 124.34 46.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.11 -141.92 8.39 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.529 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.531 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 11.1 ttm-85 -151.71 115.56 4.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.313 0.578 . . . . 0.0 110.724 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.479 HG21 ' CE2' ' A' ' 84' ' ' TYR . 13.5 p -121.07 6.8 10.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.83 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 11.7 t70 -142.9 -169.62 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.698 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.496 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 40.9 p-10 -150.55 -2.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 110.41 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -100.44 4.94 44.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.79 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 138.58 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.19 63.21 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -47.66 115.74 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.347 0.594 . . . . 0.0 111.645 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.47 -163.02 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.73 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.637 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.66 140.25 97.98 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.707 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 Cg_endo -56.81 -31.41 88.45 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 121.942 1.761 . . . . 0.0 111.999 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -64.37 -35.44 80.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.811 ' O ' HG23 ' A' ' 118' ' ' THR . 79.6 mt-30 -87.7 -13.17 43.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.048 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.489 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 4.5 mtm -107.86 -2.17 20.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.95 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 9.2 mt-10 -63.92 -46.52 84.45 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.889 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -78.66 115.11 18.15 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.821 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 m -106.48 32.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.338 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -139.68 85.36 2.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.857 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.8 t -151.05 115.74 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.479 ' CE2' HG21 ' A' ' 66' ' ' THR . 68.7 m-85 -124.97 157.66 35.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.913 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 63' ' ' TYR . 62.1 tp -148.13 87.83 5.64 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.726 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -46.96 -46.5 18.59 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.735 2.29 . . . . 0.0 114.064 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -53.32 -27.07 21.27 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.66 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.738 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.615 ' CE1' HG12 ' A' ' 58' ' ' VAL . 45.9 t80 -67.51 -47.19 70.69 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.2 pttt -65.0 -39.61 93.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.585 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.6 mt -59.79 -45.43 94.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.944 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 91.4 mmm -69.82 -37.34 76.19 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.249 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.467 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 66.3 m -58.57 -45.12 89.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.24 -38.82 91.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.409 HH11 HG13 ' A' ' 104' ' ' VAL . 61.5 mtt180 -76.09 -34.01 59.52 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.6 m -113.88 -16.83 12.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.467 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -58.99 136.53 57.97 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.52 -0.737 . . . . 0.0 111.839 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 69.96 13.12 7.92 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.944 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -112.42 145.33 40.35 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.5 m -71.21 -30.13 66.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -143.79 158.53 43.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.431 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 t -155.82 137.03 13.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.764 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -126.23 128.9 71.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.497 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 46' ' ' ILE . 58.7 t -146.34 142.86 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -74.85 116.24 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.9 42.46 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.547 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.18 -125.99 1.04 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.95 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 107' ' ' GLY . 44.5 t 28.94 -155.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.459 0.647 . . . . 0.0 112.039 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.542 ' N ' ' OG ' ' A' ' 108' ' ' SER . 71.2 m-20 -62.19 -9.68 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.4 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.0 -11.16 59.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.11 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.9 m-85 -143.45 126.68 9.02 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.795 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.578 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.0 Cg_exo -47.7 -157.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.826 2.35 . . . . 0.0 112.42 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -139.1 88.88 12.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -75.69 -46.51 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.832 2.355 . . . . 0.0 112.838 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -132.31 79.53 65.64 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-O 121.673 0.749 . . . . 0.0 110.589 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 26.3 Cg_exo -57.5 130.14 37.45 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.846 2.364 . . . . 0.0 111.919 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.16 -9.32 46.15 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.941 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.3 m -106.57 148.41 28.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.997 0.898 . . . . 0.0 108.965 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.518 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 8.2 t80 -88.27 97.85 11.26 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 14.1 mttt -75.78 -154.1 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.912 1.339 . . . . 0.0 113.435 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.531 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -173.74 170.01 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.11 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.4 tp -131.53 125.03 31.34 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -118.05 127.54 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.039 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.462 HG22 ' HB1' ' A' ' 61' ' ' ALA . 59.5 t -131.13 123.43 53.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.638 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.96 131.16 55.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.688 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.84 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.0 p90 -152.92 165.94 33.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.165 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.442 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 36.6 m-20 -116.97 161.82 18.76 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.311 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.407 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 94.5 m -116.25 115.91 26.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.838 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.4 156.32 67.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.228 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -54.86 148.27 47.24 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.025 1.817 . . . . 0.0 112.159 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -73.3 -77.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.674 ' H ' ' CD ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -96.3 138.96 33.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.016 0.436 . . . . 0.0 111.395 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 133' ' ' VAL . 33.4 m -148.51 115.73 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.226 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.512 -179.422 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.49 ' O3 ' ' NZ ' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' C ' HD23 ' A' ' 30' ' ' LEU . 1.6 tt -130.46 88.18 48.02 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.824 0.345 . . . . 0.0 110.545 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -52.99 149.91 25.2 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.684 2.256 . . . . 0.0 112.573 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -82.38 -2.5 53.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.368 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.89 19.96 79.75 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.7 OUTLIER -159.62 49.4 0.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 0.0 110.326 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.427 ' HG2' ' N ' ' A' ' 36' ' ' ARG . 43.0 ttm 57.68 161.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.115 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.427 ' N ' ' HG2' ' A' ' 35' ' ' MET . 3.6 mtt-85 -90.72 144.56 25.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HD2' ' OE2' ' A' ' 123' ' ' GLU . 50.6 ttp85 -150.77 133.81 16.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.312 0.577 . . . . 0.0 111.906 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 53.3 mp0 -130.62 149.35 52.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.368 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.738 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -141.6 139.06 33.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.665 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.738 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.95 142.97 36.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.201 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.5 m -71.62 134.6 46.49 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 81.8 tt0 -42.95 135.8 2.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.576 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.94 -9.74 63.84 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.099 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.72 150.58 47.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 119.03 1.415 . . . . 0.0 110.741 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 20.9 Cg_endo -68.23 142.51 55.65 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.072 1.848 . . . . 0.0 111.866 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.9 tt -118.03 143.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 88.8 tt0 -130.19 129.18 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.505 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD12 ' SG ' ' A' ' 96' ' ' CYS . 13.6 mt -110.29 146.03 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.336 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.549 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 72.4 mtt180 -145.41 134.23 22.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.36 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.462 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -102.52 142.9 25.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.77 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 42.6 Cg_endo -69.75 155.11 66.84 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.658 2.238 . . . . 0.0 112.607 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.68 -131.84 35.65 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.199 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -105.18 25.32 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.844 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -79.71 164.18 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.738 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.35 147.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 0.0 110.083 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.957 HG23 ' CD2' ' A' ' 126' ' ' TYR . 86.3 mt -71.66 139.88 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.33 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.465 ' HG3' ' H ' ' A' ' 127' ' ' ASP . 2.9 ptp -132.02 102.17 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.536 HG12 ' CE1' ' A' ' 89' ' ' PHE . 63.4 t -63.95 124.58 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.221 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.0 mm-40 -103.03 -51.76 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 7.6 m-20 -148.94 146.78 28.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.136 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.76 156.53 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.005 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.574 HD21 ' HA ' ' A' ' 84' ' ' TYR . 8.7 t30 -152.91 150.79 29.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.954 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -119.38 124.99 47.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -138.46 6.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.67 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -154.6 114.57 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.408 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.485 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 6.0 p -125.51 6.46 7.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.1 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -148.26 156.95 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' O ' ' CE ' ' A' ' 78' ' ' MET . 55.9 p30 -118.33 5.81 11.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.03 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -103.76 4.62 35.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 mm -113.03 136.94 47.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.49 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m 54.98 72.4 0.48 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.805 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -55.77 124.7 18.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.97 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -141.22 -164.14 1.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.739 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 2.7 p-10 -59.1 139.48 87.73 Favored Pre-proline 0 C--N 1.333 -0.132 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.399 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -54.67 -37.32 91.31 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.591 2.194 . . . . 0.0 113.672 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -62.51 -34.95 77.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.934 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.799 ' NE2' ' H61' ' A' ' 136' ' ' RAM . 47.3 mt-30 -88.23 9.49 22.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.068 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . 77.2 mtp -122.69 -6.24 8.6 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.385 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 90.7 mt-10 -62.63 -49.24 75.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.994 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.34 116.3 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.625 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -107.01 34.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.262 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 92.9 mm-40 -139.84 85.35 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.085 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.476 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 26.5 t -148.97 121.68 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.574 ' HA ' HD21 ' A' ' 62' ' ' ASN . 38.0 m-85 -130.44 153.05 49.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.505 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 88' ' ' ALA . 44.4 tp -141.65 94.29 7.44 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 -48.22 22.66 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.556 2.171 . . . . 0.0 113.173 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.5 m-20 -56.77 -24.88 53.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.503 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.63 -30.81 44.56 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.733 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.536 ' CE1' HG12 ' A' ' 58' ' ' VAL . 53.7 t80 -64.91 -42.84 94.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.1 ptpt -64.19 -42.18 96.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.785 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.711 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 36.4 mt -60.1 -50.0 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.173 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.441 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 95.9 mmm -66.71 -34.91 78.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.741 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.556 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.4 m -59.84 -45.92 90.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.066 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -65.85 -34.22 77.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.489 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.711 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 31.5 mtm180 -80.97 -32.19 34.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.766 ' SG ' HD12 ' A' ' 48' ' ' LEU . 84.2 m -109.6 -19.61 13.14 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 93' ' ' SER . 82.1 m-20 -58.75 133.99 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.249 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 65.02 12.74 8.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.581 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.94 146.23 41.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.0 m -72.22 -31.65 66.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.924 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 157.77 42.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.61 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.721 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.8 p -154.82 142.15 19.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.641 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 47.1 t -116.53 131.91 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.491 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.521 HG11 ' NH2' ' A' ' 95' ' ' ARG . 90.5 t -144.46 140.8 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.607 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -80.54 119.46 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.59 28.55 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.722 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 176.88 177.11 45.57 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.954 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 4.2 t 92.78 -155.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.996 0.427 . . . . 0.0 110.774 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -62.21 -11.09 12.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.905 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.5 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -78.52 -19.31 53.23 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.296 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.9 m-85 -136.98 129.26 17.06 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.992 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.5 Cg_exo -48.68 -155.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.47 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -138.49 89.48 13.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 0.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.0 -30.67 0.67 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.064 2.51 . . . . 0.0 113.544 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.579 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -149.04 66.46 8.68 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-O 120.93 0.395 . . . . 0.0 111.192 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.22 135.27 69.11 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.122 1.881 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' N ' ' O2 ' ' A' ' 136' ' ' RAM . . . 106.47 -14.99 42.61 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.766 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.501 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 20.8 m -107.79 153.52 22.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.146 0.973 . . . . 0.0 109.433 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.559 ' HB3' HH12 ' A' ' 65' ' ' ARG . 7.6 t80 -86.73 97.47 10.61 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.579 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 13.2 mttp -72.4 -164.13 0.14 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.903 -1.498 . . . . 0.0 113.528 -177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.613 ' HB2' HD21 ' A' ' 39' ' ' LEU . 9.3 p90 -170.44 167.2 8.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.138 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.8 tp -129.2 124.79 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.9 tt0 -119.9 125.08 47.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.9 t -128.26 123.5 60.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.684 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -109.64 128.82 55.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.142 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.957 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.5 p90 -153.33 174.01 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.377 0.608 . . . . 0.0 111.637 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.465 ' H ' ' HG3' ' A' ' 57' ' ' MET . 21.9 m-20 -127.43 162.62 25.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.225 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.474 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.0 m -112.22 120.22 41.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.47 156.93 74.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.839 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -56.52 141.68 90.26 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.047 1.831 . . . . 0.0 112.967 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -74.8 -45.47 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.177 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -97.1 -177.31 3.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.793 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.575 ' O ' ' OXT' ' A' ' 134' ' ' GLU . 4.0 p -88.93 142.58 12.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.575 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 72.1 mm-40 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.577 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.799 ' H61' ' NE2' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.586 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -53.68 -44.68 98.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.699 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 26.8 Cg_exo -57.34 148.67 69.83 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.885 2.39 . . . . 0.0 113.293 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -83.2 -4.44 58.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.373 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.41 34.82 31.19 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.87 44.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.632 0.253 . . . . 0.0 110.606 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.595 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 26.6 ttm 61.52 166.26 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' CZ ' ' HD3' ' A' ' 51' ' ' PRO . 87.0 mtt-85 -96.45 138.55 33.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.224 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.419 ' HD2' HH11 ' A' ' 37' ' ' ARG . 12.8 ttp180 -148.0 138.93 23.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 111.688 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.612 ' O ' ' OE2' ' A' ' 123' ' ' GLU . 71.4 mm-40 -131.86 146.01 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.608 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.722 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -139.72 137.53 35.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.818 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.99 145.21 37.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.137 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -65.89 132.77 49.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.254 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 37.2 tt0 -43.14 134.78 3.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.397 -0.819 . . . . 0.0 113.13 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 90.3 -1.23 79.34 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.69 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -116.16 146.25 36.78 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 118.219 1.01 . . . . 0.0 110.674 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 136.93 48.62 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.753 2.302 . . . . 0.0 112.141 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 15.5 tt -113.86 151.8 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.16 127.1 44.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.505 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.793 HD12 ' SG ' ' A' ' 102' ' ' CYS . 50.2 mt -113.54 142.89 45.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -151.19 134.81 16.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.054 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -101.25 142.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.719 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -64.18 157.83 51.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.798 2.332 . . . . 0.0 112.589 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.8 -124.78 7.3 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.299 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.6 p -109.83 22.6 15.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.005 -0.598 . . . . 0.0 111.089 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.59 167.83 20.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.34 145.71 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.348 0.594 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.745 HG23 ' CD2' ' A' ' 126' ' ' TYR . 81.8 mt -70.27 137.55 23.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.667 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 127' ' ' ASP . 2.7 ptp -134.34 100.37 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.29 124.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.451 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 73.2 mm-40 -99.77 -48.58 4.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 19.1 m-80 -153.92 152.59 30.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' A' ' 124' ' ' VAL . . . -168.91 158.03 8.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.6 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.497 HD21 ' HA ' ' A' ' 84' ' ' TYR . 4.2 t30 -149.98 148.98 29.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 111.606 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.512 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 65.3 t80 -119.47 121.74 40.14 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 155.88 -140.53 7.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.6 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 8.2 ttm180 -149.35 118.47 6.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 111.23 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.574 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 13.6 p -124.4 3.61 8.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.023 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 22.5 t70 -148.45 154.93 40.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.571 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.519 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 43.6 p30 -112.17 5.76 18.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.252 0.548 . . . . 0.0 109.767 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.589 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 29.6 mttt -104.27 7.29 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.8 mm -114.1 135.52 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 110.622 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.4 m 50.1 80.76 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.02 125.67 24.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.321 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.3 -163.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p30 -63.97 138.44 97.4 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.626 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.76 -33.65 71.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.007 1.805 . . . . 0.0 112.24 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -63.69 -36.01 82.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.475 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.809 ' O ' HG23 ' A' ' 118' ' ' THR . 76.7 mt-30 -85.94 -10.18 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.787 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.505 ' CE ' HH12 ' A' ' 65' ' ' ARG . 74.0 mtp -104.01 -2.6 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.905 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.7 mt-10 -64.49 -48.69 74.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -77.25 114.11 15.72 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.811 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.1 m -107.96 29.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.57 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -139.18 82.99 1.92 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.852 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.421 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 23.0 t -147.35 119.51 8.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.497 ' HA ' HD21 ' A' ' 62' ' ' ASN . 78.3 m-85 -129.92 155.14 46.54 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.218 0.532 . . . . 0.0 111.644 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 88' ' ' ALA . 25.5 tp -142.76 96.71 6.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.71 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -53.13 -48.04 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.637 2.225 . . . . 0.0 113.146 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.8 m-20 -55.39 -23.81 26.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.517 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.79 -35.71 66.58 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.716 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -65.04 -45.49 85.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.731 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.1 -39.81 93.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.033 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.49 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 94.4 mt -59.67 -52.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.838 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.918 ' SD ' HD21 ' A' ' 122' ' ' LEU . 18.6 mtp -68.17 -34.98 77.31 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.442 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.509 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 60.5 m -56.77 -43.63 81.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.109 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.701 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 86.8 mt-30 -68.04 -35.51 78.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.938 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.708 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 71.6 mtt180 -74.74 -34.08 62.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.856 ' N ' HH21 ' A' ' 99' ' ' ARG . 28.4 m -114.32 -18.56 11.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.528 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 45.0 m-20 -58.55 137.41 57.45 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.563 -0.71 . . . . 0.0 112.349 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 65.62 13.42 8.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.259 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.856 HH21 ' N ' ' A' ' 96' ' ' CYS . 54.7 mtm-85 -114.37 145.81 41.35 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.273 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.1 m -71.82 -32.58 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.646 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.11 155.64 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.504 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.793 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.3 p -155.01 150.23 27.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.294 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 59.4 t -127.86 131.79 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.404 HG13 ' NH1' ' A' ' 95' ' ' ARG . 60.1 t -144.66 140.5 23.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.704 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.33 119.45 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -72.17 41.98 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.31 -122.69 0.81 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.25 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER 31.64 -160.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.526 0.679 . . . . 0.0 111.473 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' OG ' ' A' ' 108' ' ' SER . 99.0 m-20 -65.43 -8.19 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.271 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.11 -11.44 59.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.592 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 112' ' ' PRO . 41.6 m-85 -142.12 126.03 9.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.235 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 111' ' ' PHE . 28.5 Cg_exo -49.42 -160.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.66 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -139.2 92.31 10.77 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.565 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.92 -38.34 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.804 2.336 . . . . 0.0 113.445 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.404 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.6 p -136.27 72.66 58.78 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -57.1 133.82 60.29 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.711 1.607 . . . . 0.0 110.853 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.24 -12.38 33.79 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 77' ' ' GLN . 97.5 m -117.59 147.18 43.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.473 0.637 . . . . 0.0 109.535 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.6 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 22.8 t80 -86.33 98.64 11.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.577 0.703 . . . . 0.0 109.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.6 mttm -71.31 -153.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.892 -177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.574 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.5 p90 -176.6 176.69 1.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 112.698 -2.046 . . . . 0.0 110.648 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.918 HD21 ' SD ' ' A' ' 92' ' ' MET . 14.3 tp -134.08 126.12 29.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.905 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.697 ' OE1' ' NE2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -124.64 128.64 49.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.656 HG21 ' SD ' ' A' ' 92' ' ' MET . 88.9 t -131.85 124.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.424 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.697 ' NE2' ' OE1' ' A' ' 123' ' ' GLU . 2.7 mp0 -107.66 129.37 55.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.745 ' CD2' HG23 ' A' ' 56' ' ' ILE . 36.8 p90 -153.01 168.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 111.724 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.595 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 2.1 m-20 -126.38 162.99 24.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.593 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.8 m -113.45 116.89 30.32 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.583 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.9 m -121.44 157.09 57.22 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.59 146.83 62.35 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.103 1.868 . . . . 0.0 112.44 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 24.9 t80 -75.55 1.04 15.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.602 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -143.11 -166.27 2.27 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.307 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.516 ' O ' ' O ' ' A' ' 134' ' ' GLU . 10.3 m -89.63 140.91 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.039 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 133' ' ' VAL . 96.8 mt-10 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 136' ' ' RAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.796 ' H ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -85.13 149.17 52.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -50.01 117.38 3.04 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.267 1.978 . . . . 0.0 111.615 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -80.15 -4.14 51.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.131 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.08 29.2 60.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -159.61 80.51 0.73 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.573 ' O ' ' O ' ' A' ' 34' ' ' LEU . 41.4 ttm 52.56 152.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.576 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 7.4 mmm180 -89.18 136.06 33.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -149.88 131.75 15.14 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.381 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -130.84 145.32 51.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.501 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 8.7 tt -137.61 137.51 38.57 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.6 145.44 35.04 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.159 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.7 m -67.97 131.35 45.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.635 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 6.4 tt0 -43.06 139.04 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.72 -1.86 83.99 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.166 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.4 158.02 37.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 118.034 0.917 . . . . 0.0 109.962 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.02 140.11 14.02 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.885 1.723 . . . . 0.0 111.631 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 20.2 tt -117.59 147.2 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.708 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.5 tt0 -126.52 128.6 47.15 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.101 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 102' ' ' CYS . 20.4 mt -115.41 141.63 47.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.708 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 89.4 mtt180 -147.82 132.86 18.22 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.183 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.7 m -99.76 138.83 20.46 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.769 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.38 161.07 46.8 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.562 2.175 . . . . 0.0 112.176 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -135.13 38.35 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -107.36 26.65 9.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 110.455 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 53.2 m-20 -80.92 166.81 20.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.063 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 148.6 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.349 0.595 . . . . 0.0 111.629 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.528 HG23 ' CD2' ' A' ' 126' ' ' TYR . 96.1 mt -69.29 134.86 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.937 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -134.83 98.39 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.891 0.853 . . . . 0.0 108.829 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.79 127.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.77 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -102.76 -48.38 4.12 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.767 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -151.73 150.96 30.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.51 . . . . 0.0 110.47 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.14 154.76 7.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.074 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.511 HD21 ' HA ' ' A' ' 84' ' ' TYR . 1.7 t30 -149.41 146.32 27.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.4 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' ' HD3' ' A' ' 120' ' ' LYS . 63.5 t80 -114.66 122.49 46.63 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.39 -139.78 6.77 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.491 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.706 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -155.42 117.1 4.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.919 179.44 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 32.9 p -123.6 8.67 8.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.583 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.7 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 50.1 t0 -150.2 158.42 44.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 44.2 p30 -115.41 5.81 14.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.688 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -106.39 6.14 30.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.528 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 29.2 mm -114.2 139.36 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.523 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 57.21 61.66 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 6.4 p-10 -46.31 118.57 1.99 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.041 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -136.16 -162.65 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.303 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -64.08 145.21 98.09 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.366 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -50.69 -38.28 55.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.54 2.16 . . . . 0.0 112.353 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -64.95 -35.66 81.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.677 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.565 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 80.7 mt-30 -83.65 -7.62 59.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 75.1 mmm -113.61 40.65 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.682 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -101.74 -59.87 1.63 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.062 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 23.7 t-20 -78.24 119.52 21.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.507 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.545 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 27.1 m -110.16 27.5 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.894 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.3 mm-40 -141.94 82.84 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.622 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.4 t -146.54 118.98 8.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' HA ' HD21 ' A' ' 62' ' ' ASN . 44.4 m-85 -123.41 156.56 35.23 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.151 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.446 HD23 ' HB3' ' A' ' 63' ' ' TYR . 28.2 tp -142.13 83.98 11.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.27 -46.41 11.59 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 123.361 2.707 . . . . 0.0 114.127 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 98.9 m-20 -54.56 -25.49 26.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.2 -32.27 47.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.282 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' O ' ' OG ' ' A' ' 93' ' ' SER . 7.7 t80 -65.63 -46.38 79.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.025 0.44 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.7 pttp -67.55 -40.39 84.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.244 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.632 HG23 ' NH1' ' A' ' 95' ' ' ARG . 79.9 mt -58.16 -49.17 82.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . 1.045 ' SD ' HD21 ' A' ' 122' ' ' LEU . 4.2 mtp -70.36 -32.44 70.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.176 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.596 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.7 m -60.24 -44.89 94.86 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.4 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -64.49 -37.41 87.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 0.0 111.496 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.632 ' NH1' HG23 ' A' ' 91' ' ' ILE . 60.0 mtt85 -77.04 -32.85 57.25 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.556 ' SG ' HD12 ' A' ' 48' ' ' LEU . 22.9 m -112.81 -13.48 13.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.55 ' CG ' ' O ' ' A' ' 93' ' ' SER . 21.0 m-20 -62.23 130.57 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.354 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 67.88 14.88 9.51 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.18 145.92 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.772 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.04 -31.8 68.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.51 154.94 40.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.208 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 48' ' ' LEU . 9.6 p -154.63 136.59 14.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.103 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 22.8 t -122.29 129.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.886 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.2 t -144.1 146.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 0.0 111.805 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.452 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.3 t -77.81 117.86 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.16 38.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.709 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.14 -125.23 0.96 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.914 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.7 t 27.99 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.967 0.413 . . . . 0.0 110.619 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.12 -10.43 22.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.856 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.64 60.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.052 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.614 ' O ' ' O ' ' A' ' 112' ' ' PRO . 83.1 m-85 -141.77 129.03 11.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.237 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 111' ' ' PHE . 50.7 Cg_exo -45.55 -158.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 123.061 2.507 . . . . 0.0 112.694 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -139.13 91.46 11.31 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.8 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.54 -50.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.125 2.55 . . . . 0.0 113.288 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.457 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -135.27 81.62 43.37 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.991 0.424 . . . . 0.0 111.473 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.11 143.65 94.96 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.598 2.199 . . . . 0.0 111.73 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.91 -5.53 56.49 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 120.634 -0.794 . . . . 0.0 113.168 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.547 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 99.3 m -115.06 147.84 39.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.706 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 11.2 t80 -87.02 97.78 10.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.465 ' HD3' ' CE2' ' A' ' 63' ' ' TYR . 19.7 mttt -73.51 -163.74 0.17 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 122.848 1.309 . . . . 0.0 113.241 -177.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.425 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 6.4 p90 -165.42 165.14 19.45 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.388 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.045 HD21 ' SD ' ' A' ' 92' ' ' MET . 35.8 tp -126.14 122.24 35.13 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.518 ' CD ' ' OE1' ' A' ' 125' ' ' GLN . 2.6 tm-20 -113.62 126.91 55.79 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.564 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.87 HG21 ' SD ' ' A' ' 92' ' ' MET . 58.6 t -133.2 120.6 40.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.979 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.518 ' OE1' ' CD ' ' A' ' 123' ' ' GLU . 2.8 mt-30 -107.37 128.27 54.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.082 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.528 ' CD2' HG23 ' A' ' 56' ' ' ILE . 33.9 p90 -153.56 171.6 18.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.74 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 40.2 m-20 -128.5 164.27 23.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.231 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.57 120.52 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.373 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 20.1 m -116.97 150.83 46.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.385 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -57.14 143.47 93.07 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.875 1.717 . . . . 0.0 112.265 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -79.32 145.45 33.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -104.38 108.84 20.44 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.719 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.1 t -93.7 133.2 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.997 0.427 . . . . 0.0 110.89 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.831 179.261 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.547 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' A' ' 32' ' ' PHE . 0.8 OUTLIER 55.32 67.98 2.77 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.368 . . . . 0.0 110.152 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HB2' ' CE2' ' A' ' 32' ' ' PHE . 19.7 Cg_exo -59.15 8.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.917 2.411 . . . . 0.0 112.181 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.644 ' O ' HD23 ' A' ' 34' ' ' LEU . 6.8 m-85 -149.71 -67.42 0.21 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.559 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.67 35.58 54.97 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -161.27 127.46 3.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.899 0.38 . . . . 0.0 110.562 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.2 ttm 72.77 144.69 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.404 0.621 . . . . 0.0 111.355 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.47 ' NH1' ' HG2' ' A' ' 36' ' ' ARG . 40.0 mtp85 -91.34 146.97 23.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.557 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -148.07 137.28 22.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -134.81 146.08 48.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.712 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.79 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -140.77 143.3 34.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.696 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.79 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -147.4 145.56 29.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.727 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.1 m -70.73 136.19 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.37 0.605 . . . . 0.0 111.122 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 7.6 tt0 -44.92 139.0 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.215 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.33 -11.99 66.82 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.702 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -118.29 153.35 51.59 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 118.395 1.098 . . . . 0.0 110.313 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.19 145.37 43.78 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.275 1.984 . . . . 0.0 113.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -114.88 149.57 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -127.14 128.78 46.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.205 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD12 ' SG ' ' A' ' 102' ' ' CYS . 31.6 mt -115.61 139.39 50.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.401 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -144.9 135.15 24.12 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.246 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -100.52 140.17 21.2 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.12 155.95 66.47 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 121.908 1.739 . . . . 0.0 111.505 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.03 -137.09 37.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 121.689 0.605 . . . . 0.0 112.625 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -100.92 22.19 12.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.446 -0.877 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -79.02 166.75 21.99 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.681 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.75 148.04 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' CD2' ' A' ' 126' ' ' TYR . 85.8 mt -71.25 137.84 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.109 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -135.1 101.64 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.27 125.43 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.348 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 97.5 mt-10 -100.04 -49.57 4.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.3 m-20 -150.19 149.4 30.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.618 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.448 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.12 152.49 7.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.712 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.591 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.6 t30 -149.32 149.15 30.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.191 0.519 . . . . 0.0 111.182 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.491 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 26.3 t80 -119.3 122.89 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -137.26 5.5 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 1.8 ttm180 -155.1 116.37 4.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.112 0.482 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.2 p -122.74 6.7 9.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 14.1 t70 -149.81 157.74 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.716 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 5.6 p-10 -113.58 5.44 16.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.189 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.489 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 31.1 mtmt -102.61 0.16 32.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.616 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 mm -113.09 138.54 42.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 48.2 m 60.87 59.18 2.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.2 0.524 . . . . 0.0 109.651 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -43.72 97.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.981 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -115.39 -174.22 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -55.78 141.01 66.98 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.896 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.7 Cg_endo -50.52 -38.77 54.94 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.149 1.9 . . . . 0.0 111.745 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.99 -35.26 80.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.15 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.674 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 79.8 mt-30 -85.41 -4.9 59.3 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.703 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 5.0 mmm -108.1 -5.15 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.201 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 68.6 mt-10 -62.54 -48.4 79.67 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.204 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -79.97 115.88 19.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 66' ' ' THR . 32.8 m -108.65 29.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.158 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -139.52 82.96 1.91 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.836 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -146.12 123.67 11.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.57 ' HA ' HD21 ' A' ' 62' ' ' ASN . 21.3 m-85 -132.85 157.3 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.173 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.551 HD21 ' HG2' ' A' ' 112' ' ' PRO . 28.7 tp -145.86 83.69 8.61 Favored Pre-proline 0 N--CA 1.462 0.159 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.36 -44.32 20.55 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 123.078 2.519 . . . . 0.0 113.674 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.3 m-20 -59.07 -25.21 63.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 91' ' ' ILE . . . -51.29 -33.39 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.012 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.411 ' O ' ' OG ' ' A' ' 93' ' ' SER . 12.2 t80 -64.23 -40.23 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.807 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -66.12 -38.25 87.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.052 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 88' ' ' ALA . 90.4 mt -57.93 -53.66 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.867 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.418 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 95.3 mmm -66.62 -34.25 77.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.023 0.439 . . . . 0.0 110.571 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.561 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.4 m -59.54 -48.61 80.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -67.69 -37.23 82.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.596 ' HE ' HG22 ' A' ' 104' ' ' VAL . 53.9 mtp85 -72.8 -34.44 66.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.413 -178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.524 ' SG ' HD12 ' A' ' 48' ' ' LEU . 26.2 m -113.44 -15.26 12.64 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.561 ' CG ' ' O ' ' A' ' 93' ' ' SER . 74.4 m-20 -58.65 132.25 53.28 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.127 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 68.47 13.37 8.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.764 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -111.4 143.05 42.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.324 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.3 m -70.42 -32.94 70.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.541 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -149.79 150.03 31.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.863 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.3 p -153.41 138.62 17.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.924 0.393 . . . . 0.0 111.052 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.1 t -116.75 131.31 69.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.661 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.596 HG22 ' HE ' ' A' ' 95' ' ' ARG . 39.7 t -139.39 149.51 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.506 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.495 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.3 t -87.13 117.68 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.59 36.02 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.209 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.44 -125.4 0.92 Allowed Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 30.77 -157.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.792 0.329 . . . . 0.0 111.214 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.92 -9.26 3.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.523 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.78 60.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.674 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 112' ' ' PRO . 53.3 m-85 -141.48 132.75 13.41 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.887 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.551 ' HG2' HD21 ' A' ' 85' ' ' LEU . 33.1 Cg_exo -49.58 -157.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.937 2.425 . . . . 0.0 112.584 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.22 87.99 22.12 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.633 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.23 -43.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.288 2.659 . . . . 0.0 113.544 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.483 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -135.72 85.54 30.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.151 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.414 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 39.6 Cg_endo -71.87 136.49 27.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.263 1.975 . . . . 0.0 111.746 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.57 -1.34 36.75 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.271 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 77' ' ' GLN . 35.2 m -122.18 146.71 46.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.22 0.51 . . . . 0.0 109.92 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 17.7 t80 -85.94 98.88 11.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 14.6 mttt -73.9 -161.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.76 1.267 . . . . 0.0 113.669 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.0 p90 -169.9 168.62 8.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.281 176.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 62' ' ' ASN . 21.9 tp -130.8 126.69 36.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 76.5 tt0 -119.84 128.9 54.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.4 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.448 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.5 t -130.27 121.3 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.111 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -107.96 125.91 52.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.805 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.6 p90 -151.9 165.69 33.79 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.133 -177.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.3 OUTLIER -120.59 159.03 26.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.997 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.7 m -110.25 118.13 35.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 m -116.17 152.38 47.76 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.377 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.69 147.97 67.97 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.812 1.675 . . . . 0.0 110.668 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.47 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 48.3 t80 -73.85 -5.05 38.63 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.38 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -97.84 131.85 43.97 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.345 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 p -88.04 136.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.215 -179.688 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.519 ' O7 ' ' O3 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.502 ' H63' ' N ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 63.1 62.73 1.73 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.641 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -69.83 128.09 15.46 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.194 1.93 . . . . 0.0 111.839 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.23 -10.56 57.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.936 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.44 9.54 83.35 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -164.69 113.99 1.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.511 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.2 mtt 57.75 132.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.482 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.515 HH11 ' HG3' ' A' ' 36' ' ' ARG . 57.1 mtt85 -99.87 154.8 18.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.851 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.645 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 2.2 ttt-85 -150.8 141.01 22.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.377 0.608 . . . . 0.0 112.1 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.603 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 35.5 mt-10 -132.44 145.09 50.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.342 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -138.65 139.07 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.904 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.97 145.38 39.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.234 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.6 m -70.1 137.45 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.484 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 38.1 tt0 -43.09 132.78 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.279 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.04 75.52 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.959 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.84 154.29 49.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 118.878 1.339 . . . . 0.0 110.751 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.8 142.79 44.18 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.699 2.266 . . . . 0.0 113.359 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.7 tt -115.97 149.9 18.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.603 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 81.0 tt0 -132.36 126.04 32.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.246 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.609 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.2 mt -113.58 143.68 44.15 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.593 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 64.7 mtt180 -149.67 132.02 15.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.397 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -99.9 140.27 21.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.966 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.1 Cg_endo -66.41 163.83 30.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.658 2.238 . . . . 0.0 112.915 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.28 -121.55 14.66 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.478 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 p -122.98 26.01 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 0.0 110.066 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.7 169.75 17.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.232 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.88 143.96 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.084 0.469 . . . . 0.0 110.696 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.746 HG23 ' CD2' ' A' ' 126' ' ' TYR . 69.3 mt -68.4 138.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.143 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.7 ptm -132.43 103.14 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.82 125.67 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.345 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -100.46 -50.18 3.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.625 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -150.57 148.35 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.402 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.608 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.85 155.74 10.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.498 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.1 t30 -152.54 151.5 30.76 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.187 0.518 . . . . 0.0 112.188 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.509 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 33.6 t80 -121.48 122.86 40.68 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.56 -141.17 7.85 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -176.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.702 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.2 ttm-85 -151.36 114.77 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.666 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.533 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 11.8 p -120.48 6.13 10.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.865 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 41.2 t0 -144.75 -170.82 3.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.613 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' O ' ' CE ' ' A' ' 78' ' ' MET . 35.0 p30 -146.24 -2.74 0.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.968 0.413 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.403 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 52.7 mtpt -103.91 9.38 36.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.122 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.33 136.33 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.8 m 54.28 70.9 0.56 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -51.53 118.82 3.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.721 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.78 -163.28 1.44 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.246 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.719 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -61.93 136.79 95.22 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.302 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.8 Cg_endo -57.1 -34.31 97.47 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.787 1.658 . . . . 0.0 112.251 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -61.62 -35.98 79.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.417 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.88 ' O ' HG23 ' A' ' 118' ' ' THR . 82.1 mt-30 -82.13 -18.56 42.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.655 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 3.7 mtm -98.8 0.38 44.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.845 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 73.9 mt-10 -64.49 -51.32 63.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.264 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -79.32 110.98 15.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.064 0.459 . . . . 0.0 111.37 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.44 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 11.0 m -103.68 33.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.38 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 22.7 mm100 -138.43 83.97 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.258 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.419 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 41.8 t -147.95 121.86 9.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.498 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.1 m-85 -130.17 156.6 44.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.921 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.552 HD21 ' HD2' ' A' ' 112' ' ' PRO . 21.6 tp -144.19 86.49 8.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.468 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.49 -46.8 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.904 2.403 . . . . 0.0 113.68 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.0 m-20 -54.11 -30.22 47.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.891 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.81 -31.2 37.55 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.574 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -64.12 -41.38 97.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.562 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 1.3 pttp -67.87 -39.73 83.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.078 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.562 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 52.8 mt -60.23 -49.85 82.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.418 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 95.0 mmm -69.94 -39.04 76.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.656 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 50.3 m -60.43 -44.45 95.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.572 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 77.4 mt-30 -64.79 -37.21 86.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.803 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.491 ' C ' ' NH1' ' A' ' 99' ' ' ARG . 67.6 mtt180 -78.69 -31.36 46.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 48' ' ' LEU . 51.6 m -111.27 -13.41 13.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.7 m-20 -64.45 131.11 46.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 67.26 13.79 9.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.605 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.491 ' NH1' ' C ' ' A' ' 95' ' ' ARG . 61.4 mtt85 -113.38 146.07 40.08 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.295 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -70.22 -31.5 68.95 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -151.92 157.78 42.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.171 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.609 ' SG ' HD12 ' A' ' 48' ' ' LEU . 29.8 p -155.48 138.5 15.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.477 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 61.5 t -123.75 130.03 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.7 146.97 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 112.078 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.8 t -79.69 119.49 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.84 39.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.82 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.6 -142.62 5.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.249 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.3 t 47.12 -151.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 111.542 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.69 -9.5 20.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.961 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.487 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -76.24 -14.48 60.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.434 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.652 ' O ' ' O ' ' A' ' 112' ' ' PRO . 95.5 m-85 -143.87 128.51 9.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.821 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 111' ' ' PHE . 53.4 Cg_exo -45.79 -157.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.662 2.241 . . . . 0.0 112.019 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -137.84 92.58 12.71 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.148 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.52 -42.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.3 2.667 . . . . 0.0 113.397 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.473 ' SG ' ' HE3' ' A' ' 120' ' ' LYS . 1.3 p -136.86 74.83 50.31 Favored Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.256 0.551 . . . . 0.0 112.404 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.75 135.13 47.08 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.114 1.876 . . . . 0.0 110.703 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' C ' ' H63' ' A' ' 136' ' ' RAM . . . 102.85 -6.87 52.31 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 77' ' ' GLN . 99.3 m -114.35 147.09 39.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.702 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.2 t80 -86.46 96.34 10.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.509 ' HD2' ' CZ ' ' A' ' 63' ' ' TYR . 36.1 mttp -72.07 -156.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.497 1.142 . . . . 0.0 112.846 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.632 ' HB2' HD21 ' A' ' 39' ' ' LEU . 10.1 p90 -175.41 172.68 2.63 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.356 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 21.5 tp -130.97 122.69 27.33 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.645 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 45.1 tt0 -119.09 130.5 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.608 HG22 ' HB1' ' A' ' 61' ' ' ALA . 65.4 t -134.5 124.39 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 119.639 -0.824 . . . . 0.0 112.325 -178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.17 131.38 55.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.301 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.746 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.0 p90 -154.74 173.69 16.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.632 0.73 . . . . 0.0 112.374 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -131.71 162.61 30.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.965 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 83.4 m -111.27 117.61 33.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.679 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.8 m -119.57 156.22 53.68 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.78 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -55.74 149.84 47.94 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.226 1.951 . . . . 0.0 111.785 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -72.87 -10.36 59.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.215 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.6 mmtm -101.7 131.01 48.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.5 p -97.47 138.74 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.016 0.436 . . . . 0.0 111.772 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.644 179.142 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.565 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.4 OUTLIER 56.1 101.82 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.912 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' O ' ' O ' ' A' ' 30' ' ' LEU . 40.0 Cg_exo -53.08 -131.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.408 2.072 . . . . 0.0 111.645 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -77.95 -17.82 56.76 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.1 14.89 81.44 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 35' ' ' MET . 17.0 tp -161.45 117.2 2.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.628 0.251 . . . . 0.0 110.394 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.508 ' O ' ' O ' ' A' ' 34' ' ' LEU . 3.2 mtt 57.07 128.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.95 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 126' ' ' TYR . 42.7 mmm-85 -90.0 138.65 31.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.222 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.632 HH21 ' CD ' ' A' ' 123' ' ' GLU . 70.4 ttt-85 -144.95 132.57 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.464 0.65 . . . . 0.0 111.46 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -133.63 144.32 49.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.409 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.0 tt -143.39 132.94 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.794 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.703 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.96 150.98 45.15 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.725 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.36 132.44 47.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.591 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 11.1 tt0 -42.43 141.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.458 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 88.65 -4.6 85.07 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.215 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -117.32 153.19 49.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 118.463 1.131 . . . . 0.0 110.857 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -68.11 137.65 41.34 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 tt -119.89 138.02 51.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.59 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.1 tt0 -122.37 131.97 54.15 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.311 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' A' ' 126' ' ' TYR . 8.9 mt -108.75 144.93 35.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.269 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.59 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 30.5 mtt85 -149.24 132.12 16.11 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.706 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -100.8 147.14 33.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.25 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.59 159.01 28.67 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.37 2.047 . . . . 0.0 111.96 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.43 -137.42 38.36 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 121.321 0.4 . . . . 0.0 112.668 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.2 p -102.64 24.14 10.96 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.674 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.65 166.06 22.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.9 142.76 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.849 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.875 HG23 ' CD2' ' A' ' 126' ' ' TYR . 88.3 mt -67.67 138.73 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.077 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.41 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.8 ptp -135.59 100.88 4.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.406 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.91 124.61 15.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.399 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.586 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.48 -51.38 3.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.419 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.586 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 28.4 m-20 -148.28 145.75 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.67 ' CB ' HG22 ' A' ' 124' ' ' VAL . . . -166.92 155.04 9.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.761 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' HD12 ' A' ' 122' ' ' LEU . 10.5 t30 -153.78 154.58 34.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.241 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.591 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 85.4 t80 -120.07 122.64 41.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.19 7.62 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.04 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.758 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 13.7 ttm180 -156.89 116.23 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.419 HG21 ' CE2' ' A' ' 84' ' ' TYR . 7.6 p -124.53 8.73 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 57.9 t0 -147.35 157.6 43.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.506 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.587 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p-10 -114.18 0.2 14.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -102.22 6.57 40.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.25 135.29 50.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 110.16 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 60.63 61.27 1.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.228 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.626 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.6 p30 -41.3 104.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.583 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -124.28 -164.69 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.96 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.47 145.09 98.58 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.694 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.8 Cg_endo -55.3 -37.96 94.12 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.239 1.959 . . . . 0.0 112.714 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.51 -32.88 74.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.784 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.682 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 82.2 mt-30 -85.71 -11.39 53.81 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.797 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.758 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 3.1 mmt -100.74 -4.89 27.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.647 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 83.8 mt-10 -61.06 -56.2 23.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -79.42 118.02 20.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.433 0.635 . . . . 0.0 112.65 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.455 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 33.9 m -109.24 28.9 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.676 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.455 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 29.9 mm100 -141.71 87.13 2.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.5 t -145.51 120.22 9.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.477 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.6 m-85 -127.93 155.72 43.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 112.007 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.528 HD21 ' HG2' ' A' ' 112' ' ' PRO . 13.1 tp -148.34 91.89 4.67 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.166 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.54 -46.6 28.74 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.151 1.9 . . . . 0.0 112.868 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 74.5 m-20 -50.05 -31.29 12.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.38 -31.98 36.43 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.597 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -64.48 -47.88 77.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.584 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 2.0 ptpp? -64.02 -41.56 97.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.502 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 98.0 mt -59.97 -48.9 86.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.865 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . 1.038 ' SD ' HD21 ' A' ' 122' ' ' LEU . 63.1 mtp -69.87 -32.47 70.84 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.292 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.431 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 19.8 m -59.93 -45.89 91.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.627 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.61 -38.97 88.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.45 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -73.84 -37.29 64.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.4 m -113.54 -22.34 10.36 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 50.9 m-20 -55.3 140.55 38.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 69.95 12.94 7.93 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.157 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 99' ' ' ARG . 51.0 mtt85 -113.22 145.27 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.329 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.5 m -71.64 -28.83 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.58 155.31 42.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.547 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.81 143.97 26.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.113 0.483 . . . . 0.0 111.066 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.07 125.87 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.623 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -143.06 144.24 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.693 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.608 ' C ' ' H ' ' A' ' 107' ' ' GLY . 8.3 t -79.45 121.6 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.385 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -67.06 26.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.641 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . -178.94 172.13 44.31 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.028 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 4.3 t 97.26 -156.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 110.217 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.62 -10.71 38.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.176 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.35 -21.47 58.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.9 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.8 m-85 -138.27 125.95 13.72 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.744 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.3 Cg_exo -46.29 -155.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.764 2.31 . . . . 0.0 112.688 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -138.02 92.07 12.76 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.18 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -73.95 -54.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.531 2.154 . . . . 0.0 112.988 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.73 89.33 17.97 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.986 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.11 141.58 94.28 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.609 2.206 . . . . 0.0 111.64 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.92 4.99 57.63 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.749 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 77' ' ' GLN . 58.1 m -126.48 146.55 50.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.658 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 9.4 t80 -87.93 97.66 11.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 4.9 mtmp? -79.61 -158.96 0.18 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.644 1.212 . . . . 0.0 113.679 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.442 ' H ' ' HB3' ' A' ' 120' ' ' LYS . 9.8 p90 -172.44 175.56 3.53 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.543 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.038 HD21 ' SD ' ' A' ' 92' ' ' MET . 19.5 tp -132.17 124.17 28.5 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.477 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.632 ' CD ' HH21 ' A' ' 37' ' ' ARG . 78.6 tt0 -117.77 130.44 56.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.736 HG21 ' SD ' ' A' ' 92' ' ' MET . 97.2 t -134.4 123.4 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.013 -1.075 . . . . 0.0 113.113 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -110.98 128.32 55.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.071 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.875 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.3 p90 -152.29 168.71 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 111.842 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 57' ' ' MET . 86.2 m-20 -119.35 160.35 22.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.5 m -112.51 128.07 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.53 155.45 80.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.69 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -55.63 148.06 56.31 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.182 1.921 . . . . 0.0 112.12 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 28.0 t80 -72.53 -136.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.672 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.604 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 7.2 tptt -92.86 -71.0 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.5 t -90.97 129.22 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.221 -0.396 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.455 -179.35 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.537 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' CD1' ' H ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -74.36 157.61 86.25 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 33' ' ' GLY . 10.1 Cg_endo -54.61 136.16 69.51 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.176 1.917 . . . . 0.0 110.968 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 64.0 t80 -74.66 13.25 0.65 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . 74.33 36.02 51.13 Favored Glycine 0 C--N 1.33 0.246 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tp -157.93 -29.55 0.08 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.05 -0.575 . . . . 0.0 109.793 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.8 ttm 62.83 155.51 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.285 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -93.41 149.0 21.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.155 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -149.56 132.54 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.372 0.606 . . . . 0.0 111.158 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.0 mp0 -129.17 146.79 51.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.615 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -142.24 139.64 32.02 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.985 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.836 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.94 146.53 37.49 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.265 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.5 m -68.28 129.92 41.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.201 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 77.0 tt0 -45.41 142.53 2.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.99 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.412 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 93.11 -12.96 68.8 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.554 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.5 m-85 -115.74 149.97 44.03 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 118.256 1.028 . . . . 0.0 110.084 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.73 143.46 61.84 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.551 2.167 . . . . 0.0 113.439 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.3 tt -115.67 149.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.664 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.4 tt0 -129.2 128.97 44.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.494 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.558 HD12 ' SG ' ' A' ' 102' ' ' CYS . 38.4 mt -115.36 143.62 45.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.919 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 74.3 mtt180 -150.01 129.55 13.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.073 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.8 m -97.55 145.4 29.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.9 Cg_endo -69.04 158.91 56.07 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.609 2.206 . . . . 0.0 112.654 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.28 -130.74 25.08 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.328 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -107.33 22.29 16.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.819 -0.69 . . . . 0.0 111.232 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.12 168.96 19.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.447 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 131' ' ' TYR . 31.9 m -127.89 147.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.232 0.539 . . . . 0.0 110.271 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.675 HG23 ' CD1' ' A' ' 126' ' ' TYR . 79.5 mt -68.96 136.09 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.553 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.433 ' CE ' HG11 ' A' ' 129' ' ' VAL . 3.4 ptp -130.18 99.54 5.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 176.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.619 HG12 ' CE1' ' A' ' 89' ' ' PHE . 61.2 t -64.07 125.93 21.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.724 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.49 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 78.2 mm-40 -101.07 -51.43 3.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.742 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 25.3 m-20 -149.67 148.64 29.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.224 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.84 152.42 11.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.983 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' HD12 ' A' ' 122' ' ' LEU . 9.8 t30 -150.4 149.34 29.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.222 0.534 . . . . 0.0 111.706 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.496 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 81.9 t80 -118.53 122.52 42.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 0.0 108.839 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 157.26 -140.69 7.29 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.35 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.527 HH12 ' HB3' ' A' ' 119' ' ' TYR . 10.2 ttm180 -153.5 115.44 4.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.172 0.51 . . . . 0.0 110.603 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 p -121.59 7.38 10.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.356 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -150.01 157.18 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.886 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 44.2 p30 -113.74 4.29 15.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.706 0.289 . . . . 0.0 110.39 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 91.9 mttt -104.47 7.22 35.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.626 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.6 mm -113.87 138.17 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.883 0.373 . . . . 0.0 110.722 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.3 m 54.18 70.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.0 p30 -47.82 120.3 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 111.739 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -137.89 -165.14 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.011 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.605 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 1.9 p-10 -67.97 143.54 96.35 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.23 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -51.43 -36.31 58.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.264 1.976 . . . . 0.0 112.062 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.412 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 6.5 m-85 -65.99 -41.36 91.19 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.704 ' OE1' ' H61' ' A' ' 136' ' ' RAM . 31.7 mt-30 -86.96 -2.32 58.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.343 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.1 mtp -110.02 -6.76 15.06 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.777 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.23 -45.43 84.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.124 -0.63 . . . . 0.0 112.129 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 54.9 t30 -76.81 116.25 17.31 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.918 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -109.27 30.83 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -141.38 86.56 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.404 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 54.0 t -145.75 120.01 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.512 ' HA ' HD21 ' A' ' 62' ' ' ASN . 72.1 m-85 -132.43 154.69 49.6 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.124 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.6 HD21 ' HG2' ' A' ' 112' ' ' PRO . 65.1 tp -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.7 -48.6 13.67 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.275 2.65 . . . . 0.0 113.54 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 94.7 m-20 -58.25 -20.95 46.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.726 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.17 -36.05 60.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.729 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.619 ' CE1' HG12 ' A' ' 58' ' ' VAL . 51.7 t80 -64.33 -40.39 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.075 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 7.9 pttp -64.3 -40.68 96.43 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.367 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.426 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.7 mt -60.32 -47.9 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.637 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.8 mmm -69.32 -38.83 78.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.529 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 3.7 m -60.82 -43.4 98.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.784 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -66.45 -37.68 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 111.607 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HE ' HG23 ' A' ' 91' ' ' ILE . 90.4 mtt-85 -75.52 -33.14 60.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.4 m -113.15 -16.22 12.62 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.545 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.2 m-20 -59.51 137.23 58.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.98 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 65.64 14.72 9.68 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.934 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -119.46 149.47 41.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.47 -32.91 68.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.353 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -154.2 156.92 38.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.2 p -154.8 150.52 27.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.238 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.53 128.99 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 46' ' ' ILE . 44.9 t -143.61 143.7 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.949 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.07 118.46 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -72.56 43.75 0.11 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.54 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.87 -127.37 1.11 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.493 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' GLY . 47.2 t 29.43 -153.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.406 . . . . 0.0 110.982 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.515 ' N ' ' OG ' ' A' ' 108' ' ' SER . 14.0 m-20 -64.79 -9.86 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.3 -13.16 59.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.739 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.0 m-85 -139.34 126.45 12.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.6 ' HG2' HD21 ' A' ' 85' ' ' LEU . 22.5 Cg_exo -51.14 -155.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.443 2.095 . . . . 0.0 111.581 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -136.58 89.44 18.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.639 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.6 -26.62 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 22.2 p -158.53 97.13 1.78 Allowed Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.402 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.27 138.84 22.9 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.714 2.276 . . . . 0.0 113.058 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.37 57.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.765 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.3 m -118.37 145.78 44.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.527 ' HB3' HH12 ' A' ' 65' ' ' ARG . 7.9 t80 -88.15 98.69 11.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.496 ' HD2' ' CZ ' ' A' ' 63' ' ' TYR . 27.1 mttt -72.76 -156.57 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.679 1.228 . . . . 0.0 113.309 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.582 ' HB2' HD21 ' A' ' 39' ' ' LEU . 5.3 p90 -174.86 172.54 2.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.138 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.9 tp -130.56 122.52 27.69 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -117.38 128.76 55.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.638 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.9 t -134.49 122.54 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.762 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.24 129.81 55.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.675 ' CD1' HG23 ' A' ' 56' ' ' ILE . 41.3 p90 -155.43 173.88 16.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.137 0.494 . . . . 0.0 111.953 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 57' ' ' MET . 29.9 m-20 -127.67 163.46 24.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.534 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.469 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.6 m -114.07 108.99 17.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.453 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.433 HG11 ' CE ' ' A' ' 57' ' ' MET . 1.5 m -113.6 167.52 9.26 Favored Pre-proline 0 N--CA 1.465 0.311 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.1 145.06 93.67 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.217 1.944 . . . . 0.0 112.407 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.429 ' CD1' HG11 ' A' ' 55' ' ' VAL . 25.3 t80 -75.51 4.81 6.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.5 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 133' ' ' VAL . 4.6 tmtt? -90.98 121.06 32.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.955 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.474 ' N ' ' HD3' ' A' ' 132' ' ' LYS . 9.2 p -88.38 140.75 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.964 0.412 . . . . 0.0 111.569 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.948 179.903 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.704 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.548 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -117.14 166.81 12.11 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.666 0.27 . . . . 0.0 110.363 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -55.59 140.03 83.27 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.652 2.235 . . . . 0.0 113.005 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -78.85 0.49 26.97 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.87 43.17 35.65 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.486 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.545 ' O ' ' O ' ' A' ' 35' ' ' MET . 23.6 tp -158.56 -18.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.007 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 34' ' ' LEU . 14.1 mtp 54.62 144.76 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.952 0.406 . . . . 0.0 110.859 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -91.37 146.2 24.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' NH2' ' HG2' ' A' ' 125' ' ' GLN . 42.4 ttm105 -147.36 136.39 22.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.497 0.665 . . . . 0.0 111.472 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.63 ' HG3' HD23 ' A' ' 48' ' ' LEU . 68.4 mm-40 -128.69 142.71 50.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.025 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -139.76 135.32 32.97 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.629 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.97 148.22 35.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.417 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 m -69.89 134.36 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.744 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.55 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 22.5 tt0 -42.68 137.69 2.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.81 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.45 -4.69 80.22 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.53 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.47 150.53 46.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 118.585 1.193 . . . . 0.0 109.997 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.37 142.04 36.38 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 38' ' ' GLU . 17.5 tt -118.37 147.12 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -127.11 129.84 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.346 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.757 HD12 ' SG ' ' A' ' 96' ' ' CYS . 19.6 mt -115.04 142.47 46.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -148.45 135.34 20.0 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.473 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.521 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.23 140.42 21.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.746 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.3 Cg_endo -70.39 159.41 53.04 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.477 2.118 . . . . 0.0 111.948 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.78 -138.67 33.65 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.002 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -100.56 24.79 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.117 -0.541 . . . . 0.0 111.211 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.04 164.33 24.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.301 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 m -124.97 140.88 46.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.651 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.039 HG23 ' CD2' ' A' ' 126' ' ' TYR . 67.3 mt -67.22 138.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.535 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.8 ptp -133.99 98.52 4.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.694 0.759 . . . . 0.0 109.171 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.75 125.73 20.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.988 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.48 -46.49 4.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -150.21 147.66 27.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.952 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.39 151.86 5.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.914 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 122' ' ' LEU . 2.5 t30 -149.3 151.48 34.24 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.744 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.55 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 80.8 t80 -118.12 122.78 43.95 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.88 -138.71 6.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.388 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.551 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 14.7 ttm-85 -157.86 117.63 3.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 111.329 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.484 ' CG2' ' CZ ' ' A' ' 84' ' ' TYR . 5.0 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.631 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.508 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.1 t0 -147.72 -171.74 3.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.226 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 37.3 p30 -146.17 -0.47 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 2.8 mtmp? -103.94 7.13 36.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.479 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mm -118.31 139.63 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.0 m 59.51 58.56 2.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.5 p-10 -44.52 121.48 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.19 -170.11 3.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.034 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.3 p30 -61.91 138.23 95.55 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.688 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.8 Cg_endo -49.86 -33.34 32.87 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.51 2.14 . . . . 0.0 113.322 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -63.55 -37.05 85.84 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.681 ' OE1' ' H61' ' A' ' 136' ' ' RAM . 26.0 mt-30 -89.47 8.76 29.32 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.387 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.45 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 78.7 mtp -124.91 -1.97 7.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 69.5 mt-10 -61.61 -53.2 59.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.293 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.0 t30 -76.97 117.07 18.2 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.428 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 67' ' ' ASP . 23.8 m -108.87 27.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.566 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -138.34 85.81 2.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.037 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 48.6 t -147.04 119.02 8.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CZ ' ' CG2' ' A' ' 66' ' ' THR . 83.1 m-85 -129.77 155.34 46.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.56 . . . . 0.0 111.625 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.725 HD21 ' HG2' ' A' ' 112' ' ' PRO . 26.1 tp -147.66 90.64 5.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.999 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.58 -44.26 31.04 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 113.348 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.0 m-20 -55.19 -27.4 45.65 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.62 -33.43 33.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.368 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.53 -42.81 91.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.095 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.8 pttt -64.36 -41.83 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.653 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.525 HG23 ' HE ' ' A' ' 95' ' ' ARG . 97.6 mt -59.67 -49.53 83.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.048 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.432 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 96.8 mmm -68.11 -35.4 78.08 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.767 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.477 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 66.3 m -59.58 -45.62 91.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -66.29 -35.12 79.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.584 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.525 ' HE ' HG23 ' A' ' 91' ' ' ILE . 94.2 mtt-85 -79.96 -32.85 39.92 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 48' ' ' LEU . 58.0 m -111.98 -15.87 13.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.477 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -60.62 134.32 56.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 65.03 12.62 8.06 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.649 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.09 145.6 40.62 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.329 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.4 m -70.27 -31.11 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.292 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.1 158.46 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.399 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.725 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.3 p -156.17 143.68 19.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.428 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.5 t -122.24 127.6 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.39 146.28 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.479 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -85.52 120.83 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.829 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.42 28.83 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.438 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.593 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . -179.96 179.08 48.81 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.469 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.3 t 88.86 -158.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.57 -10.65 19.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.88 58.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.82 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 39.5 m-85 -140.87 131.12 13.32 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.006 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.725 ' HG2' HD21 ' A' ' 85' ' ' LEU . 32.1 Cg_exo -49.72 -162.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.869 2.379 . . . . 0.0 112.964 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -138.16 91.6 12.85 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.452 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.453 ' HD2' ' HZ3' ' A' ' 120' ' ' LYS . 83.7 Cg_endo -86.56 -44.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 123.355 2.703 . . . . 0.0 113.391 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.485 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.8 p -134.99 79.4 51.27 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.9 140.5 79.88 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.024 1.816 . . . . 0.0 111.963 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.52 -2.15 58.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.293 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.582 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 51.8 m -114.76 147.71 39.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.626 0.713 . . . . 0.0 109.085 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.551 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.6 t80 -86.97 96.99 10.46 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 18.4 mtmt -76.74 -164.16 0.4 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.079 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.455 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 9.0 p90 -166.24 169.26 14.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.653 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 62' ' ' ASN . 18.2 tp -130.85 125.32 33.32 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 69.7 tt0 -118.74 129.06 55.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.101 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.62 HG22 ' HB1' ' A' ' 61' ' ' ALA . 80.5 t -131.93 122.98 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.619 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.465 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -110.34 128.98 55.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.039 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.5 p90 -151.23 163.54 38.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.324 0.583 . . . . 0.0 111.656 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 57' ' ' MET . 95.4 m-20 -115.83 158.09 23.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.317 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.446 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 96.5 m -109.69 125.6 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.34 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.31 149.7 74.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.45 146.18 43.04 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.338 2.025 . . . . 0.0 111.918 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.04 37.05 0.36 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.32 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -99.26 109.45 22.1 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.838 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.413 HG12 ' HG2' ' A' ' 134' ' ' GLU . 39.2 t -97.64 129.99 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' A' ' 133' ' ' VAL . 80.5 mm-40 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.891 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.56 ' O3 ' ' O7 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.681 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' C ' ' O ' ' A' ' 29' ' ' GLY . 8.2 mt 32.01 60.03 1.3 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 110.426 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.0 144.29 99.43 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 C-N-CA 122.774 2.316 . . . . 0.0 113.169 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -80.78 -34.66 34.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.998 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.49 1.2 89.34 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' MET . 27.5 tp -159.05 113.55 2.43 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.784 0.326 . . . . 0.0 111.297 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 34' ' ' LEU . 93.3 mtp 52.49 141.42 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.532 0.682 . . . . 0.0 111.846 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.785 HH12 ' H ' ' A' ' 128' ' ' CYS . 82.6 mtt85 -90.25 150.13 22.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.803 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -141.58 137.29 31.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.204 0.526 . . . . 0.0 110.851 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 44.2 mp0 -134.92 141.99 46.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -140.48 134.16 30.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.744 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.668 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.67 144.72 44.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.024 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.9 m -71.99 131.1 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.462 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 34.5 tt0 -42.95 135.96 2.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.628 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.48 -9.8 66.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.126 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.7 155.72 50.36 Favored Pre-proline 0 CA--C 1.52 -0.206 0 CA-C-N 118.963 1.382 . . . . 0.0 110.675 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.89 143.54 33.27 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.235 1.957 . . . . 0.0 113.387 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 104' ' ' VAL . 18.3 tt -116.12 145.93 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 86.6 tt0 -130.79 129.83 42.93 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.989 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.632 HD12 ' SG ' ' A' ' 102' ' ' CYS . 23.9 mt -113.79 145.72 41.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.268 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 98.4 mtt180 -150.25 136.15 18.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.167 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.451 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -104.66 138.25 19.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.119 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 12.0 Cg_endo -63.82 155.51 63.34 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.567 2.178 . . . . 0.0 112.705 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.04 -132.14 32.94 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.613 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.4 p -103.62 26.55 8.38 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -80.75 162.39 24.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.881 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -131.12 146.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.093 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.837 HG23 ' CD1' ' A' ' 126' ' ' TYR . 63.1 mt -67.04 138.11 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 111.518 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.619 ' O ' ' CG ' ' A' ' 57' ' ' MET . 10.4 ptm -130.45 98.07 4.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.567 HG12 ' HE1' ' A' ' 89' ' ' PHE . 61.0 t -65.63 125.77 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.967 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.69 -45.59 5.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -151.8 150.35 30.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.106 0.479 . . . . 0.0 110.664 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.489 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -169.08 152.16 5.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.848 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 1.2 t30 -150.39 151.8 33.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.968 0.413 . . . . 0.0 111.617 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.545 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 47.7 t80 -120.26 126.16 49.9 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.74 -137.7 5.79 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.677 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 15.7 ttm-85 -156.25 118.18 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.723 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.427 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 4.2 p -123.88 11.57 9.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.232 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.578 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.8 t0 -144.94 -170.5 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.752 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 46.5 p30 -146.49 -4.12 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.172 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -103.43 5.98 37.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 71' ' ' CYS . 32.4 mm -108.98 139.65 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.818 0.342 . . . . 0.0 110.552 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' ASP . 26.7 m 64.66 24.79 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.754 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.57 ' C ' ' O ' ' A' ' 71' ' ' CYS . 14.3 p30 -3.28 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.545 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -113.63 -167.66 1.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.704 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -62.17 145.58 93.42 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.251 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -58.99 -38.47 87.77 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.776 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -63.92 -39.62 94.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.897 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.704 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.9 mt-30 -84.83 -10.32 57.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.677 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 48.7 mmm -109.96 -2.96 16.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mt-10 -66.46 -44.36 82.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.562 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -78.26 121.27 24.19 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 67' ' ' ASP . 22.9 m -112.75 31.2 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.835 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -140.52 86.31 2.06 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.3 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.8 t -150.34 117.46 5.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 66' ' ' THR . 73.0 m-85 -127.46 157.57 39.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.908 0.385 . . . . 0.0 111.233 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 112' ' ' PRO . 40.6 tp -147.03 87.21 6.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.417 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -44.04 -46.04 11.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.504 2.136 . . . . 0.0 114.081 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.7 m-20 -54.93 -26.84 38.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.94 -33.05 35.67 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.994 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.567 ' HE1' HG12 ' A' ' 58' ' ' VAL . 57.1 t80 -66.24 -44.94 82.31 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 3.0 pttt -65.08 -40.32 94.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.42 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.465 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 83.3 mt -59.87 -49.31 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.761 ' SD ' HD21 ' A' ' 122' ' ' LEU . 74.4 mtp -72.83 -35.13 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.491 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.473 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 69.4 m -58.48 -42.69 88.12 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -66.28 -35.47 80.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 110.753 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 92.9 mtt-85 -79.14 -31.89 44.2 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 48' ' ' LEU . 57.4 m -112.68 -20.87 11.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 69.7 m-20 -60.58 134.45 57.09 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.904 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 66.04 13.8 9.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.693 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -116.68 147.98 41.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.207 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.9 m -72.05 -32.0 66.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.451 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -154.21 156.28 36.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.743 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.632 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.6 p -155.47 146.74 22.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 58.2 t -126.35 132.57 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.523 ' O ' HG22 ' A' ' 46' ' ' ILE . 42.9 t -143.81 139.45 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.611 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.7 t -76.48 118.76 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.99 28.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.004 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 178.2 -177.29 48.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.4 t 91.4 -162.77 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.836 0.35 . . . . 0.0 110.286 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.18 -9.24 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.24 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.44 56.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.302 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.584 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.0 m-85 -135.64 125.88 16.68 Favored Pre-proline 0 N--CA 1.455 -0.222 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.777 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 111' ' ' PHE . 27.2 Cg_exo -49.18 -158.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.518 2.145 . . . . 0.0 111.565 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -138.41 93.26 11.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -86.98 -12.82 4.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 123.185 2.59 . . . . 0.0 112.648 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.428 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -168.6 92.42 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.5 133.67 14.63 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.876 2.384 . . . . 0.0 112.828 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.03 11.52 36.79 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.887 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 77' ' ' GLN . 47.3 m -127.91 145.63 50.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 6.5 t80 -83.55 98.27 9.48 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 6.1 mtmp? -77.25 -167.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.69 1.234 . . . . 0.0 113.683 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.486 ' HB2' HD21 ' A' ' 39' ' ' LEU . 6.5 p90 -168.11 173.85 7.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.232 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.761 HD21 ' SD ' ' A' ' 92' ' ' MET . 26.4 tp -128.73 119.34 24.42 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.093 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -114.35 132.27 56.26 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.729 HG21 ' CE ' ' A' ' 92' ' ' MET . 95.1 t -131.24 149.32 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.16 127.83 28.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.837 ' CD1' HG23 ' A' ' 56' ' ' ILE . 20.8 p90 -158.73 174.33 15.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.812 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.37 158.17 36.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.696 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.785 ' H ' HH12 ' A' ' 36' ' ' ARG . 62.3 m -106.35 123.9 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.146 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 55' ' ' VAL . 4.9 m -130.54 157.4 77.65 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.502 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.18 144.1 95.88 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.361 2.04 . . . . 0.0 113.084 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -76.96 -4.04 41.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.979 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -137.71 127.03 24.7 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.671 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 133' ' ' VAL . 8.5 m -94.7 132.55 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.224 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.477 179.261 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.581 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 56.78 58.26 8.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.128 0.489 . . . . 0.0 110.416 -179.631 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.3 130.14 24.62 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.853 2.369 . . . . 0.0 111.734 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -81.46 -4.75 56.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.945 0.402 . . . . 0.0 110.352 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.91 29.7 50.49 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.776 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.572 HD13 ' N ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -160.47 113.72 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.072 0.463 . . . . 0.0 110.472 179.294 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.572 ' N ' HD13 ' A' ' 34' ' ' LEU . 28.1 mtt 58.96 125.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.432 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 62.5 mtp85 -88.76 150.82 22.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.497 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 33.0 ttp-105 -142.75 137.13 29.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.865 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.2 mp0 -137.59 144.14 41.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.528 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.775 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -139.21 139.22 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.801 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.775 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.09 142.51 34.13 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.597 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.4 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 16.6 m -71.08 135.48 47.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.543 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 84.2 tt0 -44.97 137.51 4.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.12 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.285 177.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.36 149.63 46.3 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 118.994 1.397 . . . . 0.0 110.319 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.18 146.12 68.88 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.346 2.031 . . . . 0.0 113.597 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 104' ' ' VAL . 15.2 tt -115.39 144.51 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.669 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 51.2 tt0 -121.35 128.0 51.82 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.463 -178.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.824 HD12 ' SG ' ' A' ' 102' ' ' CYS . 43.8 mt -117.79 140.32 49.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.669 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 89.5 mtt-85 -148.92 136.32 20.24 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.47 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.6 m -103.18 138.13 19.46 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.392 179.002 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 24.1 Cg_endo -66.54 156.01 67.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.473 2.115 . . . . 0.0 112.26 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.49 -134.67 38.11 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -103.41 25.1 10.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.503 . . . . 0.0 110.544 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.97 163.09 25.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.019 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG11 ' CD1' ' A' ' 131' ' ' TYR . 4.4 m -126.64 144.04 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.412 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.005 HG23 ' CD1' ' A' ' 126' ' ' TYR . 88.3 mt -68.31 137.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.114 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.4 ptm -130.9 99.04 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 t -61.46 123.37 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.585 -177.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.574 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.6 mm-40 -98.66 -50.63 4.18 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.6 m-20 -153.74 153.74 32.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.123 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.48 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.6 157.51 8.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.099 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.779 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.7 t30 -150.43 153.58 36.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.148 0.499 . . . . 0.0 111.992 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.518 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 32.1 t80 -123.35 121.09 34.93 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.59 -139.26 6.28 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.938 -177.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 6.6 ttm180 -155.5 116.72 3.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.141 0.496 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 p -124.22 10.21 8.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.973 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 37.4 t0 -145.87 -175.2 4.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.451 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 33.1 p30 -141.89 3.01 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.414 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 3.2 mtmp? -107.61 6.12 27.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.216 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.2 mm -117.81 137.85 50.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.5 m 54.47 74.91 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.767 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -53.62 125.42 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.408 0.623 . . . . 0.0 112.026 -178.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.88 -177.52 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.213 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -59.32 147.6 75.39 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.281 0.562 . . . . 0.0 110.066 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.4 Cg_endo -53.83 -38.52 85.63 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.114 1.876 . . . . 0.0 111.457 -178.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -61.44 -33.0 72.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.583 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 72.1 mt-30 -91.15 -6.2 53.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.438 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 73' ' ' ALA . 75.1 mtp -109.12 -9.1 15.06 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 40.9 mt-10 -63.89 -48.23 77.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.087 -178.344 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -81.21 116.83 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.536 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 20.9 m -106.66 33.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.554 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 90.6 mm-40 -141.76 86.72 2.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.2 t -145.4 118.22 8.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.411 ' HA ' HD21 ' A' ' 62' ' ' ASN . 94.3 m-85 -129.08 154.82 46.31 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.579 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.436 HD21 ' HD2' ' A' ' 112' ' ' PRO . 26.8 tp -147.16 89.2 5.62 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.26 -46.98 13.22 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 123.555 2.837 . . . . 0.0 115.094 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.5 m-20 -60.86 -14.03 19.4 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 62' ' ' ASN . . . -52.87 -36.34 59.0 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.358 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -64.56 -43.52 93.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.307 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.03 -42.18 99.71 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.723 -178.508 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.604 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 44.2 mt -60.27 -50.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.69 0.281 . . . . 0.0 111.305 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.456 ' SD ' HD21 ' A' ' 122' ' ' LEU . 83.6 mmm -66.98 -35.26 79.56 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.617 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.482 ' HB3' HD21 ' A' ' 97' ' ' ASN . 69.9 m -60.63 -48.59 81.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -66.74 -38.85 87.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.051 0.453 . . . . 0.0 111.355 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.604 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 83.9 mtt-85 -74.21 -34.23 63.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.588 ' SG ' HD12 ' A' ' 48' ' ' LEU . 56.4 m -112.62 -16.31 12.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -60.57 138.56 58.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.929 -0.709 . . . . 0.0 112.495 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 62.03 13.4 5.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.979 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -116.23 146.66 42.17 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.453 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -73.52 -28.0 61.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.825 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -153.03 153.59 33.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.824 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.1 p -154.02 141.99 20.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.619 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.63 128.77 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.355 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 46' ' ' ILE . 45.3 t -139.42 141.36 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.082 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.615 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -80.8 119.76 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -64.89 28.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.982 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 176.58 -175.97 47.72 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 90.01 -159.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.524 . . . . 0.0 110.61 179.407 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -62.49 -9.5 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.751 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.409 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -79.61 -18.37 51.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.553 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -140.88 129.92 12.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.434 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.553 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.8 Cg_exo -49.99 -153.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.267 1.978 . . . . 0.0 112.46 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -140.88 91.02 9.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.275 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 73.3 Cg_endo -81.58 -28.61 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.656 2.237 . . . . 0.0 113.031 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.446 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.8 p -146.11 77.22 12.04 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.07 131.97 49.16 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.244 1.962 . . . . 0.0 111.585 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.63 3.64 58.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.771 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.54 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 93.2 m -116.95 145.95 43.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.19 0.995 . . . . 0.0 109.519 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.707 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 11.5 t80 -88.22 96.85 10.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.518 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 26.2 mttt -76.32 -161.8 0.2 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.488 -177.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 14.2 p90 -170.69 172.42 5.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.69 176.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 62' ' ' ASN . 61.5 tp -129.59 124.44 33.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.041 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -116.86 128.9 55.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.941 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.48 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.0 t -132.17 120.57 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 119.463 -0.895 . . . . 0.0 113.096 -178.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -106.97 123.99 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.005 ' CD1' HG23 ' A' ' 56' ' ' ILE . 17.5 p90 -154.08 174.88 14.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.555 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.627 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.4 OUTLIER -127.7 159.98 33.07 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.597 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.432 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 83.7 m -108.93 115.04 29.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.1 m -115.73 155.49 47.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.47 142.95 98.38 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.911 1.741 . . . . 0.0 112.224 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.578 ' CD1' HG11 ' A' ' 55' ' ' VAL . 24.4 t80 -79.39 -118.46 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.207 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.457 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 67.6 mttm -147.01 88.42 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.58 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.0 m -150.27 118.87 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.973 0.416 . . . . 0.0 110.818 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.81 179.931 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.543 ' O3 ' ' OE2' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 71.11 39.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.013 0.435 . . . . 0.0 109.96 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -47.28 158.51 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.795 2.33 . . . . 0.0 112.237 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.56 7.43 6.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.937 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.46 43.86 7.19 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.85 101.58 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.483 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 2.7 mtm 61.78 134.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.152 0.501 . . . . 0.0 111.276 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 -91.58 147.39 23.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.951 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.73 137.1 23.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.333 0.587 . . . . 0.0 111.69 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.3 mp0 -135.25 146.16 48.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.785 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.407 179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.662 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.63 148.61 44.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.176 0.513 . . . . 0.0 111.116 -179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.8 m -70.56 133.31 46.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.918 -178.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.575 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 5.8 tt0 -44.96 139.12 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.471 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -9.89 73.9 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.924 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -117.45 150.46 46.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 118.415 1.107 . . . . 0.0 110.555 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 138.56 55.82 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.584 2.19 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 tt -113.62 145.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -124.42 128.77 49.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.234 -178.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.514 HD12 ' SG ' ' A' ' 96' ' ' CYS . 50.3 mt -113.99 142.4 46.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.707 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -152.23 137.03 17.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.5 -178.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.82 149.74 36.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.916 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.4 Cg_endo -72.38 159.36 49.54 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.691 2.261 . . . . 0.0 112.757 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.87 -118.04 6.73 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.264 178.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -125.85 24.12 7.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -75.54 171.2 14.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.98 149.09 29.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.495 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.964 HG23 ' CD1' ' A' ' 126' ' ' TYR . 66.1 mt -73.45 138.87 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.623 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.7 ptm -133.29 100.24 4.78 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.524 HG12 ' HE1' ' A' ' 89' ' ' PHE . 59.7 t -63.12 124.12 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.853 -178.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 84.0 mt-10 -102.62 -45.71 4.96 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.5 m-20 -150.64 148.74 28.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.0 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.621 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.41 152.41 7.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.946 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' O ' HD12 ' A' ' 122' ' ' LEU . 9.0 t-20 -149.76 150.19 31.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.149 0.5 . . . . 0.0 111.509 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.575 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 57.4 t80 -120.74 122.39 40.3 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.48 -137.35 5.43 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.76 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 11.1 ttm-85 -154.69 119.47 4.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.959 0.409 . . . . 0.0 111.473 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.582 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 10.5 p -123.4 7.53 9.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.807 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 61.9 t0 -148.76 154.87 40.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.901 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p-10 -112.18 3.56 17.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 110.521 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -109.2 9.39 26.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.323 -178.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 mm -112.76 137.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.4 m 54.73 73.03 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.397 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.12 120.12 6.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.787 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -136.87 -164.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.151 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.577 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -64.32 138.2 97.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 7.2 Cg_endo -54.24 -31.99 68.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.968 1.779 . . . . 0.0 111.929 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -62.36 -41.89 98.97 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 118' ' ' THR . 29.0 mt-30 -92.45 -2.98 55.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.889 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.76 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 51.4 mmm -115.29 -4.1 12.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.111 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mm-40 -69.49 -38.85 77.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.063 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -76.07 124.13 26.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.599 -178.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.73 29.47 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -139.34 85.65 2.07 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.411 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.462 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.4 t -147.66 124.5 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -134.2 155.63 49.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.276 0.56 . . . . 0.0 111.752 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 112' ' ' PRO . 52.0 tp -147.17 95.5 4.39 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.962 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.17 -47.6 26.61 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.582 2.188 . . . . 0.0 113.568 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 90.0 m-20 -54.38 -21.6 10.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.837 -178.09 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.4 65.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.431 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' HE1' HG12 ' A' ' 58' ' ' VAL . 59.1 t80 -65.06 -40.95 95.44 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.4 pttp -65.13 -38.2 89.89 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 64.4 mt -61.3 -51.57 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.5 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.867 ' SD ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.41 -34.5 76.11 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.864 -178.867 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.5 m -61.02 -47.42 86.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.5 -35.97 80.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.622 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 94.9 mtt-85 -77.35 -35.02 55.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -177.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 48' ' ' LEU . 57.5 m -112.67 -15.69 12.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -177.14 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.6 m-20 -60.59 139.28 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.03 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 65.45 12.82 8.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.631 178.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -117.32 147.75 42.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.278 0.561 . . . . 0.0 110.915 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 m -72.78 -31.78 65.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.927 179.319 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -152.75 155.92 38.11 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.168 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 48' ' ' LEU . 30.2 p -155.01 144.8 21.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.846 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.4 125.12 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.161 178.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 t -140.35 142.55 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.867 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 107' ' ' GLY . 2.6 t -70.81 119.94 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.161 179.066 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -66.73 39.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.879 -178.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.32 -121.82 0.78 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.007 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 29.52 -155.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.439 0.637 . . . . 0.0 111.137 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -64.82 -11.55 38.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.49 60.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.859 -178.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 68.1 m-85 -144.52 129.46 9.33 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.012 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 49.2 Cg_exo -46.65 -159.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.558 2.172 . . . . 0.0 112.943 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -138.81 90.35 12.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.67 -53.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.152 2.568 . . . . 0.0 113.18 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -125.35 76.85 68.62 Favored Pre-proline 0 C--O 1.238 0.476 0 CA-C-O 121.181 0.515 . . . . 0.0 111.598 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.51 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 14.1 Cg_endo -63.07 131.98 34.81 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.705 1.604 . . . . 0.0 111.469 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.05 -11.27 34.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.227 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 77' ' ' GLN . 79.6 m -110.05 149.2 30.35 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.4 t80 -85.19 97.8 10.11 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.509 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 16.8 mtmt -72.09 -169.8 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 123.131 1.443 . . . . 0.0 114.572 -177.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.582 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.6 p90 -164.21 165.91 21.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 112.014 -2.357 . . . . 0.0 110.317 176.379 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.732 HD21 ' SD ' ' A' ' 92' ' ' MET . 43.1 tp -126.8 123.05 36.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.464 ' OE2' ' OE1' ' A' ' 125' ' ' GLN . 43.2 tt0 -120.4 126.72 51.16 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.561 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.867 HG21 ' SD ' ' A' ' 92' ' ' MET . 37.3 t -133.07 126.78 53.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.474 -178.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.464 ' OE1' ' OE2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -114.09 131.49 56.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.987 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.964 ' CD1' HG23 ' A' ' 56' ' ' ILE . 27.9 p90 -153.84 169.18 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 112.007 -178.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.483 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 82.7 m-20 -122.72 162.03 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.76 179.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.477 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.4 m -109.26 131.96 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.23 161.71 59.51 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.593 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -63.15 143.22 89.61 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 112.828 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -79.77 124.22 28.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.334 179.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -106.95 136.44 46.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 134' ' ' GLU . 23.4 t -89.29 138.57 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 133' ' ' VAL . 76.6 tt0 . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.767 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.603 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp 50.07 90.46 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.709 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -55.84 145.33 73.25 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 121.96 1.773 . . . . 0.0 111.113 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' C ' ' H ' ' A' ' 34' ' ' LEU . 32.3 t80 -148.17 7.79 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.488 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 67.12 -7.88 1.55 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.253 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -157.79 103.9 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 111.032 179.954 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 34' ' ' LEU . 8.1 mtt 58.06 138.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.141 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.562 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 65.4 mtt85 -88.55 145.0 25.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 39.2 ttp180 -147.03 139.7 24.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.336 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.687 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.8 mp0 -133.11 142.37 48.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.236 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -141.44 137.42 32.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.706 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.99 149.08 36.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.691 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.7 m -68.53 131.64 45.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 48.5 tt0 -45.9 142.65 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.431 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.0 -6.9 82.87 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.761 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.94 140.64 27.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.832 0.816 . . . . 0.0 110.016 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.14 141.48 88.57 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.514 2.142 . . . . 0.0 113.606 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 38' ' ' GLU . 13.0 tt -120.01 145.09 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.63 130.37 52.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.149 0.499 . . . . 0.0 112.18 -178.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.914 HD12 ' SG ' ' A' ' 102' ' ' CYS . 16.5 mt -113.21 143.41 44.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -150.05 135.16 17.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.066 -178.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.8 m -101.81 148.71 35.68 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.723 179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 60.4 Cg_endo -73.91 157.95 46.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.134 2.556 . . . . 0.0 112.34 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.92 -128.07 32.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 p -113.85 24.53 12.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -77.65 168.26 20.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.296 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.428 HG11 ' HD1' ' A' ' 131' ' ' TYR . 23.7 m -126.79 147.74 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.486 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.917 HG23 ' CD1' ' A' ' 126' ' ' TYR . 92.4 mt -72.55 140.02 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.395 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptp -131.87 102.0 5.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 93' ' ' SER . 99.9 t -63.93 123.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.093 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.3 mm-40 -102.17 -50.49 3.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' HB2' ' NE2' ' A' ' 125' ' ' GLN . 46.4 m-20 -146.86 144.18 29.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.447 -179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.743 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.22 148.26 6.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.847 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 4.8 t30 -150.92 156.81 41.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.366 0.603 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.547 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 49.4 t80 -120.27 122.13 40.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.09 -143.47 9.26 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.999 -177.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.687 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.6 ttm-85 -150.63 115.79 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.383 0.611 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 84' ' ' TYR . 19.7 p -123.52 3.45 9.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.355 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.684 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 53.7 t0 -145.04 153.24 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.224 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 38.6 p30 -112.55 0.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 43.3 mttm -102.48 1.82 35.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.401 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mm -110.44 138.8 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.391 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m 56.34 70.25 0.66 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.997 -179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -54.26 121.04 7.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.82 -163.05 1.46 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.028 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.02 143.91 97.4 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.27 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.0 Cg_endo -56.74 -38.69 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.515 2.144 . . . . 0.0 113.498 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -63.77 -29.95 71.1 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.183 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.7 mt-30 -88.33 -12.86 42.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.052 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 73.0 mtp -102.97 -5.4 23.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 57.3 mm-40 -65.23 -47.33 77.18 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.453 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 45.3 t30 -78.61 111.74 15.0 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.888 -178.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.464 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 33.3 m -103.34 31.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.464 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 25.6 mm100 -142.89 86.95 1.95 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.554 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.4 t -149.45 119.74 7.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.081 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' CE2' HG21 ' A' ' 66' ' ' THR . 51.2 m-85 -129.47 147.39 51.28 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.266 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.504 HD21 ' HG2' ' A' ' 112' ' ' PRO . 31.3 tp -138.31 91.97 12.34 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -50.26 -45.87 31.58 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.768 2.312 . . . . 0.0 113.319 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.6 m-20 -53.64 -30.6 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.246 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.93 54.03 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.188 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.509 ' O ' ' OG ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -65.5 -44.32 87.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.241 178.624 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.23 -41.19 97.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 -179.311 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.522 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 60.7 mt -60.69 -48.91 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.02 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.29 -36.19 81.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.918 0.389 . . . . 0.0 110.499 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 15.8 m -59.88 -45.43 92.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -65.93 -35.87 81.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.518 0.675 . . . . 0.0 110.883 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.492 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 95.1 mtt-85 -76.08 -34.25 59.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.624 ' SG ' HD12 ' A' ' 48' ' ' LEU . 33.0 m -112.42 -13.73 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' SER . 83.0 m-20 -60.77 134.59 57.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.273 0.559 . . . . 0.0 112.208 -179.278 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 66.37 12.73 8.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.679 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -115.8 147.72 40.67 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.281 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.9 m -74.02 -30.91 62.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -152.03 153.19 33.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.914 ' SG ' HD12 ' A' ' 48' ' ' LEU . 20.3 p -154.68 139.63 17.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.4 124.58 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 105' ' ' VAL . 57.9 t -138.74 151.83 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 112.123 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.4 t -84.5 116.57 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.184 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -67.22 40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.059 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 178.3 -131.03 1.67 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.753 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t 32.75 -150.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.036 -0.582 . . . . 0.0 112.227 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.46 -11.74 36.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.698 -178.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.83 -12.33 59.77 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.613 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.0 m-85 -142.2 124.73 9.19 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.445 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -46.23 -159.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.079 2.519 . . . . 0.0 113.547 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -137.05 85.82 21.74 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.34 -34.33 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.966 2.444 . . . . 0.0 112.775 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.415 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.0 p -145.73 89.99 6.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.88 139.04 42.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.812 2.341 . . . . 0.0 112.75 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.04 15.66 47.59 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.49 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.3 m -128.93 144.65 51.24 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.687 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 11.5 t80 -89.03 97.24 11.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.164 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.547 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 16.3 mttt -74.0 -153.77 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.765 1.269 . . . . 0.0 113.034 -177.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.524 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.4 p90 -175.6 171.6 2.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.275 -2.239 . . . . 0.0 109.085 176.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 18.1 tp -127.49 120.38 28.18 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 80.8 tt0 -113.11 125.65 54.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.743 HG22 ' HB1' ' A' ' 61' ' ' ALA . 74.1 t -135.75 124.79 39.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.202 -178.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.526 ' NE2' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -113.68 130.62 56.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.069 179.026 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.917 ' CD1' HG23 ' A' ' 56' ' ' ILE . 37.8 p90 -154.47 173.36 16.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 111.454 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.458 ' HA ' HH11 ' A' ' 36' ' ' ARG . 88.3 m-20 -127.51 161.72 28.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.562 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.5 m -109.49 117.54 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.262 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.07 158.19 61.35 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.921 -179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.87 145.51 90.5 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.164 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.428 ' HD1' HG11 ' A' ' 55' ' ' VAL . 79.6 t80 -75.76 -30.61 59.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.341 179.061 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 133' ' ' VAL . 25.9 tttm -95.19 -144.4 0.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.389 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.473 ' H ' ' HG2' ' A' ' 132' ' ' LYS . 1.3 m -147.09 124.24 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.382 . . . . 0.0 111.019 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.861 179.28 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.46 ' H63' ' N ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.73 64.55 69.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.22 0.533 . . . . 0.0 111.77 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.83 146.27 91.59 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.636 2.224 . . . . 0.0 111.213 178.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -78.95 -14.5 59.18 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.2 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.12 24.93 56.61 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.691 178.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.616 ' O ' ' O ' ' A' ' 35' ' ' MET . 1.4 tt -161.02 77.66 0.58 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.485 0.643 . . . . 0.0 111.089 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.616 ' O ' ' O ' ' A' ' 34' ' ' LEU . 4.3 mtt 52.74 146.59 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.513 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 66.0 mtp85 -89.88 145.39 25.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.576 ' NH2' ' OE2' ' A' ' 123' ' ' GLU . 74.6 ttt180 -147.77 131.81 17.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.686 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.613 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 46.4 mt-10 -132.54 145.62 51.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.045 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.1 tt -141.12 141.94 34.14 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.843 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.49 146.23 36.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.468 -178.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.34 130.0 41.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.973 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.558 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 5.9 tt0 -40.39 136.13 1.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.126 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.45 83.7 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.111 -0.949 . . . . 0.0 114.173 177.123 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -117.8 148.18 42.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 118.994 1.397 . . . . 0.0 111.074 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.03 137.68 63.41 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.518 2.145 . . . . 0.0 113.32 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.4 143.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.71 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 44.7 tt0 -131.24 127.18 37.31 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.554 -178.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 102' ' ' CYS . 16.1 mt -108.7 144.58 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.164 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.71 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 93.3 mtt-85 -149.15 127.22 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.274 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -95.78 141.57 23.35 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.704 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 15.3 Cg_endo -66.6 158.7 54.47 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.031 1.821 . . . . 0.0 112.245 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.66 -134.28 34.75 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.427 0.459 . . . . 0.0 112.946 178.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.4 p -104.81 22.62 14.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.94 -0.63 . . . . 0.0 110.913 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -75.91 166.62 23.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.743 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.439 HG11 ' HD1' ' A' ' 131' ' ' TYR . 20.2 m -126.98 144.87 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.521 -179.646 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.837 HG23 ' CD2' ' A' ' 126' ' ' TYR . 86.0 mt -70.23 136.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.143 0.497 . . . . 0.0 112.088 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.7 ptp -130.43 98.9 4.82 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.632 HG12 ' CE1' ' A' ' 89' ' ' PHE . 53.4 t -62.99 123.61 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.79 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.404 ' C ' ' CG ' ' A' ' 60' ' ' ASN . 73.4 mm-40 -99.49 -45.12 5.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' CG ' ' C ' ' A' ' 59' ' ' GLU . 2.8 m-80 -154.12 148.14 25.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.304 -179.085 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.26 152.87 11.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.885 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.739 ' O ' HD12 ' A' ' 122' ' ' LEU . 11.2 t30 -149.32 153.65 37.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.428 -179.114 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.492 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 61.6 t80 -125.84 125.69 43.27 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.06 -137.96 5.88 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -177.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.599 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -155.02 114.97 3.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 111.055 179.299 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.454 HG21 ' CE2' ' A' ' 84' ' ' TYR . 13.9 p -119.26 9.49 11.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.626 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 44.7 t0 -143.49 -167.12 2.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.612 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.626 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 53.9 p30 -151.83 -5.89 0.24 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 38.1 mttm -97.36 11.04 38.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.9 mm -115.03 138.56 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.939 0.4 . . . . 0.0 110.312 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m 56.92 70.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.117 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.6 p-10 -51.39 117.33 2.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.584 0.707 . . . . 0.0 111.315 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.94 -163.84 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.555 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.676 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 3.4 p30 -60.71 132.71 91.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 119.164 -1.014 . . . . 0.0 108.667 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -57.0 -27.14 72.08 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.452 2.101 . . . . 0.0 113.968 -178.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -63.88 -30.02 71.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.032 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.676 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.0 mt-30 -88.59 -5.72 57.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.516 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.599 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 6.0 mtm -110.84 -1.48 16.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.264 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 49.9 mt-10 -60.97 -52.32 65.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.963 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.98 107.76 11.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.051 -0.406 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 67' ' ' ASP . 19.6 m -101.4 31.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.33 0.586 . . . . 0.0 110.662 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -139.26 85.9 2.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.415 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 43.5 t -149.32 115.39 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.454 ' CE2' HG21 ' A' ' 66' ' ' THR . 91.1 m-85 -124.25 156.01 37.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.727 0.299 . . . . 0.0 111.221 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 112' ' ' PRO . 55.1 tp -142.69 82.02 12.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -44.91 -45.42 13.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.245 2.63 . . . . 0.0 114.256 -177.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 86.6 m-20 -57.1 -25.29 58.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.885 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.36 -34.77 49.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.576 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.632 ' CE1' HG12 ' A' ' 58' ' ' VAL . 26.7 t80 -64.1 -40.37 96.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.8 pttm -67.17 -39.25 86.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.835 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.669 HG23 ' NH1' ' A' ' 95' ' ' ARG . 69.9 mt -60.19 -52.45 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' MET . . . . . 1.063 ' SD ' HD21 ' A' ' 122' ' ' LEU . 62.1 mtp -69.68 -32.56 71.25 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.478 ' HB3' HD21 ' A' ' 97' ' ' ASN . 62.5 m -59.97 -43.37 95.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.592 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 90.4 mt-30 -66.59 -36.23 82.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.353 0.596 . . . . 0.0 110.014 178.393 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.669 ' NH1' HG23 ' A' ' 91' ' ' ILE . 52.9 mtt85 -77.45 -34.08 54.54 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.607 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.4 m -110.89 -16.19 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.478 HD21 ' HB3' ' A' ' 93' ' ' SER . 77.0 m-20 -61.44 133.39 55.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.804 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 66.52 13.31 9.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.255 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.592 ' NH2' ' O ' ' A' ' 94' ' ' GLN . 42.9 mtt85 -113.89 147.03 39.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.944 178.181 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -71.04 -31.32 67.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.623 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 156.59 35.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.102 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.3 p -153.6 142.34 21.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.29 126.25 70.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.328 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.71 146.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.855 -178.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.45 120.26 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.268 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.76 43.5 0.09 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.165 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.1 -126.72 1.03 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 29.36 -154.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.239 0.543 . . . . 0.0 112.209 179.588 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -64.43 -10.56 25.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.642 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.05 59.9 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.807 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 112' ' ' PRO . 64.4 m-85 -142.69 126.76 9.68 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.684 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.567 ' HG2' HD21 ' A' ' 85' ' ' LEU . 23.4 Cg_exo -50.1 -156.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.323 2.015 . . . . 0.0 112.436 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 20.9 t0 -139.35 93.21 10.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.411 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.49 -38.55 0.98 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.714 2.276 . . . . 0.0 113.328 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -140.25 79.08 22.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.057 0.456 . . . . 0.0 110.995 -179.349 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 17.2 Cg_exo -56.18 133.4 57.83 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.187 1.924 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.46 -10.9 56.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.888 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 77' ' ' GLN . 62.9 m -105.95 147.54 28.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.616 0.708 . . . . 0.0 109.104 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.593 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 t80 -84.37 97.61 9.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.492 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 22.5 mtmm -73.54 -171.65 1.05 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.457 1.599 . . . . 0.0 115.083 -177.056 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.6 p90 -164.47 167.73 19.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 111.58 -2.555 . . . . 0.0 110.579 177.1 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.063 HD21 ' SD ' ' A' ' 92' ' ' MET . 25.9 tp -129.33 122.56 29.78 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.049 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.576 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 83.5 tt0 -115.33 132.93 56.46 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.774 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.687 HG21 ' SD ' ' A' ' 92' ' ' MET . 41.5 t -133.33 144.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.82 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.26 130.44 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.837 ' CD2' HG23 ' A' ' 56' ' ' ILE . 27.9 p90 -156.09 171.62 19.82 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.138 -178.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 57' ' ' MET . 87.8 m-20 -125.5 162.22 25.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.775 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 92.4 m -108.93 125.52 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.7 m -130.34 157.58 76.9 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.674 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -59.59 148.93 85.29 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.025 1.816 . . . . 0.0 111.979 178.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' HD1' HG11 ' A' ' 55' ' ' VAL . 46.1 t80 -74.8 1.61 12.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -95.63 135.35 37.42 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.634 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 133' ' ' VAL . 7.6 p -90.18 126.6 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.655 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.497 -179.632 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.421 ' H82' ' CB ' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.558 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.2 mp 64.99 65.93 0.93 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 111.546 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.86 -95.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.345 2.03 . . . . 0.0 111.877 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 55.5 t80 -80.17 -6.0 57.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.798 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.23 19.02 70.32 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 35' ' ' MET . 10.6 tp -161.33 63.45 0.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER 49.23 173.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.485 -179.614 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.525 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 3.3 mtm-85 -93.09 142.72 26.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.168 179.122 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' HE ' ' HG2' ' A' ' 125' ' ' GLN . 41.0 ttm180 -146.69 135.84 22.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' HD23 ' A' ' 48' ' ' LEU . 78.5 mm-40 -132.04 143.6 50.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.672 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.2 tt -139.16 141.09 38.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.774 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.91 142.73 34.4 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.266 -179.175 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.448 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 65.7 m -66.84 134.45 52.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.994 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 5.4 tt0 -44.04 134.86 4.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.118 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -4.91 79.67 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.326 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 12.1 m-85 -118.1 150.08 46.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 118.189 0.995 . . . . 0.0 110.798 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 24.4 Cg_endo -65.94 141.76 65.95 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.879 2.386 . . . . 0.0 113.722 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.0 tt -117.3 145.53 22.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.135 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.445 ' HG3' HG22 ' A' ' 103' ' ' VAL . 80.2 tt0 -127.5 129.29 47.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.317 -178.159 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.764 HD12 ' SG ' ' A' ' 102' ' ' CYS . 40.4 mt -112.44 141.81 45.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.538 178.284 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -149.43 132.85 16.6 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.577 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.8 m -102.68 142.98 25.68 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.901 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.17 161.59 44.15 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.6 2.2 . . . . 0.0 112.844 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.03 -128.1 33.34 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.6 p -112.88 25.84 11.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.45 166.82 22.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG11 ' CD1' ' A' ' 131' ' ' TYR . 8.5 m -127.62 143.99 38.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.936 HG23 ' CD2' ' A' ' 126' ' ' TYR . 92.0 mt -69.48 139.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.234 -178.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 127' ' ' ASP . 4.0 ptp -132.85 103.12 5.93 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.67 125.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.25 -178.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 96.0 mt-10 -102.94 -51.0 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -149.05 145.1 27.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.202 0.525 . . . . 0.0 110.549 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.494 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.85 156.22 10.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.716 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.449 ' O ' HD12 ' A' ' 122' ' ' LEU . 6.4 t30 -152.59 154.95 36.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.177 0.513 . . . . 0.0 111.618 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 76.9 t80 -122.39 122.48 39.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.445 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.11 -142.45 8.68 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -177.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -151.6 119.15 6.05 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.17 0.51 . . . . 0.0 111.722 179.11 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.413 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 26.6 p -128.09 5.49 5.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.557 179.134 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.745 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 61.8 t0 -144.39 151.63 39.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.399 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.658 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 40.7 p30 -112.66 3.5 16.65 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.471 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 15.7 mttt -103.1 8.52 38.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.737 -178.518 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.2 mm -112.31 135.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 -179.089 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m 55.69 72.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.611 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 57.8 p30 -49.65 106.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.529 0.68 . . . . 0.0 112.19 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.56 -166.78 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.152 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.626 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.18 141.6 97.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 5.9 Cg_endo -54.99 -33.82 84.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 121.895 1.73 . . . . 0.0 112.509 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -63.51 -40.26 96.57 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.708 ' OE1' ' H61' ' A' ' 136' ' ' RAM . 25.5 mt-30 -90.37 -6.68 54.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.974 0.416 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.445 ' HE3' ' NH2' ' A' ' 65' ' ' ARG . 80.2 mmm -106.66 -5.23 18.76 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.758 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.583 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 1.9 mm-40 -66.98 -46.58 74.18 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.225 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.7 t30 -78.25 122.99 26.43 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.838 -178.26 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.24 32.59 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.1 85.5 2.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.496 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.402 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 2.2 t -151.27 121.22 7.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.9 m-85 -131.75 156.59 45.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.964 0.411 . . . . 0.0 111.939 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' A' ' 88' ' ' ALA . 27.8 tp -147.93 87.66 5.76 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.567 178.297 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -48.03 -46.6 21.64 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.621 2.214 . . . . 0.0 113.361 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.5 m-20 -55.15 -23.92 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.124 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.432 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.59 -33.08 63.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.615 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' O ' ' OG ' ' A' ' 93' ' ' SER . 4.7 t80 -65.18 -40.75 94.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.598 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 10.1 pttp -64.87 -40.6 95.39 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.39 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 60.6 mt -59.94 -50.52 79.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.703 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.419 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 96.0 mmm -67.16 -33.99 76.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.502 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 28.1 m -60.02 -45.09 93.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.283 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.71 -36.78 83.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.179 0.514 . . . . 0.0 111.01 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.822 ' CZ ' HG13 ' A' ' 104' ' ' VAL . 16.9 mtp180 -74.09 -35.4 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.455 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.584 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.2 m -112.99 -12.88 13.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.151 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.567 ' HB3' ' H82' ' A' ' 135' ' ' NAG . 68.2 m-20 -60.02 133.76 56.4 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.55 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 67.31 13.83 9.5 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 178.257 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -113.85 145.16 41.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.802 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.7 m -69.13 -31.26 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.257 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 155.4 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.267 179.326 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.764 ' SG ' HD12 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -153.86 130.8 10.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.25 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.445 HG22 ' HG3' ' A' ' 47' ' ' GLU . 97.3 t -114.25 132.4 63.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.875 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.822 HG13 ' CZ ' ' A' ' 95' ' ' ARG . 43.5 t -144.03 149.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -83.62 117.52 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.08 37.48 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.62 -178.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.94 -127.73 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.554 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 107' ' ' GLY . 12.4 t 31.69 -153.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.46 -9.08 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.101 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.36 60.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.922 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -141.57 126.36 10.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.8 Cg_exo -49.96 -154.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.602 2.201 . . . . 0.0 112.162 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -137.72 87.39 17.25 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -84.7 -20.89 3.57 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.313 2.675 . . . . 0.0 114.092 -179.337 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.508 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -153.49 73.47 6.71 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 121.109 0.48 . . . . 0.0 110.858 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 19.1 Cg_endo -63.26 135.42 50.33 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.084 1.856 . . . . 0.0 112.048 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.76 -12.0 53.35 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.586 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -111.25 149.79 30.52 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.187 0.994 . . . . 0.0 108.835 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.2 t80 -82.2 98.5 8.76 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.257 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.508 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 20.7 mttt -70.89 -160.74 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.652 1.215 . . . . 0.0 112.98 -178.418 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -176.5 171.73 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.052 176.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 111' ' ' PHE . 20.3 tp -130.11 123.83 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.666 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 57.6 tt0 -117.89 125.07 49.8 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.494 HG22 ' HB1' ' A' ' 61' ' ' ALA . 29.9 t -131.01 124.73 56.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.938 -178.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.46 ' HG2' ' HE ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -109.48 131.41 55.09 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.936 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.8 p90 -151.46 171.93 16.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.357 -178.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.455 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 48.9 m-20 -127.08 160.9 29.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.898 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.525 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 84.2 m -112.6 120.94 43.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.744 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 30.7 m -121.16 149.18 50.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.902 179.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -54.57 143.45 68.09 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.83 1.686 . . . . 0.0 112.163 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.436 ' CD1' HG11 ' A' ' 55' ' ' VAL . 30.3 t80 -81.85 -12.88 58.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.63 179.433 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -98.21 135.82 39.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 133' ' ' VAL . 13.1 p -152.12 120.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.333 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.505 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 62.5 tt0 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.46 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.567 ' H82' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' RAM . . . . . 0.708 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.456 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 65.4 mtp85 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.598 0.237 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -153.12 138.37 17.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.296 0.57 . . . . 0.0 112.161 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.765 ' CD ' HD23 ' A' ' 48' ' ' LEU . 86.8 mt-10 -131.16 149.5 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -136.26 139.55 42.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.873 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.9 145.18 32.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.034 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.3 m -71.25 133.66 46.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.457 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 79.7 tt0 -44.27 137.16 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.496 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.22 -6.94 72.4 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.402 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.442 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 15.1 m-85 -116.9 153.78 49.46 Favored Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 118.972 1.386 . . . . 0.0 111.154 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.05 141.8 40.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.124 1.883 . . . . 0.0 112.725 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 16.5 tt -116.33 144.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 86.0 tt0 -129.98 127.71 40.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.261 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.892 HD12 ' SG ' ' A' ' 102' ' ' CYS . 19.9 mt -111.45 144.74 40.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.254 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.519 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 62.7 mtt180 -147.93 126.62 12.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.309 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -95.39 144.54 27.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 27.6 Cg_endo -68.55 157.3 62.39 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.481 2.12 . . . . 0.0 112.295 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.43 -134.51 29.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.438 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -104.63 23.05 13.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -77.67 167.67 21.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.85 145.65 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.635 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.655 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.4 mt -67.91 136.21 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.821 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.591 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.2 ptm -132.5 100.79 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.539 HG12 ' HE1' ' A' ' 89' ' ' PHE . 25.4 t -64.16 124.77 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.403 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.562 ' OE1' ' OD1' ' A' ' 127' ' ' ASP . 46.9 mt-10 -102.04 -50.61 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.855 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -148.23 146.5 28.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.948 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.646 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.8 153.83 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.531 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.766 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.2 t30 -151.54 154.16 35.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.159 0.504 . . . . 0.0 111.796 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 30.2 t80 -123.57 122.83 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -138.89 6.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 5.3 ttm-85 -155.69 115.52 3.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.057 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.545 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 14.8 p -124.8 7.67 8.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.525 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -146.95 155.47 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.523 ' O ' ' HE2' ' A' ' 78' ' ' MET . 58.7 p30 -110.16 0.69 18.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 14.2 mttp -105.75 8.86 33.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.776 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.646 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 46.1 mm -113.72 136.27 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.781 0.324 . . . . 0.0 110.512 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 51.6 m 59.99 63.7 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -47.99 109.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 112.25 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -128.35 -164.81 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.758 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.687 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -62.85 144.73 96.63 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.173 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.2 Cg_endo -54.78 -37.59 92.08 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.34 2.027 . . . . 0.0 112.52 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -63.86 -34.47 78.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.597 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.687 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.3 mt-30 -86.82 -10.73 52.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.523 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 88.1 mtp -102.21 -5.49 24.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 37.6 mm-40 -63.99 -52.63 58.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -78.84 115.48 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.379 0.609 . . . . 0.0 112.517 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.531 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.2 m -107.17 32.28 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.127 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -139.93 85.51 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.113 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.443 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.6 t -148.11 118.79 7.51 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.426 ' HA ' HD21 ' A' ' 62' ' ' ASN . 55.9 m-85 -125.74 152.85 44.79 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.08 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 85' ' ' LEU . 35.0 tp -147.17 83.66 7.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.66 -47.25 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.078 2.519 . . . . 0.0 113.308 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 82.3 m-20 -54.11 -23.76 15.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.802 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.33 56.78 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.098 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' HE1' HG12 ' A' ' 58' ' ' VAL . 33.7 t80 -64.03 -42.85 96.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.99 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 14.4 pttm -63.92 -38.35 90.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.106 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.452 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 69.1 mt -60.98 -52.22 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.306 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.5 mmm -68.48 -36.24 78.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.068 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.8 m -60.43 -47.29 86.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -66.55 -36.84 83.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.452 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 89.5 mtt-85 -76.96 -32.91 57.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.616 ' SG ' HD12 ' A' ' 48' ' ' LEU . 61.6 m -111.29 -15.29 13.65 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.539 ' CG ' ' O ' ' A' ' 93' ' ' SER . 48.2 m-20 -60.04 134.07 56.7 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.665 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 66.38 13.53 9.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -115.95 147.35 41.25 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.57 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.7 m -72.53 -31.47 65.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.718 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.48 154.65 35.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.892 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.2 p -155.16 136.94 14.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.747 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 47' ' ' GLU . 20.6 t -116.93 130.59 71.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 46' ' ' ILE . 42.3 t -143.09 146.87 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.599 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -80.76 118.49 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.01 37.44 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.723 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.74 -130.16 1.46 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.564 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 107' ' ' GLY . 3.5 t 36.64 -154.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -63.27 -9.01 9.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.273 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.15 -13.45 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.558 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.583 ' O ' ' O ' ' A' ' 112' ' ' PRO . 62.1 m-85 -140.58 128.19 12.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.448 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.4 Cg_exo -48.61 -158.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.352 2.034 . . . . 0.0 111.984 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.19 91.85 12.62 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -82.59 -46.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.134 2.556 . . . . 0.0 113.112 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.5 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -131.79 77.97 71.29 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-O 121.112 0.482 . . . . 0.0 111.319 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.49 131.6 34.53 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.748 1.632 . . . . 0.0 111.739 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.49 -6.59 38.88 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.526 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 77' ' ' GLN . 96.7 m -112.49 147.58 36.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.636 0.718 . . . . 0.0 109.336 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.544 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.3 t80 -85.87 98.43 10.77 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.5 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 11.9 mttp -76.51 -163.01 0.29 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 123.078 1.418 . . . . 0.0 113.803 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.545 ' OH ' ' N ' ' A' ' 66' ' ' THR . 5.7 p90 -169.29 171.9 7.61 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.44 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 62' ' ' ASN . 55.2 tp -129.26 122.55 29.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.088 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 54.7 tt0 -115.31 128.42 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.372 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.646 HG22 ' HB1' ' A' ' 61' ' ' ALA . 44.5 t -135.54 123.77 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.48 -0.888 . . . . 0.0 113.141 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.0 129.32 54.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.655 ' CD2' HG23 ' A' ' 56' ' ' ILE . 35.7 p90 -152.21 166.96 30.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.237 0.541 . . . . 0.0 111.873 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.562 ' OD1' ' OE1' ' A' ' 59' ' ' GLU . 3.1 m-20 -126.75 161.74 27.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.241 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.456 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 65.3 m -111.96 122.26 47.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.623 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.5 m -124.86 154.41 70.82 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 122.342 2.028 . . . . 0.0 112.446 178.761 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.425 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 68.6 ttt-85 -143.93 140.43 29.69 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.967 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG3' HD23 ' A' ' 48' ' ' LEU . 71.7 mm-40 -137.51 140.32 41.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.58 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -142.36 128.75 20.04 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.555 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -129.91 145.65 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.946 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.6 m -67.78 133.84 49.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.907 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.96 136.63 2.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.015 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.74 -2.96 82.98 Favored Glycine 0 N--CA 1.453 -0.198 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.712 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -117.05 150.76 46.58 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.0 0.9 . . . . 0.0 110.706 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.04 140.64 45.92 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.45 2.1 . . . . 0.0 112.714 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 104' ' ' VAL . 14.4 tt -114.05 149.04 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 48.8 tt0 -126.55 127.86 45.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.154 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 102' ' ' CYS . 19.3 mt -115.62 138.87 50.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 79.1 mtt180 -146.9 130.75 17.09 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.753 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.9 m -98.15 146.23 31.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.933 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 128' ' ' CYS . 51.8 Cg_endo -72.84 158.68 49.74 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.724 2.283 . . . . 0.0 112.29 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.83 -129.35 26.41 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.805 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -110.27 25.66 11.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.09 167.84 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.158 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.86 145.0 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.126 0.489 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.952 HG23 ' CD2' ' A' ' 126' ' ' TYR . 73.4 mt -67.89 137.61 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.686 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.7 ptp -132.52 100.87 5.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 t -63.23 126.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.766 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -101.63 -51.22 3.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.114 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -148.96 147.05 28.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.625 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.84 151.92 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.401 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 122' ' ' LEU . 13.2 t30 -152.39 161.79 42.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.397 0.618 . . . . 0.0 111.856 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.488 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 80.6 t80 -126.73 125.0 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -141.08 7.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.531 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.73 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.6 ttm-85 -155.04 114.87 3.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.266 0.555 . . . . 0.0 111.166 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 69.8 p -119.89 8.87 11.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.066 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.644 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.2 t0 -145.05 -170.11 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.417 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.584 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 2.9 p30 -146.04 -0.51 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.756 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -107.71 8.74 29.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.213 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.574 ' HB ' HH22 ' A' ' 65' ' ' ARG . 35.2 mm -102.74 134.55 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.578 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' ASP . 73.8 m 55.75 24.15 6.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.648 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.58 ' C ' ' O ' ' A' ' 71' ' ' CYS . 15.8 t70 1.43 105.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB3' ' CG ' ' A' ' 78' ' ' MET . . . -121.7 -166.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.062 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -63.31 146.25 96.34 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.066 179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.541 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -58.4 -37.65 93.93 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.2 1.933 . . . . 0.0 112.571 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.48 -42.71 95.73 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.554 HE21 ' CG ' ' A' ' 74' ' ' ASP . 28.9 mt-30 -84.12 -6.14 59.36 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.037 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.466 ' CG ' ' HB3' ' A' ' 73' ' ' ALA . 54.7 mmm -112.51 0.43 15.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.195 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 18.0 mt-10 -64.32 -47.85 77.85 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.934 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -78.86 113.71 17.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.446 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 67' ' ' ASP . 7.7 m -105.75 35.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.083 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -140.03 87.26 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.894 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.47 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.5 t -151.75 116.43 5.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.428 ' HA ' HD21 ' A' ' 62' ' ' ASN . 86.1 m-85 -125.29 156.13 39.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.942 0.401 . . . . 0.0 111.035 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.584 HD21 ' HG2' ' A' ' 112' ' ' PRO . 27.0 tp -145.59 91.1 5.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -48.89 -45.25 29.31 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.433 2.089 . . . . 0.0 111.622 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 65.9 m-20 -54.38 -30.92 53.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.447 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.32 -32.54 49.42 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.242 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -65.09 -43.98 90.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.4 pttp -66.08 -38.23 87.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.527 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.452 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 84.1 mt -59.88 -53.28 50.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.732 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 91.8 mmm -67.52 -34.73 77.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.518 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.464 ' HB3' HD21 ' A' ' 97' ' ' ASN . 23.8 m -58.91 -46.7 87.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.186 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.07 -37.62 84.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.757 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.452 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 96.3 mtt-85 -73.98 -33.62 63.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.2 m -114.71 -13.72 12.05 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.464 HD21 ' HB3' ' A' ' 93' ' ' SER . 88.5 m-20 -61.22 135.91 57.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.009 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 67.83 13.91 9.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.523 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -116.1 146.74 41.98 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.072 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -72.41 -31.67 65.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.716 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 155.26 38.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.681 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.1 p -156.19 133.96 11.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.724 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.15 126.89 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 46' ' ' ILE . 45.0 t -139.35 146.21 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 111.614 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.66 119.6 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 38.38 0.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.118 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.35 -124.19 0.89 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.937 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.71 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 31.04 -158.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.717 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.71 ' N ' ' OG ' ' A' ' 108' ' ' SER . 89.6 m-20 -64.4 -9.23 16.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.6 -8.96 58.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.249 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 112' ' ' PRO . 32.3 m-85 -141.05 131.18 13.15 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.075 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.584 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.9 Cg_exo -48.76 -163.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.343 2.029 . . . . 0.0 111.767 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.569 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -136.87 89.24 17.49 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.303 -179.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.78 -54.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.992 2.461 . . . . 0.0 113.139 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 4.1 p -127.49 72.87 77.89 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.887 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -58.74 131.85 44.56 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.908 1.739 . . . . 0.0 111.582 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.91 -16.96 32.95 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.803 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' GLN . 43.4 m -102.91 153.5 20.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.064 0.932 . . . . 0.0 108.495 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.73 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 21.2 t80 -86.21 99.31 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.527 0.68 . . . . 0.0 109.506 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.488 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 4.8 mtmp? -81.99 -159.27 0.28 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.599 1.19 . . . . 0.0 113.875 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 19.9 p90 -174.9 174.19 2.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.34 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 62' ' ' ASN . 18.7 tp -131.51 125.06 31.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.425 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 75.3 tt0 -121.18 130.79 53.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.625 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.8 t -134.41 123.47 42.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.011 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -109.7 129.71 55.58 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.952 ' CD2' HG23 ' A' ' 56' ' ' ILE . 40.9 p90 -153.56 169.76 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.51 0.671 . . . . 0.0 111.851 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -124.15 160.67 27.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.418 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.409 ' CB ' ' HD2' ' A' ' 51' ' ' PRO . 93.0 m -113.57 112.25 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.77 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.1 165.65 13.65 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.635 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo . . . . . 0 C--N 1.311 -1.408 0 C-N-CA 121.669 1.58 . . . . 0.0 111.63 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.571 ' NH1' ' HD3' ' A' ' 51' ' ' PRO . 19.9 mtp180 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.497 ' HE ' ' CG ' ' A' ' 123' ' ' GLU . 74.7 ttt180 -148.28 133.78 18.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.299 0.571 . . . . 0.0 110.984 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -129.57 146.45 51.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.517 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 121' ' ' TYR . 7.5 tt -141.6 127.88 19.84 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -130.81 147.47 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.045 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 m -70.05 132.2 45.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.519 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 17.4 tt0 -44.82 140.47 2.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.782 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 92.06 -8.28 77.99 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.818 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 18.7 m-85 -117.2 147.62 40.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 118.353 1.077 . . . . 0.0 109.928 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.95 146.24 76.88 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.342 2.028 . . . . 0.0 113.069 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 104' ' ' VAL . 20.9 tt -120.47 148.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.943 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.659 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 80.8 tt0 -132.63 126.96 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -112.91 143.38 44.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.659 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 97.8 mtt180 -144.78 134.31 23.28 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.518 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.486 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.7 m -103.79 143.65 27.08 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.274 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.571 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 49.3 Cg_endo -73.03 154.71 52.78 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 112.346 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.5 51.09 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.827 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -113.77 27.94 9.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -80.28 167.83 19.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.52 150.05 33.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.797 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.011 HG23 ' CD1' ' A' ' 126' ' ' TYR . 53.6 mt -71.05 138.14 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.181 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.438 ' HG3' ' H ' ' A' ' 127' ' ' ASP . 3.0 ptp -131.04 98.01 4.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.584 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.0 t -64.54 126.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.914 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -103.54 -46.78 4.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -150.53 147.55 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.447 0.642 . . . . 0.0 111.13 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.64 154.86 10.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.241 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.542 HD21 ' HA ' ' A' ' 84' ' ' TYR . 6.1 t30 -150.5 151.41 32.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.06 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.416 ' CE2' ' HD3' ' A' ' 120' ' ' LYS . 47.5 t80 -119.88 122.93 42.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.34 -138.39 5.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.881 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 7.1 ttm-85 -155.21 115.4 3.79 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.168 -0.516 . . . . 0.0 109.845 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 p -122.39 11.49 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.044 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.635 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 49.9 t0 -146.91 -171.03 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.272 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.635 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 56.1 p30 -144.55 -0.33 0.96 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -103.9 6.3 36.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.209 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 40.1 mm -113.34 137.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m 57.25 70.56 0.64 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.128 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -53.12 122.16 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.387 0.613 . . . . 0.0 112.084 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -139.97 -163.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 141.07 98.0 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.9 Cg_endo -56.82 -35.03 97.9 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.344 2.029 . . . . 0.0 112.554 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -63.16 -36.87 85.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.591 HE21 ' CG ' ' A' ' 74' ' ' ASP . 29.4 mt-30 -88.14 12.54 13.39 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.233 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 75.8 mtp -129.0 -2.99 5.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 53.5 mm-40 -63.27 -47.25 83.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.987 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.44 119.29 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.419 . . . . 0.0 111.912 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 81' ' ' VAL . 5.3 m -111.37 31.66 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.623 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -136.23 85.84 2.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.48 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.3 t -149.15 112.57 5.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.542 ' HA ' HD21 ' A' ' 62' ' ' ASN . 72.8 m-85 -128.19 152.56 47.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.648 0.261 . . . . 0.0 110.945 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.76 86.76 7.72 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -45.98 -48.43 12.7 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.86 2.374 . . . . 0.0 114.904 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 37.6 m-20 -58.54 -21.89 53.83 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.27 61.65 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.565 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CE1' HG12 ' A' ' 58' ' ' VAL . 54.5 t80 -63.81 -41.83 97.8 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.6 pttm -66.54 -38.5 87.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.573 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.406 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 88.5 mt -60.74 -50.7 79.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.804 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.5 ' SD ' HG11 ' A' ' 104' ' ' VAL . 98.6 mmm -67.75 -35.63 79.08 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.11 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 16.4 m -61.82 -46.1 90.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.391 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.92 -35.6 81.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.562 0.696 . . . . 0.0 110.424 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' A' ' 104' ' ' VAL . 23.1 mtp85 -74.47 -34.0 63.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.6 m -112.39 -21.46 11.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' SER . 60.4 m-20 -56.25 129.72 41.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 72.05 14.33 5.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.829 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 84.5 mtt180 -117.12 149.22 40.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.585 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.0 m -71.28 -33.42 69.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.501 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.68 155.01 35.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.98 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.5 p -151.44 149.88 29.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.978 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.56 126.66 75.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 46' ' ' ILE . 44.0 t -137.34 144.03 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -85.8 122.15 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.373 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -66.81 23.56 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . -179.59 173.09 44.95 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.935 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.606 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.7 t 94.79 -155.55 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -66.32 -11.19 49.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.008 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.97 -18.47 60.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.55 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.527 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.5 m-85 -141.47 131.22 12.76 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.575 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 111' ' ' PHE . 36.1 Cg_exo -50.64 -156.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.404 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.13 95.63 10.52 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.769 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -82.98 -50.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.657 2.238 . . . . 0.0 113.564 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.478 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 11.2 p -133.05 84.8 47.56 Favored Pre-proline 0 N--CA 1.466 0.36 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.098 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.02 136.1 50.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.08 1.853 . . . . 0.0 112.328 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.6 -4.8 47.22 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.361 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.2 m -114.4 149.3 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.169 0.984 . . . . 0.0 108.655 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.564 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 7.3 t80 -85.09 98.99 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 18.6 mttt -76.05 -165.61 0.49 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.918 1.342 . . . . 0.0 113.363 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' HB2' HD21 ' A' ' 39' ' ' LEU . 8.4 p90 -167.83 167.46 12.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.251 -2.25 . . . . 0.0 109.769 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 25.9 tp -127.76 123.33 35.04 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.699 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 3.4 tm-20 -117.61 129.42 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.11 119.65 41.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.699 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 1.7 mp0 -102.69 127.8 49.67 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.011 ' CD1' HG23 ' A' ' 56' ' ' ILE . 18.6 p90 -154.77 170.48 21.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.58 0.705 . . . . 0.0 112.517 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.438 ' H ' ' HG3' ' A' ' 57' ' ' MET . 97.6 m-20 -128.13 163.34 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.779 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.458 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 92.6 m -109.46 114.51 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.367 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.64 151.02 47.9 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 N--CA 1.491 1.33 0 C-N-CA 121.587 1.525 . . . . 0.0 112.342 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.529 ' CZ ' ' H ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.467 HH11 ' HD3' ' A' ' 37' ' ' ARG . 37.9 ttp-105 -149.93 137.56 20.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.318 0.58 . . . . 0.0 111.024 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 57.4 mp0 -134.51 146.04 49.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -138.1 137.59 37.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.014 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.672 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.41 143.74 34.09 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.883 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.0 m -70.54 133.96 47.24 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -42.21 136.54 2.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.876 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.12 74.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.094 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.69 149.88 45.89 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-N 119.118 1.459 . . . . 0.0 112.02 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.83 137.61 64.01 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.124 2.549 . . . . 0.0 113.06 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -120.06 142.36 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.631 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.3 tt0 -130.03 129.25 43.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.611 -0.835 . . . . 0.0 113.224 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.456 HD12 ' SG ' ' A' ' 96' ' ' CYS . 30.6 mt -109.93 145.75 36.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.631 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 46.4 mtt85 -148.14 132.27 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.591 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.424 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -98.16 144.33 27.87 Favored Pre-proline 0 N--CA 1.455 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 56.9 Cg_endo -71.1 159.31 52.64 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.215 2.61 . . . . 0.0 112.593 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.46 -120.08 12.6 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.782 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -125.73 26.44 6.67 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.747 0.308 . . . . 0.0 110.996 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -77.41 169.97 17.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.509 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.76 143.09 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.116 HG23 ' CD2' ' A' ' 126' ' ' TYR . 78.0 mt -69.74 140.36 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.586 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.421 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.0 ptp -133.84 100.51 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.637 HG12 ' HE1' ' A' ' 89' ' ' PHE . 17.4 t -64.89 127.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.445 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.57 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 76.6 mt-10 -104.25 -49.64 3.54 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.794 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.7 m-20 -147.42 145.47 29.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.089 0.471 . . . . 0.0 110.725 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.0 154.74 9.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.967 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -152.08 156.79 40.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.286 0.565 . . . . 0.0 111.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 70.3 t80 -125.62 119.68 28.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 120' ' ' LYS . . . 156.66 -136.74 5.11 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.69 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 9.2 ttm-85 -154.94 118.03 4.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.329 0.585 . . . . 0.0 112.063 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 p -124.73 6.07 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.356 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 56.1 t0 -146.7 154.81 41.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.955 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 51.7 p30 -113.05 2.59 15.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.458 ' O ' HD13 ' A' ' 70' ' ' ILE . 18.5 mttt -104.6 5.99 34.18 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.944 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 69' ' ' LYS . 27.7 mm -115.69 139.65 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.624 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.3 m 53.77 71.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 39.2 p-10 -54.09 128.55 31.19 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 111.599 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -144.31 -165.87 2.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.282 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.692 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -61.88 142.48 94.97 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.16 -35.35 95.12 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.241 1.961 . . . . 0.0 112.827 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.6 -33.88 75.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.957 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.573 ' O ' HG23 ' A' ' 118' ' ' THR . 75.3 mt-30 -89.01 6.64 38.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.92 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.4 mtp -125.73 -3.96 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 39.1 mm-40 -61.54 -45.94 92.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.951 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -83.03 113.27 20.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.621 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 21.3 m -104.16 33.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.316 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.621 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.9 mm-40 -138.69 85.6 2.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 41.5 t -148.53 122.47 9.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.6 m-85 -131.86 154.14 49.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.14 86.43 7.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.334 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -46.88 -45.98 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.029 2.486 . . . . 0.0 113.162 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 75.7 m-20 -53.01 -29.45 29.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.35 -31.41 33.43 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.573 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.637 ' HE1' HG12 ' A' ' 58' ' ' VAL . 50.9 t80 -67.9 -47.89 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 pttp -64.1 -41.91 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.395 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 70.6 mt -59.53 -48.69 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.051 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.939 ' SD ' HD21 ' A' ' 122' ' ' LEU . 46.0 mtp -70.84 -34.85 72.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.77 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.515 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 23.6 m -57.42 -42.97 83.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.831 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.52 -37.85 87.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.598 HH21 ' HG2' ' A' ' 92' ' ' MET . 36.8 mtm180 -76.38 -30.58 57.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.456 ' SG ' HD12 ' A' ' 48' ' ' LEU . 75.5 m -112.6 -21.42 11.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.515 ' CG ' ' O ' ' A' ' 93' ' ' SER . 69.4 m-20 -55.51 135.64 50.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.984 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 64.05 13.54 7.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.669 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -115.97 147.93 40.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.366 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.1 m -71.63 -33.93 69.35 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.795 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.02 159.23 40.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.278 0.561 . . . . 0.0 110.867 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.6 p -155.5 138.85 15.76 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.701 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' A' ' 47' ' ' GLU . 21.8 t -120.19 126.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 64.6 t -143.64 146.04 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -75.11 117.67 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.57 42.79 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 175.22 -127.25 1.25 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 35.82 -150.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.129 -0.536 . . . . 0.0 111.381 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.45 -9.62 13.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.12 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.487 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -76.85 -17.23 59.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.169 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.2 m-85 -139.7 130.51 14.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.794 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.7 Cg_exo -52.01 -153.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.459 2.106 . . . . 0.0 112.423 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -137.19 93.71 12.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.44 -51.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 123.034 2.489 . . . . 0.0 113.283 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.403 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.4 p -131.62 79.54 68.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.391 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -62.91 138.86 70.73 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.53 2.154 . . . . 0.0 112.53 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.55 -2.54 49.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.898 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 77' ' ' GLN . 95.1 m -120.5 148.85 43.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.106 0.453 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.615 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.1 t80 -86.3 96.68 10.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.465 ' CD ' ' CE2' ' A' ' 63' ' ' TYR . 37.0 mttt -68.12 -156.33 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.217 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.4 p90 -176.38 168.58 2.76 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 112.665 -2.061 . . . . 0.0 109.37 176.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.939 HD21 ' SD ' ' A' ' 92' ' ' MET . 12.9 tp -129.7 122.79 29.64 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.495 ' OE2' ' NE2' ' A' ' 125' ' ' GLN . 78.2 tt0 -117.77 131.2 56.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.797 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.95 119.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.495 ' NE2' ' OE2' ' A' ' 123' ' ' GLU . 5.1 mp0 -105.04 124.55 49.73 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.116 ' CD2' HG23 ' A' ' 56' ' ' ILE . 23.8 p90 -154.22 166.97 31.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.715 0.769 . . . . 0.0 112.055 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.459 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 83.5 m-20 -123.31 162.0 23.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.259 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.529 ' H ' ' CZ ' ' A' ' 36' ' ' ARG . 86.4 m -110.38 119.69 40.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.906 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.1 m -117.59 156.52 49.32 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.481 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.485 1.004 0 C-N-CA 121.598 1.532 . . . . 0.0 111.078 178.58 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.486 ' NH2' ' HG3' ' A' ' 51' ' ' PRO . 4.2 mtt-85 . . . . . 0 C--O 1.232 0.18 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 37' ' ' ARG . 13.0 ttt180 -142.28 136.66 29.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.096 0.475 . . . . 0.0 110.387 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' HG2' HD23 ' A' ' 48' ' ' LEU . 58.2 mp0 -133.65 143.56 48.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.533 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -139.42 136.27 34.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.512 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.736 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.84 144.95 32.72 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.447 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 25.6 m -71.21 133.68 46.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 9.2 tt0 -45.07 140.91 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.486 0.66 . . . . 0.0 112.511 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 94.12 -12.15 69.55 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.71 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.9 m-85 -116.74 155.64 48.75 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 118.405 1.103 . . . . 0.0 110.051 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.55 146.86 31.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.475 2.117 . . . . 0.0 113.948 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 104' ' ' VAL . 11.4 tt -118.57 145.82 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.913 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -126.64 127.81 45.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.884 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.679 HD12 ' SG ' ' A' ' 102' ' ' CYS . 44.9 mt -112.93 145.11 41.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -150.79 131.84 14.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.77 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -100.03 145.77 30.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.685 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.486 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 43.5 Cg_endo -72.35 160.38 47.1 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.462 2.108 . . . . 0.0 113.073 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.15 -130.68 28.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -107.43 24.45 12.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.34 166.55 22.53 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.829 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 m -127.46 143.38 40.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.113 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.827 HG23 ' CD1' ' A' ' 126' ' ' TYR . 95.3 mt -67.08 138.09 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.622 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -130.41 98.38 4.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.22 123.72 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.38 -48.25 4.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.5 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -147.6 145.6 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.254 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.665 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.64 151.1 9.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.552 HD21 ' HA ' ' A' ' 84' ' ' TYR . 6.7 t30 -150.4 152.34 34.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.929 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.503 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 66.4 t80 -122.65 125.25 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.468 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.89 -136.31 4.99 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.589 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 6.1 ttm180 -156.6 117.98 3.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.006 0.432 . . . . 0.0 111.127 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.553 ' HG1' ' HH ' ' A' ' 121' ' ' TYR . 26.2 p -124.69 7.7 8.19 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.73 152.68 40.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.517 ' O ' ' HE1' ' A' ' 78' ' ' MET . 20.9 p-10 -109.68 -0.36 18.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.333 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -106.37 8.74 31.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.116 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.5 mm -114.31 139.81 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.569 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.6 m 57.48 64.75 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -46.93 120.82 3.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.813 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -139.52 -167.08 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.933 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -63.02 142.51 97.68 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.037 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.58 -36.09 79.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 121.784 1.656 . . . . 0.0 112.762 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -64.59 -33.77 76.7 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.681 ' O ' HG23 ' A' ' 118' ' ' THR . 81.4 mt-30 -84.04 -12.62 54.88 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.828 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.517 ' HE1' ' O ' ' A' ' 68' ' ' ASP . 66.4 mtp -103.95 -2.18 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 52.6 mm-40 -58.96 -53.2 61.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.806 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -80.43 122.52 27.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.01 28.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.058 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -143.73 90.64 2.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -145.79 120.93 10.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.663 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 5.9 m-85 -128.75 153.02 47.79 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.616 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.747 HD21 ' HG2' ' A' ' 112' ' ' PRO . 13.7 tp -146.08 91.2 5.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.705 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -49.24 -46.27 26.59 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.228 2.619 . . . . 0.0 113.751 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 23.9 m-20 -53.74 -22.31 8.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.03 -33.49 57.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.763 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -64.8 -44.46 89.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.166 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.9 pttt -65.86 -40.07 91.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.983 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.527 HG23 ' NH1' ' A' ' 95' ' ' ARG . 79.5 mt -60.49 -51.39 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.861 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.445 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 93.0 mmm -68.17 -37.0 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.569 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.45 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 60.9 m -60.31 -44.26 95.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.117 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -65.44 -37.94 88.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.295 0.569 . . . . 0.0 110.665 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.553 HH11 ' HG3' ' A' ' 95' ' ' ARG . 51.4 mtt85 -76.26 -33.3 59.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.8 m -111.94 -15.16 13.39 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 70.2 m-20 -62.72 135.21 57.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.634 -0.827 . . . . 0.0 111.669 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 64.99 11.48 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt-85 -112.71 145.5 40.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 110.595 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.9 m -72.76 -31.28 64.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.479 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.13 155.23 38.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.262 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.679 ' SG ' HD12 ' A' ' 48' ' ' LEU . 29.3 p -153.76 139.7 18.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.882 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.0 t -119.06 131.05 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 46' ' ' ILE . 17.6 t -141.99 152.01 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.425 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.81 120.79 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.71 38.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.362 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.84 -125.7 0.98 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.175 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 31.36 -158.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.257 0.551 . . . . 0.0 112.022 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.72 -10.52 19.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.627 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.83 59.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.089 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.5 m-85 -142.51 132.72 12.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.366 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.747 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.6 Cg_exo -49.95 -159.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -139.01 86.44 15.01 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.474 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.544 ' HD2' ' HZ3' ' A' ' 120' ' ' LYS . 66.8 Cg_endo -79.32 -29.0 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.718 2.279 . . . . 0.0 113.136 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.1 p -155.67 83.84 3.54 Favored Pre-proline 0 C--N 1.332 -0.155 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.688 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.02 140.87 42.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.94 1.76 . . . . 0.0 112.039 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.54 -2.02 46.03 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.372 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.1 m -117.61 147.02 43.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 8.9 t80 -84.61 98.2 10.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.544 ' HZ3' ' HD2' ' A' ' 114' ' ' PRO . 21.3 mtmt -77.58 -166.78 0.81 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.469 1.128 . . . . 0.0 113.401 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.553 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 40.0 p90 -167.32 168.6 13.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.621 -2.082 . . . . 0.0 110.321 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.3 tp -127.02 124.93 40.52 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.541 ' HG3' HE21 ' A' ' 125' ' ' GLN . 15.3 tp10 -117.22 128.23 54.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.066 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.665 HG22 ' HB1' ' A' ' 61' ' ' ALA . 41.5 t -135.79 125.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.262 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.541 HE21 ' HG3' ' A' ' 123' ' ' GLU . 2.6 mt-30 -112.83 130.72 55.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.827 ' CD1' HG23 ' A' ' 56' ' ' ILE . 27.5 p90 -153.82 173.24 16.15 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.089 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -124.78 158.83 32.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.352 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.5 m -105.95 119.43 39.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.49 158.11 68.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.66 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 N--CA 1.493 1.478 0 C-N-CA 122.096 1.864 . . . . 0.0 112.06 179.445 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 49' ' ' ARG . 70.8 mtp180 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -156.09 137.99 14.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.893 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -127.06 149.96 49.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.204 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -138.83 142.21 38.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.836 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -144.29 144.96 31.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.356 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 7.6 m -71.55 134.6 46.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 110.436 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 87.2 tt0 -43.24 138.51 2.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.134 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.66 -7.65 77.21 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.816 -1.084 . . . . 0.0 114.298 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.56 153.91 50.55 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 119.068 1.434 . . . . 0.0 110.909 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.84 140.84 47.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.589 2.192 . . . . 0.0 113.748 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 14.1 tt -116.84 146.36 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.604 ' HG3' HG22 ' A' ' 103' ' ' VAL . 78.7 tt0 -126.2 127.77 46.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.095 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.668 HD12 ' SG ' ' A' ' 102' ' ' CYS . 50.1 mt -115.88 138.55 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.545 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 18.8 mtp180 -146.5 133.51 20.3 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.283 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -98.66 136.72 20.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.86 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.522 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 55.6 Cg_endo -70.25 158.29 56.78 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.415 2.077 . . . . 0.0 111.458 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.23 -141.41 30.33 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.652 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.0 p -98.63 22.2 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -78.88 165.09 23.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.7 0.286 . . . . 0.0 110.86 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.57 148.69 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.534 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.795 HG23 ' CD2' ' A' ' 126' ' ' TYR . 78.5 mt -71.19 136.06 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.653 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.36 101.8 5.12 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.402 ' HB ' HD21 ' A' ' 97' ' ' ASN . 40.3 t -66.43 127.04 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.457 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 71.3 mm-40 -103.92 -48.29 3.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.816 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 65.1 m-20 -148.49 145.76 28.07 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.13 154.23 7.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.851 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.509 HD21 ' HA ' ' A' ' 84' ' ' TYR . 6.0 t30 -150.24 151.99 33.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.37 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.626 ' CD2' ' CG ' ' A' ' 111' ' ' PHE . 54.9 t80 -118.4 121.09 39.5 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.6 -135.33 4.54 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.382 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.525 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 10.5 ttm-85 -156.55 117.53 3.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 111.362 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.475 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 23.6 p -122.87 9.44 9.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.071 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 15.2 t0 -147.2 -178.22 6.1 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.135 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 69' ' ' LYS . 54.7 p30 -138.36 -0.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.065 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 20.4 mttp -102.65 2.83 36.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.844 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.67 137.7 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.019 0.437 . . . . 0.0 110.855 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.4 m 54.63 70.79 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.14 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.0 p30 -52.09 125.95 17.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.923 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -143.91 -163.61 1.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 142.64 98.21 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.301 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.7 Cg_endo -54.44 -35.93 86.41 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.952 1.768 . . . . 0.0 112.008 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -63.87 -37.18 86.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 118' ' ' THR . 81.2 mt-30 -83.46 -9.72 58.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.359 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.9 mtp -106.04 -0.92 24.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 76.2 mt-10 -60.47 -53.04 62.33 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.08 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 48.9 t30 -76.54 117.46 18.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.578 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.0 m -107.71 29.42 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.832 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.8 mm-40 -141.01 85.37 1.98 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.389 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.428 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 44.8 t -146.94 124.23 11.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.509 ' HA ' HD21 ' A' ' 62' ' ' ASN . 58.1 m-85 -133.54 159.04 41.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' A' ' 112' ' ' PRO . 12.7 tp -147.73 94.99 4.3 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.18 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.48 -43.83 31.82 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.825 2.35 . . . . 0.0 114.06 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 65.4 m-20 -61.16 -23.68 65.74 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.59 62.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.928 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.569 ' O ' ' OG ' ' A' ' 93' ' ' SER . 17.3 t80 -67.12 -47.73 70.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.069 0.461 . . . . 0.0 112.087 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 pttm -67.23 -41.22 86.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.965 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.61 HG22 HH21 ' A' ' 95' ' ' ARG . 69.7 mt -61.39 -47.41 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.795 ' SD ' ' NH1' ' A' ' 95' ' ' ARG . 96.2 mmm -66.97 -36.13 81.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 5.1 m -60.88 -42.11 97.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.93 -36.82 85.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 111.245 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 1.124 ' NH1' HG11 ' A' ' 104' ' ' VAL . 20.8 mtm180 -76.17 -33.34 59.34 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.418 ' SG ' HD12 ' A' ' 48' ' ' LEU . 36.2 m -113.66 -14.02 12.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.577 ' CG ' ' O ' ' A' ' 93' ' ' SER . 2.7 m120 -58.58 136.88 57.71 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.807 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 67.04 14.37 9.8 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.017 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -116.49 147.01 42.16 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.306 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.5 m -73.76 -31.93 63.57 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.086 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 153.37 37.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.449 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.1 p -156.75 131.33 8.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.604 HG22 ' HG3' ' A' ' 47' ' ' GLU . 22.4 t -121.72 125.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.124 HG11 ' NH1' ' A' ' 95' ' ' ARG . 91.5 t -141.94 146.4 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.441 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.5 120.23 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.98 41.76 0.06 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.82 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 108' ' ' SER . . . 179.3 -130.66 1.55 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.353 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 107' ' ' GLY . 5.9 t 31.58 -146.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.019 0.438 . . . . 0.0 110.943 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.05 -10.27 13.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.14 -21.76 53.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.265 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.626 ' CG ' ' CD2' ' A' ' 63' ' ' TYR . 36.1 m-85 -138.26 128.98 15.46 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.494 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.8 Cg_exo -52.18 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.855 1.703 . . . . 0.0 111.645 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -140.06 80.39 20.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.296 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.57 -19.89 18.5 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.572 2.181 . . . . 0.0 113.171 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.629 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.8 p -157.12 80.37 3.45 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.484 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -65.95 139.23 55.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.122 1.881 . . . . 0.0 111.698 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.14 -3.16 47.63 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.576 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.1 m -120.29 145.62 46.9 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.641 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 15.7 t80 -84.74 96.95 9.41 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.629 ' NZ ' ' O ' ' A' ' 115' ' ' CYS . 20.3 mtmm -71.47 -165.97 0.17 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.576 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.635 ' HB2' HD21 ' A' ' 39' ' ' LEU . 9.0 p90 -168.16 169.27 11.11 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 62' ' ' ASN . 40.6 tp -128.02 123.64 35.19 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -116.55 127.41 54.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.137 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.19 121.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.346 -0.941 . . . . 0.0 112.535 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.56 127.72 52.35 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.795 ' CD2' HG23 ' A' ' 56' ' ' ILE . 36.0 p90 -152.32 168.8 24.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.317 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -126.73 162.62 25.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.424 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 86.1 m -113.61 113.89 25.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 0.0 110.239 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 m -115.19 156.88 44.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo . . . . . 0 C--N 1.312 -1.376 0 C-N-CA 121.594 1.529 . . . . 0.0 110.942 178.407 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 . . . . . 0 C--O 1.233 0.19 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.555 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 40.2 ttt-85 -147.73 141.09 25.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.441 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -130.06 145.61 51.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.554 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.7 tt -139.31 137.93 36.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.585 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.7 144.14 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.873 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.68 130.41 43.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.568 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.495 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 31.0 tt0 -41.39 136.87 1.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.324 0.583 . . . . 0.0 112.183 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.09 76.75 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.084 -0.962 . . . . 0.0 114.179 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -115.48 152.56 47.19 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 118.896 1.348 . . . . 0.0 111.193 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 19.1 Cg_endo -69.88 139.9 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.02 1.813 . . . . 0.0 112.341 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 tt -115.19 147.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.657 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 40.8 tt0 -126.83 129.17 47.76 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.185 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.655 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.6 mt -115.87 138.86 50.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.657 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 91.1 mtt180 -144.09 132.68 22.27 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.931 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -100.3 138.89 20.32 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.215 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.08 157.83 53.49 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.367 2.045 . . . . 0.0 111.612 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.1 38.28 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.9 p -103.1 25.11 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.333 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.52 164.2 24.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.088 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -125.64 146.24 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.752 HG23 ' CD2' ' A' ' 126' ' ' TYR . 70.4 mt -69.31 134.63 29.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.162 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.5 ptp -129.39 97.76 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.623 HG12 ' HE1' ' A' ' 89' ' ' PHE . 32.7 t -61.7 125.26 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.955 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.509 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 79.7 mm-40 -101.35 -49.84 3.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.745 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.1 m-20 -152.27 150.61 29.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -169.66 156.59 6.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.647 ' O ' HD12 ' A' ' 122' ' ' LEU . 13.5 t30 -151.36 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.528 0.68 . . . . 0.0 111.606 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.649 ' HB3' HD23 ' A' ' 85' ' ' LEU . 35.9 t80 -123.01 120.33 33.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.69 -140.42 6.91 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.416 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.666 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 5.3 ttm180 -157.55 118.27 3.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 0.0 111.978 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.548 ' HG1' ' HH ' ' A' ' 121' ' ' TYR . 72.7 p -125.76 7.42 7.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.401 0.62 . . . . 0.0 109.704 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 54.6 t0 -146.43 154.13 41.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.4 p30 -114.17 3.1 15.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 110.424 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 87.1 mttt -104.6 4.64 33.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.774 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.4 mm -110.84 137.58 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.6 m 55.95 62.94 2.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -44.61 121.0 2.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -140.41 -166.81 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.355 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.618 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -62.55 133.58 94.81 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.437 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -51.78 -34.78 56.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.181 1.921 . . . . 0.0 113.224 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.8 -37.1 85.37 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.589 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 81.7 mt-30 -80.12 -17.89 51.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.254 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.666 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 7.9 mtm -102.18 1.39 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 55.3 mm-40 -61.97 -47.59 84.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.699 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.55 114.39 19.41 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 66' ' ' THR . 15.6 m -104.34 34.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.944 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.578 HE21 ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -143.95 88.07 1.95 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.944 0.402 . . . . 0.0 111.739 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.475 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.0 t -147.39 122.78 10.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.52 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.6 m-85 -126.02 153.81 43.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 111.796 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' A' ' 63' ' ' TYR . 46.3 tp -147.92 85.94 6.33 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.92 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.82 -49.35 16.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.919 2.412 . . . . 0.0 113.061 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.5 m-20 -49.13 -30.35 6.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -32.8 53.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.822 0.344 . . . . 0.0 111.11 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.623 ' HE1' HG12 ' A' ' 58' ' ' VAL . 59.3 t80 -65.08 -41.89 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 34.2 pttt -65.86 -40.67 91.88 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.806 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.3 mt -60.27 -48.75 86.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.868 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -70.03 -36.61 75.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.114 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.486 ' HB3' HD21 ' A' ' 97' ' ' ASN . 19.8 m -58.79 -47.61 84.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.549 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -65.1 -35.93 82.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.05 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.631 HH12 ' HB1' ' A' ' 110' ' ' ALA . 99.5 mtt180 -79.9 -30.57 40.11 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.0 m -112.43 -20.18 11.88 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.486 HD21 ' HB3' ' A' ' 93' ' ' SER . 89.4 m-20 -58.25 135.87 57.21 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.8 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 64.53 13.06 7.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.851 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 95' ' ' ARG . 75.0 mtp180 -114.02 145.66 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.2 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.4 m -71.79 -30.98 66.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.454 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.44 152.8 31.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.655 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.6 p -151.91 141.76 21.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.48 128.96 75.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.809 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.553 ' CG1' HH11 ' A' ' 95' ' ' ARG . 22.6 t -144.7 147.58 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.229 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -78.71 118.39 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.903 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.94 41.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.8 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 175.54 -123.04 0.9 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.178 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.6 t 31.04 -157.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.911 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.94 -9.58 22.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.851 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.631 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -75.72 -9.39 58.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.524 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.8 m-85 -144.0 133.54 11.61 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.858 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 44.9 Cg_exo -49.62 -161.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.925 1.75 . . . . 0.0 111.334 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -139.29 97.6 8.49 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.042 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.25 -58.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.847 2.364 . . . . 0.0 112.725 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.422 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 8.4 p -126.56 80.37 69.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.177 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -64.71 137.82 55.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.79 1.66 . . . . 0.0 111.942 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.52 -13.75 22.9 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.737 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -111.09 151.74 27.73 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.258 0.529 . . . . 0.0 109.983 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.587 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.5 t80 -85.63 96.96 9.84 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.474 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 12.6 mttp -76.4 -161.19 0.17 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.729 1.252 . . . . 0.0 113.125 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 5.6 p90 -168.93 171.17 8.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.955 -1.93 . . . . 0.0 110.732 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 62' ' ' ASN . 35.9 tp -129.86 123.52 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.555 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 69.9 tt0 -118.65 129.42 55.29 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.421 HG22 ' HB1' ' A' ' 61' ' ' ALA . 43.2 t -131.46 121.74 48.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.965 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.496 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.9 mp0 -105.37 129.1 53.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.752 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.9 p90 -152.69 167.36 29.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.307 0.575 . . . . 0.0 111.896 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.441 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 96.8 m-20 -123.51 159.56 28.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.066 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.6 m -114.47 107.43 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -111.08 158.06 36.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo . . . . . 0 C--N 1.312 -1.384 0 C-N-CA 121.962 1.775 . . . . 0.0 111.912 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -149.7 137.33 20.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.41 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.448 ' HB3' HD11 ' A' ' 46' ' ' ILE . 57.9 mm-40 -134.86 148.98 50.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.901 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -140.28 144.46 36.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.254 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.908 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -145.97 145.33 30.6 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.108 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.7 m -66.2 131.08 45.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.725 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -42.24 132.04 3.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.685 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.5 76.38 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.065 -0.97 . . . . 0.0 113.252 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -118.06 151.09 48.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 118.238 1.019 . . . . 0.0 110.309 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.94 139.7 33.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.616 2.211 . . . . 0.0 113.384 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 38' ' ' GLU . 20.7 tt -114.65 140.64 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -117.51 132.3 56.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.689 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' GLN . 10.7 mt -114.87 142.22 46.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.401 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -149.8 134.84 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.646 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.457 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.5 m -102.15 142.76 25.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.932 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 44.3 Cg_endo -69.73 156.44 63.41 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.846 2.364 . . . . 0.0 112.01 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.08 -127.9 29.58 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.241 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 p -110.59 23.9 13.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.039 -0.58 . . . . 0.0 111.303 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -79.34 169.34 18.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.74 146.88 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.413 0.625 . . . . 0.0 110.598 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.671 HG23 ' CD1' ' A' ' 126' ' ' TYR . 85.5 mt -68.18 137.19 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.063 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.1 ptm -132.34 100.81 5.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.641 HG23 ' OD1' ' A' ' 97' ' ' ASN . 41.1 t -64.54 125.38 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.667 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.94 -48.91 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -153.48 150.35 28.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.444 0.64 . . . . 0.0 110.417 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -170.53 156.18 5.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.595 ' O ' HD12 ' A' ' 122' ' ' LEU . 8.8 t30 -150.58 154.9 38.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.785 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 33.9 t80 -117.31 117.47 29.62 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.65 -137.71 5.35 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.498 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.685 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -160.61 121.83 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.368 0.604 . . . . 0.0 112.036 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 HG21 ' CE1' ' A' ' 84' ' ' TYR . 8.1 p -124.2 8.9 8.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.54 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.622 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 49.4 t0 -143.6 -170.14 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.834 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.574 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 22.3 p30 -148.17 -0.4 0.59 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.745 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -104.56 7.57 35.2 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.0 mm -108.51 135.6 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.6 m 55.58 69.95 0.68 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 34.4 p30 -48.39 111.87 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.62 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.29 -162.18 1.18 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.766 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -64.18 141.37 98.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.473 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.6 Cg_endo -55.95 -38.95 93.93 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.393 2.062 . . . . 0.0 112.904 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.81 -34.48 77.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.048 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.766 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 72.3 mt-30 -87.23 -11.96 48.18 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.302 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.477 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.4 mmm -100.59 -3.98 29.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.372 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 21.6 mt-10 -66.9 -47.57 71.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.9 t30 -79.31 119.81 22.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.752 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.4 33.3 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.782 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -141.63 86.9 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.312 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 51.3 t -149.8 120.85 7.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.886 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.559 ' CE1' HG21 ' A' ' 66' ' ' THR . 97.3 m-85 -131.24 149.57 52.51 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.913 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' A' ' 63' ' ' TYR . 38.1 tp -138.42 90.85 12.88 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.32 -47.76 25.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.657 2.238 . . . . 0.0 113.364 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 69.4 m-20 -54.33 -23.74 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.03 54.44 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.938 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 58' ' ' VAL . 61.5 t80 -65.05 -43.43 92.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.82 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 15.5 pttm -64.44 -39.99 94.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.293 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.642 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 72.3 mt -58.55 -50.53 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.023 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.412 ' HE3' ' SG ' ' A' ' 96' ' ' CYS . 93.8 mmm -68.43 -35.47 77.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.062 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.479 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.4 m -58.1 -48.49 80.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.355 0.597 . . . . 0.0 110.647 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -67.7 -37.51 82.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.642 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 66.8 mtt-85 -76.61 -36.4 57.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.412 ' SG ' ' HE3' ' A' ' 92' ' ' MET . 4.7 m -114.16 -20.74 10.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.641 ' OD1' HG23 ' A' ' 58' ' ' VAL . 46.5 m-20 -59.36 139.87 56.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.683 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 23.5 m-20 70.6 15.04 7.18 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.956 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -119.17 149.9 40.96 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.048 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 m -70.48 -32.92 70.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -144.81 158.77 43.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.848 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 29.9 t -155.15 142.81 19.78 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.317 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.0 129.11 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.133 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 t -145.33 142.59 22.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.272 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.0 t -77.02 119.15 24.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.382 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.05 30.94 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.055 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 177.95 175.99 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.652 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 3.1 t 95.95 -158.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.266 0.555 . . . . 0.0 110.872 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.78 -8.56 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.365 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.499 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -82.01 -11.47 58.81 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.073 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.2 m-85 -140.62 126.43 11.48 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.976 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.602 ' O ' ' O ' ' A' ' 111' ' ' PHE . 51.0 Cg_exo -46.24 -159.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.792 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.45 93.23 12.86 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.264 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.89 -55.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.222 2.615 . . . . 0.0 112.991 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.473 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 26.5 p -127.47 90.3 48.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.508 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.37 140.03 47.17 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.897 2.398 . . . . 0.0 111.814 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.05 4.62 56.57 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.735 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.4 m -127.71 146.53 50.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.565 0.682 . . . . 0.0 109.351 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.685 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 29.3 t80 -86.52 99.14 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.473 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 23.0 mttt -73.35 -156.22 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.436 1.112 . . . . 0.0 113.645 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -175.41 174.94 2.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.753 -2.022 . . . . 0.0 110.105 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 62' ' ' ASN . 16.9 tp -131.9 123.52 27.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.265 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.481 ' HG2' HE21 ' A' ' 125' ' ' GLN . 83.7 tt0 -115.18 128.34 56.12 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.14 118.27 40.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.723 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.481 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.3 mt-30 -106.34 129.17 54.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.671 ' CD1' HG23 ' A' ' 56' ' ' ILE . 40.3 p90 -153.26 171.48 18.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.444 0.64 . . . . 0.0 111.774 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -129.6 160.82 32.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.204 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 86.2 m -110.38 123.79 50.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.74 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.83 157.4 63.19 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.115 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo . . . . . 0 N--CA 1.499 1.795 0 C-N-CA 122.442 2.095 . . . . 0.0 112.316 179.821 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 36' ' ' ARG . 50.7 mtp85 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 60.5 ttp180 -148.85 135.99 20.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.501 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 28.6 mp0 -133.18 148.76 52.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.098 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.48 144.78 38.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.943 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -144.3 143.75 31.15 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.428 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.9 m -69.26 132.53 46.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.342 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.496 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 37.7 tt0 -44.63 139.95 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.21 -8.08 80.44 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.601 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -113.55 149.96 42.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 118.343 1.072 . . . . 0.0 110.878 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.49 139.58 49.59 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.636 2.224 . . . . 0.0 113.116 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 9.3 tt -118.42 146.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.725 ' CD ' HH21 ' A' ' 49' ' ' ARG . 88.1 tt0 -129.7 129.94 44.86 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.483 HD12 ' SG ' ' A' ' 96' ' ' CYS . 29.6 mt -114.17 146.67 40.03 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.725 HH21 ' CD ' ' A' ' 47' ' ' GLU . 84.1 mtt180 -147.17 136.24 22.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.192 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 137.01 19.14 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.156 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.92 158.81 56.44 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.498 2.132 . . . . 0.0 112.061 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.56 -130.62 34.7 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -108.43 26.01 10.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.608 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -79.85 165.19 22.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.916 0.389 . . . . 0.0 110.8 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 129' ' ' VAL . 31.0 m -127.74 145.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.054 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.002 HG23 ' CD1' ' A' ' 126' ' ' TYR . 84.9 mt -69.37 138.3 22.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.575 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.6 ptp -132.08 99.27 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG12 ' CE1' ' A' ' 89' ' ' PHE . 47.0 t -62.53 123.63 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.512 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.96 -47.73 3.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.738 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -146.27 142.45 28.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.547 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.57 154.0 11.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.675 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.787 ' O ' HD12 ' A' ' 122' ' ' LEU . 7.7 t30 -152.26 150.29 29.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 112.054 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.615 ' HB3' HD23 ' A' ' 85' ' ' LEU . 47.2 t80 -117.21 119.97 36.84 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.27 -138.41 5.86 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 10.6 ttm-85 -158.4 119.16 3.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.4 0.619 . . . . 0.0 111.378 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.563 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 32.3 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.349 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 16.0 t70 -146.99 -170.95 3.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.944 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 51.4 p30 -146.92 -2.06 0.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.521 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -102.88 5.15 38.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.86 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.9 mm -106.8 137.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.129 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.8 m 56.89 66.2 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.628 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.6 p-10 -47.98 121.34 4.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.592 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -143.79 -165.73 2.18 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.738 ' CG ' HE21 ' A' ' 77' ' ' GLN . 0.4 OUTLIER -63.7 140.63 97.84 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.174 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.532 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -56.33 -36.91 97.61 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.983 2.455 . . . . 0.0 114.151 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -65.82 -32.71 74.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.487 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.738 HE21 ' CG ' ' A' ' 74' ' ' ASP . 27.7 mt-30 -88.82 10.43 21.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.691 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.4 mtm -132.82 0.9 3.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.398 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.6 mt-10 -63.16 -48.0 80.28 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.721 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -76.17 114.66 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 111.773 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.511 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 35.9 m -107.08 31.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.978 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.511 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.3 mm100 -141.4 87.45 2.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 15.5 t -148.06 123.51 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.502 ' HA ' HD21 ' A' ' 62' ' ' ASN . 91.7 m-85 -127.86 151.96 48.42 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.55 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 63' ' ' TYR . 57.9 tp -146.95 85.73 6.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.092 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -45.89 -44.36 18.58 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.21 2.607 . . . . 0.0 114.665 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 51.1 m-20 -56.02 -24.76 41.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.04 -31.44 51.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' O ' ' OG ' ' A' ' 93' ' ' SER . 82.5 t80 -65.17 -47.36 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 12.6 pttp -64.82 -37.71 88.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.741 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 93.7 mt -61.79 -52.46 60.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.405 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.485 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 31.2 m -63.15 -47.54 82.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.016 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -68.08 -36.67 80.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 73.6 mtt180 -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 48' ' ' LEU . 82.7 m -110.52 -22.18 11.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 88.6 m-20 -57.54 134.02 55.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.399 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 66.89 9.79 7.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.038 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.621 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 62.4 mtt85 -111.97 146.43 37.85 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.253 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.4 m -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.547 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.21 156.01 34.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -154.65 142.4 19.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 59.6 t -123.58 123.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.078 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.572 HG13 ' NH1' ' A' ' 95' ' ' ARG . 45.2 t -138.08 145.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.33 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -77.78 118.49 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.28 41.59 0.05 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.646 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.78 -125.5 0.99 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.593 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 107' ' ' GLY . 32.5 t 31.06 -155.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 0.0 111.578 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.466 ' N ' ' OG ' ' A' ' 108' ' ' SER . 96.5 m-20 -65.17 -10.51 31.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.712 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.51 59.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.472 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.1 m-85 -142.19 130.27 11.66 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.061 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 48.4 Cg_exo -47.66 -157.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.713 2.276 . . . . 0.0 112.546 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -139.08 91.75 11.22 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.45 -46.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.509 2.139 . . . . 0.0 113.168 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.6 p -140.69 85.21 13.0 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.855 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -58.97 146.9 92.38 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.239 2.626 . . . . 0.0 111.728 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.98 63.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.324 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.0 m -130.98 144.36 51.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.3 t80 -86.54 96.66 10.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.458 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 24.1 mtmm -74.27 -168.49 0.66 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.927 1.346 . . . . 0.0 114.005 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.781 ' HB2' HD21 ' A' ' 39' ' ' LEU . 12.7 p90 -167.03 169.07 13.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.146 -2.297 . . . . 0.0 110.68 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 62' ' ' ASN . 58.9 tp -131.4 125.64 33.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.343 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.617 ' OE1' HD12 ' A' ' 39' ' ' LEU . 10.6 tp10 -118.48 131.28 56.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.895 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.547 HG22 ' HB1' ' A' ' 61' ' ' ALA . 44.0 t -135.39 123.07 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.467 HE21 ' HG3' ' A' ' 123' ' ' GLU . 2.3 mt-30 -107.39 126.76 52.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.829 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.002 ' CD1' HG23 ' A' ' 56' ' ' ILE . 34.9 p90 -153.78 168.35 26.59 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.743 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 92.6 m-20 -119.89 159.61 24.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.964 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 55.0 m -111.49 111.42 22.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.353 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 55' ' ' VAL . 5.1 m -115.72 156.45 46.29 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 N--CA 1.495 1.595 0 C-N-CA 122.124 1.882 . . . . 0.0 111.981 -179.536 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.71 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 68.3 mtp85 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.593 ' HE ' ' CG ' ' A' ' 125' ' ' GLN . 40.8 ttm180 -147.08 132.57 18.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.539 0.685 . . . . 0.0 110.972 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.499 ' HG3' HD23 ' A' ' 48' ' ' LEU . 67.9 mm-40 -128.13 143.01 51.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.524 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.9 tt -139.24 137.97 36.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.795 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.673 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.6 142.88 32.21 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.124 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 31.0 m -67.89 138.1 55.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.935 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 13.8 tt0 -42.86 139.28 1.72 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.3 0.572 . . . . 0.0 112.512 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.99 -5.55 83.15 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.735 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -115.41 152.79 47.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 118.506 1.153 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.24 143.55 39.8 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 122.512 2.141 . . . . 0.0 113.461 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.02 143.64 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.654 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 88.0 tt0 -126.14 127.99 46.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.423 0.63 . . . . 0.0 111.698 -177.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.8 HD12 ' SG ' ' A' ' 102' ' ' CYS . 23.3 mt -113.57 140.75 47.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.71 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 97.4 mtt180 -144.79 131.23 19.76 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.828 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.2 m -100.65 146.63 32.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.27 157.28 37.5 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.343 2.028 . . . . 0.0 112.415 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 54.9 -133.98 47.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.166 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -107.2 25.3 11.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.114 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -78.65 165.98 23.04 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.94 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.45 145.78 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.488 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.847 HG23 ' CD2' ' A' ' 126' ' ' TYR . 77.9 mt -68.67 135.7 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.628 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.2 ptm -129.96 100.06 5.32 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.97 124.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.43 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -100.13 -51.2 3.74 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.441 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 40.6 m-80 -150.03 147.51 27.92 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.998 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.787 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -163.25 151.47 13.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.858 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.567 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.2 t30 -152.41 148.62 27.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.403 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 59.4 t80 -117.93 123.62 46.26 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.443 ' HA2' ' CD ' ' A' ' 120' ' ' LYS . . . 158.83 -139.6 6.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.616 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 5.1 ttm180 -157.11 116.79 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.442 . . . . 0.0 111.51 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.458 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 41.8 p -125.37 8.8 7.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.9 t0 -147.49 158.33 43.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p30 -115.23 3.17 14.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.697 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 16.8 mtpt -105.23 0.58 27.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.735 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.4 mm -113.14 138.46 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.4 m 59.81 61.18 1.98 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -51.96 125.98 16.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.004 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.44 -164.83 2.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.006 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.673 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -60.87 135.0 92.67 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 3.6 Cg_endo -52.3 -33.38 55.34 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.409 2.073 . . . . 0.0 113.934 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -34.88 79.05 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.673 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 30.0 mt-30 -89.08 12.59 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.524 ' HE1' ' O ' ' A' ' 68' ' ' ASP . 82.9 mtp -129.36 -3.81 4.9 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.082 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.0 mt-10 -59.99 -50.93 71.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.532 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -78.41 113.88 16.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 29.6 m -105.39 32.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.289 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.2 mm100 -141.05 87.95 2.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 31.5 t -146.54 122.88 10.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -129.97 152.05 49.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.941 0.4 . . . . 0.0 111.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.708 HD21 ' HG2' ' A' ' 112' ' ' PRO . 32.9 tp -144.63 90.43 6.45 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.968 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -48.78 -47.24 21.72 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.648 2.232 . . . . 0.0 113.743 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.2 m-20 -56.72 -29.13 62.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.38 -32.04 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.832 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 60' ' ' ASN . 74.0 t80 -64.46 -40.32 95.48 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 3.4 ptmt -66.54 -40.95 89.34 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.618 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.493 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 77.8 mt -59.88 -50.32 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.104 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.929 ' SD ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.03 -32.72 73.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.366 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 53.4 m -62.48 -47.15 85.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.676 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -67.46 -33.56 75.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 58.1 mtt180 -79.81 -32.11 40.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 48' ' ' LEU . 63.5 m -113.7 -16.36 12.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.559 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.5 m-20 -60.06 130.9 48.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.595 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 68.86 14.66 8.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.858 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt180 -115.05 146.74 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.274 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.2 m -72.2 -32.13 66.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.739 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.16 154.58 32.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.233 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.8 ' SG ' HD12 ' A' ' 48' ' ' LEU . 19.1 p -153.46 148.59 26.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.908 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.62 126.22 66.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.2 t -142.49 143.13 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.27 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 t -77.23 118.2 23.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -71.6 44.48 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.53 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.59 -124.92 0.93 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.689 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 28.13 -153.34 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 111.183 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.12 -10.15 20.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.077 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.0 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.292 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.3 m-85 -143.51 130.21 10.45 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.396 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.708 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.9 Cg_exo -47.74 -158.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.443 2.096 . . . . 0.0 112.479 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -138.81 91.91 11.54 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.68 -38.83 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.518 2.145 . . . . 0.0 113.14 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.05 84.4 11.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.674 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -65.6 139.84 60.07 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.259 2.639 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.5 -1.38 62.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.367 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.3 m -114.07 146.35 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.5 t80 -87.43 97.16 10.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 24.3 mtmm -74.58 -165.84 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.952 1.358 . . . . 0.0 114.251 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HB2' HD21 ' A' ' 39' ' ' LEU . 12.9 p90 -165.26 165.58 19.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.317 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.631 HD21 ' SD ' ' A' ' 92' ' ' MET . 25.7 tp -128.12 126.38 41.01 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.2 tt0 -124.82 127.55 47.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.753 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.929 HG21 ' SD ' ' A' ' 92' ' ' MET . 60.4 t -131.83 128.19 59.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.115 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.593 ' CG ' ' HE ' ' A' ' 37' ' ' ARG . 3.1 mp0 -109.83 132.15 54.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.327 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.847 ' CD2' HG23 ' A' ' 56' ' ' ILE . 42.4 p90 -156.84 171.71 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 57' ' ' MET . 73.2 m-20 -129.58 161.12 31.25 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.791 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.8 m -113.33 124.62 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.677 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.9 157.36 60.38 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.142 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo . . . . . 0 C--N 1.311 -1.4 0 C-N-CA 121.641 1.561 . . . . 0.0 111.272 178.931 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HD2' HH11 ' A' ' 36' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -146.76 136.22 22.87 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.109 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' CB ' HD11 ' A' ' 46' ' ' ILE . 68.1 mm-40 -130.14 147.35 51.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.557 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.1 tt -139.61 134.97 32.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.63 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.52 147.37 45.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.406 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -67.67 131.52 45.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 61.4 tt0 -42.14 138.47 1.62 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.601 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.52 79.2 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.611 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.55 147.46 40.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 118.52 1.16 . . . . 0.0 110.493 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.08 137.81 45.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.758 2.306 . . . . 0.0 112.605 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.483 HD11 ' CB ' ' A' ' 38' ' ' GLU . 17.5 tt -111.23 148.36 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -127.78 127.72 44.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.003 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.5 mt -116.83 144.83 44.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.363 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -149.23 133.65 17.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.22 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.5 m -99.88 138.74 20.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.162 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -66.94 161.35 42.84 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.65 2.233 . . . . 0.0 113.244 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.7 -136.4 13.65 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 p -97.43 23.51 7.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.821 -0.69 . . . . 0.0 110.407 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -79.39 161.3 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.782 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.8 143.4 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.165 0.507 . . . . 0.0 110.396 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.84 HG23 ' CD2' ' A' ' 126' ' ' TYR . 93.6 mt -68.67 139.97 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.447 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 2.0 ptp -135.15 103.25 5.47 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.912 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.615 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.4 t -63.88 124.62 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.248 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -102.59 -51.34 3.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.91 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -150.27 145.43 26.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.578 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.36 154.73 7.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.401 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.671 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.4 t30 -152.41 153.44 33.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.286 0.565 . . . . 0.0 111.559 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.567 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 50.1 t80 -118.81 124.34 46.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.11 -141.92 8.39 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.529 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.531 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 11.1 ttm-85 -151.71 115.56 4.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.313 0.578 . . . . 0.0 110.724 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.479 HG21 ' CE2' ' A' ' 84' ' ' TYR . 13.5 p -121.07 6.8 10.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.83 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 11.7 t70 -142.9 -169.62 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.698 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.496 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 40.9 p-10 -150.55 -2.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 110.41 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -100.44 4.94 44.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.79 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 138.58 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.19 63.21 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -47.66 115.74 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.347 0.594 . . . . 0.0 111.645 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.47 -163.02 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.73 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.637 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.66 140.25 97.98 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.707 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 Cg_endo -56.81 -31.41 88.45 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 121.942 1.761 . . . . 0.0 111.999 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -64.37 -35.44 80.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.811 ' O ' HG23 ' A' ' 118' ' ' THR . 79.6 mt-30 -87.7 -13.17 43.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.048 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.489 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 4.5 mtm -107.86 -2.17 20.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.95 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 9.2 mt-10 -63.92 -46.52 84.45 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.889 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -78.66 115.11 18.15 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.821 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.457 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 12.0 m -106.48 32.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.338 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.457 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.8 mm-40 -139.68 85.36 2.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.857 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.8 t -151.05 115.74 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.479 ' CE2' HG21 ' A' ' 66' ' ' THR . 68.7 m-85 -124.97 157.66 35.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.913 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 63' ' ' TYR . 62.1 tp -148.13 87.83 5.64 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.726 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -46.96 -46.5 18.59 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.735 2.29 . . . . 0.0 114.064 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -53.32 -27.07 21.27 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.66 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.738 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.615 ' CE1' HG12 ' A' ' 58' ' ' VAL . 45.9 t80 -67.51 -47.19 70.69 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.2 pttt -65.0 -39.61 93.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.585 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.6 mt -59.79 -45.43 94.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.944 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 91.4 mmm -69.82 -37.34 76.19 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.249 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.467 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 66.3 m -58.57 -45.12 89.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.24 -38.82 91.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.409 HH11 HG13 ' A' ' 104' ' ' VAL . 61.5 mtt180 -76.09 -34.01 59.52 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.6 m -113.88 -16.83 12.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.467 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -58.99 136.53 57.97 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.52 -0.737 . . . . 0.0 111.839 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 69.96 13.12 7.92 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.944 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -112.42 145.33 40.35 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.5 m -71.21 -30.13 66.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -143.79 158.53 43.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.431 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 t -155.82 137.03 13.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.764 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -126.23 128.9 71.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.497 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 46' ' ' ILE . 58.7 t -146.34 142.86 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -74.85 116.24 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.9 42.46 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.547 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.18 -125.99 1.04 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.95 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 107' ' ' GLY . 44.5 t 28.94 -155.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.459 0.647 . . . . 0.0 112.039 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.542 ' N ' ' OG ' ' A' ' 108' ' ' SER . 71.2 m-20 -62.19 -9.68 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.4 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.0 -11.16 59.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.11 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.9 m-85 -143.45 126.68 9.02 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.795 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.578 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.0 Cg_exo -47.7 -157.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.826 2.35 . . . . 0.0 112.42 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -139.1 88.88 12.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -75.69 -46.51 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.832 2.355 . . . . 0.0 112.838 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -132.31 79.53 65.64 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-O 121.673 0.749 . . . . 0.0 110.589 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -57.5 130.14 37.45 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.846 2.364 . . . . 0.0 111.919 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.16 -9.32 46.15 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.941 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.3 m -106.57 148.41 28.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.997 0.898 . . . . 0.0 108.965 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.518 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 8.2 t80 -88.27 97.85 11.26 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 14.1 mttt -75.78 -154.1 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.912 1.339 . . . . 0.0 113.435 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.531 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -173.74 170.01 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.11 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.4 tp -131.53 125.03 31.34 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HG2' HE21 ' A' ' 125' ' ' GLN . 76.6 tt0 -118.05 127.54 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.039 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.462 HG22 ' HB1' ' A' ' 61' ' ' ALA . 59.5 t -131.13 123.43 53.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.638 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.544 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.5 mp0 -109.96 131.16 55.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.688 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.84 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.0 p90 -152.92 165.94 33.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.165 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.442 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 36.6 m-20 -116.97 161.82 18.76 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.311 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.407 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 94.5 m -116.25 115.91 26.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.838 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.4 156.32 67.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.228 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo . . . . . 0 N--CA 1.492 1.439 0 C-N-CA 122.025 1.817 . . . . 0.0 112.159 179.311 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HD2' ' OE2' ' A' ' 123' ' ' GLU . 50.6 ttp85 -150.77 133.81 16.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.312 0.577 . . . . 0.0 111.906 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 53.3 mp0 -130.62 149.35 52.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.368 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.738 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -141.6 139.06 33.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.665 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.738 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.95 142.97 36.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.201 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.5 m -71.62 134.6 46.49 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -42.95 135.8 2.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.576 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.94 -9.74 63.84 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.099 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.72 150.58 47.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 119.03 1.415 . . . . 0.0 110.741 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 20.9 Cg_endo -68.23 142.51 55.65 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.072 1.848 . . . . 0.0 111.866 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.9 tt -118.03 143.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 88.8 tt0 -130.19 129.18 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.505 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD12 ' SG ' ' A' ' 96' ' ' CYS . 13.6 mt -110.29 146.03 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.336 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.549 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 72.4 mtt180 -145.41 134.23 22.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.36 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.462 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -102.52 142.9 25.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.77 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 42.6 Cg_endo -69.75 155.11 66.84 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.658 2.238 . . . . 0.0 112.607 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.68 -131.84 35.65 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.199 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -105.18 25.32 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.844 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -79.71 164.18 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.738 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.35 147.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 0.0 110.083 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.957 HG23 ' CD2' ' A' ' 126' ' ' TYR . 86.3 mt -71.66 139.88 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.33 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.465 ' HG3' ' H ' ' A' ' 127' ' ' ASP . 2.9 ptp -132.02 102.17 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.536 HG12 ' CE1' ' A' ' 89' ' ' PHE . 63.4 t -63.95 124.58 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.221 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.0 mm-40 -103.03 -51.76 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 7.6 m-20 -148.94 146.78 28.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.136 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.76 156.53 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.005 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.574 HD21 ' HA ' ' A' ' 84' ' ' TYR . 8.7 t30 -152.91 150.79 29.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.954 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -119.38 124.99 47.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -138.46 6.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.67 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -154.6 114.57 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.408 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.485 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 6.0 p -125.51 6.46 7.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.1 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -148.26 156.95 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' O ' ' CE ' ' A' ' 78' ' ' MET . 55.9 p30 -118.33 5.81 11.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.03 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -103.76 4.62 35.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 mm -113.03 136.94 47.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.49 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m 54.98 72.4 0.48 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.805 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -55.77 124.7 18.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.97 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -141.22 -164.14 1.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.739 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.73 ' CG ' HE21 ' A' ' 77' ' ' GLN . 2.7 p-10 -59.1 139.48 87.73 Favored Pre-proline 0 C--N 1.333 -0.132 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.399 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -54.67 -37.32 91.31 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.591 2.194 . . . . 0.0 113.672 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -62.51 -34.95 77.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.934 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.73 HE21 ' CG ' ' A' ' 74' ' ' ASP . 31.0 mt-30 -88.23 9.49 22.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.068 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . 77.2 mtp -122.69 -6.24 8.6 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.385 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 90.7 mt-10 -62.63 -49.24 75.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.994 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.34 116.3 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.625 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -107.01 34.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.262 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 92.9 mm-40 -139.84 85.35 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.085 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.476 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 26.5 t -148.97 121.68 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.574 ' HA ' HD21 ' A' ' 62' ' ' ASN . 38.0 m-85 -130.44 153.05 49.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.505 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 88' ' ' ALA . 44.4 tp -141.65 94.29 7.44 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 -48.22 22.66 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.556 2.171 . . . . 0.0 113.173 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.5 m-20 -56.77 -24.88 53.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.503 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.63 -30.81 44.56 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.733 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.536 ' CE1' HG12 ' A' ' 58' ' ' VAL . 53.7 t80 -64.91 -42.84 94.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.1 ptpt -64.19 -42.18 96.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.785 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.711 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 36.4 mt -60.1 -50.0 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.173 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.441 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 95.9 mmm -66.71 -34.91 78.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.741 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.556 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.4 m -59.84 -45.92 90.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.066 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -65.85 -34.22 77.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.489 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.711 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 31.5 mtm180 -80.97 -32.19 34.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.766 ' SG ' HD12 ' A' ' 48' ' ' LEU . 84.2 m -109.6 -19.61 13.14 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 93' ' ' SER . 82.1 m-20 -58.75 133.99 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.249 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 65.02 12.74 8.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.581 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.94 146.23 41.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.0 m -72.22 -31.65 66.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.924 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 157.77 42.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.61 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.721 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.8 p -154.82 142.15 19.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.641 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 47.1 t -116.53 131.91 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.491 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.521 HG11 ' NH2' ' A' ' 95' ' ' ARG . 90.5 t -144.46 140.8 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.607 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -80.54 119.46 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.59 28.55 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.722 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 176.88 177.11 45.57 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.954 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 4.2 t 92.78 -155.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.996 0.427 . . . . 0.0 110.774 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -62.21 -11.09 12.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.905 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.5 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -78.52 -19.31 53.23 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.296 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.9 m-85 -136.98 129.26 17.06 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.992 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.5 Cg_exo -48.68 -155.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.47 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -138.49 89.48 13.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 0.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.0 -30.67 0.67 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.064 2.51 . . . . 0.0 113.544 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.579 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -149.04 66.46 8.68 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-O 120.93 0.395 . . . . 0.0 111.192 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.22 135.27 69.11 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.122 1.881 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.47 -14.99 42.61 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.766 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.493 HG22 ' HD2' ' A' ' 65' ' ' ARG . 20.8 m -107.79 153.52 22.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.146 0.973 . . . . 0.0 109.433 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.559 ' HB3' HH12 ' A' ' 65' ' ' ARG . 7.6 t80 -86.73 97.47 10.61 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.579 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 13.2 mttp -72.4 -164.13 0.14 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.903 -1.498 . . . . 0.0 113.528 -177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.613 ' HB2' HD21 ' A' ' 39' ' ' LEU . 9.3 p90 -170.44 167.2 8.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.138 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.8 tp -129.2 124.79 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.9 tt0 -119.9 125.08 47.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.9 t -128.26 123.5 60.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.684 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -109.64 128.82 55.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.142 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.957 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.5 p90 -153.33 174.01 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.377 0.608 . . . . 0.0 111.637 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.465 ' H ' ' HG3' ' A' ' 57' ' ' MET . 21.9 m-20 -127.43 162.62 25.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.225 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.474 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.0 m -112.22 120.22 41.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.47 156.93 74.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.839 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 N--CA 1.493 1.485 0 C-N-CA 122.047 1.831 . . . . 0.0 112.967 -179.434 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' CZ ' ' HD3' ' A' ' 51' ' ' PRO . 87.0 mtt-85 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.419 ' HD2' HH11 ' A' ' 37' ' ' ARG . 12.8 ttp180 -148.0 138.93 23.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 111.688 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.612 ' O ' ' OE2' ' A' ' 123' ' ' GLU . 71.4 mm-40 -131.86 146.01 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.608 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.722 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -139.72 137.53 35.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.818 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.99 145.21 37.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.137 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -65.89 132.77 49.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.254 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 37.2 tt0 -43.14 134.78 3.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.397 -0.819 . . . . 0.0 113.13 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 90.3 -1.23 79.34 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.69 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -116.16 146.25 36.78 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 118.219 1.01 . . . . 0.0 110.674 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 136.93 48.62 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.753 2.302 . . . . 0.0 112.141 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 15.5 tt -113.86 151.8 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.16 127.1 44.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.505 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.793 HD12 ' SG ' ' A' ' 102' ' ' CYS . 50.2 mt -113.54 142.89 45.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -151.19 134.81 16.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.054 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -101.25 142.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.719 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -64.18 157.83 51.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.798 2.332 . . . . 0.0 112.589 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.8 -124.78 7.3 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.299 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.6 p -109.83 22.6 15.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.005 -0.598 . . . . 0.0 111.089 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.59 167.83 20.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.34 145.71 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.348 0.594 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.745 HG23 ' CD2' ' A' ' 126' ' ' TYR . 81.8 mt -70.27 137.55 23.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.667 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 127' ' ' ASP . 2.7 ptp -134.34 100.37 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.29 124.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.451 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 73.2 mm-40 -99.77 -48.58 4.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 19.1 m-80 -153.92 152.59 30.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' A' ' 124' ' ' VAL . . . -168.91 158.03 8.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.6 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.497 HD21 ' HA ' ' A' ' 84' ' ' TYR . 4.2 t30 -149.98 148.98 29.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 111.606 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.512 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 65.3 t80 -119.47 121.74 40.14 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 155.88 -140.53 7.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.6 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 8.2 ttm180 -149.35 118.47 6.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 111.23 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.574 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 13.6 p -124.4 3.61 8.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.023 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 22.5 t70 -148.45 154.93 40.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.571 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.519 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 43.6 p30 -112.17 5.76 18.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.252 0.548 . . . . 0.0 109.767 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.589 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 29.6 mttt -104.27 7.29 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.8 mm -114.1 135.52 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 110.622 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.4 m 50.1 80.76 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.02 125.67 24.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.321 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.3 -163.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p30 -63.97 138.44 97.4 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.626 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.76 -33.65 71.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.007 1.805 . . . . 0.0 112.24 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -63.69 -36.01 82.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.475 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.809 ' O ' HG23 ' A' ' 118' ' ' THR . 76.7 mt-30 -85.94 -10.18 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.787 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.505 ' CE ' HH12 ' A' ' 65' ' ' ARG . 74.0 mtp -104.01 -2.6 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.905 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.7 mt-10 -64.49 -48.69 74.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -77.25 114.11 15.72 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.811 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.499 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 23.1 m -107.96 29.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.57 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -139.18 82.99 1.92 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.852 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.421 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 23.0 t -147.35 119.51 8.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.497 ' HA ' HD21 ' A' ' 62' ' ' ASN . 78.3 m-85 -129.92 155.14 46.54 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.218 0.532 . . . . 0.0 111.644 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 88' ' ' ALA . 25.5 tp -142.76 96.71 6.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.71 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -53.13 -48.04 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.637 2.225 . . . . 0.0 113.146 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.8 m-20 -55.39 -23.81 26.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.517 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.79 -35.71 66.58 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.716 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -65.04 -45.49 85.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.731 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.1 -39.81 93.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.033 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.49 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 94.4 mt -59.67 -52.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.838 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.918 ' SD ' HD21 ' A' ' 122' ' ' LEU . 18.6 mtp -68.17 -34.98 77.31 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.442 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.509 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 60.5 m -56.77 -43.63 81.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.109 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.701 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 86.8 mt-30 -68.04 -35.51 78.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.938 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.708 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 71.6 mtt180 -74.74 -34.08 62.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.856 ' N ' HH21 ' A' ' 99' ' ' ARG . 28.4 m -114.32 -18.56 11.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.528 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 45.0 m-20 -58.55 137.41 57.45 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.563 -0.71 . . . . 0.0 112.349 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 65.62 13.42 8.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.259 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.856 HH21 ' N ' ' A' ' 96' ' ' CYS . 54.7 mtm-85 -114.37 145.81 41.35 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.273 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.1 m -71.82 -32.58 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.646 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.11 155.64 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.504 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.793 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.3 p -155.01 150.23 27.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.294 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 59.4 t -127.86 131.79 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.404 HG13 ' NH1' ' A' ' 95' ' ' ARG . 60.1 t -144.66 140.5 23.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.704 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.33 119.45 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -72.17 41.98 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.31 -122.69 0.81 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.25 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER 31.64 -160.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.526 0.679 . . . . 0.0 111.473 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' OG ' ' A' ' 108' ' ' SER . 99.0 m-20 -65.43 -8.19 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.271 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.11 -11.44 59.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.592 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 112' ' ' PRO . 41.6 m-85 -142.12 126.03 9.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.235 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 111' ' ' PHE . 28.5 Cg_exo -49.42 -160.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.66 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -139.2 92.31 10.77 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.565 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.92 -38.34 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.804 2.336 . . . . 0.0 113.445 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.404 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.6 p -136.27 72.66 58.78 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -57.1 133.82 60.29 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.711 1.607 . . . . 0.0 110.853 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.24 -12.38 33.79 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 77' ' ' GLN . 97.5 m -117.59 147.18 43.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.473 0.637 . . . . 0.0 109.535 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.6 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 22.8 t80 -86.33 98.64 11.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.577 0.703 . . . . 0.0 109.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.6 mttm -71.31 -153.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.892 -177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.574 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.5 p90 -176.6 176.69 1.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 112.698 -2.046 . . . . 0.0 110.648 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.918 HD21 ' SD ' ' A' ' 92' ' ' MET . 14.3 tp -134.08 126.12 29.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.905 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.697 ' OE1' ' NE2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -124.64 128.64 49.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.656 HG21 ' SD ' ' A' ' 92' ' ' MET . 88.9 t -131.85 124.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.424 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.697 ' NE2' ' OE1' ' A' ' 123' ' ' GLU . 2.7 mp0 -107.66 129.37 55.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.745 ' CD2' HG23 ' A' ' 56' ' ' ILE . 36.8 p90 -153.01 168.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 111.724 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.475 ' OD1' ' C ' ' A' ' 126' ' ' TYR . 2.1 m-20 -126.38 162.99 24.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.593 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.8 m -113.45 116.89 30.32 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.583 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.9 m -121.44 157.09 57.22 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.496 1.622 0 C-N-CA 122.103 1.868 . . . . 0.0 112.44 179.573 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 7.4 mmm180 . . . . . 0 CA--C 1.52 -0.176 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -149.88 131.75 15.14 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.381 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -130.84 145.32 51.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.501 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 8.7 tt -137.61 137.51 38.57 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.6 145.44 35.04 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.159 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.7 m -67.97 131.35 45.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.635 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 6.4 tt0 -43.06 139.04 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.72 -1.86 83.99 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.166 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.4 158.02 37.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 118.034 0.917 . . . . 0.0 109.962 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.02 140.11 14.02 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.885 1.723 . . . . 0.0 111.631 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 20.2 tt -117.59 147.2 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.708 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.5 tt0 -126.52 128.6 47.15 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.101 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 102' ' ' CYS . 20.4 mt -115.41 141.63 47.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.708 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 89.4 mtt180 -147.82 132.86 18.22 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.183 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.7 m -99.76 138.83 20.46 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.769 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.38 161.07 46.8 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.562 2.175 . . . . 0.0 112.176 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -135.13 38.35 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -107.36 26.65 9.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 110.455 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 53.2 m-20 -80.92 166.81 20.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.063 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 148.6 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.349 0.595 . . . . 0.0 111.629 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.528 HG23 ' CD2' ' A' ' 126' ' ' TYR . 96.1 mt -69.29 134.86 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.937 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -134.83 98.39 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.891 0.853 . . . . 0.0 108.829 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.403 ' HB ' HD21 ' A' ' 97' ' ' ASN . 58.0 t -64.79 127.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.77 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -102.76 -48.38 4.12 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.767 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -151.73 150.96 30.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.51 . . . . 0.0 110.47 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.14 154.76 7.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.074 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.511 HD21 ' HA ' ' A' ' 84' ' ' TYR . 1.7 t30 -149.41 146.32 27.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.4 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' ' HD3' ' A' ' 120' ' ' LYS . 63.5 t80 -114.66 122.49 46.63 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.39 -139.78 6.77 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.491 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.706 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -155.42 117.1 4.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.919 179.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 32.9 p -123.6 8.67 8.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.583 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.7 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 50.1 t0 -150.2 158.42 44.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 44.2 p30 -115.41 5.81 14.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.688 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -106.39 6.14 30.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.528 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 29.2 mm -114.2 139.36 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.523 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 57.21 61.66 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 6.4 p-10 -46.31 118.57 1.99 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.041 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -136.16 -162.65 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.303 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -64.08 145.21 98.09 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.366 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -50.69 -38.28 55.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.54 2.16 . . . . 0.0 112.353 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -64.95 -35.66 81.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.677 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.565 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 80.7 mt-30 -83.65 -7.62 59.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 75.1 mmm -113.61 40.65 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.682 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -101.74 -59.87 1.63 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.062 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 17.8 t30 -78.24 119.52 21.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.507 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.545 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 27.1 m -110.16 27.5 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.894 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.3 mm-40 -141.94 82.84 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.622 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.4 t -146.54 118.98 8.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.511 ' HA ' HD21 ' A' ' 62' ' ' ASN . 44.4 m-85 -123.41 156.56 35.23 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.151 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.446 HD23 ' HB3' ' A' ' 63' ' ' TYR . 28.2 tp -142.13 83.98 11.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.27 -46.41 11.59 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 123.361 2.707 . . . . 0.0 114.127 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 98.9 m-20 -54.56 -25.49 26.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.2 -32.27 47.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.282 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.596 ' O ' ' OG ' ' A' ' 93' ' ' SER . 7.7 t80 -65.63 -46.38 79.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.025 0.44 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.7 pttp -67.55 -40.39 84.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.244 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.632 HG23 ' NH1' ' A' ' 95' ' ' ARG . 79.9 mt -58.16 -49.17 82.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 1.045 ' SD ' HD21 ' A' ' 122' ' ' LEU . 4.2 mtp -70.36 -32.44 70.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.176 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.596 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.7 m -60.24 -44.89 94.86 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.4 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -64.49 -37.41 87.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 0.0 111.496 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.632 ' NH1' HG23 ' A' ' 91' ' ' ILE . 60.0 mtt85 -77.04 -32.85 57.25 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.556 ' SG ' HD12 ' A' ' 48' ' ' LEU . 22.9 m -112.81 -13.48 13.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.55 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.6 m120 -62.23 130.57 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.354 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 67.88 14.88 9.51 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.18 145.92 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.772 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.04 -31.8 68.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.51 154.94 40.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.208 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 48' ' ' LEU . 9.6 p -154.63 136.59 14.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.103 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 22.8 t -122.29 129.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.886 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.2 t -144.1 146.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 0.0 111.805 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.452 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.3 t -77.81 117.86 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.16 38.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.709 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.14 -125.23 0.96 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.914 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.7 t 27.99 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.967 0.413 . . . . 0.0 110.619 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.12 -10.43 22.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.856 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.64 60.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.052 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.614 ' O ' ' O ' ' A' ' 112' ' ' PRO . 83.1 m-85 -141.77 129.03 11.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.237 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 111' ' ' PHE . 50.7 Cg_exo -45.55 -158.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 123.061 2.507 . . . . 0.0 112.694 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -139.13 91.46 11.31 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.8 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.54 -50.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.125 2.55 . . . . 0.0 113.288 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.457 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -135.27 81.62 43.37 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.991 0.424 . . . . 0.0 111.473 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.11 143.65 94.96 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.598 2.199 . . . . 0.0 111.73 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.91 -5.53 56.49 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 120.634 -0.794 . . . . 0.0 113.168 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 77' ' ' GLN . 99.3 m -115.06 147.84 39.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.706 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 11.2 t80 -87.02 97.78 10.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.465 ' HD3' ' CE2' ' A' ' 63' ' ' TYR . 19.7 mttt -73.51 -163.74 0.17 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 122.848 1.309 . . . . 0.0 113.241 -177.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.425 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 6.4 p90 -165.42 165.14 19.45 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.388 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.045 HD21 ' SD ' ' A' ' 92' ' ' MET . 35.8 tp -126.14 122.24 35.13 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.672 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 2.6 tm-20 -113.62 126.91 55.79 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.564 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.87 HG21 ' SD ' ' A' ' 92' ' ' MET . 58.6 t -133.2 120.6 40.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.979 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.672 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 5.3 mt-30 -107.37 128.27 54.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.082 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.528 ' CD2' HG23 ' A' ' 56' ' ' ILE . 33.9 p90 -153.56 171.6 18.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.74 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 40.2 m-20 -128.5 164.27 23.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.231 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.57 120.52 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.373 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 20.1 m -116.97 150.83 46.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.385 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 C--N 1.312 -1.374 0 C-N-CA 121.875 1.717 . . . . 0.0 112.265 179.421 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.47 ' NH1' ' HG2' ' A' ' 36' ' ' ARG . 40.0 mtp85 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -148.07 137.28 22.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -134.81 146.08 48.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.712 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.79 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -140.77 143.3 34.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.696 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.79 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -147.4 145.56 29.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.727 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.1 m -70.73 136.19 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.37 0.605 . . . . 0.0 111.122 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 7.6 tt0 -44.92 139.0 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.215 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.33 -11.99 66.82 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.702 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -118.29 153.35 51.59 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 118.395 1.098 . . . . 0.0 110.313 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.19 145.37 43.78 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.275 1.984 . . . . 0.0 113.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -114.88 149.57 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -127.14 128.78 46.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.205 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD12 ' SG ' ' A' ' 102' ' ' CYS . 31.6 mt -115.61 139.39 50.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.401 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -144.9 135.15 24.12 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.246 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -100.52 140.17 21.2 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.12 155.95 66.47 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 121.908 1.739 . . . . 0.0 111.505 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.03 -137.09 37.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 121.689 0.605 . . . . 0.0 112.625 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -100.92 22.19 12.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.446 -0.877 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -79.02 166.75 21.99 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.681 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.75 148.04 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' CD2' ' A' ' 126' ' ' TYR . 85.8 mt -71.25 137.84 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.109 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -135.1 101.64 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.27 125.43 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.348 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.577 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 97.5 mt-10 -100.04 -49.57 4.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.3 m-20 -150.19 149.4 30.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.618 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.448 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.12 152.49 7.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.712 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.591 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.6 t30 -149.32 149.15 30.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.191 0.519 . . . . 0.0 111.182 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.491 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 26.3 t80 -119.3 122.89 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -137.26 5.5 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 1.8 ttm180 -155.1 116.37 4.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.112 0.482 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.2 p -122.74 6.7 9.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 14.1 t70 -149.81 157.74 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.716 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 5.6 p-10 -113.58 5.44 16.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.189 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.489 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 31.1 mtmt -102.61 0.16 32.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.616 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 mm -113.09 138.54 42.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 48.2 m 60.87 59.18 2.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.2 0.524 . . . . 0.0 109.651 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -43.72 97.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.981 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -115.39 -174.22 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -55.78 141.01 66.98 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.896 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.7 Cg_endo -50.52 -38.77 54.94 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.149 1.9 . . . . 0.0 111.745 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.99 -35.26 80.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.15 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.674 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 79.8 mt-30 -85.41 -4.9 59.3 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.703 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 5.0 mmm -108.1 -5.15 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.201 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 68.6 mt-10 -62.54 -48.4 79.67 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.204 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -79.97 115.88 19.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 66' ' ' THR . 32.8 m -108.65 29.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.158 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -139.52 82.96 1.91 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.836 -179.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -146.12 123.67 11.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.57 ' HA ' HD21 ' A' ' 62' ' ' ASN . 21.3 m-85 -132.85 157.3 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.173 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.551 HD21 ' HG2' ' A' ' 112' ' ' PRO . 28.7 tp -145.86 83.69 8.61 Favored Pre-proline 0 N--CA 1.462 0.159 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.36 -44.32 20.55 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 123.078 2.519 . . . . 0.0 113.674 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.3 m-20 -59.07 -25.21 63.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 91' ' ' ILE . . . -51.29 -33.39 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.012 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.411 ' O ' ' OG ' ' A' ' 93' ' ' SER . 12.2 t80 -64.23 -40.23 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.807 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -66.12 -38.25 87.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.052 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 88' ' ' ALA . 90.4 mt -57.93 -53.66 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.867 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.418 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 95.3 mmm -66.62 -34.25 77.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.023 0.439 . . . . 0.0 110.571 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.561 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.4 m -59.54 -48.61 80.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.69 -37.23 82.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.596 ' HE ' HG22 ' A' ' 104' ' ' VAL . 53.9 mtp85 -72.8 -34.44 66.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.413 -178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.524 ' SG ' HD12 ' A' ' 48' ' ' LEU . 26.2 m -113.44 -15.26 12.64 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.561 ' CG ' ' O ' ' A' ' 93' ' ' SER . 74.4 m-20 -58.65 132.25 53.28 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.127 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 68.47 13.37 8.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.764 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -111.4 143.05 42.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.324 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.3 m -70.42 -32.94 70.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.541 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -149.79 150.03 31.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.863 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.3 p -153.41 138.62 17.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.924 0.393 . . . . 0.0 111.052 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.1 t -116.75 131.31 69.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.661 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.596 HG22 ' HE ' ' A' ' 95' ' ' ARG . 39.7 t -139.39 149.51 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.506 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.495 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.3 t -87.13 117.68 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.59 36.02 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.209 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.44 -125.4 0.92 Allowed Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 30.77 -157.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.792 0.329 . . . . 0.0 111.214 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.92 -9.26 3.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.523 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.78 60.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.674 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 112' ' ' PRO . 53.3 m-85 -141.48 132.75 13.41 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.887 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.551 ' HG2' HD21 ' A' ' 85' ' ' LEU . 33.1 Cg_exo -49.58 -157.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.937 2.425 . . . . 0.0 112.584 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.22 87.99 22.12 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.633 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.23 -43.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.288 2.659 . . . . 0.0 113.544 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.483 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -135.72 85.54 30.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.151 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.87 136.49 27.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.263 1.975 . . . . 0.0 111.746 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.57 -1.34 36.75 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.271 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 77' ' ' GLN . 35.2 m -122.18 146.71 46.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.22 0.51 . . . . 0.0 109.92 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 17.7 t80 -85.94 98.88 11.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 14.6 mttt -73.9 -161.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.76 1.267 . . . . 0.0 113.669 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.0 p90 -169.9 168.62 8.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.281 176.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 62' ' ' ASN . 21.9 tp -130.8 126.69 36.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.542 ' HG2' HE21 ' A' ' 125' ' ' GLN . 76.5 tt0 -119.84 128.9 54.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.4 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.448 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.5 t -130.27 121.3 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.111 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.542 HE21 ' HG2' ' A' ' 123' ' ' GLU . 3.6 mt-30 -107.96 125.91 52.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.805 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.6 p90 -151.9 165.69 33.79 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.133 -177.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.3 OUTLIER -120.59 159.03 26.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.997 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.7 m -110.25 118.13 35.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 m -116.17 152.38 47.76 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.377 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.303 -1.85 0 C-N-CA 121.812 1.675 . . . . 0.0 110.668 179.225 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.515 HH11 ' HG3' ' A' ' 36' ' ' ARG . 57.1 mtt85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.653 0.263 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.645 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 2.2 ttt-85 -150.8 141.01 22.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.377 0.608 . . . . 0.0 112.1 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.603 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 35.5 mt-10 -132.44 145.09 50.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.342 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -138.65 139.07 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.904 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.97 145.38 39.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.234 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.6 m -70.1 137.45 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.484 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -43.09 132.78 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.279 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.04 75.52 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.959 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.84 154.29 49.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 118.878 1.339 . . . . 0.0 110.751 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.8 142.79 44.18 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.699 2.266 . . . . 0.0 113.359 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.7 tt -115.97 149.9 18.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.603 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 81.0 tt0 -132.36 126.04 32.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.246 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.609 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.2 mt -113.58 143.68 44.15 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.593 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 64.7 mtt180 -149.67 132.02 15.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.397 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -99.9 140.27 21.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.966 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.1 Cg_endo -66.41 163.83 30.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.658 2.238 . . . . 0.0 112.915 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.28 -121.55 14.66 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.478 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 p -122.98 26.01 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 0.0 110.066 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.7 169.75 17.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.232 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.88 143.96 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.084 0.469 . . . . 0.0 110.696 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.746 HG23 ' CD2' ' A' ' 126' ' ' TYR . 69.3 mt -68.4 138.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.143 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.7 ptm -132.43 103.14 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.82 125.67 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.345 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -100.46 -50.18 3.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.625 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -150.57 148.35 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.402 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.608 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.85 155.74 10.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.498 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.1 t30 -152.54 151.5 30.76 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.187 0.518 . . . . 0.0 112.188 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.509 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 33.6 t80 -121.48 122.86 40.68 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.56 -141.17 7.85 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -176.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.702 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.2 ttm-85 -151.36 114.77 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.666 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.533 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 11.8 p -120.48 6.13 10.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.865 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 41.2 t0 -144.75 -170.82 3.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.613 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' O ' ' CE ' ' A' ' 78' ' ' MET . 35.0 p30 -146.24 -2.74 0.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.968 0.413 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.403 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 52.7 mtpt -103.91 9.38 36.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.122 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.33 136.33 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.8 m 54.28 70.9 0.56 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -51.53 118.82 3.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.721 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.78 -163.28 1.44 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.246 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.719 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -61.93 136.79 95.22 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.302 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.8 Cg_endo -57.1 -34.31 97.47 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.787 1.658 . . . . 0.0 112.251 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -61.62 -35.98 79.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.417 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.88 ' O ' HG23 ' A' ' 118' ' ' THR . 82.1 mt-30 -82.13 -18.56 42.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.655 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 3.7 mtm -98.8 0.38 44.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.845 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 73.9 mt-10 -64.49 -51.32 63.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.264 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -79.32 110.98 15.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.064 0.459 . . . . 0.0 111.37 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.44 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 11.0 m -103.68 33.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.38 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 22.7 mm100 -138.43 83.97 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.258 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.419 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 41.8 t -147.95 121.86 9.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.498 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.1 m-85 -130.17 156.6 44.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.921 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.552 HD21 ' HD2' ' A' ' 112' ' ' PRO . 21.6 tp -144.19 86.49 8.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.468 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.49 -46.8 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.904 2.403 . . . . 0.0 113.68 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.0 m-20 -54.11 -30.22 47.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.891 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.81 -31.2 37.55 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.574 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -64.12 -41.38 97.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.562 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 1.3 pttp -67.87 -39.73 83.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.078 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.562 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 52.8 mt -60.23 -49.85 82.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.418 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 95.0 mmm -69.94 -39.04 76.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.656 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 50.3 m -60.43 -44.45 95.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.572 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 77.4 mt-30 -64.79 -37.21 86.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.803 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.491 ' C ' ' NH1' ' A' ' 99' ' ' ARG . 67.6 mtt180 -78.69 -31.36 46.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 48' ' ' LEU . 51.6 m -111.27 -13.41 13.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.7 m-20 -64.45 131.11 46.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 67.26 13.79 9.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.605 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.491 ' NH1' ' C ' ' A' ' 95' ' ' ARG . 61.4 mtt85 -113.38 146.07 40.08 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.295 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -70.22 -31.5 68.95 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.92 157.78 42.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.171 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.609 ' SG ' HD12 ' A' ' 48' ' ' LEU . 29.8 p -155.48 138.5 15.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.477 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 61.5 t -123.75 130.03 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.7 146.97 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 112.078 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.8 t -79.69 119.49 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.84 39.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.82 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.6 -142.62 5.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.249 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.3 t 47.12 -151.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 111.542 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.69 -9.5 20.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.961 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.487 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -76.24 -14.48 60.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.434 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.652 ' O ' ' O ' ' A' ' 112' ' ' PRO . 95.5 m-85 -143.87 128.51 9.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.821 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 111' ' ' PHE . 53.4 Cg_exo -45.79 -157.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.662 2.241 . . . . 0.0 112.019 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -137.84 92.58 12.71 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.148 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.52 -42.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.3 2.667 . . . . 0.0 113.397 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.473 ' SG ' ' HE3' ' A' ' 120' ' ' LYS . 1.3 p -136.86 74.83 50.31 Favored Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.256 0.551 . . . . 0.0 112.404 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.75 135.13 47.08 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.114 1.876 . . . . 0.0 110.703 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.85 -6.87 52.31 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 77' ' ' GLN . 99.3 m -114.35 147.09 39.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.702 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.2 t80 -86.46 96.34 10.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.509 ' HD2' ' CZ ' ' A' ' 63' ' ' TYR . 36.1 mttp -72.07 -156.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.497 1.142 . . . . 0.0 112.846 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.632 ' HB2' HD21 ' A' ' 39' ' ' LEU . 10.1 p90 -175.41 172.68 2.63 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.356 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 21.5 tp -130.97 122.69 27.33 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.645 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 45.1 tt0 -119.09 130.5 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.608 HG22 ' HB1' ' A' ' 61' ' ' ALA . 65.4 t -134.5 124.39 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 119.639 -0.824 . . . . 0.0 112.325 -178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.17 131.38 55.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.301 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.746 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.0 p90 -154.74 173.69 16.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.632 0.73 . . . . 0.0 112.374 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -131.71 162.61 30.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.965 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 83.4 m -111.27 117.61 33.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.679 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.8 m -119.57 156.22 53.68 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.78 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo . . . . . 0 N--CA 1.492 1.434 0 C-N-CA 122.226 1.951 . . . . 0.0 111.785 179.153 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 126' ' ' TYR . 42.7 mmm-85 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.632 HH21 ' CD ' ' A' ' 123' ' ' GLU . 70.4 ttt-85 -144.95 132.57 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.464 0.65 . . . . 0.0 111.46 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -133.63 144.32 49.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.409 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.0 tt -143.39 132.94 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.794 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.703 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.96 150.98 45.15 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.725 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.36 132.44 47.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.591 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 11.1 tt0 -42.43 141.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.458 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 88.65 -4.6 85.07 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.215 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -117.32 153.19 49.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 118.463 1.131 . . . . 0.0 110.857 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -68.11 137.65 41.34 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 tt -119.89 138.02 51.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.59 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.1 tt0 -122.37 131.97 54.15 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.311 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' A' ' 126' ' ' TYR . 8.9 mt -108.75 144.93 35.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.269 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.59 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 30.5 mtt85 -149.24 132.12 16.11 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.706 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -100.8 147.14 33.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.25 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.59 159.01 28.67 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.37 2.047 . . . . 0.0 111.96 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.43 -137.42 38.36 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 121.321 0.4 . . . . 0.0 112.668 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.2 p -102.64 24.14 10.96 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.674 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.65 166.06 22.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.9 142.76 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.849 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.875 HG23 ' CD2' ' A' ' 126' ' ' TYR . 88.3 mt -67.67 138.73 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.077 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.41 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.8 ptp -135.59 100.88 4.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.406 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.91 124.61 15.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.399 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.586 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.48 -51.38 3.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.419 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.586 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 28.4 m-20 -148.28 145.75 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.67 ' CB ' HG22 ' A' ' 124' ' ' VAL . . . -166.92 155.04 9.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.761 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' HD12 ' A' ' 122' ' ' LEU . 10.5 t30 -153.78 154.58 34.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.241 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.591 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 85.4 t80 -120.07 122.64 41.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.19 7.62 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.04 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.758 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 13.7 ttm180 -156.89 116.23 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.419 HG21 ' CE2' ' A' ' 84' ' ' TYR . 7.6 p -124.53 8.73 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 57.9 t0 -147.35 157.6 43.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.506 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.587 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p-10 -114.18 0.2 14.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -102.22 6.57 40.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.25 135.29 50.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 110.16 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 60.63 61.27 1.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.228 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.626 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.6 p30 -41.3 104.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.583 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -124.28 -164.69 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.96 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.47 145.09 98.58 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.694 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.8 Cg_endo -55.3 -37.96 94.12 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.239 1.959 . . . . 0.0 112.714 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.51 -32.88 74.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.784 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.682 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 82.2 mt-30 -85.71 -11.39 53.81 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.797 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.758 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 3.1 mmt -100.74 -4.89 27.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.647 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 83.8 mt-10 -61.06 -56.2 23.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -79.42 118.02 20.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.433 0.635 . . . . 0.0 112.65 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.605 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.9 m -109.24 28.9 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.676 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.605 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.7 mm-40 -141.71 87.13 2.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.5 t -145.51 120.22 9.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.477 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.6 m-85 -127.93 155.72 43.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 112.007 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.528 HD21 ' HG2' ' A' ' 112' ' ' PRO . 13.1 tp -148.34 91.89 4.67 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.166 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.54 -46.6 28.74 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.151 1.9 . . . . 0.0 112.868 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 74.5 m-20 -50.05 -31.29 12.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.38 -31.98 36.43 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.597 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -64.48 -47.88 77.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.584 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 2.0 ptpp? -64.02 -41.56 97.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.502 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 98.0 mt -59.97 -48.9 86.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.865 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 1.038 ' SD ' HD21 ' A' ' 122' ' ' LEU . 63.1 mtp -69.87 -32.47 70.84 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.292 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.431 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 19.8 m -59.93 -45.89 91.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.627 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.61 -38.97 88.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.45 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -73.84 -37.29 64.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.4 m -113.54 -22.34 10.36 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 50.9 m-20 -55.3 140.55 38.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 69.95 12.94 7.93 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.157 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 99' ' ' ARG . 51.0 mtt85 -113.22 145.27 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.329 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.5 m -71.64 -28.83 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.58 155.31 42.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.547 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.81 143.97 26.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.113 0.483 . . . . 0.0 111.066 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.07 125.87 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.623 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -143.06 144.24 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.693 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.608 ' C ' ' H ' ' A' ' 107' ' ' GLY . 8.3 t -79.45 121.6 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.385 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -67.06 26.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.641 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . -178.94 172.13 44.31 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.028 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 4.3 t 97.26 -156.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 110.217 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.62 -10.71 38.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.176 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.35 -21.47 58.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.9 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.8 m-85 -138.27 125.95 13.72 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.744 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.3 Cg_exo -46.29 -155.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.764 2.31 . . . . 0.0 112.688 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -138.02 92.07 12.76 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.18 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -73.95 -54.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.531 2.154 . . . . 0.0 112.988 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.73 89.33 17.97 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.986 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.11 141.58 94.28 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.609 2.206 . . . . 0.0 111.64 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.92 4.99 57.63 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.749 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 77' ' ' GLN . 58.1 m -126.48 146.55 50.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.658 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 9.4 t80 -87.93 97.66 11.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 4.9 mtmp? -79.61 -158.96 0.18 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.644 1.212 . . . . 0.0 113.679 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.442 ' H ' ' HB3' ' A' ' 120' ' ' LYS . 9.8 p90 -172.44 175.56 3.53 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.543 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.038 HD21 ' SD ' ' A' ' 92' ' ' MET . 19.5 tp -132.17 124.17 28.5 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.477 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.632 ' CD ' HH21 ' A' ' 37' ' ' ARG . 78.6 tt0 -117.77 130.44 56.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.736 HG21 ' SD ' ' A' ' 92' ' ' MET . 97.2 t -134.4 123.4 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.013 -1.075 . . . . 0.0 113.113 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.514 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -110.98 128.32 55.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.071 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.875 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.3 p90 -152.29 168.71 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 111.842 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 57' ' ' MET . 86.2 m-20 -119.35 160.35 22.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.5 m -112.51 128.07 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.53 155.45 80.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.69 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo . . . . . 0 N--CA 1.491 1.365 0 C-N-CA 122.182 1.921 . . . . 0.0 112.12 178.89 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.85 0.357 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -149.56 132.54 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.372 0.606 . . . . 0.0 111.158 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.0 mp0 -129.17 146.79 51.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.615 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -142.24 139.64 32.02 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.985 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.836 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.94 146.53 37.49 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.265 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.5 m -68.28 129.92 41.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.201 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 77.0 tt0 -45.41 142.53 2.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.99 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.412 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 93.11 -12.96 68.8 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.554 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.5 m-85 -115.74 149.97 44.03 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 118.256 1.028 . . . . 0.0 110.084 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.73 143.46 61.84 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.551 2.167 . . . . 0.0 113.439 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.3 tt -115.67 149.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.664 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.4 tt0 -129.2 128.97 44.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.494 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.558 HD12 ' SG ' ' A' ' 102' ' ' CYS . 38.4 mt -115.36 143.62 45.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.919 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 74.3 mtt180 -150.01 129.55 13.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.073 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.8 m -97.55 145.4 29.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.9 Cg_endo -69.04 158.91 56.07 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.609 2.206 . . . . 0.0 112.654 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.28 -130.74 25.08 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.328 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -107.33 22.29 16.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.819 -0.69 . . . . 0.0 111.232 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.12 168.96 19.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.447 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.89 147.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.232 0.539 . . . . 0.0 110.271 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.675 HG23 ' CD1' ' A' ' 126' ' ' TYR . 79.5 mt -68.96 136.09 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.553 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.433 ' CE ' HG11 ' A' ' 129' ' ' VAL . 3.4 ptp -130.18 99.54 5.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 176.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.619 HG12 ' CE1' ' A' ' 89' ' ' PHE . 61.2 t -64.07 125.93 21.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.724 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.49 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 78.2 mm-40 -101.07 -51.43 3.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.742 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 25.3 m-20 -149.67 148.64 29.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.224 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.84 152.42 11.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.983 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' HD12 ' A' ' 122' ' ' LEU . 9.8 t30 -150.4 149.34 29.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.222 0.534 . . . . 0.0 111.706 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.496 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 81.9 t80 -118.53 122.52 42.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 0.0 108.839 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 157.26 -140.69 7.29 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.35 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.527 HH12 ' HB3' ' A' ' 119' ' ' TYR . 10.2 ttm180 -153.5 115.44 4.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.172 0.51 . . . . 0.0 110.603 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 p -121.59 7.38 10.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.356 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -150.01 157.18 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.886 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 44.2 p30 -113.74 4.29 15.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.706 0.289 . . . . 0.0 110.39 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 91.9 mttt -104.47 7.22 35.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.626 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.6 mm -113.87 138.17 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.883 0.373 . . . . 0.0 110.722 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.3 m 54.18 70.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.0 p30 -47.82 120.3 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 111.739 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -137.89 -165.14 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.011 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.605 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 1.9 p-10 -67.97 143.54 96.35 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.23 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -51.43 -36.31 58.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.264 1.976 . . . . 0.0 112.062 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.412 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 6.5 m-85 -65.99 -41.36 91.19 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.482 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 31.7 mt-30 -86.96 -2.32 58.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.343 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.1 mtp -110.02 -6.76 15.06 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.777 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.23 -45.43 84.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.124 -0.63 . . . . 0.0 112.129 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 54.9 t30 -76.81 116.25 17.31 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.918 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.553 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 32.2 m -109.27 30.83 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -141.38 86.56 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.404 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 54.0 t -145.75 120.01 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.512 ' HA ' HD21 ' A' ' 62' ' ' ASN . 72.1 m-85 -132.43 154.69 49.6 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.124 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.6 HD21 ' HG2' ' A' ' 112' ' ' PRO . 65.1 tp -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.7 -48.6 13.67 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.275 2.65 . . . . 0.0 113.54 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 94.7 m-20 -58.25 -20.95 46.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.726 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.17 -36.05 60.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.729 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.619 ' CE1' HG12 ' A' ' 58' ' ' VAL . 51.7 t80 -64.33 -40.39 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.075 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 7.9 pttp -64.3 -40.68 96.43 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.367 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.426 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.7 mt -60.32 -47.9 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.637 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.8 mmm -69.32 -38.83 78.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.529 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 3.7 m -60.82 -43.4 98.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.784 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -66.45 -37.68 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 111.607 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HE ' HG23 ' A' ' 91' ' ' ILE . 90.4 mtt-85 -75.52 -33.14 60.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.4 m -113.15 -16.22 12.62 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.545 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.2 m-20 -59.51 137.23 58.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.98 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 65.64 14.72 9.68 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.934 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -119.46 149.47 41.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.47 -32.91 68.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.353 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.2 156.92 38.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.2 p -154.8 150.52 27.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.238 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.53 128.99 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 46' ' ' ILE . 44.9 t -143.61 143.7 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.949 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.07 118.46 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -72.56 43.75 0.11 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.54 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.87 -127.37 1.11 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.493 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' GLY . 47.2 t 29.43 -153.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.406 . . . . 0.0 110.982 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.515 ' N ' ' OG ' ' A' ' 108' ' ' SER . 14.0 m-20 -64.79 -9.86 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.3 -13.16 59.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.739 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.0 m-85 -139.34 126.45 12.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.6 ' HG2' HD21 ' A' ' 85' ' ' LEU . 22.5 Cg_exo -51.14 -155.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.443 2.095 . . . . 0.0 111.581 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -136.58 89.44 18.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.639 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.6 -26.62 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 22.2 p -158.53 97.13 1.78 Allowed Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.402 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.27 138.84 22.9 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.714 2.276 . . . . 0.0 113.058 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.37 57.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.765 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.3 m -118.37 145.78 44.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.527 ' HB3' HH12 ' A' ' 65' ' ' ARG . 7.9 t80 -88.15 98.69 11.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.496 ' HD2' ' CZ ' ' A' ' 63' ' ' TYR . 27.1 mttt -72.76 -156.57 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.679 1.228 . . . . 0.0 113.309 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.582 ' HB2' HD21 ' A' ' 39' ' ' LEU . 5.3 p90 -174.86 172.54 2.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.138 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.9 tp -130.56 122.52 27.69 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.472 ' HG2' HE21 ' A' ' 125' ' ' GLN . 74.4 tt0 -117.38 128.76 55.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.638 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.9 t -134.49 122.54 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.762 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.472 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.0 mt-30 -111.24 129.81 55.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.675 ' CD1' HG23 ' A' ' 56' ' ' ILE . 41.3 p90 -155.43 173.88 16.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.137 0.494 . . . . 0.0 111.953 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 57' ' ' MET . 29.9 m-20 -127.67 163.46 24.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.534 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.469 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.6 m -114.07 108.99 17.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.453 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.433 HG11 ' CE ' ' A' ' 57' ' ' MET . 1.5 m -113.6 167.52 9.26 Favored Pre-proline 0 N--CA 1.465 0.311 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo . . . . . 0 N--CA 1.489 1.236 0 C-N-CA 122.217 1.944 . . . . 0.0 112.407 -179.574 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' NH2' ' HG2' ' A' ' 125' ' ' GLN . 42.4 ttm105 -147.36 136.39 22.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.497 0.665 . . . . 0.0 111.472 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.63 ' HG3' HD23 ' A' ' 48' ' ' LEU . 68.4 mm-40 -128.69 142.71 50.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.025 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -139.76 135.32 32.97 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.629 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.97 148.22 35.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.417 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 m -69.89 134.36 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.744 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 22.5 tt0 -42.68 137.69 2.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.81 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.45 -4.69 80.22 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.53 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.47 150.53 46.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 118.585 1.193 . . . . 0.0 109.997 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.37 142.04 36.38 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 38' ' ' GLU . 17.5 tt -118.37 147.12 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -127.11 129.84 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.346 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.757 HD12 ' SG ' ' A' ' 96' ' ' CYS . 19.6 mt -115.04 142.47 46.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -148.45 135.34 20.0 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.473 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.521 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.23 140.42 21.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.746 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.3 Cg_endo -70.39 159.41 53.04 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.477 2.118 . . . . 0.0 111.948 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.78 -138.67 33.65 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.002 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -100.56 24.79 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.117 -0.541 . . . . 0.0 111.211 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.04 164.33 24.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.301 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 m -124.97 140.88 46.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.651 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.039 HG23 ' CD2' ' A' ' 126' ' ' TYR . 67.3 mt -67.22 138.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.535 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.8 ptp -133.99 98.52 4.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.694 0.759 . . . . 0.0 109.171 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.75 125.73 20.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.988 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.48 -46.49 4.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -150.21 147.66 27.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.952 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.39 151.86 5.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.914 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 122' ' ' LEU . 2.5 t30 -149.3 151.48 34.24 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.744 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.55 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 80.8 t80 -118.12 122.78 43.95 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.88 -138.71 6.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.388 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.551 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 14.7 ttm-85 -157.86 117.63 3.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 111.329 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.484 ' CG2' ' CZ ' ' A' ' 84' ' ' TYR . 5.0 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.631 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.508 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.1 t0 -147.72 -171.74 3.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.226 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 37.3 p30 -146.17 -0.47 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 2.8 mtmp? -103.94 7.13 36.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.479 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mm -118.31 139.63 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.0 m 59.51 58.56 2.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.5 p-10 -44.52 121.48 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.19 -170.11 3.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.034 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.3 p30 -61.91 138.23 95.55 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.688 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.8 Cg_endo -49.86 -33.34 32.87 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.51 2.14 . . . . 0.0 113.322 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -63.55 -37.05 85.84 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.413 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 26.0 mt-30 -89.47 8.76 29.32 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.387 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.45 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 78.7 mtp -124.91 -1.97 7.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 69.5 mt-10 -61.61 -53.2 59.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.293 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.0 t30 -76.97 117.07 18.2 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.428 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.533 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 23.8 m -108.87 27.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.566 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 93.5 mm-40 -138.34 85.81 2.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.037 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 48.6 t -147.04 119.02 8.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CZ ' ' CG2' ' A' ' 66' ' ' THR . 83.1 m-85 -129.77 155.34 46.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.56 . . . . 0.0 111.625 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.725 HD21 ' HG2' ' A' ' 112' ' ' PRO . 26.1 tp -147.66 90.64 5.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.999 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.58 -44.26 31.04 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 113.348 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.0 m-20 -55.19 -27.4 45.65 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.62 -33.43 33.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.368 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.53 -42.81 91.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.095 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.8 pttt -64.36 -41.83 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.653 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.525 HG23 ' HE ' ' A' ' 95' ' ' ARG . 97.6 mt -59.67 -49.53 83.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.048 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.432 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 96.8 mmm -68.11 -35.4 78.08 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.767 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.477 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 66.3 m -59.58 -45.62 91.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -66.29 -35.12 79.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.584 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.525 ' HE ' HG23 ' A' ' 91' ' ' ILE . 94.2 mtt-85 -79.96 -32.85 39.92 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 48' ' ' LEU . 58.0 m -111.98 -15.87 13.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.477 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -60.62 134.32 56.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 65.03 12.62 8.06 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.649 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.09 145.6 40.62 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.329 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.4 m -70.27 -31.11 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.292 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.1 158.46 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.399 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.725 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.3 p -156.17 143.68 19.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.428 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.5 t -122.24 127.6 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.39 146.28 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.479 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -85.52 120.83 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.829 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.42 28.83 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.438 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.593 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . -179.96 179.08 48.81 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.469 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.3 t 88.86 -158.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.57 -10.65 19.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.88 58.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.82 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 39.5 m-85 -140.87 131.12 13.32 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.006 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.725 ' HG2' HD21 ' A' ' 85' ' ' LEU . 32.1 Cg_exo -49.72 -162.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.869 2.379 . . . . 0.0 112.964 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -138.16 91.6 12.85 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.452 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.56 -44.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 123.355 2.703 . . . . 0.0 113.391 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.485 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.8 p -134.99 79.4 51.27 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.9 140.5 79.88 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.024 1.816 . . . . 0.0 111.963 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.52 -2.15 58.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.293 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.432 ' CG2' ' HD2' ' A' ' 65' ' ' ARG . 51.8 m -114.76 147.71 39.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.626 0.713 . . . . 0.0 109.085 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.551 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.6 t80 -86.97 96.99 10.46 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 18.4 mtmt -76.74 -164.16 0.4 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.079 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.455 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 9.0 p90 -166.24 169.26 14.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.653 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 62' ' ' ASN . 18.2 tp -130.85 125.32 33.32 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.441 ' HG2' HE21 ' A' ' 125' ' ' GLN . 69.7 tt0 -118.74 129.06 55.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.101 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.62 HG22 ' HB1' ' A' ' 61' ' ' ALA . 80.5 t -131.93 122.98 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.619 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.465 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 2.4 mt-30 -110.34 128.98 55.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.039 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.5 p90 -151.23 163.54 38.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.324 0.583 . . . . 0.0 111.656 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 57' ' ' MET . 95.4 m-20 -115.83 158.09 23.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.317 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.446 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 96.5 m -109.69 125.6 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.34 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.31 149.7 74.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 N--CA 1.492 1.41 0 C-N-CA 122.338 2.025 . . . . 0.0 111.918 179.638 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.785 HH12 ' H ' ' A' ' 128' ' ' CYS . 82.6 mtt85 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -141.58 137.29 31.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.204 0.526 . . . . 0.0 110.851 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 44.2 mp0 -134.92 141.99 46.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -140.48 134.16 30.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.744 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.668 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.67 144.72 44.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.024 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.9 m -71.99 131.1 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.462 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 34.5 tt0 -42.95 135.96 2.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.628 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.48 -9.8 66.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.126 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.7 155.72 50.36 Favored Pre-proline 0 CA--C 1.52 -0.206 0 CA-C-N 118.963 1.382 . . . . 0.0 110.675 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.89 143.54 33.27 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.235 1.957 . . . . 0.0 113.387 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 104' ' ' VAL . 18.3 tt -116.12 145.93 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 86.6 tt0 -130.79 129.83 42.93 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.989 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.632 HD12 ' SG ' ' A' ' 102' ' ' CYS . 23.9 mt -113.79 145.72 41.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.268 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 98.4 mtt180 -150.25 136.15 18.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.167 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.451 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -104.66 138.25 19.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.119 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 12.0 Cg_endo -63.82 155.51 63.34 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.567 2.178 . . . . 0.0 112.705 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.04 -132.14 32.94 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.613 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.4 p -103.62 26.55 8.38 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -80.75 162.39 24.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.881 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -131.12 146.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.093 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.837 HG23 ' CD1' ' A' ' 126' ' ' TYR . 63.1 mt -67.04 138.11 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 111.518 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.619 ' O ' ' CG ' ' A' ' 57' ' ' MET . 10.4 ptm -130.45 98.07 4.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.567 HG12 ' HE1' ' A' ' 89' ' ' PHE . 61.0 t -65.63 125.77 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.967 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.69 -45.59 5.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -151.8 150.35 30.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.106 0.479 . . . . 0.0 110.664 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.489 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -169.08 152.16 5.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.848 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 1.2 t30 -150.39 151.8 33.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.968 0.413 . . . . 0.0 111.617 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.545 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 47.7 t80 -120.26 126.16 49.9 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.74 -137.7 5.79 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.677 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 15.7 ttm-85 -156.25 118.18 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.723 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.427 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 4.2 p -123.88 11.57 9.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.232 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.578 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.8 t0 -144.94 -170.5 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.752 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 46.5 p30 -146.49 -4.12 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.172 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -103.43 5.98 37.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 71' ' ' CYS . 32.4 mm -108.98 139.65 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.818 0.342 . . . . 0.0 110.552 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' ASP . 26.7 m 64.66 24.79 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.754 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.57 ' C ' ' O ' ' A' ' 71' ' ' CYS . 14.3 p30 -3.28 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.545 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -113.63 -167.66 1.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.704 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -62.17 145.58 93.42 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.251 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -58.99 -38.47 87.77 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.776 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -63.92 -39.62 94.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.897 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.704 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.9 mt-30 -84.83 -10.32 57.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.677 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 48.7 mmm -109.96 -2.96 16.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mt-10 -66.46 -44.36 82.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.562 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -78.26 121.27 24.19 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 67' ' ' ASP . 22.9 m -112.75 31.2 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.835 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -140.52 86.31 2.06 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.3 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.8 t -150.34 117.46 5.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 66' ' ' THR . 73.0 m-85 -127.46 157.57 39.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.908 0.385 . . . . 0.0 111.233 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 112' ' ' PRO . 40.6 tp -147.03 87.21 6.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.417 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -44.04 -46.04 11.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.504 2.136 . . . . 0.0 114.081 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.7 m-20 -54.93 -26.84 38.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.94 -33.05 35.67 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.994 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.567 ' HE1' HG12 ' A' ' 58' ' ' VAL . 57.1 t80 -66.24 -44.94 82.31 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 3.0 pttt -65.08 -40.32 94.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.42 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.465 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 83.3 mt -59.87 -49.31 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.761 ' SD ' HD21 ' A' ' 122' ' ' LEU . 74.4 mtp -72.83 -35.13 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.491 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.473 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 69.4 m -58.48 -42.69 88.12 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -66.28 -35.47 80.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 110.753 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 92.9 mtt-85 -79.14 -31.89 44.2 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 48' ' ' LEU . 57.4 m -112.68 -20.87 11.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 69.7 m-20 -60.58 134.45 57.09 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.904 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 66.04 13.8 9.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.693 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -116.68 147.98 41.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.207 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.9 m -72.05 -32.0 66.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.451 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.21 156.28 36.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.743 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.632 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.6 p -155.47 146.74 22.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 58.2 t -126.35 132.57 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.523 ' O ' HG22 ' A' ' 46' ' ' ILE . 42.9 t -143.81 139.45 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.611 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.7 t -76.48 118.76 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.99 28.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.004 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 178.2 -177.29 48.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.4 t 91.4 -162.77 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.836 0.35 . . . . 0.0 110.286 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.18 -9.24 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.24 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.44 56.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.302 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.584 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.0 m-85 -135.64 125.88 16.68 Favored Pre-proline 0 N--CA 1.455 -0.222 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.777 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 111' ' ' PHE . 27.2 Cg_exo -49.18 -158.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.518 2.145 . . . . 0.0 111.565 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -138.41 93.26 11.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -86.98 -12.82 4.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 123.185 2.59 . . . . 0.0 112.648 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.428 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -168.6 92.42 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.5 133.67 14.63 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.876 2.384 . . . . 0.0 112.828 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.03 11.52 36.79 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.887 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 77' ' ' GLN . 47.3 m -127.91 145.63 50.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 6.5 t80 -83.55 98.27 9.48 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 6.1 mtmp? -77.25 -167.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.69 1.234 . . . . 0.0 113.683 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.486 ' HB2' HD21 ' A' ' 39' ' ' LEU . 6.5 p90 -168.11 173.85 7.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.232 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.761 HD21 ' SD ' ' A' ' 92' ' ' MET . 26.4 tp -128.73 119.34 24.42 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.093 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -114.35 132.27 56.26 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.729 HG21 ' CE ' ' A' ' 92' ' ' MET . 95.1 t -131.24 149.32 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.16 127.83 28.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.837 ' CD1' HG23 ' A' ' 56' ' ' ILE . 20.8 p90 -158.73 174.33 15.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.812 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.37 158.17 36.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.696 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.785 ' H ' HH12 ' A' ' 36' ' ' ARG . 62.3 m -106.35 123.9 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.146 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 55' ' ' VAL . 4.9 m -130.54 157.4 77.65 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.502 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo . . . . . 0 N--CA 1.496 1.66 0 C-N-CA 122.361 2.04 . . . . 0.0 113.084 -179.848 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 62.5 mtp85 . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 33.0 ttp-105 -142.75 137.13 29.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.865 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.2 mp0 -137.59 144.14 41.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.528 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.775 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -139.21 139.22 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.801 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.775 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.09 142.51 34.13 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.597 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.4 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 16.6 m -71.08 135.48 47.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 84.2 tt0 -44.97 137.51 4.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.12 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.285 177.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.36 149.63 46.3 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 118.994 1.397 . . . . 0.0 110.319 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.18 146.12 68.88 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.346 2.031 . . . . 0.0 113.597 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 104' ' ' VAL . 15.2 tt -115.39 144.51 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.669 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 51.2 tt0 -121.35 128.0 51.82 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.463 -178.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.824 HD12 ' SG ' ' A' ' 102' ' ' CYS . 43.8 mt -117.79 140.32 49.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.669 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 89.5 mtt-85 -148.92 136.32 20.24 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.47 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.6 m -103.18 138.13 19.46 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.392 179.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 24.1 Cg_endo -66.54 156.01 67.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.473 2.115 . . . . 0.0 112.26 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.49 -134.67 38.11 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -103.41 25.1 10.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.503 . . . . 0.0 110.544 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.97 163.09 25.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.019 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.64 144.04 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.412 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.005 HG23 ' CD1' ' A' ' 126' ' ' TYR . 88.3 mt -68.31 137.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.114 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.4 ptm -130.9 99.04 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 t -61.46 123.37 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.585 -177.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.574 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.6 mm-40 -98.66 -50.63 4.18 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.6 m-20 -153.74 153.74 32.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.123 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.48 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.6 157.51 8.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.099 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.779 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.7 t30 -150.43 153.58 36.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.148 0.499 . . . . 0.0 111.992 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.518 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 32.1 t80 -123.35 121.09 34.93 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.59 -139.26 6.28 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.938 -177.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 6.6 ttm180 -155.5 116.72 3.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.141 0.496 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 p -124.22 10.21 8.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.973 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 37.4 t0 -145.87 -175.2 4.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.451 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 33.1 p30 -141.89 3.01 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.414 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 3.2 mtmp? -107.61 6.12 27.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.216 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.2 mm -117.81 137.85 50.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.5 m 54.47 74.91 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.767 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -53.62 125.42 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.408 0.623 . . . . 0.0 112.026 -178.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.88 -177.52 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.213 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -59.32 147.6 75.39 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.281 0.562 . . . . 0.0 110.066 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.4 Cg_endo -53.83 -38.52 85.63 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.114 1.876 . . . . 0.0 111.457 -178.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -61.44 -33.0 72.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.583 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 72.1 mt-30 -91.15 -6.2 53.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.438 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 73' ' ' ALA . 75.1 mtp -109.12 -9.1 15.06 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 40.9 mt-10 -63.89 -48.23 77.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.087 -178.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -81.21 116.83 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.536 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 20.9 m -106.66 33.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.554 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 90.6 mm-40 -141.76 86.72 2.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.2 t -145.4 118.22 8.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.411 ' HA ' HD21 ' A' ' 62' ' ' ASN . 94.3 m-85 -129.08 154.82 46.31 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.579 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.436 HD21 ' HD2' ' A' ' 112' ' ' PRO . 26.8 tp -147.16 89.2 5.62 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.26 -46.98 13.22 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 123.555 2.837 . . . . 0.0 115.094 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.5 m-20 -60.86 -14.03 19.4 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 62' ' ' ASN . . . -52.87 -36.34 59.0 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.358 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -64.56 -43.52 93.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.307 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.03 -42.18 99.71 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.723 -178.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.604 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 44.2 mt -60.27 -50.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.69 0.281 . . . . 0.0 111.305 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.456 ' SD ' HD21 ' A' ' 122' ' ' LEU . 83.6 mmm -66.98 -35.26 79.56 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.617 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.482 ' HB3' HD21 ' A' ' 97' ' ' ASN . 69.9 m -60.63 -48.59 81.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.74 -38.85 87.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.051 0.453 . . . . 0.0 111.355 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.604 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 83.9 mtt-85 -74.21 -34.23 63.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.588 ' SG ' HD12 ' A' ' 48' ' ' LEU . 56.4 m -112.62 -16.31 12.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -60.57 138.56 58.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.929 -0.709 . . . . 0.0 112.495 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 62.03 13.4 5.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.979 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -116.23 146.66 42.17 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.453 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -73.52 -28.0 61.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.825 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.489 HE21 ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -153.03 153.59 33.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.135 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.824 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.1 p -154.02 141.99 20.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.619 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.63 128.77 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.355 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 46' ' ' ILE . 45.3 t -139.42 141.36 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.082 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.615 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -80.8 119.76 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -64.89 28.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.982 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 176.58 -175.97 47.72 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 90.01 -159.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.524 . . . . 0.0 110.61 179.407 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -62.49 -9.5 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.751 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.409 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -79.61 -18.37 51.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.553 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -140.88 129.92 12.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.434 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.553 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.8 Cg_exo -49.99 -153.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.267 1.978 . . . . 0.0 112.46 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -140.88 91.02 9.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.275 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 73.3 Cg_endo -81.58 -28.61 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.656 2.237 . . . . 0.0 113.031 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.446 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.8 p -146.11 77.22 12.04 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.07 131.97 49.16 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.244 1.962 . . . . 0.0 111.585 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.63 3.64 58.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.771 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 77' ' ' GLN . 93.2 m -116.95 145.95 43.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.19 0.995 . . . . 0.0 109.519 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.707 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 11.5 t80 -88.22 96.85 10.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.518 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 26.2 mttt -76.32 -161.8 0.2 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.488 -177.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 14.2 p90 -170.69 172.42 5.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.69 176.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 62' ' ' ASN . 61.5 tp -129.59 124.44 33.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -116.86 128.9 55.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.941 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.48 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.0 t -132.17 120.57 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 119.463 -0.895 . . . . 0.0 113.096 -178.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -106.97 123.99 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.005 ' CD1' HG23 ' A' ' 56' ' ' ILE . 17.5 p90 -154.08 174.88 14.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.555 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.627 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.4 OUTLIER -127.7 159.98 33.07 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.597 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.432 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 83.7 m -108.93 115.04 29.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.1 m -115.73 155.49 47.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo . . . . . 0 C--N 1.31 -1.465 0 C-N-CA 121.911 1.741 . . . . 0.0 112.224 -179.929 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.785 0.326 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.73 137.1 23.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.333 0.587 . . . . 0.0 111.69 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.3 mp0 -135.25 146.16 48.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.785 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.407 179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.662 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.63 148.61 44.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.176 0.513 . . . . 0.0 111.116 -179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.8 m -70.56 133.31 46.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.918 -178.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 5.8 tt0 -44.96 139.12 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.471 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -9.89 73.9 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.924 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -117.45 150.46 46.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 118.415 1.107 . . . . 0.0 110.555 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 138.56 55.82 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.584 2.19 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 tt -113.62 145.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -124.42 128.77 49.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.234 -178.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.514 HD12 ' SG ' ' A' ' 96' ' ' CYS . 50.3 mt -113.99 142.4 46.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.707 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -152.23 137.03 17.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.5 -178.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.82 149.74 36.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.916 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.4 Cg_endo -72.38 159.36 49.54 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.691 2.261 . . . . 0.0 112.757 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.87 -118.04 6.73 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.264 178.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -125.85 24.12 7.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -75.54 171.2 14.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.98 149.09 29.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.495 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.964 HG23 ' CD1' ' A' ' 126' ' ' TYR . 66.1 mt -73.45 138.87 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.623 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.7 ptm -133.29 100.24 4.78 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.524 HG12 ' HE1' ' A' ' 89' ' ' PHE . 59.7 t -63.12 124.12 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.853 -178.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 84.0 mt-10 -102.62 -45.71 4.96 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.5 m-20 -150.64 148.74 28.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.0 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.621 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.41 152.41 7.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.946 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.463 HD21 ' HA ' ' A' ' 84' ' ' TYR . 5.3 t30 -149.76 150.19 31.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.149 0.5 . . . . 0.0 111.509 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.575 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 57.4 t80 -120.74 122.39 40.3 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.48 -137.35 5.43 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.76 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 11.1 ttm-85 -154.69 119.47 4.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.959 0.409 . . . . 0.0 111.473 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.582 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 10.5 p -123.4 7.53 9.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.807 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 61.9 t0 -148.76 154.87 40.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.901 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p-10 -112.18 3.56 17.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 110.521 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -109.2 9.39 26.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.323 -178.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 mm -112.76 137.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.4 m 54.73 73.03 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.397 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.12 120.12 6.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.787 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -136.87 -164.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.577 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -64.32 138.2 97.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 7.2 Cg_endo -54.24 -31.99 68.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.968 1.779 . . . . 0.0 111.929 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -62.36 -41.89 98.97 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 118' ' ' THR . 29.0 mt-30 -92.45 -2.98 55.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.889 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.76 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 51.4 mmm -115.29 -4.1 12.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.111 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mm-40 -69.49 -38.85 77.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.063 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -76.07 124.13 26.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.599 -178.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.73 29.47 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -139.34 85.65 2.07 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.411 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.462 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.4 t -147.66 124.5 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.463 ' HA ' HD21 ' A' ' 62' ' ' ASN . 94.0 m-85 -134.2 155.63 49.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.276 0.56 . . . . 0.0 111.752 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 112' ' ' PRO . 52.0 tp -147.17 95.5 4.39 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.962 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.17 -47.6 26.61 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.582 2.188 . . . . 0.0 113.568 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 90.0 m-20 -54.38 -21.6 10.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.837 -178.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.4 65.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.431 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' HE1' HG12 ' A' ' 58' ' ' VAL . 59.1 t80 -65.06 -40.95 95.44 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.4 pttp -65.13 -38.2 89.89 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 64.4 mt -61.3 -51.57 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.5 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.867 ' SD ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.41 -34.5 76.11 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.864 -178.867 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.5 m -61.02 -47.42 86.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.5 -35.97 80.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.622 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 94.9 mtt-85 -77.35 -35.02 55.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -177.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 48' ' ' LEU . 57.5 m -112.67 -15.69 12.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -177.14 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.6 m-20 -60.59 139.28 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.03 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 65.45 12.82 8.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.631 178.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -117.32 147.75 42.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.278 0.561 . . . . 0.0 110.915 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 m -72.78 -31.78 65.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.927 179.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -152.75 155.92 38.11 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.168 179.439 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 48' ' ' LEU . 30.2 p -155.01 144.8 21.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.846 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.4 125.12 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.161 178.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 t -140.35 142.55 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.867 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 107' ' ' GLY . 2.6 t -70.81 119.94 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.161 179.066 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -66.73 39.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.879 -178.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.32 -121.82 0.78 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.007 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 29.52 -155.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.439 0.637 . . . . 0.0 111.137 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -64.82 -11.55 38.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.49 60.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.859 -178.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 68.1 m-85 -144.52 129.46 9.33 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.012 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 49.2 Cg_exo -46.65 -159.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.558 2.172 . . . . 0.0 112.943 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -138.81 90.35 12.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.67 -53.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.152 2.568 . . . . 0.0 113.18 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -125.35 76.85 68.62 Favored Pre-proline 0 C--O 1.238 0.476 0 CA-C-O 121.181 0.515 . . . . 0.0 111.598 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.07 131.98 34.81 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.705 1.604 . . . . 0.0 111.469 179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.05 -11.27 34.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.227 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 77' ' ' GLN . 79.6 m -110.05 149.2 30.35 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.4 t80 -85.19 97.8 10.11 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.509 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 16.8 mtmt -72.09 -169.8 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 123.131 1.443 . . . . 0.0 114.572 -177.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.582 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.6 p90 -164.21 165.91 21.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 112.014 -2.357 . . . . 0.0 110.317 176.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.732 HD21 ' SD ' ' A' ' 92' ' ' MET . 43.1 tp -126.8 123.05 36.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.614 ' OE2' ' NE2' ' A' ' 125' ' ' GLN . 43.2 tt0 -120.4 126.72 51.16 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.561 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.867 HG21 ' SD ' ' A' ' 92' ' ' MET . 37.3 t -133.07 126.78 53.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.474 -178.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.614 ' NE2' ' OE2' ' A' ' 123' ' ' GLU . 3.1 mp0 -114.09 131.49 56.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.964 ' CD1' HG23 ' A' ' 56' ' ' ILE . 27.9 p90 -153.84 169.18 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 112.007 -178.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -122.72 162.03 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.76 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.477 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.4 m -109.26 131.96 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.23 161.71 59.51 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.593 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 N--CA 1.493 1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 112.828 -179.097 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.562 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 65.4 mtt85 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.498 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 39.2 ttp180 -147.03 139.7 24.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.336 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.687 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.8 mp0 -133.11 142.37 48.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.236 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -141.44 137.42 32.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.706 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.99 149.08 36.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.691 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.7 m -68.53 131.64 45.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 48.5 tt0 -45.9 142.65 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.431 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.0 -6.9 82.87 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.761 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.94 140.64 27.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.832 0.816 . . . . 0.0 110.016 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.14 141.48 88.57 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.514 2.142 . . . . 0.0 113.606 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 38' ' ' GLU . 13.0 tt -120.01 145.09 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.63 130.37 52.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.149 0.499 . . . . 0.0 112.18 -178.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.914 HD12 ' SG ' ' A' ' 102' ' ' CYS . 16.5 mt -113.21 143.41 44.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -150.05 135.16 17.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.066 -178.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.8 m -101.81 148.71 35.68 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.723 179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 60.4 Cg_endo -73.91 157.95 46.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.134 2.556 . . . . 0.0 112.34 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.92 -128.07 32.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 p -113.85 24.53 12.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -77.65 168.26 20.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.296 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 m -126.79 147.74 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.486 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.917 HG23 ' CD1' ' A' ' 126' ' ' TYR . 92.4 mt -72.55 140.02 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.395 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptp -131.87 102.0 5.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 93' ' ' SER . 99.9 t -63.93 123.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.093 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.3 mm-40 -102.17 -50.49 3.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 46.4 m-20 -146.86 144.18 29.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.447 -179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.743 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.22 148.26 6.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.847 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 4.8 t30 -150.92 156.81 41.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.366 0.603 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.547 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 49.4 t80 -120.27 122.13 40.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.09 -143.47 9.26 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.999 -177.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.687 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.6 ttm-85 -150.63 115.79 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.383 0.611 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 84' ' ' TYR . 19.7 p -123.52 3.45 9.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.355 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.684 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 53.7 t0 -145.04 153.24 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.224 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 38.6 p30 -112.55 0.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 43.3 mttm -102.48 1.82 35.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.401 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mm -110.44 138.8 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.391 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m 56.34 70.25 0.66 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.997 -179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -54.26 121.04 7.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.82 -163.05 1.46 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.028 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.02 143.91 97.4 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.27 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.0 Cg_endo -56.74 -38.69 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.515 2.144 . . . . 0.0 113.498 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -63.77 -29.95 71.1 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.183 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.7 mt-30 -88.33 -12.86 42.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.052 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 73.0 mtp -102.97 -5.4 23.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 57.3 mm-40 -65.23 -47.33 77.18 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.453 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 45.3 t30 -78.61 111.74 15.0 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.888 -178.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.614 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.3 m -103.34 31.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.614 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 96.7 mm-40 -142.89 86.95 1.95 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.554 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.4 t -149.45 119.74 7.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.511 ' CE2' HG21 ' A' ' 66' ' ' THR . 51.2 m-85 -129.47 147.39 51.28 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.266 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.504 HD21 ' HG2' ' A' ' 112' ' ' PRO . 31.3 tp -138.31 91.97 12.34 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -50.26 -45.87 31.58 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.768 2.312 . . . . 0.0 113.319 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.6 m-20 -53.64 -30.6 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.246 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.93 54.03 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.188 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.509 ' O ' ' OG ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -65.5 -44.32 87.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.241 178.624 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.23 -41.19 97.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 -179.311 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.522 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 60.7 mt -60.69 -48.91 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.02 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.29 -36.19 81.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.918 0.389 . . . . 0.0 110.499 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 15.8 m -59.88 -45.43 92.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -65.93 -35.87 81.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.518 0.675 . . . . 0.0 110.883 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.492 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 95.1 mtt-85 -76.08 -34.25 59.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.624 ' SG ' HD12 ' A' ' 48' ' ' LEU . 33.0 m -112.42 -13.73 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' SER . 83.0 m-20 -60.77 134.59 57.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.273 0.559 . . . . 0.0 112.208 -179.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 66.37 12.73 8.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.679 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -115.8 147.72 40.67 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.281 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.9 m -74.02 -30.91 62.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.415 ' HB2' HE21 ' A' ' 101' ' ' GLN . 0.0 OUTLIER -152.03 153.19 33.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 179.938 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.914 ' SG ' HD12 ' A' ' 48' ' ' LEU . 20.3 p -154.68 139.63 17.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.4 124.58 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 105' ' ' VAL . 57.9 t -138.74 151.83 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 112.123 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.4 t -84.5 116.57 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.184 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -67.22 40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.059 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 178.3 -131.03 1.67 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.753 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t 32.75 -150.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.036 -0.582 . . . . 0.0 112.227 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.46 -11.74 36.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.698 -178.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.83 -12.33 59.77 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.613 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.0 m-85 -142.2 124.73 9.19 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.445 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -46.23 -159.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.079 2.519 . . . . 0.0 113.547 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -137.05 85.82 21.74 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.34 -34.33 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.966 2.444 . . . . 0.0 112.775 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.415 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.0 p -145.73 89.99 6.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.88 139.04 42.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.812 2.341 . . . . 0.0 112.75 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.04 15.66 47.59 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.49 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.3 m -128.93 144.65 51.24 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.687 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 11.5 t80 -89.03 97.24 11.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.164 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.547 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 16.3 mttt -74.0 -153.77 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.765 1.269 . . . . 0.0 113.034 -177.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.4 p90 -175.6 171.6 2.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.275 -2.239 . . . . 0.0 109.085 176.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 18.1 tp -127.49 120.38 28.18 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.541 ' HG2' HE21 ' A' ' 125' ' ' GLN . 80.8 tt0 -113.11 125.65 54.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.743 HG22 ' HB1' ' A' ' 61' ' ' ALA . 74.1 t -135.75 124.79 39.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.202 -178.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.541 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.9 mp0 -113.68 130.62 56.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.069 179.026 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.917 ' CD1' HG23 ' A' ' 56' ' ' ILE . 37.8 p90 -154.47 173.36 16.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 111.454 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.458 ' HA ' HH11 ' A' ' 36' ' ' ARG . 88.3 m-20 -127.51 161.72 28.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.562 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.5 m -109.49 117.54 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.262 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.07 158.19 61.35 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.921 -179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 N--CA 1.496 1.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.164 -179.723 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 66.0 mtp85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.576 ' NH2' ' OE2' ' A' ' 123' ' ' GLU . 74.6 ttt180 -147.77 131.81 17.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.686 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.613 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 46.4 mt-10 -132.54 145.62 51.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.045 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.1 tt -141.12 141.94 34.14 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.843 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.49 146.23 36.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.468 -178.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.34 130.0 41.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.973 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -40.39 136.13 1.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.45 83.7 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.111 -0.949 . . . . 0.0 114.173 177.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -117.8 148.18 42.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 118.994 1.397 . . . . 0.0 111.074 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.03 137.68 63.41 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.518 2.145 . . . . 0.0 113.32 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.4 143.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.71 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 44.7 tt0 -131.24 127.18 37.31 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.554 -178.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 102' ' ' CYS . 16.1 mt -108.7 144.58 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.164 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.71 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 93.3 mtt-85 -149.15 127.22 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.274 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -95.78 141.57 23.35 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.704 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 15.3 Cg_endo -66.6 158.7 54.47 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.031 1.821 . . . . 0.0 112.245 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.66 -134.28 34.75 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.427 0.459 . . . . 0.0 112.946 178.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.4 p -104.81 22.62 14.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.94 -0.63 . . . . 0.0 110.913 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -75.91 166.62 23.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.743 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 m -126.98 144.87 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.521 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.837 HG23 ' CD2' ' A' ' 126' ' ' TYR . 86.0 mt -70.23 136.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.143 0.497 . . . . 0.0 112.088 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.7 ptp -130.43 98.9 4.82 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.632 HG12 ' CE1' ' A' ' 89' ' ' PHE . 53.4 t -62.99 123.61 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.79 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.404 ' C ' ' CG ' ' A' ' 60' ' ' ASN . 73.4 mm-40 -99.49 -45.12 5.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' CG ' ' C ' ' A' ' 59' ' ' GLU . 2.8 m-80 -154.12 148.14 25.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.304 -179.085 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.26 152.87 11.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.885 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.739 ' O ' HD12 ' A' ' 122' ' ' LEU . 11.2 t30 -149.32 153.65 37.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.428 -179.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.492 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 61.6 t80 -125.84 125.69 43.27 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.06 -137.96 5.88 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -177.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.599 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -155.02 114.97 3.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 111.055 179.299 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.454 HG21 ' CE2' ' A' ' 84' ' ' TYR . 13.9 p -119.26 9.49 11.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.626 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 44.7 t0 -143.49 -167.12 2.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.612 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.626 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 53.9 p30 -151.83 -5.89 0.24 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 38.1 mttm -97.36 11.04 38.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.9 mm -115.03 138.56 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.939 0.4 . . . . 0.0 110.312 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m 56.92 70.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.117 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.6 p-10 -51.39 117.33 2.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.584 0.707 . . . . 0.0 111.315 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.94 -163.84 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.676 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 3.4 p30 -60.71 132.71 91.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 119.164 -1.014 . . . . 0.0 108.667 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -57.0 -27.14 72.08 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.452 2.101 . . . . 0.0 113.968 -178.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -63.88 -30.02 71.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.032 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.676 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.0 mt-30 -88.59 -5.72 57.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.516 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.599 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 6.0 mtm -110.84 -1.48 16.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.264 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 49.9 mt-10 -60.97 -52.32 65.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.963 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.98 107.76 11.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.051 -0.406 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 67' ' ' ASP . 19.6 m -101.4 31.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.33 0.586 . . . . 0.0 110.662 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -139.26 85.9 2.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.415 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 43.5 t -149.32 115.39 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.454 ' CE2' HG21 ' A' ' 66' ' ' THR . 91.1 m-85 -124.25 156.01 37.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.727 0.299 . . . . 0.0 111.221 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 112' ' ' PRO . 55.1 tp -142.69 82.02 12.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -44.91 -45.42 13.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.245 2.63 . . . . 0.0 114.256 -177.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 86.6 m-20 -57.1 -25.29 58.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.885 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.36 -34.77 49.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.576 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.632 ' CE1' HG12 ' A' ' 58' ' ' VAL . 26.7 t80 -64.1 -40.37 96.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.8 pttm -67.17 -39.25 86.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.835 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.669 HG23 ' NH1' ' A' ' 95' ' ' ARG . 69.9 mt -60.19 -52.45 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 1.063 ' SD ' HD21 ' A' ' 122' ' ' LEU . 62.1 mtp -69.68 -32.56 71.25 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.478 ' HB3' HD21 ' A' ' 97' ' ' ASN . 62.5 m -59.97 -43.37 95.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.592 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 90.4 mt-30 -66.59 -36.23 82.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.353 0.596 . . . . 0.0 110.014 178.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.669 ' NH1' HG23 ' A' ' 91' ' ' ILE . 52.9 mtt85 -77.45 -34.08 54.54 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.607 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.4 m -110.89 -16.19 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.478 HD21 ' HB3' ' A' ' 93' ' ' SER . 77.0 m-20 -61.44 133.39 55.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.804 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 66.52 13.31 9.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.592 ' NH2' ' O ' ' A' ' 94' ' ' GLN . 42.9 mtt85 -113.89 147.03 39.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.944 178.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -71.04 -31.32 67.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.623 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 156.59 35.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.102 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.3 p -153.6 142.34 21.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.29 126.25 70.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.328 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.71 146.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.855 -178.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.45 120.26 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.268 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.76 43.5 0.09 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.165 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.1 -126.72 1.03 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 29.36 -154.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.239 0.543 . . . . 0.0 112.209 179.588 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -64.43 -10.56 25.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.642 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.05 59.9 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.807 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 112' ' ' PRO . 64.4 m-85 -142.69 126.76 9.68 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.684 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.567 ' HG2' HD21 ' A' ' 85' ' ' LEU . 23.4 Cg_exo -50.1 -156.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.323 2.015 . . . . 0.0 112.436 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.459 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 20.9 t0 -139.35 93.21 10.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.411 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.49 -38.55 0.98 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.714 2.276 . . . . 0.0 113.328 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -140.25 79.08 22.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.057 0.456 . . . . 0.0 110.995 -179.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 17.2 Cg_exo -56.18 133.4 57.83 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.187 1.924 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.46 -10.9 56.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.888 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 77' ' ' GLN . 62.9 m -105.95 147.54 28.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.616 0.708 . . . . 0.0 109.104 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.593 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 t80 -84.37 97.61 9.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.492 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 22.5 mtmm -73.54 -171.65 1.05 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.457 1.599 . . . . 0.0 115.083 -177.056 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.6 p90 -164.47 167.73 19.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 111.58 -2.555 . . . . 0.0 110.579 177.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.063 HD21 ' SD ' ' A' ' 92' ' ' MET . 25.9 tp -129.33 122.56 29.78 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.576 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 83.5 tt0 -115.33 132.93 56.46 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.774 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.687 HG21 ' SD ' ' A' ' 92' ' ' MET . 41.5 t -133.33 144.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.82 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.539 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -133.26 130.44 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.837 ' CD2' HG23 ' A' ' 56' ' ' ILE . 27.9 p90 -156.09 171.62 19.82 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.138 -178.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 57' ' ' MET . 87.8 m-20 -125.5 162.22 25.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.775 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 92.4 m -108.93 125.52 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.7 m -130.34 157.58 76.9 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.674 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.492 1.41 0 C-N-CA 122.025 1.816 . . . . 0.0 111.979 178.796 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.525 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 3.3 mtm-85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' HE ' ' HG2' ' A' ' 125' ' ' GLN . 41.0 ttm180 -146.69 135.84 22.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' HD23 ' A' ' 48' ' ' LEU . 78.5 mm-40 -132.04 143.6 50.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.672 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.2 tt -139.16 141.09 38.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.774 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.91 142.73 34.4 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.266 -179.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.448 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 65.7 m -66.84 134.45 52.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.994 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 5.4 tt0 -44.04 134.86 4.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -4.91 79.67 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.326 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 12.1 m-85 -118.1 150.08 46.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 118.189 0.995 . . . . 0.0 110.798 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 24.4 Cg_endo -65.94 141.76 65.95 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.879 2.386 . . . . 0.0 113.722 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.0 tt -117.3 145.53 22.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.445 ' HG3' HG22 ' A' ' 103' ' ' VAL . 80.2 tt0 -127.5 129.29 47.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.317 -178.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.764 HD12 ' SG ' ' A' ' 102' ' ' CYS . 40.4 mt -112.44 141.81 45.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.538 178.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -149.43 132.85 16.6 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.577 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.8 m -102.68 142.98 25.68 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.901 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.17 161.59 44.15 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.6 2.2 . . . . 0.0 112.844 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.03 -128.1 33.34 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.6 p -112.88 25.84 11.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.45 166.82 22.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.5 m -127.62 143.99 38.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.936 HG23 ' CD2' ' A' ' 126' ' ' TYR . 92.0 mt -69.48 139.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.234 -178.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 127' ' ' ASP . 4.0 ptp -132.85 103.12 5.93 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.67 125.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.25 -178.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 96.0 mt-10 -102.94 -51.0 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -149.05 145.1 27.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.202 0.525 . . . . 0.0 110.549 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.494 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.85 156.22 10.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.716 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.449 ' O ' HD12 ' A' ' 122' ' ' LEU . 6.4 t30 -152.59 154.95 36.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.177 0.513 . . . . 0.0 111.618 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 76.9 t80 -122.39 122.48 39.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.445 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.11 -142.45 8.68 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -177.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -151.6 119.15 6.05 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.17 0.51 . . . . 0.0 111.722 179.11 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.413 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 26.6 p -128.09 5.49 5.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.557 179.134 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.745 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 61.8 t0 -144.39 151.63 39.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.399 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.658 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 40.7 p30 -112.66 3.5 16.65 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.471 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 15.7 mttt -103.1 8.52 38.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.737 -178.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.2 mm -112.31 135.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 -179.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m 55.69 72.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.611 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 57.8 p30 -49.65 106.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.529 0.68 . . . . 0.0 112.19 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.56 -166.78 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.152 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.626 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.18 141.6 97.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 5.9 Cg_endo -54.99 -33.82 84.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 121.895 1.73 . . . . 0.0 112.509 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -63.51 -40.26 96.57 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.463 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 25.5 mt-30 -90.37 -6.68 54.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.974 0.416 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.445 ' HE3' ' NH2' ' A' ' 65' ' ' ARG . 80.2 mmm -106.66 -5.23 18.76 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.758 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.583 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 1.9 mm-40 -66.98 -46.58 74.18 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.7 t30 -78.25 122.99 26.43 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.838 -178.26 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.24 32.59 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.1 85.5 2.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.496 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.402 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 2.2 t -151.27 121.22 7.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.9 m-85 -131.75 156.59 45.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.964 0.411 . . . . 0.0 111.939 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' A' ' 88' ' ' ALA . 27.8 tp -147.93 87.66 5.76 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.567 178.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -48.03 -46.6 21.64 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.621 2.214 . . . . 0.0 113.361 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.5 m-20 -55.15 -23.92 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.124 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.432 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.59 -33.08 63.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.615 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' O ' ' OG ' ' A' ' 93' ' ' SER . 4.7 t80 -65.18 -40.75 94.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.598 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 10.1 pttp -64.87 -40.6 95.39 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.39 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 60.6 mt -59.94 -50.52 79.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.703 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.419 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 96.0 mmm -67.16 -33.99 76.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.502 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 28.1 m -60.02 -45.09 93.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.283 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.71 -36.78 83.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.179 0.514 . . . . 0.0 111.01 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.822 ' CZ ' HG13 ' A' ' 104' ' ' VAL . 16.9 mtp180 -74.09 -35.4 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.584 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.2 m -112.99 -12.88 13.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.151 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.502 ' CG ' ' O ' ' A' ' 93' ' ' SER . 68.2 m-20 -60.02 133.76 56.4 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.55 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 67.31 13.83 9.5 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 178.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -113.85 145.16 41.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.802 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.7 m -69.13 -31.26 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 155.4 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.267 179.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.764 ' SG ' HD12 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -153.86 130.8 10.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.25 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.445 HG22 ' HG3' ' A' ' 47' ' ' GLU . 97.3 t -114.25 132.4 63.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.875 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.822 HG13 ' CZ ' ' A' ' 95' ' ' ARG . 43.5 t -144.03 149.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -83.62 117.52 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.08 37.48 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.62 -178.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.94 -127.73 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.554 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 107' ' ' GLY . 12.4 t 31.69 -153.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.46 -9.08 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.101 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.36 60.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.922 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -141.57 126.36 10.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.8 Cg_exo -49.96 -154.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.602 2.201 . . . . 0.0 112.162 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -137.72 87.39 17.25 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -84.7 -20.89 3.57 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.313 2.675 . . . . 0.0 114.092 -179.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.508 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -153.49 73.47 6.71 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 121.109 0.48 . . . . 0.0 110.858 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.26 135.42 50.33 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.084 1.856 . . . . 0.0 112.048 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.76 -12.0 53.35 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.586 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -111.25 149.79 30.52 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.187 0.994 . . . . 0.0 108.835 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.2 t80 -82.2 98.5 8.76 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.257 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.508 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 20.7 mttt -70.89 -160.74 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.652 1.215 . . . . 0.0 112.98 -178.418 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -176.5 171.73 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.052 176.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 111' ' ' PHE . 20.3 tp -130.11 123.83 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 57.6 tt0 -117.89 125.07 49.8 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.494 HG22 ' HB1' ' A' ' 61' ' ' ALA . 29.9 t -131.01 124.73 56.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.938 -178.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.46 ' HG2' ' HE ' ' A' ' 37' ' ' ARG . 1.6 mt-30 -109.48 131.41 55.09 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.936 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.8 p90 -151.46 171.93 16.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.357 -178.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.455 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 48.9 m-20 -127.08 160.9 29.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.898 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.525 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 84.2 m -112.6 120.94 43.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.744 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 30.7 m -121.16 149.18 50.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.902 179.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 121.83 1.686 . . . . 0.0 112.163 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.441 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.649 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 16.1 mt -55.81 -36.24 43.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.919 -0.141 . . . . 0.0 111.183 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 5.1 Cg_endo -82.76 -157.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.858 2.372 . . . . 0.0 111.963 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' O ' HD23 ' A' ' 34' ' ' LEU . 63.0 m-85 -79.52 -7.62 58.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 110.722 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.46 19.82 64.97 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.8 OUTLIER -166.4 129.77 2.0 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.414 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 34' ' ' LEU . 6.0 mtt 47.96 117.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.244 0.545 . . . . 0.0 111.164 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.456 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 65.4 mtp85 -93.45 153.06 18.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.736 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -153.12 138.37 17.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.296 0.57 . . . . 0.0 112.161 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.765 ' CD ' HD23 ' A' ' 48' ' ' LEU . 86.8 mt-10 -131.16 149.5 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -136.26 139.55 42.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.873 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.9 145.18 32.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.034 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.3 m -71.25 133.66 46.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.457 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.573 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 79.7 tt0 -44.27 137.16 3.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.496 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.22 -6.94 72.4 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.243 -0.889 . . . . 0.0 114.402 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.442 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 15.1 m-85 -116.9 153.78 49.46 Favored Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 118.972 1.386 . . . . 0.0 111.154 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.05 141.8 40.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.124 1.883 . . . . 0.0 112.725 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 16.5 tt -116.33 144.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 86.0 tt0 -129.98 127.71 40.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.261 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.892 HD12 ' SG ' ' A' ' 102' ' ' CYS . 19.9 mt -111.45 144.74 40.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.254 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.519 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 62.7 mtt180 -147.93 126.62 12.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.309 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -95.39 144.54 27.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 27.6 Cg_endo -68.55 157.3 62.39 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.481 2.12 . . . . 0.0 112.295 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.43 -134.51 29.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.438 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -104.63 23.05 13.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -77.67 167.67 21.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 m -126.85 145.65 34.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.635 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.655 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.4 mt -67.91 136.21 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.821 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.591 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.2 ptm -132.5 100.79 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.539 HG12 ' HE1' ' A' ' 89' ' ' PHE . 25.4 t -64.16 124.77 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.403 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.562 ' OE1' ' OD1' ' A' ' 127' ' ' ASP . 46.9 mt-10 -102.04 -50.61 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.855 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -148.23 146.5 28.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.948 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.646 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.8 153.83 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.531 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.766 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.2 t30 -151.54 154.16 35.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.159 0.504 . . . . 0.0 111.796 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.568 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 30.2 t80 -123.57 122.83 39.18 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -138.89 6.08 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 5.3 ttm-85 -155.69 115.52 3.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.057 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.545 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 14.8 p -124.8 7.67 8.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.525 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -146.95 155.47 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.523 ' O ' ' HE2' ' A' ' 78' ' ' MET . 58.7 p30 -110.16 0.69 18.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 14.2 mttp -105.75 8.86 33.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.776 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.646 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 46.1 mm -113.72 136.27 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.781 0.324 . . . . 0.0 110.512 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 51.6 m 59.99 63.7 1.4 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -47.99 109.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 112.25 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -128.35 -164.81 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.758 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.687 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -62.85 144.73 96.63 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.173 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.2 Cg_endo -54.78 -37.59 92.08 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.34 2.027 . . . . 0.0 112.52 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -63.86 -34.47 78.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.597 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.687 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.3 mt-30 -86.82 -10.73 52.82 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.523 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 88.1 mtp -102.21 -5.49 24.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 37.6 mm-40 -63.99 -52.63 58.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -78.84 115.48 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.379 0.609 . . . . 0.0 112.517 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.531 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.2 m -107.17 32.28 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.127 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -139.93 85.51 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.113 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.443 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.6 t -148.11 118.79 7.51 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.426 ' HA ' HD21 ' A' ' 62' ' ' ASN . 55.9 m-85 -125.74 152.85 44.79 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.08 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 85' ' ' LEU . 35.0 tp -147.17 83.66 7.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.66 -47.25 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.078 2.519 . . . . 0.0 113.308 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 82.3 m-20 -54.11 -23.76 15.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.802 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.38 -32.33 56.78 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.098 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' HE1' HG12 ' A' ' 58' ' ' VAL . 33.7 t80 -64.03 -42.85 96.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.99 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 14.4 pttm -63.92 -38.35 90.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.106 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 69.1 mt -60.98 -52.22 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.306 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.5 mmm -68.48 -36.24 78.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.068 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.8 m -60.43 -47.29 86.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -66.55 -36.84 83.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.452 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 89.5 mtt-85 -76.96 -32.91 57.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.616 ' SG ' HD12 ' A' ' 48' ' ' LEU . 61.6 m -111.29 -15.29 13.65 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.539 ' CG ' ' O ' ' A' ' 93' ' ' SER . 48.2 m-20 -60.04 134.07 56.7 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.665 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 66.38 13.53 9.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -115.95 147.35 41.25 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.57 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.7 m -72.53 -31.47 65.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.718 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.48 154.65 35.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.892 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.2 p -155.16 136.94 14.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.747 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 47' ' ' GLU . 20.6 t -116.93 130.59 71.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 46' ' ' ILE . 42.3 t -143.09 146.87 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.599 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -80.76 118.49 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.01 37.44 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.723 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.74 -130.16 1.46 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.564 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 107' ' ' GLY . 3.5 t 36.64 -154.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -63.27 -9.01 9.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.273 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.15 -13.45 59.86 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.558 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.583 ' O ' ' O ' ' A' ' 112' ' ' PRO . 62.1 m-85 -140.58 128.19 12.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.448 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.4 Cg_exo -48.61 -158.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.352 2.034 . . . . 0.0 111.984 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.19 91.85 12.62 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.505 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -82.59 -46.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.134 2.556 . . . . 0.0 113.112 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.5 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -131.79 77.97 71.29 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-O 121.112 0.482 . . . . 0.0 111.319 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.404 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 9.9 Cg_endo -62.49 131.6 34.53 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.748 1.632 . . . . 0.0 111.739 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.49 -6.59 38.88 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.526 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.586 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 96.7 m -112.49 147.58 36.25 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.636 0.718 . . . . 0.0 109.336 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.544 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.3 t80 -85.87 98.43 10.77 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.524 ' NZ ' ' O3 ' ' A' ' 136' ' ' RAM . 11.9 mttp -76.51 -163.01 0.29 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 123.078 1.418 . . . . 0.0 113.803 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.545 ' OH ' ' N ' ' A' ' 66' ' ' THR . 5.7 p90 -169.29 171.9 7.61 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.44 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 62' ' ' ASN . 55.2 tp -129.26 122.55 29.87 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.088 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 54.7 tt0 -115.31 128.42 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.372 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.646 HG22 ' HB1' ' A' ' 61' ' ' ALA . 44.5 t -135.54 123.77 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.48 -0.888 . . . . 0.0 113.141 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.0 129.32 54.81 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.655 ' CD2' HG23 ' A' ' 56' ' ' ILE . 35.7 p90 -152.21 166.96 30.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.237 0.541 . . . . 0.0 111.873 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.562 ' OD1' ' OE1' ' A' ' 59' ' ' GLU . 3.1 m-20 -126.75 161.74 27.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.241 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.456 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 65.3 m -111.96 122.26 47.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.623 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.5 m -124.86 154.41 70.82 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.63 149.05 60.86 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.342 2.028 . . . . 0.0 112.446 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -76.47 2.08 14.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.888 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.703 ' CD ' ' N ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -144.56 -163.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.577 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 134' ' ' GLU . 7.6 p -86.68 132.2 32.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.07 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 133' ' ' VAL . 21.3 tp10 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.324 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.425 ' H82' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.586 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.718 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -130.28 142.06 44.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.844 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -68.88 148.83 71.56 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.389 2.059 . . . . 0.0 111.601 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -78.93 -5.54 53.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.238 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.93 38.82 94.57 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -155.36 55.89 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.04 0.448 . . . . 0.0 110.295 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' LEU . 5.4 mtt 57.91 150.64 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.993 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -90.45 147.95 23.08 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 68.6 ttt-85 -143.93 140.43 29.69 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.967 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG3' HD23 ' A' ' 48' ' ' LEU . 71.7 mm-40 -137.51 140.32 41.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.58 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -142.36 128.75 20.04 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.555 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -129.91 145.65 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.946 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.6 m -67.78 133.84 49.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.907 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.593 ' OE2' ' O4 ' ' A' ' 136' ' ' RAM . 0.0 OUTLIER -42.96 136.63 2.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.015 -178.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.74 -2.96 82.98 Favored Glycine 0 N--CA 1.453 -0.198 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.712 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -117.05 150.76 46.58 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.0 0.9 . . . . 0.0 110.706 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.04 140.64 45.92 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.45 2.1 . . . . 0.0 112.714 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 104' ' ' VAL . 14.4 tt -114.05 149.04 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 48.8 tt0 -126.55 127.86 45.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.154 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 102' ' ' CYS . 19.3 mt -115.62 138.87 50.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 79.1 mtt180 -146.9 130.75 17.09 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.753 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.9 m -98.15 146.23 31.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.933 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 128' ' ' CYS . 51.8 Cg_endo -72.84 158.68 49.74 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.724 2.283 . . . . 0.0 112.29 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.83 -129.35 26.41 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.805 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -110.27 25.66 11.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.09 167.84 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.158 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.86 145.0 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.126 0.489 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.952 HG23 ' CD2' ' A' ' 126' ' ' TYR . 73.4 mt -67.89 137.61 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.686 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.7 ptp -132.52 100.87 5.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 t -63.23 126.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.766 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -101.63 -51.22 3.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.114 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -148.96 147.05 28.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.625 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.84 151.92 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.401 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 122' ' ' LEU . 13.2 t30 -152.39 161.79 42.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.397 0.618 . . . . 0.0 111.856 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.488 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 80.6 t80 -126.73 125.0 41.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -141.08 7.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.531 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.73 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.6 ttm-85 -155.04 114.87 3.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.266 0.555 . . . . 0.0 111.166 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 69.8 p -119.89 8.87 11.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.066 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.644 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.2 t0 -145.05 -170.11 3.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.417 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.584 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 2.9 p30 -146.04 -0.51 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.756 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -107.71 8.74 29.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.213 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.574 ' HB ' HH22 ' A' ' 65' ' ' ARG . 35.2 mm -102.74 134.55 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.578 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' ASP . 73.8 m 55.75 24.15 6.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.648 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.58 ' C ' ' O ' ' A' ' 71' ' ' CYS . 15.8 t70 1.43 105.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.982 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB3' ' CG ' ' A' ' 78' ' ' MET . . . -121.7 -166.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.062 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -63.31 146.25 96.34 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.066 179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.541 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -58.4 -37.65 93.93 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.2 1.933 . . . . 0.0 112.571 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -64.48 -42.71 95.73 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.688 ' OE1' ' H61' ' A' ' 136' ' ' RAM . 28.9 mt-30 -84.12 -6.14 59.36 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.037 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.466 ' CG ' ' HB3' ' A' ' 73' ' ' ALA . 54.7 mmm -112.51 0.43 15.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.195 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 18.0 mt-10 -64.32 -47.85 77.85 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.934 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -78.86 113.71 17.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.446 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 67' ' ' ASP . 7.7 m -105.75 35.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.083 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -140.03 87.26 2.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.894 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.47 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.5 t -151.75 116.43 5.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.428 ' HA ' HD21 ' A' ' 62' ' ' ASN . 86.1 m-85 -125.29 156.13 39.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.942 0.401 . . . . 0.0 111.035 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.584 HD21 ' HG2' ' A' ' 112' ' ' PRO . 27.0 tp -145.59 91.1 5.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -48.89 -45.25 29.31 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.433 2.089 . . . . 0.0 111.622 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 65.9 m-20 -54.38 -30.92 53.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.447 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.32 -32.54 49.42 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.242 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -65.09 -43.98 90.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.4 pttp -66.08 -38.23 87.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.527 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 84.1 mt -59.88 -53.28 50.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.732 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 91.8 mmm -67.52 -34.73 77.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.518 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.464 ' HB3' HD21 ' A' ' 97' ' ' ASN . 23.8 m -58.91 -46.7 87.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.186 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.07 -37.62 84.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.757 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.452 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 96.3 mtt-85 -73.98 -33.62 63.91 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.2 m -114.71 -13.72 12.05 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.464 HD21 ' HB3' ' A' ' 93' ' ' SER . 88.5 m-20 -61.22 135.91 57.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.009 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 67.83 13.91 9.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.523 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -116.1 146.74 41.98 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.072 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -72.41 -31.67 65.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.716 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 155.26 38.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.681 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.1 p -156.19 133.96 11.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.724 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.15 126.89 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 46' ' ' ILE . 45.0 t -139.35 146.21 25.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 111.614 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.66 119.6 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 38.38 0.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.118 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.35 -124.19 0.89 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.937 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.71 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 31.04 -158.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.717 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.71 ' N ' ' OG ' ' A' ' 108' ' ' SER . 89.6 m-20 -64.4 -9.23 16.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.6 -8.96 58.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.249 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 112' ' ' PRO . 32.3 m-85 -141.05 131.18 13.15 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.075 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.584 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.9 Cg_exo -48.76 -163.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.343 2.029 . . . . 0.0 111.767 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.569 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -136.87 89.24 17.49 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.303 -179.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.78 -54.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.992 2.461 . . . . 0.0 113.139 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 4.1 p -127.49 72.87 77.89 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.887 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -58.74 131.85 44.56 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.908 1.739 . . . . 0.0 111.582 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.473 ' N ' ' O2 ' ' A' ' 136' ' ' RAM . . . 108.91 -16.96 32.95 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.803 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' GLN . 43.4 m -102.91 153.5 20.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.064 0.932 . . . . 0.0 108.495 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.73 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 21.2 t80 -86.21 99.31 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.527 0.68 . . . . 0.0 109.506 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.488 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 4.8 mtmp? -81.99 -159.27 0.28 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.599 1.19 . . . . 0.0 113.875 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 19.9 p90 -174.9 174.19 2.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.34 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 62' ' ' ASN . 18.7 tp -131.51 125.06 31.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.425 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 75.3 tt0 -121.18 130.79 53.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.625 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.8 t -134.41 123.47 42.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.011 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -109.7 129.71 55.58 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.952 ' CD2' HG23 ' A' ' 56' ' ' ILE . 40.9 p90 -153.56 169.76 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.51 0.671 . . . . 0.0 111.851 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.408 ' OD1' ' HG2' ' A' ' 35' ' ' MET . 74.8 m-20 -124.15 160.67 27.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.418 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.409 ' CB ' ' HD2' ' A' ' 51' ' ' PRO . 93.0 m -113.57 112.25 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.77 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.1 165.65 13.65 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.635 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -65.61 148.53 87.32 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.669 1.58 . . . . 0.0 111.63 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.413 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 35.2 t80 -72.24 -96.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.138 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 25.4 tttt -90.29 -74.13 0.5 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.567 ' O ' ' O ' ' A' ' 134' ' ' GLU . 92.7 t -143.71 136.36 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.851 0.358 . . . . 0.0 110.932 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 133' ' ' VAL . 82.9 tt0 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.701 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.688 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 mp -70.42 145.46 93.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.3 134.74 65.83 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.385 2.057 . . . . 0.0 111.184 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -74.71 -54.05 8.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.574 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.01 23.71 76.92 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.671 HD23 ' N ' ' A' ' 35' ' ' MET . 1.1 tt -161.5 124.11 3.06 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.688 0.28 . . . . 0.0 110.49 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.671 ' N ' HD23 ' A' ' 34' ' ' LEU . 2.6 mtt 58.06 153.9 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.296 0.57 . . . . 0.0 111.124 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.571 ' NH1' ' HD3' ' A' ' 51' ' ' PRO . 19.9 mtp180 -90.82 146.39 23.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.213 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.497 ' HE ' ' CG ' ' A' ' 123' ' ' GLU . 74.7 ttt180 -148.28 133.78 18.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.299 0.571 . . . . 0.0 110.984 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -129.57 146.45 51.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.517 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 121' ' ' TYR . 7.5 tt -141.6 127.88 19.84 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -130.81 147.47 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.045 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 m -70.05 132.2 45.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.519 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.598 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 17.4 tt0 -44.82 140.47 2.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.782 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 92.06 -8.28 77.99 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.818 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 18.7 m-85 -117.2 147.62 40.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 118.353 1.077 . . . . 0.0 109.928 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.95 146.24 76.88 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.342 2.028 . . . . 0.0 113.069 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 104' ' ' VAL . 20.9 tt -120.47 148.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.943 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.659 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 80.8 tt0 -132.63 126.96 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -112.91 143.38 44.29 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.659 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 97.8 mtt180 -144.78 134.31 23.28 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.518 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.486 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.7 m -103.79 143.65 27.08 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.274 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.571 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 49.3 Cg_endo -73.03 154.71 52.78 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 112.346 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.5 51.09 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.827 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -113.77 27.94 9.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -80.28 167.83 19.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.52 150.05 33.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.797 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.011 HG23 ' CD1' ' A' ' 126' ' ' TYR . 53.6 mt -71.05 138.14 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.181 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.438 ' HG3' ' H ' ' A' ' 127' ' ' ASP . 3.0 ptp -131.04 98.01 4.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.584 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.0 t -64.54 126.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.914 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -103.54 -46.78 4.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -150.53 147.55 27.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.447 0.642 . . . . 0.0 111.13 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.64 154.86 10.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.241 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.542 HD21 ' HA ' ' A' ' 84' ' ' TYR . 6.1 t30 -150.5 151.41 32.64 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.06 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.416 ' CE2' ' HD3' ' A' ' 120' ' ' LYS . 47.5 t80 -119.88 122.93 42.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.34 -138.39 5.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.881 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.622 ' NH2' ' O ' ' A' ' 70' ' ' ILE . 7.1 ttm-85 -155.21 115.4 3.79 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.168 -0.516 . . . . 0.0 109.845 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 p -122.39 11.49 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.044 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.635 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 49.9 t0 -146.91 -171.03 3.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.272 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.635 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 56.1 p30 -144.55 -0.33 0.96 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -103.9 6.3 36.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.209 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 40.1 mm -113.34 137.46 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m 57.25 70.56 0.64 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.128 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -53.12 122.16 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.387 0.613 . . . . 0.0 112.084 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -139.97 -163.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 141.07 98.0 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.9 Cg_endo -56.82 -35.03 97.9 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.344 2.029 . . . . 0.0 112.554 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -63.16 -36.87 85.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.638 ' OE1' ' H61' ' A' ' 136' ' ' RAM . 29.4 mt-30 -88.14 12.54 13.39 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.233 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 75.8 mtp -129.0 -2.99 5.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 53.5 mm-40 -63.27 -47.25 83.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.987 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.44 119.29 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.419 . . . . 0.0 111.912 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 81' ' ' VAL . 5.3 m -111.37 31.66 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.623 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -136.23 85.84 2.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.48 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.3 t -149.15 112.57 5.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.542 ' HA ' HD21 ' A' ' 62' ' ' ASN . 72.8 m-85 -128.19 152.56 47.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.648 0.261 . . . . 0.0 110.945 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.76 86.76 7.72 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -45.98 -48.43 12.7 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.86 2.374 . . . . 0.0 114.904 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 37.6 m-20 -58.54 -21.89 53.83 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.27 61.65 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.565 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CE1' HG12 ' A' ' 58' ' ' VAL . 54.5 t80 -63.81 -41.83 97.8 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.6 pttm -66.54 -38.5 87.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.573 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.406 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 88.5 mt -60.74 -50.7 79.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.804 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.5 ' SD ' HG11 ' A' ' 104' ' ' VAL . 98.6 mmm -67.75 -35.63 79.08 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.11 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 16.4 m -61.82 -46.1 90.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.391 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.92 -35.6 81.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.562 0.696 . . . . 0.0 110.424 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' A' ' 104' ' ' VAL . 23.1 mtp85 -74.47 -34.0 63.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.6 m -112.39 -21.46 11.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' SER . 60.4 m-20 -56.25 129.72 41.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 72.05 14.33 5.74 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.829 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 84.5 mtt180 -117.12 149.22 40.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.585 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.0 m -71.28 -33.42 69.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.501 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.68 155.01 35.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.98 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.5 p -151.44 149.88 29.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.978 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.56 126.66 75.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 46' ' ' ILE . 44.0 t -137.34 144.03 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -85.8 122.15 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.373 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -66.81 23.56 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.675 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . -179.59 173.09 44.95 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.935 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.606 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.7 t 94.79 -155.55 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -66.32 -11.19 49.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.008 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.97 -18.47 60.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.55 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.527 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.5 m-85 -141.47 131.22 12.76 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.575 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 111' ' ' PHE . 36.1 Cg_exo -50.64 -156.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.404 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -138.13 95.63 10.52 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.769 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -82.98 -50.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.657 2.238 . . . . 0.0 113.564 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.478 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 11.2 p -133.05 84.8 47.56 Favored Pre-proline 0 N--CA 1.466 0.36 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.098 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.431 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 27.1 Cg_endo -64.02 136.1 50.81 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.08 1.853 . . . . 0.0 112.328 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.6 -4.8 47.22 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.361 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.403 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 67.2 m -114.4 149.3 36.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.169 0.984 . . . . 0.0 108.655 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.564 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 7.3 t80 -85.09 98.99 10.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 18.6 mttt -76.05 -165.61 0.49 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.918 1.342 . . . . 0.0 113.363 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' HB2' HD21 ' A' ' 39' ' ' LEU . 8.4 p90 -167.83 167.46 12.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 112.251 -2.25 . . . . 0.0 109.769 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 25.9 tp -127.76 123.33 35.04 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.699 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 3.4 tm-20 -117.61 129.42 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.11 119.65 41.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.699 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 1.7 mp0 -102.69 127.8 49.67 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.011 ' CD1' HG23 ' A' ' 56' ' ' ILE . 18.6 p90 -154.77 170.48 21.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.58 0.705 . . . . 0.0 112.517 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.438 ' H ' ' HG3' ' A' ' 57' ' ' MET . 97.6 m-20 -128.13 163.34 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.779 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.458 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 92.6 m -109.46 114.51 28.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.367 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.64 151.02 47.9 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.66 141.91 83.18 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.587 1.525 . . . . 0.0 112.342 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -79.26 136.98 37.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.803 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -92.36 129.12 38.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.455 ' O ' ' OXT' ' A' ' 134' ' ' GLU . 86.8 t -97.45 134.59 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.455 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 73.1 tt0 . . . . . 0 C--O 1.218 -0.59 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.523 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.638 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -125.01 57.8 16.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.726 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.67 143.1 12.99 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.278 2.652 . . . . 0.0 112.342 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -82.11 -6.03 58.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.634 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.65 21.17 76.26 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -154.03 98.4 2.16 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.823 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.582 ' O ' ' O ' ' A' ' 34' ' ' LEU . 9.7 mtt 50.26 134.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.863 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.529 ' CZ ' ' H ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -93.16 144.33 25.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.833 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.467 HH11 ' HD3' ' A' ' 37' ' ' ARG . 37.9 ttp-105 -149.93 137.56 20.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.318 0.58 . . . . 0.0 111.024 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 57.4 mp0 -134.51 146.04 49.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -138.1 137.59 37.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.014 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.672 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.41 143.74 34.09 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.883 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.0 m -70.54 133.96 47.24 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 84.8 tt0 -42.21 136.54 2.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.876 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.45 -6.12 74.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.804 -1.089 . . . . 0.0 114.094 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.69 149.88 45.89 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-N 119.118 1.459 . . . . 0.0 112.02 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.83 137.61 64.01 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 123.124 2.549 . . . . 0.0 113.06 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -120.06 142.36 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.631 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.3 tt0 -130.03 129.25 43.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.611 -0.835 . . . . 0.0 113.224 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.456 HD12 ' SG ' ' A' ' 96' ' ' CYS . 30.6 mt -109.93 145.75 36.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.631 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 46.4 mtt85 -148.14 132.27 17.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.591 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.424 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -98.16 144.33 27.87 Favored Pre-proline 0 N--CA 1.455 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 56.9 Cg_endo -71.1 159.31 52.64 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 123.215 2.61 . . . . 0.0 112.593 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.46 -120.08 12.6 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.782 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -125.73 26.44 6.67 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.747 0.308 . . . . 0.0 110.996 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -77.41 169.97 17.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.509 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.76 143.09 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.284 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.116 HG23 ' CD2' ' A' ' 126' ' ' TYR . 78.0 mt -69.74 140.36 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.586 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.421 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.0 ptp -133.84 100.51 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.637 HG12 ' HE1' ' A' ' 89' ' ' PHE . 17.4 t -64.89 127.12 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.445 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.57 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 76.6 mt-10 -104.25 -49.64 3.54 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.794 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.7 m-20 -147.42 145.47 29.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.089 0.471 . . . . 0.0 110.725 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.0 154.74 9.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.967 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -152.08 156.79 40.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.286 0.565 . . . . 0.0 111.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 70.3 t80 -125.62 119.68 28.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 120' ' ' LYS . . . 156.66 -136.74 5.11 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.69 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 9.2 ttm-85 -154.94 118.03 4.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.329 0.585 . . . . 0.0 112.063 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 p -124.73 6.07 8.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.356 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 56.1 t0 -146.7 154.81 41.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.955 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 51.7 p30 -113.05 2.59 15.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.458 ' O ' HD13 ' A' ' 70' ' ' ILE . 18.5 mttt -104.6 5.99 34.18 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.944 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 69' ' ' LYS . 27.7 mm -115.69 139.65 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.624 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.3 m 53.77 71.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 39.2 p-10 -54.09 128.55 31.19 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 111.599 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -144.31 -165.87 2.24 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.282 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.692 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -61.88 142.48 94.97 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.16 -35.35 95.12 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.241 1.961 . . . . 0.0 112.827 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.6 -33.88 75.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.957 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.573 ' O ' HG23 ' A' ' 118' ' ' THR . 75.3 mt-30 -89.01 6.64 38.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.92 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.4 mtp -125.73 -3.96 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 39.1 mm-40 -61.54 -45.94 92.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.951 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -83.03 113.27 20.47 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.621 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 21.3 m -104.16 33.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.316 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.621 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.9 mm-40 -138.69 85.6 2.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 41.5 t -148.53 122.47 9.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.6 m-85 -131.86 154.14 49.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 tp -146.14 86.43 7.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.334 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -46.88 -45.98 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.029 2.486 . . . . 0.0 113.162 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 75.7 m-20 -53.01 -29.45 29.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.35 -31.41 33.43 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.573 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.637 ' HE1' HG12 ' A' ' 58' ' ' VAL . 50.9 t80 -67.9 -47.89 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 pttp -64.1 -41.91 97.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.395 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.51 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 70.6 mt -59.53 -48.69 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.051 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.939 ' SD ' HD21 ' A' ' 122' ' ' LEU . 46.0 mtp -70.84 -34.85 72.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.77 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.515 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 23.6 m -57.42 -42.97 83.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.831 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.52 -37.85 87.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.598 HH21 ' HG2' ' A' ' 92' ' ' MET . 36.8 mtm180 -76.38 -30.58 57.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.456 ' SG ' HD12 ' A' ' 48' ' ' LEU . 75.5 m -112.6 -21.42 11.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.515 ' CG ' ' O ' ' A' ' 93' ' ' SER . 69.4 m-20 -55.51 135.64 50.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.984 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 64.05 13.54 7.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.669 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -115.97 147.93 40.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.366 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.1 m -71.63 -33.93 69.35 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.795 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.02 159.23 40.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.278 0.561 . . . . 0.0 110.867 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.6 p -155.5 138.85 15.76 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.701 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' A' ' 47' ' ' GLU . 21.8 t -120.19 126.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 64.6 t -143.64 146.04 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -75.11 117.67 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.57 42.79 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 175.22 -127.25 1.25 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 35.82 -150.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.129 -0.536 . . . . 0.0 111.381 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.45 -9.62 13.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.12 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.487 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -76.85 -17.23 59.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.169 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.2 m-85 -139.7 130.51 14.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.794 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.7 Cg_exo -52.01 -153.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.459 2.106 . . . . 0.0 112.423 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -137.19 93.71 12.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.44 -51.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 123.034 2.489 . . . . 0.0 113.283 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.403 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.4 p -131.62 79.54 68.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.391 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -62.91 138.86 70.73 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.53 2.154 . . . . 0.0 112.53 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.55 -2.54 49.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.898 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 77' ' ' GLN . 95.1 m -120.5 148.85 43.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.106 0.453 . . . . 0.0 109.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.615 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.1 t80 -86.3 96.68 10.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.465 ' CD ' ' CE2' ' A' ' 63' ' ' TYR . 37.0 mttt -68.12 -156.33 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.217 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.4 p90 -176.38 168.58 2.76 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 112.665 -2.061 . . . . 0.0 109.37 176.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.939 HD21 ' SD ' ' A' ' 92' ' ' MET . 12.9 tp -129.7 122.79 29.64 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.495 ' OE2' ' NE2' ' A' ' 125' ' ' GLN . 78.2 tt0 -117.77 131.2 56.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.797 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.95 119.4 36.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.495 ' NE2' ' OE2' ' A' ' 123' ' ' GLU . 5.1 mp0 -105.04 124.55 49.73 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.116 ' CD2' HG23 ' A' ' 56' ' ' ILE . 23.8 p90 -154.22 166.97 31.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.715 0.769 . . . . 0.0 112.055 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.459 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 83.5 m-20 -123.31 162.0 23.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.259 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.529 ' H ' ' CZ ' ' A' ' 36' ' ' ARG . 86.4 m -110.38 119.69 40.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.906 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.1 m -117.59 156.52 49.32 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.481 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -64.86 144.12 82.06 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 C-N-CA 121.598 1.532 . . . . 0.0 111.078 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.587 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 39.3 t80 -78.71 -175.14 4.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.981 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.587 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 57.3 mttm -93.17 144.25 25.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.248 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 134' ' ' GLU . 13.2 p -144.7 138.95 23.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.393 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 133' ' ' VAL . 66.9 mm-40 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.97 -1.014 . . . . 0.0 111.026 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.402 ' H82' ' HB2' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.451 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.8 mm? -67.25 -45.56 50.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.629 0.252 . . . . 0.0 111.033 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 55.6 Cg_endo -78.84 59.46 7.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.573 2.182 . . . . 0.0 112.385 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 70.9 t80 -78.45 0.31 26.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.965 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.12 31.04 62.11 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -163.71 118.5 1.58 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.469 ' N ' HD13 ' A' ' 34' ' ' LEU . 25.0 mtt 52.97 108.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.595 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.486 ' NH2' ' HG3' ' A' ' 51' ' ' PRO . 4.2 mtt-85 -88.88 154.34 20.33 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 37' ' ' ARG . 13.0 ttt180 -142.28 136.66 29.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.096 0.475 . . . . 0.0 110.387 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' HG2' HD23 ' A' ' 48' ' ' LEU . 58.2 mp0 -133.65 143.56 48.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.533 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -139.42 136.27 34.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.512 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.736 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.84 144.95 32.72 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.447 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 25.6 m -71.21 133.68 46.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 9.2 tt0 -45.07 140.91 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.486 0.66 . . . . 0.0 112.511 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 94.12 -12.15 69.55 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.71 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.9 m-85 -116.74 155.64 48.75 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 118.405 1.103 . . . . 0.0 110.051 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.55 146.86 31.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.475 2.117 . . . . 0.0 113.948 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 104' ' ' VAL . 11.4 tt -118.57 145.82 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.913 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -126.64 127.81 45.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.884 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.679 HD12 ' SG ' ' A' ' 102' ' ' CYS . 44.9 mt -112.93 145.11 41.35 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -150.79 131.84 14.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.77 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 m -100.03 145.77 30.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.685 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.486 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 43.5 Cg_endo -72.35 160.38 47.1 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.462 2.108 . . . . 0.0 113.073 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.15 -130.68 28.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 p -107.43 24.45 12.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.34 166.55 22.53 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.829 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.575 HG11 ' HD1' ' A' ' 131' ' ' TYR . 25.8 m -127.46 143.38 40.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.113 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.827 HG23 ' CD1' ' A' ' 126' ' ' TYR . 95.3 mt -67.08 138.09 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.622 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -130.41 98.38 4.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.22 123.72 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.38 -48.25 4.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.5 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -147.6 145.6 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.254 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.665 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.64 151.1 9.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.552 HD21 ' HA ' ' A' ' 84' ' ' TYR . 6.7 t30 -150.4 152.34 34.2 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.929 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.503 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 66.4 t80 -122.65 125.25 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.468 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.89 -136.31 4.99 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.589 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 6.1 ttm180 -156.6 117.98 3.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.006 0.432 . . . . 0.0 111.127 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.553 ' HG1' ' HH ' ' A' ' 121' ' ' TYR . 26.2 p -124.69 7.7 8.19 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.73 152.68 40.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.517 ' O ' ' HE1' ' A' ' 78' ' ' MET . 20.9 p-10 -109.68 -0.36 18.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.333 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -106.37 8.74 31.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.116 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.5 mm -114.31 139.81 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.569 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.6 m 57.48 64.75 1.5 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -46.93 120.82 3.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.813 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -139.52 -167.08 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.933 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -63.02 142.51 97.68 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.037 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.58 -36.09 79.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 121.784 1.656 . . . . 0.0 112.762 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -64.59 -33.77 76.7 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.195 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.681 ' O ' HG23 ' A' ' 118' ' ' THR . 81.4 mt-30 -84.04 -12.62 54.88 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.828 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.517 ' HE1' ' O ' ' A' ' 68' ' ' ASP . 66.4 mtp -103.95 -2.18 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 52.6 mm-40 -58.96 -53.2 61.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.806 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -80.43 122.52 27.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.01 28.2 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.058 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -143.73 90.64 2.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -145.79 120.93 10.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.663 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 5.9 m-85 -128.75 153.02 47.79 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.616 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.747 HD21 ' HG2' ' A' ' 112' ' ' PRO . 13.7 tp -146.08 91.2 5.58 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.705 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -49.24 -46.27 26.59 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.228 2.619 . . . . 0.0 113.751 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 23.9 m-20 -53.74 -22.31 8.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.03 -33.49 57.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.763 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -64.8 -44.46 89.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.166 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.9 pttt -65.86 -40.07 91.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.983 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.527 HG23 ' NH1' ' A' ' 95' ' ' ARG . 79.5 mt -60.49 -51.39 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.861 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.445 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 93.0 mmm -68.17 -37.0 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.569 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.45 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 60.9 m -60.31 -44.26 95.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.117 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -65.44 -37.94 88.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.295 0.569 . . . . 0.0 110.665 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.553 HH11 ' HG3' ' A' ' 95' ' ' ARG . 51.4 mtt85 -76.26 -33.3 59.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.8 m -111.94 -15.16 13.39 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 70.2 m-20 -62.72 135.21 57.24 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.634 -0.827 . . . . 0.0 111.669 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 64.99 11.48 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.156 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt-85 -112.71 145.5 40.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 110.595 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.9 m -72.76 -31.28 64.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.479 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.13 155.23 38.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.262 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.679 ' SG ' HD12 ' A' ' 48' ' ' LEU . 29.3 p -153.76 139.7 18.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.882 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.0 t -119.06 131.05 72.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 46' ' ' ILE . 17.6 t -141.99 152.01 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.425 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.81 120.79 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -68.71 38.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.362 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.84 -125.7 0.98 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.175 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 31.36 -158.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.257 0.551 . . . . 0.0 112.022 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.72 -10.52 19.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.627 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.83 59.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.089 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.524 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.5 m-85 -142.51 132.72 12.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.366 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.747 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.6 Cg_exo -49.95 -159.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -139.01 86.44 15.01 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.474 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.544 ' HD2' ' HZ3' ' A' ' 120' ' ' LYS . 66.8 Cg_endo -79.32 -29.0 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.718 2.279 . . . . 0.0 113.136 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.1 p -155.67 83.84 3.54 Favored Pre-proline 0 C--N 1.332 -0.155 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.688 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 18.4 Cg_endo -70.02 140.87 42.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.94 1.76 . . . . 0.0 112.039 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.432 ' N ' ' O2 ' ' A' ' 136' ' ' RAM . . . 103.54 -2.02 46.03 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.372 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.1 m -117.61 147.02 43.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 8.9 t80 -84.61 98.2 10.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.544 ' HZ3' ' HD2' ' A' ' 114' ' ' PRO . 21.3 mtmt -77.58 -166.78 0.81 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.469 1.128 . . . . 0.0 113.401 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.553 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 40.0 p90 -167.32 168.6 13.1 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.621 -2.082 . . . . 0.0 110.321 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.3 tp -127.02 124.93 40.52 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.541 ' HG3' HE21 ' A' ' 125' ' ' GLN . 15.3 tp10 -117.22 128.23 54.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.066 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.665 HG22 ' HB1' ' A' ' 61' ' ' ALA . 41.5 t -135.79 125.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.262 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.541 HE21 ' HG3' ' A' ' 123' ' ' GLU . 2.6 mt-30 -112.83 130.72 55.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.827 ' CD1' HG23 ' A' ' 56' ' ' ILE . 27.5 p90 -153.82 173.24 16.15 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.089 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -124.78 158.83 32.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.352 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.5 m -105.95 119.43 39.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.49 158.11 68.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.66 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.32 145.22 88.62 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.096 1.864 . . . . 0.0 112.06 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.575 ' HD1' HG11 ' A' ' 55' ' ' VAL . 79.7 t80 -72.7 -12.81 61.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.903 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -97.3 135.43 39.23 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.449 ' O ' ' OXT' ' A' ' 134' ' ' GLU . 81.3 t -141.84 117.4 5.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.987 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 71.1 tt0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.544 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.444 ' O7 ' ' O3 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.564 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.458 ' O ' HD22 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -127.7 74.25 78.31 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.244 0.545 . . . . 0.0 110.334 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.37 152.31 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.287 2.658 . . . . 0.0 112.472 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' C ' ' H ' ' A' ' 34' ' ' LEU . 2.1 m-85 -78.19 4.87 11.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.28 -33.76 0.95 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.049 HD22 ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -159.22 107.54 1.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.741 0.781 . . . . 0.0 111.567 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' LEU . 8.2 mtp 53.95 150.78 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.737 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 49' ' ' ARG . 70.8 mtp180 -96.56 146.09 25.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -156.09 137.99 14.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.893 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -127.06 149.96 49.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.204 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -138.83 142.21 38.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.836 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -144.29 144.96 31.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.356 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 7.6 m -71.55 134.6 46.57 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 110.436 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.615 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 87.2 tt0 -43.24 138.51 2.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.134 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.66 -7.65 77.21 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.816 -1.084 . . . . 0.0 114.298 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.56 153.91 50.55 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 119.068 1.434 . . . . 0.0 110.909 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.84 140.84 47.37 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.589 2.192 . . . . 0.0 113.748 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 14.1 tt -116.84 146.36 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.604 ' HG3' HG22 ' A' ' 103' ' ' VAL . 78.7 tt0 -126.2 127.77 46.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.095 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.668 HD12 ' SG ' ' A' ' 102' ' ' CYS . 50.1 mt -115.88 138.55 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.545 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 18.8 mtp180 -146.5 133.51 20.3 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.283 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -98.66 136.72 20.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.86 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.522 ' HD3' ' NH1' ' A' ' 36' ' ' ARG . 55.6 Cg_endo -70.25 158.29 56.78 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.415 2.077 . . . . 0.0 111.458 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.23 -141.41 30.33 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.652 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.0 p -98.63 22.2 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.268 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -78.88 165.09 23.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.7 0.286 . . . . 0.0 110.86 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.57 148.69 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.186 0.517 . . . . 0.0 110.534 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.795 HG23 ' CD2' ' A' ' 126' ' ' TYR . 78.5 mt -71.19 136.06 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.653 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.36 101.8 5.12 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' HB ' HD21 ' A' ' 97' ' ' ASN . 40.3 t -66.43 127.04 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.457 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 71.3 mm-40 -103.92 -48.29 3.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.816 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 65.1 m-20 -148.49 145.76 28.07 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.13 154.23 7.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.851 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.509 HD21 ' HA ' ' A' ' 84' ' ' TYR . 6.0 t30 -150.24 151.99 33.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.37 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.626 ' CD2' ' CG ' ' A' ' 111' ' ' PHE . 54.9 t80 -118.4 121.09 39.5 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.6 -135.33 4.54 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.382 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.525 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 10.5 ttm-85 -156.55 117.53 3.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 111.362 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.475 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 23.6 p -122.87 9.44 9.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.071 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 15.2 t0 -147.2 -178.22 6.1 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.135 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 69' ' ' LYS . 54.7 p30 -138.36 -0.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.065 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 20.4 mttp -102.65 2.83 36.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.844 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.67 137.7 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.019 0.437 . . . . 0.0 110.855 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.4 m 54.63 70.79 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.14 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.0 p30 -52.09 125.95 17.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.923 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -143.91 -163.61 1.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.68 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -64.01 142.64 98.21 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.301 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.7 Cg_endo -54.44 -35.93 86.41 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.952 1.768 . . . . 0.0 112.008 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -63.87 -37.18 86.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 118' ' ' THR . 81.2 mt-30 -83.46 -9.72 58.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.359 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.9 mtp -106.04 -0.92 24.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 76.2 mt-10 -60.47 -53.04 62.33 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.08 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 48.9 t30 -76.54 117.46 18.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.578 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.0 m -107.71 29.42 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.832 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.8 mm-40 -141.01 85.37 1.98 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.389 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.428 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 44.8 t -146.94 124.23 11.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.509 ' HA ' HD21 ' A' ' 62' ' ' ASN . 58.1 m-85 -133.54 159.04 41.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.487 HD21 ' HG2' ' A' ' 112' ' ' PRO . 12.7 tp -147.73 94.99 4.3 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.18 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.48 -43.83 31.82 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.825 2.35 . . . . 0.0 114.06 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 65.4 m-20 -61.16 -23.68 65.74 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.59 62.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.928 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.569 ' O ' ' OG ' ' A' ' 93' ' ' SER . 17.3 t80 -67.12 -47.73 70.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.069 0.461 . . . . 0.0 112.087 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 pttm -67.23 -41.22 86.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.965 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.61 HG22 HH21 ' A' ' 95' ' ' ARG . 69.7 mt -61.39 -47.41 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.795 ' SD ' ' NH1' ' A' ' 95' ' ' ARG . 96.2 mmm -66.97 -36.13 81.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 5.1 m -60.88 -42.11 97.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -64.93 -36.82 85.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.056 0.455 . . . . 0.0 111.245 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 1.124 ' NH1' HG11 ' A' ' 104' ' ' VAL . 20.8 mtm180 -76.17 -33.34 59.34 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.418 ' SG ' HD12 ' A' ' 48' ' ' LEU . 36.2 m -113.66 -14.02 12.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.577 ' CG ' ' O ' ' A' ' 93' ' ' SER . 2.7 m120 -58.58 136.88 57.71 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.807 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 67.04 14.37 9.8 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.017 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -116.49 147.01 42.16 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.306 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.5 m -73.76 -31.93 63.57 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.086 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 153.37 37.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.449 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.1 p -156.75 131.33 8.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.604 HG22 ' HG3' ' A' ' 47' ' ' GLU . 22.4 t -121.72 125.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.124 HG11 ' NH1' ' A' ' 95' ' ' ARG . 91.5 t -141.94 146.4 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.441 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.5 120.23 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.98 41.76 0.06 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.82 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 108' ' ' SER . . . 179.3 -130.66 1.55 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.353 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 107' ' ' GLY . 5.9 t 31.58 -146.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.019 0.438 . . . . 0.0 110.943 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.05 -10.27 13.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.14 -21.76 53.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.265 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.626 ' CG ' ' CD2' ' A' ' 63' ' ' TYR . 36.1 m-85 -138.26 128.98 15.46 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.494 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.8 Cg_exo -52.18 -150.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.855 1.703 . . . . 0.0 111.645 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -140.06 80.39 20.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.296 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.57 -19.89 18.5 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.572 2.181 . . . . 0.0 113.171 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.629 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.8 p -157.12 80.37 3.45 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.484 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -65.95 139.23 55.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.122 1.881 . . . . 0.0 111.698 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.14 -3.16 47.63 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.576 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.1 m -120.29 145.62 46.9 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.641 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 15.7 t80 -84.74 96.95 9.41 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.629 ' NZ ' ' O ' ' A' ' 115' ' ' CYS . 20.3 mtmm -71.47 -165.97 0.17 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.576 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.635 ' HB2' HD21 ' A' ' 39' ' ' LEU . 9.0 p90 -168.16 169.27 11.11 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 62' ' ' ASN . 40.6 tp -128.02 123.64 35.19 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -116.55 127.41 54.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.137 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.19 121.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.346 -0.941 . . . . 0.0 112.535 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.56 127.72 52.35 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.795 ' CD2' HG23 ' A' ' 56' ' ' ILE . 36.0 p90 -152.32 168.8 24.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 111.317 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -126.73 162.62 25.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.424 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 86.1 m -113.61 113.89 25.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.018 0.437 . . . . 0.0 110.239 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 m -115.19 156.88 44.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.929 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -60.12 147.25 93.95 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 121.594 1.529 . . . . 0.0 110.942 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.579 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 28.2 t80 -72.76 -143.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.331 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.579 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 41.1 tttp -90.82 -81.71 0.3 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.739 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.75 144.97 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.398 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.433 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.559 ' H83' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.615 ' O3 ' ' OE2' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mt -125.0 73.15 65.17 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -68.2 140.51 49.36 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.236 1.957 . . . . 0.0 111.924 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 79.3 t80 -78.68 0.02 28.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 109.917 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.9 22.87 73.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.4 OUTLIER -162.98 121.29 2.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.075 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.557 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 55.02 136.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 110.793 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -97.6 150.54 21.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.758 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.555 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 40.2 ttt-85 -147.73 141.09 25.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.441 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -130.06 145.61 51.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.554 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.7 tt -139.31 137.93 36.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.7 144.14 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.873 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.68 130.41 43.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.568 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.495 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 31.0 tt0 -41.39 136.87 1.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.324 0.583 . . . . 0.0 112.183 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.3 -4.09 76.75 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.084 -0.962 . . . . 0.0 114.179 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -115.48 152.56 47.19 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 118.896 1.348 . . . . 0.0 111.193 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 19.1 Cg_endo -69.88 139.9 40.93 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.02 1.813 . . . . 0.0 112.341 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.3 tt -115.19 147.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.657 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 40.8 tt0 -126.83 129.17 47.76 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.185 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.655 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.6 mt -115.87 138.86 50.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.657 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 91.1 mtt180 -144.09 132.68 22.27 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.931 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -100.3 138.89 20.32 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.215 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.08 157.83 53.49 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.367 2.045 . . . . 0.0 111.612 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.1 38.28 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.9 p -103.1 25.11 9.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.333 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.52 164.2 24.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.088 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.691 HG11 ' CD1' ' A' ' 131' ' ' TYR . 29.8 m -125.64 146.24 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 110.506 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.752 HG23 ' CD2' ' A' ' 126' ' ' TYR . 70.4 mt -69.31 134.63 29.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.162 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.5 ptp -129.39 97.76 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.623 HG12 ' HE1' ' A' ' 89' ' ' PHE . 32.7 t -61.7 125.26 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.955 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 79.7 mm-40 -101.35 -49.84 3.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.745 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.1 m-20 -152.27 150.61 29.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -169.66 156.59 6.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.647 ' O ' HD12 ' A' ' 122' ' ' LEU . 13.5 t30 -151.36 158.77 44.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.528 0.68 . . . . 0.0 111.606 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.649 ' HB3' HD23 ' A' ' 85' ' ' LEU . 35.9 t80 -123.01 120.33 33.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.69 -140.42 6.91 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.416 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.666 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 5.3 ttm180 -157.55 118.27 3.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.953 0.406 . . . . 0.0 111.978 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.548 ' HG1' ' HH ' ' A' ' 121' ' ' TYR . 72.7 p -125.76 7.42 7.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.401 0.62 . . . . 0.0 109.704 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 54.6 t0 -146.43 154.13 41.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.4 p30 -114.17 3.1 15.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 110.424 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 87.1 mttt -104.6 4.64 33.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.774 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.4 mm -110.84 137.58 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.6 m 55.95 62.94 2.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -44.61 121.0 2.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -140.41 -166.81 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.355 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.618 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -62.55 133.58 94.81 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.437 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -51.78 -34.78 56.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.181 1.921 . . . . 0.0 113.224 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.8 -37.1 85.37 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.589 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 81.7 mt-30 -80.12 -17.89 51.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.254 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.666 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 7.9 mtm -102.18 1.39 35.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 55.3 mm-40 -61.97 -47.59 84.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.699 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.55 114.39 19.41 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 66' ' ' THR . 15.6 m -104.34 34.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.944 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.578 HE21 ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -143.95 88.07 1.95 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.944 0.402 . . . . 0.0 111.739 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.475 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.0 t -147.39 122.78 10.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.52 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.6 m-85 -126.02 153.81 43.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 111.796 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' A' ' 63' ' ' TYR . 46.3 tp -147.92 85.94 6.33 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.92 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.82 -49.35 16.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.919 2.412 . . . . 0.0 113.061 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.5 m-20 -49.13 -30.35 6.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -32.8 53.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.822 0.344 . . . . 0.0 111.11 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.623 ' HE1' HG12 ' A' ' 58' ' ' VAL . 59.3 t80 -65.08 -41.89 94.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 34.2 pttt -65.86 -40.67 91.88 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.806 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.3 mt -60.27 -48.75 86.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.868 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -70.03 -36.61 75.2 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.114 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.486 ' HB3' HD21 ' A' ' 97' ' ' ASN . 19.8 m -58.79 -47.61 84.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.25 0.548 . . . . 0.0 110.549 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -65.1 -35.93 82.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.05 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.631 HH12 ' HB1' ' A' ' 110' ' ' ALA . 99.5 mtt180 -79.9 -30.57 40.11 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.0 m -112.43 -20.18 11.88 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.486 HD21 ' HB3' ' A' ' 93' ' ' SER . 89.4 m-20 -58.25 135.87 57.21 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.8 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 64.53 13.06 7.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.851 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 95' ' ' ARG . 75.0 mtp180 -114.02 145.66 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.2 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.4 m -71.79 -30.98 66.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.454 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.44 152.8 31.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.039 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.655 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.6 p -151.91 141.76 21.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.93 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.48 128.96 75.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.809 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.553 ' CG1' HH11 ' A' ' 95' ' ' ARG . 22.6 t -144.7 147.58 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.229 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -78.71 118.39 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.903 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.94 41.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.8 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 175.54 -123.04 0.9 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.178 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.6 t 31.04 -157.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.163 0.506 . . . . 0.0 110.911 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.94 -9.58 22.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.851 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.631 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -75.72 -9.39 58.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.524 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.8 m-85 -144.0 133.54 11.61 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.858 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 44.9 Cg_exo -49.62 -161.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.925 1.75 . . . . 0.0 111.334 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -139.29 97.6 8.49 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.042 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.25 -58.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.847 2.364 . . . . 0.0 112.725 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.422 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 8.4 p -126.56 80.37 69.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.177 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 24.9 Cg_endo -64.71 137.82 55.84 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.79 1.66 . . . . 0.0 111.942 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.506 ' N ' ' O2 ' ' A' ' 136' ' ' RAM . . . 113.52 -13.75 22.9 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.737 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.538 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 1.0 OUTLIER -111.09 151.74 27.73 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.258 0.529 . . . . 0.0 109.983 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.587 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 7.5 t80 -85.63 96.96 9.84 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.474 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 12.6 mttp -76.4 -161.19 0.17 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.729 1.252 . . . . 0.0 113.125 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 5.6 p90 -168.93 171.17 8.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.955 -1.93 . . . . 0.0 110.732 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 62' ' ' ASN . 35.9 tp -129.86 123.52 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.555 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 69.9 tt0 -118.65 129.42 55.29 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.421 HG22 ' HB1' ' A' ' 61' ' ' ALA . 43.2 t -131.46 121.74 48.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.965 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.496 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.9 mp0 -105.37 129.1 53.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.752 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.9 p90 -152.69 167.36 29.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.307 0.575 . . . . 0.0 111.896 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.441 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 96.8 m-20 -123.51 159.56 28.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.066 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.6 m -114.47 107.43 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -111.08 158.06 36.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -54.81 143.92 68.65 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.962 1.775 . . . . 0.0 111.912 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.691 ' CD1' HG11 ' A' ' 55' ' ' VAL . 10.6 t80 -78.19 -77.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.022 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.499 ' CG ' ' CD2' ' A' ' 131' ' ' TYR . 0.0 OUTLIER -142.28 101.77 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.362 178.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.19 136.16 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.837 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.099 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.538 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD23 ' HD2' ' A' ' 31' ' ' PRO . 10.5 mt -67.05 150.85 97.69 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.03 0.443 . . . . 0.0 110.911 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' HD23 ' A' ' 30' ' ' LEU . 19.3 Cg_endo -63.32 173.13 4.48 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.822 2.348 . . . . 0.0 112.069 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 57.7 t80 -73.01 6.59 2.56 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.681 -0.408 . . . . 0.0 109.947 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . 62.19 -1.47 1.41 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.892 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.612 HD23 ' C ' ' A' ' 34' ' ' LEU . 5.9 tt -158.37 98.29 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.039 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.626 ' SD ' ' OD1' ' A' ' 127' ' ' ASP . 2.4 ttp 47.59 165.45 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.472 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 -91.17 137.92 31.99 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -149.7 137.33 20.09 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.41 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.448 ' HB3' HD11 ' A' ' 46' ' ' ILE . 57.9 mm-40 -134.86 148.98 50.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.901 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -140.28 144.46 36.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.254 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.908 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -145.97 145.33 30.6 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.108 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.7 m -66.2 131.08 45.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.725 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -42.24 132.04 3.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.685 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.5 76.38 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.065 -0.97 . . . . 0.0 113.252 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -118.06 151.09 48.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 118.238 1.019 . . . . 0.0 110.309 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.94 139.7 33.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.616 2.211 . . . . 0.0 113.384 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 38' ' ' GLU . 20.7 tt -114.65 140.64 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -117.51 132.3 56.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.689 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' GLN . 10.7 mt -114.87 142.22 46.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.401 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -149.8 134.84 17.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.646 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.457 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.5 m -102.15 142.76 25.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.932 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 44.3 Cg_endo -69.73 156.44 63.41 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.846 2.364 . . . . 0.0 112.01 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.08 -127.9 29.58 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.241 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 p -110.59 23.9 13.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.039 -0.58 . . . . 0.0 111.303 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -79.34 169.34 18.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.74 146.88 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.413 0.625 . . . . 0.0 110.598 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.671 HG23 ' CD1' ' A' ' 126' ' ' TYR . 85.5 mt -68.18 137.19 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.063 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.1 ptm -132.34 100.81 5.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.641 HG23 ' OD1' ' A' ' 97' ' ' ASN . 41.1 t -64.54 125.38 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.667 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -101.94 -48.91 4.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.671 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -153.48 150.35 28.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.444 0.64 . . . . 0.0 110.417 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -170.53 156.18 5.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.595 ' O ' HD12 ' A' ' 122' ' ' LEU . 8.8 t30 -150.58 154.9 38.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.785 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.411 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 33.9 t80 -117.31 117.47 29.62 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.65 -137.71 5.35 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.498 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.685 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -160.61 121.83 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.368 0.604 . . . . 0.0 112.036 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 HG21 ' CE1' ' A' ' 84' ' ' TYR . 8.1 p -124.2 8.9 8.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.54 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.622 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 49.4 t0 -143.6 -170.14 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.834 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.574 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 22.3 p30 -148.17 -0.4 0.59 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.745 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -104.56 7.57 35.2 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.0 mm -108.51 135.6 46.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.6 m 55.58 69.95 0.68 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 34.4 p30 -48.39 111.87 0.51 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.62 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.29 -162.18 1.18 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.766 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -64.18 141.37 98.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.473 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.6 Cg_endo -55.95 -38.95 93.93 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.393 2.062 . . . . 0.0 112.904 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.81 -34.48 77.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.048 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.766 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 72.3 mt-30 -87.23 -11.96 48.18 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.302 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.477 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.4 mmm -100.59 -3.98 29.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.372 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 21.6 mt-10 -66.9 -47.57 71.37 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.9 t30 -79.31 119.81 22.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.752 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.7 m -110.4 33.3 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.782 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -141.63 86.9 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.312 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 51.3 t -149.8 120.85 7.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.886 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.559 ' CE1' HG21 ' A' ' 66' ' ' THR . 97.3 m-85 -131.24 149.57 52.51 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.913 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' A' ' 63' ' ' TYR . 38.1 tp -138.42 90.85 12.88 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.32 -47.76 25.67 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.657 2.238 . . . . 0.0 113.364 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 69.4 m-20 -54.33 -23.74 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.03 54.44 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.938 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 58' ' ' VAL . 61.5 t80 -65.05 -43.43 92.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.82 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 15.5 pttm -64.44 -39.99 94.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.293 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.642 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 72.3 mt -58.55 -50.53 78.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.023 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.412 ' HE3' ' SG ' ' A' ' 96' ' ' CYS . 93.8 mmm -68.43 -35.47 77.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.062 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.479 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.4 m -58.1 -48.49 80.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.355 0.597 . . . . 0.0 110.647 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -67.7 -37.51 82.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.439 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.642 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 66.8 mtt-85 -76.61 -36.4 57.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.412 ' SG ' ' HE3' ' A' ' 92' ' ' MET . 4.7 m -114.16 -20.74 10.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.641 ' OD1' HG23 ' A' ' 58' ' ' VAL . 46.5 m-20 -59.36 139.87 56.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.683 -178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 23.5 m-20 70.6 15.04 7.18 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.956 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -119.17 149.9 40.96 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.048 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 m -70.48 -32.92 70.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -144.81 158.77 43.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.848 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 29.9 t -155.15 142.81 19.78 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.317 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.0 129.11 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.133 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 t -145.33 142.59 22.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.272 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.0 t -77.02 119.15 24.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.382 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.05 30.94 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.055 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 177.95 175.99 45.57 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.652 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 3.1 t 95.95 -158.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.266 0.555 . . . . 0.0 110.872 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -65.78 -8.56 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.365 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.499 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -82.01 -11.47 58.81 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.073 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.2 m-85 -140.62 126.43 11.48 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.976 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.602 ' O ' ' O ' ' A' ' 111' ' ' PHE . 51.0 Cg_exo -46.24 -159.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.792 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.45 93.23 12.86 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.264 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.89 -55.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.222 2.615 . . . . 0.0 112.991 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.473 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 26.5 p -127.47 90.3 48.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.508 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.37 140.03 47.17 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.897 2.398 . . . . 0.0 111.814 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.05 4.62 56.57 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.735 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.4 m -127.71 146.53 50.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.565 0.682 . . . . 0.0 109.351 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.685 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 29.3 t80 -86.52 99.14 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.473 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 23.0 mttt -73.35 -156.22 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.436 1.112 . . . . 0.0 113.645 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -175.41 174.94 2.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.753 -2.022 . . . . 0.0 110.105 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 62' ' ' ASN . 16.9 tp -131.9 123.52 27.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.265 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.481 ' HG2' HE21 ' A' ' 125' ' ' GLN . 83.7 tt0 -115.18 128.34 56.12 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.14 118.27 40.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.723 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.481 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.3 mt-30 -106.34 129.17 54.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.671 ' CD1' HG23 ' A' ' 56' ' ' ILE . 40.3 p90 -153.26 171.48 18.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.444 0.64 . . . . 0.0 111.774 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.626 ' OD1' ' SD ' ' A' ' 35' ' ' MET . 0.5 OUTLIER -129.6 160.82 32.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.204 178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 86.2 m -110.38 123.79 50.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.74 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.83 157.4 63.19 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.115 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.35 149.65 88.49 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.442 2.095 . . . . 0.0 112.316 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -79.27 -5.05 53.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.686 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -136.02 102.61 5.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.719 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.74 132.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.071 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.988 179.266 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.473 ' H63' ' N ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 29' ' ' GLY . 1.8 mm? 29.22 87.44 0.1 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.958 0.409 . . . . 0.0 110.872 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.34 150.67 19.63 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.001 2.467 . . . . 0.0 111.878 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -82.6 -1.42 50.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.408 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.89 42.06 39.22 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.523 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.72 39.61 0.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.095 0.474 . . . . 0.0 110.912 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.3 ttm 64.43 143.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.089 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 36' ' ' ARG . 50.7 mtp85 -92.63 147.38 22.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 60.5 ttp180 -148.85 135.99 20.06 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.501 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 28.6 mp0 -133.18 148.76 52.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.098 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.48 144.78 38.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.943 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -144.3 143.75 31.15 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.428 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.9 m -69.26 132.53 46.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.342 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.61 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 37.7 tt0 -44.63 139.95 2.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.21 -8.08 80.44 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.601 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -113.55 149.96 42.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 118.343 1.072 . . . . 0.0 110.878 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.49 139.58 49.59 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.636 2.224 . . . . 0.0 113.116 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 9.3 tt -118.42 146.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.725 ' CD ' HH21 ' A' ' 49' ' ' ARG . 88.1 tt0 -129.7 129.94 44.86 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.483 HD12 ' SG ' ' A' ' 96' ' ' CYS . 29.6 mt -114.17 146.67 40.03 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.725 HH21 ' CD ' ' A' ' 47' ' ' GLU . 84.1 mtt180 -147.17 136.24 22.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.192 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -103.15 137.01 19.14 Favored Pre-proline 0 C--N 1.333 -0.134 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.156 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.92 158.81 56.44 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.498 2.132 . . . . 0.0 112.061 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.56 -130.62 34.7 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.5 p -108.43 26.01 10.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.608 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -79.85 165.19 22.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.916 0.389 . . . . 0.0 110.8 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 129' ' ' VAL . 31.0 m -127.74 145.81 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.054 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.002 HG23 ' CD1' ' A' ' 126' ' ' TYR . 84.9 mt -69.37 138.3 22.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.575 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.6 ptp -132.08 99.27 4.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG12 ' CE1' ' A' ' 89' ' ' PHE . 47.0 t -62.53 123.63 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.512 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.96 -47.73 3.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.738 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -146.27 142.45 28.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.547 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.57 154.0 11.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.675 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.787 ' O ' HD12 ' A' ' 122' ' ' LEU . 7.7 t30 -152.26 150.29 29.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 112.054 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.615 ' HB3' HD23 ' A' ' 85' ' ' LEU . 47.2 t80 -117.21 119.97 36.84 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.27 -138.41 5.86 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 10.6 ttm-85 -158.4 119.16 3.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.4 0.619 . . . . 0.0 111.378 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.563 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 32.3 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.349 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 16.0 t70 -146.99 -170.95 3.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.944 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 51.4 p30 -146.92 -2.06 0.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.521 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -102.88 5.15 38.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.86 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.9 mm -106.8 137.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.129 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.8 m 56.89 66.2 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.409 -0.517 . . . . 0.0 109.628 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.6 p-10 -47.98 121.34 4.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.592 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -143.79 -165.73 2.18 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.738 ' CG ' HE21 ' A' ' 77' ' ' GLN . 0.4 OUTLIER -63.7 140.63 97.84 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.174 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.532 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -56.33 -36.91 97.61 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.983 2.455 . . . . 0.0 114.151 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -65.82 -32.71 74.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.487 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.738 HE21 ' CG ' ' A' ' 74' ' ' ASP . 27.7 mt-30 -88.82 10.43 21.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.691 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.4 mtm -132.82 0.9 3.57 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.398 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.6 mt-10 -63.16 -48.0 80.28 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.721 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -76.17 114.66 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 111.773 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.511 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 35.9 m -107.08 31.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.978 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.511 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.3 mm100 -141.4 87.45 2.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 15.5 t -148.06 123.51 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.502 ' HA ' HD21 ' A' ' 62' ' ' ASN . 91.7 m-85 -127.86 151.96 48.42 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.55 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 63' ' ' TYR . 57.9 tp -146.95 85.73 6.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.092 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -45.89 -44.36 18.58 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.21 2.607 . . . . 0.0 114.665 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 51.1 m-20 -56.02 -24.76 41.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.04 -31.44 51.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' O ' ' OG ' ' A' ' 93' ' ' SER . 82.5 t80 -65.17 -47.36 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 12.6 pttp -64.82 -37.71 88.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.741 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 93.7 mt -61.79 -52.46 60.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.405 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.485 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 31.2 m -63.15 -47.54 82.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.016 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -68.08 -36.67 80.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 73.6 mtt180 -76.88 -33.62 57.82 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 48' ' ' LEU . 82.7 m -110.52 -22.18 11.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 88.6 m-20 -57.54 134.02 55.75 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.399 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 66.89 9.79 7.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.038 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.621 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 62.4 mtt85 -111.97 146.43 37.85 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.253 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.4 m -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.547 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.21 156.01 34.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -154.65 142.4 19.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 59.6 t -123.58 123.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.078 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.572 HG13 ' NH1' ' A' ' 95' ' ' ARG . 45.2 t -138.08 145.75 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.33 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -77.78 118.49 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.28 41.59 0.05 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.646 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.78 -125.5 0.99 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.593 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 107' ' ' GLY . 32.5 t 31.06 -155.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.383 0.611 . . . . 0.0 111.578 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.466 ' N ' ' OG ' ' A' ' 108' ' ' SER . 96.5 m-20 -65.17 -10.51 31.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.712 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.18 -13.51 59.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.472 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.1 m-85 -142.19 130.27 11.66 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.061 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 48.4 Cg_exo -47.66 -157.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.713 2.276 . . . . 0.0 112.546 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -139.08 91.75 11.22 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.45 -46.49 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.509 2.139 . . . . 0.0 113.168 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.6 p -140.69 85.21 13.0 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.855 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -58.97 146.9 92.38 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.239 2.626 . . . . 0.0 111.728 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.98 63.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.324 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.638 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 91.0 m -130.98 144.36 51.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.3 t80 -86.54 96.66 10.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.458 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 24.1 mtmm -74.27 -168.49 0.66 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.927 1.346 . . . . 0.0 114.005 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.781 ' HB2' HD21 ' A' ' 39' ' ' LEU . 12.7 p90 -167.03 169.07 13.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.146 -2.297 . . . . 0.0 110.68 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 62' ' ' ASN . 58.9 tp -131.4 125.64 33.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.343 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.617 ' OE1' HD12 ' A' ' 39' ' ' LEU . 10.6 tp10 -118.48 131.28 56.25 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.895 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.547 HG22 ' HB1' ' A' ' 61' ' ' ALA . 44.0 t -135.39 123.07 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.467 HE21 ' HG3' ' A' ' 123' ' ' GLU . 2.3 mt-30 -107.39 126.76 52.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.829 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.002 ' CD1' HG23 ' A' ' 56' ' ' ILE . 34.9 p90 -153.78 168.35 26.59 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.743 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 92.6 m-20 -119.89 159.61 24.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.964 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 55.0 m -111.49 111.42 22.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.353 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 55' ' ' VAL . 5.1 m -115.72 156.45 46.29 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -55.13 148.43 49.07 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.124 1.882 . . . . 0.0 111.981 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -74.68 -96.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -91.7 131.12 37.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.896 0.379 . . . . 0.0 110.645 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 134' ' ' GLU . 14.0 p -88.32 138.97 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.979 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 133' ' ' VAL . 81.7 tt0 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.003 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.445 ' H82' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.653 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.596 ' O ' ' O ' ' A' ' 31' ' ' PRO . 9.7 mp 54.81 60.66 9.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 110.047 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 30' ' ' LEU . 81.9 Cg_exo -38.69 -118.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.718 2.945 . . . . 0.0 112.571 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.542 ' C ' ' H ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -77.31 -6.73 54.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.313 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.35 -29.5 0.26 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.134 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 32' ' ' PHE . 18.9 tp -162.18 110.33 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.036 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 34' ' ' LEU . 83.4 mtp 58.48 151.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.365 0.602 . . . . 0.0 111.608 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.71 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 68.3 mtp85 -90.25 142.74 27.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.148 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.593 ' HE ' ' CG ' ' A' ' 125' ' ' GLN . 40.8 ttm180 -147.08 132.57 18.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.539 0.685 . . . . 0.0 110.972 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.499 ' HG3' HD23 ' A' ' 48' ' ' LEU . 67.9 mm-40 -128.13 143.01 51.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.524 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.9 tt -139.24 137.97 36.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.795 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.673 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.6 142.88 32.21 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.124 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 31.0 m -67.89 138.1 55.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.935 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 13.8 tt0 -42.86 139.28 1.72 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.3 0.572 . . . . 0.0 112.512 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.99 -5.55 83.15 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.735 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -115.41 152.79 47.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 118.506 1.153 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.24 143.55 39.8 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 122.512 2.141 . . . . 0.0 113.461 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 tt -117.02 143.64 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.654 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 88.0 tt0 -126.14 127.99 46.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.423 0.63 . . . . 0.0 111.698 -177.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.8 HD12 ' SG ' ' A' ' 102' ' ' CYS . 23.3 mt -113.57 140.75 47.91 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.71 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 97.4 mtt180 -144.79 131.23 19.76 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.828 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.2 m -100.65 146.63 32.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.27 157.28 37.5 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.343 2.028 . . . . 0.0 112.415 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 54.9 -133.98 47.87 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.166 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.6 p -107.2 25.3 11.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.114 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -78.65 165.98 23.04 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.94 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.8 m -124.45 145.78 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.488 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.847 HG23 ' CD2' ' A' ' 126' ' ' TYR . 77.9 mt -68.67 135.7 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.628 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.2 ptm -129.96 100.06 5.32 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.97 124.48 19.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.43 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -100.13 -51.2 3.74 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.441 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 40.6 m-80 -150.03 147.51 27.92 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.998 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.787 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -163.25 151.47 13.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.858 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.567 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.2 t30 -152.41 148.62 27.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.403 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 59.4 t80 -117.93 123.62 46.26 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.443 ' HA2' ' CD ' ' A' ' 120' ' ' LYS . . . 158.83 -139.6 6.36 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.616 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 5.1 ttm180 -157.11 116.79 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.442 . . . . 0.0 111.51 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.458 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 41.8 p -125.37 8.8 7.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.228 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.9 t0 -147.49 158.33 43.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.558 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p30 -115.23 3.17 14.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.697 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 16.8 mtpt -105.23 0.58 27.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.735 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.4 mm -113.14 138.46 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.4 m 59.81 61.18 1.98 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 109.737 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -51.96 125.98 16.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.004 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.44 -164.83 2.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.006 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.673 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -60.87 135.0 92.67 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 3.6 Cg_endo -52.3 -33.38 55.34 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.409 2.073 . . . . 0.0 113.934 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.15 -34.88 79.05 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.673 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 30.0 mt-30 -89.08 12.59 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.524 ' HE1' ' O ' ' A' ' 68' ' ' ASP . 82.9 mtp -129.36 -3.81 4.9 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.082 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.0 mt-10 -59.99 -50.93 71.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.532 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -78.41 113.88 16.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 29.6 m -105.39 32.44 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.289 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.2 mm100 -141.05 87.95 2.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.503 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 31.5 t -146.54 122.88 10.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -129.97 152.05 49.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.941 0.4 . . . . 0.0 111.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.708 HD21 ' HG2' ' A' ' 112' ' ' PRO . 32.9 tp -144.63 90.43 6.45 Favored Pre-proline 0 CA--C 1.528 0.106 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.968 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -48.78 -47.24 21.72 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.648 2.232 . . . . 0.0 113.743 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.2 m-20 -56.72 -29.13 62.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.38 -32.04 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.832 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 60' ' ' ASN . 74.0 t80 -64.46 -40.32 95.48 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 3.4 ptmt -66.54 -40.95 89.34 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.618 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.493 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 77.8 mt -59.88 -50.32 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.104 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.929 ' SD ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.03 -32.72 73.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.366 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 53.4 m -62.48 -47.15 85.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.676 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -67.46 -33.56 75.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 58.1 mtt180 -79.81 -32.11 40.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 48' ' ' LEU . 63.5 m -113.7 -16.36 12.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.559 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.5 m-20 -60.06 130.9 48.99 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.595 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 68.86 14.66 8.93 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.858 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 93.4 mtt180 -115.05 146.74 40.98 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.274 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.2 m -72.2 -32.13 66.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.739 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.16 154.58 32.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.233 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.8 ' SG ' HD12 ' A' ' 48' ' ' LEU . 19.1 p -153.46 148.59 26.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.908 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -127.62 126.22 66.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.2 t -142.49 143.13 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.27 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 t -77.23 118.2 23.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -71.6 44.48 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.53 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.59 -124.92 0.93 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.689 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER 28.13 -153.34 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 111.183 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -64.12 -10.15 20.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.077 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.0 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.292 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 59.3 m-85 -143.51 130.21 10.45 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.396 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.708 ' HG2' HD21 ' A' ' 85' ' ' LEU . 31.9 Cg_exo -47.74 -158.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.443 2.096 . . . . 0.0 112.479 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -138.81 91.91 11.54 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.68 -38.83 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.518 2.145 . . . . 0.0 113.14 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.05 84.4 11.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.674 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -65.6 139.84 60.07 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.259 2.639 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.5 -1.38 62.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.367 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.576 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 22.3 m -114.07 146.35 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.5 t80 -87.43 97.16 10.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 24.3 mtmm -74.58 -165.84 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.952 1.358 . . . . 0.0 114.251 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HB2' HD21 ' A' ' 39' ' ' LEU . 12.9 p90 -165.26 165.58 19.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.317 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.631 HD21 ' SD ' ' A' ' 92' ' ' MET . 25.7 tp -128.12 126.38 41.01 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.2 tt0 -124.82 127.55 47.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.753 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.929 HG21 ' SD ' ' A' ' 92' ' ' MET . 60.4 t -131.83 128.19 59.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.115 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.593 ' CG ' ' HE ' ' A' ' 37' ' ' ARG . 3.1 mp0 -109.83 132.15 54.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.327 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.847 ' CD2' HG23 ' A' ' 56' ' ' ILE . 42.4 p90 -156.84 171.71 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 57' ' ' MET . 73.2 m-20 -129.58 161.12 31.25 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.791 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.8 m -113.33 124.62 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.677 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.9 157.36 60.38 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.142 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -54.93 140.93 79.17 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.641 1.561 . . . . 0.0 111.272 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -83.37 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.241 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -103.32 132.07 49.87 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.109 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.5 p -93.73 133.24 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.847 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.794 -179.739 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.576 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.5 mt -112.35 109.89 53.63 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.357 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.96 -13.35 1.76 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.297 1.998 . . . . 0.0 112.085 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -153.55 -49.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.726 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.67 21.89 73.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 35' ' ' MET . 23.3 tp -160.82 119.33 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.717 0.294 . . . . 0.0 110.465 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 34' ' ' LEU . 16.7 mtt 49.91 109.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.714 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HD2' HH11 ' A' ' 36' ' ' ARG . 0.2 OUTLIER -89.95 151.86 21.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -146.76 136.22 22.87 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.109 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' CB ' HD11 ' A' ' 46' ' ' ILE . 68.1 mm-40 -130.14 147.35 51.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.557 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.1 tt -139.61 134.97 32.83 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.63 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.52 147.37 45.14 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.406 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -67.67 131.52 45.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.869 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 61.4 tt0 -42.14 138.47 1.62 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.601 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.52 79.2 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.611 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.55 147.46 40.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 118.52 1.16 . . . . 0.0 110.493 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.08 137.81 45.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.758 2.306 . . . . 0.0 112.605 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.483 HD11 ' CB ' ' A' ' 38' ' ' GLU . 17.5 tt -111.23 148.36 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -127.78 127.72 44.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.003 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.5 mt -116.83 144.83 44.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.363 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -149.23 133.65 17.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.22 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.5 m -99.88 138.74 20.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.162 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -66.94 161.35 42.84 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.65 2.233 . . . . 0.0 113.244 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.7 -136.4 13.65 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 p -97.43 23.51 7.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.821 -0.69 . . . . 0.0 110.407 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -79.39 161.3 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.782 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.8 143.4 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.165 0.507 . . . . 0.0 110.396 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.84 HG23 ' CD2' ' A' ' 126' ' ' TYR . 93.6 mt -68.67 139.97 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.447 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 2.0 ptp -135.15 103.25 5.47 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.912 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.615 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.4 t -63.88 124.62 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.248 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -102.59 -51.34 3.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.91 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -150.27 145.43 26.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.578 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.36 154.73 7.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.401 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.671 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.4 t30 -152.41 153.44 33.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.286 0.565 . . . . 0.0 111.559 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.567 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 50.1 t80 -118.81 124.34 46.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.11 -141.92 8.39 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.529 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.531 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 11.1 ttm-85 -151.71 115.56 4.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.313 0.578 . . . . 0.0 110.724 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.479 HG21 ' CE2' ' A' ' 84' ' ' TYR . 13.5 p -121.07 6.8 10.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.83 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 11.7 t70 -142.9 -169.62 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.698 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.496 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 40.9 p-10 -150.55 -2.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 110.41 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -100.44 4.94 44.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.79 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 138.58 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m 60.19 63.21 1.45 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -47.66 115.74 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.347 0.594 . . . . 0.0 111.645 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.47 -163.02 1.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.73 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.637 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.66 140.25 97.98 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.707 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 Cg_endo -56.81 -31.41 88.45 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 121.942 1.761 . . . . 0.0 111.999 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -64.37 -35.44 80.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.811 ' O ' HG23 ' A' ' 118' ' ' THR . 79.6 mt-30 -87.7 -13.17 43.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.048 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.489 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 4.5 mtm -107.86 -2.17 20.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.95 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 9.2 mt-10 -63.92 -46.52 84.45 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.889 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -78.66 115.11 18.15 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.821 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.457 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 12.0 m -106.48 32.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.338 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.457 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.8 mm-40 -139.68 85.36 2.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.857 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.8 t -151.05 115.74 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.479 ' CE2' HG21 ' A' ' 66' ' ' THR . 68.7 m-85 -124.97 157.66 35.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.913 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 63' ' ' TYR . 62.1 tp -148.13 87.83 5.64 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.726 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -46.96 -46.5 18.59 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.735 2.29 . . . . 0.0 114.064 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -53.32 -27.07 21.27 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.66 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.738 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.615 ' CE1' HG12 ' A' ' 58' ' ' VAL . 45.9 t80 -67.51 -47.19 70.69 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.2 pttt -65.0 -39.61 93.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.585 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.6 mt -59.79 -45.43 94.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.944 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 91.4 mmm -69.82 -37.34 76.19 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.249 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.467 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 66.3 m -58.57 -45.12 89.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.496 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -65.24 -38.82 91.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.338 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.409 HH11 HG13 ' A' ' 104' ' ' VAL . 61.5 mtt180 -76.09 -34.01 59.52 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.6 m -113.88 -16.83 12.16 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.467 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -58.99 136.53 57.97 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.52 -0.737 . . . . 0.0 111.839 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 69.96 13.12 7.92 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.944 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -112.42 145.33 40.35 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.221 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.5 m -71.21 -30.13 66.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -143.79 158.53 43.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.431 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 t -155.82 137.03 13.82 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.764 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.2 t -126.23 128.9 71.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.497 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 46' ' ' ILE . 58.7 t -146.34 142.86 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -74.85 116.24 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.9 42.46 0.07 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.547 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.18 -125.99 1.04 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.95 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.549 ' O ' ' O ' ' A' ' 107' ' ' GLY . 44.5 t 28.94 -155.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.459 0.647 . . . . 0.0 112.039 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.542 ' N ' ' OG ' ' A' ' 108' ' ' SER . 71.2 m-20 -62.19 -9.68 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.4 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.0 -11.16 59.8 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.11 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.578 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.9 m-85 -143.45 126.68 9.02 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.795 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.578 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.0 Cg_exo -47.7 -157.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.826 2.35 . . . . 0.0 112.42 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -139.1 88.88 12.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -75.69 -46.51 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.832 2.355 . . . . 0.0 112.838 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -132.31 79.53 65.64 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-O 121.673 0.749 . . . . 0.0 110.589 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 26.3 Cg_exo -57.5 130.14 37.45 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.846 2.364 . . . . 0.0 111.919 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.16 -9.32 46.15 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.941 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.3 m -106.57 148.41 28.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.997 0.898 . . . . 0.0 108.965 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.518 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 8.2 t80 -88.27 97.85 11.26 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 14.1 mttt -75.78 -154.1 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.912 1.339 . . . . 0.0 113.435 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.531 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -173.74 170.01 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.11 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.4 tp -131.53 125.03 31.34 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HG2' HE21 ' A' ' 125' ' ' GLN . 76.6 tt0 -118.05 127.54 53.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.039 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.462 HG22 ' HB1' ' A' ' 61' ' ' ALA . 59.5 t -131.13 123.43 53.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.638 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.544 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.5 mp0 -109.96 131.16 55.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.688 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.84 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.0 p90 -152.92 165.94 33.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.165 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.442 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 36.6 m-20 -116.97 161.82 18.76 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.311 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.407 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 94.5 m -116.25 115.91 26.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.838 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.4 156.32 67.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.228 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -54.86 148.27 47.24 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.025 1.817 . . . . 0.0 112.159 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -73.3 -77.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.674 ' H ' ' CD ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -96.3 138.96 33.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.016 0.436 . . . . 0.0 111.395 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 133' ' ' VAL . 33.4 m -148.51 115.73 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.226 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.512 -179.422 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.49 ' O3 ' ' NZ ' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' C ' HD23 ' A' ' 30' ' ' LEU . 1.6 tt -130.46 88.18 48.02 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.824 0.345 . . . . 0.0 110.545 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -52.99 149.91 25.2 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.684 2.256 . . . . 0.0 112.573 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -82.38 -2.5 53.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.368 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.89 19.96 79.75 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.7 OUTLIER -159.62 49.4 0.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 0.0 110.326 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.427 ' HG2' ' N ' ' A' ' 36' ' ' ARG . 43.0 ttm 57.68 161.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.115 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.427 ' N ' ' HG2' ' A' ' 35' ' ' MET . 3.6 mtt-85 -90.72 144.56 25.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HD2' ' OE2' ' A' ' 123' ' ' GLU . 50.6 ttp85 -150.77 133.81 16.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.312 0.577 . . . . 0.0 111.906 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 53.3 mp0 -130.62 149.35 52.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.368 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.738 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -141.6 139.06 33.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.665 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.738 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.95 142.97 36.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.201 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.5 m -71.62 134.6 46.49 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 81.8 tt0 -42.95 135.8 2.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.576 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.94 -9.74 63.84 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.086 -0.961 . . . . 0.0 114.099 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.72 150.58 47.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 119.03 1.415 . . . . 0.0 110.741 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 20.9 Cg_endo -68.23 142.51 55.65 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.072 1.848 . . . . 0.0 111.866 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.9 tt -118.03 143.88 27.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 88.8 tt0 -130.19 129.18 43.08 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.505 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD12 ' SG ' ' A' ' 96' ' ' CYS . 13.6 mt -110.29 146.03 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.336 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.549 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 72.4 mtt180 -145.41 134.23 22.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.786 -0.765 . . . . 0.0 111.36 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.462 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -102.52 142.9 25.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.77 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 42.6 Cg_endo -69.75 155.11 66.84 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.658 2.238 . . . . 0.0 112.607 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.68 -131.84 35.65 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.199 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -105.18 25.32 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.844 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -79.71 164.18 23.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.738 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.35 147.74 32.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 0.0 110.083 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.957 HG23 ' CD2' ' A' ' 126' ' ' TYR . 86.3 mt -71.66 139.88 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.33 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.465 ' HG3' ' H ' ' A' ' 127' ' ' ASP . 2.9 ptp -132.02 102.17 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.536 HG12 ' CE1' ' A' ' 89' ' ' PHE . 63.4 t -63.95 124.58 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.221 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.0 mm-40 -103.03 -51.76 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 7.6 m-20 -148.94 146.78 28.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.136 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.76 156.53 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.005 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.574 HD21 ' HA ' ' A' ' 84' ' ' TYR . 8.7 t30 -152.91 150.79 29.64 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.954 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -119.38 124.99 47.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.57 -138.46 6.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.67 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -154.6 114.57 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.408 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.485 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 6.0 p -125.51 6.46 7.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.1 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -148.26 156.95 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.541 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' O ' ' CE ' ' A' ' 78' ' ' MET . 55.9 p30 -118.33 5.81 11.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.03 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -103.76 4.62 35.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.967 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 mm -113.03 136.94 47.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.49 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.1 m 54.98 72.4 0.48 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.805 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -55.77 124.7 18.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.97 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -141.22 -164.14 1.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.739 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.73 ' CG ' HE21 ' A' ' 77' ' ' GLN . 2.7 p-10 -59.1 139.48 87.73 Favored Pre-proline 0 C--N 1.333 -0.132 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.399 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -54.67 -37.32 91.31 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.591 2.194 . . . . 0.0 113.672 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -62.51 -34.95 77.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.934 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.73 HE21 ' CG ' ' A' ' 74' ' ' ASP . 31.0 mt-30 -88.23 9.49 22.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.068 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . 77.2 mtp -122.69 -6.24 8.6 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.385 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 90.7 mt-10 -62.63 -49.24 75.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.994 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.34 116.3 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.625 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -107.01 34.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.262 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 92.9 mm-40 -139.84 85.35 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.085 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.476 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 26.5 t -148.97 121.68 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.574 ' HA ' HD21 ' A' ' 62' ' ' ASN . 38.0 m-85 -130.44 153.05 49.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.505 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 88' ' ' ALA . 44.4 tp -141.65 94.29 7.44 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.98 -48.22 22.66 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.556 2.171 . . . . 0.0 113.173 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.5 m-20 -56.77 -24.88 53.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.503 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.63 -30.81 44.56 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.733 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.536 ' CE1' HG12 ' A' ' 58' ' ' VAL . 53.7 t80 -64.91 -42.84 94.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 2.1 ptpt -64.19 -42.18 96.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.785 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.711 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 36.4 mt -60.1 -50.0 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.173 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.441 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 95.9 mmm -66.71 -34.91 78.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.741 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.556 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.4 m -59.84 -45.92 90.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.066 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -65.85 -34.22 77.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.489 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.711 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 31.5 mtm180 -80.97 -32.19 34.5 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.766 ' SG ' HD12 ' A' ' 48' ' ' LEU . 84.2 m -109.6 -19.61 13.14 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 93' ' ' SER . 82.1 m-20 -58.75 133.99 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.249 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 65.02 12.74 8.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.581 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -114.94 146.23 41.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.0 m -72.22 -31.65 66.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.924 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 157.77 42.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.61 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.721 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.8 p -154.82 142.15 19.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.641 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 47.1 t -116.53 131.91 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.491 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.521 HG11 ' NH2' ' A' ' 95' ' ' ARG . 90.5 t -144.46 140.8 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.607 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -80.54 119.46 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.59 28.55 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.722 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 176.88 177.11 45.57 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.954 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 4.2 t 92.78 -155.66 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.996 0.427 . . . . 0.0 110.774 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -62.21 -11.09 12.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.905 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.5 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -78.52 -19.31 53.23 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.296 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.9 m-85 -136.98 129.26 17.06 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.992 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.5 Cg_exo -48.68 -155.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.47 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -138.49 89.48 13.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 0.0 110.095 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.0 -30.67 0.67 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.064 2.51 . . . . 0.0 113.544 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.579 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -149.04 66.46 8.68 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-O 120.93 0.395 . . . . 0.0 111.192 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.22 135.27 69.11 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.122 1.881 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' N ' ' O2 ' ' A' ' 136' ' ' RAM . . . 106.47 -14.99 42.61 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.766 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.501 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 20.8 m -107.79 153.52 22.87 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.146 0.973 . . . . 0.0 109.433 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.559 ' HB3' HH12 ' A' ' 65' ' ' ARG . 7.6 t80 -86.73 97.47 10.61 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.579 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 13.2 mttp -72.4 -164.13 0.14 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.903 -1.498 . . . . 0.0 113.528 -177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.613 ' HB2' HD21 ' A' ' 39' ' ' LEU . 9.3 p90 -170.44 167.2 8.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.138 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.8 tp -129.2 124.79 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.9 tt0 -119.9 125.08 47.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.9 t -128.26 123.5 60.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.684 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -109.64 128.82 55.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.142 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.957 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.5 p90 -153.33 174.01 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.377 0.608 . . . . 0.0 111.637 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.465 ' H ' ' HG3' ' A' ' 57' ' ' MET . 21.9 m-20 -127.43 162.62 25.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.225 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.474 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.0 m -112.22 120.22 41.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.47 156.93 74.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.839 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -56.52 141.68 90.26 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.047 1.831 . . . . 0.0 112.967 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -74.8 -45.47 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.177 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -97.1 -177.31 3.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.793 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.575 ' O ' ' OXT' ' A' ' 134' ' ' GLU . 4.0 p -88.93 142.58 12.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.575 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 72.1 mm-40 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.577 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.654 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.586 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -53.68 -44.68 98.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.699 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 26.8 Cg_exo -57.34 148.67 69.83 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.885 2.39 . . . . 0.0 113.293 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -83.2 -4.44 58.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.373 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.41 34.82 31.19 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.87 44.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.632 0.253 . . . . 0.0 110.606 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.595 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 26.6 ttm 61.52 166.26 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' CZ ' ' HD3' ' A' ' 51' ' ' PRO . 87.0 mtt-85 -96.45 138.55 33.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.224 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.419 ' HD2' HH11 ' A' ' 37' ' ' ARG . 12.8 ttp180 -148.0 138.93 23.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 111.688 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.612 ' O ' ' OE2' ' A' ' 123' ' ' GLU . 71.4 mm-40 -131.86 146.01 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.608 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.722 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -139.72 137.53 35.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.818 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.99 145.21 37.55 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.137 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -65.89 132.77 49.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.254 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 37.2 tt0 -43.14 134.78 3.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.397 -0.819 . . . . 0.0 113.13 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 90.3 -1.23 79.34 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.69 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -116.16 146.25 36.78 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 118.219 1.01 . . . . 0.0 110.674 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 136.93 48.62 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.753 2.302 . . . . 0.0 112.141 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 15.5 tt -113.86 151.8 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.16 127.1 44.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.505 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.793 HD12 ' SG ' ' A' ' 102' ' ' CYS . 50.2 mt -113.54 142.89 45.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -151.19 134.81 16.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.054 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -101.25 142.44 24.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.719 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -64.18 157.83 51.61 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.798 2.332 . . . . 0.0 112.589 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.8 -124.78 7.3 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.299 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.6 p -109.83 22.6 15.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.005 -0.598 . . . . 0.0 111.089 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.59 167.83 20.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.34 145.71 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.348 0.594 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.745 HG23 ' CD2' ' A' ' 126' ' ' TYR . 81.8 mt -70.27 137.55 23.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.667 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 127' ' ' ASP . 2.7 ptp -134.34 100.37 4.66 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.29 124.6 18.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.451 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 73.2 mm-40 -99.77 -48.58 4.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 19.1 m-80 -153.92 152.59 30.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.686 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' A' ' 124' ' ' VAL . . . -168.91 158.03 8.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.6 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.497 HD21 ' HA ' ' A' ' 84' ' ' TYR . 4.2 t30 -149.98 148.98 29.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 111.606 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.512 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 65.3 t80 -119.47 121.74 40.14 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 155.88 -140.53 7.35 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.6 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 8.2 ttm180 -149.35 118.47 6.77 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 111.23 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.574 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 13.6 p -124.4 3.61 8.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.023 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 22.5 t70 -148.45 154.93 40.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.571 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.519 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 43.6 p30 -112.17 5.76 18.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.252 0.548 . . . . 0.0 109.767 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.589 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 29.6 mttt -104.27 7.29 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.8 mm -114.1 135.52 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 110.622 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.4 m 50.1 80.76 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.02 125.67 24.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.321 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.3 -163.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p30 -63.97 138.44 97.4 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.626 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.3 Cg_endo -53.76 -33.65 71.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.007 1.805 . . . . 0.0 112.24 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -63.69 -36.01 82.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.475 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.809 ' O ' HG23 ' A' ' 118' ' ' THR . 76.7 mt-30 -85.94 -10.18 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.787 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.505 ' CE ' HH12 ' A' ' 65' ' ' ARG . 74.0 mtp -104.01 -2.6 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.905 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 67.7 mt-10 -64.49 -48.69 74.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -77.25 114.11 15.72 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.811 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.499 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 23.1 m -107.96 29.61 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.57 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -139.18 82.99 1.92 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.852 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.421 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 23.0 t -147.35 119.51 8.29 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.497 ' HA ' HD21 ' A' ' 62' ' ' ASN . 78.3 m-85 -129.92 155.14 46.54 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.218 0.532 . . . . 0.0 111.644 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 88' ' ' ALA . 25.5 tp -142.76 96.71 6.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.71 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -53.13 -48.04 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.637 2.225 . . . . 0.0 113.146 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.8 m-20 -55.39 -23.81 26.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.517 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.79 -35.71 66.58 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.716 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -65.04 -45.49 85.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.731 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.1 -39.81 93.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.033 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.49 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 94.4 mt -59.67 -52.96 54.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.838 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.918 ' SD ' HD21 ' A' ' 122' ' ' LEU . 18.6 mtp -68.17 -34.98 77.31 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.442 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.509 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 60.5 m -56.77 -43.63 81.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.109 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.701 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 86.8 mt-30 -68.04 -35.51 78.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.938 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.708 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 71.6 mtt180 -74.74 -34.08 62.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.856 ' N ' HH21 ' A' ' 99' ' ' ARG . 28.4 m -114.32 -18.56 11.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.528 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 45.0 m-20 -58.55 137.41 57.45 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.563 -0.71 . . . . 0.0 112.349 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 65.62 13.42 8.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.259 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.856 HH21 ' N ' ' A' ' 96' ' ' CYS . 54.7 mtm-85 -114.37 145.81 41.35 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.273 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.1 m -71.82 -32.58 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.646 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.11 155.64 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.504 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.793 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.3 p -155.01 150.23 27.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.294 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 59.4 t -127.86 131.79 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.907 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.404 HG13 ' NH1' ' A' ' 95' ' ' ARG . 60.1 t -144.66 140.5 23.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.704 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.33 119.45 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -72.17 41.98 0.09 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.31 -122.69 0.81 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.25 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER 31.64 -160.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.526 0.679 . . . . 0.0 111.473 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.643 ' N ' ' OG ' ' A' ' 108' ' ' SER . 99.0 m-20 -65.43 -8.19 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.271 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.11 -11.44 59.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.592 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.526 ' O ' ' O ' ' A' ' 112' ' ' PRO . 41.6 m-85 -142.12 126.03 9.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.235 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 111' ' ' PHE . 28.5 Cg_exo -49.42 -160.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.66 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -139.2 92.31 10.77 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.565 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.92 -38.34 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.804 2.336 . . . . 0.0 113.445 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.404 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.6 p -136.27 72.66 58.78 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -57.1 133.82 60.29 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.711 1.607 . . . . 0.0 110.853 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.24 -12.38 33.79 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.404 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 77' ' ' GLN . 97.5 m -117.59 147.18 43.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.473 0.637 . . . . 0.0 109.535 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.6 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 22.8 t80 -86.33 98.64 11.09 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.577 0.703 . . . . 0.0 109.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.6 mttm -71.31 -153.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.516 -1.22 . . . . 0.0 113.892 -177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.574 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.5 p90 -176.6 176.69 1.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 112.698 -2.046 . . . . 0.0 110.648 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.918 HD21 ' SD ' ' A' ' 92' ' ' MET . 14.3 tp -134.08 126.12 29.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.905 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.697 ' OE1' ' NE2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -124.64 128.64 49.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.656 HG21 ' SD ' ' A' ' 92' ' ' MET . 88.9 t -131.85 124.64 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.424 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.697 ' NE2' ' OE1' ' A' ' 123' ' ' GLU . 2.7 mp0 -107.66 129.37 55.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.745 ' CD2' HG23 ' A' ' 56' ' ' ILE . 36.8 p90 -153.01 168.81 24.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 111.724 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.595 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 2.1 m-20 -126.38 162.99 24.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.593 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.8 m -113.45 116.89 30.32 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.583 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.9 m -121.44 157.09 57.22 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.59 146.83 62.35 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.103 1.868 . . . . 0.0 112.44 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 24.9 t80 -75.55 1.04 15.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.602 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -143.11 -166.27 2.27 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.307 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.516 ' O ' ' O ' ' A' ' 134' ' ' GLU . 10.3 m -89.63 140.91 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.039 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 133' ' ' VAL . 96.8 mt-10 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.796 ' H ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -85.13 149.17 52.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -50.01 117.38 3.04 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.267 1.978 . . . . 0.0 111.615 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -80.15 -4.14 51.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.131 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.08 29.2 60.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -159.61 80.51 0.73 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.573 ' O ' ' O ' ' A' ' 34' ' ' LEU . 41.4 ttm 52.56 152.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.576 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 126' ' ' TYR . 7.4 mmm180 -89.18 136.06 33.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -149.88 131.75 15.14 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.381 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -130.84 145.32 51.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.501 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 8.7 tt -137.61 137.51 38.57 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.6 145.44 35.04 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.159 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.7 m -67.97 131.35 45.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.635 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 6.4 tt0 -43.06 139.04 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.72 -1.86 83.99 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.166 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -111.4 158.02 37.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 118.034 0.917 . . . . 0.0 109.962 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.02 140.11 14.02 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 121.885 1.723 . . . . 0.0 111.631 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 20.2 tt -117.59 147.2 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.708 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.5 tt0 -126.52 128.6 47.15 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.101 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.891 HD12 ' SG ' ' A' ' 102' ' ' CYS . 20.4 mt -115.41 141.63 47.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.708 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 89.4 mtt180 -147.82 132.86 18.22 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.183 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.7 m -99.76 138.83 20.46 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.769 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.38 161.07 46.8 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.562 2.175 . . . . 0.0 112.176 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -135.13 38.35 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -107.36 26.65 9.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 110.455 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 53.2 m-20 -80.92 166.81 20.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.063 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 148.6 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.349 0.595 . . . . 0.0 111.629 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.528 HG23 ' CD2' ' A' ' 126' ' ' TYR . 96.1 mt -69.29 134.86 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.937 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -134.83 98.39 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.891 0.853 . . . . 0.0 108.829 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.403 ' HB ' HD21 ' A' ' 97' ' ' ASN . 58.0 t -64.79 127.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.77 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -102.76 -48.38 4.12 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.767 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -151.73 150.96 30.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.51 . . . . 0.0 110.47 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.14 154.76 7.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.074 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.511 HD21 ' HA ' ' A' ' 84' ' ' TYR . 1.7 t30 -149.41 146.32 27.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.127 0.489 . . . . 0.0 111.4 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' ' HD3' ' A' ' 120' ' ' LYS . 63.5 t80 -114.66 122.49 46.63 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.39 -139.78 6.77 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.491 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.706 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -155.42 117.1 4.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.919 179.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 32.9 p -123.6 8.67 8.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.583 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.7 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 50.1 t0 -150.2 158.42 44.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 44.2 p30 -115.41 5.81 14.64 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.688 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -106.39 6.14 30.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.528 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 29.2 mm -114.2 139.36 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.523 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 57.21 61.66 2.47 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 6.4 p-10 -46.31 118.57 1.99 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.041 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -136.16 -162.65 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.303 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -64.08 145.21 98.09 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.366 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -50.69 -38.28 55.62 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.54 2.16 . . . . 0.0 112.353 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -64.95 -35.66 81.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.677 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.565 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 80.7 mt-30 -83.65 -7.62 59.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 74' ' ' ASP . 75.1 mmm -113.61 40.65 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.682 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -101.74 -59.87 1.63 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.062 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 17.8 t30 -78.24 119.52 21.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.507 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.545 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 27.1 m -110.16 27.5 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.894 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.3 mm-40 -141.94 82.84 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.622 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.4 t -146.54 118.98 8.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' HA ' HD21 ' A' ' 62' ' ' ASN . 44.4 m-85 -123.41 156.56 35.23 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.151 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.446 HD23 ' HB3' ' A' ' 63' ' ' TYR . 28.2 tp -142.13 83.98 11.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.27 -46.41 11.59 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 123.361 2.707 . . . . 0.0 114.127 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 98.9 m-20 -54.56 -25.49 26.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.2 -32.27 47.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.282 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' O ' ' OG ' ' A' ' 93' ' ' SER . 7.7 t80 -65.63 -46.38 79.45 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.025 0.44 . . . . 0.0 111.742 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.7 pttp -67.55 -40.39 84.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.244 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.632 HG23 ' NH1' ' A' ' 95' ' ' ARG . 79.9 mt -58.16 -49.17 82.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.236 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 1.045 ' SD ' HD21 ' A' ' 122' ' ' LEU . 4.2 mtp -70.36 -32.44 70.12 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.176 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.596 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.7 m -60.24 -44.89 94.86 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.4 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -64.49 -37.41 87.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 0.0 111.496 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.632 ' NH1' HG23 ' A' ' 91' ' ' ILE . 60.0 mtt85 -77.04 -32.85 57.25 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.556 ' SG ' HD12 ' A' ' 48' ' ' LEU . 22.9 m -112.81 -13.48 13.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.55 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.6 m120 -62.23 130.57 46.01 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.354 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 67.88 14.88 9.51 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.18 145.92 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.772 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.04 -31.8 68.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.51 154.94 40.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.208 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.891 ' SG ' HD12 ' A' ' 48' ' ' LEU . 9.6 p -154.63 136.59 14.61 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.103 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 22.8 t -122.29 129.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.886 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.2 t -144.1 146.16 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 0.0 111.805 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.452 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.3 t -77.81 117.86 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -69.16 38.89 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.709 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.14 -125.23 0.96 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.914 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.7 t 27.99 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.967 0.413 . . . . 0.0 110.619 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.12 -10.43 22.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.856 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.64 60.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.052 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.614 ' O ' ' O ' ' A' ' 112' ' ' PRO . 83.1 m-85 -141.77 129.03 11.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.237 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 111' ' ' PHE . 50.7 Cg_exo -45.55 -158.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 123.061 2.507 . . . . 0.0 112.694 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -139.13 91.46 11.31 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.8 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.54 -50.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.125 2.55 . . . . 0.0 113.288 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.457 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -135.27 81.62 43.37 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.991 0.424 . . . . 0.0 111.473 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.11 143.65 94.96 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 122.598 2.199 . . . . 0.0 111.73 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.91 -5.53 56.49 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 120.634 -0.794 . . . . 0.0 113.168 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.547 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 99.3 m -115.06 147.84 39.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.706 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 11.2 t80 -87.02 97.78 10.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.465 ' HD3' ' CE2' ' A' ' 63' ' ' TYR . 19.7 mttt -73.51 -163.74 0.17 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 122.848 1.309 . . . . 0.0 113.241 -177.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.425 ' HH ' ' HG1' ' A' ' 66' ' ' THR . 6.4 p90 -165.42 165.14 19.45 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.388 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.045 HD21 ' SD ' ' A' ' 92' ' ' MET . 35.8 tp -126.14 122.24 35.13 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.672 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 2.6 tm-20 -113.62 126.91 55.79 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.564 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.87 HG21 ' SD ' ' A' ' 92' ' ' MET . 58.6 t -133.2 120.6 40.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.979 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.672 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 5.3 mt-30 -107.37 128.27 54.31 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.082 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.528 ' CD2' HG23 ' A' ' 56' ' ' ILE . 33.9 p90 -153.56 171.6 18.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.74 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' A' ' 57' ' ' MET . 40.2 m-20 -128.5 164.27 23.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.231 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.57 120.52 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.373 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 20.1 m -116.97 150.83 46.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.385 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -57.14 143.47 93.07 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.875 1.717 . . . . 0.0 112.265 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -79.32 145.45 33.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -104.38 108.84 20.44 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.719 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.1 t -93.7 133.2 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.997 0.427 . . . . 0.0 110.89 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.831 179.261 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.547 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' A' ' 32' ' ' PHE . 0.8 OUTLIER 55.32 67.98 2.77 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.872 0.368 . . . . 0.0 110.152 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HB2' ' CE2' ' A' ' 32' ' ' PHE . 19.7 Cg_exo -59.15 8.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.917 2.411 . . . . 0.0 112.181 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.644 ' O ' HD23 ' A' ' 34' ' ' LEU . 6.8 m-85 -149.71 -67.42 0.21 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.559 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.67 35.58 54.97 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -161.27 127.46 3.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.899 0.38 . . . . 0.0 110.562 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.2 ttm 72.77 144.69 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.404 0.621 . . . . 0.0 111.355 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.47 ' NH1' ' HG2' ' A' ' 36' ' ' ARG . 40.0 mtp85 -91.34 146.97 23.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.557 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -148.07 137.28 22.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -134.81 146.08 48.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.712 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.79 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.9 tt -140.77 143.3 34.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.696 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.79 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -147.4 145.56 29.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.727 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.1 m -70.73 136.19 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.37 0.605 . . . . 0.0 111.122 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 7.6 tt0 -44.92 139.0 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.215 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.33 -11.99 66.82 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.702 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -118.29 153.35 51.59 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 118.395 1.098 . . . . 0.0 110.313 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.19 145.37 43.78 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.275 1.984 . . . . 0.0 113.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -114.88 149.57 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -127.14 128.78 46.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.205 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD12 ' SG ' ' A' ' 102' ' ' CYS . 31.6 mt -115.61 139.39 50.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.401 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -144.9 135.15 24.12 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.246 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 m -100.52 140.17 21.2 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.12 155.95 66.47 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 121.908 1.739 . . . . 0.0 111.505 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.03 -137.09 37.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 121.689 0.605 . . . . 0.0 112.625 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 p -100.92 22.19 12.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.446 -0.877 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -79.02 166.75 21.99 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.681 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -127.75 148.04 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' CD2' ' A' ' 126' ' ' TYR . 85.8 mt -71.25 137.84 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.109 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -135.1 101.64 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.27 125.43 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.348 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 97.5 mt-10 -100.04 -49.57 4.27 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.3 m-20 -150.19 149.4 30.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.618 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.448 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.12 152.49 7.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.712 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.591 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.6 t30 -149.32 149.15 30.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.191 0.519 . . . . 0.0 111.182 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.491 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 26.3 t80 -119.3 122.89 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -137.26 5.5 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 1.8 ttm180 -155.1 116.37 4.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.112 0.482 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 7.2 p -122.74 6.7 9.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' N ' ' A' ' 69' ' ' LYS . 14.1 t70 -149.81 157.74 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.716 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 5.6 p-10 -113.58 5.44 16.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.189 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.489 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 31.1 mtmt -102.61 0.16 32.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.616 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.1 mm -113.09 138.54 42.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 48.2 m 60.87 59.18 2.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.2 0.524 . . . . 0.0 109.651 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -43.72 97.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.981 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -115.39 -174.22 2.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -55.78 141.01 66.98 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.896 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.7 Cg_endo -50.52 -38.77 54.94 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.149 1.9 . . . . 0.0 111.745 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.99 -35.26 80.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.15 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.674 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 79.8 mt-30 -85.41 -4.9 59.3 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.703 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 5.0 mmm -108.1 -5.15 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.201 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 68.6 mt-10 -62.54 -48.4 79.67 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.204 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -79.97 115.88 19.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 66' ' ' THR . 32.8 m -108.65 29.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.158 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' A' ' 82' ' ' GLN . 0.3 OUTLIER -139.52 82.96 1.91 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.836 -179.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.9 t -146.12 123.67 11.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.57 ' HA ' HD21 ' A' ' 62' ' ' ASN . 21.3 m-85 -132.85 157.3 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.173 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.551 HD21 ' HG2' ' A' ' 112' ' ' PRO . 28.7 tp -145.86 83.69 8.61 Favored Pre-proline 0 N--CA 1.462 0.159 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -46.36 -44.32 20.55 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 123.078 2.519 . . . . 0.0 113.674 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.3 m-20 -59.07 -25.21 63.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 91' ' ' ILE . . . -51.29 -33.39 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.012 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.411 ' O ' ' OG ' ' A' ' 93' ' ' SER . 12.2 t80 -64.23 -40.23 95.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.807 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -66.12 -38.25 87.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.052 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 88' ' ' ALA . 90.4 mt -57.93 -53.66 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.867 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.418 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 95.3 mmm -66.62 -34.25 77.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.023 0.439 . . . . 0.0 110.571 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.561 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.4 m -59.54 -48.61 80.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -67.69 -37.23 82.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.434 0.635 . . . . 0.0 111.404 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.596 ' HE ' HG22 ' A' ' 104' ' ' VAL . 53.9 mtp85 -72.8 -34.44 66.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.413 -178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.524 ' SG ' HD12 ' A' ' 48' ' ' LEU . 26.2 m -113.44 -15.26 12.64 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.561 ' CG ' ' O ' ' A' ' 93' ' ' SER . 74.4 m-20 -58.65 132.25 53.28 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.127 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 68.47 13.37 8.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.764 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -111.4 143.05 42.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.324 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.3 m -70.42 -32.94 70.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.541 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -149.79 150.03 31.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.863 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 48' ' ' LEU . 12.3 p -153.41 138.62 17.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.924 0.393 . . . . 0.0 111.052 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.1 t -116.75 131.31 69.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.661 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.596 HG22 ' HE ' ' A' ' 95' ' ' ARG . 39.7 t -139.39 149.51 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.506 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.495 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.3 t -87.13 117.68 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.59 36.02 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.209 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.44 -125.4 0.92 Allowed Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 30.77 -157.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.792 0.329 . . . . 0.0 111.214 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.92 -9.26 3.95 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.523 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.24 -18.78 60.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.674 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 112' ' ' PRO . 53.3 m-85 -141.48 132.75 13.41 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.887 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.551 ' HG2' HD21 ' A' ' 85' ' ' LEU . 33.1 Cg_exo -49.58 -157.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.937 2.425 . . . . 0.0 112.584 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -136.22 87.99 22.12 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.633 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.23 -43.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.288 2.659 . . . . 0.0 113.544 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.483 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -135.72 85.54 30.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.151 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.414 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 39.6 Cg_endo -71.87 136.49 27.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.263 1.975 . . . . 0.0 111.746 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.57 -1.34 36.75 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.271 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 77' ' ' GLN . 35.2 m -122.18 146.71 46.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.22 0.51 . . . . 0.0 109.92 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 17.7 t80 -85.94 98.88 11.05 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 14.6 mttt -73.9 -161.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.76 1.267 . . . . 0.0 113.669 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.0 p90 -169.9 168.62 8.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.281 176.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 62' ' ' ASN . 21.9 tp -130.8 126.69 36.97 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.542 ' HG2' HE21 ' A' ' 125' ' ' GLN . 76.5 tt0 -119.84 128.9 54.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.4 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.448 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.5 t -130.27 121.3 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.111 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.542 HE21 ' HG2' ' A' ' 123' ' ' GLU . 3.6 mt-30 -107.96 125.91 52.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.805 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.6 p90 -151.9 165.69 33.79 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.133 -177.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.3 OUTLIER -120.59 159.03 26.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.997 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.7 m -110.25 118.13 35.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 m -116.17 152.38 47.76 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.377 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.69 147.97 67.97 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.812 1.675 . . . . 0.0 110.668 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.47 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 48.3 t80 -73.85 -5.05 38.63 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.38 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -97.84 131.85 43.97 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.345 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.5 p -88.04 136.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.215 -179.688 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.519 ' O7 ' ' O3 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.502 ' H63' ' N ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 63.1 62.73 1.73 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.641 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -69.83 128.09 15.46 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.194 1.93 . . . . 0.0 111.839 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.23 -10.56 57.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.936 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.44 9.54 83.35 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -164.69 113.99 1.12 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.511 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.2 mtt 57.75 132.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.482 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.515 HH11 ' HG3' ' A' ' 36' ' ' ARG . 57.1 mtt85 -99.87 154.8 18.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.851 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.645 ' NE ' ' OE2' ' A' ' 123' ' ' GLU . 2.2 ttt-85 -150.8 141.01 22.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.377 0.608 . . . . 0.0 112.1 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.603 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 35.5 mt-10 -132.44 145.09 50.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.342 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -138.65 139.07 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.904 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.97 145.38 39.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.234 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.6 m -70.1 137.45 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.484 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 38.1 tt0 -43.09 132.78 4.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.279 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.04 75.52 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.959 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.84 154.29 49.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 118.878 1.339 . . . . 0.0 110.751 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.8 142.79 44.18 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.699 2.266 . . . . 0.0 113.359 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.7 tt -115.97 149.9 18.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.603 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 81.0 tt0 -132.36 126.04 32.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.246 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.609 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.2 mt -113.58 143.68 44.15 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.593 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 64.7 mtt180 -149.67 132.02 15.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.397 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -99.9 140.27 21.41 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.966 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.1 Cg_endo -66.41 163.83 30.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.658 2.238 . . . . 0.0 112.915 -178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.28 -121.55 14.66 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.478 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 p -122.98 26.01 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 0.0 110.066 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.7 169.75 17.77 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.232 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.88 143.96 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.084 0.469 . . . . 0.0 110.696 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.746 HG23 ' CD2' ' A' ' 126' ' ' TYR . 69.3 mt -68.4 138.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.143 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.7 ptm -132.43 103.14 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.82 125.67 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.345 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -100.46 -50.18 3.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.625 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -150.57 148.35 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.402 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.608 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.85 155.74 10.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.498 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.1 t30 -152.54 151.5 30.76 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.187 0.518 . . . . 0.0 112.188 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.509 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 33.6 t80 -121.48 122.86 40.68 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.56 -141.17 7.85 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -176.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.702 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.2 ttm-85 -151.36 114.77 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.222 0.534 . . . . 0.0 110.666 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.533 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 11.8 p -120.48 6.13 10.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.865 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 41.2 t0 -144.75 -170.82 3.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.613 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' O ' ' CE ' ' A' ' 78' ' ' MET . 35.0 p30 -146.24 -2.74 0.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.968 0.413 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.403 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 52.7 mtpt -103.91 9.38 36.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.122 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.33 136.33 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.8 m 54.28 70.9 0.56 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -51.53 118.82 3.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.721 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.78 -163.28 1.44 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.246 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.719 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -61.93 136.79 95.22 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.302 179.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.8 Cg_endo -57.1 -34.31 97.47 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.787 1.658 . . . . 0.0 112.251 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -61.62 -35.98 79.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.417 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.88 ' O ' HG23 ' A' ' 118' ' ' THR . 82.1 mt-30 -82.13 -18.56 42.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.655 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 3.7 mtm -98.8 0.38 44.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.845 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 73.9 mt-10 -64.49 -51.32 63.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.264 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -79.32 110.98 15.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.064 0.459 . . . . 0.0 111.37 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.44 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 11.0 m -103.68 33.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.38 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 22.7 mm100 -138.43 83.97 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.258 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.419 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 41.8 t -147.95 121.86 9.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.498 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.1 m-85 -130.17 156.6 44.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.921 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.552 HD21 ' HD2' ' A' ' 112' ' ' PRO . 21.6 tp -144.19 86.49 8.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.468 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.49 -46.8 14.04 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.904 2.403 . . . . 0.0 113.68 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 99.0 m-20 -54.11 -30.22 47.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.891 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.81 -31.2 37.55 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.574 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -64.12 -41.38 97.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.112 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.562 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 1.3 pttp -67.87 -39.73 83.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.078 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.562 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 52.8 mt -60.23 -49.85 82.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.83 -178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.418 ' HE2' ' HB3' ' A' ' 92' ' ' MET . 95.0 mmm -69.94 -39.04 76.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.656 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 50.3 m -60.43 -44.45 95.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.572 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 77.4 mt-30 -64.79 -37.21 86.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.803 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.491 ' C ' ' NH1' ' A' ' 99' ' ' ARG . 67.6 mtt180 -78.69 -31.36 46.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 48' ' ' LEU . 51.6 m -111.27 -13.41 13.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.7 m-20 -64.45 131.11 46.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 67.26 13.79 9.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.605 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.491 ' NH1' ' C ' ' A' ' 95' ' ' ARG . 61.4 mtt85 -113.38 146.07 40.08 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.295 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -70.22 -31.5 68.95 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.92 157.78 42.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.171 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.609 ' SG ' HD12 ' A' ' 48' ' ' LEU . 29.8 p -155.48 138.5 15.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.477 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 61.5 t -123.75 130.03 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.7 146.97 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 112.078 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.8 t -79.69 119.49 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.84 39.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.82 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 179.6 -142.62 5.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.249 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.3 t 47.12 -151.76 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 111.542 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.69 -9.5 20.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.961 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.487 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -76.24 -14.48 60.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.434 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.652 ' O ' ' O ' ' A' ' 112' ' ' PRO . 95.5 m-85 -143.87 128.51 9.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.821 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 111' ' ' PHE . 53.4 Cg_exo -45.79 -157.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.662 2.241 . . . . 0.0 112.019 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -137.84 92.58 12.71 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.148 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.52 -42.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.3 2.667 . . . . 0.0 113.397 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.473 ' SG ' ' HE3' ' A' ' 120' ' ' LYS . 1.3 p -136.86 74.83 50.31 Favored Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.256 0.551 . . . . 0.0 112.404 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.75 135.13 47.08 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.114 1.876 . . . . 0.0 110.703 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' C ' ' H63' ' A' ' 136' ' ' RAM . . . 102.85 -6.87 52.31 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 77' ' ' GLN . 99.3 m -114.35 147.09 39.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.702 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 8.2 t80 -86.46 96.34 10.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.509 ' HD2' ' CZ ' ' A' ' 63' ' ' TYR . 36.1 mttp -72.07 -156.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.497 1.142 . . . . 0.0 112.846 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.632 ' HB2' HD21 ' A' ' 39' ' ' LEU . 10.1 p90 -175.41 172.68 2.63 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 112.71 -2.041 . . . . 0.0 110.356 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 21.5 tp -130.97 122.69 27.33 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.645 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 45.1 tt0 -119.09 130.5 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.608 HG22 ' HB1' ' A' ' 61' ' ' ALA . 65.4 t -134.5 124.39 44.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 119.639 -0.824 . . . . 0.0 112.325 -178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -109.17 131.38 55.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.301 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.746 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.0 p90 -154.74 173.69 16.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.632 0.73 . . . . 0.0 112.374 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -131.71 162.61 30.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.965 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 83.4 m -111.27 117.61 33.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.679 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.8 m -119.57 156.22 53.68 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.78 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -55.74 149.84 47.94 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.226 1.951 . . . . 0.0 111.785 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -72.87 -10.36 59.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.215 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.6 mmtm -101.7 131.01 48.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.5 p -97.47 138.74 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.016 0.436 . . . . 0.0 111.772 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.644 179.142 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.565 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.4 OUTLIER 56.1 101.82 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.912 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' O ' ' O ' ' A' ' 30' ' ' LEU . 40.0 Cg_exo -53.08 -131.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.408 2.072 . . . . 0.0 111.645 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -77.95 -17.82 56.76 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.1 14.89 81.44 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 35' ' ' MET . 17.0 tp -161.45 117.2 2.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.628 0.251 . . . . 0.0 110.394 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.508 ' O ' ' O ' ' A' ' 34' ' ' LEU . 3.2 mtt 57.07 128.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.95 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 126' ' ' TYR . 42.7 mmm-85 -90.0 138.65 31.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.222 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.632 HH21 ' CD ' ' A' ' 123' ' ' GLU . 70.4 ttt-85 -144.95 132.57 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.464 0.65 . . . . 0.0 111.46 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -133.63 144.32 49.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.409 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.0 tt -143.39 132.94 23.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.794 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.703 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.96 150.98 45.15 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.725 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.36 132.44 47.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.591 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 11.1 tt0 -42.43 141.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.458 -178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 106' ' ' ALA . . . 88.65 -4.6 85.07 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.215 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -117.32 153.19 49.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 118.463 1.131 . . . . 0.0 110.857 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -68.11 137.65 41.34 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.569 2.179 . . . . 0.0 113.225 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 tt -119.89 138.02 51.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.59 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 87.1 tt0 -122.37 131.97 54.15 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.311 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' A' ' 126' ' ' TYR . 8.9 mt -108.75 144.93 35.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.269 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.59 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 30.5 mtt85 -149.24 132.12 16.11 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.706 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.4 m -100.8 147.14 33.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.25 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.59 159.01 28.67 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.37 2.047 . . . . 0.0 111.96 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.43 -137.42 38.36 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 121.321 0.4 . . . . 0.0 112.668 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.2 p -102.64 24.14 10.96 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.674 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.65 166.06 22.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.523 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.9 142.76 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.849 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.875 HG23 ' CD2' ' A' ' 126' ' ' TYR . 88.3 mt -67.67 138.73 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.077 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.41 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.8 ptp -135.59 100.88 4.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.406 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.91 124.61 15.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.399 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.586 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.48 -51.38 3.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.419 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.586 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 28.4 m-20 -148.28 145.75 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.67 ' CB ' HG22 ' A' ' 124' ' ' VAL . . . -166.92 155.04 9.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.761 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.513 ' O ' HD12 ' A' ' 122' ' ' LEU . 10.5 t30 -153.78 154.58 34.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.241 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.591 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 85.4 t80 -120.07 122.64 41.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.4 -141.19 7.62 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.04 -176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.758 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 13.7 ttm180 -156.89 116.23 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.419 HG21 ' CE2' ' A' ' 84' ' ' TYR . 7.6 p -124.53 8.73 8.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.407 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 57.9 t0 -147.35 157.6 43.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.506 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.587 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.7 p-10 -114.18 0.2 14.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.811 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -102.22 6.57 40.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.25 135.29 50.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.95 0.405 . . . . 0.0 110.16 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.0 m 60.63 61.27 1.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.228 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.626 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.6 p30 -41.3 104.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.583 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -124.28 -164.69 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.96 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -64.47 145.09 98.58 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.694 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.8 Cg_endo -55.3 -37.96 94.12 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.239 1.959 . . . . 0.0 112.714 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.51 -32.88 74.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.784 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.682 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 82.2 mt-30 -85.71 -11.39 53.81 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.797 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.758 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 3.1 mmt -100.74 -4.89 27.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.647 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 83.8 mt-10 -61.06 -56.2 23.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -79.42 118.02 20.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.433 0.635 . . . . 0.0 112.65 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.605 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.9 m -109.24 28.9 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.676 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.605 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.7 mm-40 -141.71 87.13 2.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.5 t -145.51 120.22 9.85 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.477 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.6 m-85 -127.93 155.72 43.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 112.007 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.528 HD21 ' HG2' ' A' ' 112' ' ' PRO . 13.1 tp -148.34 91.89 4.67 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.166 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.54 -46.6 28.74 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.151 1.9 . . . . 0.0 112.868 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 74.5 m-20 -50.05 -31.29 12.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -177.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.38 -31.98 36.43 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.597 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -64.48 -47.88 77.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.584 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 2.0 ptpp? -64.02 -41.56 97.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.298 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.502 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 98.0 mt -59.97 -48.9 86.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.865 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 1.038 ' SD ' HD21 ' A' ' 122' ' ' LEU . 63.1 mtp -69.87 -32.47 70.84 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.292 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.431 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 19.8 m -59.93 -45.89 91.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.627 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.61 -38.97 88.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.45 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -73.84 -37.29 64.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.4 m -113.54 -22.34 10.36 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 50.9 m-20 -55.3 140.55 38.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 69.95 12.94 7.93 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.157 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 99' ' ' ARG . 51.0 mtt85 -113.22 145.27 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.329 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.5 m -71.64 -28.83 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.58 155.31 42.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.547 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.81 143.97 26.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.113 0.483 . . . . 0.0 111.066 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.07 125.87 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.623 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -143.06 144.24 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.693 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.608 ' C ' ' H ' ' A' ' 107' ' ' GLY . 8.3 t -79.45 121.6 33.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.385 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 43' ' ' GLY . . . -67.06 26.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.641 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . -178.94 172.13 44.31 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.028 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 4.3 t 97.26 -156.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 110.217 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.62 -10.71 38.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.176 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.35 -21.47 58.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.9 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.8 m-85 -138.27 125.95 13.72 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.744 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 32.3 Cg_exo -46.29 -155.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.764 2.31 . . . . 0.0 112.688 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -138.02 92.07 12.76 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.18 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -73.95 -54.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.531 2.154 . . . . 0.0 112.988 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.73 89.33 17.97 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.986 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.11 141.58 94.28 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.609 2.206 . . . . 0.0 111.64 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.92 4.99 57.63 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.749 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 77' ' ' GLN . 58.1 m -126.48 146.55 50.06 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.658 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 9.4 t80 -87.93 97.66 11.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 4.9 mtmp? -79.61 -158.96 0.18 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.644 1.212 . . . . 0.0 113.679 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.442 ' H ' ' HB3' ' A' ' 120' ' ' LYS . 9.8 p90 -172.44 175.56 3.53 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.85 -1.977 . . . . 0.0 110.543 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.038 HD21 ' SD ' ' A' ' 92' ' ' MET . 19.5 tp -132.17 124.17 28.5 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.477 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.632 ' CD ' HH21 ' A' ' 37' ' ' ARG . 78.6 tt0 -117.77 130.44 56.3 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.736 HG21 ' SD ' ' A' ' 92' ' ' MET . 97.2 t -134.4 123.4 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.013 -1.075 . . . . 0.0 113.113 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.514 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -110.98 128.32 55.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.071 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.875 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.3 p90 -152.29 168.71 24.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 111.842 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 57' ' ' MET . 86.2 m-20 -119.35 160.35 22.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.5 m -112.51 128.07 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.53 155.45 80.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.69 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -55.63 148.06 56.31 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.182 1.921 . . . . 0.0 112.12 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' A' ' 132' ' ' LYS . 28.0 t80 -72.53 -136.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.672 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.604 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 7.2 tptt -92.86 -71.0 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.5 t -90.97 129.22 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.221 -0.396 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.455 -179.35 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.537 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' CD1' ' H ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -74.36 157.61 86.25 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 33' ' ' GLY . 10.1 Cg_endo -54.61 136.16 69.51 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.176 1.917 . . . . 0.0 110.968 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 64.0 t80 -74.66 13.25 0.65 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . 74.33 36.02 51.13 Favored Glycine 0 C--N 1.33 0.246 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tp -157.93 -29.55 0.08 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.05 -0.575 . . . . 0.0 109.793 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.8 ttm 62.83 155.51 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.285 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -93.41 149.0 21.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.155 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 ttp180 -149.56 132.54 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.372 0.606 . . . . 0.0 111.158 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.635 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.0 mp0 -129.17 146.79 51.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.615 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -142.24 139.64 32.02 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.985 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.836 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.94 146.53 37.49 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.265 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.5 m -68.28 129.92 41.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.201 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 77.0 tt0 -45.41 142.53 2.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.99 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.412 ' C ' ' CD1' ' A' ' 44' ' ' TYR . . . 93.11 -12.96 68.8 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.554 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.5 m-85 -115.74 149.97 44.03 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 118.256 1.028 . . . . 0.0 110.084 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.73 143.46 61.84 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.551 2.167 . . . . 0.0 113.439 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.3 tt -115.67 149.78 17.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.664 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 39.4 tt0 -129.2 128.97 44.42 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.494 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.558 HD12 ' SG ' ' A' ' 102' ' ' CYS . 38.4 mt -115.36 143.62 45.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.919 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 74.3 mtt180 -150.01 129.55 13.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.073 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.8 m -97.55 145.4 29.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.9 Cg_endo -69.04 158.91 56.07 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.609 2.206 . . . . 0.0 112.654 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.28 -130.74 25.08 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.328 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -107.33 22.29 16.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.819 -0.69 . . . . 0.0 111.232 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.12 168.96 19.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.693 0.282 . . . . 0.0 110.447 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 131' ' ' TYR . 31.9 m -127.89 147.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.232 0.539 . . . . 0.0 110.271 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.675 HG23 ' CD1' ' A' ' 126' ' ' TYR . 79.5 mt -68.96 136.09 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.553 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.433 ' CE ' HG11 ' A' ' 129' ' ' VAL . 3.4 ptp -130.18 99.54 5.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 176.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.619 HG12 ' CE1' ' A' ' 89' ' ' PHE . 61.2 t -64.07 125.93 21.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.724 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.49 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 78.2 mm-40 -101.07 -51.43 3.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.742 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 25.3 m-20 -149.67 148.64 29.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.224 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.84 152.42 11.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.983 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' HD12 ' A' ' 122' ' ' LEU . 9.8 t30 -150.4 149.34 29.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.222 0.534 . . . . 0.0 111.706 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.496 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 81.9 t80 -118.53 122.52 42.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 0.0 108.839 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 157.26 -140.69 7.29 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.35 -177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.527 HH12 ' HB3' ' A' ' 119' ' ' TYR . 10.2 ttm180 -153.5 115.44 4.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.172 0.51 . . . . 0.0 110.603 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 p -121.59 7.38 10.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.356 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -150.01 157.18 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.886 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 44.2 p30 -113.74 4.29 15.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.706 0.289 . . . . 0.0 110.39 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 91.9 mttt -104.47 7.22 35.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.626 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.6 mm -113.87 138.17 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.883 0.373 . . . . 0.0 110.722 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.3 m 54.18 70.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.0 p30 -47.82 120.3 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 111.739 -178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -137.89 -165.14 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.011 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.605 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 1.9 p-10 -67.97 143.54 96.35 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.23 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -51.43 -36.31 58.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.264 1.976 . . . . 0.0 112.062 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.412 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 6.5 m-85 -65.99 -41.36 91.19 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.704 ' OE1' ' H61' ' A' ' 136' ' ' RAM . 31.7 mt-30 -86.96 -2.32 58.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.343 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 80.1 mtp -110.02 -6.76 15.06 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.777 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.23 -45.43 84.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.124 -0.63 . . . . 0.0 112.129 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 54.9 t30 -76.81 116.25 17.31 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.918 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.553 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 32.2 m -109.27 30.83 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.7 mm-40 -141.38 86.56 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.404 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 54.0 t -145.75 120.01 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.512 ' HA ' HD21 ' A' ' 62' ' ' ASN . 72.1 m-85 -132.43 154.69 49.6 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.124 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.6 HD21 ' HG2' ' A' ' 112' ' ' PRO . 65.1 tp -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.7 -48.6 13.67 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.275 2.65 . . . . 0.0 113.54 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 94.7 m-20 -58.25 -20.95 46.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.726 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.17 -36.05 60.46 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.729 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.619 ' CE1' HG12 ' A' ' 58' ' ' VAL . 51.7 t80 -64.33 -40.39 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.075 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 7.9 pttp -64.3 -40.68 96.43 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.367 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.426 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.7 mt -60.32 -47.9 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.637 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.8 mmm -69.32 -38.83 78.4 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.529 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 3.7 m -60.82 -43.4 98.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.784 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -66.45 -37.68 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 111.607 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HE ' HG23 ' A' ' 91' ' ' ILE . 90.4 mtt-85 -75.52 -33.14 60.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.4 m -113.15 -16.22 12.62 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.545 ' CG ' ' O ' ' A' ' 93' ' ' SER . 8.2 m-20 -59.51 137.23 58.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.98 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 65.64 14.72 9.68 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.934 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -119.46 149.47 41.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.515 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -71.47 -32.91 68.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.353 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.2 156.92 38.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.2 p -154.8 150.52 27.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.238 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.53 128.99 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 46' ' ' ILE . 44.9 t -143.61 143.7 24.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.949 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.07 118.46 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -72.56 43.75 0.11 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.54 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.87 -127.37 1.11 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.493 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.555 ' O ' ' O ' ' A' ' 107' ' ' GLY . 47.2 t 29.43 -153.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.952 0.406 . . . . 0.0 110.982 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.515 ' N ' ' OG ' ' A' ' 108' ' ' SER . 14.0 m-20 -64.79 -9.86 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.3 -13.16 59.99 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.739 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 112' ' ' PRO . 61.0 m-85 -139.34 126.45 12.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.823 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.6 ' HG2' HD21 ' A' ' 85' ' ' LEU . 22.5 Cg_exo -51.14 -155.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.443 2.095 . . . . 0.0 111.581 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -136.58 89.44 18.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.639 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.6 -26.62 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.665 2.243 . . . . 0.0 113.001 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 22.2 p -158.53 97.13 1.78 Allowed Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.402 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.27 138.84 22.9 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.714 2.276 . . . . 0.0 113.058 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.37 57.72 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.765 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.3 m -118.37 145.78 44.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.527 ' HB3' HH12 ' A' ' 65' ' ' ARG . 7.9 t80 -88.15 98.69 11.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.496 ' HD2' ' CZ ' ' A' ' 63' ' ' TYR . 27.1 mttt -72.76 -156.57 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.679 1.228 . . . . 0.0 113.309 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.582 ' HB2' HD21 ' A' ' 39' ' ' LEU . 5.3 p90 -174.86 172.54 2.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.324 -2.216 . . . . 0.0 110.138 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.9 tp -130.56 122.52 27.69 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.472 ' HG2' HE21 ' A' ' 125' ' ' GLN . 74.4 tt0 -117.38 128.76 55.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.638 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.9 t -134.49 122.54 39.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.762 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.472 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.0 mt-30 -111.24 129.81 55.85 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.675 ' CD1' HG23 ' A' ' 56' ' ' ILE . 41.3 p90 -155.43 173.88 16.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.137 0.494 . . . . 0.0 111.953 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 57' ' ' MET . 29.9 m-20 -127.67 163.46 24.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.534 179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.469 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.6 m -114.07 108.99 17.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.453 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.433 HG11 ' CE ' ' A' ' 57' ' ' MET . 1.5 m -113.6 167.52 9.26 Favored Pre-proline 0 N--CA 1.465 0.311 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.1 145.06 93.67 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.217 1.944 . . . . 0.0 112.407 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.429 ' CD1' HG11 ' A' ' 55' ' ' VAL . 25.3 t80 -75.51 4.81 6.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.5 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 133' ' ' VAL . 4.6 tmtt? -90.98 121.06 32.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.955 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.474 ' N ' ' HD3' ' A' ' 132' ' ' LYS . 9.2 p -88.38 140.75 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.964 0.412 . . . . 0.0 111.569 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.948 179.903 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.704 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.548 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -117.14 166.81 12.11 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.666 0.27 . . . . 0.0 110.363 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -55.59 140.03 83.27 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.652 2.235 . . . . 0.0 113.005 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -78.85 0.49 26.97 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.87 43.17 35.65 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.486 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.545 ' O ' ' O ' ' A' ' 35' ' ' MET . 23.6 tp -158.56 -18.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.007 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 34' ' ' LEU . 14.1 mtp 54.62 144.76 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.952 0.406 . . . . 0.0 110.859 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -91.37 146.2 24.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' NH2' ' HG2' ' A' ' 125' ' ' GLN . 42.4 ttm105 -147.36 136.39 22.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.497 0.665 . . . . 0.0 111.472 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.63 ' HG3' HD23 ' A' ' 48' ' ' LEU . 68.4 mm-40 -128.69 142.71 50.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.025 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -139.76 135.32 32.97 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.629 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.97 148.22 35.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.417 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 m -69.89 134.36 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.744 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.55 ' CD ' ' OH ' ' A' ' 63' ' ' TYR . 22.5 tt0 -42.68 137.69 2.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.81 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.45 -4.69 80.22 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.53 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.47 150.53 46.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 118.585 1.193 . . . . 0.0 109.997 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.37 142.04 36.38 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 38' ' ' GLU . 17.5 tt -118.37 147.12 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -127.11 129.84 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.346 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.757 HD12 ' SG ' ' A' ' 96' ' ' CYS . 19.6 mt -115.04 142.47 46.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -148.45 135.34 20.0 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.473 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.521 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.23 140.42 21.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.746 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.3 Cg_endo -70.39 159.41 53.04 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.477 2.118 . . . . 0.0 111.948 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.78 -138.67 33.65 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.002 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -100.56 24.79 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.117 -0.541 . . . . 0.0 111.211 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.04 164.33 24.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.301 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 m -124.97 140.88 46.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.651 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.039 HG23 ' CD2' ' A' ' 126' ' ' TYR . 67.3 mt -67.22 138.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.535 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.8 ptp -133.99 98.52 4.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.694 0.759 . . . . 0.0 109.171 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.75 125.73 20.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.988 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.48 -46.49 4.55 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -150.21 147.66 27.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.952 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.39 151.86 5.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.914 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 122' ' ' LEU . 2.5 t30 -149.3 151.48 34.24 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.744 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.55 ' OH ' ' CD ' ' A' ' 42' ' ' GLU . 80.8 t80 -118.12 122.78 43.95 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.88 -138.71 6.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.388 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.551 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 14.7 ttm-85 -157.86 117.63 3.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 111.329 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.484 ' CG2' ' CZ ' ' A' ' 84' ' ' TYR . 5.0 p -123.27 10.4 9.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.631 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.508 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 14.1 t0 -147.72 -171.74 3.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.226 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 37.3 p30 -146.17 -0.47 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 2.8 mtmp? -103.94 7.13 36.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.479 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 mm -118.31 139.63 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.0 m 59.51 58.56 2.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 50.5 p-10 -44.52 121.48 2.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.19 -170.11 3.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.034 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.3 p30 -61.91 138.23 95.55 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.688 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.8 Cg_endo -49.86 -33.34 32.87 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.51 2.14 . . . . 0.0 113.322 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -63.55 -37.05 85.84 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.933 0.397 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.681 ' OE1' ' H61' ' A' ' 136' ' ' RAM . 26.0 mt-30 -89.47 8.76 29.32 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.387 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.45 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 78.7 mtp -124.91 -1.97 7.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 69.5 mt-10 -61.61 -53.2 59.38 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.293 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.0 t30 -76.97 117.07 18.2 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.428 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.533 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 23.8 m -108.87 27.34 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.566 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 93.5 mm-40 -138.34 85.81 2.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.037 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 48.6 t -147.04 119.02 8.16 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CZ ' ' CG2' ' A' ' 66' ' ' THR . 83.1 m-85 -129.77 155.34 46.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.56 . . . . 0.0 111.625 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.725 HD21 ' HG2' ' A' ' 112' ' ' PRO . 26.1 tp -147.66 90.64 5.13 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.999 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.58 -44.26 31.04 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 113.348 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.0 m-20 -55.19 -27.4 45.65 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.62 -33.43 33.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.919 -0.713 . . . . 0.0 110.368 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.53 -42.81 91.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.095 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.8 pttt -64.36 -41.83 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.653 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.525 HG23 ' HE ' ' A' ' 95' ' ' ARG . 97.6 mt -59.67 -49.53 83.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.048 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.432 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 96.8 mmm -68.11 -35.4 78.08 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.767 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.477 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 66.3 m -59.58 -45.62 91.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.059 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -66.29 -35.12 79.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.584 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.525 ' HE ' HG23 ' A' ' 91' ' ' ILE . 94.2 mtt-85 -79.96 -32.85 39.92 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 48' ' ' LEU . 58.0 m -111.98 -15.87 13.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.477 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -60.62 134.32 56.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 65.03 12.62 8.06 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.649 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.09 145.6 40.62 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.329 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.4 m -70.27 -31.11 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.292 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.1 158.46 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.399 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.725 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.3 p -156.17 143.68 19.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.428 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.5 t -122.24 127.6 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.39 146.28 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.479 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.6 t -85.52 120.83 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.829 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.42 28.83 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.438 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.593 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . -179.96 179.08 48.81 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.469 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.3 t 88.86 -158.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.57 -10.65 19.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.88 58.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.82 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 39.5 m-85 -140.87 131.12 13.32 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.006 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.725 ' HG2' HD21 ' A' ' 85' ' ' LEU . 32.1 Cg_exo -49.72 -162.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.869 2.379 . . . . 0.0 112.964 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -138.16 91.6 12.85 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.452 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.453 ' HD2' ' HZ3' ' A' ' 120' ' ' LYS . 83.7 Cg_endo -86.56 -44.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 123.355 2.703 . . . . 0.0 113.391 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.485 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.8 p -134.99 79.4 51.27 Favored Pre-proline 0 N--CA 1.466 0.352 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.9 140.5 79.88 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.024 1.816 . . . . 0.0 111.963 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.52 -2.15 58.86 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.293 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.582 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 51.8 m -114.76 147.71 39.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.626 0.713 . . . . 0.0 109.085 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.551 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 9.6 t80 -86.97 96.99 10.46 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 18.4 mtmt -76.74 -164.16 0.4 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.079 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.455 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 9.0 p90 -166.24 169.26 14.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.653 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 62' ' ' ASN . 18.2 tp -130.85 125.32 33.32 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.441 ' HG2' HE21 ' A' ' 125' ' ' GLN . 69.7 tt0 -118.74 129.06 55.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.101 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.62 HG22 ' HB1' ' A' ' 61' ' ' ALA . 80.5 t -131.93 122.98 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.619 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.465 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 2.4 mt-30 -110.34 128.98 55.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.039 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.5 p90 -151.23 163.54 38.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.324 0.583 . . . . 0.0 111.656 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 57' ' ' MET . 95.4 m-20 -115.83 158.09 23.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.317 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.446 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 96.5 m -109.69 125.6 52.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.34 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.31 149.7 74.37 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.45 146.18 43.04 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.338 2.025 . . . . 0.0 111.918 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.04 37.05 0.36 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.32 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -99.26 109.45 22.1 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.838 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.413 HG12 ' HG2' ' A' ' 134' ' ' GLU . 39.2 t -97.64 129.99 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' A' ' 133' ' ' VAL . 80.5 mm-40 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.891 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.56 ' O3 ' ' O7 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.681 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' C ' ' O ' ' A' ' 29' ' ' GLY . 8.2 mt 32.01 60.03 1.3 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 110.426 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.0 144.29 99.43 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 C-N-CA 122.774 2.316 . . . . 0.0 113.169 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -80.78 -34.66 34.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.998 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.49 1.2 89.34 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' MET . 27.5 tp -159.05 113.55 2.43 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.784 0.326 . . . . 0.0 111.297 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 34' ' ' LEU . 93.3 mtp 52.49 141.42 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.532 0.682 . . . . 0.0 111.846 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.785 HH12 ' H ' ' A' ' 128' ' ' CYS . 82.6 mtt85 -90.25 150.13 22.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.803 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -141.58 137.29 31.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.204 0.526 . . . . 0.0 110.851 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 44.2 mp0 -134.92 141.99 46.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -140.48 134.16 30.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.744 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.668 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.67 144.72 44.11 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.024 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.9 m -71.99 131.1 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.462 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 34.5 tt0 -42.95 135.96 2.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.628 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.48 -9.8 66.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.126 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -117.7 155.72 50.36 Favored Pre-proline 0 CA--C 1.52 -0.206 0 CA-C-N 118.963 1.382 . . . . 0.0 110.675 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.89 143.54 33.27 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.235 1.957 . . . . 0.0 113.387 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 104' ' ' VAL . 18.3 tt -116.12 145.93 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 86.6 tt0 -130.79 129.83 42.93 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.989 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.632 HD12 ' SG ' ' A' ' 102' ' ' CYS . 23.9 mt -113.79 145.72 41.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.268 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.527 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 98.4 mtt180 -150.25 136.15 18.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.167 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.451 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -104.66 138.25 19.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.119 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 12.0 Cg_endo -63.82 155.51 63.34 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.567 2.178 . . . . 0.0 112.705 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.04 -132.14 32.94 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.613 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.4 p -103.62 26.55 8.38 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -80.75 162.39 24.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.881 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -131.12 146.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.093 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.837 HG23 ' CD1' ' A' ' 126' ' ' TYR . 63.1 mt -67.04 138.11 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 111.518 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.619 ' O ' ' CG ' ' A' ' 57' ' ' MET . 10.4 ptm -130.45 98.07 4.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.567 HG12 ' HE1' ' A' ' 89' ' ' PHE . 61.0 t -65.63 125.77 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.967 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.69 -45.59 5.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -151.8 150.35 30.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.106 0.479 . . . . 0.0 110.664 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.489 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -169.08 152.16 5.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.848 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 1.2 t30 -150.39 151.8 33.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.968 0.413 . . . . 0.0 111.617 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.545 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 47.7 t80 -120.26 126.16 49.9 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.74 -137.7 5.79 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.677 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 15.7 ttm-85 -156.25 118.18 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.723 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.427 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 4.2 p -123.88 11.57 9.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.232 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.578 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.8 t0 -144.94 -170.5 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.752 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 46.5 p30 -146.49 -4.12 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.172 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -103.43 5.98 37.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.431 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 71' ' ' CYS . 32.4 mm -108.98 139.65 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.818 0.342 . . . . 0.0 110.552 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' ASP . 26.7 m 64.66 24.79 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.754 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.57 ' C ' ' O ' ' A' ' 71' ' ' CYS . 14.3 p30 -3.28 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.545 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -113.63 -167.66 1.23 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.704 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -62.17 145.58 93.42 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.251 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -58.99 -38.47 87.77 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.776 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -63.92 -39.62 94.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.897 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.704 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 77.9 mt-30 -84.83 -10.32 57.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.677 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 48.7 mmm -109.96 -2.96 16.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mt-10 -66.46 -44.36 82.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.562 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -78.26 121.27 24.19 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 67' ' ' ASP . 22.9 m -112.75 31.2 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.835 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -140.52 86.31 2.06 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.3 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.8 t -150.34 117.46 5.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 66' ' ' THR . 73.0 m-85 -127.46 157.57 39.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.908 0.385 . . . . 0.0 111.233 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 112' ' ' PRO . 40.6 tp -147.03 87.21 6.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.417 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -44.04 -46.04 11.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.504 2.136 . . . . 0.0 114.081 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.7 m-20 -54.93 -26.84 38.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.94 -33.05 35.67 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.994 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.567 ' HE1' HG12 ' A' ' 58' ' ' VAL . 57.1 t80 -66.24 -44.94 82.31 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 3.0 pttt -65.08 -40.32 94.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.42 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.465 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 83.3 mt -59.87 -49.31 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.825 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.761 ' SD ' HD21 ' A' ' 122' ' ' LEU . 74.4 mtp -72.83 -35.13 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.491 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.473 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 69.4 m -58.48 -42.69 88.12 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -66.28 -35.47 80.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 110.753 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 92.9 mtt-85 -79.14 -31.89 44.2 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 48' ' ' LEU . 57.4 m -112.68 -20.87 11.52 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 69.7 m-20 -60.58 134.45 57.09 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.904 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 66.04 13.8 9.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.693 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -116.68 147.98 41.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.207 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.9 m -72.05 -32.0 66.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.451 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.21 156.28 36.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.743 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.632 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.6 p -155.47 146.74 22.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 58.2 t -126.35 132.57 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.523 ' O ' HG22 ' A' ' 46' ' ' ILE . 42.9 t -143.81 139.45 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.611 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.7 t -76.48 118.76 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.99 28.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.004 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 178.2 -177.29 48.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 1.4 t 91.4 -162.77 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.836 0.35 . . . . 0.0 110.286 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.18 -9.24 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.24 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.44 56.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.302 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.584 ' O ' ' O ' ' A' ' 112' ' ' PRO . 46.0 m-85 -135.64 125.88 16.68 Favored Pre-proline 0 N--CA 1.455 -0.222 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.777 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 111' ' ' PHE . 27.2 Cg_exo -49.18 -158.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.518 2.145 . . . . 0.0 111.565 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -138.41 93.26 11.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -86.98 -12.82 4.83 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 123.185 2.59 . . . . 0.0 112.648 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.428 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -168.6 92.42 0.6 Allowed Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.5 133.67 14.63 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.876 2.384 . . . . 0.0 112.828 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.03 11.52 36.79 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.887 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 77' ' ' GLN . 47.3 m -127.91 145.63 50.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 6.5 t80 -83.55 98.27 9.48 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 6.1 mtmp? -77.25 -167.07 0.82 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.69 1.234 . . . . 0.0 113.683 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.486 ' HB2' HD21 ' A' ' 39' ' ' LEU . 6.5 p90 -168.11 173.85 7.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.232 177.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.761 HD21 ' SD ' ' A' ' 92' ' ' MET . 26.4 tp -128.73 119.34 24.42 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.093 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -114.35 132.27 56.26 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.729 HG21 ' CE ' ' A' ' 92' ' ' MET . 95.1 t -131.24 149.32 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.16 127.83 28.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.837 ' CD1' HG23 ' A' ' 56' ' ' ILE . 20.8 p90 -158.73 174.33 15.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.812 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.37 158.17 36.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.696 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.785 ' H ' HH12 ' A' ' 36' ' ' ARG . 62.3 m -106.35 123.9 48.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.146 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 55' ' ' VAL . 4.9 m -130.54 157.4 77.65 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.502 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -58.18 144.1 95.88 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.361 2.04 . . . . 0.0 113.084 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -76.96 -4.04 41.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.979 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -137.71 127.03 24.7 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.671 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 133' ' ' VAL . 8.5 m -94.7 132.55 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.224 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.477 179.261 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.581 ' O4 ' ' O ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 56.78 58.26 8.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.128 0.489 . . . . 0.0 110.416 -179.631 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.3 130.14 24.62 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.853 2.369 . . . . 0.0 111.734 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -81.46 -4.75 56.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.945 0.402 . . . . 0.0 110.352 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.91 29.7 50.49 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.776 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.572 HD13 ' N ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -160.47 113.72 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.072 0.463 . . . . 0.0 110.472 179.294 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.572 ' N ' HD13 ' A' ' 34' ' ' LEU . 28.1 mtt 58.96 125.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.432 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 62.5 mtp85 -88.76 150.82 22.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.497 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 33.0 ttp-105 -142.75 137.13 29.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.865 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.2 mp0 -137.59 144.14 41.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.528 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.775 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -139.21 139.22 37.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.801 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.775 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.09 142.51 34.13 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.597 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.4 ' HB3' ' CE2' ' A' ' 119' ' ' TYR . 16.6 m -71.08 135.48 47.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.555 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.543 ' OE2' ' O3 ' ' A' ' 136' ' ' RAM . 84.2 tt0 -44.97 137.51 4.12 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.12 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.115 -0.948 . . . . 0.0 114.285 177.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.36 149.63 46.3 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 118.994 1.397 . . . . 0.0 110.319 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.18 146.12 68.88 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.346 2.031 . . . . 0.0 113.597 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 104' ' ' VAL . 15.2 tt -115.39 144.51 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.669 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 51.2 tt0 -121.35 128.0 51.82 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.463 -178.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.824 HD12 ' SG ' ' A' ' 102' ' ' CYS . 43.8 mt -117.79 140.32 49.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.669 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 89.5 mtt-85 -148.92 136.32 20.24 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.47 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.6 m -103.18 138.13 19.46 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.392 179.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 24.1 Cg_endo -66.54 156.01 67.53 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.473 2.115 . . . . 0.0 112.26 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.49 -134.67 38.11 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -103.41 25.1 10.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.503 . . . . 0.0 110.544 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -78.97 163.09 25.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.019 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG11 ' CD1' ' A' ' 131' ' ' TYR . 4.4 m -126.64 144.04 38.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.412 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.005 HG23 ' CD1' ' A' ' 126' ' ' TYR . 88.3 mt -68.31 137.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.114 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.606 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.4 ptm -130.9 99.04 4.78 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.0 t -61.46 123.37 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.585 -177.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.574 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.6 mm-40 -98.66 -50.63 4.18 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 30.6 m-20 -153.74 153.74 32.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.123 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.48 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -168.6 157.51 8.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.099 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.779 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.7 t30 -150.43 153.58 36.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.148 0.499 . . . . 0.0 111.992 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.518 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 32.1 t80 -123.35 121.09 34.93 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.59 -139.26 6.28 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.938 -177.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 6.6 ttm180 -155.5 116.72 3.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.141 0.496 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 p -124.22 10.21 8.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.973 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 37.4 t0 -145.87 -175.2 4.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.451 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 33.1 p30 -141.89 3.01 1.6 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.414 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 3.2 mtmp? -107.61 6.12 27.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.216 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.2 mm -117.81 137.85 50.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.5 m 54.47 74.91 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.767 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -53.62 125.42 18.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.408 0.623 . . . . 0.0 112.026 -178.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -138.88 -177.52 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.213 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.661 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.4 OUTLIER -59.32 147.6 75.39 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.281 0.562 . . . . 0.0 110.066 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.4 Cg_endo -53.83 -38.52 85.63 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.114 1.876 . . . . 0.0 111.457 -178.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -61.44 -33.0 72.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.583 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 72.1 mt-30 -91.15 -6.2 53.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.438 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 73' ' ' ALA . 75.1 mtp -109.12 -9.1 15.06 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 40.9 mt-10 -63.89 -48.23 77.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.087 -178.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -81.21 116.83 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.536 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 20.9 m -106.66 33.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.554 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 90.6 mm-40 -141.76 86.72 2.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 42.2 t -145.4 118.22 8.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.411 ' HA ' HD21 ' A' ' 62' ' ' ASN . 94.3 m-85 -129.08 154.82 46.31 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.579 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.436 HD21 ' HD2' ' A' ' 112' ' ' PRO . 26.8 tp -147.16 89.2 5.62 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.26 -46.98 13.22 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 123.555 2.837 . . . . 0.0 115.094 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 95.5 m-20 -60.86 -14.03 19.4 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 62' ' ' ASN . . . -52.87 -36.34 59.0 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.358 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -64.56 -43.52 93.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.307 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -63.03 -42.18 99.71 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.723 -178.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.604 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 44.2 mt -60.27 -50.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.69 0.281 . . . . 0.0 111.305 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.456 ' SD ' HD21 ' A' ' 122' ' ' LEU . 83.6 mmm -66.98 -35.26 79.56 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.617 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.482 ' HB3' HD21 ' A' ' 97' ' ' ASN . 69.9 m -60.63 -48.59 81.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.74 -38.85 87.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.051 0.453 . . . . 0.0 111.355 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.604 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 83.9 mtt-85 -74.21 -34.23 63.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.588 ' SG ' HD12 ' A' ' 48' ' ' LEU . 56.4 m -112.62 -16.31 12.84 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -60.57 138.56 58.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.929 -0.709 . . . . 0.0 112.495 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 62.03 13.4 5.65 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.979 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -116.23 146.66 42.17 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.453 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.5 m -73.52 -28.0 61.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.825 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.489 HE21 ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -153.03 153.59 33.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.066 179.135 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.824 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.1 p -154.02 141.99 20.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.619 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.63 128.77 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.355 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 46' ' ' ILE . 45.3 t -139.42 141.36 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.082 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.615 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.4 t -80.8 119.76 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -64.89 28.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.982 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 176.58 -175.97 47.72 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 90.01 -159.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.524 . . . . 0.0 110.61 179.407 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -62.49 -9.5 8.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.751 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.409 ' O ' HD13 ' A' ' 91' ' ' ILE . . . -79.61 -18.37 51.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.553 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -140.88 129.92 12.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.434 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.553 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.8 Cg_exo -49.99 -153.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.267 1.978 . . . . 0.0 112.46 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -140.88 91.02 9.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.275 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 73.3 Cg_endo -81.58 -28.61 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.656 2.237 . . . . 0.0 113.031 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.446 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.8 p -146.11 77.22 12.04 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.07 131.97 49.16 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.244 1.962 . . . . 0.0 111.585 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.63 3.64 58.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.771 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.54 ' O ' ' O4 ' ' A' ' 136' ' ' RAM . 93.2 m -116.95 145.95 43.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.19 0.995 . . . . 0.0 109.519 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.707 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 11.5 t80 -88.22 96.85 10.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.518 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 26.2 mttt -76.32 -161.8 0.2 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.488 -177.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 14.2 p90 -170.69 172.42 5.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.69 176.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 62' ' ' ASN . 61.5 tp -129.59 124.44 33.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -116.86 128.9 55.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.417 -0.81 . . . . 0.0 108.941 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.48 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.0 t -132.17 120.57 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 119.463 -0.895 . . . . 0.0 113.096 -178.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -106.97 123.99 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.005 ' CD1' HG23 ' A' ' 56' ' ' ILE . 17.5 p90 -154.08 174.88 14.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.555 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.627 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.4 OUTLIER -127.7 159.98 33.07 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.597 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.432 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 83.7 m -108.93 115.04 29.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.042 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.1 m -115.73 155.49 47.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.47 142.95 98.38 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.911 1.741 . . . . 0.0 112.224 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.578 ' CD1' HG11 ' A' ' 55' ' ' VAL . 24.4 t80 -79.39 -118.46 0.02 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.207 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.457 ' N ' ' CG ' ' A' ' 131' ' ' TYR . 67.6 mttm -147.01 88.42 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.58 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.0 m -150.27 118.87 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.973 0.416 . . . . 0.0 110.818 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.81 179.931 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.543 ' O3 ' ' OE2' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.76 71.11 39.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.013 0.435 . . . . 0.0 109.96 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -47.28 158.51 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.795 2.33 . . . . 0.0 112.237 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.56 7.43 6.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.937 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.46 43.86 7.19 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.85 101.58 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.483 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 2.7 mtm 61.78 134.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.152 0.501 . . . . 0.0 111.276 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 -91.58 147.39 23.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.951 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -146.73 137.1 23.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.333 0.587 . . . . 0.0 111.69 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.3 mp0 -135.25 146.16 48.3 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.785 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -143.03 133.09 24.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.407 179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.662 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.63 148.61 44.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.176 0.513 . . . . 0.0 111.116 -179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.8 m -70.56 133.31 46.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.918 -178.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.575 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 5.8 tt0 -44.96 139.12 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.471 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -9.89 73.9 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.924 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -117.45 150.46 46.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 118.415 1.107 . . . . 0.0 110.555 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 138.56 55.82 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.584 2.19 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.3 tt -113.62 145.22 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -124.42 128.77 49.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.234 -178.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.514 HD12 ' SG ' ' A' ' 96' ' ' CYS . 50.3 mt -113.99 142.4 46.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.707 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -152.23 137.03 17.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.5 -178.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.9 m -101.82 149.74 36.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.916 178.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.4 Cg_endo -72.38 159.36 49.54 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.691 2.261 . . . . 0.0 112.757 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.87 -118.04 6.73 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.264 178.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -125.85 24.12 7.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -75.54 171.2 14.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.98 149.09 29.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.495 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.964 HG23 ' CD1' ' A' ' 126' ' ' TYR . 66.1 mt -73.45 138.87 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.623 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.7 ptm -133.29 100.24 4.78 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.524 HG12 ' HE1' ' A' ' 89' ' ' PHE . 59.7 t -63.12 124.12 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.853 -178.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 84.0 mt-10 -102.62 -45.71 4.96 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.5 m-20 -150.64 148.74 28.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.0 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.621 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.41 152.41 7.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.946 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.463 HD21 ' HA ' ' A' ' 84' ' ' TYR . 5.3 t30 -149.76 150.19 31.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.149 0.5 . . . . 0.0 111.509 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.575 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 57.4 t80 -120.74 122.39 40.3 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.48 -137.35 5.43 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.76 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 11.1 ttm-85 -154.69 119.47 4.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.959 0.409 . . . . 0.0 111.473 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.582 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 10.5 p -123.4 7.53 9.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.807 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 61.9 t0 -148.76 154.87 40.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.901 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 35.4 p-10 -112.18 3.56 17.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 110.521 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -109.2 9.39 26.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.323 -178.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 mm -112.76 137.01 47.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.4 m 54.73 73.03 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.397 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -54.12 120.12 6.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.787 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -136.87 -164.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.577 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -64.32 138.2 97.36 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 7.2 Cg_endo -54.24 -31.99 68.99 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.968 1.779 . . . . 0.0 111.929 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -62.36 -41.89 98.97 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 118' ' ' THR . 29.0 mt-30 -92.45 -2.98 55.9 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.889 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.76 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 51.4 mmm -115.29 -4.1 12.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.111 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.58 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.1 mm-40 -69.49 -38.85 77.84 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.063 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -76.07 124.13 26.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.599 -178.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.73 29.47 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -139.34 85.65 2.07 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.411 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.462 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 53.4 t -147.66 124.5 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.411 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.463 ' HA ' HD21 ' A' ' 62' ' ' ASN . 94.0 m-85 -134.2 155.63 49.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.276 0.56 . . . . 0.0 111.752 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 112' ' ' PRO . 52.0 tp -147.17 95.5 4.39 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.962 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -53.17 -47.6 26.61 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.582 2.188 . . . . 0.0 113.568 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 90.0 m-20 -54.38 -21.6 10.06 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.837 -178.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.4 65.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.431 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' HE1' HG12 ' A' ' 58' ' ' VAL . 59.1 t80 -65.06 -40.95 95.44 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.4 pttp -65.13 -38.2 89.89 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 64.4 mt -61.3 -51.57 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.5 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.867 ' SD ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -68.41 -34.5 76.11 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.864 -178.867 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.5 m -61.02 -47.42 86.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.5 -35.97 80.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.288 179.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.622 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 94.9 mtt-85 -77.35 -35.02 55.0 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -177.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 48' ' ' LEU . 57.5 m -112.67 -15.69 12.94 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -177.14 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 93' ' ' SER . 95.6 m-20 -60.59 139.28 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.03 -178.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 65.45 12.82 8.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.631 178.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -117.32 147.75 42.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.278 0.561 . . . . 0.0 110.915 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 m -72.78 -31.78 65.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.927 179.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -152.75 155.92 38.11 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.168 179.439 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 48' ' ' LEU . 30.2 p -155.01 144.8 21.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.846 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 73.6 t -127.4 125.12 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.161 178.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 t -140.35 142.55 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.867 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 107' ' ' GLY . 2.6 t -70.81 119.94 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.161 179.066 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -66.73 39.2 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.879 -178.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 178.32 -121.82 0.78 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.007 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 29.52 -155.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.439 0.637 . . . . 0.0 111.137 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -64.82 -11.55 38.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.49 60.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.859 -178.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 68.1 m-85 -144.52 129.46 9.33 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.012 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 49.2 Cg_exo -46.65 -159.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.558 2.172 . . . . 0.0 112.943 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -138.81 90.35 12.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.67 -53.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.152 2.568 . . . . 0.0 113.18 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -125.35 76.85 68.62 Favored Pre-proline 0 C--O 1.238 0.476 0 CA-C-O 121.181 0.515 . . . . 0.0 111.598 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.51 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 14.1 Cg_endo -63.07 131.98 34.81 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.705 1.604 . . . . 0.0 111.469 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.05 -11.27 34.26 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.227 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 77' ' ' GLN . 79.6 m -110.05 149.2 30.35 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.4 t80 -85.19 97.8 10.11 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.509 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 16.8 mtmt -72.09 -169.8 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 123.131 1.443 . . . . 0.0 114.572 -177.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.582 ' OH ' ' N ' ' A' ' 66' ' ' THR . 4.6 p90 -164.21 165.91 21.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 112.014 -2.357 . . . . 0.0 110.317 176.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.732 HD21 ' SD ' ' A' ' 92' ' ' MET . 43.1 tp -126.8 123.05 36.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.614 ' OE2' ' NE2' ' A' ' 125' ' ' GLN . 43.2 tt0 -120.4 126.72 51.16 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.561 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.867 HG21 ' SD ' ' A' ' 92' ' ' MET . 37.3 t -133.07 126.78 53.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.474 -178.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.614 ' NE2' ' OE2' ' A' ' 123' ' ' GLU . 3.1 mp0 -114.09 131.49 56.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.964 ' CD1' HG23 ' A' ' 56' ' ' ILE . 27.9 p90 -153.84 169.18 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 112.007 -178.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.483 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 82.7 m-20 -122.72 162.03 22.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.76 179.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.477 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.4 m -109.26 131.96 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.23 161.71 59.51 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.593 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -63.15 143.22 89.61 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 112.828 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -79.77 124.22 28.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.334 179.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -106.95 136.44 46.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 134' ' ' GLU . 23.4 t -89.29 138.57 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 133' ' ' VAL . 76.6 tt0 . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.767 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.603 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp 50.07 90.46 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.709 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -55.84 145.33 73.25 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 121.96 1.773 . . . . 0.0 111.113 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' C ' ' H ' ' A' ' 34' ' ' LEU . 32.3 t80 -148.17 7.79 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.488 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 67.12 -7.88 1.55 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.253 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -157.79 103.9 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 111.032 179.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 34' ' ' LEU . 8.1 mtt 58.06 138.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.141 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.562 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 65.4 mtt85 -88.55 145.0 25.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 39.2 ttp180 -147.03 139.7 24.95 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.336 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.687 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.8 mp0 -133.11 142.37 48.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.236 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.2 tt -141.44 137.42 32.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.706 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -143.99 149.08 36.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.691 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 58.7 m -68.53 131.64 45.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.696 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 48.5 tt0 -45.9 142.65 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.431 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.0 -6.9 82.87 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.761 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.94 140.64 27.2 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.832 0.816 . . . . 0.0 110.016 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.14 141.48 88.57 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.514 2.142 . . . . 0.0 113.606 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 38' ' ' GLU . 13.0 tt -120.01 145.09 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.63 130.37 52.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.149 0.499 . . . . 0.0 112.18 -178.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.914 HD12 ' SG ' ' A' ' 102' ' ' CYS . 16.5 mt -113.21 143.41 44.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -150.05 135.16 17.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.066 -178.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.8 m -101.81 148.71 35.68 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.723 179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 60.4 Cg_endo -73.91 157.95 46.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.134 2.556 . . . . 0.0 112.34 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.92 -128.07 32.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 p -113.85 24.53 12.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.595 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -77.65 168.26 20.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.296 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.428 HG11 ' HD1' ' A' ' 131' ' ' TYR . 23.7 m -126.79 147.74 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.486 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.917 HG23 ' CD1' ' A' ' 126' ' ' TYR . 92.4 mt -72.55 140.02 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.395 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptp -131.87 102.0 5.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 93' ' ' SER . 99.9 t -63.93 123.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.093 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.3 mm-40 -102.17 -50.49 3.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 46.4 m-20 -146.86 144.18 29.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.447 -179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.743 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.22 148.26 6.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.847 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 63' ' ' TYR . 4.8 t30 -150.92 156.81 41.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.366 0.603 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.547 ' CE1' ' CD ' ' A' ' 120' ' ' LYS . 49.4 t80 -120.27 122.13 40.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.09 -143.47 9.26 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.999 -177.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.687 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.6 ttm-85 -150.63 115.79 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.383 0.611 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 84' ' ' TYR . 19.7 p -123.52 3.45 9.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.355 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.684 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 53.7 t0 -145.04 153.24 41.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.224 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 38.6 p30 -112.55 0.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 43.3 mttm -102.48 1.82 35.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.401 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mm -110.44 138.8 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.391 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m 56.34 70.25 0.66 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.997 -179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -54.26 121.04 7.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.87 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.82 -163.05 1.46 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.028 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.02 143.91 97.4 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.27 179.822 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.0 Cg_endo -56.74 -38.69 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.515 2.144 . . . . 0.0 113.498 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -63.77 -29.95 71.1 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.183 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.7 mt-30 -88.33 -12.86 42.23 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.052 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 73.0 mtp -102.97 -5.4 23.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 57.3 mm-40 -65.23 -47.33 77.18 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.453 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 45.3 t30 -78.61 111.74 15.0 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.888 -178.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.614 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.3 m -103.34 31.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.62 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.614 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 96.7 mm-40 -142.89 86.95 1.95 Allowed 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.554 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.4 t -149.45 119.74 7.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' CE2' HG21 ' A' ' 66' ' ' THR . 51.2 m-85 -129.47 147.39 51.28 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.266 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.504 HD21 ' HG2' ' A' ' 112' ' ' PRO . 31.3 tp -138.31 91.97 12.34 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -50.26 -45.87 31.58 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.768 2.312 . . . . 0.0 113.319 -178.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.6 m-20 -53.64 -30.6 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.246 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.93 54.03 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.188 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.509 ' O ' ' OG ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -65.5 -44.32 87.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.241 178.624 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.23 -41.19 97.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.604 -179.311 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.522 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 60.7 mt -60.69 -48.91 86.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.02 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.29 -36.19 81.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.918 0.389 . . . . 0.0 110.499 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 15.8 m -59.88 -45.43 92.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -65.93 -35.87 81.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.518 0.675 . . . . 0.0 110.883 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.492 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 95.1 mtt-85 -76.08 -34.25 59.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.624 ' SG ' HD12 ' A' ' 48' ' ' LEU . 33.0 m -112.42 -13.73 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -177.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' SER . 83.0 m-20 -60.77 134.59 57.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.273 0.559 . . . . 0.0 112.208 -179.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 66.37 12.73 8.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.679 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -115.8 147.72 40.67 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.281 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.9 m -74.02 -30.91 62.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.415 ' HB2' HE21 ' A' ' 101' ' ' GLN . 0.0 OUTLIER -152.03 153.19 33.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.561 179.938 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.914 ' SG ' HD12 ' A' ' 48' ' ' LEU . 20.3 p -154.68 139.63 17.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.4 124.58 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 105' ' ' VAL . 57.9 t -138.74 151.83 24.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.158 0.504 . . . . 0.0 112.123 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 107' ' ' GLY . 3.4 t -84.5 116.57 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.184 178.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -67.22 40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.059 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 105' ' ' VAL . . . 178.3 -131.03 1.67 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.753 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t 32.75 -150.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.036 -0.582 . . . . 0.0 112.227 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.46 -11.74 36.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.698 -178.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.83 -12.33 59.77 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.613 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.571 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.0 m-85 -142.2 124.73 9.19 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.445 178.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -46.23 -159.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.079 2.519 . . . . 0.0 113.547 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -137.05 85.82 21.74 Favored Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.34 -34.33 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.966 2.444 . . . . 0.0 112.775 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.415 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.0 p -145.73 89.99 6.04 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.88 139.04 42.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.812 2.341 . . . . 0.0 112.75 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.04 15.66 47.59 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.49 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.3 m -128.93 144.65 51.24 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.687 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 11.5 t80 -89.03 97.24 11.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.164 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.547 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 16.3 mttt -74.0 -153.77 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.765 1.269 . . . . 0.0 113.034 -177.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.524 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.4 p90 -175.6 171.6 2.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 112.275 -2.239 . . . . 0.0 109.085 176.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 18.1 tp -127.49 120.38 28.18 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.541 ' HG2' HE21 ' A' ' 125' ' ' GLN . 80.8 tt0 -113.11 125.65 54.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.743 HG22 ' HB1' ' A' ' 61' ' ' ALA . 74.1 t -135.75 124.79 39.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.202 -178.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.541 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.9 mp0 -113.68 130.62 56.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.069 179.026 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.917 ' CD1' HG23 ' A' ' 56' ' ' ILE . 37.8 p90 -154.47 173.36 16.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 111.454 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.458 ' HA ' HH11 ' A' ' 36' ' ' ARG . 88.3 m-20 -127.51 161.72 28.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.562 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.5 m -109.49 117.54 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.262 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.07 158.19 61.35 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.921 -179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.87 145.51 90.5 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.164 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.428 ' HD1' HG11 ' A' ' 55' ' ' VAL . 79.6 t80 -75.76 -30.61 59.22 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.341 179.061 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 133' ' ' VAL . 25.9 tttm -95.19 -144.4 0.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.389 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.473 ' H ' ' HG2' ' A' ' 132' ' ' LYS . 1.3 m -147.09 124.24 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.382 . . . . 0.0 111.019 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.861 179.28 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.46 ' H63' ' N ' ' A' ' 118' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.73 64.55 69.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.22 0.533 . . . . 0.0 111.77 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.83 146.27 91.59 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.636 2.224 . . . . 0.0 111.213 178.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -78.95 -14.5 59.18 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.2 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.12 24.93 56.61 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.691 178.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.616 ' O ' ' O ' ' A' ' 35' ' ' MET . 1.4 tt -161.02 77.66 0.58 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.485 0.643 . . . . 0.0 111.089 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.616 ' O ' ' O ' ' A' ' 34' ' ' LEU . 4.3 mtt 52.74 146.59 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.513 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 49' ' ' ARG . 66.0 mtp85 -89.88 145.39 25.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.576 ' NH2' ' OE2' ' A' ' 123' ' ' GLU . 74.6 ttt180 -147.77 131.81 17.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.686 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.613 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 46.4 mt-10 -132.54 145.62 51.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.045 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.1 tt -141.12 141.94 34.14 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.843 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.49 146.23 36.18 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.468 -178.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 92.5 m -67.34 130.0 41.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.973 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.558 ' OE1' ' O4 ' ' A' ' 136' ' ' RAM . 5.9 tt0 -40.39 136.13 1.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.126 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.45 83.7 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.111 -0.949 . . . . 0.0 114.173 177.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -117.8 148.18 42.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 118.994 1.397 . . . . 0.0 111.074 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -63.03 137.68 63.41 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.518 2.145 . . . . 0.0 113.32 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.4 143.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.71 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 44.7 tt0 -131.24 127.18 37.31 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.554 -178.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 102' ' ' CYS . 16.1 mt -108.7 144.58 36.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.164 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.71 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 93.3 mtt-85 -149.15 127.22 11.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.274 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.8 m -95.78 141.57 23.35 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.704 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 15.3 Cg_endo -66.6 158.7 54.47 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.031 1.821 . . . . 0.0 112.245 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.66 -134.28 34.75 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.427 0.459 . . . . 0.0 112.946 178.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.4 p -104.81 22.62 14.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.94 -0.63 . . . . 0.0 110.913 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -75.91 166.62 23.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.743 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.439 HG11 ' HD1' ' A' ' 131' ' ' TYR . 20.2 m -126.98 144.87 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.521 -179.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.837 HG23 ' CD2' ' A' ' 126' ' ' TYR . 86.0 mt -70.23 136.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.143 0.497 . . . . 0.0 112.088 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.7 ptp -130.43 98.9 4.82 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.632 HG12 ' CE1' ' A' ' 89' ' ' PHE . 53.4 t -62.99 123.61 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.79 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.404 ' C ' ' CG ' ' A' ' 60' ' ' ASN . 73.4 mm-40 -99.49 -45.12 5.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' CG ' ' C ' ' A' ' 59' ' ' GLU . 2.8 m-80 -154.12 148.14 25.67 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.304 -179.085 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.26 152.87 11.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.885 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.739 ' O ' HD12 ' A' ' 122' ' ' LEU . 11.2 t30 -149.32 153.65 37.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.428 -179.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.492 ' CE1' ' HD2' ' A' ' 120' ' ' LYS . 61.6 t80 -125.84 125.69 43.27 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.06 -137.96 5.88 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -177.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.599 ' NH2' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -155.02 114.97 3.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.97 0.414 . . . . 0.0 111.055 179.299 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.454 HG21 ' CE2' ' A' ' 84' ' ' TYR . 13.9 p -119.26 9.49 11.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.935 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.626 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 44.7 t0 -143.49 -167.12 2.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.612 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.626 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 53.9 p30 -151.83 -5.89 0.24 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 38.1 mttm -97.36 11.04 38.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.9 mm -115.03 138.56 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.939 0.4 . . . . 0.0 110.312 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m 56.92 70.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.117 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.6 p-10 -51.39 117.33 2.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.584 0.707 . . . . 0.0 111.315 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.94 -163.84 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.676 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 3.4 p30 -60.71 132.71 91.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 119.164 -1.014 . . . . 0.0 108.667 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.6 Cg_endo -57.0 -27.14 72.08 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.452 2.101 . . . . 0.0 113.968 -178.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -63.88 -30.02 71.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.032 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.676 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.0 mt-30 -88.59 -5.72 57.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.516 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.599 ' SD ' ' NH2' ' A' ' 65' ' ' ARG . 6.0 mtm -110.84 -1.48 16.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.264 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 49.9 mt-10 -60.97 -52.32 65.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.963 -178.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.98 107.76 11.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.051 -0.406 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 67' ' ' ASP . 19.6 m -101.4 31.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.33 0.586 . . . . 0.0 110.662 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -139.26 85.9 2.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.538 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.415 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 43.5 t -149.32 115.39 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.454 ' CE2' HG21 ' A' ' 66' ' ' THR . 91.1 m-85 -124.25 156.01 37.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.727 0.299 . . . . 0.0 111.221 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 112' ' ' PRO . 55.1 tp -142.69 82.02 12.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -44.91 -45.42 13.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.245 2.63 . . . . 0.0 114.256 -177.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 86.6 m-20 -57.1 -25.29 58.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.885 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.36 -34.77 49.12 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.576 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.632 ' CE1' HG12 ' A' ' 58' ' ' VAL . 26.7 t80 -64.1 -40.37 96.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.8 pttm -67.17 -39.25 86.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.835 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.669 HG23 ' NH1' ' A' ' 95' ' ' ARG . 69.9 mt -60.19 -52.45 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 1.063 ' SD ' HD21 ' A' ' 122' ' ' LEU . 62.1 mtp -69.68 -32.56 71.25 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.478 ' HB3' HD21 ' A' ' 97' ' ' ASN . 62.5 m -59.97 -43.37 95.14 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.592 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 90.4 mt-30 -66.59 -36.23 82.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.353 0.596 . . . . 0.0 110.014 178.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.669 ' NH1' HG23 ' A' ' 91' ' ' ILE . 52.9 mtt85 -77.45 -34.08 54.54 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.607 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.4 m -110.89 -16.19 13.6 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.478 HD21 ' HB3' ' A' ' 93' ' ' SER . 77.0 m-20 -61.44 133.39 55.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.804 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 66.52 13.31 9.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.592 ' NH2' ' O ' ' A' ' 94' ' ' GLN . 42.9 mtt85 -113.89 147.03 39.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.944 178.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -71.04 -31.32 67.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.623 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 156.59 35.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.102 178.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.3 p -153.6 142.34 21.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.29 126.25 70.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.328 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.71 146.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.855 -178.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.45 120.26 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.268 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.76 43.5 0.09 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.165 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.1 -126.72 1.03 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.611 179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 29.36 -154.87 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.239 0.543 . . . . 0.0 112.209 179.588 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -64.43 -10.56 25.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.642 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.96 -14.05 59.9 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.807 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 112' ' ' PRO . 64.4 m-85 -142.69 126.76 9.68 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.684 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.567 ' HG2' HD21 ' A' ' 85' ' ' LEU . 23.4 Cg_exo -50.1 -156.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.323 2.015 . . . . 0.0 112.436 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 20.9 t0 -139.35 93.21 10.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.411 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.49 -38.55 0.98 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.714 2.276 . . . . 0.0 113.328 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -140.25 79.08 22.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.057 0.456 . . . . 0.0 110.995 -179.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 17.2 Cg_exo -56.18 133.4 57.83 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.187 1.924 . . . . 0.0 111.578 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 102.46 -10.9 56.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.888 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 77' ' ' GLN . 62.9 m -105.95 147.54 28.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.616 0.708 . . . . 0.0 109.104 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.593 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 t80 -84.37 97.61 9.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.492 ' HD2' ' CE1' ' A' ' 63' ' ' TYR . 22.5 mtmm -73.54 -171.65 1.05 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.457 1.599 . . . . 0.0 115.083 -177.056 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.6 p90 -164.47 167.73 19.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 111.58 -2.555 . . . . 0.0 110.579 177.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.063 HD21 ' SD ' ' A' ' 92' ' ' MET . 25.9 tp -129.33 122.56 29.78 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.576 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 83.5 tt0 -115.33 132.93 56.46 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.774 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.687 HG21 ' SD ' ' A' ' 92' ' ' MET . 41.5 t -133.33 144.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.82 -178.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.539 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -133.26 130.44 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.837 ' CD2' HG23 ' A' ' 56' ' ' ILE . 27.9 p90 -156.09 171.62 19.82 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.138 -178.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 57' ' ' MET . 87.8 m-20 -125.5 162.22 25.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.775 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 92.4 m -108.93 125.52 52.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.7 m -130.34 157.58 76.9 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.674 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -59.59 148.93 85.29 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.025 1.816 . . . . 0.0 111.979 178.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' HD1' HG11 ' A' ' 55' ' ' VAL . 46.1 t80 -74.8 1.61 12.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -95.63 135.35 37.42 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.634 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 133' ' ' VAL . 7.6 p -90.18 126.6 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.655 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.497 -179.632 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.421 ' H82' ' CB ' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.558 ' O4 ' ' OE1' ' A' ' 42' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.2 mp 64.99 65.93 0.93 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 111.546 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.86 -95.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.345 2.03 . . . . 0.0 111.877 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 55.5 t80 -80.17 -6.0 57.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.798 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.23 19.02 70.32 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 35' ' ' MET . 10.6 tp -161.33 63.45 0.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER 49.23 173.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.485 -179.614 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.525 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 3.3 mtm-85 -93.09 142.72 26.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.168 179.122 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' HE ' ' HG2' ' A' ' 125' ' ' GLN . 41.0 ttm180 -146.69 135.84 22.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.272 0.558 . . . . 0.0 111.279 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' HG3' HD23 ' A' ' 48' ' ' LEU . 78.5 mm-40 -132.04 143.6 50.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.672 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.2 tt -139.16 141.09 38.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.774 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.91 142.73 34.4 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.266 -179.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.448 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 65.7 m -66.84 134.45 52.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.994 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 106' ' ' ALA . 5.4 tt0 -44.04 134.86 4.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -4.91 79.67 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.326 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 12.1 m-85 -118.1 150.08 46.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 118.189 0.995 . . . . 0.0 110.798 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 24.4 Cg_endo -65.94 141.76 65.95 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.879 2.386 . . . . 0.0 113.722 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 17.0 tt -117.3 145.53 22.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.445 ' HG3' HG22 ' A' ' 103' ' ' VAL . 80.2 tt0 -127.5 129.29 47.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.317 -178.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.764 HD12 ' SG ' ' A' ' 102' ' ' CYS . 40.4 mt -112.44 141.81 45.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.538 178.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -149.43 132.85 16.6 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.577 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 56' ' ' ILE . 5.8 m -102.68 142.98 25.68 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.901 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.17 161.59 44.15 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.6 2.2 . . . . 0.0 112.844 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.03 -128.1 33.34 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.6 p -112.88 25.84 11.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.45 166.82 22.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.032 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG11 ' CD1' ' A' ' 131' ' ' TYR . 8.5 m -127.62 143.99 38.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.936 HG23 ' CD2' ' A' ' 126' ' ' TYR . 92.0 mt -69.48 139.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.234 -178.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 127' ' ' ASP . 4.0 ptp -132.85 103.12 5.93 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.67 125.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.25 -178.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 96.0 mt-10 -102.94 -51.0 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -149.05 145.1 27.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.202 0.525 . . . . 0.0 110.549 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.494 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.85 156.22 10.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.716 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.449 ' O ' HD12 ' A' ' 122' ' ' LEU . 6.4 t30 -152.59 154.95 36.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.177 0.513 . . . . 0.0 111.618 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 120' ' ' LYS . 76.9 t80 -122.39 122.48 39.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.445 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.11 -142.45 8.68 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -177.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -151.6 119.15 6.05 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.17 0.51 . . . . 0.0 111.722 179.11 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.413 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 26.6 p -128.09 5.49 5.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.557 179.134 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.745 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 61.8 t0 -144.39 151.63 39.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.399 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.658 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 40.7 p30 -112.66 3.5 16.65 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.471 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 15.7 mttt -103.1 8.52 38.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.737 -178.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.2 mm -112.31 135.87 50.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 110.914 -179.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m 55.69 72.12 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.611 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 57.8 p30 -49.65 106.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.529 0.68 . . . . 0.0 112.19 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.56 -166.78 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.152 178.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.626 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.18 141.6 97.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.258 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.583 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 5.9 Cg_endo -54.99 -33.82 84.49 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 121.895 1.73 . . . . 0.0 112.509 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -63.51 -40.26 96.57 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.708 ' OE1' ' H61' ' A' ' 136' ' ' RAM . 25.5 mt-30 -90.37 -6.68 54.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.974 0.416 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.445 ' HE3' ' NH2' ' A' ' 65' ' ' ARG . 80.2 mmm -106.66 -5.23 18.76 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.758 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.583 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 1.9 mm-40 -66.98 -46.58 74.18 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 47.7 t30 -78.25 122.99 26.43 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.838 -178.26 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.24 32.59 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.1 85.5 2.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.496 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.402 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 2.2 t -151.27 121.22 7.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 17.9 m-85 -131.75 156.59 45.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.964 0.411 . . . . 0.0 111.939 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' A' ' 88' ' ' ALA . 27.8 tp -147.93 87.66 5.76 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.567 178.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -48.03 -46.6 21.64 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.621 2.214 . . . . 0.0 113.361 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 91.5 m-20 -55.15 -23.92 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.124 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.432 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.59 -33.08 63.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.615 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' O ' ' OG ' ' A' ' 93' ' ' SER . 4.7 t80 -65.18 -40.75 94.67 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.598 179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.47 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 10.1 pttp -64.87 -40.6 95.39 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.39 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.47 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 60.6 mt -59.94 -50.52 79.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.703 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.419 ' HB3' ' HE2' ' A' ' 92' ' ' MET . 96.0 mmm -67.16 -33.99 76.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.502 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 28.1 m -60.02 -45.09 93.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.283 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.71 -36.78 83.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.179 0.514 . . . . 0.0 111.01 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.822 ' CZ ' HG13 ' A' ' 104' ' ' VAL . 16.9 mtp180 -74.09 -35.4 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.584 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.2 m -112.99 -12.88 13.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.151 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.567 ' HB3' ' H82' ' A' ' 135' ' ' NAG . 68.2 m-20 -60.02 133.76 56.4 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.55 -179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 67.31 13.83 9.5 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 178.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -113.85 145.16 41.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.802 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.7 m -69.13 -31.26 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.83 155.4 40.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.267 179.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.764 ' SG ' HD12 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -153.86 130.8 10.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.25 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.445 HG22 ' HG3' ' A' ' 47' ' ' GLU . 97.3 t -114.25 132.4 63.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.875 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.822 HG13 ' CZ ' ' A' ' 95' ' ' ARG . 43.5 t -144.03 149.71 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 107' ' ' GLY . 2.5 t -83.62 117.52 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 42' ' ' GLU . . . -70.08 37.48 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.62 -178.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.94 -127.73 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.554 179.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 107' ' ' GLY . 12.4 t 31.69 -153.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.46 -9.08 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.101 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.0 -14.36 60.23 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.922 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -141.57 126.36 10.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 111' ' ' PHE . 34.8 Cg_exo -49.96 -154.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.602 2.201 . . . . 0.0 112.162 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -137.72 87.39 17.25 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -84.7 -20.89 3.57 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.313 2.675 . . . . 0.0 114.092 -179.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.508 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 3.1 p -153.49 73.47 6.71 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 121.109 0.48 . . . . 0.0 110.858 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' O2 ' ' A' ' 136' ' ' RAM . 19.1 Cg_endo -63.26 135.42 50.33 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.084 1.856 . . . . 0.0 112.048 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.76 -12.0 53.35 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.586 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 m -111.25 149.79 30.52 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.187 0.994 . . . . 0.0 108.835 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.2 t80 -82.2 98.5 8.76 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.257 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.508 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 20.7 mttt -70.89 -160.74 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.652 1.215 . . . . 0.0 112.98 -178.418 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.6 p90 -176.5 171.73 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.052 176.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 111' ' ' PHE . 20.3 tp -130.11 123.83 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 57.6 tt0 -117.89 125.07 49.8 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.494 HG22 ' HB1' ' A' ' 61' ' ' ALA . 29.9 t -131.01 124.73 56.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.938 -178.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.46 ' HG2' ' HE ' ' A' ' 37' ' ' ARG . 1.6 mt-30 -109.48 131.41 55.09 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.936 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.8 p90 -151.46 171.93 16.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.357 -178.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.455 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 48.9 m-20 -127.08 160.9 29.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.898 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.525 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 84.2 m -112.6 120.94 43.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.744 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 30.7 m -121.16 149.18 50.98 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.902 179.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -54.57 143.45 68.09 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.83 1.686 . . . . 0.0 112.163 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.436 ' CD1' HG11 ' A' ' 55' ' ' VAL . 30.3 t80 -81.85 -12.88 58.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.63 179.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -98.21 135.82 39.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 133' ' ' VAL . 13.1 p -152.12 120.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.333 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.505 ' OXT' ' O ' ' A' ' 133' ' ' VAL . 62.5 tt0 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.46 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.567 ' H82' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' RAM . . . . . 0.708 ' H61' ' OE1' ' A' ' 77' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_